2020擭搙 杒棦戝妛堛妛晹丒戝妛昦堾尋媶嬈愌廤(HTML斉)
乮拲丗尨杮偱屼妋擣壓偝偄乯
夝朥妛 (彫愳扨埵)
[妛夛丒尋媶夛摍]
723001. [妛夛 (慡崙)] (堦斒島墘) 僸儊僟僇廤抍偺僸僄儔儖僉乕宍惉偵娭傢傞擼偺暘巕婎斦偺夝柧. 搉晹椛攏丆彑懞孾巎1, 埨釼丂尗, 屼梎恀曚, 抾撪廏柧 (1夝朥): 擔杮摦暔妛夛戞91夞戝夛2020 (2020/9/4), Web奐嵜.
723002. [妛夛 (慡崙)] (堦斒島墘) 僸儊僟僇廤抍偵偍偄偰僸僄儔儖僉乕宍惉偑僆僗偲儊僗偺幮夛娭學偵梌偊傞塭嬁. 嶳壓朑奊, 搉晹椛攏, 埨釼丂尗, 彑懞孾巎1, 屼梎恀曚, 抾撪廏柧 (1夝朥): 擔杮摦暔妛夛戞91夞戝夛2020 (2020/9/4), Web奐嵜.
723003. [妛夛 (慡崙)] (堦斒島墘) Wavy儊僟僇偵偍偗傞愐拰淾嬋偺掕検夝愅偲尨場堚揱巕曄堎偺扵嶕. 彑懞孾巎1, 搰揷捈塸, 惣隊弐擵2, 撪揷寬懢榊3, 崅憡徎巑3, 彫愳尦擵1 (1夝朥, 2宍懺宯, 3惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15), Web奐嵜.
723004. [妛夛 (慡崙)] (堦斒島墘) LAMP朄傪巊梡偟偨夝朥懱偵偍偗傞寢妀嬠偺恦懍専嵏. 嶰塝惓柧1, 怴堜梇懢1, 嬍栘塸柧2, 彑懞孾巎1, 彫愳尦擵1 (1夝朥, 2椪彴夝朥嫵堢): 戞126夞擔杮夝朥妛夛憤夛丒慡崙妛弍廤夛/戞98夞擔杮惗棟妛夛戝夛 崌摨戝夛 (2021/3/27), Web奐嵜.
723005. [妛夛 (慡崙)] (堦斒島墘) Quantification of spinal curvature and identification of its candidate genes in wy medaka (Oryzias latipes). 彑懞孾巎1, 搰揷捈塸, 撪揷寬懢榊2, 惣隊弐擵3, 崅憡徎巑2, 彫愳尦擵1 (1夝朥, 2惍奜, 3宍懺宯): 戞126夞擔杮夝朥妛夛憤夛丒慡崙妛弍廤夛/戞98夞擔杮惗棟妛夛戝夛崌摨戝夛 (2021/3/28-30), Web奐嵜.
723006. [妛夛 (慡崙)] (堦斒島墘) Rosette agent (Sphaerothecum denstruens) infection in laboratory medaka. 惣隊弐擵1, 彑懞孾巎2, 崻杮揟巕3, 摗扟榓巕4, Oota H, Oga A, Okayasu I, Michael L Kent, Oda S, 彫愳尦擵2 (1宍懺宯, 2夝朥, 3僶僀僆僀儊乕僕尋媶僙, 4DNA幚尡僙): 戞126夞擔杮夝朥妛夛憤夛丒慡崙妛弍廤夛/戞98夞擔杮惗棟妛夛戝夛崌摨戝夛 (2021/3/28-30), Web奐嵜.
732001. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 儊僟僇偲扵傞恖椶恑壔. 彑懞孾巎 (夝朥): 柸娧栁婌愭惗屼戅怑婰擮僔儞億僕僂儉乽惗棟恖椶妛亊寍弍岺妛亊儗僕儕僄儞僗乿 (2021/3/12), Web奐嵜.
733001. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 栰惗儊僟僇廤抍傪梡偄偨僸僩怴婏惈捛媮峴摦偵娭楢偡傞堚揱巕偺摨掕. 彑懞孾巎1, 栘懞暥徍丆懢揷攷庽 (1夝朥): 乽弌儐乕儔僔傾偺摑崌揑恖椶巎妛: 暥柧憂弌儊僇僯僘儉偺夝柧乿戞4夞慡懱夛媍 (2021/1/9) , Web奐嵜.
'19擭搙埲慜暘
[妛夛丒尋媶夛摍]
'19-723001. [妛夛 (慡崙)] (堦斒島墘) 朞榓怘墫悈張抲偵傛傞偛堚懱偺擏娽揑丒慻怐妛揑強尒偺専摙. 捰尨憇暯, 崅嫶峃懣, 揷搰岝惙, 媑懞棞嵐, 怴堜梇懢1, 嶰塝惓柧1, 嬍栘塸柧2, 彑懞孾巎1, 彫愳尦擵1 (1夝朥, 2椪彴夝朥嫵堢): 戞125夞擔杮夝朥妛夛憤夛丒慡崙妛弍廤夛 (2020/3/25), 帍忋奐嵜.
'19-723002. [妛夛 (慡崙)] (堦斒島墘) 夝朥幚廗幒偵偍偗傞旝惗暔偵傛傞墭愼偺杊巭曽朄偺専摙偲敪惗偺尨場挷嵏. 嶰塝惓柧1, 怴堜梇懢1, 嬍栘塸柧2, 彑懞孾巎1, 彫愳尦擵1 (1夝朥, 2椪彴夝朥嫵堢): 戞125夞擔杮夝朥妛夛憤夛丒慡崙妛弍廤夛 (2020/3/27), 帍忋奐嵜.
夝朥妛 (嶃忋扨埵)
[妛弍榑暥]
110001. [尨挊] Discrete localization patterns of Arf6, and its activators EFA6A and BRAG2, and its effector PIP5kinase兞 on myofibrils of myotubes and plasma membranes of myoblasts in developing skeletal muscles of mice. Chomphoo S, Sakagami H1, Kondo H, Hipkaeo W: Acta Histochem 2020/4; 122 (3): 151513. (嶃忋梞峴1: 1夝朥)
110002. [尨挊] BRAG2a Mediates mGluR-Dependent AMPA Receptor Internalization at Excitatory Postsynapses through the Interaction with PSD-95 and Endophilin 3. Fukaya M1, Sugawara T1, Hara Y1, Itakura M2, Watanabe M, Sakagami H1: J Neurosci 2020/5; 40 (22): 4277-96. (怺扟徆峅1, 悰尨寬擵1, 尨丂朏怢1, 斅憅丂惤2, 嶃忋梞峴1: 1夝朥, 2惗壔)
110003. [尨挊] Data on the effects of Charcot-Marie-Tooth disease type 2N-associated AARS missense mutation (Arg329-to-His) on the cell biological properties. Imaizumi N, Takeuchi Y, Hirano H, Torii T, Seki Y, Morimoto T, Miyamoto Y, Sakagami H1, Yamauchi J: Data Brief 2019/5; 25: 104029. (嶃忋梞峴1: 1夝朥)
110004. [尨挊] The Vps52 subunit of the GARP and EARP complexes is a novel Arf6-interacting protein that negatively regulates neurite outgrowth of hippocampal neurons. Ibuchi K1, Fukaya M2, Shinohara T2, Hara Y2, Shiroshima T3, Sugawara T2, Sakagami H2: Brain Res 2020/10; 1745: 146905. (堜熀娧懢1, 怺扟徆峅2, 幝尨揙楴2, 尨丂朏怢2, 忛搰抦巕3, 悰尨寬擵2, 嶃忋梞峴2: 1戝妛堾堛椕宯尋媶壢, 2夝朥, 3宍懺宯)
110005. [尨挊] Nicotine Rescues Depressive-like Behaviors via 兛7-type Nicotinic Acetylcholine Receptor Activation in CaMKIV Null Mice. Moriguchi S, Inagaki R, Yi L, Shibata M, Sakagami H1, Fukunaga K: Mol Neurobiol 2020/12; 57 (12): 4929-40. (嶃忋梞峴1: 1夝朥)
'19擭搙埲慜暘
[妛夛丒尋媶夛摍]
'18-723001. [妛夛 (慡崙)] (堦斒島墘) Arf6妶惈壔惂屼場巕cytohesin 2偺嬊嵼夝愅偲醬捝惂屼婡峔偵偍偗傞栶妱. 埳摗桜巕1, 怺扟徆峅2, 壀杮峗巏1, 嶃忋梞峴2 (1杻悓, 2夝朥): 戞124夞擔杮夝朥妛夛慡崙妛弍廤夛 (2019/3/27), 怴妰.
惗棟妛 (愳忋扨埵)
[妛夛丒尋媶夛摍]
723007. [妛夛 (慡崙)] (堦斒島墘) 恄宱嵶朎儅乕僇乕梲惈/僌儕傾嵶朎儅乕僇乕堿惈偺攟梴偘偭帟椶拞悤恄宱嵶朎偼嵶朎暘楐偡傞. 斾棷娫峅旤 (惗棟): 戞126夞擔杮夝朥妛夛憤夛丒慡崙妛弍廤夛/戞98夞擔杮惗棟妛夛戝夛 崌摨戝夛 (2021/3/28), Web奐嵜.
惗棟妛 (崅嫶扨埵)
[妛弍榑暥]
110006. [尨挊] TRPA1 and TRPV1 channels participate in atmospheric-pressure plasma-induced [Ca2+]i response. Kawase M, Chen W, Kawaguchi K, Nyasha MR, Sasaki S, Hatakeyama H1, Kaneko T, Kanzaki M: Sci Rep 2020/6; 10 (1): 9687. (敥嶳桾峃1: 1惗棟)
110007. [尨挊] Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation. Yasuoka Y1, Fukuyama T2, Izumi Y, Nakayama Y, Inoue H, Yanagita K, Oshima T3, Yamazaki T2, Uematsu T2, Kobayashi N2, Shimada Y2, Nagaba Y2, Mukoyama M, Yamashita T, Sato Y4, Sands JM, Kawahara K1, Nonoguchi H2: Physiol Rep 2020/6; 8 (12): e14485. (埨壀桳婭巕1, 暉嶳丂棽2, 戝搱桭旤3, 嶳嶈戝夑2, 怉徏悞擵2, 彫椦寷拤2, 搰揷朏棽2, 挿応丂懽2, 嵅摗梇堦4, 壨尨崕夒1, 栰乆岥攷巎2 (1惗棟, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3惗暔暔棟宯, 4堛椕塹惗妛晹)
110008. [尨挊] MEK/ERK Signaling in 兝-Cells Bifunctionally Regulates 兝-Cell Mass and Glucose-Stimulated Insulin Secretion Response to Maintain Glucose Homeostasis. Matsumoto-Ikushima Y, Awazawa M, Kobayashi N, Osonoi S, Takemiya S, Kobayashi H, Suwanai H, Morimoto Y, Soeda K, Adachi J, Muratani M, Charron J, Mizukami H, Takahashi N1, Ueki K: Diabetes 2021/7; 70 (7): 1519-35. (崅嫶椣巕1: 1惗棟)
110009. [尨挊] Differentiation of endogenous erythropoietin and exogenous ESAs by Western blotting. Yasuoka Y1, Fukuyama T2, Izumi Y, Yamashita T, Nakayama Y, Inoue H, Kengo Yanagita K, Oshima T3, Yamazaki T2, Uematsu T2, Kobayashi N2, Shimada Y2, Nagaba Y2, Mukoyama M, Sato Y4, Sands JM, Kawahara K1, Nonoguchi H2: Heliyon 2020/11; 6 (11): e05389. (埨壀桳婭巕1, 暉嶳丂棽2, 戝搱桭旤3, 嶳嶈戝夑2, 怉徏悞擵2, 彫椦寷拤2, 搰揷朏棽2, 挿応丂懽2, 嵅摗梇堦4, 壨尨崕夒1, 栰乆岥攷巎2 (1惗棟, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3惗暔暔棟宯, 4堛椕塹惗妛晹)
110010. [尨挊] Melanophilin Accelerates Insulin Granule Fusion without Predocking to the Plasma Membrane. Wang H, Mizuno K, Takahashi N1, Kobayashi E, Shirakawa J, Terauchi Y, Kasai H, Okunishi K, Izumi T: Diabetes 2020/12; 69 (12): 2655-66. (崅嫶椣巕1: 1惗棟)
310001. [徢椺曬崘] The work style and living condition survey of diabetologists and the expectations for the Japan Diabetes Society: results of questionnaires about the current state and the future prospect of their carrier in 2017. Naruse K1, Abiko A1, Nakayama H1, Tanaka N1, Ikeda K1, Imachi H1, Usigome E1, Umayahara Y1, Ota S1, Okada Y1, Kodani N1, Takahashi N1,2, Terai A1, Nakamura A1, Fujikawa R1, Miura J1, Morita E1, Yanagimachi M1, Ueki K1 (1Japan Diabetes Society Committee to Promote Female Diabetologists): Diabetol Int 2020/6; 11 (4): 299-308. (崅嫶椣巕1,2: 2惗棟)
522001. [島嵗]亂摿廤: 僀儞僗儕儞暘斿婡峔偲偦偺堎忢亃2. 僀儞僗儕儞奐岥曻弌偺儊僇僯僘儉. 崅嫶椣巕 (惗棟): 寧姧摐擜昦 2020/11; 12 (7): 13-9.
[挊丂彂]
620001. [妛弍彂 (暘扴幏昅)]亂椪彴専嵏僈僀僪2020擭夵掶斉丂偙傟偩偗偼昁梫側専嵏偺偡偡傔偐偨丒僨乕僞偺傛傒偐偨亃2. 戙幱丒撪暘斿専嵏丂A. 摐戙幱丂働僩儞丒働僩儞懱暘夋 (寣塼偍傛傃擜), p.260-2. 崅嫶椣巕1, 栧榚丂岶 (1惗棟), 曇: 戝惣岹柧, Medical Practice曇廤埾堳夛, 暥岝摪, 搶嫗, 2020/6敪峴.
620002. [妛弍彂 (暘扴幏昅)]亂昗弨栻棟妛 戞8斉亃戞III曇丂栻暔偲婍姱昦懺惂屼丂戞18復撪暘斿丒戙幱宯丂鋁憻儂儖儌儞, 戙幱 (摐擜昦帯椕栻, 帀幙堎忢徢帯椕栻, 捝晽帯椕栻, 價僞儈儞椶), p.395-419. 斞栰惓岝, 搉绯桾巌, 撪揷怣栫, 姡丂捈婸, 抾撪榓旻, 恄扟愮柧, 崟悾丂摍, 楅栘廏揟, 愇堜朚柧, 埨堜惓恖, 嬥堜岲崕, 枒丂惓岾, 淎悾尓憿, 屆愳揘巎, 暉杮惤擇, 崅嫶椣巕1, 庣壆嫳帰, 嬎屗宧懢, 懞墇棽擵, 杧丂惓晀, 攏搱惓棽2 (1惗棟, 2栻棟), 娔廋: 斞栰惓岝, 曇: 楅栘廏揟, 嬥堜岲崕, 堛妛彂堾, 搶嫗, 2021/3敪峴.
[妛夛丒尋媶夛摍]
713001. [妛夛 (崙嵺)] (堦斒島墘) Potentiation of presynaptic functions by mechanosensing the spine enlargement in rat hippocampus. Ucar H, Watanabe S, Noguchi J, Yagishita S, Morimoto Y, Takahashi N1, Kasai H: The 12th Federation of European Neuroscience Societies Forum (2020/7/11-15), Web奐嵜. (崅嫶椣巕1: 1惗棟)
722001. [妛夛 (慡崙)] (僔儞億僕僂儉) 鋁兝嵶朎撪晹偵偍偗傞僀儞僗儕儞暘斿梓棻偺嫇摦寁應. 敥嶳桾峃 (惗棟): 戞43夞擔杮暘巕惗暔妛夛擭夛 (2020/12/3), Web奐嵜.
723008. [妛夛 (慡崙)] (堦斒島墘) 僂僃僗僞儞僽儘僢僥傿儞僌偵傛傞寣塼, 擜拞僄儕僗儘億僄僠儞偺専弌. 埨壀桳婭巕1, 暉嶳丂棽, 愹桾堦榊, 戝搱桭旤2, 嵅摗梇堦, 岦嶳惌巙, 嶳壓揘榊, 壨尨崕夒, 栰乆岥攷巎 (1惗棟, 2惗暔暔棟宯): 戞63夞擔杮恡憻妛夛妛弍憤夛 (2020/8/19), 墶昹 (僴僀僽儕僢僪奐嵜).
723009. [妛夛 (慡崙)] (堦斒島墘) 鋁兝嵶朎撪晹偵偍偗傞僀儞僗儕儞暘斿梓棻偺嫇摦傪崅惛搙偵壜帇壔寁應偡傞偨傔偺庤朄偺奐戱. 敥嶳桾峃1, 戝搱桭旤2, 崅嫶椣巕1 (1惗棟, 2惗暔暔棟宯): 戞63夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2020/10/5), Web奐嵜.
723010. [妛夛 (慡崙)] (堦斒島墘) GLUT4嵶朎枌堏峴傪惂屼偡傞僀儞僗儕儞弶婜嶌梡夁掱偺崅惛搙壜帇壔夝愅. 恄嶈丂揥, 敥嶳桾峃1 (1惗棟): 戞63夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2020/10/5), Web奐嵜.
723011. [妛夛 (慡崙)] (堦斒島墘) Single molecule analysis of insulin granule movement within pancreatic 兝-cells. 敥嶳桾峃1, 戝搱桭旤2, 崅嫶椣巕1 (1惗棟, 2惗暔暔棟宯): 戞126夞擔杮夝朥妛夛憤夛丒慡崙妛弍廤夛/戞98夞擔杮惗棟妛夛戝夛 崌摨戝夛 (2021/3/29), Web奐嵜.
723012. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 嵶朎婡擻偺壜帇壔. 崅嫶椣巕 (惗棟): 戞85夞擔杮斿擜婍壢妛夛搶晹憤夛 (2020/9/25), Web奐嵜.
惗壔妛 (嶄扨埵)
[妛弍榑暥]
110011. [尨挊] Thymidylate synthase inhibitor raltitrexed can induce high levels of DNA damage in MYCN-amplified neuroblastoma cells. Yamashita K, Kiyonari S1, Tsubota S, Kishida S, Sakai R1, Kadomatsu K: Cancer Sci 2020/7; 111 (7): 2431-9. (惔惉怣堦1, 嶄丂棽堦1: 1惗壔)
110012. [尨挊] Functional maintenance of calcium store by ShcB adaptor protein in cerebellar Purkinje cells. Kakizawa S, Kishimoto Y, Yamamoto S, Onga K, Yasuda K, Miyamoto Y, Watanabe M, Sakai R1, Mori N: Sci Rep 2020/9; 10 (1): 14475. (嶄丂棽堦1: 1惗壔)
110013. [尨挊] Age-Dependent Shift of AMPA Receptors From Synapses to Intracellular Compartments in Alzheimer's Disease: Immunocytochemical Analysis of the CA1 Hippocampal Region in APP/PS1 Transgenic Mouse Model. Mart抧-Belmonte A, Aguado C, Alfaro-Ru抸 R, Itakura M1, Moreno-Mart抧ez AE, de la Ossa L, Moln噐 E, Fukazawa Y, Luj噉 R: Front Aging Neurosci 2020/10; 12: 577996. (斅憅丂惤1: 1惗壔)
110014. [尨挊] Rats deficient in the GAD65 isoform exhibit epilepsy and premature lethality. Kakizaki T, Ohshiro T, Itakura M1, Konno K, Watanabe M, Mushiake H, Yanagawa Y: FASEB J 2021/2; 35 (2): e21224. (斅憅丂惤1: 1惗壔)
[妛夛丒尋媶夛摍]
713002. [妛夛 (崙嵺)] (堦斒島墘) Functional analysis of FGFR2 binding target protein in scirrhous gastric cancer. Sakai R1, Shirakihara T1: The 14th International Conference on Protein Phosphatase (2020/12/11), Kobe, Japan. (嶄丂棽堦1, 敀栘尨戶嵠1: 1惗壔)
723013. [妛夛 (慡崙)] (堦斒島墘) 僠儈僕儖巁崌惉峺慺慾奞嵻偼MYCN憹暆宆恄宱夎庮嵶朎偺撪場惈DNA懝彎傪懀恑偡傞. 惔惉怣堦1, 嶄丂棽堦1, 栧徏寬帯 (1惗壔): 戞79夞擔杮娻妛夛妛弍憤夛 (2020/10/3), 峀搰 (僴僀僽儕僢僪奐嵜).
'19擭搙埲慜暘
[妛弍榑暥]
'19-110001. [尨挊] Advantages of Acute Brain Slices Prepared at Physiological Temperature in the Characterization of Synaptic Functions. Eguchi K, Velicky P, Hollergschwandtner E, Itakura M1, Fukazawa Y, Danzl JG, Shigemoto R: Front Cell Neurosci 2020/3; 14: 63. (斅憅丂惤1: 1惗壔)
'19-110002. [尨挊] Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration. Sawayama T, Katsuhiko Nakashima K, Tohru Ichimura T, Sakai R1, Takamasa Uekita T: Oncol Rep 2019/10; 42 (4): 1507-16. (嶄丂棽堦1: 1惗壔)
惗壔妛 (漭戙扨埵)
[妛弍榑暥]
110015. [尨挊] Optimizing Nervous System-Specific Gene Targeting with Cre Driver Lines: Prevalence of Germline Recombination and Influencing Factors. Luo L, Ambrozkiewicz MC, Benseler F, Chen C, Dumontier E, Falkner S, Furlanis E, Gomez AM, Hoshina N, Huang W-H, Hutchison MA, Itoh-Maruoka Y, Lavery LA, Li W, Maruo T1, Motohashi J, Ling-Lin Pai E, Pelkey KA, Pereira A, Philips T, Sinclair JL, Stogsdill JA, Traunm焞ler L, Wang J, Wortel J, You W, Abumaria N, Beier KT, Brose N, Burgess HA, Cepko CL, Cloutier J-F, Eroglu C, Goebbels S, Kaeser PS, Kay JN, Lu W, Luo L, Mandai K1, McBain CJ, Nave K-A, Prado MAM, Prado VF, Rothstein J, Rubenstein JLR, Saher G, Sakimura K, Sanes JR, Scheiffele P, Takai Y, Umemori H, Verhage M, Yuzaki M, Zoghbi HY, Kawabe H, Ann Marie Craig AM: Neuron 2020/4; 106 (1): 37-65.e5. (娵旜抦旻1, 漭戙尋擇1: 1惗壔)
110016. [尨挊] Nectin-2兛 is localized at cholinergic neuron dendrites and regulates synapse formation in the medial habenula. Shiotani H, Miyata M, Kameyama T, Mandai K1, Yamasaki M, Watanabe M, Mizutani K, Takai Y: J Comp Neurol 2021/2; 529 (2): 450-77. (漭戙尋擇1: 1惗壔)
110017. [尨挊] Identification of Sox2 and NeuN Double-Positive Cells in the Mouse Hypothalamic Arcuate Nucleus and Their Reduction in Number With Aging. Sugiura A, Shimizu T, Kameyama T, Maruo T1, Kedashiro S, Miyata M, Mizutani K, Takai Y: Front Aging Neurosci 2021/3; 12: 609911. doi: 10.3389/fnagi.2020.609911. eCollection 2020. (娵旜抦旻1: 1惗壔)
暘巕堚揱妛
[妛弍榑暥]
110018. [尨挊] Gorlin syndrome-induced pluripotent stem cells form medulloblastoma with loss of heterozygosity in PTCH1. Ikemoto Y1, Miyashita T2, Nasu M, Hatsuse H3, Kajiwara K, Fujii K, Motojima T, Kokido I, Toyoda M, Umezawa A: Aging (Albany NY) 2020/5; 12 (10): 9935-47. (抮杮丂桪1, 媨壓弐擵2, 弶悾梞旤3: 1戝妛堾堛椕宯尋媶壢, 2暘巕堚揱, 3昦懺丒恌椕宯)
110019. [尨挊] A phase I/IIa double blind single institute trial of low dose sirolimus for Pendred syndrome/DFNB4. Fujioka M1, Akiyama T, Hosoya M, Kikuchi K, Fujiki Y, Saito Y, Yoshihama K, Ozawa H, Tsukada K, Nishio SY, Usami SI, Matsunaga T, Hasegawa T, Sato Y Ogawa K: Medicine (Baltimore) 2020/5; 99 (19): e19763. (摗壀惓恖1: 1暘巕堚揱)
110020. [尨挊] Low-dose rapamycin-induced autophagy in cochlear outer sulcus cells. Saegusa C, Hotoya M, Nishiyama T, Saeki T, Fujimoto C, Okano H, Fujioka M1, Ogawa K: Laryngoscope Investig Otolaryngol 2020/5; 5 (3): 520-8. (摗壀惓恖1: 1暘巕堚揱)
110021. [尨挊] Differences in hearing levels between siblings with hearing loss caused by GJB2 mutations. Fujioka M1, Hosoya M, Nara K, Morimoto N, Sakamoto H, Ohtsu M, Nakano A, Arimoto Y, Masauda S, Sugiuchi T, Masuda S, Morita N, Ogawa K, Kaga K, Matsunaga T: Auris Nasus Larynx 2020/12; 47 (6): 938-42. (摗壀惓恖1: 1暘巕堚揱)
110022. [尨挊] The common marmoset as suitable nonhuman alternative for the analysis of primate cochlear development. Hosoya M, Fujioka M1, Murayama AY, Okano H, Ogawa K: FEBS J 2021/1; 288 (1): 325-53. (摗壀惓恖1: 1暘巕堚揱)
110023. [尨挊] Deficiency of large tumor suppressor kinase 1 causes congenital hearing loss associated with cochlear abnormalities in mice. Nishiyama T, Fujioka M1, Saegusa C, Oishi N, Harada T, Hosoya M, Saya H, Ogawa K: Biochem Biophys Res Commun 2021/1; 534: 921-6. (摗壀惓恖1: 1暘巕堚揱)
110024. [尨挊] Specific temperament in patients with nevoid basal cell carcinoma syndrome. Uchikawa H, Fujii K, Shiohama T, Nakazato M, Shimizu E, Miyashita T1, Shimojo N: Pediatr Int 2021/2: 63 (2): 177-82. (媨壓弐擵1: 1暘巕堚揱)
110025. [尨挊] Hydroxyapatite Prostheses in Endoscopic Transcanal Stapes Surgery for Otosclerosis Cases. Hosoya M, Fujioka M1, Ogawa K: Ear Nose Throat J 2021/2; 145561321989143. (摗壀惓恖1: 1暘巕堚揱)
110026. [尨挊] Multicenter phase III trial of regenerative treatment for chronic tympanic membrane perforation. Kanemaru SI, Kanai R, Omori K, Yamamoto N, Okano T, Kishimoto I, Ogawa K, Kanzaki S, Fujioka M1, Oishi N, Naito Y, Kakehata S, Nakamura H, Yamada S, Omae K, Kawamoto A, Fukushima M: Auris Nasus Larynx 2021/12; 48 (6): 1054-60. doi: 10.1016/j.anl.2021.02.007. Epub 2021 Mar 26. (摗壀惓恖1: 1暘巕堚揱)
120001. [尨挊] 奜帹摴娻徢椺22帹偺専摙. 楅栘惉彯, 戝愇捈庽, 彫郪岹擵, 恄嶈丂徎, 摗壀惓恖1, 惣嶳悞宱, 栰岥丂彑, 嵶扟丂惤, 娭悈恀棟巕, 嵵摗丂恀, 彫愳丂堣 (1暘巕堚揱): 擔杮帹旲堲岮壢妛夛夛曬 2021/3; 124 (3): 197-204.
522002. [島嵗]亂摿廤: 擄挳偺帯椕亅嵞惗堛椕偐傜恖岺挳妎婍傑偱亃堚揱惈擄挳偵懳偡傞iPS嵶朎憂栻亅儁儞僪儗僢僪徢岓孮偵懳偡傞掅梡検僔儘儕儉僗椕朄亅. 摗壀惓恖 (暘巕堚揱): 堛妛偺偁備傒 2021/2; 276 (7): 695-701.
522003. [島嵗]亂楢嵹: 嵞惗堛椕偼偳偙傑偱恑傫偩偐亃vol.12 撪帹惈擄挳偵懳偡傞iPS嵶朎憂栻. 摗壀惓恖 (暘巕堚揱): 堛妛偺偁備傒 2020/9; 274 (11): 1119-27.
[挊丂彂]
622001. [妛弍彂 (東栿)]亂僷僞乕僜儞椪彴傾儗儖僊乕妛 (Patterson's Allergic Diseases, 8th Edition)亃Section VII 忋婥摴幘姵丂27 旲億儕乕僾, 旲暃旲峯墛, 偍傛傃旕傾儗儖僊乕惈旲墛, p.687-702. 摗壀惓恖 (暘巕堚揱), 栿: 宑滀傾儗儖僊乕僙儞僞乕, 娔廋: 暉塱嫽堧, 娔栿: 惓栘崕媂, 怷揷媣旤巕, 庬悾孾巑, 恄嶈丂徎, 怺愳榓屓, 惓壀寶梞, 儊僨傿僇儖丒僒僀僄儞僗丒僀儞僞乕僫僔儑僫儖, 搶嫗, 2020/9敪峴.
[妛夛丒尋媶夛摍]
713003. [妛夛 (崙嵺)] (堦斒島墘) Tympanoplasty type 1 (TP1) with inlay technique by Transcanal Endoscopic Ear Surgery (TEES). Kitamura M, Hosoya M, Kanzaki S, Ogawa K, Fujioka M1: AAO-HNSF 2020 Virtual Annual Meeting & OTO Experience (2020/9/13-10/25) , Web奐嵜. (摗壀惓恖1: 1暘巕堚揱)
722002. [妛夛 (慡崙)] (僔儞億僕僂儉) 姴嵶朎堛妛傪墳梡偟偨嵟愭抂偺堛椕-姶壒擄挳傊偺挧愴-. 摗壀惓恖 (暘巕堚揱): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27-5/18), Web奐嵜.
722003. [妛夛 (慡崙)] (僔儞億僕僂儉) 僨僕僞儖僿儖僗偲iPS嵶朎媄弍偵傛傞挳椡丒暯峵妎偺僄儞僪僞僀僾夝愅偲屄暿壔堛椕. 摗壀惓恖 (暘巕堚揱): 戞20夞擔杮峈壛楊堛妛夛憤夛 (2020/9/26), Web奐嵜.
723014. [妛夛 (慡崙)] (堦斒島墘) 堦懁惈拞帹愭揤婏宍偺挳椡夵慞庤弍慜屻偵偍偗傞慡擼僐僱僋僩乕儉偺曄壔. 摗壀惓恖1, 戝愇捈庽, 嵶扟丂惤, 杒懞丂廩, 挿扟晹壞婓, 搒抸怢壚, 恄嶈丂徎, 彫愳丂堣 (1暘巕堚揱): 戞65夞擔杮挳妎堛妛夛憤夛丒妛弍島墘夛 (2020/10/7-9), 柤屆壆 (僴僀僽儕僢僪奐嵜).
723015. [妛夛 (慡崙)] (堦斒島墘) 崅楊幰偺挳妎偲曢傜偟曽偲寬峃偵娭偡傞妛弍挷嵏 (戞3曬): 85亅89嵨偺挳椡暘晍. 湯揷偐偍傝, 摗壀惓恖1, 栰岥丂彑, 杧丂柧旤, 栻巘娵椷巕, 惣嶳悞宱, 愇愳丂揙, 楅栘惉彯, 嵶扟丂惤, 杒懞丂廩, 挿扟晹壞婓, 壀杮峃廏, 戝愇捈庽, 恄嶈丂徎, 彫愳丂堣 (1暘巕堚揱): 戞65夞擔杮挳妎堛妛夛憤夛丒妛弍島墘夛 (2020/10/7-9), 柤屆壆 (僴僀僽儕僢僪奐嵜).
723016. [妛夛 (慡崙)] (堦斒島墘) Alport徢岓孮9壠宯偵偍偗傞僒僽僞僀僾暿挳妎偍傛傃挳椡宱夁偺専摙. 徏鴵嵅塰巕, 徏塱払梇, 柋戜塸庽, 撧椙惔岝, 堜忋嵐憦, 嵶扟丂惤, 摗壀惓恖1, 彫愳丂堣 (1暘巕堚揱): 戞65夞擔杮挳妎堛妛夛憤夛丒妛弍島墘夛 (2020/10/7-9), 柤屆壆 (僴僀僽儕僢僪奐嵜).
723017. [妛夛 (慡崙)] (堦斒島墘) 恄宱慄堐庮徢2宆偵懳偡傞VEGFR儚僋僠儞偺椪彴帋尡 (A clinical study of VEGF receptor peptide vaccine in Neurofibromatosis type 2). 屗揷惓攷, 揷懞椇懢, 摗壀惓恖1, 怷杮桟婭撧, 旜尨寬懢榊, 彫悪寬嶰, 戝愇桾旤巕, 嵅摗悙恗, 摗尨峀榓, 堷抧揘榊, 栰楬偟偺傇, 戝愇捈庽, 彫愳丂堣, 壨忋丂桾, 戝暯婱擵, 媑揷堦惉 (1暘巕堚揱): 戞79夞擔杮擼恄宱奜壢妛夛憤夛 (2020/10/15-17), 壀嶳.
723018. [妛夛 (慡崙)] (堦斒島墘) 栐梾揑堚揱巕敪尰夝愅偵傛傞怴婯帺屓柶塽惈擄挳儌僨儖儅僂僗偺暘巕惗暔妛揑専摙. 嶰巬抭崄, 摗壀惓恖1, 嵶扟丂惤, 恄嶈丂徎, 彫愳丂堣 (1暘巕堚揱): 戞30夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2020/11/12) , 暉壀.
723019. [妛夛 (慡崙)] (堦斒島墘) 撪帹姶妎忋旂傊偺柶塽姲梕攋抅偵傛傞T嵶朎埶懚惈帺屓柶塽惈擄挳僩儔儞僗僕僃僯僢僋儅僂僗偺庽棫偲婡擻夝愅. 摗壀惓恖1, 悈懌朚梇, 嶰巬抭崄, 恄嶈丂徎, 彫愳丂堣 (1暘巕堚揱): 戞30夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2020/11/12) , 暉壀.
723020. [妛夛 (慡崙)] (堦斒島墘)摉壢偵偍偗傞撪帇嬀壓帹彫崪婏宍庤弍徢椺17椺偺専摙. 惎栰桳幯, 嵶扟丂惤, 摗壀惓恖1, 恄嶈丂徎, 戝愇捈庽, 挿扟晹壞婓, 杒懞丂廩, 搒抸怢壚, 彫愳丂堣 (1暘巕堚揱): 戞30夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2020/11/13), 暉壀.
723021. [妛夛 (慡崙)] (堦斒島墘) 宱奜帹摴揑撪帇嬀壓帹壢庤弍偵傛傝恌抐丆帯椕傪峴偭偨拞帹庮釒偺堦椺. 恵揷屽巎, 杒懞丂廩, 挿扟晹壞婓, 搒抸怢壚, 嵶扟丂惤, 戝愇捈庽, 恄嶈丂徎, 愳堜揷傒傎, 婽嶳崄怐, 摗壀惓恖1, 彫愳丂堣 (1暘巕堚揱): 戞30夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2020/11/13), 暉壀.
723022. [妛夛 (慡崙)] (堦斒島墘) Pendred徢岓孮16椺偵偍偗傞挳椡偲慜掚婡擻偺曄摦. 湯揷偐偍傝, 嶳栰绯媊惏, 摗壀惓恖1, 栻巘娵椷巕, 杧丂柧旤, 彫愳丂堣 (1暘巕堚揱): 戞79夞擔杮傔傑偄暯峵堛妛夛憤夛丒妛弍島墘夛 (2020/11/25-27), 墶昹.
723023. [妛夛 (慡崙)] (堦斒島墘) 曣斄惈婎掙嵶朎娻徢岓孮偺庮釃昦曄偵懳偟僀儈僉儌僪奜梡帯椕傪峴偭偨堦椺. 幠揷抦擵, 娾壓愰旻, 搉曈丂摰, 崅娫姲擵, 戝搱梇堦榊, 搉曈戝曘, 媨壓弐擵1 (1暘巕堚揱): 戞36夞擔杮旂晢埆惈庮釃妛夛妛弍戝夛 (2021/1/8-9), 墶昹.
733002. [妛夛 (尋媶夛丒抧曽夛)] (堦斒島墘) 幘姵摦暔儌僨儖晄嵼偺iPS嵶朎憂栻尋媶. 摗壀惓恖 (暘巕堚揱): 戞15夞Science-ome (2020/7/22) , Web奐嵜.
733003. [妛夛 (尋媶夛丒抧曽夛)] (堦斒島墘) 暦偙偊偺掅壓傪杊偖偵偼? 帯偡偵偼? 摗壀惓恖 (暘巕堚揱): 2020擭搙戞1夞搒堛妛尋搒柉島嵗 (2020/9/18), Web奐嵜.
733004. [妛夛 (尋媶夛丒抧曽夛)] (堦斒島墘) common marmoset偺擄挳儌僨儖偵偍偗傞MRS夝愅. 暯椦尮婓, 孖尨丂徛, 媑娵戝曘, 敤丂弮堦, 摗壀惓恖1, 彫搰攷屓, 壀栰James梞彯 (1暘巕堚揱): 戞10夞擔杮儅乕儌僙僢僩尋媶夛戝夛 (2021/1/26-27), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-120001. [尨挊] 挳妎夁晀傪庡慽偲偟偨暋悢偺姶妎夁晀傪桳偡傞徢椺偺専摙: "Sensory Modulation Disorder"偲偄偆幘姵奣擮偲帹旲堲岮壢堛偑棷堄偡傋偒揰偵偮偄偰. 恄嶈丂徎, 孎嶈攷堦, 曅壀偪側偮, 揷暃恀旤, 楅栘朄恇, 徏嶈嵅塰巕, 敂扟寬恖, 摗壀惓恖1, 戝愇捈庽, 彫愳丂堣 (1暘巕堚揱): 擔杮帹旲堲岮壢妛夛夛曬 2020/3; 123 (3): 236-42.
'19-522001. [島嵗]亂摿廤: 擄挳傪側偍偡-2020擭斉亃姶壒擄挳偲iPS憂栻. 摗壀惓恖1, 嵶扟丂惤 (1暘巕堚揱): JOHNS 2020/1; 36 (1): 101-4.
[妛夛丒尋媶夛摍]
'19-713001. [妛夛 (崙嵺)] (堦斒島墘) Cochlear development of a Non-Human primate model animal, Common Marmoset. Hosoya M, Fujioka M1, Ogawa K: ARO 2020 43rd Annual MidWinter Meeting, (2020/1/25-29), San Jose, USA. (摗壀惓恖1: 1暘巕堚揱)
'19-713002. [妛夛 (崙嵺)] (堦斒島墘) Selective and super-selective induction of cochlear hair cells from human iPS cells. Saeki T, Hosoya M, Fujioka M1, Ogawa K, Okano H: ARO 2020 43rd Annual MidWinter Meeting, (2020/1/25-29), San Jose, USA. (摗壀惓恖1: 1暘巕堚揱)
'19-713003. [妛夛 (崙嵺)] (堦斒島墘) Investigating the effects of exonic and intronic variants of NF2 on pre-mRNA splicing. Noguchi M, Fujioka M1, Oishi N, Mutai H, Nara K, Matsunaga T, Ogawa K, Wasano K: ARO 2020 43rd Annual MidWinter Meeting, (2020/1/25-29), San Jose, USA. (摗壀惓恖1: 1暘巕堚揱)
'19-713004. [妛夛 (崙嵺)] (堦斒島墘) LATS1 deficiency cause congenital hearing loss associated with mouse cochlea abnormally. Nishiyama T, Fujioka M1, Hosoya M, Oishi N, Harada T, Ogawa K: ARO 2020 43rd Annual MidWinter Meeting, (2020/1/25-29), San Jose, USA. (摗壀惓恖1: 1暘巕堚揱)
栻棟妛
[妛弍榑暥]
110027. [尨挊] EP3 signaling in dendritic cells promotes liver repair by inducing IL-13-mediated macrophage differentiation in mice. Nakamoto S1, Ito Y2, Nishizawa N3, Goto T1, Kojo K4, Kumamoto Y3, Watanabe M5, Narumiya S, Majima M2: FASEB J 2020/4; 34 (4): 5610-27. (拞杮廋巌1, 埳摗媊栫2, 惣郪怢嫳3, 屻摗戩栫1, 屆忛丂寷4, 孏尦梇夘3, 搉绮徆旻5, 攏搱惓棽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3堦斒丒彫帣丒娞抇鋁奜, 4壓晹徚壔娗奜, 5杒棦戝妛杒棦尋媶強昦堾)
110028. [尨挊] RAMP1 signaling in immune cells regulates inflammation-associated lymphangiogenesis. Tsuru S1, Ito Y2, Matsuda H1, Hosono K2, Inoue T3, Nakamoto S4, Kurashige C1, Mishima T5, Tsujikawa K, Okamoto H1, Majima M2: Lab Invest 2020/5; 100 (5): 738-50. (捗棷悽棦1, 埳摗媊栫2, 徏揷峅旤1, 嵶栰壛撧巕2, 堜忋抭恗3, 拞杮廋巌4, 錟廳愮奊1, 旤搰棙徍5, 壀杮峗巏1, 攏搱惓棽2: 1杻悓, 2栻棟, 3徚壔婍撪, 4戝妛堾堛椕宯尋媶壢, 5怱憻寣娗奜)
110029. [尨挊] Lymphangiogenesis induced by vascular endothelial growth factor receptor 1 signaling contributes to the progression of endometriosis in mice. Hattori K1, Ito Y2, Honda M1, Sekiguchi K3, Hosono K2, Shibuya M, Unno N3, Majima M2: J Pharmacol Sci 2020/8; 143 (4): 255-63. (暈晹嬁巕1, 埳摗媊栫2, 杮揷夒巕1, 娭岥榓婇3, 嵶栰壛撧巕2, 奀栰怣栫3, 攏搱惓棽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3嶻壢)
110030. [尨挊] Prostaglandin E receptor EP4 stimulates lymphangiogenesis to promote mucosal healing during DSS-induced colitis. Hosono K1, Kojo K2, Narumiya S, Majima M1, Ito Y1: Biomed Pharmacother 2020/8; 128: 110264. (嵶栰壛撧巕1, 屆忛丂寷2, 攏搱惓棽1, 埳摗媊栫1: 1栻棟, 2壓晹徚壔娗奜)
110031. [尨挊] Lymphangiogenesis and accumulation of reparative macrophages contribute to liver repair after hepatic ischemia-reperfusion injury. Nakamoto S1, Ito Y2, Nishizawa N3, Goto T1, Kojo K4, Kumamoto Y3, Watanabe M5, Majima M2: Angiogenesis 2020/8; 23 (3): 395-410. (拞杮廋巌1, 埳摗媊栫2, 惣郪怢嫳3, 屻摗戩栫1, 屆忛丂寷4, 孏尦梇夘3, 搉绮徆旻5, 攏搱惓棽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3堦斒丒彫帣丒娞抇鋁奜, 4壓晹徚壔娗奜, 5杒棦戝妛杒棦尋媶強昦堾)
110032. [尨挊] Inhibition of receptor activity-modifying protein 1 suppresses the development of endometriosis and the formation of blood and lymphatic vessels. Honda M1, Ito Y2, Hattori K1, Hosono K2, Sekiguchi K3, Unno N3, Majima M2: J Cell Mol Med 2020/10; 24 (20): 11984-97. (杮揷夒巕1, 埳摗媊栫2, 暈晹嬁巕1, 嵶栰壛撧巕2, 娭岥榓婇3, 奀栰怣栫3, 攏搱惓棽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3嶻壢)
110033. [尨挊] Platelets prevent the development of monocrotaline-induced liver injury in mice. Otaka F1, Ito Y2, Goto T1, Eshima K3, Amano H2, Koizumi W4, Majima M2: Toxicol Lett 2020/12; 335: 71-81. (戝崅巎惞1, 埳摗媊栫2, 屻摗戩栫1, 峕搰峩擇3, 揤栰塸庽2, 彫愹榓嶰榊4, 攏搱惓棽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3柶塽, 4徚壔婍撪)
[妛夛丒尋媶夛摍]
722004. [妛夛 (慡崙)] (僔儞億僕僂儉) 慻怐廋暅偵偍偗傞儕儞僷娗怴惗傪惂屼偡傞僾儘僗僞僌儔儞僕儞PGE2偺婡擻揑栶妱. 埳摗媊栫1, 嵶栰壛撧巕1, 揤栰塸庽1, 攏搱惓棽1 (1栻棟): 戞41夞擔杮墛徢丒嵞惗堛妛夛 (2020/7/8-9), Web奐嵜.
722005. [妛夛 (慡崙)] (彽懸島墘摍) 墛徢帪偺儕儞僷娗怴惗傪憹嫮偡傞嵶朎摿堎揑僩儘儞儃僉僒儞庴梕懱僔僌僫儖偺栶妱. 嵶栰壛撧巕1, 埳摗媊栫1, 攏搱惓棽1 (1栻棟): 戞44夞擔杮儕儞僷妛夛憤夛 (2020/9/11), 戝媨.
722006. [妛夛 (慡崙)] (僔儞億僕僂儉) 儕儞僷娗怴惗傪惂屼偡傞恄宱儁僾僠僪CGRP偺栶妱. 嵶栰壛撧巕1, 埳摗媊栫1, 捗棷悽棦2, 揤栰塸庽1, 攏搱惓棽1 (1栻棟, 2杻悓): 戞44夞擔杮儕儞僷妛夛憤夛 (2020/9/11-12), 戝媨.
723024. [妛夛 (慡崙)] (億僗僞乕) 儅僂僗巕媨撪枌徢偵偍偗傞RAMP1偺寣娗丒儕儞僷娗怴惗懀恑嶌梡. 杮揷夒巕1, 埳摗媊栫2, 暈晹嬁巕1, 嵶栰壛撧巕2, 拞杮廋巌1, 戝崅巎惞1, 捗棷悽棦3, 攏搱惓棽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3杻悓): 戞41夞擔杮墛徢丒嵞惗堛妛夛 (2020/7/8-9), Web奐嵜.
723025. [妛夛 (慡崙)] (億僗僞乕) 僩儘儞儃僉僒儞A2庴梕懱僔僌僫儖偼, 儌僲僋儘僞儕儞桿摫娞忈奞傪梷惂偡傞. 戝崅巎惞1, 埳摗媊栫2, 暈晹嬁巕1, 杮揷夒巕1, 戝媣曐攷悽3, 嵶栰壛撧巕2, 彫愹榓嶰榊4, 攏搱惓棽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3怱憻寣娗奜, 4徚壔婍撪): 戞41夞擔杮墛徢丒嵞惗堛妛夛 (2020/7/8-9), Web奐嵜.
723026. [妛夛 (慡崙)] (億僗僞乕) EP4僔僌僫儖偼儕儞僷娗宍惉偺憹嫮偵傛傝DSS桿敪戝挵墛屻偺擲枌慻怐廋暅傪夵慞偡傞. 嵶栰壛撧巕1, 埳摗媊栫1, 攏搱惓棽1 (1栻棟): 戞41夞擔杮墛徢丒嵞惗堛妛夛 (2020/7/8-9), Web奐嵜.
723027. [妛夛 (慡崙)] (堦斒岥墘) 儅僂僗巕媨撪枌徢偵偍偗傞RAMP1偺儕儞僷娗怴惗懀恑嶌梡. 杮揷夒巕1, 埳摗媊栫2, 暈晹嬁巕1, 嵶栰壛撧巕2, 戝崅巎惞1, 攏搱惓棽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟): 戞44夞擔杮儕儞僷妛夛憤夛 (2020/9/11-12), 戝媨.
723028. [妛夛 (慡崙)] (堦斒岥墘) 儌僲僋儘僞儕儞桿摫娞忈奞屻偺娞廋暅偵偼SDF-1/CXCR4傪夘偟偰儅僋儘僼傽乕僕偑娭梌偡傞. 埳摗媊栫1, 戝崅巎惞2, 屻摗戩栫2, 嵶栰壛撧巕1, 敤拞丂岞1, 揤栰塸庽1 (1栻棟, 2戝妛堾堛椕宯尋媶壢): 戞94夞擔杮栻棟妛夛擭夛 (2021/3/8-10), 嶥杫 (僴僀僽儕僢僪奐嵜).
723029. [妛夛 (慡崙)] (堦斒岥墘) LPS桿敪暊枌墛儅僂僗偺墶妘枌儕儞僷娗怴惗, 儕儞僷僪儗僫乕僕婡擻偵偍偗傞僩儘儞儃僉僒儞庴梕懱僔僌僫儖偺栶妱. 嵶栰壛撧巕1, 埳摗媊栫1, 徏揷峅旤2, 捗棷悽棦2, 敤拞丂岞1, 攏搱惓棽1, 惉媨丂廃, 揤栰塸庽1 (1栻棟, 2杻悓): 戞94夞擔杮栻棟妛夛擭夛 (2021/3/8-10), 嶥杫 (僴僀僽儕僢僪奐嵜).
723030. [妛夛 (慡崙)] (堦斒岥墘) Role of NKT cells in liver repair after hepatic ischemia-reperfusion injury in mice. 屻摗戩栫1, 埳摗媊栫2, 拞杮廋巌1, 嵅摗丂夒3, 嵶栰壛撧巕2, 敤拞丂岞2, 揤栰塸庽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3柶塽): 戞94夞擔杮栻棟妛夛擭夛 (2021/3/8-10), 嶥杫 (僴僀僽儕僢僪奐嵜).
723031. [妛夛 (慡崙)] (堦斒岥墘) 僽儗僆儅僀僔儞桿敪攛慄堐徢儌僨儖偵偍偗傞VEGFR1-TK僔僌僫儖偺栶妱. 揤栰塸庽1, 徏堜孾晇2, 埳摗媊栫1, 峕搰峩擇3, 敤拞丂岞1, 嵶栰壛撧巕1, 廰扟惓巎, 攏搱惓棽1 (1栻棟, 2屇媧婍奜, 3柶塽): 戞94夞擔杮栻棟妛夛擭夛 (2021/3/8-10), 嶥杫 (僴僀僽儕僢僪奐嵜).
723032. [妛夛 (慡崙)] (億僗僞乕) 寣彫斅偼儌僲僋儘僞儕儞桿摫娞忈奞傪寉尭偡傞. 戝崅巎惞1, 埳摗媊栫2, 嵶栰壛撧巕2, 敤拞丂岞2, 彫愹榓嶰榊3, 揤栰塸庽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3徚壔婍撪): 戞94夞擔杮栻棟妛夛擭夛 (2021/3/8-10), 嶥杫 (僴僀僽儕僢僪奐嵜).
723033. [妛夛 (慡崙)] (億僗僞乕) 媫惈娞忈奞屻偺娞廋暅偵偼儕儞僷娗怴惗偲儅僋儘僼傽乕僕偑婑梌偡傞. 拞杮廋巌1, 埳摗媊栫2, 屻摗戩栫1, 嵶栰壛撧巕2, 敤拞丂岞2, 攏搱惓棽2, 揤栰塸庽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟): 戞94夞擔杮栻棟妛夛擭夛 (2021/3/8-10), 嶥杫 (僴僀僽儕僢僪奐嵜).
723034. [妛夛 (慡崙)] (億僗僞乕) 擏夎慻怐宍惉傪懀恑偡傞mPGES-1/PGE2宱楬偺栶妱. 暫摢揙栫, 揤栰塸庽1, 埳摗媊栫1, 嵶栰壛撧巕1, 敤拞丂岞1, 峕搰峩擇2, 怉徏丂抭, 怰椙惷抝, 晲揷丂孾3 (1栻棟, 2柶塽, 3宍惉丒旤奜): 戞94夞擔杮栻棟妛夛擭夛 (2021/3/8-10), 嶥杫 (僴僀僽儕僢僪奐嵜).
733005. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 娞椶摯暵嵡徢岓孮偵偍偗傞寣彫斅偺栶妱. 戝崅巎惞1, 埳摗媊栫2, 屻摗戩栫1, 嵶栰壛撧巕2, 敤拞丂岞2, 彫愹榓嶰榊3, 揤栰塸庽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3徚壔婍撪): 戞143夞擔杮栻棟妛夛娭搶晹夛 (2020/10/24), Web奐嵜.
733006. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) mPGES-1/PGE2axis偵傛傞擏夎慻怐宍惉儊僇僯僘儉偺専摙. 暫摢揙栫, 揤栰塸庽1, 埳摗媊栫1, 嵶栰壛撧巕1, 敤拞丂岞1, 峕搰峩擇2, 怉徏丂抭, 怰椙惷抝, 晲揷丂孾3 (1栻棟, 2柶塽, 3宍惉丒旤奜): 戞143夞擔杮栻棟妛夛娭搶晹夛 (2020/10/24), Web奐嵜.
旝惗暔妛
[妛弍榑暥]
110034. [尨挊] Micromonospora pelagivivens sp. nov., a new species of the genus Micromonospora isolated from deep-sea sediment in Japan. Intra B, Panbangred W, Inahashi Y, Tak� A1, Mori M, Omura S, Matsumoto A: Int J Syst Evol Microbiol 2020/5; 70 (5): 3069-75. (晲丂丂峎1: 1旝惗暔)
110035. [尨挊] IgE reactivity to fish allergens from Pacific cod (Gadus macrocephalus) in atopic dogs. Imanishi I1, Uchiyama J, Mizukami K, Kamiie J, Kurata K, Iyori K, Fujimura M, Shimakura K, Nishifuji K, Sakaguchi M: BMC Vet Res 2020/9; 16 (1): 341. (崱惣巗楴1: 1旝惗暔)
110036. [尨挊] Analysis of a plasmid encoding botulinum neurotoxin type G gene in Clostridium argentinense. Sakaguchi Y1, Uchiyama J, Tak� A1, Gotoh K, Sakaguchi M, Suzuki T, Yamamoto Y, Hosomi K, Kohda T, Mukamoto M, Kozaki S, Hayashi S1, Oguma K: Anaerobe 2020/12; 66: 102281. (嶃岥媊旻1, 晲丂丂峎1, 椦丂弐帯1: 1旝惗暔)
110037. [尨挊] Detection of Penicillin G Produced by Penicillium chrysogenum with Raman Microspectroscopy and Multivariate Curve Resolution-Alternating Least-Squares Methods. Horii S, Ando M, Samuel AZ, Tak� A1, Nakashima T, Matsumoto A, Takahashi Y, Takeyama H: J Nat Prod 2020/11; 83 (11): 3223-9. (晲丂丂峎1: 1旝惗暔)
521001. [夝愢]亂Helicobacter怴嬠庬敪尒!亃2020擭偵彸擣偝傟偨Helicobacter懏偺怴嬠庬偺徯夘亅曬崘榑暥傛傝亅. 椦丂弐帯 (旝惗暔): Helicobacter Research 2020/11; 24 (2): 226-8.
521002. [夝愢] 恾夝亅擽旂徢 椪彴堛偵抦偭偰傎偟偄昞嵼惈擽旂徢. 崱惣巗楴 (旝惗暔): 廱堛椪彴旂晢壢2021/3; 27 (1): 33-40.
522004. [島嵗]亂嬞媫摿廤: 怴宆僐儘僫僂僀儖僗姶愼徢 (COVID-19)乣杊嬠杊陘偺娤揰偐傜乣亃6. 怴宆僐儘僫僂僀儖僗僷儞僨儈僢僋婜偵偍偗傞姶愼娗棟偲娕岇. 埳摗摴巕1, 椦丂弐帯2 (1娕岇妛晹, 2旝惗暔): 擔杮杊嬠杊陘妛夛帍 2020/9; 48 (9): 481-6.
530001. [偦偺懠 (Erratum)] Corrigendum: Micromonospora pelagivivens sp. nov., a new species of the genus Micromonospora isolated from deep-sea sediment in Japan. Intra B, Panbangred W, Inahashi Y, Tak� A1, Mori M, Omura S, Matsumoto A: Int J Syst Evol Microbiol 2020/8; 70 (8): 4843. (晲丂丂峎1: 1旝惗暔)
540001. [偦偺懠 (尋媶曬崘彂)]亂2019擭搙杒棦戝妛堛妛晹偗傗偒夛尋媶彆惉乽僋儘僗僩儕僨傿僆僀僨僗丒僨傿僼傿僔儖姶愼徢偺帯椕偵桳梡側曻慄嬠偺暘棧偲偦偺帯椕傊偺墳梡 (尋媶婜娫: 2019擭搙)乿亃尋媶戙昞幰: 晲丂丂峎1, 嫟摨尋媶幰: 嶃岥媊旻1, 椦丂弐帯1, 撪嶳弤暯, 屻摗榓媊, 枀旜廩晀, 壛摗偼傞, 堫嫶桟婲2, 徏杮岤巕2 (1旝惗暔, 2杒棦惗柦壢妛尋媶強):乽僋儘僗僩儕僨傿僆僀僨僗丒僨傿僼傿僔儖姶愼徢偺帯椕偵桳梡側曻慄嬠偺暘棧偲偦偺帯椕傊偺墳梡乿2019擭搙曬崘彂 2020/4.
540002. [偦偺懠 (尋媶曬崘彂)]亂壢妛尋媶旓曗彆嬥丒婎斦尋媶 (C)乽僨傿僼傿僔儖嬠僶僋僥儕僆僼傽乕僕偺廻庡擣幆婡峔偺夝柧媦傃帯椕偲梊杊傊偺墳梡 (尋媶婜娫: 2019擭搙乣2021擭搙)乿亃尋媶戙昞幰: 嶃岥媊旻1, 尋媶暘扴幰: 壛摗偼傞, 戝媨捈栘, 撪嶳弤暯, 屻摗榓媊, 枀旜廩晀, 椦丂弐帯1 (1旝惗暔:乽僨傿僼傿僔儖嬠僶僋僥儕僆僼傽乕僕偺廻庡擣幆婡峔偺夝柧媦傃帯椕偲梊杊傊偺墳梡乿2019擭搙幚巤忬嫷曬崘彂 2020/5; https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-19K07560/19K075602019hokoku/.
540003. [偦偺懠 (尋媶曬崘彂)]亂壢妛尋媶旓曗彆嬥丒婎斦尋媶 (C)乽僼傽乕僕撪嵼壔偵傛傞僺儘儕嬠偺帩懕姶愼婡峔偺専徹 (尋媶婜娫: 2018擭搙乣2020擭搙)乿亃尋媶戙昞幰: 撪嶳弤暯, 尋媶暘扴幰: 徏嶈栁揥, 椦丂弐帯1, 嶃岥媊旻1, 嶰幒恗旤 (1旝惗暔):乽僼傽乕僕撪嵼壔偵傛傞僺儘儕嬠偺帩懕姶愼婡峔偺専徹乿2019擭搙幚巤忬嫷曬崘彂 2020/5; https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-18K07127/18K071272019hokoku/.
540004. [偦偺懠 (峀曬帍)] 堛妛晹偗傗偒夛尋媶彆惉傪庴偗偰. 崱惣巗楴 (旝惗暔): 杒棦戝妛堛妛晹僯儏乕僘 2020/10; 406: 3.
540005. [偦偺懠 (峀曬帍)] 偔偡偺偒. 嶃岥媊旻 (旝惗暔): 杒棦戝妛堛妛晹僯儏乕僘 2020/11; 407: 17.
540006. [偦偺懠 (峀曬帍)] 2020擭搙暥晹壢妛徣壢妛尋媶旓彆惉傪庴偗偰. 晲丂丂峎 (旝惗暔): 杒棦戝妛堛妛晹僯儏乕僘 2020/11; 407: 9.
540007. [偦偺懠 (尋媶曬崘彂)]亂傗偢傗怘偲寬峃尋媶強丒2019擭搙尋媶彆惉尋媶乽怘暔偑傕偨傜偡寬峃偲偺娭楢亅桳梡惈曻慄嬠偺挵撪偵偍偗傞栶妱亅(尋媶婜娫: 2019擭搙)乿亃尋媶戙昞幰: 晲丂丂峎1, 巜摫幰: 嶃岥媊旻1, 嫟摨尋媶幰: 壛摗偼傞, 椦丂弐帯1 (1旝惗暔):乽怘暔偑傕偨傜偡寬峃偲偺娭楢亅桳梡惈曻慄嬠偺挵撪偵偍偗傞栶妱亅乿2019擭搙拞娫曬崘彂 2021/1.
[挊丂彂]
620003. [妛弍彂 (暘扴幏昅)]亂僺儘儕嬠彍嬠帯椕僷乕僼僃僋僩僈僀僪 戞3斉亃戞5復 僺儘儕彍嬠帯椕偲堓娻丂1僺儘儕嬠偺婎慴抦幆丂抦偭偰偍偒偨偄僺儘儕嬠偺嵶嬠妛揑摿挜, p.193-5. 嶅丂怣淎, 徏媣埿巎, 惵嶳怢榊, 斏揷偝偲傒, 崅栘撝巌, 壂杮拤媊, 懞忋榓惉, 拞搰帬旤, 崅嫶怣堦, 娫晹崕桾, 嵅摗婱堦, 娾杮弤堦, 峚忋桾巑, 拞懞徆懢榊, 楅栘廏榓, 惣郪弐岹, 峳愳淎巙, 彫堜屗孫梇, 戝憪晀巎, 晉揷庻旻, 嶰椫梞恖, 墫扟徍巕, 堜杮堦榊, 屆揷棽媣, 嶳弌旤曚巕, 嬀丂戩攏, 楅栘悞峅, 旙岥桭梞, 摽塱寬屷, 壛摗惏堦, 墱揷恀庫旤, 嵅塝棿懢榊, 摗栰揘楴, 釼摗丂暽, 暉揷擻孾, 孖尨捈恖, 埳摗溎朏, 壓嶳丂崕, 弔娫丂尗, 枛淎枮旻, 壨杮攷暥, 嶳杮払抝, 懢揷峗椙, 愒徏懽師, 嶳壀媑惗, 悪嶳晀榊, 橺嬍夒柧, 摗壀棙惗, 悈栰尦晇, 晲丂丂恑, 椦丂弐帯1, 忋懞捈幚, 媏抧惓屽, 壛摗尦巏, 愺崄惓攷, 彫椦惓柧, 堜忋榓旻, 埳摗岞孭 (1旝惗暔), 曇挊: 嶅丂怣淎, 擔杮堛帠怴曬幮, 搶嫗, 2020/10敪峴.
620004. [妛弍彂 (娔廋丒曇廤)]亂僐儞僷僋僩旝惗暔妛 夵掶戞5斉亃戞2復嵶嬠, 戞4復恀嬠, 戞7復柵嬠偲徚撆. 彫孎湪擇, 杧揷丂攷, 椦丂弐帯1, 愇屗丂憦, 嶚尨揝暯, 嶃岥媊旻1, 敆丂峃恗, 墶揷寷帯, 屆嶳桾婯, 摗揷捈媣, 嶳揷夒晇, 摗桭寢幚巕, 宍嶳桪巕, 拞惣夒庽, 彑擇堣晇, 徏壓丂帯 (1旝惗暔), 娔廋: 彫孎湪擇, 杧揷丂攷, 曇: 椦丂弐帯1, 愇屗丂憦 撿峕摪, 搶嫗, 2021/3敪峴.
620005. [妛弍彂 (暘扴幏昅)]亂僐儞僷僋僩旝惗暔妛 夵掶戞5斉亃戞2復嵶嬠丂G. 柍夎朎曃惈寵婥惈嬠, p.53-4, H. 桳夎朎曃惈寵婥惈嬠, p.55-7. 彫孎湪擇, 椦丂弐帯1, 嶚尨揝暯, 嶃岥媊旻1, 愇屗丂憦, 敆丂峃恗, 墶揷寷帯, 媑嶳桾婯, 摗揷捈媣, 嶳揷夒晇, 摗桭寢幚巕, 宍嶳桪巕, 拞惣夒庽, 彑擇堣抝, 徏壓丂帯 (1旝惗暔), 娔廋: 彫孎湪擇, 杧揷丂攷, 曇: 椦丂弐帯1, 愇屗丂憦 撿峕摪, 搶嫗, 2021/3敪峴.
[妛夛丒尋媶夛摍]
713004. [妛夛 (崙嵺)] (堦斒島墘) Analysis of botulinum neurotoxin type B6 gene-encoding plasmid in Clostridium botulinum type B. Sakaguchi Y1, Hosomi K, Kohda T, Umeda K, Uchiyama J, Take A1, Goto K, Senoh M, Hayashi S1, Kozaki S, Mukamoto M: ASM microbe 2020 (2020/6/18), Chicago, USA. (嶃岥媊旻1, 晲丂丂峎1, 椦丂弐帯1: 1旝惗暔)
721001. [妛夛 (慡崙)] (摿暿島墘) Clostridioides difficile姶愼徢偵懳偡傞暢曋旝惗暔堏怉偺塭嬁乣僸僩挵撪旝惗暔憄媦傃儊僞儃儘乕儉偺夝愅乣. 嶃岥媊旻1, 屻摗榓媊, 晲丂丂峎1, 旜鴵敼恖, 忛戙峃婱, 榓媣揷岝婤, 椦丂弐帯1, 戝媨捈栘, 壛摗偼傞 (1旝惗暔): 戞94夞擔杮嵶嬠妛夛憤夛 (2021/3/23), Web奐嵜.
722007. [妛夛 (慡崙)] (彽懸島墘摍) 擔杮僿儕僐僶僋僞乕妛夛Helicobacter pylori栻嵻懴惈婎弨僷僱儖偺嶌惢. 墶揷寷帯, 椦丂弐帯1, 抾撪孾峎, 墶揷怢堦, 戝鴵宧巕 (1旝惗暔): 戞26夞擔杮僿儕僐僶僋僞乕妛夛妛弍廤夛 (2021/1/8), 昹徏.
722008. [妛夛 (慡崙)] (彽懸島墘摍) 挵撪旝惗暔憄偺崱. 嶃岥媊旻1, 尨丂塸庽 (1旝惗暔): 戞94夞擔杮嵶嬠妛夛憤夛 (2021/3/23), Web奐嵜.
722009. [妛夛 (慡崙)] (彽懸島墘摍) 僽僪僂媴嬠偺奜暘斿撆慺偲僯僢僠偺峔抸. 崱惣巗楴1, 娾悾拤峴, 惣摗岞巌 (1旝惗暔): 戞94夞擔杮嵶嬠妛夛憤夛 (2021/3/23), Web奐嵜.
723035. [妛夛 (慡崙)] (堦斒島墘) 僀僰偺弮寣庬僐儘僯乕傪棙梡偟偨傾僩僺乕惈旂晢墛偵娭楢偟偨岥峯丒挵撪嵶嬠憄偺曄摦偺夝愅. 奀栰挬崄, 崱惣巗楴1, 悈忋孿擇榊, 戝嬿懜巎, 屲廫棐姲崅, 懞忋桾怣, 搰丂埢崄, 愇尨尯婎, 塅崻桳旤, 嶃岥夒峅, 撪嶳弤暯 (1旝惗暔): 戞163夞擔杮廱堛妛夛妛弍廤夛 (2020/9/14-30), Web奐嵜.
723036. [妛夛 (慡崙)] (堦斒島墘) Staphylococcus pseudintermedius偺僀僰傾僩僺乕惈旂晢墛憹埆場巕偺扵嶕. 掃堜戝姴, 搰憅廏彑, 撪嶳弤暯, 崱惣巗楴1, 嶁杮廋巑, 旙岥戶杹, 埳渘宑懢, 壓抮寬懢, 摗懞惓恖, 嶃岥夒峅 (1旝惗暔): 戞163夞擔杮廱堛妛夛妛弍廤夛 (2020/9/14-30), Web奐嵜.
723037. [妛夛 (慡崙)] (堦斒島墘) 怘暔偐傜暘棧偟偨曻慄嬠偺挵撪娐嫬惗懚擻偺昡壙. 晲丂丂峎1, 嶃岥媊旻1, 堫嫶桟婲, 屻摗榓媊, 椦丂弐帯1, 戝媨捈栘, 壛摗偼傞 (1旝惗暔): 戞94夞擔杮嵶嬠妛夛憤夛 (2021/3/23), Web奐嵜.
723038. [妛夛 (慡崙)] (堦斒島墘) 僼傽乕僕桼棃梟嬠峺慺S25-3LYS偺僀僰昞嵼惈擽旂徢偵懳偡傞椪彴墳梡惈偺専摙. 崱惣巗楴1, 惣摗岞巌, 挬斾撧椙懢, 椦丂弐帯1, 捗媣堜棙峀, 撪嶳弤暯 (1旝惗暔): 戞94夞擔杮嵶嬠妛夛憤夛 (2021/3/23), Web奐嵜.
723039. [妛夛 (慡崙)] (堦斒島墘) 栻嵻懴惈Helicobacter pylori嬠姅偺婎弨僷僱儖. 椦丂弐帯1, 戝鴵宧巕, 抾撪孾峎, 墶揷寷帯, 墶揷怢堦, 椦尨奊旤巕 (1旝惗暔): 戞94夞擔杮嵶嬠妛夛憤夛 (2021/3/25), Web奐嵜.
723040. [妛夛 (慡崙)] (堦斒島墘) 暢曋旝惗暔堏怉偵傛傝Clostridioides difficile姶愼徢偺嵞敪梊杊岠壥傪帵偟偨徢椺偵偍偗傞挵撪旝惗暔憄媦傃偦偺戙幱嶻暔偺夝愅. 嶃岥媊旻1, 屻摗榓媊, 晲丂丂峎1, 旜鴵敼恖, 忛戙峃婱, 榓媣揷岝婤, 椦丂弐帯1, 壛摗偼傞, 戝媨捈栘 (1旝惗暔): 擔杮栻妛夛戞141擭夛 (2021/3/26), Web奐嵜.
733007. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 暋悢偺廱堛宯婡娭偵偍偗傞僀僰偺擽旂徢傗傾儗儖僊乕惈旂晢墛偵懳偡傞峈嬠栻旕埶懚揑側庢傝慻傒. 撪嶳弤暯, 崱惣巗楴1, 惣摗岞巌, 暉嶳朁婫, 埳渘宑懢, 捗媣堜棙峀, 嶃岥夒峅 (1旝惗暔): 戞65夞擔杮僽僪僂媴嬠尋媶夛 (2020/10/16), Web奐嵜.
733008. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嬠庬摨掕偵擄廰偟偨姶愼惈怱撪枌墛偺1椺. 壀懞丂弜, 柧忛惓攷, 悪壓桋擵, 揷晹堜巎巕, 嵅摗桪壚棟, 崱惣巗楴1, 撪嶳弤暯, 埳渘宑懢, 慭榓桾擵 (1旝惗暔): 擔杮撪壢妛夛戞666夞娭搶抧曽夛 (2021/2/7), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-530001. [偦偺懠 (Letter)] Abnormal whiskers in a Persian cat resembling shaft disorder of Abyssinian cats. Miyata C, Imanishi I1, Shimazaki Y, Ida R, Nishifuji K: Jpn J Vet Dermatol (廱堛椪彴旂晢壢) 2020/3; 26 (3): 145-6. (崱惣巗楴1: 1旝惗暔)
婑惗拵妛丒擬懷堛妛
[妛弍榑暥]
110038. [尨挊] Natural nodular worm infection in goats induces eosinophil extracellular DNA trap (EET) formation. Anisuzzaman , Anas A, Yasin MG, Labony SS, Hossain MM, Begum N, Hatta T1, Tsuji N1, Alim MA: Parasitol Int 2020/12; 79: 102178. 敧揷妜巑1, 捯丂彯棙1 (1婑惗拵丒擬懷堛妛)
110039. [尨挊] Prevalence of Trichinella T9 in Japanese black bears (Ursus thibetanus japonicus) in Iwate prefecture, Japan. Tominaga T, Aoki M, Biswas PG, Hatta T1, Itagaki T: Parasitol Int 2021/2; 80: 102217. 敧揷妜巑1 (1婑惗拵丒擬懷堛妛)
520001. [憤愢] 儅僟僯偺恖岺媧寣乣夁嫀丒尰嵼丒枹棃乣. 敧揷妜巑 (婑惗拵丒擬懷堛妛): 塹惗摦暔 2020/3; 71 (1): 15-23.
[挊丂彂]
620006. [妛弍彂 (暘扴幏昅)]亂壠抺揱愼昦僴儞僪僽僢僋亃2. 撏弌揱愼昦丂2-61儘僀僐僠僩僝乕儞徢, p.262-3. 敧揷妜巑1, 懠47柤 (1婑惗拵丒擬懷堛妛), 曇: 懞忋尗擇, 旻栰峅堦, 挬憅彂揦, 搶嫗, 2020/11敪峴.
[妛夛丒尋媶夛摍]
723041. [妛夛 (慡崙)] (堦斒島墘) 僼僞僩僎僠儅僟僯怢挿場巕1兛 (EF1兛) 堚揱巕偺忋棳椞堟夝愅. 僄儅僯儏僄儖僿儖僫儞僨僗, 僐僼傿僐僼傿, 捸愳戝屽1, 嶰忋朳巕, 徏椦丂惤, 捯丂彯棙1, 揷拠揘栫, 敧揷妜巑1 (1婑惗拵丒擬懷堛妛): 戞72夞擔杮塹惗摦暔妛夛戝夛 (2020/4/17-19), 戝夛偑拞巭偺堊傒側偟奐嵜.
723042. [妛夛 (慡崙)] (堦斒島墘) 僼僞僩僎僠儅僟僯偺泱敪惗偵偍偗傞屆揟揑僩儔儞僗僋儕僾僩乕儉夝愅. 僐僼傿僐僼傿, 僄儅僯儏僄儖僿儖僫儞僨僗, 僒儈儏僄儖僟僕, 僟僯僄儖儔僛僋億, 捸愳戝屽1, 嶰忋朳巕, 徏椦丂惤, 娾塱巎楴, 捯丂彯棙1, 敧揷妜巑1 (1婑惗拵丒擬懷堛妛): 戞72夞擔杮塹惗摦暔妛夛戝夛 (2020/4/17-19), 戝夛偑拞巭偺堊傒側偟奐嵜.
昦棟妛 (懞塤扨埵)
[妛弍榑暥]
110040. [尨挊] STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy. Arwert EN, Milford EL, Rullan A, Derzsi S, Hooper S, Kato T1, Mansfield D, Melcher A, Harrington KJ, Sahai E: Nat Cell Biol 2020/7; 22 (7): 758-66. (壛摗戶嵠1: 1昦棟)
110041. [尨挊] Expression of CA2 and CA9 carbonic anhydrases in ulcerative colitis and ulcerative colitis-associated colorectal cancer Nakada N1, Mikami T, Horie K, Nagashio R2, Sakurai Y1, Sanoyama I1, Yoshida T1, Sada M3, Kobayashi K3,4, Sato Y2, Okayasu I, Murakumo Y1: Pathol Int 2020/8; 70 (8): 523-32. (拠揷揟峀1, 挿墫丂椇2, 烴堜桋崅1, 崃嶳丂摓1, 媑揷丂岟1, 嵅揷旤榓3, 彫椦惔揟3,4, 嵅摗梇堦2, 懞塤朏庽1: 1昦棟, 2堛椕塹惗妛晹, 3徚壔婍撪, 4怴悽婭堛椕丒墶抐揑堛椕)
110042. [尨挊] SSEA-3 and 4 are not essential for the induction or properties of mouse iPS cells. Hamamura K, Hotta H, Murakumo Y1, Shibuya H, Kondo Y, Furukawa K: J Oral Sci 2020/9; 62 (4): 393-6. (懞塤朏庽1: 1昦棟)
110043. [尨挊] Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors. Sakurai Y1, Ichinoe M1, Yoshida K, Nakazato Y, Saito S, Satoh M2, Nakada N1, Sanoyama I1, Umezawa A3, Numata Y3, Shi-Xu J1, Ichihara M, Takahashi M, Murakumo Y1: Cancer Lett 2020/10; 489: 100-10. (烴堜桋崅1, 堦屗徆柧1, 嵅摗丂夒2, 拠揷揟峀1, 崃嶳丂摓1, 攡戲撝巕3, 徖揷夑巕3, 徲丂郪悡1, 懞塤朏庽1: 1昦棟, 2柶塽, 3宍懺宯)
110044. [尨挊] CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-兝 signaling. Taki T, Shiraki Y, Enomoto A, Weng L, Chen C, Asai N, Murakumo Y1, Yokoi K, Takahashi M, Mii S: Cancer Sci 2020/12; 111 (12): 4616-28. (懞塤朏庽1: 1昦棟)
[妛夛丒尋媶夛摍]
723043. [妛夛 (慡崙)] (堦斒島墘) 岺妛揑夝愅媄弍偵傛傞埆惈拞旂庮偺媞娤揑恌抐巜昗峔抸. 栘懞暥堦, 捗揷悙婓, 戝搰寬屷, 嶳岥夒峗, 懞塤朏庽1, 嵅摗擵弐2 (1昦棟, 2屇媧婍奜): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20), Web奐嵜.
723044. [妛夛 (慡崙)] (堦斒島墘) 埆惈崟怓庮偵偍偗傞REV7偺婡擻夝愅. 惎栰徍朏1, 堦屗徆柧1, 烴堜桋崅1, 懞塤朏庽1 (1昦棟) 戞79夞擔杮娻妛夛妛弍憤夛 (2020/10/1), 峀搰 (僴僀僽儕僢僪奐嵜).
723045. [妛夛 (慡崙)] (堦斒島墘) 嬤埵埶懚惈價僆僠儞昗幆朄偵傛傞怴婯REV7寢崌僞儞僷僋幙偺摨掕. 捙柤桬婱1, 烴堜桋崅2, 壛摗戶嵠2, 堦屗徆柧2, 懞塤朏庽2 (1戝妛堾堛椕宯尋媶壢, 2昦棟): 戞79夞擔杮娻妛夛妛弍憤夛 (2020/10/1), 峀搰 (僴僀僽儕僢僪奐嵜).
723046. [妛夛 (慡崙)] (堦斒島墘) 嵶朎娫愙拝偲嵶朎奜儅僩儕僋僗暘夝偺憡屳嶌梡偼丆滸暯忋旂娻偺怹弫僷僞乕儞偲惉挿傪嫤挷揑偵寛掕偡傞. 壛摗戶嵠1, 懞塤朏庽1 (1昦棟) 戞79夞擔杮娻妛夛妛弍憤夛 (2020/10/1), 峀搰 (僴僀僽儕僢僪奐嵜).
723047. [妛夛 (慡崙)] (堦斒島墘) 庤弍専懱傪梡偄偨鋁娻偵偍偗傞BRCAness偺夝愅. 澍尨彨椙1, 壛摗戶嵠2, 埨払丂夣1, 烴堜桋崅2, 堦屗徆柧2, 懞塤朏庽2 (1戝妛堾堛椕宯尋媶壢, 2昦棟): 戞79夞擔杮娻妛夛妛弍憤夛 (2020/10/1), 峀搰 (僴僀僽儕僢僪奐嵜).
723048. [妛夛 (慡崙)] (堦斒島墘) 鋁憻娻偺梊屻偵偍偗傞CD109敪尰偺堄媊偺夝愅. 埨払丂夣1, 烴堜桋崅2, 壛摗戶嵠2, 堦屗徆柧2, 懞塤朏庽2 (1戝妛堾堛椕宯尋媶壢, 2昦棟): 戞79夞擔杮娻妛夛妛弍憤夛 (2020/10/1), 峀搰 (僴僀僽儕僢僪奐嵜).
723049. [妛夛 (慡崙)] (堦斒島墘) 彫嵶朎攛娻偵偍偗傞REV7敪尰偺惗暔妛揑堄媊. 崃嶳丂摓1, 堦屗徆柧1, 烴堜桋崅1, 懞塤朏庽1 (1昦棟) 戞79夞擔杮娻妛夛妛弍憤夛 (2020/10/1), 峀搰 (僴僀僽儕僢僪奐嵜).
'19擭搙埲慜暘
[妛夛丒尋媶夛摍]
'19-723003. [妛夛 (慡崙)] (堦斒島墘) 惗怋嵶朎堐帩偍傛傃惛巕宍惉偵偍偗傞DNA懝彎墳摎抈敀REV7偺廳梫惈. 堥奓撧乆巕, 烴堜桋崅1, 壛摗戶嵠1, 堦屗徆柧1, 徖揷夑巕2, 攡戲撝巕2, 懞塤朏庽1 (1昦棟, 2宍懺宯): 戞108夞擔杮昦棟妛夛憤夛 (2019/5/9), 搶嫗.
昦棟妛 (嶰巬扨埵)
[妛弍榑暥]
110045. [尨挊] S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma. Tochimoto M1, Oguri Y2, Hashimura M2, Konno R, Matsumoto T1, Yokoi A3, Kodera Y, Saegusa M1: Lab Invest 2020/5; 100 (5): 682-95. (撊杮徆岶1, 彫孖峃巕2, 嫶懞旤婭2, 徏杮弐塸1, 墶堜垽崄3, 嶰巬丂怣1: 1昦棟, 2宍懺宯, 3戝妛堾堛椕宯尋媶壢)
110046. [尨挊] Upregulation of fibronectin following loss of p53 function is a poor prognostic factor in ovarian carcinoma with a unique immunophenotype. Yokoi A1, Matsumoto T2, Oguri Y3, Hasegawa Y, Tochimoto M1, Nakagawa M, Saegusa M2: Cell Commun Signal 2020/7; 18 (1): 103. (墶堜垽崄1, 徏杮弐塸2, 彫孖峃巕3, 撊杮徆岶1, 嶰巬丂怣2: 1戝妛堾堛椕宯尋媶壢, 2昦棟, 3宍懺宯)
110047. [尨挊] S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma. Hiruta A1, Oguri Y2, Yokoi A1, Matsumoto T3, Oda Y1, Tomohiro M, Hashimura M2, Jiang Z, Tochimoto M3, Nakagawa M1, Saegusa M3: Am J Pathol 2020/11; 190 (11): 2304-16. (昰揷丂垽1, 彫孖峃巕2, 墶堜垽崄1, 徏杮弐塸3, 彫揷桽夘1, 嫶懞旤婭2, 撊杮徆岶3, 拞愳錆桽1, 嶰巬丂怣3: 1戝妛堾堛椕宯尋媶壢, 2宍懺宯, 3昦棟)
110048. [尨挊] Requirements of LEFTY and Nodal overexpression for tumor cell survival under hypoxia in glioblastoma. Matsumoto T1, Chino H, Akiya M1, Hashimura M2, Yokoi A3, Tochimoto M1, Nakagawa M3, Jiang Z, Saegusa M1: Mol Carcinog 2020/12; 59 (12): 1409-19. (徏杮弐塸1, 廐扟徆巎1, 嫶懞旤婭2, 墶堜垽崄3, 撊杮徆岶1, 拞愳錆桽3, 嶰巬丂怣1: 1昦棟, 2宍懺宯, 3戝妛堾堛椕宯尋媶壢)
[妛夛丒尋媶夛摍]
722010. [妛夛 (慡崙)] (彽懸島墘摍) 昦棟専懱傪梡偄偨棏憙柧嵶朎娻偺怴婯僶僀僆儅乕僇乕扵嶕: Lefty偺摨掕偲偦偺椪彴揑堄媊偺専摙. 廐扟徆巎1, 愳搰桽夘, 彫帥媊抝, 墶堜垽崄2, 彫孖峃巕3, 嫶懞旤婭3, 嶰巬丂怣1 (1昦棟, 2戝妛堾堛椕宯尋媶壢, 3宍懺宯): 戞71夞擔杮揹婥塲摦妛夛憤夛 (2020/11/13), Web奐嵜.
723050. [妛夛 (慡崙)] (堦斒島墘) 棏憙柧嵶朎娻偺p53/Fibronectin axis偼怴婯梊屻場巕偱偁傞. 墶堜垽崄1, 彫孖峃巕2, 徏杮弐塸3, 嶰巬丂怣3 (1戝妛堾堛椕宯尋媶壢, 2宍懺宯, 3昦棟): 戞109夞擔杮昦棟妛夛憤夛 (2020/7/1-31), Web奐嵜.
723051. [妛夛 (慡崙)] (堦斒島墘) 恑峴婜戝挵娻偺兝-僇僥僯儞丆PD1/PDL1偵傛傞娻姴嵶朎僯僢僠宍惉偲NCRT帯椕岠壥. 搉绯搒擳1, 崅嫶攷擵2, 嫶懞旤婭3, 將帞丂墌4, 怣懢徍巕5, 嶰巬丂怣5 (1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3宍懺宯, 4擼奜, 5昦棟): 戞109夞擔杮昦棟妛夛憤夛 (2020/7/1-31), Web奐嵜.
723052. [妛夛 (慡崙)] (堦斒島墘) 棏憙娻偵偍偗傞ALK梲惈娻偺摨掕偲偦偺惗暔妛揑摿惈偺夝柧. 彫揷桽夘1, 徏杮弐塸2, 嶰巬丂怣2 (1戝妛堾堛椕宯尋媶壢, 2昦棟): 戞109夞擔杮昦棟妛夛憤夛 (2020/7/1-31), Web奐嵜.
723053. [妛夛 (慡崙)] (堦斒島墘) S100A4偵傛傞恑峴婜捈挵娻偺弍慜壔妛曻幩慄椕朄掞峈擻妉摼婡峔偺夝柧. 怣懢徍巕1, 崅嫶攷擵2, 嫶懞旤婭3, 彫孖峃巕3, 徏杮弐塸1, 嶰巬丂怣1 (1昦棟, 2堛椕塹惗妛晹, 3宍懺宯): 戞109夞擔杮昦棟妛夛憤夛 (2020/7/1-31), Web奐嵜.
723054. [妛夛 (慡崙)] (堦斒島墘) 朥専恡偺昗杮嶌惢偵偮偄偰偺専摙. 廐扟徆巎1, 撊杮徆峫1, 嶰巬丂怣1 (1昦棟) 戞109夞擔杮昦棟妛夛憤夛 (2020/7/1-31), Web奐嵜.
723055. [妛夛 (慡崙)] (堦斒島墘) 巕媨娻擏庮偺S100A4/旕嬝嵶朎儈僆僔儞II宯偵傛傞擏庮惉暘桿摫婡峔偺夝柧. 撊杮徆岶1, 彫孖峃巕2, 嵁栰丂椇, 徏杮弐塸1, 彫帥媊抝, 嶰巬丂怣1 (1昦棟, 2宍懺宯): 戞109夞擔杮昦棟妛夛憤夛 (2020/7/1-31), Web奐嵜.
723056. [妛夛 (慡崙)] (堦斒島墘) EBP50偼棏憙柧嵶朎娻偺嵞敪丒梊屻晄椙場巕偱偁傞. 徏杮弐塸1, 墶堜垽崄2, 嵁栰丂椇, 彫帥媊抝, 嶰巬丂怣1 (1昦棟, 2戝妛堾堛椕宯尋媶壢): 戞109夞擔杮昦棟妛夛憤夛 (2020/7/1-31), Web奐嵜.
723057. [妛夛 (慡崙)] (堦斒島墘) 棏憙燋塼娻偺恑揥夁掱偵偍偗傞S100A4/Myosin9宯偺壥偨偡栶妱. 昰揷丂垽1, 彫孖峃巕2, 墶堜垽崄1, 嶰巬丂怣3 (1戝妛堾堛椕宯尋媶壢, 2宍懺宯, 3昦棟): 戞109夞擔杮昦棟妛夛憤夛 (2020/7/1-31), Web奐嵜.
塹惗妛
[妛弍榑暥]
110049. [尨挊] Predictors of post-cancer diagnosis resignation among Japanese cancer survivors. Endo M, Muto G1, Imai Y, Mitsui K, Nishimura K, Hayashi K: J Cancer Surviv 2020/4; 14 (2): 106-13. (晲摗丂崉1: 1塹惗)
110050. [尨挊] Exposure Assessment of Cadmium in Female Farmers in Cadmium-Polluted Areas in Northern Japan. Horiguchi H1, Oguma E2, Sasaki S, Miyamoto K, Hosoi Y, Ono A3, Kayama F: Toxics 2020/6; 8 (2): 44. (杧岥暫崉1, 彫孎墄巕2, 彫栰丂峎3: 1塹惗, 2梊杊堛妛宯, 3戝妛堾堛椕宯尋媶壢)
110051. [尨挊] Comparative 兞-H2AX analysis for assessment of the genotoxicity of six aromatic amines implicated in bladder cancer in human urothelial cell line. Qi Y1, Toyooka T, Nie J, Ohta H, Koda S, Wang RS: Toxicol In Vitro 2020/8; 66: 104880. (Yonggang Qi1: 1戝妛堾堛椕宯尋媶壢)
110052. [尨挊] Combined effects of occupational exposure to hazardous operations and lifestyle-related factors on cancer incidence. Fukai K, Kojimahara N, Hoshi K1, Toyota A, Tatemichi M: Cancer Sci 2020/12; 111 (12): 4581-4593. (惎丂壚朏1: 1塹惗)
110053. [尨挊] Predictors of resignation and sick leave after cancer diagnosis among Japanese breast cancer survivors: a cross-sectional study. Mitsui K, Endo M, Imai Y, Ueda Y, Ogawa H, Muto G1, Yan Y, Deshpande GA, Terao Y, Takeda S, Tanigawa T, Nishimura K, Hayashi K, Saito M, Kokaze A: BMC Public Health 2021/1; 21 (1): 138. (晲摗丂崉1: 1塹惗)
110054. [尨挊] Social participation and mortality according to company size of the longest-held job among older men in Japan: A 6-year follow-up study from the JAGES. Kanamori S, Kondo N, Takamiya T, Kikuchi H, Inoue S, Tsuji T, Kai Y, Muto G1, Kondo K: J Occup Health 2021/1; 63 (1): e12216. (晲摗丂崉1: 1塹惗)
110055. [尨挊] Reassessment of the threshold of the blood lead level to increase urinary 兟-aminolevulinic acid based on their relationship in recent lead workers in Japan. Ono A1, Horiguchi H2: J Occup Health 2021/1; 63 (1): e12202. (彫栰丂峎1, 杧岥暫崉2: 1戝妛堾堛椕宯尋媶壢, 2塹惗)
110056. [尨挊] The relationship of hospital stay and readmission with employment status. Kojimahara N, Hoshi K1, Tatemichi M, Toyota A: Ind Health 2021/2; 59 (1): 18-26. (惎丂壚朏1: 1塹惗)
120002. [尨挊] 慡崙楯嵭昦堾偵偍偗傞攋楐擼摦柆釒3,963椺偺晹埵丒惈嵎丒擭楊偵娭偡傞専摙. 朙揷復岹, 棫摴徆岾, 彫搰尨揟巕, 惎丂壚朏1 (1塹惗): 擼懖拞 2020/7; 42 (4): 233-8.
120003. [尨挊] 慡崙楯嵭昦堾偵偍偗傞攋楐擼摦柆釒3,963 椺偺晹埵丒惈嵎丒擭楊偵娭偡傞専摙. 朙揷復岹, 棫摴徆岾, 彫搰尨揟巕, 惎丂壚朏1 (1塹惗): 擼懖拞 2020/7; 42 (4): 233-8.
120004. [尨挊] 娗棟塰梴巑偺妶梡偵傛傝摿掕曐寬巜摫偺幚巤棪岦忋偵岦偗偨寬恌婡娭偺庢傝慻傒. 陰摗壺巕, 戝慜棙捠, 掃壀彯巙, 晲摗丂崉1, 戝慜桼旤, 揤栰旤棦, 徏杮丂晼, 峳栘撧撨, 庒椦旤岾, 嶳嶈堖捗巕 (1塹惗): 擔杮寬峃堛椕妛夛嶨帍 2020; 8: 21-6.
120005. [尨挊] 怴宆僐儘僫僂僀儖僗姶愼奼戝偵敽偆嬞媫帠懺愰尵拞偺嶻嬈曐寬妶摦. 庣揷桽嶌, 愇郪揘榊, 妬栘斏擵, 烴栘墍巕, 郪揷桳婌巕, 庬巗愛巕, 晲摗丂崉1, 恄揷嫶岹帯 (1塹惗): 嶻嬈塹惗妛嶨帍 2021/3; J-STAGE憗婜岞奐: 1-29.
520002. [憤愢] 墦妘婡婍傪梡偄偨楯摥幰偺寬峃娗棟: 嶻嬈曐寬椞堟偵偍偗傞墦妘婡婍傪梡偄偨寬峃娗棟偺僔僗僥儅僥傿僢僋儗價儏乕偲墦妘嶻嬈堛柺愙偵娭偡傞朄惂搙偺尰忬. 恄揷嫶岹帯, 愇郪揘榊, 妬栘斏擵, 晲摗丂崉1, 庣揷桽嶌, 戝恄丂柧 (1塹惗): 嶻嬈堛妛儗價儏乕 2020/5; 33 (1): 59-81.
520003. [憤愢] 擔杮恖偵偍偗傞怘昳偐傜偺僇僪儈僂儉敇業偺尰忬. 杧岥暫崉 (塹惗): 杒棦堛妛 2020/12; 50 (2): 77-85.
522005. [島嵗]亂摿廤: 奜崙恖楯摥幰偺怑応偺埨慡塹惗亃7. 奜崙寳弌恎楯摥幰偺寬峃壽戣偲夝寛傊偺揥朷亅儊儞僞儖僿儖僗, 姶愼徢偲堛椕懱惂. 晲摗丂崉1, 晉揷丂栁, 墦摗尮庽, 墶嶳榓恗 (1塹惗): 嶻嬈堛妛僕儍乕僫儖 2020/5; 43 (3): 41-6.
522006. [島嵗]亂戞66夞 崱廡偺僥乕儅亃姵幰偺帯椕偲巇帠偺椉棫巟墖 (憤榑丒慜曇). 晲摗丂崉 (塹惗): 擔杮堛帠怴曬 2020/7; 5019: 12-3.
522007. [島嵗]亂戞67夞 崱廡偺僥乕儅亃姵幰偺帯椕偲巇帠偺椉棫巟墖 (憤榑丒屻曇). 晲摗丂崉 (塹惗): 擔杮堛帠怴曬 2020/7; 5020: 12-3.
522008. [島嵗] 墦妘偱峴偆僐儞僒儖僞儞僩妶摦帠椺. 妬栘斏擵, 愇堜棟撧, 晲摗丂崉1, 恄揷嫶岹栬 (1塹惗): 埨慡塹惗僐儞僒儖僞儞僩 2020/7; 40 (135): 57-62.
522009. [島嵗]亂摿廤: 惗柦丒娐嫬椣棟偲儕僥儔僔乕亃壔妛暔幙摍偺娐嫬栤戣偵懳偡傞儕僗僋僐儈儏僯働乕僔儑儞亅帩懕壜擻側幮夛偺幚尰偵岦偗偨慡悽戙宆SDG倱娐嫬丒寬峃儕僥儔僔乕偺揥朷亅. 晲摗丂崉1, 愇嫶嶗巕, 墦摗尮庽, 戝怷桼婭1, 墶嶳榓恗 (1塹惗): 曐寬偺壢妛 2020/10; 62 (10): 678-685.
540008. [偦偺懠 (Plain language summary東栿)] 摿廤崋: 僐儘僫僂僀儖僗 (COVID-19):僷儞僨儈僢僋帪偺嬛墝偵岠壥揑側慖戰巿 (Cochrane Special Collections: Coronavirus (COVID-19): effective options for quitting smoking during the pandemic. Hartmann-Boyce, Nicola Lindson, Toby Lasserson, Monaz Mehta). 東栿: 惎丂壚朏1, 娔栿: 惔尨峃夘 (1塹惗): 2020/4; https://www.cochrane.org/ja/effective-options-for-quitting-smoking-during-the-covid-19-pandemic.
540009. [偦偺懠 (Plain language summary東栿)] 媔墝幰偑嬛墝栻偺巊梡傪憹傗偡偙偲傪巟墖偱偒傞偐? (Interventions to increase adherence to medications for tobacco dependence. Hollands GJ, Naughton F, Farley A, Lindson N, Aveyard P). 東栿: 惎丂壚朏1, 娔栿: 惔尨峃夘 (1塹惗): Cochrane Database of Systematic Reviews 2019, Issue 8. Art. No.: CD009164. DOI: 10.1002/14651858.CD009164.pub3. 2020/5; https://www.cochrane.org/ja/CD009164/TOBACCO_chi-yan-zhe-gajin-yan-yao-noshi-yong-wozeng-yasukotowozhi-yuan-dekiruka.
540010. [偦偺懠 (暥專徯夘)] 帠柋強娐嫬偲婥暘偵娭偡傞尋媶偺暥專専摙. 塝愳壛戙巕, 墶嶳榓恗, 晲摗丂崉1 (1塹惗): 嶻嬈堛妛僕儍乕僫儖 2020/9; 43 (5): 99-106.
540011. [偦偺懠 (尋媶曬崘彂)]亂撈棫峴惌朄恖楯摥幰寬峃埨慡婡峔乽椷榓2擭搙丒擖堾姵幰昦怑楌挷嵏婎慴夝愅 (2005 擭搙乣2018 擭搙昦怑楌僨乕僞巊梡)乿亃棫摴徆岾, 彫搰尨揟巕, 惎丂壚朏1, 朙揷復岹 (1塹惗):乽椷榓2擭搙丒擖堾姵幰昦怑楌挷嵏婎慴夝愅 (2005 擭搙乣2018 擭搙昦怑楌僨乕僞巊梡)乿尋媶曬崘彂 2021/2: p.1-102. https://www.research.johas.go.jp/bs/doc/20210402.pdf.
540012. [偦偺懠 (尋媶曬崘彂)]亂岞塿朄恖僼傽僀僓乕僿儖僗儕僒乕僠怳嫽嵿抍丂尋媶彆惉嬥亃 晲摗丂崉 (塹惗): 僼傽僀僓乕僿儖僗儕僒乕僠怳嫽嵿抍 尋媶惉壥曬崘彂 2021/3.
540013. [偦偺懠 (尋媶曬崘彂)]亂堦斒嵿抍朄恖僿儖僗僒僀僄儞僗僙儞僞乕尋媶彆惉嬥亃 晲摗丂崉 (塹惗): 堦斒嵿抍朄恖僿儖僗僒僀僄儞僗僙儞僞乕尋媶彆惉嬥 尋媶幚愌曬崘彂 2021/3.
540014. [偦偺懠 (尋媶曬崘彂)]亂楯嵭幘昦椪彴尋媶帠嬈旓曗彆嬥 (190402-01)乽帠柋強塹惗婎弨婯懃偵娭偡傞尋媶亅懨摉惈偲崙嵺婎弨偲偺挷榓亅乿亃晲摗丂崉1, 壴棦恀摴, 嫶杮弔抝, 陰摗岹擵, 拞懞桾擵, 墶嶳榓恗, 徏暯丂峗, 墦摗尮庽 (1塹惗): 椷榓2擭搙憤妵丒暘扴曬崘彂 2021/3.
540015. [偦偺懠 (尋媶曬崘彂)]亂楯嵭幘昦椪彴尋媶帠嬈旓曗彆嬥 (180703-01)乽怑嬈惈僗僩儗僗娙堈挷嵏昜偺奜崙斉嶌惉偵娭偡傞尋媶乿亃墶嶳榓恗, 搾愺帒擵, 榓揷峩帯, 扟愳丂晲, 墦摗尮庽, 塝愳壛戙巕, 晲摗丂崉1, 彫揷愗桪巕, 揷拞岝婭 (1塹惗): 椷榓2擭搙摑妵丒暘扴曬崘彂 2021/3.
[挊丂彂]
620007. [妛弍彂 (暘扴幏昅)]亂嶻嬈堛僈僀僪戞3斉亃戞10復摥偒曽夵妚丂4帯椕偲巇帠偺椉棫巟墖亅楯摥幰杮恖傪拞怱偲偟偨帠嬈応偲堛椕婡娭偺楢懷悇恑傪栚巜偟偰亅, p.588. 暉杮惓彑, 殺摗嬦巎, 憹揷岾峅, 憹揷婱旤巕, 曯丂棽擵, 戝捨抭擵, 拞扟丂撝, 嶰戭桾擇, 壛摗寷拤, 郷杮榡抝, 屲廫棐愮戙, 戝栰柧旻, 怺郪寬擇, 昹揷撃榊, 惣擶怉婯廏, 暉揷恀栫, 懞揷丂崕, 惸摗惌旻, 嶳撪丂攷, 崅揷楃巕, 彫愳峃嫳, 媨墇梇堦, 淺晊旤撧巕, 戝嫶丂椡, 塅巑丂攷, 嵅摗峀榓, 嶳杮寬栫, 恵夑枩抭, 媨杮弐柧, 崅栰抦庽, 媑懞桋巌, 崟栘愰晇, 宩愳廋堦, 埌尨丂棨, 愇愳峗擇, 拞愳榓旤, 嶳帥丂榡, 拞捯傔偖傒, 堜弌峀岾, 桳攏廏峎, 桹堜旤榓巕, 彫揷愗桪巕, 壓岝婸堦, 扟嶳壚捗巕, 屲枴廏曚, 戝棦丂岤, 妢尨墄晇, 嶳杮彯庻, 堦悪惓恗, 壛晹丂桬, 媨撪攷岾, 帥揷桬恖, 孍揷徆巌, 壀嶈榓岝, 壛摗丂尦, 拞栰垽巕, 怷嶈旤撧巕, 彫尨丂怴, 枛塱怲夘, 洈栘攷堦, 搰杻堖巕, 搶愳杻巕, 晲摗丂崉1, 墦摗尮庽, 彫搰尨揟巕, 徏塱愮廐, 媑愳丂揙, 墫郪桭婯, 彫墥峃斖, 堫奯丂拞, 屲枴溎懢榊, 嵅乆栘晀, 椦丂梞巕, 搰捗柧恖, 掔丂柧弮2, 屆娬斾搇巙, 庬巗愛巕, 崱堜揝暯, 彫敤奊旤巕 (1塹惗, 2岞廜塹惗), 曇: 擔杮嶻嬈塹惗妛夛娭搶嶻嬈堛晹夛, 擔杮堛帠怴曬幮, 搶嫗, 2020/12敪峴.
620008. [妛弍彂 (娔廋丒曇廤丒偦偺懠)]亂憤崌恌椕愱栧尋廋亅岞幃僥僉僗僩僽僢僋亅亃戞8復峫椂偡傋偒幮夛忣惃惂搙丂幮夛曐尟匓. 晲摗丂崉 (塹惗), 曇: 擔杮愱栧堛婡峔憤崌恌椕愱栧堛専摙埾堳夛, 擔宱BP, 搶嫗, 2020/12敪峴.
620009. [妛弍彂 (暘扴幏昅)]亂崙柉偺塰梴敀彂2020擭搙斉 姶愼徢偺棳峴偲塰梴偺崱屻亃戞2晹柶塽婡擻偵偍偗傞塰梴偺栶妱丂戞1復柶塽宯偺偟偔傒亅惗懱杊屼偵偍偗傞墛徢偲塰梴, p.73. 拞懞挌師, 娵愇惢栻姅幃夛幮, 庰堜丂揙, 楡懞桭庽媣, 壓揷丂惷, 擺孾堦榊, 杧岥堩巕, 晲摗丂崉1, 峅揷検擇, 尨丂峗桽, 幠揷廳怣, 楅栘巙曐巕, 晲揷榓桼, 扟岥塸婌, NPO朄恖傐偗偭偲僗僥乕僔儑儞, 拞懞堢巕, 峕晹丂摰, 栰岥嵤壚 (1塹惗), 娔廋: 拞懞挌師, 擔杮堛椕婇夋, 搶嫗, 2020/12敪峴.
[妛夛丒尋媶夛摍]
722011. [妛夛 (慡崙)] (僔儞億僕僂儉) 僀僞僀僀僞僀昦偺揥朷乣崱屻偺梊應偲懳嶔. 杧岥暫崉 (塹惗): 戞91夞擔杮塹惗妛夛妛弍憤夛 (2021/3/8), Web奐嵜.
723058. [妛夛 (慡崙)] (堦斒島墘) 戞3師嶻嬈偺嬈柋埾戸壓惪峔憿偵婲場偡傞埨慡塹惗偺壽戣:摨堦嶌嬈丆摨堦埨慡塹惗傊. 戝怷桼婭1, 晲摗丂崉1, 墶嶳榓恗, 墦摗尮庽, 暉揷丂梞, 戝栴傔偖傒, 嶳嶈桭忎, 徏暯丂峗 , 愇堜棟撧, 杧岥暫崉1 (1塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12), 帍忋奐嵜丒Web奐嵜.
723059. [妛夛 (慡崙)] (堦斒島墘) AI傪梡偄偨怑堟50枩恖僨乕僞/儊僞儃僴僀儕僗僋幰偺寬恌屻庴恌峴摦梊應儌僨儖偺奐敪. 晲摗丂崉1, 曅嬎椚巕, 墦摗尮庽, 暉揷丂梞, 墶嶳榓恗, 杒懞暥旻, 戝栴傔偖傒, 愇堜棟撧, 戝怷桼婭1, 杧岥暫崉1 (1塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12), 帍忋奐嵜丒Web奐嵜.
723060. [妛夛 (慡崙)] (堦斒島墘) 帯椕偲廇楯偺椉棫巟墖loT/AI僔僗僥儉偺奐敪. 墦摗尮庽, 晲摗丂崉1, 陰摗岝峕, 愹丂攷擵 (1塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12-28), 帍忋奐嵜丒Web奐嵜.
723061. [妛夛 (慡崙)] (堦斒島墘) 僠僃僢僋儕僗僩30傪梡偄偨拞彫婇嬈偱偺帯椕偲巇帠偺椉棫巟墖僀儞僞乕僱僢僩挷嵏. 愳枖壺戙, 摗堜朁巕, 晲摗丂崉1, 崅嶳攷岝, 徏梩丂惸, 壀丂宧擵, 徏暯丂峗 (1塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12-28), 帍忋奐嵜丒Web奐嵜.
723062. [妛夛 (慡崙)] (堦斒島墘) 寬峃恌抐偲帠屻慬抲丒惗妶廗姷昦巜摫7. 晲摗丂崉 (塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12-28), 帍忋奐嵜丒Web奐嵜.
723063. [妛夛 (慡崙)] (堦斒島墘) 摿庩寬峃恌抐偺庴恌楌偲偑傫偺滊姵偵娭偡傞専摙亅慡崙楯嵭昦堾昦怑楌挷嵏僨乕僞傛傝亅. 怺堜峲懢, 彫搰尨揟巕, 惎丂壚朏1, 朙揷復岹, 棫摴徆岾 (1塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12-28), 帍忋奐嵜丒Web奐嵜, 擔杮嶻嬈塹惗妛夛島墘廤 擔杮嶻嬈塹惗妛夛帍 2020/5; 62 (椪帪憹姧崋): 505.
723064. [妛夛 (慡崙)] (堦斒島墘) 慡崙楯嵭昦堾丒擖堾姵幰昦怑楌挷嵏偵偍偗傞姵幰偲偟偰偺堛巘偺摥偒曽偲惗妶廗姷偺曄壔. 惎丂壚朏1, 彫搰尨揟巕, 棫摴徆岾, 朙揷復岹 (1塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12-28), 帍忋奐嵜丒Web奐嵜, 擔杮嶻嬈塹惗妛夛島墘廤 擔杮嶻嬈塹惗妛夛帍 2020/5; 62 (椪帪憹姧崋): 539.
723065. [妛夛 (慡崙)] (堦斒島墘) 僇僪儈僂儉搳梌儔僢僩偵偍偗傞枛徑寣拞僄儕僗儘億僄僠儞偲恡憻偱偺僄儕僗儘億僄僠儞敪尰偲偺娭學. 杧岥暫崉1, 彫孎墄巕, 埨壀桳婭巕2, 戝怷桼婭1, 壨尨崕夒, 栰乆岥攷巎 (1塹惗, 2惗棟): 戞47夞擔杮撆惈妛夛妛弍擭夛 (2020/6/29), Web奐嵜.
723066. [妛夛 (慡崙)] (堦斒島墘) 僼儗僀儖忬懺偵偁傞娭愡儕僂儅僠姵幰偲抧堟嵼廧崅楊幰偺斾妑専摙. 忋抧崄搈, 彫搱夒戙, 埨壀幚壚巕, 晲摗丂崉1, 斞捤尯柧, 嵵摗丂柉, 搉绯旤婱, 楅栘掑晇, 抾撪尋帪, 庒堜寶巙, 旜搰弐擵, 嬤摗崕懃 (1塹惗): 戞79夞擔杮岞廜塹惗妛夛憤夛 (2020/10/20-22), Web奐嵜.
723067. [妛夛 (慡崙)] (堦斒島墘) 幮夛嶲壛偲僼儗僀儖: 娭愡儕儏僂儅僠姵幰偲乽寬峃偲偔傜偟偺挷嵏2016乿嶲壛幰偺斾妑. 彫搱夒戙, 埨壀幚壚巕, 晲摗丂崉1, 斞捤尯柧, 嵵摗丂柉, 搉绯旤婱, 楅栘掑晇, 抾撪尋帪, 庒堜寶巙, 旜搰弐擵, 嬤摗崕懃 (1塹惗): 戞79夞擔杮岞廜塹惗妛夛憤夛 (2020/10/20-22), Web奐嵜.
723068. [妛夛 (慡崙)] (堦斒島墘) 抝惈崅楊幰偵偍偗傞嵟挿怑偺婇嬈婯柾暿偺幮夛嶲壛偲巰朣偺娭楢: JAGES僗僞僨傿. 嬥怷丂屽, 嬤摗彯屓, 崅媨朁巕, 媏抮岹岾, 堜忋丂栁, 捯丂戝巑, 峛斻桾巕, 晲摗丂崉1, 嬤摗崕懃 (1塹惗): 戞79夞擔杮岞廜塹惗妛夛憤夛 (2020/10/20-22), Web奐嵜.
723069. [妛夛 (慡崙)] (堦斒島墘) 婇嬈偵偍偗傞帯椕偲巇帠偺椉棫巟墖偺尰忬偵娭偡傞専摙. 摗堜朁巕, 壀丂宧擵, 晲摗丂崉1, 怷岥師榊, 彫嶳慞巕, 徏暯丂峗 (1塹惗): 戞79夞擔杮岞廜塹惗妛夛憤夛 (2020/10/20-22), Web奐嵜.
723070. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃(墦妘嶻嬈塹惗尋媶帺桼廤夛僌儖乕僾専摙夛) 帠椺偐傜妛傇, 墦妘柺愙偺懀恑梫場丒慾奞梫場乣昁梫廫暘忦審傪専摙偡傞乣. 烴栘墍巕, 晲摗丂崉1 (1塹惗): 戞30夞擔杮嶻嬈塹惗妛夛慡崙嫤媍夛 (2020/11/20-30), Web奐嵜.
723071. [妛夛 (慡崙)] (堦斒島墘) 2-儊儖僇僾僩儀儞僝僠傾僝乕儖嶌梡偵傛傞兞-H2AX惗惉偲偦偺桿摫儊僇僯僘儉偵娭偡傞尋媶. 孷丂塱崉, 朙壀払巑, 杧岥暫崉1, 墹丂悙惗, 峛揷栁庽 (1塹惗): 擔杮娐嫬曄堎尨妛夛戞49夞戝夛 (2020/11/26-27), 徖捗, 擔杮娐嫬曄堎尨妛夛戞49夞戝夛梫巪廤 2020/11; p.92.
723072. [妛夛 (慡崙)] (堦斒島墘) 堦斒昦堾偺恡幘姵姵幰偵偍偗傞崅兝2-儈僋儘僌儘僽儕儞擜徢. 杧岥暫崉1, 彫孎墄巕, 戝怷桼婭1, 彫椦搷巕2, 徏愳妜媣, 郪懞徆恖, 媏抧岶嵠, 埳摗孿屷, 媨搰峕棦巕, 崅嫶丂椛3 (1塹惗, 2梊杊堛妛宯, 3恡憻撪): 戞91夞擔杮塹惗妛夛妛弍憤夛 (2021/3/6), Web奐嵜.
723073. [妛夛 (慡崙)] (億僗僞乕) 墛徢惈挵幘姵偲嵟挿怑嬈楌偲偺娭楢亅慡崙楯嵭昦堾昦怑楌僨乕僞儀乕僗傛傝亅. 屆壆桟巕, 怺堜峲懢, 拞郪徦巕, 彫搰尨揟巕, 惎丂壚朏1, 朙揷復岹, 棫摴徆岾 (1塹惗): 戞91夞擔杮塹惗妛夛妛弍憤夛 (2021/3/6-8), Web奐嵜, 戞91夞擔杮塹惗妛夛妛弍憤夛島墘廤 擔杮塹惗妛嶨帍 2021/3; 76 (suppl): s179.
723074. [妛夛 (慡崙)] (億僗僞乕) 桳奞嶌嬈偺嬈柋楌偲媔墝偺暋崌揑敇業偑攛偑傫滊姵偵媦傏偡塭嬁. 怺堜峲懢, 彫搰尨揟巕, 惎丂壚朏1, 屆壆桟巕, 朙揷復岹, 棫摴徆岾 (1塹惗): 戞91夞擔杮塹惗妛夛妛弍憤夛 (2021/3/6-8), Web奐嵜, 戞91夞擔杮塹惗妛夛妛弍憤夛島墘廤 擔杮塹惗妛嶨帍 2021/3; 76 (suppl): s186.
723075. [妛夛 (慡崙)] (堦斒島墘) 庒庤妶惈壔娭楢婇夋乽庒庤偐傜偺恡憻儕僴價儕僥乕僔儑儞 (妛夛) 傊偺採尵乿恡憻儕僴價儕僥乕僔儑儞偺塣摦僾儘僌儔儉偲昡壙偵娭偡傞採尵. 楅栘桾懢1, 尨揷垽塱, 惎丂壚朏2, 敀娾丂寬, 暉揷丂宧, 徏塱撃旻3 (1戝妛堾堛椕宯尋媶壢, 2塹惗, 3堛椕塹惗妛晹): 戞11夞擔杮恡憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛 (2021/3/20), Web奐嵜, 擔杮恡憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛僾儘僌儔儉丒彺榐廤 2021; 11th: 162.
733009. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恡擜嵶娗婡擻忈奞傪娷傓廤抍偵偍偗傞寣拞丒擜拞僇僪儈僂儉擹搙偺敇業巜昗偲偟偰偺懨摉惈偺専摙. 杧岥暫崉1, 彫孎墄巕, 懞揷彑宧, 嵅乆栘晀, 媨杮壚戙巕, 戝栰抭巕, 彫徏揷撝, 孎郪桼旤巕 (1塹惗): 儊僞儖僶僀僆僒僀僄儞僗尋媶夛2020 (2020/11/6), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-540001. [偦偺懠 (尋媶曬崘彂)]亂楯嵭幘昦椪彴尋媶帠嬈旓曗彆嬥 (170401-01)亃婇嬈丒嶻嬈曐寬僗僞僢僼丒堛椕婡娭偺楢実偵傛傞椉棫巟墖僔僗僥儉偺奐敪: 帯椕偲巇帠偺椉棫巟墖偵偍偗傞堛椕婡娭偺栶妱亅拞彫婇嬈傪娷傔偨怑堟丒嶻嬈堛偲偺楢実偺暘愅偲庢慻傒亅. 徏暯丂峗 (庡擟尋媶幰), 墶嶳榓恗, 晲摗丂崉1 (1塹惗): 暯惉29擭-椷榓尦擭搙憤崌尋媶曬崘彂 2020/3; p.36-43.
[妛夛丒尋媶夛摍]
'19-723004. [妛夛 (慡崙)] (堦斒岥墘) 僷儔僞儖僶乕偺埵抲偺堘偄偑敪岅帪偺擼妶摦偵梌偊傞塭嬁. 曅壀壛撧巕, 惗揷棿暯, 摗尨丂婎, 愮尨丂峎, 彫椦丂崉, 惎丂壚朏1, 彫栰媩奊, 嬍抲彑巌 (1塹惗): 岞塿幮抍朄恖擔杮曗捲帟壢妛夛戞128夞妛弍戝夛 (2019/5/12), 嶥杫, 擔杮曗捲帟壢妛夛帍 戞128夞擔杮曗捲帟壢妛夛 妛弍戝夛僾儘僌儔儉彺榐廤2019; 11 (128夞摿暿崋): 173. https://www.knt.co.jp/ec/2019/jps128/pdf/shoroku2.pdf.
'19-723005. [妛夛 (慡崙)] (堦斒島墘) 慡崙楯嵭昦堾昦怑楌挷嵏僨乕僞傪梡偄偨怑庬偲擼丒怱寣娗幘姵偺敪徢偵娭偡傞専摙. 怺堜峲懢, 棫摴徆岾, 彫搰尨揟巕, 惎丂壚朏1, 朙揷復岹 (1塹惗): 戞30夞擔杮塽妛夛妛弍憤夛 (2020/2/20-22), 嫗搒, 戞30夞擔杮塽妛夛妛弍憤夛島墘廤 2020/2; 30 (suppl): 129.
'19-733001. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恌椕僈僀僪儔僀儞偺弌棃曽偲撉傒曽. 惎丂壚朏 (塹惗): 擔杮桳昦幰帟壢堛椕妛夛戞9夞妛弍嫵堢僙儈僫乕 (2019/11/17), 搶嫗, 戞9夞妛弍嫵堢僙儈僫乕僾儘僌儔儉丒彺榐廤 p.16-7.
'19-733002. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 枬惈墛徢 (Th2宆) 敪徢婡彉偵娭偡傞柶塽 惂屼偲娐嫬梫場偺専摙. 晲摗丂崉 (塹惗): 戞13夞僾儘僌儗僗儗億乕僩夛媍 (2020/1/15), 憡柾尨.
岞廜塹惗妛
[妛弍榑暥]
110057. [尨挊] Internal consistency reliability, construct validity, and item response characteristics of the Kessler 6 scale among hospital nurses in Vietnam. Kawakami N, Tran TTT, Watanabe K, Imamura K, Nguyen HT, Sasaki N, Kuribayashi K, Sakuraya A, Nguyen QT, Nguyen NT, Bui TM, Nguyen GTH, Minas H, Tsutsumi A1: PLoS One 2020/5; 15 (5): e0233119. (掔丂柧弮1: 1岞廜塹惗)
110058. [尨挊] The Association Between Unit-Level Workplace Social Capital and Intention to Leave Among Employees in Health Care Settings: A Cross-Sectional Multilevel Study. Iida M, Watanabe K, Ando E, Tsuno K, Inoue A1, Kurioka S, Kawakami N: J Occup Environ Med 2020/5; 62 (5): e186-91. (堜忋彶恇1: 1岞廜塹惗)
110059. [尨挊] Cumulative Exposure to Long Working Hours and Occurrence of Ischemic Heart Disease: Evidence From the CONSTANCES Cohort at Inception. Fadel M, Li J, Sembajwe G, Gagliardi D, Pico F, Ozguler A, Evanoff BA, Baer M, Tsutsumi A1, Iavicoli S, Leclerc A, Roquelaure Y, Siegrist J, Descatha A: J Am Heart Assoc 2020/6; 9 (12): e015753. (掔丂柧弮1: 1岞廜塹惗)
110060. [尨挊] Combined effect of high stress and job dissatisfaction on long-term sickness absence: a 1-year prospective study of Japanese employees. Inoue A1, Kachi Y1, Eguchi H1, Shimazu A, Kawakami N, Tsutsumi A1: Environmental and Occupational Health Practice 2020/6; 2 (1): eohp.2020-0002-OA. (堜忋彶恇1, 壜抦桰巕1, 峕岥丂彯1, 掔丂柧弮1: 1岞廜塹惗)
110061. [尨挊] Workplace social capital and refraining from seeking medical care in Japanese employees: a 1-year prospective cohort study Inoue A1, Tsutsumi A1, Eguchi H1, Kachi Y1, Shimazu A, Miyaki K, Takahashi M, Kurioka S, Enta K, Kosugi Y, Totsuzaki T, Kawakami N: BMJ Open 2020/8; 10 (8): e036910. (堜忋彶恇1, 掔丂柧弮1, 峕岥丂彯1, 壜抦桰巕1: 1岞廜塹惗)
110062. [尨挊] Construct validity and test-retest reliability of the World Mental Health Japan version of the World Health Organization Health and Work Performance Questionnaire Short Version: a preliminary study. Kawakami N, Inoue A1, Tsuchiya M, Watanabe K, Imamura K, Iida M, Nishi D: Ind Health 2020/8; 58 (4): 375-87. (堜忋彶恇1: 1岞廜塹惗)
110063. [尨挊] The effect of exposure to long working hours on ischaemic heart disease: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Li J, Pega F, Ujita Y, Brisson C, Clays E, Descatha A, Ferrario MM, Godderis L, Iavicoli S, Landsbergis PA, Metzendorf MI, Morgan RL, Pachito DV, Pikhart H, Richter B, Roncaioli M, Rugulies R, Schnall PL, Sembajwe G, Trudel X, Tsutsumi A1, Woodruff TJ, Johannes Siegrist J: Environ Int 2020/9; 142: 105739. (掔丂柧弮1: 1岞廜塹惗)
110064. [尨挊] Psychosocial Work Environment Explains the Association of Job Dissatisfaction With Long-term Sickness Absence: A One-Year Prospect Study of Japanese Employees. Inoue A1, Tsutsumi A1, Kachi Y1, Eguchi H1, Shimazu A, Kawakami N: J Epidemiol 2020/9; 30 (9): 390-5. (堜忋彶恇1, 掔丂柧弮1, 壜抦桰巕1, 峕岥丂彯1: 1岞廜塹惗)
110065. [尨挊] Parental cohabitation and mental well-being amongst young adults in the world's densest population with least affordable housing: Evidence from the FAMILY cohort. Hikichi H1, Ni MY, Leung GM: J Affect Disord 2020/9; 274: 698-703. (堷抧攷擵1: 1岞廜塹惗)
110066. [尨挊] The effect of exposure to long working hours on stroke: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Descatha A, Sembajwe G, Pega F, Ujita Y, Baer M, Boccuni F, Di Tecco C, Duret C, Evanoff BA, Gagliardi D, Godderis L, Kang SK, Kim BJ, Li J, Magnusson Hanson LL, Marinaccio A, Ozguler A, Pachito D, Pell J, Pico F, Ronchetti M, Roquelaure Y, Rugulies R, Schouteden M, Siegrist J, Tsutsumi A1, Iavicoli S: Environ Int 2020/9; 142: 105746. (掔丂柧弮1: 1岞廜塹惗)
110067. [尨挊] Which autistic traits are related to depressive symptoms in Japanese workers?. Suzuki T, Miyaki K, Tsutsumi A1: Ind Health 2020/10; 58 (5): 414-22. (掔丂柧弮1: 1岞廜塹惗)
110068. [尨挊] What Kind of Intervention Is Effective for Improving Subjective Well-Being Among Workers? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Sakuraya A, Imamura K, Watanabe K, Asai Y, Ando E, Eguchi H1, Nishida N, Kobayashi Y, Arima H, Iwanaga M, Otsuka Y, Sasaki N, Inoue A1, Inoue R, Tsuno K, Hino A, Shimazu A, Tsutsumi A1, Kawakami N: Front Psychol 2020/11; 11: 528656. (峕岥丂彯1, 堜忋彶恇1: 掔丂柧弮1: 1岞廜塹惗)
110069. [尨挊] Associations Between Community Social Capital and Preservation of Functional Capacity in the Aftermath of a Major Disaster. Gero K, Hikichi H1, Aida J, Kondo K, Kawachi I: Am J Epidemiol 2020/11; 189 (11): 1369-78. (堷抧攷擵1: 1岞廜塹惗)
110070. [尨挊] Andropause symptoms and sickness absence in Japanese male workers: a prospective study. Hirokawa K, Fujii Y, Taniguchi T, Takaki J, Tsutsumi A1: Aging Male 2020/12; 23 (5): 1545-52. (掔丂柧弮1: 1岞廜塹惗)
110071. [尨挊] Household income and the risk of incident hypertension in employees at multiple workplaces in Japan: J-HOPE. Yanagiya S, Nakamura K, Ukawa S, Tsutsumi A1, Atsumi T, Tamakoshi A: Hypertens Res 2020/12; 43 (12): 1445-53. (掔丂柧弮1: 1岞廜塹惗)
110072. [尨挊] Work Engagement and Work Performance Among Japanese Workers: A 1-Year Prospective Cohort Study. Eguchi H1, Inoue A1, Kachi Y1, Miyaki K, Tsutsumi A1: J Occup Environ Med 2020/12; 62 (12): 993-7. (峕岥丂彯1, 堜忋彶恇1, 壜抦桰巕1, 掔丂柧弮1: 1岞廜塹惗)
110073. [尨挊] Mothers' nonstandard work schedules and adolescent obesity: a population-based cross-sectional study in the Tokyo metropolitan area. Kachi Y1, Abe A, Eguchi H1, Inoue A1, Tsutsumi A1: BMC Public Health 2021/1; 21 (1): 237. (壜抦桰巕1, 峕岥丂彯1, 堜忋彶恇1, 掔丂柧弮1: 1岞廜塹惗)
110074. [尨挊] Association between maternity harassment and depression during pregnancy amid the COVID-19 state of emergency. Kachi Y1, Fujiwara T, Eguchi H1, Inoue A1, Baba S, Ohta H1, Tsutsumi A1: J Occup Health 2021/1; 63 (1): e12196. (壜抦桰巕1, 峕岥丂彯1, 堜忋彶恇1, 懢揷丂姲1, 掔丂柧弮1: 1岞廜塹惗)
110075. [尨挊] Mothers' nonstandard work schedules and adolescent obesity: a population-based cross-sectional study in the Tokyo metropolitan area. Kachi Y1, Abe A, Eguchi H1, Inoue A1, Tsutsumi A1: BMC Public Health 2021/1; 21 (1): 237. (壜抦桰巕1, 峕岥丂彯1, 堜忋彶恇1, 掔丂柧弮1: 1岞廜塹惗)
110076. [尨挊] Six-year follow-up study of residential displacement and health outcomes following the 2011 Japan Earthquake and Tsunami. Hikichi H1, Aida J, Kondo K, Kawachi I: Proc Natl Acad Sci U S A 2021/1; 118 (2): e2014226118. (堷抧攷擵1: 1岞廜塹惗)
110077. [尨挊] Effects of Smartphone-Based Stress Management on Improving Work Engagement Among Nurses in Vietnam: Secondary Analysis of a Three-Arm Randomized Controlled Trial Sasaki N, Imamura K, Tran TTT, Nguyen HT, Kuribayashi K, Sakuraya A, Bui TM, Nguyen QT, Nguyen NT, Nguyen GTH, Zhang MW, Minas H, Sekiya Y, Watanabe K, Tsutsumi A1, Shimazu A, Kawakami N: J Med Internet Res 2021/2; 23 (2): e20445. (掔丂柧弮1: 1岞廜塹惗)
220001. [弨尨挊 (挷嵏曬崘)] 廬嬈堳8柤偺彫婯柾楇嵶婇嬈偵偍偗傞嶲壛宆怑応夵慞儌僨儖帠嬈偺2擭娫偺庢傝慻傒. 崟栘恗旤, 怷岥師榊, 撪揷梲擵, 戝嫶巎巕, 屲廫棐愮戙, 彫揷愗桪巕, 搰捗柧恖, 掔丂柧弮1, 嬔屗揟巕, 尨扟棽巎, 媑愳墄巕, 媑愳丂揙, 愳忋寷恖 (1岞廜塹惗): 嶻嬈塹惗妛嶨帍 2020/11; 62 (6): 249-60.
510001. [憤愢] Cross-sectional association between working and depression prevalence in cancer survivors: a literature review. Ota A, Kawada K, Tsutsumi A1, Yatsuya H: Environmental and Occupational Health Practice 2020/6; 2 (1): eohp.2020-0006-RA. (掔丂柧弮1: 1岞廜塹惗)
510002. [憤愢] Implementation and effectiveness of the Stress Check Program, a national program to monitor and control workplace psychosocial factors in Japan: a systematic review. Translated secondary publication. Tsutsumi A1, Sasaki N, Komase Y, Watanabe K, Inoue A1, Imamura K, Kawakami N: International Journal of Workplace Health Management 2020/12; 13 (6): 649-70. (掔丂柧弮1, 堜忋彶恇1: 1岞廜塹惗)
522010. [島嵗]亂摿廤: 忈奞幰屬梡偲嶻嬈僗僩儗僗1亃忈奞偺偁傞楯摥幰偺廇嬈忋偺僗僩儗僗偲巟墖偲嶻嬈曐寬怑偺栶妱. 峕岥丂彯 (岞廜塹惗): 嶻嬈僗僩儗僗尋媶 2020/4; 27 (2): 193-201.
522011. [島嵗]亂摿廤: 嬈庬丒怑庬偲嶻嬈僗僩儗僗懳嶔亃怑嬈娫偵偍偗傞怱偺寬峃奿嵎亅怑嬈惈僗僩儗僗傊偺傾僾儘乕僠亅. 堜忋彶恇 (岞廜塹惗): 嶻嬈僗僩儗僗尋媶 2020/8; 27 (3): 309-18.
522012. [島嵗]亂楢嵹: 嵟愭抂堛椕偺崱亃怑偺晄埨掕惈偲怱棟揑僗僩儗僗斀墳偲偺娭楢偵懳偡傞巇帠偺帒尮偺娚徴岠壥. 堜忋彶恇 (岞廜塹惗): Medical Science Digest 2020/12; 46 (14): 878-81.
530002. [偦偺懠 (Opinions)] Workstyle reform for Japanese doctors. Tsutsumi A1: Environmental and Occupational Health Practice 2020/6; 2 (1): eohp.2020-0008-OP. (掔丂柧弮1: 1岞廜塹惗)
530003. [偦偺懠 (Editorial)] Emerging issues in the occupational health field. Tsutsumi A1: Environ Occup Health Practice 2020/6; 2 (1). doi.org/10.1539/eohp.2.1-ED. (掔丂柧弮1: 1岞廜塹惗)
530004. [偦偺懠 (Opinion)] Suicide prevention for workers in the era of with- and after-Corona. Tsutsumi A1: Environmental and Occupational Health Practice 2021/3; 3 (1): 2020-0020-OP. (掔丂柧弮1: 1岞廜塹惗)
540016. [偦偺懠 (榑抎)] 僥儗儚乕僋偲儊儞僞儖僿儖僗. 掔丂柧弮 (岞廜塹惗): 嶻嬈堛妛僕儍乕僫儖 2020/11; 43 (6): 106-8.
540017. [偦偺懠 (妛夛曬崘)]亂嶻嬈曐寬崙撪娭楢僯儏乕僗亃戞36夞擔杮僗僩儗僗妛夛妛弍憤夛奐嵜曬崘. 堜忋彶恇1, 掔丂柧弮1 (1岞廜塹惗): 嶻嬈堛妛僕儍乕僫儖 2021/3; 44 (2): 58-62.
540018. [偦偺懠 (尋媶曬崘彂)]亂楯嵭幘昦椪彴尋媶帠嬈旓曗彆嬥乽帠嬈応偵偍偄偰帯椕偲巇帠偺椉棫巟墖傪偡傞偨傔偺攝椂偲偦偺寛掕僾儘僙僗偵偐傫偡傞尋媶乿亃峕岥丂彯1 (尋媶戙昞幰), 掔丂柧弮1, 嵅乆栘帯堦榊2, 恵夑枩抭, 搉曈丂揘, 嶳栰壝媣, 惸摗丂憦, 屆壆攷峴, 怷揷揘栫, 妬栘斏擵, 杒嫃丂柧, 怷塱梇懢, 晲摗丂崉3, 堜忋彶恇1 (1岞廜塹惗, 2怴悽婭堛椕丒墶抐揑堛椕, 3塹惗): 椷榓2擭搙憤妵丒暘扴尋媶曬崘彂 2021/3.
[挊丂彂]
610001. [妛弍彂 (暘扴幏昅)]亂Health in Japan: Social Epidemiology of Japan since the 1964 Tokyo Olympics亃Japan's Miracle Decades: Harmony, Hard Work, and Health, p.85-100. Tsutsumi A1, Editors: Brunner E, Cable N, IsoH, Oxford University Press, UK, 2020/8. (掔丂柧弮1: 1岞廜塹惗)
620010. [妛弍彂 (暘扴幏昅)]亂幮夛丒娐嫬偲寬峃丂岞廜塹惗妛丂2021擭搙斉亃CHAPTER 9丂惛恄幘姵, p.95-100. 掔丂柧弮 (岞廜塹惗), 曇挊: 桍愳丂梞, 旜搰弐擵, 堛帟栻弌斉姅幃夛幮, 搶嫗, 2021/1敪峴.
620011. [妛弍彂 (暘扴幏昅)]亂幮夛丒娐嫬偲寬峃丂岞廜塹惗妛丂2021擭搙斉亃CHAPTER 10丂帺嶦, 晄椂偺帠屘, 媠懸, 朶椡, p.101-4. 掔丂柧弮 (岞廜塹惗), 曇挊: 桍愳丂梞, 旜搰弐擵, 堛帟栻弌斉姅幃夛幮, 搶嫗, 2021/1敪峴.
620012. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓 2021擭斉丂巹偼偙偆帯椕偟偰偄傞亃16. 惛恄幘姵丂怑応晄揔墳徢, p.1114-5. 掔丂柧弮 (岞廜塹惗), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒堦惉, 堛妛彂堾, 搶嫗, 2021/1敪峴.
620013. [妛弍彂 (暘扴幏昅)]亂嶻嬈堛僈僀僪戞3斉亃戞11復嶻嬈塹惗妶摦偵栶棫偮抦幆丂7 楯摥惗嶻惈偲嶻嬈曐寬, p.674-81. 掔丂柧弮 (岞廜塹惗), 曇: 擔杮嶻嬈塹惗妛夛娭搶嶻嬈堛晹夛, 擔杮堛帠怴曬幮, 搶嫗, 2020/12敪峴.
620014. [妛弍彂 (暘扴幏昅)]亂僜乕僔儍儖丒僉儍僺僞儖偲寬峃丒暉巸丂幚徹尋媶偺庤朄偐傜惌嶔丒幚慔傊偺墳梡傑偱亃戞13復怑堟偱偺寬峃偯偔傝偲僜乕僔儍儖丒僉儍僺僞儖亅塽妛尋媶偺摓払揰偲壽戣, p.238-53. 堜忋彶恇1, 崅旜憤巌 (1岞廜塹惗), 曇挊: 嬤摗崕懃, 儈僱儖償傽彂朳, 嫗搒, 2020/4敪峴.
620015. [妛弍彂 (暘扴幏昅)]亂傾僋僥傿僽岞廜塹惗妛儔乕僯儞僌亃2 寬峃偲偼 (幮夛塽妛), p.23-42. 壜抦桰巕 (岞廜塹惗), 曇: 摗扟崕屓, 戨岥丂揙, 僂僀僱僢僩, 怴妰, 2020/7敪峴.
620016. [妛弍彂 (扨挊)]亂曐堢墍偵捠偊側偄巕偳傕偨偪亅乽柍墍帣乿偲偄偆埮亃壜抦桰巕 (岞廜塹惗), 拀杸彂朳, 搶嫗, 2020/4敪峴.
[妛夛丒尋媶夛摍]
722012. [妛夛 (慡崙)] (僔儞億僕僂儉) 怑応娐嫬夵慞. 掔丂柧弮 (岞廜塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12-28), 帍忋奐嵜丒Web奐嵜.
722013. [妛夛 (慡崙)] (彽懸島墘摍) Organizational justice and refraining from seeking medical care among Japanese employees: a 1-year prospective cohort study. 堜忋彶恇 (岞廜塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12-28), 帍忋奐嵜丒Web奐嵜.
722014. [妛夛 (慡崙)] (僔儞億僕僂儉) 楯摥幰偺儊儞僞儖僿儖僗偲帺嶦懳嶔. 掔丂柧弮 (岞廜塹惗): 戞79夞擔杮岞廜塹惗妛夛憤夛 (2020/10/20), Web奐嵜.
722015. [妛夛 (慡崙)] (僔儞億僕僂儉) 擭戙暿偺堷偒偙傕傝偺幘姵丆梊杊丒懳嶔. 掔丂柧弮 (岞廜塹惗): 戞79夞擔杮岞廜塹惗妛夛憤夛 (2020/10/22), Web奐嵜.
722016. [妛夛 (慡崙)] (僔儞億僕僂儉) 僗僩儗僗僠僃僢僋偺尰忬偲崱屻偺壽戣. 掔丂柧弮 (岞廜塹惗): 戞28夞擔杮嶻嬈僗僩儗僗妛夛 (2020/12/4), Web奐嵜.
723076. [妛夛 (慡崙)] (堦斒島墘) 崅僗僩儗僗偲怑柋晄枮懌偺慻崌偣偑挿婜幘昦媥嬈偵媦傏偡塭嬁: 恖帠婰榐偵傛傞廲抐尋媶. 堜忋彶恇1, 壜抦桰巕1, 峕岥丂彯1, 搰捗柧恖, 愳忋寷恖, 掔丂柧弮1 (1岞廜塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/5/14), 埉愳 (帍
723077. [妛夛 (慡崙)] (堦斒島墘) 怑応偺僴儔僗儊儞僩偺宱嵪懝幐: 幘昦媥嬈丒楯摥惗嶻惈丒棧怑偺娤揰偐傜. 捗栰崄撧旤, 愳忋寷恖, 掔丂柧弮1, 搰捗柧恖, 堜忋彶恇1, 媑愳丂揙, 彫揷愗桪巕, 壓岝婸堦 (1岞廜塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12-28), 帍忋奐嵜丒Web奐嵜.
723078. [妛夛 (慡崙)] (堦斒島墘) 幮夛宱嵪揑巜昗偲傾儖僨僗僥儘儞偲偺娭楢: J-HOPE尋媶偺墶抐暘愅. 壜抦桰巕1, 堜忋彶恇1, 峕岥丂彯1, 掔丂柧弮1 (1岞廜塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12-28), 帍忋奐嵜丒Web奐嵜.
723079. [妛夛 (慡崙)] (堦斒島墘) 巇帠偺梫媮搙僐儞僩儘乕儖僒億乕僩儌僨儖媦傃搘椡曬廣晄嬒峵儌僨儖偲HRQoL偺娭楢. 擔崅寢堖, 愳忋寷恖, 崱懞岾懢榊, 堜忋彶恇1, 搰捗柧恖, 媑愳丂揙, 淎丂彯揟, 愺堜桾旤, 彫揷愗桪巕, 媑愳墄巕, 搉曈榓峀, 掔丂柧弮1 (1岞廜塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12-28), 帍忋奐嵜丒Web奐嵜.
723080. [妛夛 (慡崙)] (堦斒島墘) 儚乕僋僄儞僎僀僕儊儞僩偺巇帠偺僷僼僅乕儅儞僗偵媦傏偡塭嬁偺専摙 峕岥丂彯1, 掔丂柧弮1, 堜忋彶恇1, 壜抦桰巕1, 媨栘岾堦 (1岞廜塹惗): 戞93夞擔杮嶻嬈塹惗妛夛 (2020/6/12-28), 帍忋奐嵜丒Web奐嵜.
723081. [妛夛 (慡崙)] (堦斒島墘) 儅僞僯僥傿僴儔僗儊儞僩偲擠怭拞偺梷偆偮偲偺娭楢: 怴宆僐儘僫僂僀儖僗嬞媫帠懺愰尵壓偱偺専摙. 壜抦桰巕1, 摗尨晲抝, 峕岥丂彯1, 堜忋彶恇1, 攏応岾巕, 懢揷丂姲1, 掔丂柧弮1 (1岞廜塹惗): 戞36夞擔杮僗僩儗僗妛夛妛弍憤夛 (2020/10/24-25), Web奐嵜.
723082. [妛夛 (慡崙)] (堦斒島墘) 帺暵徢摿惈偲嬈柋僷僼僅乕儅儞僗偲偺娭楢偵懳偡傞巇帠偺僐儞僩儘乕儖偺廋忺岠壥. 堜忋彶恇1, 峕岥丂彯1, 壜抦桰巕1, 媨栘岾堦, 楅栘抦巕, 掔丂柧弮1 (1岞廜塹惗): 戞36夞擔杮僗僩儗僗妛夛妛弍憤夛 (2020/10/24-25), Web奐嵜.
723083. [妛夛 (慡崙)] (堦斒島墘) 帪娫奜楯摥帪娫偲惛恄揑寬峃偲偺娭楢: 1擭娫偺廲抐尋媶. 堜忋椾巕1, 掔丂柧弮2, 娾揷丂徃, 堜忋彶恇2, 峕岥丂彯2, 壜抦桰巕2, 峳堜桳旤3 (1戝妛堾堛椕宯尋媶壢, 2岞廜塹惗, 3堛椕偺幙丒埨慡悇恑幒): 戞30夞擔杮嶻嬈塹惗妛夛慡崙嫤媍夛 (2020/11/22), Web奐嵜.
723084. [妛夛 (慡崙)] (堦斒島墘) 晝恊偺堢帣嶲壛傪慾奞丒懀恑偡傞梫場偺扵嶕亅擇廫堦悽婭弌惗帣廲抐挷嵏傛傝. 墇抭恀撧旤, 壛摗彸旻, 壜抦桰巕1, 抾尨寬擇 (1岞廜塹惗): 戞31夞擔杮塽妛夛妛弍憤夛 (2021/1/27-29), Web奐嵜.
732002. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 楯摥幰偺僗僩儗僗偲寬峃懳嶔. 掔丂柧弮 (岞廜塹惗): 夁楯巰摍杊巭懳嶔悇恑僔儞億僕僂儉 (2020/11/11), 搶嫗.
732003. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 儕儌乕僩儚乕僋偺壽戣. 掔丂柧弮 (岞廜塹惗): 夁楯巰摍杊巭懳嶔悇恑僔儞億僕僂儉 (2020/11/16), 戝嶃.
'19擭搙埲慜暘
[妛弍榑暥]
'19-110003. [尨挊] Reliability and validity of the Vietnamese version of the 9-item Utrecht Work Engagement Scale. Tran TTT, Watanabe K, Imamura K, Nguyen HT, Sasaki N, Kuribayashi K, Sakuraya A, Nguyen NT, Bui TM, Nguyen QT, Truong TQ, Nguyen GTH, Minas H, Tsustumi A1, Shimazu A, Kawakami N: J Occup Health 2020/1; 62 (1): e12157. (掔丂柧弮1: 1岞廜塹惗)
'19-110004. [尨挊] Effect of implementing an overwork-prevention act on working hours and overwork-related disease: A mediation analysis. Lin RT, Liang YW, Takahashi M, Eguchi H1, Tsutsumi A1, Lin SH: J Occup Health 2020/1; 62 (1): e12148. (峕岥丂彯1, 掔丂柧弮1: 1岞廜塹惗)
'19-110005. [尨挊] Socio-Economic Disparities in Early Childhood Education Enrollment: Japanese Population-Based Study. Kachi Y1, Kato T, Kawachi I: J Epidemiol 2020/3; 30 (3): 143-50. (壜抦桰巕1: 1岞廜塹惗)
'19-522002. [島嵗]亂摿廤: 摿廤 嶻嬈僗僩儗僗偲彮巕壔懳嶔亃搘椡亅曬廣晄嬒峵儌僨儖. 掔丂柧弮 (岞廜塹惗): 嶻嬈僗僩儗僗尋媶 2019/4; 26 (2): 243-8.
朄堛妛
[妛弍榑暥]
110078. [尨挊] Circumstances and factors of sleep-related sudden infancy deaths in Japan. Osawa M, Ueno Y, Ikeda N, Ikematsu K, Yamamoto T, Irie W1, Kozawa S, Kotani H, Hamayasu H, Murase T, Shingu K, Sugimoto M, Nagao R, Kakimoto Y: PLoS One 2020/4; 15 (8): e0233253. (擖峕丂徛1: 1朄堛)
110079. [尨挊] Individual identification using the RapidHITTM ID system for forensic samples. Murakami C1, Wataru Irie W1, Sasaki C1, Nakamaru N2, Sakamoto M2, Nagato J2, Satoh F1: Leg Med (Tokyo) 2020/11; 47: 101776. (懞忋愮崄巕1, 擖峕丂徛1, 嵅乆栘愮庻巕1, 拞娵彯旤2, 嶃杮搷巕2, 挿栧弮暯2, 嵅摗暥巕1: 1朄堛, 2宍懺宯)
320001. [徢椺曬崘] 愭揤惈愐拰懁淾徢傪崌暪偟偨儅儖僼傽儞徢岓孮偺梒帣朥専椺. 嵅摗暥巕1, 擖峕丂徛1, 懞忋愮崄巕1, 嵅乆栘愮庻巕1 (1朄堛): 擔杮SIDS丒擕梒帣撍慠巰梊杊妛夛嶨帍 2020/12; 20 (1): 37-42.
520004. [憤愢] 朄堛夝朥帪偵摼偨忣曬偵婎偯偔SUID偺幚懺偲娐嫬梫場偺挷嵏. 戝郪帒庽1, 忋栰堈峅2, 抮揷揟徍3, 抮徏榓嵠4, 嶳杮戶杹5, 擖峕丂徛6, 彫郪廃擇7, 彫扟懽堦8 (1搶奀戝妛堛妛晹婎斦恌椕妛宯朄堛妛, 2恄屗戝妛戝妛堾堛妛尋媶壢抧堟幮夛堛妛寬峃壢妛島嵗朄堛妛暘栰, 3嬨廈戝妛戝妛堾堛妛尋媶堾朄堛妛暘栰, 4挿嶈戝妛戝妛堾堛帟栻妛憤崌尋媶壢堛椕壢妛愱峌幮夛堛椕壢妛島嵗朄堛妛暘栰, 5暫屔堛壢戝妛朄堛妛島嵗, 6朄堛, 7嶰廳戝妛戝妛堾堛妛宯尋媶壢婎慴堛妛宯島嵗朄堛朄壢妛暘栰, 8嫗搒戝妛戝妛堾堛妛尋媶壢朄堛妛島嵗): 擔杮SIDS丒擕梒帣撍慠巰梊杊妛夛嶨帍 2020/12; 20 (1): 1-5.
[妛夛丒尋媶夛摍]
723085. [妛夛 (慡崙)] (堦斒岥墘) 朄堛夝朥帪偵摼偨忣曬偵婎偯偔SUID偺幚懺偲娐嫬梫場偺挷嵏. 戝郪帒庽1, 忋栰堈峅2, 抮揷揟徍3, 抮徏榓嵠4, 嶳杮戶杹5, 擖峕丂徛6, 彫郪廃擇7, 彫扟懽堦8 (1搶奀戝妛, 2恄屗戝妛, 3嬨廈戝妛, 4挿嶈戝妛, 5暫屔堛壢戝妛, 6朄堛, 7嶰廳戝妛, 8嫗搒戝妛): 戞26夞擔杮SIDS丒擕梒帣撍慠巰梊杊妛夛妛弍廤夛 (2020/8/28), Web奐嵜, 彺榐廤 p.26.
723086. [妛夛 (慡崙)] (億僗僞乕) LC-MS/MS偵傛傞17庬丒兝庴梕懱幷抐栻偺堦惸暘愅朄偺奐敪. 揳壀宐巕1, 帥揷丂尗1, 嵅乆栘愮庻巕2, 嵅摗暥巕2, 幝捤払梇1 (1墶昹栻壢戝妛昦懺惗棟妛, 2朄堛): 戞42夞擔杮拞撆妛夛憤夛丒妛弍廤夛 (2020/9/7), Web奐嵜, 拞撆尋媶, 2020/9; 33 (2): 171.
723087. [妛夛 (慡崙)] (億僗僞乕) RapidHIT ID system傪梡偄偨朄堛妛揑帋椏偵傛傞屄恖幆暿偺桳梡惈偺専摙. 懞忋愮崄巕1, 擖峕丂徛1, 嵅乆栘愮庻巕1, 拞娵彯旤2, 挿栧弮暯2, 堜忋擔嵷巕3, 嵅摗暥巕1 (1朄堛, 2宍懺宯, 3戝妛堾堛椕宯尋媶壢): 戞104師擔杮朄堛妛夛妛弍慡崙廤夛 (2020/9/24), 嫗搒, 擔杮朄堛妛嶨帍 2020/8; 74 (1): 77.
723088. [妛夛 (慡崙)] (堦斒岥墘) 枹恌抐偺尨敪惗怱憻庮釃偵傛傞擕帣撍慠巰偺堦朥専椺. 擖峕丂徛1, 懞忋愮崄巕1, 嵅乆栘愮庻巕1, 拞娵彯旤2, 嶃杮搷巕2, 挿栧弮暯2, 堜忋擔嵷巕3, 怉揷弶峕4, 嵅摗暥巕1 (1朄堛, 2宍懺宯, 3戝妛堾堛椕宯尋媶壢, 4崙棫弞娐婍昦尋媶僙儞僞乕昦棟晹): 戞104師擔杮朄堛妛夛妛弍慡崙廤夛 (2020/9/25), 嫗搒, 擔杮朄堛妛嶨帍 2020/8; 74 (1): 54.
723089. [妛夛 (慡崙)] (億僗僞乕) 僩儕僇僽僩暈梡帺嶦椺偵偍偗傞惗懱帋椏拞傾僐僯僠儞椶偺LC-MS/MS暘愅. 嵅乆栘愮庻巕1, 懞忋愮崄巕1, 擖峕丂徛1, 拞娵彯旤2, 挿栧弮暯2, 堜忋擔嵷巕3, 嵅摗暥巕1 (1朄堛, 2宍懺宯, 3戝妛堾堛椕宯尋媶壢): 戞104師擔杮朄堛妛夛妛弍慡崙廤夛 (2020/9/25), 嫗搒, 擔杮朄堛妛嶨帍 2020/8; 74 (1): 67.
723090. [妛夛 (慡崙)] (億僗僞乕) 擕梒帣撍慠巰椺偵偍偗傞梊杊愙庬楌偺挷嵏. 戝郪帒庽1, 挿旜椓巕1, 奯杮桼晍1, 奯撪峃岹1, 捸堜廐抝1, 嵅摗暥巕2 (1搶奀戝妛堛妛晹婎斦恌椕妛宯朄堛妛, 2朄堛): 戞104師擔杮朄堛妛夛妛弍慡崙廤夛 (2020/9/25), 嫗搒, 擔杮朄堛妛嶨帍 2020/8; 74 (1): 92.
733010. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 媫惈戝摦柆夝棧偵偍偗傞昦棟慻怐妛揑専摙亅摦柆峝壔徢偲偺斾妑亅. 堜忋擔嵷巕1, 嵅摗暥巕2, 擖峕丂徛2, 懞忋愮崄巕2, 嵅乆栘愮庻巕2, 拞娵彯旤3, 挿栧弮暯3 (1戝妛堾堛椕宯尋媶壢, 2朄堛, 3宍懺宯): 戞89夞擔杮朄堛妛夛妛弍娭搶抧曽廤夛 (2020/10/10), 搶嫗, 島墘梫巪廤 2020/10; p.23.
幚尡摦暔妛
[妛弍榑暥]
110080. [尨挊] Effect of retinoic acid signaling on Ripply3 expression and pharyngeal arch morphogenesis in mouse embryos. Okubo T1, Hara K, Azuma S1, Takada S: Dev Dyn 2021/7; 250 (7): 1036-50. doi: 10.1002/dvdy.301. Epub 2021 Jan 25. (戝媣曐捈1, 搶丂掑岹1: 1(幚摦)
110081. [尨挊] Quantitative proteomic analysis and single-protein-derived tryptic peptide profiling indicate qualitative alterations of annexin A6 in the brain of wobbler mice. Nakamura M1, Mizutani K2, Kato K3, Konno R, Itakura M4, Kodera Y, Nishiyama K5, Sato T2: Kitasato Med J 2021/3; 50 (1): 76-83. (拞懞姴徍1, 悈扟榓姲2, 壛摗棙壚3, 斅憅丂惤4, 惣嶳榓棙5, 嵅摗弐嵠2: 1戝妛堾堛椕宯尋媶壢, 2幚摦, 3堚揱巕夝愅僙, 4惗壔, 5擼恄宱撪)
[妛夛丒尋媶夛摍]
733011. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嬝堔弅惈懁嶕峝壔徢儌僨儖偺嶌惉偲夝愅. 嵅摗弐嵠 (幚摦): 2020擭搙擼尋媶強嫟摨棙梡嫟摨尋媶 (嶚壀斍) 崌摨僙儈僫乕 (2021/1/20), Web奐嵜.
柶塽妛
[妛弍榑暥]
110082. [尨挊] NF-內B-inducing kinase contributes to normal development of cortical thymic epithelial cells: its possible role in shaping a proper T-cell repertoire. Eshima K1, Misawa K, Ohashi C, Noma H, Iwabuchi K1: Immunology 2020/6; 160 (2): 198-208. (峕搰峩擇1, 娾熀榓栫1: 1柶塽)
110083. [尨挊] Attenuation of experimental autoimmune uveoretinitis in mice by IKK兝 inhibitor IMD-0354. Liu Y, Kitaichi N, Wu D, Hase K, Satoh M1, Iwata D, Namba K, Kanda A, Noda K, Itai A, Iwabuchi K1, Ishida S: Biochem Biophys Res Commun 2020/7; 525 (3): 589-94. (嵅摗丂夒1, 娾熀榓栫1: 1柶塽)
110084. [尨挊] The protective function of invariant natural killer T cells in the relapse of experimental autoimmune uveoretinitis. Tajiri N1, Kato T1, Satoh M2, Iizuka M3, Taniguchi M, Kitaichi N, Iwabuchi K2: Exp Eye Res 2021/2; 203: 108406. (揷怟壞奀1, 壛摗懢婌1, 嵅摗丂夒2, 斞捤傒偝傪3, 娾熀榓栫2: 1戝妛堾堛椕宯尋媶壢, 2柶塽, 3梊杊堛妛宯)
522013. [島嵗]亂儀乕僠僃僢僩昦亅婎慴偲椪彴偺嵟怴抦尒亅亃II. 婎慴尋媶丂5. 幚尡揑帺屓柶塽惈傇偳偆枌墛儌僨儖偺墛徢惂屼. 娾熀榓栫1, 揷怟壞奀2, 壛摗懢婌2, 嵅摗丂夒1 (1柶塽, 2戝妛堾堛椕宯尋媶壢): 擔杮椪喱 2021/6; 79 (6): 843-9.
[妛夛丒尋媶夛摍]
723091. [妛夛 (慡崙)] (堦斒島墘) X楢嵔惈枬惈擏夎庮徢儌僨儖gp91phoxknock-out mouse傊偺擏夎庮宍惉桿摫偲NOX2埶懚揑嵶朎巰偺娭楢偵偮偄偰. 抾撪宐旤巕1, 戝捗丂恀, 抾撪峃梇2 (1柶塽, 2恡憻撪): 戞48夞擔杮椪彴柶塽妛夛憤夛 (2020/10/16), Web奐嵜.
733012. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嫻態旂幙忋旂嵶朎偺婡擻偵偍偗傞NF-內B-inducing kinase偺婑梌偵偮偄偰. 峕搰峩擇1, 嶰郪壚撧, 娾熀榓栫1 (1柶塽): 戞40夞擔杮嫻態尋媶夛 (2021/2/6), Web奐嵜.
抧堟帣摱惛恄壢堛椕妛
嵞惗堛椕宍惉奜壢妛
抧堟憤崌堛椕妛
墛徢惈挵幘姵嫵堢丒椪彴尋媶妛
彫帣亅彫帣弞娐婍抧堟堛椕妛
徚壔婍撪壢妛
[妛弍榑暥]
110085. [尨挊] A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus. Katada C1, Komori S2, Yoshida T3, Kawakami S2, Watanabe A1, Ishido K1, Azuma M1, Wada T1, Hosoda K4,, Yamashita K4,5, Hiki N4,, Tanabe S1,6, Ishiyama H2, Koizumi W1: Esophagus 2020/4; 17 (2): 135-40. (寴揷恊棙1, 彫怷彸巕2, 媑揷丂岟3, 愳忋惓屽2, 搉绯峎幆1, 愇屗尓師1, 搶丂悙抭1, 榓揷戱栫1 嵶揷丂宩4, 嶳壓宲巎4,5, 斾婇捈庽4,, 揷绯丂憦1,6, 愇嶳攷瀶2, 彫愹榓嶰榊1: 1徚壔婍撪, 2曻幩慄 (庮釃), 3昦棟, 4,忋晹徚壔娗奜, 5怴悽婭堛椕丒墶抐揑堛椕, 6怴悽婭堛椕丒愭抂堛椕)
110086. [尨挊] Association between macrocytosis and metachronous squamous cell carcinoma of the esophagus after endoscopic resection in men with early esophageal squamous cell carcinoma. Katada C1, Yokoyama T, Yano T, Oda I, Shimizu Y, Doyama H, Koike T, Takizawa K, Hirao M, Okada H, Yoshii T, Kubota Y, Yamanouchi T, Tsuda T, Omori T, Kobayashi N, Suzuki H, Tanabe S1,2, Hori K, Nakayama N1, Kawakubo H, Kakushima N, Matsuo Y, Ishikawa H, Yokoyama A, Muto M: Esophagus 2020/4; 17 (2): 149-58. (寴揷恊棙1, 揷绯丂憦1,2, 拞嶳徃揟1: 1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕)
110087. [尨挊] Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib. Uojima H1, Chuma M, Tanaka Y1, Hidaka H1, Nakazawa T1, Iwabuchi S, Kobayashi S, Hattori N, Ogushi K, Morimoto M, Kagawa T, Tanaka K, Kako M, Koizumi W1: Liver Cancer 2020/4; 9 (2): 193-206. (嫑搱惏婭1, 揷拞尗柧1 擔崅丂墰1, 拞郪婱廏1, 彫愹榓嶰榊1: 1徚壔婍撪)
110088. [尨挊] Multicenter database registry for endoscopic retrograde cholangiopancreatography: Japan Endoscopic Database Project. Kato M1, Tanaka K1,2, Kida M1,3, Ryozawa S1, Matsuda K1,2, Fujishiro M1,2, Saito Y1,2, Ohtsuka K1, Oda I1, Katada C1,3, Kobayashi K1,3,4, Hoteya S1, Horimatsu T1, Kodashima S1, Matsuda T1, Muto M1, Yamamoto H1, Iwakiri R2, Kutsumi H2, Miyata H2, Kato M2, Haruma K2, Fujimoto K2, Uemura N2, Kaminishi M2, Tajiri H2 (1Minimal Standard Endoscopic Database (MSED-J) Creation Subcommittee, Japan Gastroenterological Endoscopy Society, 2Japan Endoscopy Database (JED) Project Committee, Japan Gastroenterological Endoscopy Society): Dig Endosc 2020/5; 32 (4): 494-502. (栘揷岝峀1,3, 寴揷恊棙1,3, 彫椦惔揟1,3,4: 3徚壔婍撪, 4怴悽婭堛椕丒墶抐揑堛椕)
110089. [尨挊] Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection. Toyoda H, Atsukawa M, Watanabe T, Nakamuta M, Uojima H1, Nozaki A, Takaguchi K, Fujioka S, Iio E, Shima T, Akahane T, Fukunishi S, Asano T, Michitaka K, Tsuji K, Abe H, Mikami S, Okubo H, Okubo T, Shimada N, Ishikawa T, Moriya A, Tani J, Morishita A, Ogawa C, Tachi Y, Ikeda H, Yamashita N, Yasuda S, Chuma M, Tsutsui A, Hiraoka A, Ikegami T, Genda T, Tsubota A, Masaki T, Tanaka Y, Iwakiri K, Kumada T: J Gastroenterol Hepatol 2020/5; 35 (5): 855-61. (嫑搱惏婭1: 1徚壔婍撪)
110090. [尨挊] Diagnostic efficacy of white core cutoff lengths obtained by EUS-guided fine-needle biopsy using a novel 22G franseen biopsy needle and sample isolation processing by stereomicroscopy for subepithelial lesions. Okuwaki K1, Masutani H2, Kida M1, Yamauchi H1, Iwai T1, Miyata E1, Hasegawa R1, Kaneko T1, Imaizumi H1, Watanabe M1, Kurosu T1, Tadehara M2, Adachi K2, Tamaki A2, Koizumi W1: Endosc Ultrasound 2020/5-6; 9 (3): 187-92. (墱榚嫽夘1, 彙扟姲埲2, 栘揷岝峀1, 嶳撪峗巎1, 娾堜抦媣1, 媨揷塸帯1, 挿扟愳椡栫1, 嬥巕丂嫓1, 崱愹丂峅1, 搉曈恀堣1, 崟恵婱峗1, 澍尨彨椙2, 埨払丂夣2, 嬍抲柧姲2, 彫愹榓嶰榊1: 1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢)
110091. [尨挊] Usefulness of argon plasma coagulation for superficial esophageal squamous cell neoplasia in patients at high risk or with limited endoscopic resectability. Kubota Y1, Tanabe S2,3, Ishido K3, Yano T3, Wada T3, Watanabe A3, Azuma M3, Katada C3, Koizumi W3: Turk J Gastroenterol 2020/7; 31 (7): 529-37. (媣曐揷梲1, 揷绯丂憦2,3, 愇屗尓師3, 栴栰婱巎3, 榓揷戱栫3, 搉绯峎幆3, 搶丂悙抭3, 寴揷恊棙3, 彫愹榓嶰榊3: 1戝妛堾堛椕宯尋媶壢, 2怴悽婭堛椕丒愭抂堛椕, 3徚壔婍撪)
110092. [尨挊] Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema. Atsukawa M, Tsubota A, Takaguchi K, Toyoda H, Iwasa M, Ikegami T, Chuma M, Nozaki A, Uojima H1, Hiraoka A, Fukunishi S, Yokohama K, Tada T, Kato K, Abe H, Tani J, Okubo H, Watanabe T, Hattori N, Tsutsui A, Senoh T, Yoshida Y, Okubo T, Itokawa N, Nakagawa-Iwashita A, Kondo C, Arai T, Michitaka K, Iio E, Kumada T, Tanaka Y, Takei Y, Iwakiri K: J Gastroenterol Hepatol 2020/7; 35 (7): 1229-37. (嫑搱惏婭1: 1徚壔婍撪)
110093. [尨挊] Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan. Toyoda H, Atsukawa M, Watanabe T, Nakamuta M, Uojima H1, Nozaki A, Takaguchi K, Fujioka S, Iio E, Shima T, Akahane T, Fukunishi S, Asano T, Michitaka K, Tsuji K, Abe H, Mikami S, Okubo H, Okubo T, Shimada N, Ishikawa T, Moriya A, Tani J, Morishita A, Ogawa C, Tachi Y, Ikeda H, Yamashita N, Yasuda S, Chuma M, Tsutsui A, Hiraoka A, Ikegami T, Genda T, Tsubota A, Masaki T, Iwakiri K, Kumada T, Tanaka Y, Okanoue T: J Gastroenterol Hepatol 2020/8; 35 (8): 1420-5. (嫑搱惏婭1: 1徚壔婍撪)
110094. [尨挊] The Alcohol Use Disorders Identification Test and the risk of metachronous cancer after endoscopic resection of esophageal cancer. Yokoyama A, Katada C1, Yokoyama T, Takizawa K, Yano T, Oda I, Shimizu Y, Nakanishi H, Koike T, Hirao M, Okada H, Yoshii T, Katagiri A, Yamanouchi T, Matsuo Y, Kawakubo H, Kobayashi N, Ishikawa H, Muto M: Carcinogenesis 2020/8; 41 (8): 1049-56. (寴揷恊棙1: 1徚壔婍撪)
110095. [尨挊] Portal hemodynamic effects of lenvatinib in patients with advanced hepatocellular carcinoma: A prospective cohort study. Hidaka H1, Uojima H1, Nakazawa T1, Shao X, Hara Y1, Iwasaki S1, Wada N1, Kubota K1, Tanaka Y1, Shibuya A1, Kanoh Y2, Kokubu S1, Koizumi W1: Hepatol Res 2020/9; 50 (9): 1083-90. (擔崅丂墰1, 嫑搱惏婭1, 拞郪婱廏1, 尨丂桬曘1, 娾嶈廏堦榊1, 榓揷彯媣1, 孍揷岾夘1, 揷拞尗柧1, 廰扟柧棽1, 庪栰桳嶌2, 殸暘栁攷1, 彫愹榓嶰榊1: 1徚壔婍撪, 2椪専妛)
110096. [尨挊] Effectiveness of planned surveillance for detecting second primary head and neck cancers after endoscopic resection of esophageal squamous cell carcinoma. Shinozaki T, Katada C1, Shiga K, Asakage T, Yokoyama T, Yano T, Oda I, Shimizu Y, Takemura K, Ishikawa H, Yokoyama A, Muto M: Jpn J Clin Oncol 2020/9; 50 (10): 1162-7. (寴揷恊棙1: 1徚壔婍撪)
110097. [尨挊] An international, multi-institution survey on performing EUS-FNA and fine needle biopsy. Guo J, Sahai AV, Teoh A, Arcidiacono PG, Larghi A, Saftoiu A, Siddiqui AA, Arturo Arias BL, Jenssen C, Adler DG, Lakhtakia S, Seo D-W, Itokawa F, Giovannini M, Mishra G, Sabbagh L, Irisawa A, Iglesias-Garcia J, Poley JW, Vila JJ, Jesse L, Kubota K, Kalaitzakis E, Kida M1, El-Nady M, Mukai SU, Ogura T, Fusaroli P, Vilmann P, Rai P, Nguyen NQ, Ponnudurai R, Achanta CR, Baron TH, Yasuda I, Wang H-P, Hu J, Duan B, Bhutani MS, Sun S: Endosc Ultrasound 2020/9-10; 9 (5): 319-28. (栘揷岝峀1: 1徚壔婍撪)
110098. [尨挊] Safety and Efficacy of Lenvatinib Treatment in Child-Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis. Ogushi K, Chuma M, Uojima H1, Hidaka H1, Numata K, Kobayashi S, Hirose S, Hattori N, Fujikawa T, Nakazawa T1, Wada N1, Iwasaki S1, Fukushima T, Sano Y, Ueno M, Kawano K, Tsuruya K, Shomura M, Watanabe T, Matsunaga K, Kunishi Y, Saigusa Y, Irie K, Iwabuchi S, Kako M, Morimoto M, Kagawa T, Tanaka K, Maeda S: Clin Exp Gastroenterol 2020/10; 13: 385-96. (嫑搱惏婭1, 擔崅丂墰1, 拞郪婱廏1, 榓揷彯媣1, 娾嶈廏堦榊1: 1徚壔婍撪)
110099. [尨挊] Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial. Chong CCN, Lakhtakia S, Nguyen N, Hara K, Chan WK, Puri R, Almadi MA, Ang TL, Kwek A, Yasuda I, Doi S, Kida M1, Wang H-P, Cheng T-Y, Jiang Q, Yang A, Chan AWH, Chan S, Tang R, Iwashita T, Teoh AYB: Endoscopy 2020/10; 52 (10): 856-63. (栘揷岝峀1: 1徚壔婍撪)
110100. [尨挊] Long-term observation in patients with esophageal varices after endoscopic variceal ligation accompanied with 24-hour pH monitoring. Hidaka H1, Tanabe S1,2, Uojima H1, Shao X, Iwasaki S1, Wada N1, Kubota K1, Tanaka Y1, Nakazawa T1, Shibuya A1, Kokubu S1, Koizumi W1: Hepatol Res 2020/11; 50 (11): 1255-63. (擔崅丂墰1, 揷绯丂憦1,2, 嫑搱惏婭1, 娾嶈廏堦榊1, 榓揷彯媣1, 孍揷岾夘1, 揷拞尗柧1, 拞郪婱廏1, 廰扟柧棽1, 殸暘栁攷1, 彫愹榓嶰榊1: 1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕)
110101. [尨挊] Long-term outcome of endoscopic resection for intramucosal esophageal squamous cell cancer: a secondary analysis of the Japan Esophageal Cohort study. Oda I, Shimizu Y, Yoshio T, Katada C1, Yokoyama T, Yano T, Suzuki H, Abiko S, Takemura K, Koike T, Takizawa K, Hirao M, Okada H, Yoshii T, Katagiri A, Yamanouchi T, Matsuo Y, Kawakubo H, Kobayashi N, Shimoda T, Ochiai A, Ishikawa H, Yokoyama A, Muto M: Endoscopy 2020/11; 52 (11): 967-75. (寴揷恊棙1: 1徚壔婍撪)
110102. [尨挊] Optimal extent of lymph node dissection for remnant advanced gastric carcinoma after distal gastrectomy: a retrospective analysis of more than 3000 patients from the nationwide registry of the Japanese Gastric Cancer Association. Katai H1, Ishikawa T1, Akazawa K1, Fukagawa T1, Isobe Y1, Miyashiro I1, Oda I1, Tsujitani S1, Ono H1, Tanabe S1,2,3, Nunobe S1, Suzuki S1, Kakeji Y1 (1Registration Committee of the Japanese Gastric Cancer Association): Gastric Cancer 2020/11; 23 (6): 1091-101. (揷绯丂憦1,2,3: 2怴悽婭堛椕丒愭抂堛椕, 3徚壔婍撪)
110103. [尨挊] Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B. Itokawa N, Atsukawa M, Tsubota A, Takaguchi K, Nakamuta M, Hiraoka A, Kato K, Abe H, Mikami S, Shimada N, Chuma M, Nozaki A, Uojima H1, Ogawa C, Asano T, Tani J, Morishita A, Senoh T, Yamashita N, Oikawa T, Matsumoto Y, Koeda M, Yoshida Y, Tanabe T, Okubo T, Arai T, Hayama K, Iwashita-Nakagawa A, Kondo C, Tada T, Toyoda H, Kumada T, Iwakiri K: JGH Open 2020/11; 5 (1): 34-40. (嫑搱惏婭1: 1徚壔婍撪)
110104. [尨挊] Randomised comparison of postpolypectomy surveillance intervals following a two-round baseline colonoscopy: the Japan Polyp Study Workgroup. Matsuda T, Fujii T, Sano Y, Kudo S, Oda Y, Hotta K, Shimoda T, Saito Y, Kobayashi N, Sekiguchi M, Konishi K, Ikematsu H, Iishi H, Takeuchi Y, Igarashi M, Kobayashi K1, Sada M1, Yamaguchi Y, Hasuda K, Shinohara T, Ishikawa H, Murakami Y, Taniguchi H, Fujimori T, Ajioka Y, Yoshida S: Gut 2020/11; 70 (8): 1469-78. (彫椦惔揟1, 嵅揷旤榓1: 1徚壔婍撪)
110105. [尨挊] Cholecystitis after Placement of Covered Self-Expandable Metallic Stents in Patients with Distal Malignant Biliary Obstructions. Watanabe M1, Okuwaki K1, Woo J, Kida M1, Imaizumi H1, Iwai T1, Yamauchi H1, Kaneko T1, Hasegawa R1, Kurosu T1, Minato N1, Haradome H2,3, Koizumi W1: Clin Endosc 2021/7; 54 (4): 589-95. doi: 10.5946/ce.2020.136. Epub 2020 Nov 17. (搉曈恀堣1, 墱榚嫽夘1, 栘揷岝峀1, 崱愹丂峅1, 娾堜抦媣1, 嶳撪峗巎1, 嬥巕丂嫓1, 挿扟愳椡栫1, 崟恵婱峗1, 柀丂彯婱1, 尨棷峅庽2,3, 彫愹榓嶰榊1: 1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕, 3曻幩慄 (夋憸))
110106. [尨挊] Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study. Atsukawa M1, Tsubota A1, Kondo C1, Toyoda H1, Nakamuta M1, Takaguchi K1, Watanabe T1, Hiraoka A1, Uojima H1,2, Ishikawa T1, Iwasa M1, Tada T1, Nozaki A1, Chuma M1, Fukunishi S1, Asai A1, Asano T1, Ogawa C1, Abe H1, Hotta N1, Shima T1, Iio E1, Mikami S1, Tachi Y1, Fujioka S1, Okubo H1, Shimada N1, Tani J1, Hidaka I1, Moriya A1, Tsuji K1, Akahane T1, Yamashita N1, Okubo T1, Arai T1, Morita K1, Kawata K1, Tanaka Y1, Okanoue T1, Maeda S1, Kumada T1, Iwakiri K1 (1KTK49 Liver Study Group): Infect Dis Ther 2020/12; 9 (4): 851-66. (嫑搱惏婭1,2: 2徚壔婍撪)
110033. [尨挊] Platelets prevent the development of monocrotaline-induced liver injury in mice. Otaka F1, Ito Y2, Goto T1, Eshima K3, Amano H2, Koizumi W4, Majima M2: Toxicol Lett 2020/12; 335: 71-81. (戝崅巎惞1, 埳摗媊栫2, 屻摗戩栫1, 峕搰峩擇3, 揤栰塸庽2, 彫愹榓嶰榊4, 攏搱惓棽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3柶塽, 4徚壔婍撪)
110107. [尨挊] Near-focus magnification and second-generation narrow-band imaging for early gastric cancer in a randomized trial. Kakushima N, Yoshida N, Doyama H, Yano T, Horimatsu T, Uedo N, Yamamoto Y, Kanzaki H, Hori S, Yao K, Oda I, Tanabe S1,2, Yokoi C, Ohata K, Yoshimura K, Ishikawa H, Muto M: J Gastroenterol 2020/12; 55 (12): 1127-37. (揷绯丂憦1,2: 1怴悽婭堛椕丒愭抂堛椕, 2徚壔婍撪)
110108. [尨挊] Nafamostat Mesylate is Not Effective in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Matsumoto T1, Okuwaki K1, Imaizumi H1, Kida M1,2, Iwai T1, Yamauchi H1, Kaneko T1, Hasegawa R1, Masutani H3, Tadehara M3, Adachi K3, Watanabe M1, Kurosu T1, Tamaki A3, Kikuchi H1, Ohno T1, Koizumi W1: Dig Dis Sci 2021/1. doi: 10.1007/s10620-020-06782-6. Online ahead of print. (徏杮崅柧1, 墱榚嫽夘1, 崱愹丂峅1, 栘揷岝峀1,2, 娾堜抦媣1, 嶳撪峗巎1, 嬥巕丂嫓1, 挿扟愳椡栫1, 彙扟姲埲3, 澍尨彨椙3, 埨払丂夣3, 搉曈恀堣1, 崟恵婱峗1, 嬍抲柧姲3, 媏抧廏旻1, 戝栰丂棽1, 彫愹榓嶰榊1: 1徚壔婍撪, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3戝妛堾堛椕宯尋媶壢)
110109. [尨挊] EUS-guided transanastomotic drainage for severe biliopancreatic anastomotic stricture using a forward-viewing echoendoscope in patients with surgically altered anatomy. Iwai T1, Kida M1, Yamauchi H1, Okuwaki K1, Kaneko T1, Hasegawa R1, Watanabe M1, Kurosu T1, Imaizumi H1, Koizumi W1: Endosc Ultrasound 2021/1-2; 10 (1): 33-8. (娾堜抦媣1, 栘揷岝峀1, 嶳撪峗巎1, 墱榚嫽夘1, 嬥巕丂嫓1, 挿扟愳椡栫1, 搉曈恀堣1, 崟恵婱峗1, 崱愹丂峅1, 彫愹榓嶰榊1: 1徚壔婍撪)
110110. [尨挊] Comparison of the reproducibility of endoscopic scores in patients with ulcerative colitis: MES, UCEIS, and EAI scores. Kawagishi K1, Yokoyama K1, Kobayashi K1,2, Koizumi W1: Kitasato Med J 2021/3; 51 (1): 1-9. (愳娸壛撧1, 墶嶳丂孫1, 彫椦惔揟1,2, 彫愹榓嶰榊1: 1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕)
110111. [尨挊] Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging. Yoshida N, Doyama H, Yano T, Horimatsu T, Uedo N, Yamamoto Y, Kakushima N, Kanzaki H, Hori S, Yao K, Oda I, Katada C1, Yokoi C, Ohata K, Yoshimura K, Ishikawa H, Muto M: Gut 2021/1; 70 (1): 67-75. (寴揷恊棙1: 1徚壔婍撪)
110112. [尨挊] A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma. Katada C1, Sugawara M2, Hara H, Fujii H, Eguchi -Nakajima T, Ando T, Kojima T, Watanabe A1, Sakamoto Y, Ishikawa H, Hosokawa A, Hamamoto Y, Muto M, Tahara M, Koizumi W1: Jpn J Clin Oncol 2021/2; 51 (2): 199-204. (寴揷恊棙1, 悰尨廩峀2, 搉绯峎幆1, 彫愹榓嶰榊1: 1徚壔婍撪, 2栻嵻晹)
110113. [尨挊] Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes. Watanabe C, Nagahori M, Fujii T, Yokoyama K1, Yoshimura N, Kobayashi T2,3, Yamagami H, Kitamura K, Takashi K, Nakamura S, Naganuma M, Ishihara S, Esaki M, Yonezawa M, Kunisaki R, Sakuraba A, Kuji N, Miura S, Hibi T2,3, Suzuki Y, Hokari R: Dig Dis Sci 2021/2; 66 (2): 577-86. (墶嶳丂孫1, 彫椦丂戱2,3, 擔斾婭暥2,3: 1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢, 3杒棦戝妛杒棦尋媶強昦堾)
110114. [尨挊] Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis. Chuma M, Uojima H1, Hiraoka A, Kobayashi S, Toyoda H, Tada T, Hidaka H1, Iwabuchi S, Numata K, Itobayashi E, Itokawa N, Kariyama K, Ohama H, Hattori N, Hirose S, Shibata H, Tani J, Imai M, Tajiri K, Moriya S, Wada N, Iwasaki S, Fukushima T, Ueno M, Yasuda S, Atsukawa M, Nouso K, Fukunishi S, Watanabe T, Ishikawa T, Nakamura S, Morimoto M, Kagawa T, Sakamoto M, Kumada T, Maeda S: Hepatol Res 2021/2; 51 (2): 201-15. (嫑搱惏婭1, 擔崅丂墰1: 1徚壔婍撪)
110115. [尨挊] Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial. Fujitani K, Shitara K, Takashima A, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Kimura Y, Amagai K, Hosaka H, Komatsu Y, Shimada K, Kawabata R, Ohdan H, Kodera Y, Nakamura M, Eguchi-Nakajima T, Miyata Y, Moriwaki T, Kusumoto T, Nishikawa K, Ogata K, Shimura M, Morita S, Koizumi W1: Gastric Cancer 2021/3; 24 (2): 467-76. (彫愹榓嶰榊1: 1徚壔婍撪)
110116. [尨挊] A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010). Takizawa K1, Ono H1, Hasuike N1, Takashima A1, Minashi K1, Boku N1, Kushima R1, Katayama H1, Ogawa G1, Fukuda H1, Fujisaki J1, Oda I1, Yano T1, Hori S1, Doyama H1, Hirasawa K1, Yamamoto Y1, Ishihara R1, Tanabe S1,2,3, Niwa Y1, Nakagawa M1, Terashima M1, Muto M1 (1Gastrointestinal Endoscopy Group (GIESG) and the Stomach Cancer Study Group (SCSG) of Japan Clinical Oncology Group): Gastric Cancer 2021/3; 24 (2): 479-91. (揷绯丂憦1,2,3: 2怴悽婭堛椕丒愭抂堛椕, 3徚壔婍撪)
110117. [尨挊] Current status of diagnostic and therapeutic colonoscopy in Japan: The Japan Endoscopic Database Project. Saito Y1,2, Kodashima S1, Matsuda T1, Matsuda K1,2, Fujishiro M1,2, Tanaka K1,2, Kobayashi K1,3,4, Katada C1,4, Horimatsu T1, Muto M1, Ohtsuka K1, Oda I1, Kato M1, Kida M1,4,5, Hoteya S1, Yamamoto H1, Ryozawa S1, Iwakiri R2, Kutsumi H2, Kato M2, Haruma K2, Fujimoto K2, Iishi H2, Ogata H2, Uemura N2, Kaminishi M2, Tajiri H2, Inoue H2 (1MSED-J (Minimal Standard Endoscopic Database) Creation Subcommittee, Japan Gastroenterological Endoscopy Society, 2JED (Japan Endoscopy Database) Project Committee, Japan Gastroenterological Endoscopy Society): Dig Endosc 2021/3. doi: 10.1111/den.13980. Online ahead of print. (彫椦惔揟1,3,4, 寴揷恊棙1,4, 栘揷岝峀1,4,5: 3怴悽婭堛椕丒墶抐揑堛椕, 4徚壔婍撪, 5杒棦戝妛儊僨傿僇儖僙儞僞乕)
110118. [尨挊] Cholecystitis after Placement of Covered Self-Expandable Metallic Stents in Patients with Distal Malignant Biliary Obstructions. Watanabe M1, Okuwaki K1, Woo J, Kida M1, Imaizumi H1, Iwai T1, Yamauchi H1, Kaneko T1, Hasegawa R1, Kurosu T1, Minato N1, Haradome H2,3, Koizumi W1: Clin Endosc 2021/7; 54 (4): 589-95. doi: 10.5946/ce.2020.136. Epub 2020 Nov 17. (搉曈恀堣1, 墱榚嫽夘1, 栘揷岝峀1, 崱愹丂峅1, 娾堜抦媣1, 嶳撪峗巎1, 嬥巕丂嫓1, 挿扟愳椡栫1, 崟恵婱峗1, 柀丂彯婱1, 尨棷峅庽2,3, 彫愹榓嶰榊1: 1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕, 3曻幩慄 (夋憸))
120006. [尨挊] 戝挵宔幒弌寣偵懳偡傞撪帇嬀揑巭寣朄偺帯椕惉愌. 愳娸壛撧1, 彫椦惔揟1,2, 嬥郪丂弫1, 釼摗桭嵠1, 徏杮堢岹1, 暿醕朁峀1, 寎丂旤岾1, 墶嶳丂孫1, 嵅揷旤榓1, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): Progress of Digestive Endoscopy 2020/6; 96 (1): 30-4.
210001. [弨尨挊 (Research Letter)] Protein Kinase D1 (PKD1) Signaling Induces Growth-Promoting Effects in Murine Enteroids. Shimizu Y1, Sinnett-Smith J, Tenggara M, Martin MG, Rozengurt E: Cell Mol Gastroenterol Hepatol 2020/10; 10 (2): 430-3.e9. (惔悈桾婱1: 1徚壔婍撪)
310002. [徢椺曬崘] Successful Hemostasis Using an Over-the-scope Clip for a Dieulafoy's Lesion in the Greater Curvature of the Fundus. Kubota Y1, Yamauchi H2, Nakatani K3, Tanabe S2,4, Koizumi W2: Endoscopy 2020/5; 52 (5): E164-5. (媣曐揷梲1, 嶳撪峗巎2, 拞扟尋搇3, 揷绯丂憦2,4, 彫愹榓嶰榊2: 1戝妛堾堛椕宯尋媶壢, 2徚壔婍撪, 3媬柦, 4怴悽婭堛椕丒愭抂堛椕)
310003. [徢椺曬崘] Pancreatic pseudocyst-portal vein fistula: a case treated with EUS-guided cyst-drainage and a review of the literature. Masuda S, Koizumi K, Uojima H1, Tazawa T, Kimura K, Nishino T, Tasaki J, Ichita C, Sasaki A, Egashira H, Kako M: Clin J Gastroenterol 2020/8; 13 (4): 597-606. (嫑搱惏婭1: 1徚壔婍撪)
310004. [徢椺曬崘] Multiple gastrointestinal metastasis after endoscopic submucosal dissection for poorly differentiated gastric adenocarcinoma. Kubota Y1, Katada C2, Yoshida T3, Wada T2, Hosoda K4, Kawakami S5, Ishido K2, Watanabe A2, Yamashita K4,6, Ishiyama H5, Hiki N4, Tanabe S2,7, Koizumi W2: Clin J Gastroenterol 2020/10; 13 (5): 717-21. (媣曐揷梲1, 寴揷恊棙2, 媑揷丂岟3, 榓揷戱栫2, 嵶揷丂宩4, 愳忋惓屽5, 愇屗尓師2, 搉绯峎幆2, 嶳壓宲巎4,6, 愇嶳攷瀶5, 斾婇捈庽4, 揷绯丂憦2,7, 彫愹榓嶰榊2: 1戝妛堾堛椕宯尋媶壢, 2徚壔婍撪, 3昦棟, 4忋晹徚壔娗奜, 5曻幩慄 (庮釃), 6怴悽婭堛椕丒墶抐揑堛椕, 7怴悽婭堛椕丒愭抂堛椕)
310005. [徢椺曬崘] Barrett's Esophageal Adenocarcinoma Involving a White Globe Appearance within the Long-Segment Barrett's Esophagus. Kubota Y1, Tanabe S2,3, Harada Y3, Nakatani S3, Furue Y3, Wada T3, Watanabe A3, Ishido K3, Katada C3, Koizumi W3: Case Rep Gastroenterol 2020/10; 14 (3): 510-5. (媣曐揷梲1, 揷绯丂憦2,3, 尨揷梞暯3, 拞扟惇屷3, 屆峕峃柧3, 榓揷戱栫3, 搉绯峎幆3, 愇屗尓師3, 寴揷恊棙3, 彫愹榓嶰榊3: 1戝妛堾堛椕宯尋媶壢, 2怴悽婭堛椕丒愭抂堛椕, 3徚壔婍撪)
310006. [徢椺曬崘] Undifferentiated Embryonal Sarcoma of the Liver Identified after the Initial Diagnosis of a Hepatic Cyst. Manabe Y1, Uojima H1, Hidaka H1, Shao X, Iwasaki S1, Wada N1, Kubota K1, Tanaka Y1, Nakazawa T1, Shibuya A1, Ichinoe M2, Kumamoto Y3, Kaizu T3, Koizumi W1: Intern Med 2020/10; 59 (19): 2375-82. (崃晹桪嶌1, 嫑搱惏婭1, 擔崅丂墰1, 娾嶈廏堦榊1, 榓揷彯媣1, 孍揷岾夘1, 揷拞尗柧1, 拞郪婱廏1, 廰扟柧棽1, 堦屗徆柧2, 孏尦梇夘3, 奀捗婱巎3, 彫愹榓嶰榊1: 1徚壔婍撪, 2昦棟, 3堦斒丒彫帣丒娞抇鋁奜)
310007. [徢椺曬崘] Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy. Masuda S, Koizumi K, Moriya H, Nishino T, Uojima H1, Tazawa T, Kimura K, Tasaki J, Ichita C, Sasaki A, Kako M, Hidaka S, Kudo M: Intern Med 2021/1; 60 (2): 251-7. (嫑搱惏婭1: 1徚壔婍撪)
520005. [憤愢] 戝挵庮釃偵懳偡傞撪帇嬀恌抐偺恑曕亅憗婜戝挵娻傪拞怱偵亅. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪): 杒棦堛妛 2020/6; 50 (1): 1-8.
522014. [島嵗]亂摿廤: 怘摴幘姵偵懳偡傞嵟怴偺撪帇嬀恌抐偲帯椕亃3-1. 堲摢昞嵼娻偵懳偡傞撪帇嬀恌抐. 寴揷恊棙1, 壛擺岶堦2, 嵶栰峗巎2, 堦屗徆柧3, 嶳壓丂戱2, 揷绯丂憦1,4, 彫愹榓嶰榊1 (1徚壔婍撪, 2帹旲堲岮丒摢栩晹, 3昦棟, 4怴悽婭堛椕丒愭抂堛椕): 徚壔婍撪壢 2020/5; 2 (6): 69-75.
522015. [島嵗]亂摿廤: 奆偱恌傞! IBD: 懡怑庬楢実偲抧堟堛椕亃懡怑庬楢実亅奀奜偺幚懺亅. 墶嶳丂孫 (徚壔婍撪): IBD Ressearch 2020/6; 14 (2): 101-6.
522016. [島嵗]亂楢嵹: 専嵏抣偺撉傒曽亃僒儔僝僗儖僼傽僺儕僕儞暈梡屻偵敪惗偟偨2曯惈偺娞忈奞偺1椺. 嫑搱惏婭1, 擔崅丂墰1, 揷拞尗柧1, 敀堜嫗旤2 (1徚壔婍撪, 2旂晢): 椪喱徚壔婍撪壢 2020/6; 35 (6): 655-60.
522017. [島嵗]亂摿廤: 廫擇巜挵偼偙偆恌傞亃1. 廫擇巜挵傊偺撪帇嬀憓擖偲娤嶡偺幚嵺丂[奺榑] 挻壒攇撪帇嬀偵傛傞廫擇巜挵昦曄偺恌抐. 娾堜抦媣1, 栘揷岝峀1, 墱榚嫽夘1, 嶳撪峗巎1, 嬥巕丂嫓1, 挿扟愳椡栫1, 澍尨彨椙2, 埨払丂夣2, 搉曈恀堣1, 崟恵婱峗1, 崱愹丂峅1, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢): 徚壔婍撪帇嬀 2020/7; 32 (7): 971-80.
522018. [島嵗]亂摿廤: 偙傟堦嶜偱偡傋偰傢偐傞徚壔婍挻壒攇専嵏亃4-2-2-c 戞IV復 徚壔娗挻壒攇専嵏丂2. 挻壒攇撪帇嬀専嵏丂匒徚壔娗忋旂惈庮釃偺怺払搙恌丂c. 戝挵娻偺怺払搙恌抐. 彫椦惔揟1,2, 愳娸壛撧2, 寎丂旤岾2, 墶嶳丂孫2, 嵅揷旤榓2,彫愹榓嶰榊2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪): 椪喱徚壔婍撪壢 2020/8; 35 (9): 244-9.
522019. [島嵗]亂摿廤: 枬惈鋁墛亅僈僀僪儔僀儞夵掶偵岦偗偰亃6-3. 枬惈鋁墛偺帯椕丂(3) 壖惈鵑朎丒抇娗嫹嶓偺撪帇嬀帯椕. 娾堜抦媣1, 栘揷岝峀1, 墱榚嫽夘1, 嶳撪峗巎1, 嬥巕丂嫓1, 挿扟愳椡栫1, 澍尨彨椙2, 埨払丂夣2, 崱愹丂峅1, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢): 椪喱徚壔婍撪壢 2020/10; 35 (11): 1369-76.
522020. [島嵗]亂摿廤: 娞峝曄偺僩乕僞儖儅僱僕儊儞僩亃8) 栧柆寣愷徢偵懳偡傞恌抐偲帯椕. 擔崅丂墰1, 嫑搱惏婭1 (1徚壔婍撪): 娞憻僋儖僯僇儖傾僢僾僨乕僩 2020/10; 6 (2): 181-6.
522021. [島嵗]亂摿廤: 恑壔偡傞EUS亃2. 帯椕揑EUS丂[奺榑] EUS壓鋁壖惈鵑朎僪儗僫乕僕. 娾堜抦媣1, 栘揷岝峀1, 墱榚嫽夘1, 嶳撪峗巎1, 嬥巕丂嫓1, 挿扟愳椡栫1, 澍尨彨椙2, 埨払丂夣2, 崱愹丂峅1, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢): 徚壔婍撪帇嬀 2020/11 32 (11): 1701-6.
522022. [島嵗]亂庡戣II: 戝挵NET丂恌抐偲帯椕偺嵟慜慄亃I. 戝挵NET恌抐偺up-to-date. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪): 擔杮戝挵汨栧昦妛夛嶨帍 2020/11; 73 (10): 442-51.
522023. [島嵗]亂嵗択夛亃亀娞峝曄恌椕僈僀僪儔僀儞2020亁偺億僀儞僩. 媑帯恗巙, 擔崅丂墰1, 忋栰媊擵, 惔悈夒恗, 扟崌杻婭巕 (1徚壔婍撪): 擔杮徚壔婍昦妛夛嶨帍 2021/1; 118 (1): 46-54.
522024. [島嵗]亂摿廤I: 娞峝曄恌椕僈僀僪儔僀儞偺夵惓傪傔偖偭偰亃栧柆埑槾恑徢 (怘摴偍傛傃堓惷柆釒) 偺帯椕. 擔崅丂墰1, 嫑搱惏婭1, 殸暘栁攷1 (1徚壔婍撪): 徚壔婍丒娞憻撪壢 2021/2; 9 (2): 149-53.
522025. [島嵗]亂摿廤: 偄傑偝傜暦偗側偄!丂娞抇鋁幘姵丂傒側偝傫偺僊儌儞偵摎偊傑偡亃仭娞峝曄偺恌抐偲崌暪徢偵懳偡傞帯椕丂栧柆寣愷徢傪偳傫側応崌偵媈偄, 嵟怴帯椕傪峴偆偐. 擔崅丂墰1, 嫑搱惏婭1 (1徚壔婍撪): medicina 2021/3; 58 (3): 454-7.
530005. [偦偺懠 (Practice Guideline)] Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Ishihara R1, Arima M1, Iizuka T1, Oyama T1, Katada C1,2, Kato M1, Goda K1, Goto O1, Tanaka K1, Yano T1, Yoshinaga S1, Muto M1, Kawakubo H1, Fujishiro M1, Yoshida M1, Fujimoto K1, Tajiri H1, Inoue H1 (1Japan Gastroenterological Endoscopy Society Guidelines Committee of ESD/EMR for Esophageal Cancer): Dig Endosc 2020/5; 32 (4): 452-93. (寴揷恊棙1,2: 2徚壔婍撪)
530006. [偦偺懠 (Practice Guideline)] Evidence-based diagnosis and clinical practice guidelines for intestinal Beh?et's disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants. Watanabe K, Tanida S, Inoue N, Kunisaki R, Kobayashi K1,2, Nagahori M, Arai K, Uchino M, Koganei K, Kobayashi T, Takeno M, Ueno F, Matsumoto T, Mizuki N, Suzuki Y, Hisamatsu T: J Gastroenterol 2020/7; 55 (7): 679-700. (彫椦惔揟1,2: 1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪)
530007. [偦偺懠 (Erratum)] Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial. Fujitani K, Shitara K, Takashima A, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Kimura Y, Amagai K, Hosaka H, Komatsu Y, Shimada K, Kawabata R, Ohdan H, Kodera Y, Nakamura M, Eguchi-Nakajima T, Miyata Y, Moriwaki T, Kusumoto T, Nishikawa K, Ogata K, Shimura M, Morita S, Koizumi W1: Gastric Cancer 2021/3; 24 (2): 477-8. (彫愹榓嶰榊1: 1徚壔婍撪)
[挊丂彂]
620017. [妛弍彂 (暘扴幏昅)]亂暿嶜擔杮椪喱 椞堟暿徢岓孮僔儕乕僘 No.11丂徚壔娗徢岓孮 (戞3斉) III亅偦偺懠偺徚壔娗幘姵傪娷傔偰亅亃VI. 嬻挵, 夞挵, 栍挵, 寢挵, 捈挵 (忋)丂1. 姶愼徢丂(8) 挵寢妀, p.36-40. 嵅揷旤榓1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕), 擔杮椪喱幮, 搶嫗, 2020/4敪峴.
620018. [妛弍彂 (暘扴幏昅)]亂抦偭偰偍偒偨偄怴偨側張抲嬶亅摿挜偲偦偺奐敪堄恾 (徚壔婍撪帇嬀6寧憹戝崋)亃[奺榑] I. 愗彍梡/愗奐梡張抲嬶丂僐乕儖僪丒億儕儁僋僩儈乕偺偨傔偺張抲嬶, p.831-3. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪), 搶嫗堛妛幮, 搶嫗, 2020/6敪峴.
620019. [妛弍彂 (暘扴幏昅)]亂側傫偠傖偙傝傖? Part 2 (徚壔婍撪帇嬀10寧憹戝崋)亃[戝挵] 摿堎側宍懺傪掓偟偨戝挵棽婲惈昦曄偺1椺, p.1571-2. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪), 搶嫗堛妛幮, 搶嫗, 2020/10敪峴.
620020. [妛弍彂 (暘扴幏昅)]亂戝挵幘姵傾僩儔僗update (徚壔婍撪帇嬀32姫憹姧崋)亃I. 庮釃, 庮釃惈昦曄丂埆惈忋旂惈庮釃丂憗婜娻 (T1娻傪拞怱偵): 捵釃惈戝挵墛娭楢庮釃, p.28-9. 嵅揷旤榓1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕), 搶嫗堛妛幮, 搶嫗, 2020/11敪峴.
620021. [妛弍彂 (暘扴幏昅)]亂戝挵幘姵傾僩儔僗update (徚壔婍撪帇嬀32姫憹姧崋)亃I. 庮釃, 庮釃惈昦曄丂埆惈忋旂惈庮釃丂埆惈旕忋旂惈庮釃丂儕儞僷庮 (戝挵昦曄): 徚壔娗娫幙庮釃, p.52-3. 彫椦惔揟1,2, 墶嶳丂孫2, 嵅揷旤榓2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪), 搶嫗堛妛幮, 搶嫗, 2020/11敪峴.
620022. [妛弍彂 (暘扴幏昅)]亂戝挵幘姵傾僩儔僗update (徚壔婍撪帇嬀32姫憹姧崋)亃II. 姶愼徢丂嵶嬠惈丂媫惈: 昦尨惈戝挵嬠挵墛 (O157側偳), p.140-1. 彫椦惔揟1,2, 墶嶳丂孫2, 嵅揷旤榓2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪), 搶嫗堛妛幮, 搶嫗, 2020/11敪峴.
620023. [妛弍彂 (暘扴幏昅)]亂戝挵幘姵傾僩儔僗update (徚壔婍撪帇嬀32姫憹姧崋)亃V. 偦偺懠丂Angioectasia, p.264-5. 墶嶳丂孫1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕), 搶嫗堛妛幮, 搶嫗, 2020/11敪峴.
620024. [妛弍彂 (暘扴幏昅)]亂暿嶜擔杮椪喱 椞堟暿徢岓孮僔儕乕僘 No.13丂娞丒抇摴宯徢岓孮 (戞3斉) I丂偦偺懠偺娞丒抇摴宯幘姵傪娷傔偰亅娞憻曇 (忋)亃VI. 寣峴堎忢丂5. 娞撪宆栧柆埑槾恑徢, p.249-52. 擔崅丂墰1, 嫑搱惏婭1 (1徚壔婍撪): 擔杮椪喱幮, 搶嫗, 2021/1敪峴.
[妛夛丒尋媶夛摍]
712001. [妛夛 (崙嵺)] (彽懸島墘) Recent Advancement of Endoscopic Ultrasound. Kida M1,2: 僴儞僈儕乕徚壔婍昦妛夛WEB (2020/11/6), Budapest, Hungary (栘揷岝峀1,2: 1徚壔婍撪, 2杒棦戝妛儊僨傿僇儖僙儞僞乕)
712002. [妛夛 (崙嵺)] (彽懸島墘摍) Autoimmune Pancreatitis - A Challenging Differential Diagnosis -. Kida M1,2: 戞5夞EUS-ERCP connection WEB (2020/12/18), Turin, Italy. (栘揷岝峀1,2: 1徚壔婍撪, 2杒棦戝妛儊僨傿僇儖僙儞僞乕)
712003. [妛夛 (崙嵺)] (彽懸島墘摍) Role of Intraductal Ultrasonography (IDUS) for diagnosing Bilio-Pancreatic Diseases. Kida M1,2: 3rd India EUS summit 2021 (2021/1/16), Delhi, india. (栘揷岝峀1,2: 1徚壔婍撪, 2杒棦戝妛儊僨傿僇儖僙儞僞乕)
712004. [妛夛 (崙嵺)] (彽懸島墘摍) How to get clear image. Kida M1,2: WEO International School of EUS (WISE) (2021/3/13), Web奐嵜. (栘揷岝峀1,2: 1徚壔婍撪, 2杒棦戝妛儊僨傿僇儖僙儞僞乕)
721002. [妛夛 (慡崙)] (摿暿島墘) 挿婜梊屻夵慞傪栚巜偟偨娞惈擼徢娗棟. 嫑搱惏婭 (徚壔婍撪): 戞106夞擔杮徚壔婍昦妛夛憤夛 (2020/8/11-31), 帍忋奐嵜 (WEB奐嵜).
721003. [妛夛 (慡崙)] (摿暿島墘) 偙傟偐傜偺栧柆埑槾恑徢2020乣娞峝曄恌椕僈僀僪儔僀儞夵掶偵崌傢偣偰乣. 擔崅丂墰 (徚壔婍撪): 戞106夞擔杮徚壔婍昦妛夛憤夛 (2020/8/11-31), 帍忋奐嵜 (WEB奐嵜).
721004. [妛夛 (慡崙)] (摿暿島墘) 戝偒偔曄傢偭偨墛徢惈挵幘姵偺撪壢帯椕. 墶嶳丂孫 (徚壔婍撪): 戞41夞擔杮傾僼僃儗僔僗妛夛妛弍戝夛 (2020/10/23), 愮梩 (僴僀僽儕僢僪奐嵜).
721005. [妛夛 (慡崙)] (摿暿島墘) 娞峝曄崌暪徢帯椕偺儕僗僋儅僱乕僕儊儞僩乣枩偑堦偺偨傔偵乣. 擔崅丂墰 (徚壔婍撪): JDDW 2020 KOBE (2020/11/5), 恄屗 (僴僀僽儕僢僪奐嵜).
721006. [妛夛 (慡崙)] (摿暿島墘) LECS偼崅楊幰堓偑傫偵懳偡傞怴偟偄僆僾僔儑儞偲側傞偐. 揷绯丂憦1,2 (1怴悽婭堛椕丒愭抂堛椕, 2徚壔婍撪): JDDW 2020 KOBE (2020/11/6), 恄屗 (僴僀僽儕僢僪奐嵜).
721007. [妛夛 (慡崙)] (摿暿島墘) 徚壔娗撪帇嬀帯椕. 揷绯丂憦1,2 (1怴悽婭堛椕丒愭抂堛椕, 2徚壔婍撪): JDDW 2020 KOBE (2020/11/7), 恄屗 (僴僀僽儕僢僪奐嵜).
721008. [妛夛 (慡崙)] (摿暿島墘) 擔杮戝挵汨栧昦妛夛偺椣棟巜恓偲椣棟怽惪偺嵺偺拲堄帠崁. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪): 戞75夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2020/11/13-14), WEB奐嵜.
721009. [妛夛 (慡崙)] (摿暿島墘) 憹壛偡傞帯椕慖戰巿偲婎杮栻5-ASA偺埵抲偯偗. 墶嶳丂孫 (徚壔婍撪): 戞17夞擔杮徚壔娗妛夛憤夛妛弍廤夛 (2021/2/19-21), WEB奐嵜.
721010. [妛夛 (慡崙)] (摿暿島墘) 撪壢椞堟偺尰忬偲揥朷. 揷绯丂憦1,2, 彫栰桾擵3, 楅栘惏媣4, 愇愳丂戩5, 妡抧媑峅6 (1怴悽婭堛椕丒愭抂堛椕, 2徚壔婍撪, 3惷壀導棫惷壀偑傫僙儞僞乕撪帇嬀壢, 4崙棫偑傫尋媶僙儞僞乕拞墰昦堾撪帇嬀壢, 5怴妰戝妛堛帟妛憤崌昦堾堛椕忣曬晹, 6恄屗戝妛戝妛堾怘摴堓挵奜壢): 戞93夞擔杮堓娻妛夛憤夛 (2021/3/3-5), WEB奐嵜.
722017. [妛夛 (慡崙)] (僔儞億僕僂儉)亂摢栩晹昞嵼娻偺恌抐偲帯椕亃摢栩晹昞嵼娻偺撪帇嬀恌抐偲帯椕. 寴揷恊棙1, 壛擺岶堦2, 嵶栰峗巎2, 嶳壓丂戱2 (1徚壔婍撪, 2帹旲堲岮丒摢栩晹奜): 戞44夞擔杮摢栩晹娻妛夛 (2020/7/17-27), Web奐嵜.
722018. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 枬惈娞幘姵偵懕敪偟偨擇師惈柶塽惈寣彫斅尭彮徢偵懳偡傞僩儘儞儃億僄僠儞庴梕懱傾僑僯僗僩偺桳梡惈. 嫑搱惏婭1, 榓揷彯媣1, 夑屆丂崃2 (1徚壔婍撪, 2徝撿姍憅憤崌昦堾): 戞56夞擔杮娞憻妛夛憤夛 (2020/8/28-29), 戝嶃 (僴僀僽儕僢僪奐嵜).
722019. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 枬惈娞忈奞傪崌暪偡傞傾儖僐乕儖埶懚徢姵幰偵懳偡傞僫儖儊僼僃儞搳梌偵娭偡傞慜岦偒専摙. 嫑搱惏婭1, 娾嶈廏堦榊1, 擔崅丂墰1, 夑屆丂崃2 (1徚壔婍撪, 2徝撿姍憅憤崌昦堾): 戞56夞擔杮娞憻妛夛憤夛 (2020/8/28-29), 戝嶃 (僴僀僽儕僢僪奐嵜).
722020. [妛夛 (慡崙)] (嫵堢島墘) Interventional EUS 偺尰忬偲彨棃揥朷. 栘揷岝峀 (徚壔婍撪): 戞99夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2020/9/3), 嫗搒 (僴僀僽儕僢僪奐嵜).
722021. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 杮朚偵偍偗傞媔墝丒堸庰忬嫷偺昡壙傪娷傔偨怘摴撪帇嬀専嵏偺尰忬亅Japan Endoscopy Database (JED) 偵傛傞専摙亅. 寴揷恊棙1, 杧徏崅攷, 晲摗丂妛 (1徚壔婍撪): 戞99夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2020/9/2), 嫗搒 (僴僀僽儕僢僪奐嵜).
722022. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 摉堾偵偍偗傞撪帇嬀揑擕摢愗彍弍偺専摙偲壽戣. 挿扟愳椡栫1, 栘揷岝峀1, 崟恵婱峗1 (1徚壔婍撪): 戞99夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2020/9/3), 嫗搒 (僴僀僽儕僢僪奐嵜).
722023. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 抇摴幘姵偵懳偡傞撪帇嬀恌抐偲帯椕. 娾堜抦媣 (徚壔婍撪): 戞44夞擔杮徚壔婍撪帇嬀妛夛僙儈僫乕 (2020/9/30-10/28), WEB奐嵜.
722024. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 墛徢惈挵幘姵偵懳偡傞撪壢帯椕傪傕偆堦搙惍棟偡傞. 墶嶳丂孫 (徚壔婍撪): 戞44夞擔杮徚壔婍撪帇嬀妛夛僙儈僫乕 (2020/9/30-10/28), WEB奐嵜.
722025. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 娞惈擼徢偵懳偡傞儗儃僇儖僯僠儞+儕僼傽僉僔儈儞暪梡椕朄偵娭偡傞儔儞僟儉暲峴孮娫斾妑帋尡. 嫑搱惏婭1, 擔崅丂墰1, 夑屆丂崃2 (1徚壔婍撪, 2徝撿姍憅憤崌昦堾丒徚壔婍昦僙儞僞乕): JDDW 2020 KOBE (2020/11/5), 恄屗 (僴僀僽儕僢僪奐嵜).
722026. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) ERCP崲擄椺偵懳偡傞EUS壓鋁娗僪儗僫乕僕偺惉愌偲庤媄偺岺晇. 搉曈恀堣1, 墱榚嫽夘1, 栘揷岝峀1 (1徚壔婍撪): JDDW 2020 KOBE (2020/11/5), 恄屗 (僴僀僽儕僢僪奐嵜).
722027. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 怘摴昞嵼滸暯忋旂娻撪帇嬀愗彍屻偵敪惗偡傞堎帪惈摢栩晹怘摴娻偲Alcohol Use Disorders Identification Test (AUDIT) 偺娭楢. 寴揷恊棙1, 墶嶳丂尠2, 晲摗丂妛3 (1徚壔婍撪, 2崙棫媣棦昹堛椕僙儞僞乕, 3嫗搒戝晬懏昦堾丒庮釃撪壢): JDDW 2020 KOBE (2020/11/6), 恄屗 (僴僀僽儕僢僪奐嵜).
722028. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) Lenvatinib偺栧柆寣峴摦懺偵梌偊傞塭嬁乣搳梌慜屻偱偺僾儔挻壒攇傪梡偄偨専摙偐傜乣. 尨丂桬曘1, 擔崅丂墰1, 嫑搱惏婭1 (1徚壔婍撪): JDDW 2020 KOBE (2020/11/6), 恄屗 (僴僀僽儕僢僪奐嵜).
722029. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) Crohn昦偺帯椕慖戰亅奜壢帯椕偑愭偐撪壢帯椕偑愭偐撪壢堛偺慖戰亅. 墶嶳丂孫1, 彫椦惔揟1,2, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2020/11/13-14), WEB奐嵜.
723025. [妛夛 (慡崙)] (億僗僞乕) 僩儘儞儃僉僒儞A2庴梕懱僔僌僫儖偼, 儌僲僋儘僞儕儞桿摫娞忈奞傪梷惂偡傞. 戝崅巎惞1, 埳摗媊栫2, 暈晹嬁巕1, 杮揷夒巕1, 戝媣曐攷悽3, 嵶栰壛撧巕2, 彫愹榓嶰榊4, 攏搱惓棽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3怱憻寣娗奜, 4徚壔婍撪): 戞41夞擔杮墛徢丒嵞惗堛妛夛 (2020/7/8-9), Web奐嵜.
723092. [妛夛 (慡崙)] (億僗僞乕) 鋁埆惈庮釃偵懳偡傞EUS-FNAB偵偍偗傞慂巋恓偺宍忬偺堘偄偵傛傞恌抐惉愌偺斾妑専摙. 搉曈恀堣1, 墱榚嫽夘1, 崟恵婱峗1, 澍尨彨椙2, 埨払丂夣2, 彙扟姲埲2, 挿扟愳椡栫1, 嬥巕丂嫓1, 嶳撪峗巎1, 娾堜抦媣1, 崱愹丂峅1, 栘揷岝峀1, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢): 戞106夞擔杮徚壔婍昦妛夛憤夛 (2020/8/11-31), 帍忋奐嵜 (WEB奐嵜).
723093. [妛夛 (慡崙)] (億僗僞乕) 僋儘乕儞昦偵崌暪偟偨彫挵娻偺椪彴昦棟妛揑専摙. 揷绯旤撧1, 彫椦惔揟1,2, 暿醕朁峀1, 愳娸壛撧1, 寎丂旤岾1, 墶嶳丂孫1, 媣曐揷旤榓1, 彫愹榓嶰榊1, 嶰巬丂怣3 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕, 3昦棟): 戞106夞擔杮徚壔婍昦妛夛憤夛 (2020/8/11-31), 帍忋奐嵜 (WEB奐嵜).
723094. [妛夛 (慡崙)] (億僗僞乕) Crohn昦偵偍偗傞寣惔垷墧抣偵娭偡傞椪彴揑専摙. 壴壀懢榊1, 墶嶳丂孫1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞106夞擔杮徚壔婍昦妛夛憤夛 (2020/8/11-31), 帍忋奐嵜 (WEB奐嵜).
723095. [妛夛 (慡崙)] (億僗僞乕) NUDT15堚揱巕懡宍専嵏偼墛徢惈挵幘姵 (IBD) 偵偍偗傞僠僆僾儕儞惢嵻帯椕傪曄偊偨偐? 嬥郪丂弫1, 墶嶳丂孫1, 彫椦惔揟1,2, 暿醕朁峀1, 愳娸壛撧1, 寎丂旤岾1, 媣曐揷旤榓1, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞106夞擔杮徚壔婍昦妛夛憤夛 (2020/8/11-31), 帍忋奐嵜 (WEB奐嵜).
723096. [妛夛 (慡崙)] (堦斒岥墘) 崪奿嬝擏検偑梌偊傞儗儞僶僠僯僽偵懳偡傞擡梕惈偲梊屻偺専摙. 嫑搱惏婭1, 夑屆丂崃2, 擔崅丂墰1 (1徚壔婍撪, 2徝撿姍憅憤崌昦堾): 戞56夞擔杮娞憻妛夛憤夛 (2020/8/28-29), 戝嶃 (僴僀僽儕僢僪奐嵜).
723097. [妛夛 (慡崙)] (堦斒岥墘) 摉堾偵偍偗傞愗彍晄擻側恑峴丒嵞敪堓偑傫偵懳偡傞僯儃儖儅僽偺帯椕惉愌. 愇屗尓師1, 榓揷戱栫1, 彫愹榓嶰榊1, 媣曐揷梲2, 搉曈峎幆1, 搶丂悙抭1, 寴揷恊棙1, 揷绯丂憦1,3 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒愭抂堛椕): 戞99夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2020/9/2-3), 嫗搒 (僴僀僽儕僢僪奐嵜).
723098. [妛夛 (慡崙)] (堦斒岥墘) 弍屻鋁抇娗嬻挵暙崌晹嫹嶓偵偍偗傞僶儖乕儞彫挵嬀壓ERCP 崲擄椺偵懳偡傞摉堾偺岺晇. 崟恵婱峗1, 栘揷岝峀1, 彫愹榓嶰榊1, 嶳撪峗巎1, 搉曈恀堣1, 挿扟愳椡栫1, 嬥巕丂嫓1, 墱榚嫽夘1, 娾堜抦媣1 (1徚壔婍撪): 戞99夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2020/9/2-3), 嫗搒 (僴僀僽儕僢僪奐嵜).
723099. [妛夛 (慡崙)] (億僗僞乕) 峈嬅屌栻撪暈徢椺偺憗婜忋晹徚壔娗庮釃偵懳偡傞ESD屻弌寣偺専摙. 榓揷戱栫1, 揷绯丂憦1,2, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕): 戞99夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2020/9/2-3), 嫗搒 (僴僀僽儕僢僪奐嵜).
723100. [妛夛 (慡崙)] (億僗僞乕) 撪帇嬀揑揈彍屻偺戝挵T1 (SM) 娻偺捛壛挵愗彍偺揔墳婎弨偺懨摉惈偺専摙. 寎丂旤岾1, 彫椦惔揟1,2, 媣曐揷 (嵅揷) 旤榓1, 暿醕朁峀1, 愳娸壛撧1, 墶嶳丂孫1, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞99夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2020/9/2-3), 嫗搒 (僴僀僽儕僢僪奐嵜).
723101. [妛夛 (慡崙)] (億僗僞乕) 峈寣愷栻暈梡姵幰偵偍偗傞Cold polypectomy偺埨慡惈偵偮偄偰偺専摙. 堫梩婭巕1, 愳娸壛撧1, 媣曐揷 (嵅揷) 旤榓1, 暿醕朁峀1, 寎丂旤岾1, 墶嶳丂孫1, 彫椦惔揟1,2, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞99夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2020/9/2-3), 嫗搒 (僴僀僽儕僢僪奐嵜).
723102. [妛夛 (慡崙)] (億僗僞乕) ESD屻釐嵀嬤朤偺堎帪懡敪昦曄偺専摙. 杒尨丂尵1, 愇屗尓師1, 揷绯丂憦1,2, 媣曐揷梲3, 搉曈峎幆1, 榓揷戱栫1, 搶丂悙抭1, 寴揷恊棙1, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕, 3戝妛堾堛椕宯尋媶壢): 戞99夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2020/9/2-3), 嫗搒 (僴僀僽儕僢僪奐嵜).
723103. [妛夛 (慡崙)] (億僗僞乕) 枹暘壔宆憗婜堓娻偵偍偗傞H.pylori姶愼忬嫷偲椪彴昦棟妛揑摿挜. 媣曐揷梲1, 揷绯丂憦2,3, 愇屗尓師3, 榓揷戱栫3, 搉曈峎幆3, 搶丂悙抭3, 寴揷恊棙3, 彫愹榓嶰榊3 (1戝妛堾堛椕宯尋媶壢, 2怴悽婭堛椕丒愭抂堛椕, 3徚壔婍撪): 戞99夞擔杮徚壔婍撪帇嬀妛夛憤夛 (2020/9/2-3), 嫗搒 (僴僀僽儕僢僪奐嵜).
723104. [妛夛 (慡崙)] (億僗僞乕) 徚壔婍娻壔妛椕朄偵偍偄偰崪奿嬝検偑梌偊傞塭嬁偵娭偡傞専摙. 娾嶈廏堦榊1, 嫑搱惏婭1, 擔崅丂墰1, 揷绯丂憦1,2 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕): JDDW 2020 KOBE (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723105. [妛夛 (慡崙)] (億僗僞乕) WHO2019暘椶偵弨嫆偟偨鋁恄宱撪暘斿庮釃偺椪彴昦棟妛揑摿挜偲梊屻場巕偺専摙. 崃晹桪嶌1, 墱榚嫽夘1, 栘揷廩峀1, 娾堜抦媣1, 嶳撪峗巎1, 嬥巕丂嫓1, 挿扟愳椡栫1, 搉曈恀堣1, 崟恵婱峗1, 崱愹丂峅1, 彫愹榓嶰榊1 (1徚壔婍撪): JDDW 2020 KOBE (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723106. [妛夛 (慡崙)] (億僗僞乕) 崅楊敪徢偺捵釃惈戝挵墛偺幘姵妶摦惈偼崅偄偺偐?亅旕崅楊敪徢偲偺帯椕偺斾妑偐傜亅. 埳摗棽巑1, 墶嶳丂孫1, 彫椦惔揟1,2, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): JDDW 2020 KOBE (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723107. [妛夛 (慡崙)] (億僗僞乕) 旝彫堓娻偵懳偟偰撪帇嬀揑擲枌壓憌攳棧弍 (ESD) 偺帯椕惉愌偲椪彴昦棟妛揑摿挜. 愇嫶丂樞1, 揷绯丂憦1,2, 愇屗尓師1, 媣曐揷梲3, 搉绮峎幆1, 榓揷戱栫1, 寴揷恊棙1, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕, 3戝妛堾堛椕宯尋媶壢): JDDW 2020 KOBE (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723108. [妛夛 (慡崙)] (億僗僞乕) 尨場晄柧偺徚壔娗弌寣偵懳偡傞撪帇嬀恌抐丒帯椕惉愌. 愳娸壛撧1, 彫椦惔揟1,2, 暿醕朁峀1, 寎丂旤岾1, 墶嶳丂孫1, 媣曐揷 (嵅揷) 旤榓1, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): JDDW 2020 KOBE (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723109. [妛夛 (慡崙)] (億僗僞乕) 墦埵埆惈抇摴嫹嶓偵懳偡傞僼儗傾柍偟慡僇僶乕晅偒抇娗嬥懏僗僥儞僩偺桳岠惈偲埨慡惈偵娭偡傞専摙. 嵅栰払嵠1, 挿扟愳椡栫1, 栘揷岝峀1, 崱愹丂峅1, 娾堜抦媣1, 墱榚嫽夘1, 嶳撪峗巎1, 嬥巕丂嫓1, 搉曈恀堣1, 崟恵婱峗1 (1徚壔婍撪): JDDW 2020 KOBE (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723110. [妛夛 (慡崙)] (億僗僞乕) 摉堾偵偍偗傞鋁娻偵懳偡傞楢懕鋁塼嵶朎恌偺惉愌. 彫栰帥棫1, 搉曈恀堣1, 墱榚嫽夘1, 嬍抲柧姲2, 崟恵婱峗1, 埨払丂夣2, 澍尨彨椙2, 挿扟愳椡栫1, 嬥巕丂嫓1, 嶳撪峗巎1, 娾堜抦媣1, 崱愹丂峅1, 栘揷岝峀1, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢): JDDW 2020 KOBE (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723111. [妛夛 (慡崙)] (億僗僞乕) SVWC cut-off value偵婎偯偄偨EUS-FNAB偺恌抐惉愌偵娭偡傞屻岦偒専徹. 嬍抲柧姲1, 墱榚嫽夘2, 彙扟姲埲1, 搉曈恀堣2, 栘揷岝峀2, 娾堜抦媣2, 嶳撪峗巎2, 嬥巕丂嫓2, 挿扟愳椡栫2, 崟恵婱峗2, 崱愹丂峅2, 彫愹榓嶰榊2 (1戝妛堾堛椕宯尋媶壢, 2徚壔婍撪): JDDW 2020 KOBE (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723112. [妛夛 (慡崙)] (億僗僞乕) 摉堾偵偍偗傞栚揑暿偵傒偨戝挵僗僥儞僩棷抲徢椺偺専摙. 暿醕朁峀1, 嬥郪丂弫1, 愳娸壛撧1, 寎丂旤岾1, 墶嶳丂孫1, 媣曐揷 (嵅揷) 旤榓1, 彫椦惔揟1,2, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): JDDW 2020 KOBE (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723113. [妛夛 (慡崙)] (億僗僞乕) 戝挵庮釃偵懳偡傞JNET戝挵奼戝NBI暘椶偺椪彴揑桳梡惈偵偮偄偰偺専摙. 寎丂旤岾1, 彫椦惔揟1,2, 暿醕朁峀1, 愳娸壛撧1, 墶嶳丂孫1, 媣曐揷 (嵅揷) 旤榓1, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): JDDW 2020 KOBE (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723114. [妛夛 (慡崙)] (堦斒岥墘) Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma. 娾堜抦媣1, Tsujie M, Kubo S, Ura T, Hatano E, Sakai D, Takeda Y, Kaibori M, Kobayashi T, Katanuma A, Katayose Y, Fukase K, Sakurai N, Ito Y, Sato F, Maeda A, Asada M, Morizane C (1徚壔婍撪): 戞18夞擔杮椪彴庮釃妛夛妛弍廤夛 (2021/2/18-21), WEB奐嵜.
723115. [妛夛 (慡崙)] (愱廋堛僙僢僔儑儞) 戝挵宔幒弌寣偵摦柆嵡愷弍偑憈岠偟偦偺屻偵夡醩惈拵悅墛傪偒偨偟偨崅楊幰偺1椺. 崱堜寬懢1, 墶嶳丂孫1, 杒尨丂尵1, 暿醕朁峀1, 愳娸壛撧1, 嬥郪丂弫1, 媣曐揷 (嵅揷) 旤榓1, 彫愹榓嶰榊1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞17夞擔杮徚壔娗妛夛憤夛妛弍廤夛 (2021/2/19-21), WEB奐嵜.
723116. [妛夛 (慡崙)] (堦斒岥墘) 摉堾偵偍偗傞愗彍晄擻恑峴嵞敪堓娻偵懳偡傞2師帯椕nab-PTX+R-mab偺桳梡惈. 嶁晹桬懢1, 愇屗尓師1, 媣曐揷梲2, 屆峕峃柧1, 搉绯峎幆1, 榓揷戱栫1, 寴揷恊棙1, 揷绯丂憦1,3, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒愭抂堛椕): 戞93夞擔杮堓娻妛夛憤夛 (2021/3/3-5), WEB奐嵜.
723117. [妛夛 (慡崙)] (億僗僞乕) 摉堾偵偍偗傞Nivolumab搳梌拞偵ACTH扨撈寚懝徢傪棃偟偨2徢椺. 搚嫃擁懢榊1, 愇屗尓師1, 媣曐揷梲2, 屆峕峃柧1, 榓揷戱栫1, 搉曈峎幆1, 寴揷恊棙1, 揷绯丂憦1,3, 彫愹榓嶰榊1 (1徚壔婍撪, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒愭抂堛椕): 戞93夞擔杮堓娻妛夛憤夛 (2021/3/3-5), WEB奐嵜.
723032. [妛夛 (慡崙)] (億僗僞乕) 寣彫斅偼儌僲僋儘僞儕儞桿摫娞忈奞傪寉尭偡傞. 戝崅巎惞1, 埳摗媊栫2, 嵶栰壛撧巕2, 敤拞丂岞2, 彫愹榓嶰榊3, 揤栰塸庽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3徚壔婍撪): 戞94夞擔杮栻棟妛夛擭夛 (2021/3/8-10), 嶥杫 (僴僀僽儕僢僪奐嵜).
731001. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 崅楊幰捵釃惈戝挵墛偵偍偗傞幚椪彴. 墶嶳丂孫 (徚壔婍撪): 僀儉儔儞WEB僙儈僫乕 (2020/10/8), WEB奐嵜.
731002. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) IBD姵幰偝傫偺儌僠儀乕僔儑儞傾僢僾傪栚巜偟偰. 墶嶳丂孫 (徚壔婍撪): IBD恌椕曌嫮夛 (2020/10/10), WEB奐嵜.
731003. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 捵釃惈戝挵墛帯椕栻偺恑曕偲僂僗僥僉僰儅僽偺栶妱. 墶嶳丂孫 (徚壔婍撪): 僗僥儔乗儔UC揔墳捛壛僙儈僫乕 in 恄撧愳 (2020/11/10), WEB奐嵜.
731004. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 僋儘乕儞昦偺撪壢揑傾僾儘乕僠. 墶嶳丂孫 (徚壔婍撪): IBD Collaboration Seminar (2020/11/20), WEB奐嵜.
731005. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 憹偊偰偄傞墛徢惈挵幘姵偵偍偗傞怴宆僐儘僫僂僀儖僗傊偺懳墳. 墶嶳丂孫 (徚壔婍撪): 戞35夞恄宱擄昦尋廋夛 (2020/12/7), 恄撧愳.
731006. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 捵釃惈戝挵墛偺昦懺偲撪壢帯椕偺嵟怴忣曬亅怴宆僐儘僫傊偺懳墳傪娷傔偰. 彫椦惔揟1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2徚壔婍撪): 導墰捵釃惈戝挵墛帯椕僙儈僫乕 (2020/12/14), 奀榁柤.
731007. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 摉堾偵偍偗傞IBD恌椕偺尰忬偲崱屻偺堛椕楢実偵偮偄偰. 墶嶳丂孫 (徚壔婍撪): 懡杸丒憡柾尨抧嬫IBD抧堟堛椕楢実偺夛 (2021/1/21), WEB奐嵜.
731008. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 怴宆僐儘僫僂僀儖僗姶愼奼戝壓偵偍偗傞捵釃惈戝挵墛偺恌椕. 墶嶳丂孫 (徚壔婍撪): 戞70夞暯捤巗徚壔婍尋媶夛 (2021/2/3), WEB奐嵜.
731009. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 怴宆僐儘僫僂僀儖僗偵傛傝捵釃惈戝挵墛帯椕偼曄傢偭偨偺偐? 墶嶳丂孫 (徚壔婍撪): UC帯椕昦恌楢実僙儈僫乕 (2021/2/5), WEB奐嵜.
731010. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 怴宆僐儘僫僂僀儖僗姶愼壓偺捵釃惈戝挵墛帯椕. 墶嶳丂孫 (徚壔婍撪): 彫揷尨抧嬫IBD WEB僙儈僫乕 (2021/2/16), WEB奐嵜.
731011. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 捵釃惈戝挵墛帯椕栻偺恑曕偲僂僗僥僉僰儅僽偺栶妱. 墶嶳丂孫 (徚壔婍撪): 僗僥儔乗儔捵釃惈戝挵墛WEB僙儈僫乕 in 恄撧愳 (2021/2/18), WEB奐嵜.
732004. [妛夛 (抧曽夛丒尋媶夛)] (僷僱儖僨傿僗僇僢僔儑儞) 崅楊幰捵釃惈戝挵墛偺擖堾椺偵偍偗傞撪帇嬀強尒偲帯椕慖戰偺娭楢偵偮偄偰. 埳摗棽巑1, 墶嶳丂孫1, 彫椦惔揟1,2 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞110夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/5/30-31), WEB奐嵜.
732005. [妛夛 (抧曽夛丒尋媶夛)] (僷僱儖僨傿僗僇僢僔儑儞) 怘摴惷柆釒偵懳偡傞EVL帯椕慜屻偱偺怘摴堓暙崌晹偺pH抣偵墳偠偨PPI搳梌朄偺専摙. 擔崅丂墰1 殸暘栁攷2, 揷绯丂憦1,3, 嫑搱惏婭1, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴昐崌儢媢憤崌昦堾娞幘姵掅怤廝帯椕僙儞僞乕丒撪帇嬀僙儞僞乕, 3怴悽婭堛椕丒愭抂堛椕): 戞110夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/5/30-31), WEB奐嵜.
732006. [妛夛 (抧曽夛丒尋媶夛)] (價僨僆儚乕僋僔儑僢僾) 弌寣惈堓捵釃偵懳偡傞over-the-scope clip (OTSC) system偺巊梡宱尡. 媣曐揷梲1, 嶳撪峗巎2, 拞扟尋搇3 (1戝妛堾堛椕宯尋媶壢, 2徚壔婍撪, 3媬柦): 戞110夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/5/30-31), WEB奐嵜.
732007. [妛夛 (抧曽夛丒尋媶夛)] (價僨僆僔儞億僕僂儉) 鋁庮釃偵懳偡傞EUS-FNA偵偍偗傞stereomicroscopic on-site evaluation偺桳梡惈. 搉曈恀堣1, 墱榚嫽夘1, 娾堜抦媣1, 栘揷岝峀1, 彫愹榓嶰榊1 (1徚壔婍撪): 戞111夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/12/19-20), WEB奐嵜.
732008. [妛夛 (抧曽夛丒尋媶夛)] (僷僱儖僨傿僗僇僢僔儑儞) 廳徢弌寣惈徚壔惈捵釃偵懳偡傞撪帇嬀揑巭寣崲擄場巕偺専摙. 媣曐揷梲1, 嶳撪峗巎2, 拞扟尋搇3, 揷绯丂憦2,4 (1戝妛堾堛椕宯尋媶壢, 2徚壔婍撪, 3媬柦, 4怴悽婭堛椕丒愭抂堛椕): 戞111夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/12/19-20), WEB奐嵜.
732009. [妛夛 (抧曽夛丒尋媶夛)] (儚乕僋僔儑僢僾) 抇鋁撪帇嬀帯椕偵偍偗傞僫僀僠僲乕儖惢8慄僗僷僀儔儖僶僗働僢僩傪墳梡偟偨僩儔僽儖僔儏乕僥傿儞僌. 崟恵婱峗1, 栘揷岝峀1, 墱榚嫽夘1, 娾堜抦媣1, 彫愹榓嶰榊1 (1徚壔婍撪): 戞111夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/12/19-20), WEB奐嵜.
733013. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 恌抐偵嬯椂偟total biopsy栚揑偵撪帇嬀揑擲枌壓憌攳棧弍傪峴偭偨憗婜堓娻偺1椺. 斾棷娫抭婭1, 搉曈峎幆1, 揷绯丂憦1,2, 榓揷戱栫1, 愇屗尓師1, 寴揷恊棙1, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕): 戞110夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/5/30-31), WEB奐嵜.
733014. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 僔儞僌儖僶儖乕儞撪帇嬀偱揈彍偟偊偨夞挵夁岆庮偺1椺. 巗绯壴撧1, 墶嶳丂孫1, 杒尨丂尵1, 嬥郪丂弫1, 愳娸壛撧1, 暿晉朁峀1, 媣曐揷旤榓1, 彫椦惔揟1,2, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞110夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/5/30-31), WEB奐嵜.
733015. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 僷僥儞僔乕僇僾僙儖偑懾棷偟偨曻幩慄惈彫挵墛偺1椺. 尨揷梞暯1, 嬥郪丂弫1, 暿醕朁岹1, 愳娸壛撧1, 墶嶳丂孫1, 媣曐揷 (嵅揷) 旤榓1, 彫愹榓嶰榊1, 彫椦惔揟1,2, 崅嫶攷擵3 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕, 3堛椕塹惗妛晹): 擔杮徚壔婍昦妛夛娭搶巟晹戞360夞椺夛 (2020/8/3-31), WEB奐嵜.
733016. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 鋁恄宱撪暘斿庮釃偲偺娪暿偵嬯椂偟偨鋁solid-pseudopapillary neoplasm 偺堦椺. 棫愳幯寧1,2, 栘揷岝峀1,2, 杒尨丂尵1,2, 忋尨堦斂1,2, 嬥巕丂嫓1,2, 戝捤弐榓1,2, 揷尨媣旤巕1, 搉绮恀彶1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2徚壔婍撪): 擔杮徚壔婍昦妛夛娭搶巟晹戞360夞椺夛 (2020/8/3-31), WEB奐嵜.
733017. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 抇娗撪偵柪擖偟偨鋁娗嬻挵暙崌晹儘僗僩僗僥儞僩傪撪帇嬀壓偵夞廂偟摼偨堦椺. 暯堜揘旻1, 搉曈恀堣1, 崟恵婱峗1, 挿扟愳椡栫1, 墱榚嫽夘1, 娾堜抦媣1, 崱愹丂峅1, 栘揷岝峀1, 彫愹榓嶰榊1 (1徚壔婍撪): 擔杮徚壔婍昦妛夛娭搶巟晹椺夛戞361夞椺夛 (2020/9/12), WEB奐嵜.
733005. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 娞椶摯暵嵡徢岓孮偵偍偗傞寣彫斅偺栶妱. 戝崅巎惞1, 埳摗媊栫2, 屻摗戩栫1, 嵶栰壛撧巕2, 敤拞丂岞2, 彫愹榓嶰榊3, 揤栰塸庽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3徚壔婍撪): 戞143夞擔杮栻棟妛夛娭搶晹夛 (2020/10/24), Web奐嵜.
733018. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僋儘乕儞昦弶婜昦曄偺撪帇嬀偺峫嶡. 嬥郪丂弫1, 墶嶳丂孫1, 彫椦惔揟1,2, 媣曐揷 (嵅揷) 旤榓1, 暿醕朁峀1, 愳娸壛撧1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 戞27夞恄撧愳IBD尋媶夛 (2020/11/26), WEB奐嵜.
733019. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 擃崪栄敮掅宍惉徢傪攚宨偵廳撃側宱夁傪扝偭偨枬惈抇廯偆偭懾宆偺娞峝曄徢偺堦椺. 崈忋懢榊1, 嫑搱惏婭1, 娾嶈廏堦榊1, 榓揷彯媣1, 孍揷岾夘1, 擔崅丂墰1, 拞郪婱廏1, 廰扟柧棽1, 彫愹榓嶰榊1, 峕攇屗岶曘2 (1徚壔婍撪, 2彫帣): 擔杮徚壔婍昦妛夛娭搶巟晹戞362夞椺夛 (2020/12/5), WEB奐嵜.
733020. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 摉堾偱宱尡偟偨攡撆惈捈挵墛偺1椺. 墶憅峲堦1, 暿醕朁峀1, 嬥郪丂弫1, 愳娸壛撧1, 墶嶳丂孫1, 媣曐揷 (嵅揷) 旤榓1, 彫椦惔揟1,2, 懞塤朏庽3 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕, 3昦棟): 戞111夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/12/19-20), WEB奐嵜.
733021. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 拞婯柾昦堾偵偍偗傞鋁庮釃偵懳偡傞Sample Isolation Processing by Stereomicroscopy傪梡偄偨EUS-FNAB摫擖弶婜偺恌抐擻偺専徹. 堜夢桟夘1,2, 崱愹丂峅1,2, 堫梩婭巕1,2, 嬥丂柧揘1,2, 嶰巬梲堦1, 愇嶈弮榊2, 嬍抲柧姲3, 搉曈恀堣2, 彙扟姲埲3, 媣曐揷梲3, 墱榚嫽夘2 (1憡柾栰昦堾徚壔婍撪壢, 2徚壔婍撪, 3戝妛堾堛椕宯尋媶壢): 戞111夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/12/19-20), WEB奐嵜.
733022. [妛夛 (抧曽夛丒尋媶夛)] (尋廋堛僙僢僔儑儞) 懠憻婍娻儕儞僷愡揮堏偵敽偆埆惈怘摴嫹嶓偵懳偟OTSC傪暪梡偟怘摴僗僥儞僩傪棷抲偟偨2椺. 栰懞撧墰1, 榓揷戱栫1, 屆峕峃柧1, 搉曈峎幆1, 愇屗尓師1, 寴揷恊棙1, 揷绯丂憦1,2, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒愭抂堛椕): 戞111夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/12/19-20), WEB奐嵜.
733023. [妛夛 (抧曽夛丒尋媶夛)] (愱廋堛僙僢僔儑儞) 傾僼僞條昦曄偐傜挿婜宱夁偱揟宆揑僋儘乕儞昦偵恑揥偟偨堦椺. 斞揷弤婱1, 嬥郪丂弫1, 墶嶳丂孫1, 暿醕朁峀1, 愳娸壛撧1, 媣曐揷 (嵅揷) 旤榓1, 彫椦惔揟1,2, 彫愹榓嶰榊1 (1徚壔婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮徚壔婍昦妛夛娭搶巟晹戞363夞椺夛 (2021/2/27), WEB奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
H29-522001. [島嵗]亂摿廤II: 栧柆埑槾恑徢帯椕偺恑曕亃栧柆埑槾恑徢偺栻暔椕朄. 嫑搱惏婭1, 擔崅丂墰1 (1徚壔婍撪): 徚壔婍丒娞憻撪壢 2017/11; 2 (5): 534-41.
[挊丂彂]
'18-620001. [妛弍彂 (暘扴幏昅)]亂挻壒攇撪帇嬀壓慂巋弍偺偨傔偺 僐儞儀僢僋僗憱嵏幃挻壒攇撪帇嬀偵傛傞昗弨揑昤弌朄亃https://www.olympusprofed.com/jp/gi/eus/26920/. 僐儞儀僢僋僗憱嵏幃挻壒攇撪帇嬀昤弌朄昗弨壔専摙晹夛. 娔廋: 栘揷岝峀1,2, 嶳梇寬師 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2徚壔婍撪), 僆儕儞僷僗, 搶嫗, 2019/3.
'19-620001. [妛弍彂 (暘扴幏昅)]亂儔僕傾儖憱嵏幃挻壒攇撪帇嬀偵傛傞鋁丒抇摴椞堟偺昗弨揑昤弌朄亃https://www.olympusprofed.com/jp/gi/eus/27686/. 儔僕傾儖憱嵏幃挻壒攇撪帇嬀偵傛傞鋁丒抇摴椞堟偺昗弨揑昤弌朄昗弨壔専摙晹夛. 娔廋: 栘揷岝峀1,2, 埨揷寬帯楴 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2徚壔婍撪), 僆儕儞僷僗, 搶嫗, 2020/3.
戝妛堾堛椕宯尋媶壢丂徚壔婍撪壢妛
婑晬島嵗乽墛徢惈挵幘姵椪彴尋媶島嵗乿
[妛弍榑暥]
110119. [尨挊] Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial. Naganuma M1, Yokoyama Y1, Motoya S1, Watanabe K1, Sawada K1, Hirai F1, Yamamoto T1, Hanai H1, Omori T1, Kanai T1, Hibi T1,2,3 (1CAPTAIN study Group): J Gastroenterol 2020; 55 (4): 390-400. (擔斾婭暥1,2,3: 2戝妛堾堛椕宯尋媶壢, 3杒棦戝妛杒棦尋媶強昦堾)
110120. [尨挊] Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis. Naganuma M, Kobayashi T1,2, Nasuno M, Motoya S, Kato S, Matsuoka K, Hokari R, Watanabe C, Sakamoto H, Yamamoto H, Sasaki M, Watanabe K, Iijima H, Endo Y, Ichikawa H, Ozeki K, Tanida S, Ueno N, Fujiya M, Sako M, Takeuchi K, Sugimoto S, Abe T, Hibi T1,2, Suzuki Y, Kanai T: Clin Gastroenterol Hepatol 2020/5; 18 (5): 1102-11.e5. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110121. [尨挊] Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis. Kobayashi T1,2, Uda A, Udagawa E, Hibi T1,2: J Crohns Colitis 2020/6; 14 (5): 617-23. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110122. [尨挊] A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn's disease. Bamba S, Sakemi R, Fujii T, Takeda T, Fujioka S, Takenaka K, Kitamoto H, Umezawa S, Sakuraba H, Inokuchi T, Fukata N, Mizuno S, Yamashita M, Shinzaki S, Tanaka H, Takedatsu H, Ozaki R, Moriya K, Ishii M, Kinjo T, Ozeki K, Ooi M, Hayashi R, Kakimoto K, Shimodate Y, Kitamura K, Yamada A, Sonoda A, Nishida Y, Yoshioka K, Ashizuka S, Takahashi F, Shimokawa T, Kobayashi T1,2, Andoh A, Hibi T1,2: J Gastroenterol 2020/6; 55 (6): 615-26. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110123. [尨挊] Transperineal ultrasound predicts endoscopic and histological healing in ulcerative colitis. Sagami S1, Kobayashi T1,2, Aihara K, Umeda M, Morikubo H1, Matsubayashi M, Kiyohara H, Nakano M1, Ohbu M, Hibi T1,2: Aliment Pharmacol Ther 2020/6; 51 (12): 1373-83. (嵅忋怶懢榊1, 彫椦丂戱1,2, 怷媣曐戱1, 拞栰丂夒1, 擔斾婭暥1,2: 1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢)
110124. [尨挊] Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial. Vermeire S, Su C, Lawendy N, Kobayashi T1,2, Sandborn WJ, Rubin DT, Modesto I, Gardiner S, Kulisek N, Zhang H, Wang W, Pan巗 J: J Crohns Colitis 2021/7; 15 (7): 1130-41. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110125. [尨挊] Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis. Kobayashi T1,2, Ito H, Ashida T, Yokoyama T, Nagahori M, Inaba T, Shikamura M, Yamaguchi T, Hori T, Pinton P, Watanabe M, Hibi T1,2: Intest Res 2020/8. doi: 10.5217/ir.2020.00026. Online ahead of print. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110126. [尨挊] Determining the usefulness of Capsule Scoring of Ulcerative Colitis in predicting relapse of inactive ulcerative colitis. Matsubayashi M, Kobayashi T1,2, Okabayashi S, Nakano M2, Sagami S2, Ozaki R, Kiyohara H, Morikubo H2, Asonuma K2, Miyatani Y2, Maeda S, Hibi T1,2: J Gastroenterol Hepatol 2021/4; 36 (4): 943-50. doi: 10.1111/jgh.15220. Epub 2020 Sep 3. (彫椦丂戱1,2, 拞栰丂夒2, 嵅忋怶懢榊2, 怷媣曐戱2, 垻慮徖朚墰2, 媨扟樞桟2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
110127. [尨挊] Efficacy of biologic therapies for biologic-na?ve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis. Hibi T1,2, Kamae I, Pinton P, Ursos L, Iwakiri R, Hather G, Patel H: Intest Res 2021/1; 19 (1): 53-61. (擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
510003. [憤愢] Ulcerative colitis. Kobayashi T1,2, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T1,2: Nat Rev Dis Primers 2020/9; 6 (1): 74. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
522026. [島嵗]亂摿廤: 僋儘乕儞昦彫挵嫹嶓昦曄偵懳偡傞撪帇嬀揑僶儖乕儞奼挘弍亅婎杮偐傜僺僢僩僼僅乕儖傑偱亃4. 奀奜偺暥專傪撉傒夝偔亅僋儘乕儞昦嫹嶓昦曄偵懳偡傞愗奐朄偼桳岠偐? 彫椦丂戱1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾), INTESTINE 2020/8; 24 (3): 256-8.
522027. [島嵗]亂摿廤: 墛徢惈挵幘姵亅墛徢惈挵幘姵偺昦懺偲曄傢傝備偔帯椕愴棯亃<帯椕乛崌暪徢傗暪懚徢傪尒悩偊偨嵟揔帯椕>丂墛徢惈挵幘姵偺怴婯帯椕栻偲偦偺揔墳亅JAK慾奞栻, 峈IL-12/23峈懱惢嵻, 峈兛4兝7僀儞僥僌儕儞峈懱側偳偼偳偺傛偆側栻嵻偱偳偺傛偆偵巊梡偡傞偺偐?亅. 彫椦丂戱1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾) Medical Practice 2020/12; 37 (12): 1917-20.
[挊丂彂]
620025. [妛弍彂 (暘扴幏昅)] 亂暿嶜擔杮椪喱 椞堟暿徢岓孮僔儕乕僘 No.11丂徚壔娗徢岓孮 (戞3斉) III亅偦偺懠偺徚壔娗幘姵傪娷傔偰亅亃VI. 嬻挵, 夞挵, 栍挵, 寢挵, 捈挵 (忋)丂2. 墛徢惈幘姵丂(19) 徚壔娗傾儈儘僀僪乕僔僗, p.190-3. 彫椦丂戱1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾), 擔杮椪喱幮, 搶嫗, 2020/4敪峴.
620026. [妛弍彂 (暘扴幏昅)] 亂戝挵幘姵傾僩儔僗update (徚壔婍撪帇嬀32姫憹姧崋)亃III. 帺屓柶塽幘姵丒銹尨昦丒寣娗墛側偳丂Crohn昦, p.182-3. 彫椦丂戱1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾), 搶嫗堛妛幮, 搶嫗, 2020/11敪峴.
[妛夛丒尋媶夛摍]
722030. [妛夛 (慡崙)] (僽儗僢僋僼傽乕僗僩僙儈僫乕) UC帯椕偵偍偗傞曋拞僇儖僾儘僥僋僠儞偺儀僗僩儐乕僗. 彫椦丂戱1,2 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞62夞擔杮徚壔婍昦妛夛戝夛 (JDDW 2020 KOBE) (2020/11/6), 恄屗 (僴僀僽儕僢僪奐嵜).
722031. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) 捵釃惈戝挵墛偵偍偗傞宱夛堿暪梡挵娗僄僐乕偺抁婜梊屻梊應擻. 嵅忋怶懢榊1, 彫椦丂戱1,2, 怷媣曐戱1, 憡尨壚撨巕, 攡揷旤嶇, 彫揷搰堦峅, 媨扟樞桟1, 徏椦恀墰, 惔尨桾婱, 垻慮徖朚墰1, 拞栰丂夒1, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞11夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (JSIBD) (2020/12/5), Web奐嵜.
723118. [妛夛 (慡崙)] (堦斒島墘) 懱奜幃挻壒攇専嵏偺捵釃惈戝挵墛偵偍偗傞抁婜梊屻梊應擻偺夝愅. 怷媣曐戱1, 嵅忋怶懢榊1, 彫椦丂戱1,2, 憡尨壚撨巕, 攡揷旤嶇, 嬥戲揙梇, 椦丂婯棽, 媨扟樞桟1, 徏椦恀墰, 惔尨桾婱, 垻慮徖朚墰1, 拞栰丂夒1, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞57夞擔杮徚壔婍柶塽妛夛憤夛 (2020/7/2-3), 嫗搒 (帍忋奐嵜).
723119. [妛夛 (慡崙)] (堦斒島墘) 挵娗儅僋儘僼傽乕僕偺摿庩惈偲偦偺墛徢惈挵幘姵昦懺偵偍偗傞娭梌. 彫椦丂戱1,2, 抾撪丂廋, 崟徖丂抭 (1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾): 戞48夞擔杮椪彴柶塽妛夛憤夛 (2020/10/15), Web奐嵜.
723120. [妛夛 (慡崙)] (億僗僞乕) 僋儘乕儞昦彫挵昦曄偺儌僯僞儕儞僌偵偍偗傞僶僀僆儅乕僇乕偺桳岠惈. 垻慮徖朚墰1, 彫椦丂戱1,2, 嵅忋怶懢榊1, 徏椦恀墰, 怷媣曐戱1, 惔尨桾婱, 媨扟樞桟1, 拞栰丂夒1, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞62夞擔杮徚壔婍昦妛夛戝夛 (JDDW 2020 KOBE) (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723121. [妛夛 (慡崙)] (億僗僞乕) 挵娗僄僐乕偼捵釃惈戝挵墛偵偍偗傞姲夝摫擖帯椕偵懳偡傞斀墳傪梊應偱偒傞偐? 怷媣曐戱1, 嵅忋怶懢榊1, 彫椦丂戱1,2, 憡尨壚撨巕, 攡揷旤嶇, 嬥戲揙梇, 椦丂婯棽, 媨扟樞桟1, 徏椦恀墰, 惔尨桾婱, 垻慮徖朚墰1, 拞栰丂夒1, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞62夞擔杮徚壔婍昦妛夛戝夛 (JDDW 2020 KOBE) (2020/11/5-8), 恄屗 (僴僀僽儕僢僪奐嵜).
723122. [妛夛 (慡崙)] (堦斒岥墘) 僒僀僩儊僈儘僂僀儖僗弶姶愼偵傛傞娞墛, 廫擇巜挵墛傪敪徢偟偨姲夝婜僋儘乕儞昦偺堦椺. 奀峕揷桽懢, 怷媣曐戱1, 彫椦丂戱1,2, 媨扟樞桟1, 暉揷抦峀1, 垻慮徖堣墰1, 嵅忋怶懢榊1, 拞栰丂夒1, 慜揷堦榊1,3, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢, 3昦棟): 戞11夞擔杮墛徢惈挵幘姵妛夛妛弍廤夛 (JSIBD) (2020/12/5), Web奐嵜.
732010. [妛夛 (抧曽夛丒尋媶夛)] (僷僱儖僨傿僗僇僢僔儑儞) 嬤埵戝挵偑擲枌帯桙偵偁傞捵釃惈戝挵墛偺墦埵偵偺傒巆懚偡傞墛徢偼彫偝側嵞擱偺儕僗僋偵偼側傞偑戝偒側嵞擱偵偼塭嬁偟側偄. 垻慮徖朚墰1, 彫椦丂戱1,2, 嵅忋怶懢榊1, 拞栰丂夒1, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞110夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/5/30-31), Web奐嵜.
733024. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Crohn昦偵崌暪偟偨愗彍晄擻戝挵娻偵懳偡傞5-FU搳梌偱崅傾儞儌僯傾寣徢傪敽偆堄幆忈奞傪偒偨偟偨堦椺. 捈媨嬁暯1, 惣懞丂尗1, 拞嶳徃揟, 垻慮徖朚墰1, 嵅忋怶懢榊1, 彫椦丂戱1,2, 擔斾婭暥1,2, 棊崌戝庽1, 愇堜椙岾1,3, 媑揷撃巎, 怷媣曐戱1, 媨扟樞桟1, 惔尨桾婱, 徏椦恀墰, 拞栰丂夒1 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜): 擔杮徚壔婍昦妛夛娭搶巟晹丂戞359夞椺夛 (2020/5/1-29), Web奐嵜.
733025. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 慡戝挵墛宆捵釃惈戝挵墛偺墦堛偺傒偵巆懚偡傞墛徢偼梊屻偵桳堄側塭嬁傪梌偊側偄. 垻慮徖朚墰1, 彫椦丂戱1,2, 拞栰丂夒1, 崟栘桪堦榊, 擔斾婭暥1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2戝妛堾堛椕宯尋媶壢): 戞111夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/12/20), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-110006. [尨挊] High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype Kakuta Y, Izumiyama Y, Okamoto D, Nakano T, Ichikawa R, Naito T, Moroi R, Kuroha M, Kanazawa Y, Kimura T, Shiga H, Kudo H, Minegishi N, Kawai Y, Tokunaga K, Nagasaki M, Kinouchi Y, Suzuki Y, Masasmune A, Collaborators: MENDEL study group (Kobayashi T1,2): J Gastroenterol 2020/1; 55 (1): 67-77. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
'19-110007. [尨挊] Somatic inflammatory gene mutations in human ulcerative colitis epithelium. Nanki K, Fujii M, Shimokawa M, Matano M, Nishikori S, Date S, Takano A, Toshimitsu K, Ohta Y, Takahashi S, Sugimoto S, Ishimaru K, Kawasaki K, Nagai Y, Ishii R, Yoshida K, Sasaki N, Hibi T1,2, Ishihara S, Kanai T, Sato T: Nature 2020/1; 577 (7789): 254-9. (擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
'19-110008. [尨挊] Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn's disease in Japanese and Korean patients: the OPERA study. Saruta M, Park DI, Kim Y-H, Yang S-K, Jang B-I, Cheon JH, Im JP, Kanai T, Katsuno T, Ishiguro Y, Nagaoka M, Isogawa N, Li Y, Banerjee A, Ahmad A, Hassan-Zahraee M, Clare R, Gorelick KJ, Cataldi F, Watanabe M, Hibi T1,2: Intest Res 2020/1; 18 (1): 45-55. (擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
'19-110009. [尨挊] Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials. Hibi T1,2, Naganuma M, Oda E, Yamada Y, Chujoh Y, Yoshihara R, Watanabe M: Intest Res 2020/1; 18 (1): 56-68. (擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
'19-110010. [尨挊] Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study. Naganuma M1, Sugimoto S1, Fukuda T1, Mitsuyama K1, Kobayashi T1,2,3, Yoshimura N1, Ohi H1, Tanaka S1, Andoh A1, Ohmiya N1, Saigusa K1, Yamamoto T1, Morohoshi Y1, Ichikawa H1, Matsuoka K1, Hisamatsu T1, Watanabe K1, Mizuno S1, Abe T1, Suzuki Y1, Kanai T1 (1INDIGO Study Group): J Gastroenterol 2020/2; 55 (2): 169-80. (彫椦丂戱1,2,3: 2戝妛堾堛椕宯尋媶壢, 3杒棦戝妛杒棦尋媶強昦堾)
'19-110011. [尨挊] Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis. Sandborn WJ, Baert F, Danese S, Krznari玞 Z, Kobayashi T1,2, Yao X, Chen J, Rosario M, Bhatia S, Kisfalvi K, D'Haens G, Vermeire S: Gastroenterology 2020/2; 158 (3): 562-72.e12. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
'19-110012. [尨挊] Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis. Kobayashi T1,2, Udagawa E, Uda A, Hibi T1,2, Hisamatsu T: J Gastroenterol Hepatol 2020/2; 35 (2): 225-32. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
'19-110013. [尨挊] Ulcerative Colitis: Disease Burden, Impact on Daily Life, and Reluctance to Consult Medical Professionals: Results from a Japanese Internet Survey. Hibi T1,2, Ishibashi T, Ikenoue Y, Yoshihara R, Nihei A, Kobayashi T1,2: Inflamm Intest Dis 2020/2; 5 (1): 27-35. (擔斾婭暥1,2, 彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
'19-110014. [尨挊] Effects of vedolizumab in Japanese patients with Crohn's disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses. Watanabe K, Motoya S, Ogata H, Kanai T, Matsui T, Suzuki Y, Shikamura M, Sugiura K, Oda K, Hori T, Araki T, Watanabe M, Hibi T1,2: J Gastroenterol 2020/3; 55 (3): 291-306. (擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
'19-510001. [憤愢] Inflammatory Bowel Disease in Japan-Is It Similar to or Different from Westerns? Okabayashi S, Kobayashi T1,2, Hibi T1,2: J Anus Rectum Colon 2020/1; 4 (1): 1-13. (彫椦丂戱1,2, 擔斾婭暥1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
'19-530002. [偦偺懠 (Erratum)] Correction to: High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype Kakuta Y, Izumiyama Y, Okamoto D, Nakano T, Ichikawa R, Naito T, Moroi R, Kuroha M, Kanazawa Y, Kimura T, Shiga H, Kudo H, Minegishi N, Kawai Y, Tokunaga K, Nagasaki M, Kinouchi Y, Suzuki Y, Masasmune A, Collaborators: MENDEL study group (Kobayashi T1,2): J Gastroenterol 2020/1; 55 (1): 132. (彫椦丂戱1,2: 1戝妛堾堛椕宯尋媶壢, 2杒棦戝妛杒棦尋媶強昦堾)
弞娐婍撪壢妛
[妛弍榑暥]
110128. [尨挊] Physical exertion as a trigger of acute coronary syndrome caused by plaque erosion. Kato A1, Minami Y2, Katsura A1, Muramatsu Y2, Sato T2, Kakizaki R2, Nemoto T2, Hashimoto T2, Fujiyoshi K2, Meguro K2, Shimohama T2, Ako J2: J Thromb Thrombolysis 2020/4; 49 (3): 377-85. (壛摗嵤旤1, 撿丂彯尗2, 宩丂桳抭1, 懞徏桾夘2, 嵅摗弐廩2, 奰嶈椙懢2, 崻杮徠悽巙2, 嫶杮戱栱2, 摗媑榓攷2, 栚崟寬懢榊2, 壓昹岶榊2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
110129. [尨挊] A combination of depression and decreased physical function further worsens the prognosis of patients with chronic cardiovascular disease. Osada K1, Yamaoka-Tojo M2, Obara S3, Kariya H3, Kato Y1, Yuyama A1, Kamiya K2, Matsunaga A2, Ako J4: J Cardiovasc Med Cardiol 2020/4; 7 (2): 63-71. (挿揷寬嵠1, 搶瀶旤撧巕2, 墦尨恀堦3, 姟扟塸婭3, 壛摗梞暯1, 桵嶳徃斖1, 恄扟寬懢榊2, 徏塱撃旻2, 垻屆弫嵠4: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3儕僴價儕晹, 4弞娐婍撪)
110130. [尨挊] Design of Functional Electrospun Scaffolds Based on Poly (glycerol sebacate) Elastomer and Poly (lactic acid) for Cardiac Tissue Engineering. Flaig F, Ragot H, Simon A, Revet G, Kitsara M, Kitasato L1, H巄raud A, Agbulut O, Schlatter G: ACS Biomater Sci Eng 2020/4; 6 (4): 2388-400. (杒棦棞嵐1: 1弞娐婍撪)
110131. [尨挊] Effect of cardiac rehabilitation on cognitive function in elderly patients with cardiovascular diseases. Fujiyoshi K1, Minami Y1, Yamaoka-Tojo M2, Kutsuna T, Obara S3, Aoyama A4, Ako J1: PLoS One 2020/5; 15 (5): e0233688. (摗媑榓攷1, 撿丂彯尗1, 搶瀶旤撧巕2, 墦尨恀堦3, 惵嶳峎戝4, 垻屆弫嵠1: 1弞娐婍撪, 2堛椕塹惗妛晹, 3儕僴價儕晹, 4戝妛堾堛椕宯尋媶壢)
110132. [尨挊] Long-Term Prognosis of Patients with Myocardial Infarction Type 1 and Type 2 with and without Involvement of Coronary Vasospasm. Sato R, Sakamoto K, Kaikita K, Tsujita K, Nakao K, Ozaki Y, Kimura K, Ako J1, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Tanabe K, Shibata Y, Owa M, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Ohshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M: J Clin Med 2020/6; 9 (6): 1686. (垻屆弫嵠1: 1弞娐婍撪)
110133. [尨挊] Evaluation of an Integrated Device Diagnostics Algorithm to Risk Stratify Heart Failure Patients - Results From the SCAN-HF Study. Okumura K, Sasaki S, Kusano K, Mine T, Fujii K, Iwasa A, Sunagawa O, Yamabe H, Takahashi N, Ishii S1, Takeishi Y, Tsuboi N, Shizuta S, Aonuma K, Shimane A, Tada H, Ishikawa T, Tsunoda R, Numata T, Mukai Y, Kihara Y, Koehler J, Hidaka K, Sharma V: Circ J 2020/6; 84 (7): 1118-23. (愇堜弐曘1: 1弞娐婍撪)
110134. [尨挊] Endothelial glycocalyx and severity and vulnerability of coronary plaque in patients with coronary artery disease. Nemoto T1, Minami Y1, Yamaoka-Tojo M2, Kato A3, Katsura A3, Sato T1, Muramatsu Y1, Kakizaki R1, Fujiyoshi K1, Hashimoto T1, Meguro K1, Shimohama T1, Ako J1: Atherosclerosis 2020/6; 302: 1-7. (崻杮徠悽巙1, 撿丂彯尗1, 搶瀶旤撧巕2, 壛摗嵤旤3, 宩丂桳抭3, 嵅摗弐廩1, 懞徏桾夘1, 奰嶈椙懢1, 摗媑榓攷1, 嫶杮戱栱1, 栚崟寬懢榊1, 壓昹岶榊1, 垻屆弫嵠1: 1弞娐婍撪, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢)
110135. [尨挊] Healed Plaques in Patients With Stable Angina Pectoris. Russo M, Fracassi F, Kurihara O, Kim HO, Thondapu V, Araki M, Shinohara H, Sugiyama T, Yamamoto E, Lee H, Vergallo R, Crea F, Biasucci LM, Yonetsu T, Minami Y1, Soeda T, Fuster V, Jang I-K: Arterioscler Thromb Vasc Biol 2020/6; 40 (6): 1587-97. (撿丂彯尗1: 1弞娐婍撪)
110136. [尨挊] Ethnic Differences in the Pathobiology of Acute Coronary Syndromes Between Asians and Whites. Russo M, Kim HO, Thondapu V, Kurihara O, Araki M, Shinohara H, Yamamoto E, Lee H, Yonetsu T, Minami Y1, Adriaenssens T, Boeder NF, Nef HM, Crea F, Soeda T, Jang I-K: Am J Cardiol 2020/6; 125 (12): 1757-64. (撿丂彯尗1: 1弞娐婍撪)
110137. [尨挊] Seasonal Variations in the Pathogenesis of Acute Coronary Syndromes. Kurihara O, Takano M, Yamamoto E, Yonetsu T, Kakuta T, Soeda T, Yan BP, Crea F, Higuma T, Kimura S, Minami Y1, Adriaenssens T, Boeder NF, Nef HM, Kim CJ, Thondapu V, Kim HO, Russo M, Sugiyama T, Fracassi F, Lee H, Mizuno K, Jang I-K: J Am Heart Assoc 2020/7; 9 (13): e015579. (撿丂彯尗1: 1弞娐婍撪)
110138. [尨挊] Accuracy of a novel stress echocardiography pattern for myocardial bridging in patients with angina and no obstructive coronary artery disease - A retrospective and prospective cohort stud. Paragaonkar VS, Rogers IS, Su J, Forsdahl SH, Kameda R1, Schreiber D, Chan FP, Becker HC, Fleischmann D, Tremmel JA, Schnittger I: Int J Cardiol 2020/7; 311: 107-13. (婽揷丂椙1: 1弞娐婍撪)
110139. [尨挊] Five-year clinical efficacy and safety of contemporary thin-strut biodegradable polymer versus durable polymer drug-eluting stents: a systematic review and meta-analysis of 9 randomized controlled trials. Kobayashi T, Sotomi Y, Suzuki S, Suwannasom P, Nakatani S, Morino Y, Ako J1, Kozuma K, Hirayama A, Sakata Y, Higuchi Y: Cardiovasc Interv Ther 2020/7; 35 (3): 250-8. (垻屆弫嵠1: 1弞娐婍撪)
110140. [尨挊] Prediction of Long-Term Outcomes in ST-Elevation Myocardial Infarction and Non-ST Elevation Myocardial Infarction with and without Creatinine Kinase Elevation-Post-Hoc Analysis of the J-MINUET Study. Toyoda S, Sakuma M, Abe S, Inoue T, Nakao K, Ozaki Y, Kimura K, Ako J1, Noguchi T, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Okamura A, Mano T, Wake M, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Toubaru T, Saku K, Ohshima S, Miyamoto Y, Ogawa H, Ishihara M: J Clin Med 2020/8; 9 (8): 2667. (垻屆弫嵠1: 1弞娐婍撪)
110141. [尨挊] Spatial Distribution of Vulnerable Plaques: Comprehensive In Vivo Coronary Plaque Mapping. Araki M, Soeda T, Kim HO, Thondapu V, Russo M, Kurihara O, Shinohara H, Minami Y1, Higuma T, Lee H, Yonetsu T, Kakuta T, Jang I-K: JACC Cardiovasc Imaging 2020/9; 13 (9): 1989-99. (撿丂彯尗1: 1弞娐婍撪)
110142. [尨挊] Predictors of Rapid Plaque Progression: An Optical Coherence Tomography Study. Araki M, Yonetsu T, Kurihara O, Nakajima A, Lee H, Soeda T, Minami Y1, McNulty I, Uemura S, Kakuta T, Jang I-K: JACC Cardiovasc Imaging 2020/9; S1936-878X(20)30736-1. (撿丂彯尗1: 1弞娐婍撪)
110143. [尨挊] Optimal interlesion distance in ablation index-guided pulmonary vein isolation for atrial fibrillation. Kobayshi S1, Fukaya H2, Oikawa J2, Saito D1, Sato T1, Matsuura G1, Arakawa Y1, Shirakawa Y1, Nishinarita R2, Horiguchi A2, Ishizue N2, Kishihara J2, Niwano S2, Ako J2: J Interv Card Electrophysiol 2020/9. doi: 10.1007/s10840-020-00881-0. Online ahead of print. (彫椦廃暯1, 怺扟塸暯2, 媦愳丂弤2, 釼摗戝庽1, 嵅摗揘榊1, 徏塝丂尦1, 峳愳梇婭1, 敀愳桾婎1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶椕, 2弞娐婍撪)
110144. [尨挊] Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial. Okada K1, Honda Y1, Kitahara H1, Ikutomi M1, Kameda R1,2, Brooke Hollak M1, Yock PG1, Popma JJ1, Kusano H1, Cheong W-F1, Sudhir K1, Fitzgerald PJ1, Kimura T1 (1ABSORB Japan Investigators): Int J Cardiol Heart Vasc 2020/9; 31: 100623. (婽揷丂椙1,2: 2弞娐婍撪)
110145. [尨挊] Prognostic Impact of B-Type Natriuretic Peptide on Long-Term Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Myocardial Infarction Without Creatine Kinase Elevation. Takahashi N1, Ogita M1, Suwa S1, Nakao K1, Ozaki Y1, Kimura K1, Ako J1,2, Noguchi T1, Yasuda S1, Fujimoto K1, Nakama Y1, Morita T1, Shimizu W1, YSaito Y1, Hirohata A1, Morita Y1, Inoue T1, Okamura A1, Mano T1, Hirata K1, Tanabe K1, Shibata Y1, Owa M1, Tsujita K1, Funayama H1, Kokubu N1, Kozuma K1, Uemura S1, Tobaru T1, Saku K1, Oshima S1, Nishimura K1, Miyamoto Y1, Ogawa H1, Ishihara M1 (1J-MINUET investigators): Int Heart J 2020/9; 61 (5): 888-95. (垻屆弫嵠1,2: 2弞娐婍撪)
110146. [尨挊] Prediction of Lethal Arrhythmic Events Through Remote Monitoring Using Heart Rate Variability Analysis in Patients with an Implantable Cardioverter Defibrillator. Shirakawa Y1, Niwano S2, Oikawa J2, Saito D1, Sato T1, Matsuura G1, Arakawa Y1, Kobayashi S1, Nishinarita R2, Horiguchi A2, Ishizue N2, Kishihara J2, Fukaya H2, Ako J2: Int Heart J 2020/9; 61 (5): 927-35. (敀愳桾婎1, 掚栰怲堦2, 媦愳丂弤2, 釼摗戝庽1, 嵅摗揘榊1, 徏塝丂尦1, 峳愳梇婭1, 彫椦廃暯1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 娸尨丂弤2, 怺扟塸暯2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
110147. [尨挊] Impact of peripheral artery disease on prognosis after myocardial infarction: The J-MINUET study. Akahori H1, Masuyama T1, Imanaka T1, Nakao K1, Ozaki Y1, Kimura K1, Ako J1,2, Noguchi T1, Suwa S1, Fujimoto K1, Nakama Y1, Morita T1, Shimizu W1, Saito Y1, Hirohata A1, Morita Y1, Inoue T1, Okamura A1, Mano T1, Hirata K1, Tanabe K1, Shibata Y1, Owa M1, Tsujita K1, Funayama H1, Kokubu N1, Kozuma K1, Uemura S1, Tobaru T1, Saku K1, Oshima S1, Nishimura K1, Miyamoto Y1, Ogawa H1, Ishihara M1 (1J-MINUET investigators): J Cardiol 2020/10; 76 (4): 402-6. (垻屆弫嵠1,2: 2弞娐婍撪)
110148. [尨挊] Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy. Matsumoto S, Nakazawa G, Ohno Y, Ishihara M, Sakai K, Nakamura N, Murakami T, Natsumeda M, Kabuki T, Shibata A, Kida K, Konishi M, Ishii S1, Ikeda T, Ikari Y: ESC Heart Fail 2020/10; 7 (6): 4172-81. (愇堜弐曘1: 1弞娐婍撪)
110149. [尨挊] Clinical and procedure characteristics in patients treated with polytetrafluoroethylene-covered stents after coronary perforation: a CIRC-8U multicenter registry and literature review. Itoh T1, Kimura T1, Kudo A1, Morino Y1, Ikari Y1, Yoshioka K1, Nakano M1, Natsumeda M1, Sakuma M1, Inami S1, Ako J1,2, Nishinari M1,2, Shimohama T1,2, Komatsu T1, Ishikawa T1, Taguchi I1, Sugimura H1, Mitarai T1, Akashi Y1, Suzuki N1, Sugi K1, Matsumoto K1, Kohshoh H1, Yoshino H1 (1CIRC-8U Study Group): Cardiovasc Interv Ther 2020/10. doi: 10.1007/s12928-020-00716-9. Online ahead of print. (垻屆弫嵠1,2, 惣惉恀嬚1,2, 壓昹岶榊1,2: 2弞娐婍撪)
110150. [尨挊] Impact of hemodialysis on clinical and angiographic outcomes in in-stent restenotic lesions following optical coherence tomography-guided drug-coated balloon treatment. Aoki J1, Nakazawa G1, Ando K1, Nakamura S1, Tobaru T1, Sakurada M1, Okada H1, Hibi K1, Zen K1, Ikuta A1, Fujii K1, Habara M1, Ako J1,2, Asano T1, Ozaki S1, Fusazaki T1, Kozuma K1 (1ELEGANT investigators): Cardiovasc Interv Ther 2020/10. doi: 10.1007/s12928-020-00718-7. Online ahead of print. (垻屆弫嵠1,2: 2弞娐婍撪)
110151. [尨挊] Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes. Kakizaki R1, Minami Y1, Katamine M2, Katsura A2, Muramatsu Y1, Hashimoto T1, Meguro K1, Shimohama T1, Ako J1: Cardiovasc Diabetol 2020/10; 19 (1): 162. (奰嶈椙懢1, 撿丂彯尗1, 曅曯惓岍2, 宩丂桳抭2, 懞徏桾夘1, 嫶杮戱栱1, 栚崟寬懢榊1, 壓昹岶榊1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢)
110152. [尨挊] Predictors for layered coronary plaques: an optical coherence tomography study. Araki M, Yonetsu T, Russo M, Kurihara O, Kim HO, Shinohara H, Thondapu V, Soeda T, Minami Y1, Higuma T, Lee H, Kakuta T, Jang I-K: J Thromb Thrombolysis 2020/11; 50 (4): 886-94. (撿丂彯尗1: 1弞娐婍撪)
110153. [尨挊] Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trial. Tanaka A, Shimabukuro M, Machii N, Teragawa H, Okada Y, Shima KR, Takamura T, Taguchi I, Hisauchi I, Toyoda S, Matsuzawa Y, Tomiyama H, Yamaoka-Tojo M1, Ueda S, Higashi Y, Node K: J Diabetes Investig 2020/11; 11 (6): 1551-63. (搶瀶旤撧巕1: 1堛椕塹惗妛晹)
110154. [尨挊] Clinical Outcomes of Off-Label Underdosing of Direct Oral Anticoagulants After Ablation for Atrial Fibrillation. Wakamatsu Y, Nagashima K, Watanabe R, Arai M, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H1, Nakahara S, Kato T, Hayashi H, Iwasaki YK, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, Okumura Y: Int Heart J 2020/11; 61 (6): 1165-73. (怺扟塸暯1: 1弞娐婍撪)
110155. [尨挊] Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry. Iso K1, Nagashima K1, Arai M1, Watanabe R1, Yokoyama K1, Matsumoto N1, Otsuka T1, Suzuki S1, Hirata A1, Murakami M1, Takami M1, Kimura M1, Fukaya H1,2, Nakahara S1, Kato T1, Hayashi H1, Iwasaki YK1, Shimizu W1, Nakajima I1, Harada T1, Koyama J1, Okumura K1, Tokuda M1, Yamane T1, Tanimoto K1, Momiyama Y1, Nonoguchi N1, Soejima K1, Ejima K1, Hagiwara N1, Harada M1, Sonoda K1, Inoue M1, Kumagai K1, Hayashi H1, Yazaki Y1, Satomi K1, Watari Y1, Okumura Y1 (1AF Ablation Frontier Registry investigators): Heart Vessels 2021/4; 36 (4): 549-60. doi: 10.1007/s00380-020-01721-x. Epub 2020 Nov 24. (怺扟塸暯1,2: 2弞娐婍撪)
110156. [尨挊] Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE-HF cohort study. Matsue Y, Kamiya K1, Saito H, Saito K, Ogasahara Y, Maekawa E2, Konishi M, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Yonezawa R3, Oka K, Momomura SI, Kagiyama N: Eur J Heart Fail 2020/11; 22 (11): 2112-9. (恄扟寬懢榊1, 慜愳宐旤2, 暷郪棽夘3: 1堛椕塹惗妛晹, 2弞娐婍撪, 3儕僴價儕晹)
110157. [尨挊] Efficacy and safety of early initiation of eplerenone treatment in patients with acute heart failure (EARLIER trial): a multicenter, randomized, double-blind, placebo-controlled trial. Asakura M1, Ito S1, Yamada T1, Saito Y1, Kimura K1, Yamashina A1, Hirayama A1, Kobayashi Y1, Hanatani A1, Tsujimoto M1, Yasuda S1, Abe Y1, Higashino Y1, Tamaki Y1, Sugino H1, Niinuma H1, Okuhara Y1, Koitabashi T1,2, Momomura SI1, Asai K1, Nomura A1, Kawai H1, Satoh Y1, Yoshikawa T1, Hirata KI1, Yokoi Y1, Tanaka J1, Shibata Y1, Maejima Y1, Tamaki S1, Kawta H1, Iwahashi N1, Kobayashi M1, Higuchi Y1, Kada A1, Yamamoto H1, Kitakaze M1 (1EARLIER investigators and study coordinators): Eur Heart J Cardiovasc Pharmacother 2020/11; pvaa132. doi: 10.1093/ehjcvp/pvaa132. Online ahead of print. (彫斅嫶弐旤1,2: 2弞娐婍撪)
110158. [尨挊] Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design. Fujiki S1, Iijima K1, Okabe M1, Niwano S1,2, Tsujita K1, Naito S1, Ando K1, Kusano K1, Kato R1, Nitta J1, Miura T1, Mitsuhashi T1, Kario K1, Kondo Y1, Ieda M1, Hagiwara N1, Murohara T1, Takahashi K1, Tomita H1, Takeishi Y1, Anzai T1, Shimizu W1, Watanabe M1, Morino Y1, Kato T1, Tada H1, Nakagawa Y1, Yano M1, Maemura K1, Kimura T1, Yoshida H1, Ota K1, Tanaka T1, Kitamura N1, Node K1, Aizawa Y1, Shimizu I1, Izumi D1, Ozaki K1, Minamino T1 (1EMPA-ICD investigators): Diabetes Ther 2020/11; 11 (11): 2739-55. (掚栰怲堦1,2: 2弞娐婍撪)
110159. [尨挊] Novel volumetric analysis for stent expansion after drug-eluting stent implantation: An optical coherence tomography study. Katsura A1, Minami Y2, Kato A1, Muramatsu Y2, Sato T2, Hashimoto T2, Meguro K2, Shimohama T2, Ako J2: Catheter Cardiovasc Interv 2020/11; 96 (5): E501-7. (宩丂桳抭1, 撿丂彯尗2, 壛摗嵤旤1, 懞徏桾夘2, 嵅摗弐廩2, 嫶杮戱栱2, 栚崟寬懢榊2, 壓昹岶榊2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
110160. [尨挊] Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2. Watanabe H1, Morimoto T1, Ogita M1, Suwa S1, Natsuaki M1, Suematsu N1, Koeda Y1, Morino Y1, Nikaido A1, Hata Y1, Doi M1, Hibi K1, Kimura K1, Yoda S1, Kaneko T1, Nishida K1, Kawai K1, Yamaguchi K1, Wakatsuki T1, Tonoike N1, Yamamoto M1, Shimizu S1, Shimohama T1,2, Ako J1,2, Kimura T1 (1STOPDAPT-2 Investigators): Cardiovasc Interv Ther 2020/11. doi: 10.1007/s12928-020-00719-6. Online ahead of print. (壓昹岶榊1,2, 垻屆弫嵠1,2: 2弞娐婍撪)
110161. [尨挊] Energy loss by right ventricular pacing: Patients with versus without hypertrophic cardiomyopathy. Arakawa Y1, Fukaya H2, Kakizaki R2, Oikawa J2, Saito D1, Sato T1, Matsuura G1, Kobayashi S1, Shirakawa Y1, Nishinarita R2, Horiguchi A2, Ishizue N2, Nabeta T2, Kishihara J2, Niwano S2, Ako J2: J Arrhythm 2020/12; 37 (1): 203-11. (峳愳梇婭1, 怺扟塸暯2, 奰嶈椙懢2, 媦愳丂弤2, 釼摗戝庽1, 嵅摗揘榊1, 徏塝丂尦1, 彫椦廃暯1, 敀愳桾婎1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 撶揷丂寬2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶椕, 2弞娐婍撪)
110162. [尨挊] Characteristics of non-culprit plaques in acute coronary syndrome patients with layered culprit plaque. Russo M, Kim HO, Kurihara O, Araki M, Shinohara H, Thondapu V, Yonetsu T, Soeda T, Minami Y1, Higuma T, Lee H, Fracassi F, Vergallo R, Niccoli G, Crea F, Fuster V, Jang I-K: Eur Heart J Cardiovasc Imaging 2020/12; 21 (12): 1421-30. (撿丂彯尗1: 1弞娐婍撪)
110163. [尨挊] Guideline adherence and long-term clinical outcomes in patients with acute myocardial infarction: a Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) substudy. Wada H1, Ogita M1, Suwa S1, Nakao K1, Ozaki Y1, Kimura K1, Ako J1,2, Noguchi T1, Yasuda S1, Fujimoto K1, Nakama Y1, Morita T1, Shimizu W1, Saito Y1, Hirohata A1, Morita Y1, Inoue T1, Okamura A1, Mano T1, Hirata K1, Tanabe K1, Shibata Y1, Owa M1, Tsujita K1, Funayama H1, Kokubu N1, Kozuma K1, Uemura S1, Toubaru T1, Saku K1, Oshima S1, Nishimura K1, Miyamoto Y1, Ogawa H1, Ishihara M1 (1J-MINUET investigators): Eur Heart J Acute Cardiovasc Care 2020/12; 9 (8): 939-47. (垻屆弫嵠1,2: 2弞娐婍撪)
110164. [尨挊] 1-Year Safety of 3-Month Dual Antiplatelet Therapy Followed by Aspirin or P2Y 12 Receptor Inhibitor Monotherapy Using a Bioabsorbable Polymer Sirolimus-Eluting Stent. Kozuma K1, Kinoshita Y1, Hioki H1, Nanasato M1, Ito Y1, Yamaguchi J1, Shiode N1, Hibi K1, Tanabe K1, Ako J1,2, Morino Y1, Hirohata A1, Sonoda S1, Nakagawa Y1, Ikari Y1: (1MODEL U-SES Study Investigators): Circ J 2020/12; 85 (1): 19-26. (垻屆弫嵠1,2: 2弞娐婍撪)
110165. [尨挊] Invasive assessment of myocardial bridging in patients with angina and no obstructive coronary artery disease. Paragaonkar VS, Kimura T, Kameda R1, Tanaka S, Yamada R, Schwarts JG, Perl L, Rogers IS, Honda Y, Fitzgerald P, Schnittger I, Tremmel JA: EuroIntervention 2021/1; 16 (13): 1070-8. (婽揷丂椙1: 1弞娐婍撪)
110166. [尨挊] Canagliflozin Suppresses Atrial Remodeling in a Canine Atrial Fibrillation Model. Nishinarita R1, Niwano S1, Niwano H, Nakamura H1, Saito D2, Sato T2, Matsuura G2, Arakawa Y2, Kobayashi S2, Shirakawa Y2, Horiguchi A1, Ishizue N1, Igarashi T1, Yoshizawa T1, Oikawa J1, Hara Y3, Katsumura T3, Kishihara J1, Satoh A1, Fukaya H1, Sakagami H3, Ako J1: J Am Heart Assoc 2021/1; 10 (2): e017483. (惣惉揷椇1, 掚栰怲堦1, 拞懞梞斖1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 峳愳梇婭2, 彫椦廃暯2, 敀愳桾婎2, 杧岥丂垽1, 愇枛惉嵠1, 屲廫棐寶1, 媑郪抭帯1, 媦愳丂弤1, 尨丂朏怢3, 彑懞孾巎3, 娸尨丂弤1, 嵅摗丂梲1, 怺扟塸暯1, 嶃忋梞峴3, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3夝朥)
110167. [尨挊] Characteristics of non-culprit plaques in acute coronary syndrome patients with calcified plaque at the culprit lesion. Kim HO, Kim CJ, Cho J-M, Soeda T, Kurihara O, Russo M, Araki M, Lee H, Minami Y1, Jang I-K: Catheter Cardiovasc Interv 2021/2; 97 (3): E298-305. (撿丂彯尗1: 1弞娐婍撪)
110168. [尨挊] Circadian variations in pathogenesis of ST-segment elevation myocardial infarction: an optical coherence tomography study. Araki M, Yonetsu T, Kurihara O, Nakajima A, Lee H, Soeda T, Minami Y1, Higuma T, Kimura S, Takano M, Yan BP, Adriaenssens T, Boeder NF, Nef HM, Kim CJ, Crea F, Kakuta T, Jang I-K: J Thromb Thrombolysis 2021/2; 51 (2): 379-87. (撿丂彯尗1: 1弞娐婍撪)
110169. [尨挊] Achilles tendon thickening is associated with higher incidence of adverse cardiovascular event in patients with coronary artery disease. Hashimoto T1, Minami Y1, Asakura K2, Katamine M2, Kato A2, Katsura A2, Sato T1, Muramatsu Y1, Kakizaki R1, Fujiyoshi K1, Ishida K1, Kameda R1, Meguro K1, Shimohama T1, Ako J1: Heart Vessels 2021/2; 36 (2): 163-9. (嫶杮戱栱1, 撿丂彯尗1, 挬憅惔巎2, 曅曯惓岍2, 壛摗嵤旤2, 宩丂桳抭2, 嵅摗弐廩1, 懞徏桾夘1, 奰嶈椙懢1, 摗媑榓攷1, 愇揷峅婤1, 婽揷丂椙1, 栚崟寬懢榊1, 壓昹岶榊1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢)
110170. [尨挊] Day-to-Day Variation of Early Repolarization Pattern Predicts Life-Threatening Arrhythmias in Patients With Brugada Syndrome. Ishizue N1, Niwano S1, Fukaya H1, Oikawa J1, Kishihara J1, Ako J1: Circ J 2021/2; 85 (3): 300-8. (愇枛惉嵠1, 掚栰怲堦1, 怺扟塸暯1, 媦愳丂弤1, 娸尨丂弤1, 垻屆弫嵠1: 1弞娐婍撪)
110171. [尨挊] Late gadolinium enhancement for re-worsening left ventricular ejection fraction in patients with dilated cardiomyopathy. Nabeta T1, Ishii S1, Ikeda Y1, Maemura K2, Oki T2, Yazaki M2, Fujita T1, Y, Naruke T1, Inomata T1,3, Ako J1: ESC Heart Fail 2021/2; 8 (1): 615-24. (撶揷丂寬1, 愇堜弐曘1, 抮揷桽婤1, 慜懞寬帯2, 戝栘戩枻2, 栴嶈杻桼2, 摗揷揝暯1, 惉栄丂悞1, 挅枖岶尦1,3, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3杒棦戝妛杒棦尋媶強昦堾)
110172. [尨挊] Prevalence and prognostic value of the coexistence of anaemia and frailty in older patients with heart failure. Tanaka S, Kamiya K1, Saito H, Saito K, Ogasahara Y, Maekawa E2, Konishi M, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Hamazaki N3, Nozaki K3, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Wakaume K, Oka K, Momomura SI, Kagiyama N, Matsue Y: ESC Heart Fail 2021/2; 8 (1): 625-33. (恄扟寬懢榊1, 慜愳宐旤2, 郷嶈怢柧3, 栰嶈峃暯3: 1堛椕塹惗妛晹, 2弞娐婍撪, 3儕僴價儕晹)
110173. [尨挊] Clinical significance of left atrial geometry in dilated cardiomyopathy patients: A cardiovascular magnetic resonance study. Yazaki M1, Nabeta T2, Inomata T2,3, Maemura K1, Oki T1, Fujita T2, Ikeda Y2, Ishii S2, Naruke T2, Inoue Y4, Ako J2: Clin Cardiol 2021/2; 44 (2): 222-9. (栴嶈杻桼1, 撶揷丂寬2, 挅枖岶尦2,3, 慜懞寬帯1, 戝栘戩枻1, 摗揷揝暯2, 抮揷桽婤2, 愇堜弐曘2, 惉栄丂悞2, 堜忋桪夘4, 垻屆弫嵠2: 1戝妛堛妛堛椕宯尋媶壢, 2弞娐婍撪, 3杒棦戝妛杒棦尋媶強昦堾, 4曻幩慄 (夋憸))棦戝妛杒棦尋媶強昦堾)
110174. [尨挊] Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J. Nakamura M, Ako J1, Arai H, Hirayama A, Nohara A, Murakami Y, Ozaki A, Harada-Shiba M: J Atheroscler Thromb 2021/2. doi: 10.5551/jat.59543. Online ahead of print. (垻屆弫嵠1: 1弞娐婍撪)
110175. [尨挊] Clinical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infarction -J-MINUET study. Soeda T1, Okura H1, Saito Y1, Nakao K1, Ozaki Y1, Kimura K1, Ako J1,2, Noguchi T1, Suwa S1, Fujimoto K1, Nakama Y1, Morita T1, Shimizu W1, Hirohata A1, Morita Y1, Inoue T1, Okamura A1, Mano T1, Hirata K1, Tanabe K1, Shibata Y1, Owa M1, Tsujita K1, Funayama H1, Kokubu N1, Kozuma K1, Uemura S1, Toubaru T1, Saku K1, Oshima S1, Miyamoto Y1, Ogawa H1, Ishihara M1 (1J-MINUET investigators): J Cardiol 2021/2; 77 (2): 139-46. (垻屆弫嵠1,2: 2弞娐婍撪)
110176. [尨挊] A novel risk stratification system ""Angiographic GRACE Score"" for predicting in-hospital mortality of patients with acute myocardial infarction: Data from the K-ACTIVE Registry. Mitarai T, Tanabe Y, Akashi YJ, Maeda A, Ako J1, Ikari Y, Ebina T, Namiki A, Fukui K, Michishita I, Kimura K, Suzuki H: J Cardiol 2021/2; 77 (2): 179-85. (垻屆弫嵠1: 1弞娐婍撪)
110177. [尨挊] Comparison of post-stent optical coherence tomography findings among three subtypes of calcified culprit plaques in patients with acute coronary syndrome. Nakajima A, Araki M, Kurihara O, Minami Y1, Soeda T, Yonetsu T, Crea F, Takano M, Higuma T, Kakuta T, Adriaenssens T, Lee H, Nakamura S, Jang I-K: Catheter Cardiovasc Inter. 2021/3; 97 (4): 634-45. (撿丂彯尗1: 1弞娐婍撪)
110178. [尨挊] Additional posterior wall isolation is associated with gastric hypomotility in catheter ablation of atrial fibrillation. Oikawa J1, Fukaya H1, Wada T2, Horiguchi A1, Kishihara J1, Satoh A, Saito D3, Sato T3, Matsuura G3, Arakawa Y3, Kobayashi S3, Shirakawa Y3, Nishinarita R1, Ishizue N1, Katada C2, Tanabe S2,4, Niwano S1, Ako J1: Int J Cardiol 2021/3; 326: 103-8. (媦愳丂弤1, 怺扟塸暯1, 榓揷戱栫2, 杧岥丂垽1, 娸尨丂弤1, 釼摗戝庽3, 嵅摗揘榊3, 徏塝丂尦3, 峳愳梇婭3, 彫椦廃暯3, 敀愳桾婎3, 惣惉揷椇1, 愇枛惉嵠1, 寴揷恊棙2, 揷绯丂憦2,4, 掚栰怲堦1, 垻屆弫嵠1: 1弞娐婍撪, 2徚壔婍撪, 3戝妛堾堛椕宯尋媶壢, 4怴悽婭堛椕丒愭抂堛椕)
110179. [尨挊] Impact of Age on Gender Difference in Long-term Outcome of Patients With Acute Myocardial Infarction (from J-MINUET). Kimura T1, Akahori H1, Asakura M1, Nakao K1, Ozaki Y1, Kimura K1, Ako J1,2, Noguchi T1, Suwa S1, Fujimoto K1, Nakama Y1, Morita T1, Shimizu W1, Saito Y1, Hirohata A1, Morita Y1, Inoue T1, Okamura A1, Mano T1, Wake M1, Tanabe K1, Shibata Y1, Owa M1, Tsujita K1, Funayama H1, Kokubu N1, Kozuma K1, Uemura S1, Toubara T1, Saku K1, Oshima S1, Nishimura K1, Miyamoto Y1, Ogawa H1, Ishihara M1: (1MINUET Investigators): Am J Cardiol 2021/3; 142: 5-13. (垻屆弫嵠1,2: 2弞娐婍撪)
310008. [徢椺曬崘] Severe hypoperistalsis caused by a 3-min single shot cryoballoon ablation for paroxysmal atrial fibrillation: A case report. Fukaya H1, Niwano S1, Tanabe S2,3, Kishihara J1, Shirakawa Y4, Kobayashi S4, Arakawa Y4, Nishinarita R1, Horiguchi A1, Ishizue N1, Wada T3, Oikawa J1, Ako J1: J Cardiol Cases 2020/4; 22 (1): 26-8. (怺扟塸暯1, 掚栰怲堦1, 揷绯丂憦2,3, 娸尨丂弤1, 敀愳桾婎4, 彫椦廃暯4, 峳愳梇婭4, 惣惉揷椇1, 杧岥丂垽1, 愇枛惉嵠1, 榓揷戱栫3, 媦愳丂弤1, 垻屆弫嵠1: 1弞娐婍撪, 2怴悽婭堛椕丒愭抂堛椕, 3徚壔婍撪, 4戝妛堾堛椕宯尋媶壢)
310009. [徢椺曬崘] Simultaneous Transaortic Transcatheter Aortic Valve Implamtation, OffPump Coronary Artery Bypass Grafting and Pulmonary Vein Isolation. Ogiso S1, Kitamura T2, Meguro K1, Ako J1, Miyaji K2: Annals of Case Reports 2020/5; 14 (6): 308-11. (彫栘慮隳1, 杒懞丂棩2, 栚崟寬懢榊1, 垻屆弫嵠1, 媨抧丂娪2: 1弞娐婍撪, 2怱憻寣娗奜)
310010. [徢椺曬崘] Recurrent In-Stent Restenosis With Eccentric Neointimal Hyperplasia at a Lesion With Hingelike Motion. Ishida K1, Minami Y1, Fujiyoshi K1, Ishida M1, Ako J1, Inomata T1,2: JACC Cardiovasc Interv 2020/6; 13 (11): e103-4. (愇揷峅婤1, 撿丂彯尗1, 摗媑榓攷1, 愇揷嶰榓1, 垻屆弫嵠1, 挅枖岶尦1,2: 1弞娐婍撪, 2杒棦戝妛杒棦尋媶強昦堾)
310011. [徢椺曬崘] Precise Signals with a High-Density Grid Mapping Catheter Are Useful for an Entrainment Study. Oikawa J1, Fukaya H1, Niwano S1, Saito D2, Sato T2, Matsuura G2, Arakawa Y2, Kobayashi S2, Shirakawa Y2, Horiguchi A1, Nishinarita R1, Ishizue N1, Kishihara J1, Ako J1: Int Heart J 2020/7; 61 (4): 838-42. (媦愳丂弤1, 怺扟塸暯1, 掚栰怲堦1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 峳愳梇婭2, 敀愳桾婎2, 彫椦廃暯2, 杧岥丂垽1, 惣惉揷椇1, 愇枛惉嵠1, 娸尨丂弤1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢)
310012. [徢椺曬崘] Tako-tsubo-like left ventricular dysfunction in a patient with COVID-19 demonstrated by non-invasive multi-modality imaging. Fujiyoshi K1, Ako J1, Ishida K1, Ishida M1, Minami Y1, Inomata T1,2: J Nucl Cardiol 2020/10; 1-3. doi: 10.1007/s12350-020-02367-y. Online ahead of print. (摗媑榓攷1, 垻屆弫嵠1, 愇揷峅婤1, 愇揷嶰榓1, 撿丂彯尗1, 挅枖岶尦1,2: 1弞娐婍撪, 2杒棦戝妛杒棦尋媶強昦堾)
310013. [徢椺曬崘] Left Ventricular Contraction Sequence in a Case Where the QRS Changed from Left to Atypical Right Bundle Branch Block. Hara H, Nagata T1, Ito H, Niwano S2, Ako J2: Int Med Case Rep J 2020/11; 13: 573-9. (塱揷婱巕1, 掚栰怲堦2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
310014. [徢椺曬崘] Unique feature of novel activation mapping to identify the successful ablation site of atrial tachycardia. Kishihara J1, Fukaya H1, Oikawa J1, Ako J1: Heart Rhythm 2021/4; 18 (4): 653-4. doi: 10.1016/j.hrthm.2020.12.024. Epub 2020 Dec 29. (娸尨丂弤1, 怺扟塸暯1, 媦愳丂弤1, 垻屆弫嵠1: 1弞娐婍撪)
310015. [徢椺曬崘] An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis. Yazaki M1, Nabeta T2, Inomata T2,3, Ako J2: Intern Med 2021/2; 60 (4): 553-6. (栴嶈杻桼1, 撶揷丂寬2, 挅枖岶尦2,3, 垻屆弫嵠2: 1戝妛堛妛堛椕宯尋媶壢, 2弞娐婍撪, 3杒棦戝妛杒棦尋媶強昦堾)
510004. [憤愢] Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects. Li J-J, Hui-Hui Liu H-H, Wu N-Q, Yeo KK, Tan K, Ako J1, Krittayaphong R, Tan RS, Aylward PE, Baek SH, Dalal J, Fong AYY, Li Y-H, O'Brien RC, Lim TSE, Koh SYN, Scherer DJ, Tada H, Kang V, Nicholls BJSJ: Expert Opin Drug Metab Toxicol 2020/9; 16 (9): 837-51. (垻屆弫嵠1: 1弞娐婍撪)
510005. [憤愢] Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19. Yamaoka-Tojo M1: Biomed J 2020/10; 43 (5): 399-413. (搶瀶旤撧巕1: 1堛椕塹惗妛晹)
510006. [憤愢] Vascular Endothelial Glycocalyx Damage in COVID-19. Yamaoka-Tojo M1: Int J Mol Sci 2020/12; 21 (24): 9712. (搶瀶旤撧巕1: 1堛椕塹惗妛晹)
510007. [憤愢] Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics. Sakakura K, Ito Y, Shibata Y, Okamura A, Kashima Y, Nakamura S, Hamazaki Y, Ako J1, Yokoi H, Kobayashi Y, Ikari Y: Cardiovasc Inter
510008. [憤愢] 2020 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y 12 Receptor Antagonists in the Asia-Pacific Region. Tan JW, Chew DP, Abdul Kader MAS, Ako J1, Bahl VK, Chan M, Park KW, Chandra P, Hsieh I-C, Huan DQ, Johar S, Juzar DA, Kim B-K, Lee CW, Lee MK, Li Y-H, Almahmeed W, Sison EO, Tan D, Wang Y-C, Yeh SJ, Montalescot G: Eur Cardiol 2021/3; 16: e02. (垻屆弫嵠1: 1弞娐婍撪)
511001. [夝愢] Editorial to ""Infection and migration incidence of Cardiac Implantable Electrical Devices in Japan: Web-based survey results"". Niwano S1: J Arrhythm 2020/5; 36 (4): 784. (掚栰怲堦1: 1弞娐婍撪)
511002. [夝愢] Editorial to ""Safety and Efficacy of Uninterrupted Treatment with Edoxaban or Warfarin During the Peri-Procedural Period of Catheter Ablation for Atrial Fibrillation"". Fukaya H1: J Arrhythm 2020; 36 (4): 642-3. (怺扟塸暯1: 1弞娐婍撪)
522028. [島嵗]亂摿廤: 摐擜昦姵幰偺怱寣娗昦滊姵儕僗僋偵偳偆棫偪岦偐偆偐亃帯偡8丂摐擜昦姵幰偺姤摦柆幘姵傪偳偆帯椕偡傞? 抮揷桽婤1, 垻屆弫嵠2 (1媬柦, 2弞娐婍撪): Heart View 2020/7; 24 (7): 625-31.
522029. [島嵗]亂摿廤: 晄惍柆栻暔帯椕update亃怱朳嵶摦偵偍偗傞摯挷棩堐帩椕朄亅栻暔椕朄偺堄媊偲傾僽儗乕僔儑儞偲偺僴僀僽儕僢僪帯椕愴棯. 掚栰怲堦 (弞娐婍撪): 弞娐婍撪壢 2020/8; 88 (2): 137-44.
522030. [島嵗]亂摿廤: 帀幙堎忢徢偲摦柆峝壔update亃姤摦柆幘姵擇師梊杊姵幰偺帀幙娗棟. 挬憅惔巎1, 嫶杮戱栱1, 撿丂彯尗1, 垻屆弫嵠1 (1弞娐婍撪): 摐擜昦丒撪暘斿戙幱壢 2020/8; 51 (2): 110-7.
522031. [島嵗]亂摿廤: 峈寣愷椕朄亅擔忢椪彴偱偺媈栤偵墳偊傞亃仭II. 嫊寣惈怱幘姵丒壓巿摦柆幘姵偵懳偡傞峈寣愷椕朄丂P2Y12慾奞偵傛傞峈寣彫斅栻 (僋儘僺僪僌儗儖丒僾儔僗僌儗儖丒僠僇僌儗儘儖) 偼摿挜偵傛傝偳偆巊偄暘偗傞偐? 婽揷丂椙1, 壓昹岶榊1, 垻屆弫嵠1 (1弞娐婍撪): 弞娐婍僕儍乕僫儖 2020/10; 68 (4): 632-40.
522032. [島嵗]亂摿廤: 嵟怴僈僀僪儔僀儞catch-up! 晄惍柆偺栻暔椕朄亃仭晄惍柆偺娗棟丂栻暔暃嶌梡儌僯僞儕儞僌. 掚栰怲堦 (弞娐婍撪): 寧姧栻帠 2020/11; 62 (15): 2965-71.
522033. [島嵗]亂摿廤: 椪彴偵栶棫偨偣傞! 奺庬怱僄僐乕媄弍偺妶梡朄亃怱嬝幘姵偱偺妶梡朄. 彫斅嫶弐旤 (弞娐婍撪): 怱僄僐乕 2020/12; 21 (12): 1158-68.
522034. [島嵗]亂摿廤: 姤摦柆幘姵偲峈寣愷椕朄亃DOAC偺揔墳偲怴偨側壜擻惈. 栘壓戝帒1, 怺扟塸暯1, 垻屆弫嵠1 (1弞娐婍撪): 弞娐婍撪壢 2020/12; 88 (6): 604-10.
522035. [島嵗]亂摿廤: 旕曎枌徢惈怱朳嵶摦偵偍偗傞揔愗側峈嬅屌椕朄亃旕曎枌徢惈怱朳嵶摦偲嫊寣惈怱幘姵崌暪偵偍偗傞揔愗側峈寣愷椕朄. 垻屆弫嵠 (弞娐婍撪): 擔杮寣愷巭寣妛夛帍 2020/12; 31 (6): 562-70.
522036. [島嵗]亂嵗択夛亃2020擭夵掶斉 晄惍柆栻暔帯椕僈僀僪儔僀儞亅夵掶偺億僀儞僩亅. 彫椦媊揟, 抮揷棽摽, 娾嶈梇庽, 掚栰怲堦1 (1弞娐婍撪): 椪彴堛偺偨傔偺弞娐婍恌椕 2020; 33: 3-21.
522037. [島嵗]亂摿廤: 僼儗僀儖偲弞娐婍恌椕亃1. 僼儗僀儖偲媫惈姤徢岓孮. 塱揷婱巕, 撿丂彯尗1, 垻屆弫嵠1 (1弞娐婍撪): 怱憻 2021/2; 53 (2): 112-6.
530008. [偦偺懠 (Comment)] Response by Russo et al Regarding Article, ""Healed Plaques in Patients With Stable Angina Pectoris"". Russo M, Fracassi F, Kurihara O, Kim HO, Thondapu V, Araki M, Shinohara H, Sugiyama T, Yamamoto E, Lee H, Vergallo R, Crea F, Biasucci LM, Yonetsu T, Minami Y1, Soeda T, Fuster V, Jang I-K: Arterioscler Thromb Vasc Biol 2020/9; 40 (9): e258-9. (撿丂彯尗1: 1弞娐婍撪)
530009. [偦偺懠 (Erratum)] Correction to: Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics. Sakakura K, Ito Y, Shibata Y, Okamura A, Kashima Y, Nakamura S, Hamazaki Y, Ako J1, Yokoi H, Kobayashi Y, Ikari Y: Cardiovasc Interv Ther 2021/1; 36 (1): 19. (垻屆弫嵠1: 1弞娐婍撪)
530010. [偦偺懠 (Erratum)] Correction to: Influence of CYP2C19 genotypes for the effect of 1 month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12 month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT 2. Watanabe H1, Morimoto T1, Ogita M1, Suwa S1, Natsuaki M1, Suematsu N1, Koeda Y1, Morino Y1, Nikaido A1, Hata Y1, Doi M1, Hibi K1, Kimura K1, Yoda S1, Kaneko T1, Nishida K1, Kawai K1, Yamaguchi K1, Wakatsuki T1, Tonoike N1, Yamamoto M1, Shimizu S1, Shimohama T1,2, Ako J1,2, Kimura T1 (1STOPDAPT-2 Investigators): Cardiovasc Interv Ther 2021/2. doi: 10.1007/s12928-020-00741-8. Online ahead of print. (壓昹岶榊1,2, 垻屆弫嵠1,2: 2弞娐婍撪
540019. [偦偺懠 (Comment)] 戝堜揷榑暥偵懳偡傞Editorial Comment. 掚栰怲堦 (弞娐婍撪): 怱憻 2020/4; 52 (4): 436.
540020. [偦偺懠 (Comment)] 彫栰榑暥偵懳偡傞Editorial Comment: 墦妘儌僯僞儕儞僌偺椪彴墳梡柾嶕偺昁梫惈. 掚栰怲堦 (弞娐婍撪): 怱憻 2020/10; 52 (10): 1153.
540021. [偦偺懠 (Comment)] 惎榑暥偵懳偡傞Editorial Comment. 撶揷丂寬 (弞娐婍撪): 怱憻 2020/12; 52 (12): 1403.
[挊丂彂]
620027. [妛弍彂 (暘扴幏昅)]亂偳偆岠偔? 偳偆巊偆? 偑傑傞偛偲傢偐傞丂弞娐婍偺栻嵻僇僞儘僌143 (僴乕僩僫乕僔儞僌2020擭弔婫憹姧)亃戞3復 峈晄惍柆栻, p.44-64. 娸尨丂弤1 (1弞娐婍撪), 曇: 挅枖岶尦1,2 (2杒棦戝妛杒棦尋媶強昦堾), 儊僨傿僇弌斉, 戝嶃, 2020/4敪峴.
620028. [妛弍彂 (暘扴幏昅)]亂嬌傔傞弞娐婍棟妛椕朄丂弞娐婍昦傪桳偡傞姵幰偺忈奞憸偵挧傓亃Part I 棟妛椕朄偐傜尒傞弞娐婍昦偵懳偡傞儕僴價儕僥乕僔儑儞丂2. 弞娐婍堛偐傜尒偨弞娐婍棟妛椕朄偺堎媍, p.6-10. 挅枖岶尦1,2 (1杒棦戝妛杒棦尋媶強昦堾, 2弞娐婍撪), 曇: 惸摗廏擵, 壛摗丂峗, 栘懞夒旻, 暥岝摪, 搶嫗, 2020/7敪峴.
[妛夛丒尋媶夛摍]
713005. [妛夛 (崙嵺)] (堦斒島墘) Time course of left ventricular reverse remodeling in response to cardiac resynchronization therapy - Late response is a prognostic indicator similar to early response. Oki T1, Ishii S2, Maemura K1, Yazaki M1, Fujita T2, Ikeda Y3, Nabeta T2, Maekawa E2, Naruke T2, Koitabashi T2, Inomata T2,4, Ako J2: ESC heart failure 2020 (2020/5/23-26), Barcelona, Spain. (戝栘戩枻1, 愇堜弐曘2, 慜懞寬帯1, 栴嶈杻桼1, 摗揷揝暯2, 抮揷桽婤3, 撶揷丂寬2, 慜愳宐旤2, 惉栄丂悞2, 彫斅嫶弐旤2, 挅枖岶尦2,4, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3媬柦, 4杒棦戝妛杒棦尋媶強昦堾)
713006. [妛夛 (崙嵺)] (堦斒島墘) Relationship late gadolinium enhancement on cardiovascular magnetic resonance and longitudinal ejection fraction change in patients with recent onset dilated cardiomyopathy. Nabeta T1, Ishii S1, Ikeda Y2, Oki T3, Maemura K3, Yazaki Y3, Fujita T1, Naruke T1, Ako J1: ESC heart failure 2020 (2020/5/23-26), Barcelona, Spain. (撶揷丂寬1, 愇堜弐曘1, 抮揷桽婤2, 戝栘戩枻3, 慜懞寬帯3, 栴嶈杻桼3, 摗揷揝暯1, 惉栄丂悞1, 垻屆弫嵠1: 1弞娐婍撪, 2媬柦, 3戝妛堾堛椕宯尋媶壢)
713007. [妛夛 (崙嵺)] (堦斒島墘) Decline in left ventricular ejection fraction is associated with heart failure hospitalization and sudden death in patients with cardiac sarcoidosis. Takigami Y1, Nabeta T1, Ishii S1, Maemura K2, Oki T2, Yazaki M2, Fujita T1, Ikeda Y3, Naruke T1, Ako J1: ESC heart failure 2020 (2020/5/23-26), Barcelona, Spain. (戨忋丂桰1, 撶揷丂寬1, 愇堜弐曘1, 慜懞寬帯2, 戝栘戩枻2, 栴嶈杻桼2, 摗揷揝暯1, 抮揷桽婤3, 惉栄丂悞1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3媬柦)
713008. [妛夛 (崙嵺)] (堦斒島墘) Dyslipidemia : how low to go? Ako J1: APSC JCS 2020 (2020/7/27-8/1), Webinar. (垻屆弫嵠1: 1弞娐婍撪)
713009. [妛夛 (崙嵺)] (堦斒島墘) Predictors for rapid progression of coronary calcification: an optical coherence tomography (OCT) study. Nakajima A, Araki M, Kurihara O, Minami Y1, Soeda T, Higuma T, Kakuta T, Lee H, Malhotra R, Nakamura S, Jang IK: European Society of Cardiology (ESC) 2020 Annual Meeting (2020/8/29-9/1), Amsterdam, Netherlands. (撿丂彯尗1: 1弞娐婍撪)
713010. [妛夛 (崙嵺)] (堦斒島墘) Circadian variations in pathogenesis of ST-segment elevation myocardial infarction. Araki M, Yonetsu T, Kurihara O, Nakajima A, Lee H, Soeda T, Minami Y1, Yan BP, Adriaenssens T, Boeder NF, Nef HM, Kim CJ, Crea F, Kakuta T, Jang IK: European Society of Cardiology (ESC) 2020 Annual Meeting (2020/8/29-9/1), Amsterdam, Netherlands. (撿丂彯尗1: 1弞娐婍撪)
713011. [妛夛 (崙嵺)] (堦斒島墘) Predictors of rapid plaque progression: an optical coherence tomography study. Araki M, Yonetsu T, Kurihara O, Nakajima A, Lee H, Soeda T, Minami Y1, Uemura S, Kakuta T, Jang IK: European Society of Cardiology (ESC) 2020 Annual Meeting (2020/8/29-9/1), Amsterdam, Netherlands. (撿丂彯尗1: 1弞娐婍撪)
713012. [妛夛 (崙嵺)] (堦斒島墘) Remote monitoring can predict lethal arrhythmic events through time-domain analysis of heart rate variability in patients with implantable cardioverter defibrillator. Shirakawa Y1, Niwano S2, Oikawa J2, Matsuura G1, Arakawa Y1, Kobayashi S1, Nishinarita R2, Horiguchi A2, Ishizue N2, Kishihara J2, Fukaya H2, Ako J2: European Society of Cardiology (ESC) 2020 Annual Meeting (2020/8/29-9/1), Amsterdam, Netherlands. (敀愳桾婎1, 掚栰怲堦2, 媦愳丂弤2, 徏塝丂尦1, 峳愳梇婭1, 彫椦廃暯1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 娸尨丂弤2, 怺扟塸暯2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
713013. [妛夛 (崙嵺)] (堦斒島墘) Salusin 兝, a novel bio marker for risk of fatal arrhythmia in Brugada syndrome. Nishinarita R1, Niwano S1, Ishizue N1, Saito D2, Sato T2, Matsuura G2, Arakawa Y2, Kobayashi S2, Shirakawa Y2, Horiguchi A1, Nakamura H1, Igarashi G, Oikawa J1, Kishihara J1, Satoh A, Fukaya H1, Ako J1: European Society of Cardiology (ESC) 2020 Annual Meeting (2020/8/29-9/1), Amsterdam, Netherlands. (惣惉揷椇1, 掚栰怲堦1, 愇枛惉嵠1, 釼摗戝庽2, 嵅摗揘榊2, 徏塝丂尦2, 峳愳梇婭2, 彫椦廃暯2, 敀愳桾婎2, 杧岥丂垽1, 拞懞梞斖1, 媦愳丂弤1, 娸尨丂弤1, 怺扟塸暯1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢)
713014. [妛夛 (崙嵺)] (堦斒島墘) Clinical significance of left atrial geometry in patients with dilated cardiomyopathy: a cardiovascular magnetic resonance study. Yazaki M1, Nabeta T2, Inomata T2,3, Maemura K1, Oki T1, Fujita T2, Ikeda Y4, Ishii S2, Naruke T2, Ako J2: European Society of Cardiology (ESC) 2020 Annual Meeting (2020/8/29-9/1), Amsterdam, Netherlands. (栴嶈杻桼1, 撶揷丂寬2, 挅枖岶尦2,3 , 慜懞寬帯1, 戝栘戩枻1, 摗揷揝暯2, 抮揷桽婤4, 愇堜弐曘2, 惉栄丂悞2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3杒棦戝妛杒棦尋媶強昦堾 4媬柦)
713015. [妛夛 (崙嵺)] (堦斒島墘) Plaque erosion is associated with less systemic atherosclerosis than other plaque types of acute coronary syndrome. Kato A1, Minami Y2, Asakura K1, Katamine M1, Katsura A1, Muramatsu Y2, Sato T2, Kakizaki R2, Hashimoto T2, Meguro K2, Shimohama T2, Ako J2: European Society of Cardiology (ESC) 2020 Annual Meeting (2020/8/29-9/1), Amsterdam, Netherlands. (壛摗嵤旤1, 撿丂彯尗2, 挬憅惔巎1, 曅曯惓岍1, 宩丂桳抭1, 懞徏桾夘2, 嵅摗弐堯2, 奰嶈椙懢2, 嫶杮戱栱2, 栚崟寬懢榊2, 壓昹岶榊2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
713016. [妛夛 (崙嵺)] (堦斒島墘) Higher level of high sensitivity C-reactive protein is associated with more fibrocalcific plaque and longer lesion in patients with acute coronary syndrome. Katamine M1, Minami Y2, Asakura K1, Kato A1, Katsura A1, Sato T2, Muramatsu Y2, Hashimoto T2, Kameda R2, Meguro K2, Shimohama T2, Ako J2: European Society of Cardiology (ESC) 2020 Annual Meeting (2020/8/29-9/1), Amsterdam, Netherlands. (曅曯惓岍1, 撿丂彯尗2, 挬憅惔巎1, 壛摗嵤旤1, 宩丂桳抭1, 嵅摗弐堯2, 懞徏桾夘2, 嫶杮戱栱2, 婽揷丂椙2, 栚崟寬懢榊2, 壓昹岶榊2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
713017. [妛夛 (崙嵺)] (堦斒島墘) Left ventricular recovery during long-term medical treatment in comparison among morphological types of QRS complex in patients with dilated cardiomyopathy. Maemura K1, Ikeda Y2, Oki T1, Yazaki M1, Fujita T3, Nabeta T3, Ishii S3, Maekawa E3, Naruke T3, Koitabashi T3, Inomata T3,4, Ako J3: European Society of Cardiology (ESC) 2020 Annual Meeting (2020/8/29-9/1), Amsterdam, Netherlands. (慜懞寬帯1, 抮揷桽婤2, 戝栘戩枻1, 栴嶈杻桼1, 摗揷揝暯3, 撶揷丂寬3, 愇堜弐曘3, 慜愳宐旤3, 惉栄丂悞3, 彫斅嫶弐旤3, 挅枖岶尦3,4, 垻屆弫嵠3: 1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪, 4杒棦戝妛杒棦尋媶強昦堾)
713018. [妛夛 (崙嵺)] (堦斒島墘) Prognostic implications of late gadolinium enhancement for re-worsening left ventricular ejection fraction in patients with dilated cardiomyopathy: A longitudinal study of left ventricular function. Nabeta T1, Ishii S1, Ikeda Y2, Oki T3, Maemura K3, Yazaki M3, Fujita T1, Naruke T1, Inomata T1,4, Ako J1: European Society of Cardiology (ESC) 2020 Annual Meeting (2020/8/29-9/1), Amsterdam, Netherlands. (撶揷丂寬1, 愇堜弐曘1, 抮揷桽婤2, 戝栘戩枻3, 慜懞寬帯3, 栴嶈杻桼3, 摗揷揝暯1, 惉栄丂悞1, 挅枖岶尦1,4, 垻屆弫嵠1: 1弞娐婍撪, 2媬柦, 3戝妛堾堛椕宯尋媶壢, 4杒棦戝妛杒棦尋媶強昦堾)
713019. [妛夛 (崙嵺)] (堦斒島墘) Untreated Sleep Apnea Syndrome is Associated With Higher Incidence of Cardiovascular Events After Percutaneous Coronary Intervention. Fujiyoshi K1, Minami Y1, Ishida K1, Ishida M1, Wakabayashi K, Ako J1, Inomata T1,2: American Heart Association (AHA) 2020 Scientific Session (2020/11/13-17), Dallas, USA. (摗媑榓攷1, 撿丂彯尗1, 愇揷峅婤1, 愇揷嶰榓1, 垻屆弫嵠1, 挅枖岶尦1,2: 1弞娐婍撪, 2杒棦戝妛杒棦尋媶強昦堾)
713020. [妛夛 (崙嵺)] (堦斒島墘) Higher triglyceride level is associated with higher frequency of macrophage accumulation in coronary plaques. Asakura K1, Minami Y2, Katamine M1, Kato A1, Katsura A1, Sato T2, Muramatsu Y2, Hashimoto T2, Kameda R2, Meguro K2, Shimohama T2, Ako J2: American Heart Association (AHA) 2020 Scientific Session (2020/11/13-17), Dallas, USA. (挬憅惔巎1, 撿丂彯尗2, 曅曯惓岍1, 壛摗嵤旤1, 宩丂桳抭1, 嵅摗弐堯2, 懞徏桾夘2, 嫶杮戱栱2, 婽揷丂椙2, 栚崟寬懢榊2, 壓昹岶榊2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
713021. [妛夛 (崙嵺)] (堦斒島墘) Smaller stent area and eccentric expansion are associated with increased adverse events after drug-eluting stent implantation in hemodialysis patients. Katsura A1, Minami Y2, Asakura K1, Katamine M1, Kato A1, Hashimoto T2, Meguro K2, Shimohama T2, Ako J2: American Heart Association (AHA) 2020 Scientific Session (2020/11/13-17), Dallas, USA. (宩丂桳抭1, 撿丂彯尗2, 挬憅惔巎1, 曅曯惓岍1, 壛摗嵤旤1, 嫶杮戱栱2, 栚崟寬懢榊2, 壓昹岶榊2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪)
713022. [妛夛 (崙嵺)] (堦斒島墘) COVID-19 management strategies. Ako J1: ESC Acute CardioVascular Care 2021 (2021/3/14), Web奐嵜. (垻屆弫嵠1: 1弞娐婍撪)
722032. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) PCI巤峴姵幰偵偍偗傞峈寣愷椕朄. 垻屆弫嵠 (弞娐婍撪): 戞52夞擔杮摦柆峝壔妛夛憤夛丒妛弍廤夛 (2020/7/17-31), web奐嵜.
722033. [妛夛 (慡崙)] (Change practice) Change Practice in Antithrombotic Therapy after PCI. 垻屆弫嵠 (弞娐婍撪): 戞84夞擔杮弞娐婍妛夛妛弍廤夛 (2020/7/27-8/2), web奐嵜.
722034. [妛夛 (慡崙)] (僔儞億僕僂儉) 2020擭搙恌椕曬廣夵掕偺摦岦偲崱屻偺曐尟恌椕偺偁傝曽. 垻屆弫嵠 (弞娐婍撪): 戞84夞擔杮弞娐婍妛夛妛弍廤夛 (2020/7/27-8/2), web奐嵜.
722035. [妛夛 (慡崙)] (Topics) Management of Atrial Fibrillation in Patients with High Bleeding Risk. 垻屆弫嵠 (弞娐婍撪): 戞84夞擔杮弞娐婍妛夛妛弍廤夛 (2020/7/27-8/2), web奐嵜.
722036. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵡愷尮晄柧偺擼嵡愷徢 (ESUS) 偲怱僄僐乕亃婏堎惈擼嵡愷偺昦懺: 嵡愷尮偲偟偰偺棏墌岴奐懚恌抐. 彫斅嫶弐旤 (弞娐婍撪): 堦斒幮抍朄恖擔杮怱僄僐乕恾妛夛戞31夞妛弍廤夛 (2020/8/14-15), 搰崻.
722037. [妛夛 (慡崙)] (嫵堢婇夋) MitraClip傪堄幆偟偨宱怘摴僄僐乕偵傛傞憁朮曎偺昡壙. 慜愳宐旤1, 彫斅嫶弐旤1, 摗揷揝暯1, 孲嶳宐巕2, 栚崟寬懢榊1, 垻屆弫嵠1 (1弞娐婍撪, 2憤崌恌椕): 堦斒幮抍朄恖擔杮怱僄僐乕恾妛夛戞31夞妛弍廤夛 (2020/8/14-15), 搰崻.
722038. [妛夛 (慡崙)] (彽懸島墘摍) 怱憻CT, 怱憻MRI, 怱嬝僔儞僠 怱晄慡偺恌抐偵奺専嵏傪妶偐偡. 撶揷丂寬 (弞娐婍撪): 戞24夞擔杮怱晄慡妛夛妛弍廤夛 (2020/10/15-17), web奐嵜.
722039. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 怱寣娗僀儀儞僩梷惂傪尒悩偊偨摐擜昦帯椕愴棯. 垻屆弫嵠 (弞娐婍撪): 戞29夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛 (2021/2/19), Web奐嵜.
723123. [妛夛 (慡崙)] (堦斒島墘) Achilles Tendon Thickening is Associated with Higher Incidence of Adverse Cardiac Event in Patients with Coronary Artery Disease. 嫶杮戱栱1, 撿丂彯尗1, 挬憅惔巎2, 曅曯惓岍2, 壛摗嵤旤2, 宩丂桳抭2, 嵅摗弐堯1, 懞徏桾夘1, 奰嶈椙懢1, 摗媑榓攷1, 愇揷峅婤1, 婽揷丂椙1, 栚崟寬懢榊1, 壓昹岶榊1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞84夞擔杮弞娐婍妛夛妛弍廤夛 (2020/7/27-8/2), web奐嵜.
723124. [妛夛 (慡崙)] (堦斒島墘) Frequency of non-sustained ventricular tachycardia is related to lethal arrhythmia in patients with cardiac sarcoidosis implanted with cardiac electronic devices. 峳愳梇婭1, 媦愳丂弤2, 怺扟塸暯2, 撶揷丂寬2, 嵵摗戝庽1, 嵅摗揘榊1, 徏塝丂尦1, 彫椦廃暯1, 敀愳桾婎1, 愇枛惉嵠2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞84夞擔杮弞娐婍妛夛妛弍廤夛 (2020/7/27-8/2), web奐嵜.
723125. [妛夛 (慡崙)] (堦斒島墘) Optimized lesion size index (o-LSI): the novel predictor for sufficient ablation of pulmonary vein isolation. 徏塝丂尦1, 娸尨丂弤2, 怺扟塸暯2, 媦愳丂弤2, 愇枛惉嵠2, 嵵摗戝庽1, 嵅摗揘榊1, 峳愳梇婭1, 彫椦廃暯1, 敀愳桾婎1, 惣惉揷椇2, 杧岥丂垽2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞84夞擔杮弞娐婍妛夛妛弍廤夛 (2020/7/27-8/2), web奐嵜.
723126. [妛夛 (慡崙)] (堦斒島墘) Canagliflozin suppresses the Electrophysiological Changes in Isoproterenol-induced Myocardial Injury Rat Model. 彫椦廃暯1, 掚栰怲堦2, 掚栰桾宐, 嵵摗戝庽1, 嵅摗揘榊1, 徏塝丂尦1, 峳愳梇婭1, 敀愳桾婎1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 媦愳丂弤2, 娸尨丂弤2, 怺扟塸暯2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞84夞擔杮弞娐婍妛夛妛弍廤夛 (2020/7/27-8/2), web奐嵜.
723127. [妛夛 (慡崙)] (堦斒島墘) Reduced atrial conduction velocity is associated with the recurrence of atrial fibrillation after catheter ablation: Insight from an electro-anatomical mapping study. 嵅摗揘榊1, 怺扟塸暯2, 媦愳丂弤2, 嵵摗戝庽1, 徏塝丂尦1, 峳愳梇婭1, 彫椦廃暯1, 敀愳桾婎1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞84夞擔杮弞娐婍妛夛妛弍廤夛 (2020/7/27-8/2), web奐嵜.
723128. [妛夛 (慡崙)] (堦斒島墘) Clinical Impact of Ischemia-like Electrocardiography Findings during Acute Heart Failure in Patients with Nonischemic Left Ventricular Dysfunction. 慜懞寬帯1, 抮揷桽婤2, 戝栘戩枻1, 栴嶈杻桼1, 摗揷揝暯3, 撶揷丂寬3, 愇堜弐曘3, 慜愳宐旤3, 彫斅嫶弐旤3, 挅枖岶尦3,4, 垻屆弫嵠3 (1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪, 4杒棦戝妛杒棦尋媶強昦堾): 戞84夞擔杮弞娐婍妛夛妛弍廤夛 (2020/7/27-8/2), web奐嵜.
723129. [妛夛 (慡崙)] (堦斒島墘) Reduction of Intraventricular Flow Energy Loss is Associated with Ventricular Recovery after Cardiac Resynchronization Therapy. 慜懞寬帯1, 抮揷桽婤2, 奰嶈椙懢3, 戝栘戩枻1, 栴嶈杻桼1, 摗揷揝暯3, 撶揷丂寬3, 愇堜弐曘3, 慜愳宐旤3, 彫斅嫶弐旤3, 挅枖岶尦3,4, 垻屆弫嵠3 (1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪, 4杒棦戝妛杒棦尋媶強昦堾): 戞84夞擔杮弞娐婍妛夛妛弍廤夛 (2020/7/27-8/2), web奐嵜.
723130. [妛夛 (慡崙)] (堦斒島墘) Relationship between extent of late gadolinium enhancement and re-worsening left ventricular ejection fraction in patients with recent-onset non-ischemic dilated cardiomyopathy. 撶揷丂寬1, 惉栄丂悞1, 抮揷桽婤2, 戝栘戩枻3, 慜懞寬帯3, 栴嶈杻桼3, 摗揷揝暯1, 愇堜弐曘1 挅枖岶尦1,4, 垻屆弫嵠1 (1弞娐婍撪, 2媬柦, 3戝妛堾堛椕宯尋媶壢, 4杒棦戝妛杒棦尋媶強昦堾): 戞84夞擔杮弞娐婍妛夛妛弍廤夛 (2020/7/27-8/2), web奐嵜.
723131. [妛夛 (慡崙)] (堦斒島墘) 晄壜媡揑側怱撪枌忈奞傪擣傔偨偨偙偮傏宆怱嬝徢偺堦椺. 屨娾傔偖傒1, 媦愳丂弤1, 撶揷丂寬1, 怺扟塸暯1, 垻屆弫嵠1 (1弞娐婍撪): 堛妛惗丒尋廋堛偺擔杮撪壢妛夛偙偲偼偠傔 2020 (2020/8/8), 搶嫗 (web奐嵜).
723132. [妛夛 (慡崙)] (堦斒島墘) 恌抐偵嬯椂偟偨怱僞儞億僫乕僨偺堦椺. 弔栘梥夘1, 媦愳丂弤1, 怺扟塸暯1, 峳婰弔撧2, 杒懞丂棩2, 媨抧丂娪2, 垻屆弫嵠1 (1弞娐婍撪, 2怱憻寣娗奜): 堛妛惗丒尋廋堛偺擔杮撪壢妛夛偙偲偼偠傔 2020 (2020/8/8), 搶嫗 (web奐嵜).
723133. [妛夛 (慡崙)] (堦斒島墘) 掅嵍怱婡擻偺尨場恌抐偵擄廰偟偨戝摦柆曎媡棳徢傪崌暪偟偨枌條晹怱幒拞妘寚懝徢偺堦椺. 摗揷揝暯1, 彫斅嫶弐旤1, 嫶杮岶柧, 孲嶳宐巕2, 慜愳宐旤1, 媨杮棽巌3, 媨抧丂娪3, 垻屆弫嵠1 (1弞娐婍撪, 2憤崌恌椕, 3怱憻寣娗奜): 堦斒幮抍朄恖擔杮怱僄僐乕恾妛夛戞31夞妛弍廤夛 (2020/8/14-15), 搰崻.
723134. [妛夛 (慡崙)] (堦斒島墘) 宱旂揑姤摦柆宍惉弍傪巤峴偝傟偨娻姵幰偺follow up専嵏偲偦偺屻偺帯椕曽恓偺尰忬. 懞徏桾夘1, 撿丂彯尗1, 壛摗嵤旤2, 宩丂桳抭2, 嵅摗弐堯1, 嫶杮戱栱1, 栚崟寬懢榊1, 壓昹岶榊1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞3夞擔杮庮釃弞娐婍妛夛妛弍廤夛 (2020/9/11-12), web奐嵜.
723135. [妛夛 (慡崙)] (堦斒島墘) 擕娻偵崌暪偟偨媫惈攛嵡愷徢帯椕屻偵敪徢偟偨PTTM偺1椺. 愇堜弐曘1, 戝栘戩枻2, 慜懞寬帯2, 栴嶈杻桼2, 摗揷揝暯1, 抮揷桽婤3, 撶揷丂寬1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3媬柦): 戞5夞擔杮攛崅寣埑丒攛弞娐妛夛妛弍廤夛 (2020/9/26-27), web奐嵜.
723136. [妛夛 (慡崙)] (堦斒島墘) Efficacy of pulmonary vasodilators for withdrawal from mechanical circulatory support in both ventricular dysfunction caused by fulminant myocarditis. 戝栘戩枻1, 愇堜弐曘2, 慜懞寬帯1, 栴嶈杻桼1, 摗揷揝暯1, 抮揷桽婤3, 撶揷丂寬2, 慜愳宐旤2, 惉栄丂悞2, 彫斅嫶弐旤2, 挅枖岶尦2,4, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3媬柦, 4杒棦戝妛杒棦尋媶強昦堾): 戞24夞擔杮怱晄慡妛夛妛弍廤夛 (2020/10/15-17), web奐嵜.
723137. [妛夛 (慡崙)] (堦斒島墘) A Case of Takayasu Arteritis with Giant Negative T-wave newly appearing after Mitra Clip. 彫斅嫶弐旤1, 摗揷揝暯1, 慜懞寬帯2, 戝栘戩枻2, 栴嶈杻桼2, 抮揷桽婤3, 撶揷丂寬1, 愇堜弐曘1, 孲嶳宐巕4, 慜愳宐旤1, 栚崟寬懢榊1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3媬柦, 4憤崌恌椕): 戞24夞擔杮怱晄慡妛夛妛弍廤夛 (2020/10/15-17), web奐嵜.
723138. [妛夛 (慡崙)] (堦斒島墘) Rapid Progression of Pulmonary Vascular Resistance in a case with Double-Chambered Right Ventricle with Ventricular Septal Defect. 摗揷揝暯1, 彫斅嫶弐旤1, 戨忋丂桰1, 慜懞寬帯2, 戝栘戩枻2, 栴嶈杻桼2, 抮揷桽婤3, 撶揷丂寬1, 愇堜弐曘1, 孲嶳宐巕4, 慜愳宐旤1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3媬柦, 4憤崌恌椕): 戞24夞擔杮怱晄慡妛夛妛弍廤夛 (2020/10/15-17), web奐嵜.
723139. [妛夛 (慡崙)] (堦斒島墘) Decline in left ventricular ejection fraction is associated with heart failure hospitalization and sudden death in patients with cardiac sarcoidosis. 戨忋丂桰1, 撶揷丂寬1, 愇堜弐曘1, 慜懞寬帯2, 戝栘戩枻2, 栴嶈杻桼2, 摗揷揝暯1, 抮揷桽婤3, 惉栄丂悞1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3媬柦): 戞24夞擔杮怱晄慡妛夛妛弍廤夛 (2020/10/15-17), web奐嵜.
723140. [妛夛 (慡崙)] (堦斒島墘) Mechanical circulatory support for cardiopulmonary collapse type of amniotic fluid embolism. 慜懞寬帯1, 抮揷桽婤2, 戝栘戩枻1, 栴嶈杻桼1, 摗揷揝暯3, 撶揷丂寬3, 愇堜弐曘3, 慜愳宐旤3, 彫斅嫶弐旤3, 挅枖岶尦3, 垻屆弫嵠3 (1戝妛堾堛椕宯尋媶壢, 2媬柦, 3弞娐婍撪): 戞24夞擔杮怱晄慡妛夛妛弍廤夛 (2020/10/15-17), web奐嵜.
723141. [妛夛 (慡崙)] (堦斒島墘) 憿塭嵻枹巊梡偵傛傞OCT僈僀僪壓PCI. 撿丂彯尗 (弞娐婍撪): ARIA (Alliance for Revolution and Interventional Cardiology Advancement) 2020 in Silico (2020/11/22), web奐嵜.
723142. [妛夛 (慡崙)] (堦斒島墘) 恖岺曎椫傪巊梡偟偰偄側偄憁朮曎宍惉弍屻偵梟寣惈昻寣傪惗偠偨堦椺. 慜愳宐旤1, 彫斅嫶弐旤1, 嫶杮岶柧, 媦愳丂弤1, 孲嶳宐巕2, 峳婰弔撧3, 杒懞丂棩3, 媨抧丂娪3, 垻屆弫嵠1 (1弞娐婍撪, 2憤崌恌椕, 3怱憻寣娗奜): 擔杮挻壒攇堛妛夛戞93夞妛弍廤夛 (2020/12/1-3), web奐嵜, 挻壒攇堛妛 2020/11; 47 (Suppl): S212.
723143. [妛夛 (慡崙)] (堦斒島墘) Current Status of MCS and CHIP in Japan. 垻屆弫嵠 (弞娐婍撪): 戞29夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛 (2021/2/19), Web奐嵜.
723144. [妛夛 (慡崙)] (堦斒島墘) AUGUSTUS, ENTRUST-PCI. 垻屆弫嵠 (弞娐婍撪): 戞29夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛 (2021/2/20), Web奐嵜.
723145. [妛夛 (慡崙)] (堦斒島墘) 扤偑LAAC偺椙偄揔墳偐. 垻屆弫嵠 (弞娐婍撪): 戞29夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛 (2021/2/20), Web奐嵜.
723146. [妛夛 (慡崙)] (堦斒島墘) HBR-Complex偺姵幰偲Bleeding偲偺愜傝崌偄傪偳偆偮偗傞偐亅嵟怴偺抦尒偐傜. 垻屆弫嵠 (弞娐婍撪): 戞29夞擔杮怱寣娗僀儞僞乕儀儞僔儑儞帯椕妛夛 (2021/2/21), Web奐嵜.
723147. [妛夛 (慡崙)] (堦斒島墘) PCI偺崌暪徢-僗僥儞僩寣愷徢. 垻屆弫嵠 (弞娐婍撪): CVIT-TV WEB嫵堢僙儈僫乕 (2021/3/11), Web奐嵜.
723148. [妛夛 (慡崙)] (堦斒島墘) 弞娐婍幘姵傪尒悩偊偨摐擜昦帯椕乣怴偨側僄價僨儞僗傪傂傕偲偔乣. 垻屆弫嵠 (弞娐婍撪): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/26), 墶昹 (僴僀僽儕僢僪奐嵜).
723149. [妛夛 (慡崙)] (堦斒島墘) 帀幙娗棟傪娷傔偨擇師梊杊栻暔椕朄 -崅弮搙EPA傪妶偐偡. 垻屆弫嵠 (弞娐婍撪): 戞85夞擔杮弞娐婍妛夛妛弍廤夛 (2021/3/27), 墶昹 (僴僀僽儕僢僪奐嵜).
723150. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 怱寣娗昦梊杊偺偨傔偺塰梴巜摫ABC. 搶瀶旤撧巕 (堛椕塹惗妛晹): 擔杮怱憻儕僴價儕僥乕僔儑儞妛夛戞5夞娭搶峛怣墇巟晹抧曽夛 (2020/11/28), web奐嵜.
733026. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 揔愗側楢実偵傛傝憗婜恌抐偟摼偨慡恎惈傾儈儘僀僪乕僔僗偺堦椺. 徏揷懽婭1, 撶揷丂寬1, 垻屆弫嵠11 杧暷桟堦2 (1弞娐婍撪, 2寣塼撪): 擔杮撪壢妛夛戞662夞娭搶抧曽夛 (2020/9/13), 搶嫗 (web奐嵜).
733027. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摐擜昦姵幰偵偍偗傞Xience偲U-SES偺椪彴惉愌偺斾妑. 撿丂彯尗 (弞娐婍撪): 戞105夞恄撧愳PTCA尋媶夛 (2020/11/27), web奐嵜.
733028. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摐擜昦姵幰偵偍偗傞Xience偲U-SES偺椪彴惉愌偺斾妑. 撿丂彯尗 (弞娐婍撪): 戞10夞朙嫶儔僀僽僨儌儞僗僩儗乕僔儑儞僐乕僗 (2020/11/28), web奐嵜.
733029. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怱幒嵶摦偱斃憲偝傟偨昿柆桿敪惈怱嬝徢嵞敪椺. 彫栘慮隳1, 怺扟塸暯1, 栴嶈杻桼2, 撶揷丂寬1, 娸尨丂弤1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 擔杮撪壢妛夛戞665夞娭搶抧曽夛 (2020/12/12), 搶嫗 (web奐嵜).
733030. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僉儍僢僗儖儅儞昦姵幰偑敪徢偟偨傊僷儕儞婲場惈寣彫斅尭彮徢 (HIT) 偺1椺. 徏揷懽婭1, 墫栰曽柧1, 嵅摗戝曘1, 嶰扟桪懢榊1 (1弞娐婍撪): 戞258夞擔杮弞娐婍妛夛娭搶峛怣墇抧曽夛 (2020/12/12-14), web奐嵜.
733031. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 峈嬅屌椕朄壓偵敪徢偟偨椉怱朳寣愷徢偺堦椺. 嫶懞旤曐1, 晊堜戝擇榊1, 嫶杮戱栱1, 峕揷桪巕1, 斞憅憗塮巕1, 婽揷丂椙1, 彫斅嫶弐旤1, 垻屆弫嵠1 (1弞娐婍撪): 戞258夞擔杮弞娐婍妛夛娭搶峛怣墇抧曽夛 (2020/12/12-14), web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-110015. [尨挊] Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure. Yazaki M1, Nabeta T2, Inomata T2,3, Maemura K1, Ooki T1, Fujita T2, Iida Y2, Ikeda Y2, Ishii S2, Naruke T2, Ako J2: Circ Rep 2019/12; 2 (1): 51-9. (栴嶈杻桼1, 撶揷丂寬2, 挅枖岶尦2,3, 慜懞寬帯1, 戝栘戩枻1, 摗揷揝暯2, 斞揷桽堦榊2, 抮揷桽婤2, 愇堜弐曘2, 惉栄丂悞2, 垻屆弫嵠2: 1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪, 3杒棦戝妛杒棦尋媶強昦堾)
'19-522003. [島嵗]亂摿廤: 埶棅撪梕偐傜怱幘姵傪扵傞! 怱僄僐乕専嵏偺僣儃亃怱奼戝偺専嵏偺僣儃. 彫斅嫶弐旤 (弞娐婍撪): 怱僄僐乕 2019/11; 20 (11): 1102-13.
'19-522004. [島嵗]亂摿廤: 僌儕僐僇儕僢僋僗亃寣娗撪旂僌儕僐僇儕僢僋僗偲摦柆峝壔. 搶瀶旤撧巕 (堛椕塹惗妛晹): 椪彴壔妛 2020/1; 49 (1): 5-13.
'19-540002. [偦偺懠 (Comment)] 彫弌榑暥偵懳偡傞Editorial Comment. 彫斅嫶弐旤 (弞娐婍撪): 怱憻 2020/3; 52 (3): 327.
[挊丂彂]
'19-620002. [妛弍彂 (暘扴幏昅)]亂偙偺1嶜偱埨怱! 廃弍婜偺惗棟婡擻専嵏娵偛偲僈僀僪 (Medical Technology 2019擭12寧椪帪憹姧崋)亃3. 廃弍婜偵偍偗傞惗棟専嵏偺幚嵺丂2) 怱憻偺廃弍婜挻壒攇専嵏丂(3) 怱朳拞妘寚懝. 彫斅嫶弐旤 (弞娐婍撪), 堛帟栻弌斉, 搶嫗, 2019/12敪峴.
'19-620003. [妛弍彂 (暘扴幏昅)]亂僈僀僪儔僀儞偵怱僄僐乕傪惗偐偡亃III 怱嬝徢丂8 怱憻僒儖僐僀僪乕僔僗, p.84-91. 彫斅嫶弐旤 (弞娐婍撪), 曇: 悾旜桼峀, 忋搱摽媣, 儊僕僇儖價儏乕幮, 搶嫗, 2020/3敪峴.
'19-620004. [妛弍彂 (暘扴幏昅)]亂恑揥僗僥乕僕暿偵棟夝偡傞怱晄慡娕岇亃戞2復 怱晄慡僗僥乕僕B偺娕岇丂怱晄慡偺敪徢傪梊杊偡傞丂A 婍幙揑怱幘姵偺恑揥梊杊偺偨傔偺帯椕, p.46-57. 搶瀶旤撧巕 (堛椕塹惗妛晹), 曇: 崃姖傒備偒, 堛妛彂堾, 搶嫗, 2020/3敪峴.
[妛夛丒尋媶夛摍]
'19-713005. [妛夛 (崙嵺)] (堦斒島墘) A case of LGE negative cardiac sarcoidosis丂with FDG-PET and myocardial biopsy leading to early diagnosis. Koitabashi T1, Maemura K2, Ooki T2, Yazaki M2, Fujita T1, Ikeda Y3, Nabeta T1, Ishii S1, Ryo-Kooriyama K4, Maekawa E1, Naruke T1, Ako J1: WASOG2019/The 39th Annual Meeting of JSSOG (2019/10/11), Yokohama, Japan. (彫斅嫶弐旤1, 慜懞寬帯2, 戝栘戩枻2, 栴嶈杻桼2, 摗揷揝暯1, 抮揷桽婤3, 撶揷丂寬1, 愇堜弐曘1, 孲嶳宐巕4, 慜愳宐旤1, 惉栄丂悞1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3媬柦, 4憤崌恌椕)
'19-713006. [妛夛 (崙嵺)] (堦斒島墘) Comprehensive In Vivo Coronary Plaque Mapping: A 3-Vessel Optical Coherence Tomography Study. Araki M, Soeda T, Kim HO, Thondapu V, Russo M, Kurihara O, Shinohara H, Minami Y1, Higuma T, Lee H, Yonetsu T, Kakuta T, Jang IK.: American College Cardiology (ACC) 2020 Scientific Session (2020/3/28-30), Chicago, USA. (撿丂彯尗1: 1弞娐婍撪)
'19-713007. [妛夛 (崙嵺)] (堦斒島墘) Age- and gender-related differences in plaque composition of coronary lesions: an optical coherence tomography study. Sato T1, Minami Y1, Asakura K2, Kato A2, Katsura A2, Kakizaki R1, Nemoto T1, Hashimoto T1, Fujiyoshi K1, Meguro K1, Shimohama T1, Ako J1: American College Cardiology (ACC) 2020 Scientific Session (2020/3/28-30), Chicago, USA. (嵅摗弐堯1, 撿丂彯尗1, 挬憅惔巎2, 壛摗嵤旤2, 宩丂桳抭2, 奰嶈椙懢1, 崻杮徠悽巙1, 嫶杮戱栱1, 摗媑榓攷1, 栚崟寬懢榊1, 壓昹岶榊1, 垻屆弫嵠1: 1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢)
'19-713008. [妛夛 (崙嵺)] (堦斒島墘) Comparison of post-stent optical coherence tomography findings among three subtypes of calcified culprit plaques in patients with acute coronary syndrome. Nakajima A, Araki M, Kurihara O, Minami Y1, Soeda T, Yonetsu T, Crea F, Takano M, Higuma T, Kakuta T, Adriaenssens T, Lee H, Nakamura S, Jang IK: American College Cardiology (ACC) 2020 Scientific Session (2020/3/28-30), Chicago, USA. (撿丂彯尗1: 1弞娐婍撪)
'19-713009. [妛夛 (崙嵺)] (堦斒島墘) Healed Plaques in Patients With Stable Angina Pectoris. Russo M, Fracassi F, Kurihara O, Kim HO, Thondapu V, Araki M, Shinohara H, Sugiyama T, Yamamoto E, Lee H, Vergallo R, Crea F, Biasucci LM, Yonetsu T, Minami Y1, Soeda T, Fuster V, Jang IK: American College Cardiology (ACC) 2020 Scientific Session (2020/3/28-30), Chicago, USA. (撿丂彯尗1: 1弞娐婍撪)
'19-713010. [妛夛 (崙嵺)] (堦斒島墘) First-in-Human Study of the Second-Generation, Thin-Strut, Everolimus-Eluting Bioresorbable Scaffold: Final IVUS and OCT Results From the FAST Clinical Trial Nishi T, Kameda R1, Okada K, Ikutomi M, Hollak MB, Yock P, Popma J, Seneviratne S, Walters D, Whitbourn R, Stewart J, El-Jack S, Allocco D, Meredith I, Fitzgerald PJ, Honda Y: American College Cardiology (ACC) 2020 Scientific Session (2020/3/28-30), Chicago, USA. (婽揷丂椙1: 1弞娐婍撪)
'19-721001. [妛夛 (慡崙)] (摿暿島墘) 嵟怴僈僀僪儔僀儞偵増偭偨怱僄僐乕偺恑傔曽偲偦偺峫偊曽亅曎枌幘姵亅. 彫斅嫶弐旤 (弞娐婍撪): 戞44夞擔杮挻壒攇専嵏妛夛妛弍廤夛 (2019/4/28), 墶昹.
'19-721002. [妛夛 (慡崙)] (摿暿島墘)亂廃嶻婜偲怱憻昦: 廃嶻婜怱嬝徢亃弞娐婍撪壢偺乪嶻壢恌椕乫傊偺偐偐傢傝曽乣廃嶻婜怱嬝徢僴僀儕僗僋徢椺偵偍偗傞嶻壢偲偺楢実乣. 彫斅嫶弐旤1, 摗揷揝暯1, 抮揷桽婤2, 朷寧弮巕3, 奀栰怣栫3, 垻屆弫嵠1 (1弞娐婍撪, 2媬柦, 3嶻壢): 戞67夞擔杮怱憻昦妛夛妛弍廤夛 (2019/9/13), 柤屆壆.
'19-722001. [妛夛 (慡崙)] (彽懸島墘摍) 惗奤昦偲偟偰偺愭揤惈怱幘姵: 僼傽儘乕巐挜徢亅戝恖偵側偭偨僼傽儘乕巐挜徢偺懡條惈亅. 彫斅嫶弐旤1, 孲嶳宐巕2, 慜懞寬帯3, 摗揷揝暯1, 抮揷桽婤4, 撶揷丂寬1, 慜愳宐旤1, 釼栘岹暥, 媨杮棽巌5, 媨抧丂娪5, 愭嶈廏柧6,7, 垻屆弫嵠1 (1弞娐婍撪, 2憤崌恌椕, 3戝妛堾堛椕宯尋媶壢, 4媬柦, 5怱憻寣娗奜, 6怴悽婭堛椕丒愭抂堛椕, 7彫帣): 堦斒幮抍朄恖擔杮怱僄僐乕恾妛夛戞30夞妛弍廤夛 (2019/5/12), 徏杮.
'19-722002. [妛夛 (慡崙)] (彽懸島墘摍) 挻壒攇専嵏偱尒敳偔亅慡恎惈幘姵僒儖僐僀僪乕僔僗偱偺怱昦曄亅. 彫斅嫶弐旤1, 峛斻揷朙擇1, 摗揷揝暯1, 抮揷桽婤2, 撶揷丂寬1, 孲嶳宐巕3, 慜愳宐旤1, 惉栄丂悞1, 挅枖岶尦1, 垻屆弫嵠1 (1弞娐婍撪, 2媬柦, 3憤崌恌椕): 擔杮挻壒攇堛妛夛戞92夞妛弍廤夛 (2019/5/24), 搶嫗.
'19-722003. [妛夛 (慡崙)] (夛挿梫朷墘戣) 惉恖愭揤惈怱幘姵偵懳偡傞怱攛塣摦晧壸帋尡傪妶梡偟偨怱憻儕僴價儕僥乕僔儑儞. 慜愳宐旤 (弞娐婍撪): 戞22夞擔杮惉恖愭揤惈怱幘姵妛夛憤夛丒妛弍廤夛 (2020/1/17-19), 搶嫗.
'19-723006. [妛夛 (慡崙)] (堦斒島墘) Experience Using Selexipag in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension and Eisenmenger Syndrome. 彫斅嫶弐旤1, 摗揷揝暯1, 慜懞寬帯2, 抮揷桽婤3, 孲嶳宐巕4, 慜愳宐旤1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3媬柦, 4憤崌恌椕): 戞22夞擔杮惉恖愭揤惈怱幘姵妛夛憤夛丒妛弍廤夛 (2020/1/17), 搶嫗.
'19-723007. [妛夛 (慡崙)] (堦斒島墘) 恑峴惈偺塃怱婡擻晄慡偲娞峝曄偺崌暪徢偑媈傢傟傞庒擭僼傽儘乕巐挜徢姵幰傊偺帯椕慖戰. 摗揷揝暯1, 戝栘戩枻2, 慜愳宐旤1, 孲嶳宐巕3, 惉栄丂悞1, 彫斅嫶弐旤1, 揷強桽婭4, 敧孡堦婱4, 媨杮棽巌4, 媨抧丂娪4, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢, 3憤崌恌椕, 4怱憻寣娗奜): 戞22夞擔杮惉恖愭揤惈怱幘姵妛夛憤夛丒妛弍廤夛 (2020/1/17), 搶嫗.
'19-723008. [妛夛 (慡崙)] (堦斒島墘) 摿敪惈怱幒嵶摦偵懳偡傞姰慡旂壓怉崬傒宆彍嵶摦婍 (S-ICD) 偵傛傝嬥懏傾儗儖僊乕傪惗偠偨堦椺. 嵅摗揘榊1, 娸尨丂弤2, 嵵摗戝庽1, 徏塝丂尦1, 峳愳梇婭1, 彫椦廃暯1, 敀愳桾婎1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 媦愳丂弤2, 怺扟塸暯2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞12夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2020/2/6), 柤屆壆.
'19-723009. [妛夛 (慡崙)] (堦斒島墘) 儕乕僪儗僗儁乕僗儊乕僇怉偊崬傒偵傛傝姤摦柆懝彎傪棃偟偨1椺. 峳愳梇婭1, 怺扟塸暯2, 嵵摗戝庽1, 嵅摗揘榊1, 徏塝丂尦1, 彫椦廃暯1, 敀愳桾婎1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 媦愳丂弤2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞12夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2020/2/6), 柤屆壆.
'19-723010. [妛夛 (慡崙)] (堦斒島墘) 掅恎挿掅懱廳偺崅楊彈惈偵懳偡傞 儕乕僪儗僗儁乕僗儊乕僇怉崬傒弍偺専摙. 徏塝丂尦1, 娸尨丂弤2, 嶳壓尗擵夘, 愇奯惉峢, 釼摗戝庽1, 嵅摗揘榊1, 峳愳梇婭1, 敀愳桾婎1, 彫椦廃暯1, 杧岥丂垽2, 惣惉揷椇2, 愇枛惉嵠2, 媦愳丂弤2, 怺扟塸暯2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞12夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2020/2/6), 柤屆壆.
'19-723011. [妛夛 (慡崙)] (堦斒島墘) DDD儁乕僗儊乕僇怉崬傒弍屻偵嵍忋榬寣愷惈惷柆墛傪偒偨偟偨怱僒儖僐僀僪乕僔僗偺堦椺. 惣惉揷椇1, 怺扟塸暯1, 娸尨丂弤1, 嵵摗戝庽2, 徏塝丂尦2, 嵅摗揘榊2, 峳愳梇婭2, 彫椦廃暯2, 敀愳桾婎2, 杧岥丂垽1, 拞懞梞斖1, 愇枛惉嵠1, 媦愳丂弤1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞12夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2020/2/7), 柤屆壆.
'19-723012. [妛夛 (慡崙)] (堦斒島墘) Torsades de pointes偱敪徢偟偨儁乕僗儊乕僇弍屻媫惈婜偨偙偮傏怱嬝徢偺堦椺. 杧岥丂垽1, 娸尨丂弤1, 惉栄丂悞1, 嵵摗戝庽2, 戝栘戩屓2, 徏塝丂尦2, 峳愳梇婭2, 彫椦廃暯2, 敀愳桾婎2, 惣惉揷椇1, 愇枛惉嵠1, 媦愳丂弤1, 怺扟塸暯1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2戝妛堾堛椕宯尋媶壢): 戞12夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2020/2/7), 柤屆壆.
'19-723013. [妛夛 (慡崙)] (堦斒島墘) 惼庛側儕乕僪偵懳偟奜壢丒撪壢崌摨偵傛傞廤妛揑帯椕偱敳嫀偟偊偨儁乕僗儊乕僇乕億働僢僩姶愼偺堦椺. 怺扟塸暯1, 捁堜怶嶰2, 戨忋丂桰1, 嵵摗戝庽3, 徏塝丂尦3, 嵅摗揘榊3, 峳愳梇婭3, 彫椦廃暯3, 敀愳桾婎3, 杧岥丂垽1, 惣惉揷椇1, 愇枛惉嵠1, 媦愳丂弤1, 娸尨丂弤1, 掚栰怲堦1, 垻屆弫嵠1 (1弞娐婍撪, 2抧堟堛椕嫵堢, 3戝妛堾堛椕宯尋媶壢): 戞12夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2020/2/8), 柤屆壆.
'19-723014. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞儕乕僪儗僗儁乕僗儊乕僇搊応偵傛傞儁乕僔儞僌僨僶僀僗偺尰忬. 彫椦廃暯1, 娸尨丂弤2, 嵵摗戝庽1, 徏塝丂尦1, 嵅摗揘榊1, 峳愳梇婭1, 敀愳桽婎1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 媦愳丂弤2, 怺扟塸暯2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞12夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2020/2/8), 柤屆壆.
'19-723015. [妛夛 (慡崙)] (堦斒島墘) 墦妘儌僯僞儕儞僌偲怱攺曄摦夝愅傪梡偄偨怉崬傒宆彍嵶摦婍徢椺偺抳巰揑晄惍柆僀儀儞僩偺梊應. 敀愳桾婎1, 掚栰怲堦2, 媦愳丂弤2, 嵵摗戝庽1, 嵅摗揘榊1, 徏塝丂尦1, 峳愳梇婭1, 彫椦廃暯1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 娸尨丂弤2, 怺扟塸暯2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞12夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2020/2/8), 柤屆壆.
'19-723016. [妛夛 (慡崙)] (堦斒島墘) Early inappropriate shock in S-ICD due to subcutaneous air. 娸尨丂弤 (弞娐婍撪): 戞12夞怉崬傒僨僶僀僗娭楢搤婫戝夛 (2020/2/8), 柤屆壆.
'19-723017. [妛夛 (慡崙)] (堦斒島墘) 寣峴摦懺晄埨掕側嵍幒棳弌楬宆帩懕惈怱幒昿攺偵懳偟, 儔儞僕僆儘乕儖偑挊岠偟偨1椺. 媑郪抭帯1, 搶瀶戝婸1, 懞嶳桭夘, 奰嶈椙懢1, 嵅摗怢梞2, 媦愳丂弤1, 怺扟塸暯1, 垻屆弫嵠1 (1弞娐婍撪, 2媬柦): 戞47夞擔杮廤拞帯椕堛妛夛妛弍廤夛 (2020/3/7), 柤屆壆.
'19-723018. [妛夛 (慡崙)] (堦斒島墘) S-ICD杽傔崬傒屻偺塃幒棳弌楬宆帩懕惈怱幒昿攺偵懳偟, 儔儞僕僆儘乕儖偑挊岠偟偨1椺. 媑郪抭帯1, 搶瀶戝婸1, 懞嶳桭夘, 奰嶈椙懢1, 嵅摗怢梞2, 媦愳丂弤1, 怺扟塸暯1, 垻屆弫嵠1 (1弞娐婍撪, 2媬柦): 戞47夞擔杮廤拞帯椕堛妛夛妛弍廤夛 (2020/3/7), 柤屆壆.
'19-732001. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 怱憻僒儖僐僀僪乕僔僗偺怱僄僐乕恌抐乣恌抐婎弨偺夵掶偵敽偆怱僄僐乕恾専嵏偺埵抲偯偗偺曄慗. 峛斻揷朙擇1, 摗揷揝暯1, 抮揷桽婤2, 撶揷丂寬1, 孲嶳宐巕3, 慜愳宐旤1, 垻屆弫嵠1 (1弞娐婍撪, 2媬柦, 3憤崌恌椕): 擔杮挻壒攇堛妛夛戞31夞娭搶峛怣墇抧曽夛妛弍廤夛 (2019/10/19), 搶嫗.
'19-733003. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摿敪惈怱幒嵶摦偵懳偡傞姰慡旂壓怉崬傒宆彍嵶摦婍 (S-ICD) 偵傛傝嬥懏傾儗儖僊乕傪惗偠偨堦椺. 嵅摗揘榊1, 娸尨丂弤2, 嵵摗戝庽1, 徏塝丂尦1, 峳愳梇婭1, 彫椦廃暯1, 敀愳桾婎1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 媦愳丂弤2, 怺扟塸暯2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞32夞椪彴晄惍柆尋媶夛 (2020/1/11), 搶嫗.
'19-733004. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恌抐偵嬯椂偟偨怱幒婜奜廂弅偺堦椺. 徏塝丂尦1, 怺扟塸暯2, 陰摗戝庽1, 嵅摗揘榊1, 彫椦廃暯1, 峳愳梇婭1, 敀愳桾婎1, 惣惉揷椇2, 杧岥丂垽2, 愇枛惉嵠2, 媦愳丂弤2, 娸尨丂弤2, 掚栰怲堦2, 垻屆弫嵠2 (1戝妛堾堛椕宯尋媶壢, 2弞娐婍撪): 戞29夞恄撧愳丒怱揹恾曌嫮夛 (2020/1/17), 墶昹.
'19-733005. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 幐攕椺丒幐攕偟偦偆偵側偭偨徢椺偐傜妛傇Case conference 戝摦柆曎抲姺弍屻12擔栚偵嵞庤弍偲側偭偨堦椺. 彫斅嫶弐旤 (弞娐婍撪): 擔杮怱僄僐乕恾妛夛戞24夞搤婜島廗夛 (2020/1/25), 戝嶃.
'19-733006. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) case偱妛傇愭揤惈怱幘姵 扨弮惈愭揤惈怱幘姵. 彫斅嫶弐旤 (弞娐婍撪): 戞22夞僄僐乕僂儞僞乕僙儈僫乕 (2020/2/9), 徏杮.
擼恄宱撪壢妛
[妛弍榑暥]
110180. [尨挊] Pregnancy outcomes in anti-NMDA receptor encephalitis. Joubert B, Garc抋-Serra A, Planagum� J, Mart抧ez-Hernandez E, Kraft A, Palm F, Iizuka T1, Honnorat J, Leypoldt F, Graus F, Dalmau J: Neurol Neuroimmunol Neuroinflam 2020/5; 7 (3): e668. (斞捤崅峗1: 1擼恄宱撪)
110181. [尨挊] Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies. Martinez-Hernandez E, Guasp M, Anna Garc抋-Serra A, Maudes E, Arin H, Sepulveda M, Armangu� T1, Ramos AP, Ben-Hur T, Iizuka T1, Saiz A, Graus F, Dalmau J: Neurology 2020/6; 94 (22): e2302-10. (斞捤崅峗1: 1擼恄宱撪)
110182. [尨挊] Clinically based score predicting cryptogenic NORSE at the early stage of status epilepticus. Yanagida A1, Kanazawa N2, Kaneko J1, Kaneko A1, Iwase R1, Suga H1, Nonoda Y3, Onozawa Y4, Kitamura E1, Nishiyama K1, Iizuka T1: Neuroinflamm 2020/7; 7 (5): e849. (桍揷撝巕1, 嬥郪捈旤2, 嬥巕弤懢榊1, 嬥巕丂岤1, 娾悾椚巕1, 恵夑桾庽1, 栰乆揷朙3, 彫栰郪桾栫4, 杒懞塸擇1, 惣嶳榓棙1, 斞捤崅峗1: 1擼恄宱撪, 2昦懺丒恌椕宯, 3彫帣, 4椪専晹)
110183. [尨挊] Liver Injury Risk Factors in Amyotrophic Lateral Sclerosis Patients Treated with Riluzole. Kawano C1, Isozaki Y, Nakagawa A, Hirayama T1, Nishiyama K2, Kuroyama M: Yakugaku Zasshi 2020/7; 140 (7): 923-28. (愳栰愮恞1, 暯嶳晲巌1, 惣嶳榓棙2: 1栻妛晹, 2擼恄宱撪)
110184. [尨挊] Differential effects of thyrotropin releasing hormone (TRH) on motor execution and motor adaptation process in patients with spinocerebellar degeneration. Shimiz Tu, Tsutsumi R, Shimizu K, Tominaga N1,2, Nagai M1, Ugawa Y, Nishiyama K2, Hanajima R: J Neurol Sci 2020/8; 415: 116927. (晉塱撧曐旤1,2, 塱堜恀婱巕2, 惣嶳榓棙2: 1憤崌恌椕, 2擼恄宱撪)
110185. [尨挊] Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review. Lewis RA1, Cornblath DR1, Hartung HP1, Sobue G1, Lawo JP1, Mielke O1, Durn BL1, Bril V1, Merkies ISJ1, Bassett P1, Cleasby A1, van Schaik IN1 (1PATH study group), Collaborators: Nishiyama K1,2: J Peripher Nerv Syst 2020/9; 25 (3): 230-7. (惣嶳榓棙1,2: 2擼恄宱撪)
110186. [尨挊] Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations. Kano M, Takanashi M, Oyama G, Yoritaka A, Hatano T, Shiba-Fukushima K, Nagai M1, Nishiyama K1, Hasegawa K, Inoshita T, Ishikawa K, Akamatsu W, Imai Y, Bolognin S, Schwamborn JC, Hattori N: NPJ Parkinsons Dis 2020/11; 6 (1): 33. (塱堜恀婱巕1, 惣嶳榓棙1: 1擼恄宱撪)
110187. [尨挊] Functional Connectivity in Migraineurs with Photo-, Phono-, Osmophobia: Static and Dynamic Resting-state Functional Magnetic Resonance Imaging Study. Imai N, Moriya A, Kitamura E1: Neurology and Clinical Neuroscience 2020/11; 8 (6): 390-8. (杒懞塸擇1: 1擼恄宱撪)
110188. [尨挊] Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson's disease carrying the I2020T mutation in LRRK2. Ohta E1, Sone T, Ukai H, Hisamatsu T2, Kitagawa T2, Ishikawa M, Nagai M3, Ueda H, Obata F4, Okano H: Stem Cell Res 2020/12; 49: 102073. (懢揷墄楴1, 媣徏抦巕2, 杒愳婫巕2, 塱堜恀婱巕3, 彫敠暥嵠4: 1堛椕塹惗妛晹, 2椪専晹, 3擼恄宱撪, 4杒棦戝妛曐寬塹惗愱栧妛堾)
110189. [尨挊] Left Atrial Size and Ischemic Events after Ischemic Stroke or Transient Ischemic Attack in Patients with Nonvalvular Atrial Fibrillation. Tokunaga K1, Koga M1, Yoshimura S1, Okada Y1, Yamagami H1, Todo K1, Itabashi R1, Kimura K1, Sato S1, Terasaki T1, Inoue M1, Shiokawa Y1, Takagi M1, Kamiyama K1, Tanaka K1, Takizawa S1, Shiozawa M1, Okuda S1, Kameda T1, Nagakane Y1, Hasegawa Y1, Shibuya S1, Ito Y1, Matsuoka H1, Takamatsu K1, Nishiyama K1,2, Kario K1, Yagita Y1, Mizoguchi T1, Fujita K1, Ando D1, Kumamoto M1, Miwa K1, Arihiro S1, Toyoda K1 (1the SAMURAI Study Investigators): Cerebrovasc Dis 2020/12; 49: 619-24. (惣嶳榓棙1,2: 2擼恄宱撪)
110190. [尨挊] Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barr� syndrome. Yamagishi Y, Kuwahara M, Suzuki H, Masahiro Sonoo M, Kuwabara S, Yokota T, Nomura K, Chiba A, Kaji R, Kanda T, Kaida K, Mutoh T, Yamasaki R, Takashima H, Matsui M, Nishiyama K1, Sobue G, Kusunoki S: J Neurol Neurosurg Psychiatry 2020/12; 91 (12): 1339-42. (惣嶳榓棙1: 1擼恄宱撪)
110191. [尨挊] HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data. Watanabe M, Nakamura Y, Sato S, Niino M, Fukaura H, Tanaka M, Ochi H, Kanda T, Takeshita Y, Yokota T, Nishida Y, Matsui M, Nagayama S, Kusunoki S, Miyamoto K, Mizuno M, Kawachi I, Saji E, Ohashi T, Shimohama S, Hisahara S, Nishiyama K1, Iizuka T1, Nakatsuji Y, Okuno T, Ochi K, Suzumura A, Yamamoto K, Kawano Y, Tsuji S, Hirata M, Sakate R, Kimura T, Shimizu Y, Nagaishi A, Okada K, Hayashi F, Sakoda A, Masaki K, Shinoda K, Isobe N, Matsushita T, Kira J: Sci Rep 2021/1; 11 (1): 607. (惣嶳榓棙1, 斞捤崅峗1: 1擼恄宱撪)
110192. [尨挊] SIRT1 decelerates morphological processing of oligodendrocyte cell lines and regulates the expression of cytoskeleton-related oligodendrocyte proteins. Hisahara S, Iwahara N, Matsushita T, Suzuki S, Matsumura A, Fujikura M, Yokokawa K, Saito T, Manabe T, Kawamata J1, Horio Y, Shimohama S: Biochem Biophys Res Commun 2021/3; 546: 7-14. (愳枖丂弮1: 1擼恄宱撪)
110081. [尨挊] Quantitative proteomic analysis and single-protein-derived tryptic peptide profiling indicate qualitative alterations of annexin A6 in the brain of wobbler mice. Nakamura M1, Mizutani K2, Kato K3, Konno R, Itakura M4, Kodera Y, Nishiyama K5, Sato T2: Kitasato Med J 2021/3; 50 (1): 76-83. (拞懞姴徍1, 悈扟榓姲2, 壛摗棙壚3, 斅憅丂惤4, 惣嶳榓棙5, 嵅摗弐嵠2: 1戝妛堾堛椕宯尋媶壢, 2幚摦, 3堚揱巕夝愅僙, 4惗壔, 5擼恄宱撪)
210002. [抁曬] Clinically based score predicting cryptogenic NORSE. Iizuka T1, Yanagida A1: Clin Exp Neuroimmunol 2020/11; 11 (4): 207-8. (斞捤崅峗1, 桍揷撝巕1: 1擼恄宱撪)
310016. [徢椺曬崘] Neuroimaging pattern and pathophysiology of cerebellar stroke-like lesions in MELAS with m.3243A>G mutation: a case report. Oyama M, Iizuka T1, Nakahara J, Izawa Y: BMC Neurol 2020/5; 20 (1): 167. (斞捤崅峗1: 1擼恄宱撪)
310017. [徢椺曬崘] A Case of Subcortical Hemorrhage in the Left Temporal Lobe Caused by Multiple Dural Arteriovenous Fistulas. Usui R1, Ishima D1, Abe Y1, Sato Y1, Kimura A1, Kimoto T1, Nagashima M1, Adachi T1, Nagata N1, Niki J, Yamamoto D, Akutsu T1, Nishiyama K1: J Stroke Cerebrovasc Dis 2020/5; 29 (5): 104712. (塐堜丂椛1, 堜搰戝曘1, 垻晹桳婲1, 嵅摗丂桰1, 栘懞暥彨1, 栘嫋戱攏1, 挿搰丂惤1, 埨払抭旤1, 挿揷撧弿旤1, 垻媣捗擇晇1, 惣嶳榓棙1: 1擼恄宱撪)
310018. [徢椺曬崘] Hyperemesis-induced Wernicke-Korsakoff Syndrome due to Hypergastrinemia during Long-term Treatment with Proton Pump Inhibitors. Miyanaga R, Hisahara S, Ohhashi I, Yamamoto D, Matsumura A, Suzuki S, Tanimoto K, Hirakawa M, Kawamata J1, Kato J, Shimohama S: Intern Med 2020/11; 59 (21): 2783-7. (愳枖丂弮1: 1擼恄宱撪)
521003. [夝愢]亂埾堳夛採尵亃擔杮恄宱妛夛偵傛傞嵭奞懳嶔: 恄宱擄昦儕僄僝儞妶摦偺悇恑. 拞崻弐惉1, 峚岥岟堦1, 垻晹峃擇1, 擬揷捈庽1, 堜岥曐擵1, 抮揷壚惗1, 妬丂棿橺1, 婽堜丂憦1, 杒愳堦晇1, 栘懞榓旤1, 楅栘惓旻1, 崅搱丂攷1, 帥嶳桋晇1, 惣嶳榓棙1,2, 屆扟攷榓1, 徏尨墄楴1, 懞徏怲堦1, 嶳懞丂廋1, 晲揷丂撃1, 埳搶廏暥1 (1擔杮恄宱妛夛嵭奞懳嶔埾堳夛, 2擼恄宱撪): 椪彴恄宱妛 2020/10; 60 (10): 643-2.
521004. [夝愢] 媫惈婜擼峓嵡.惣嶳榓棙 (擼恄宱撪): 僪僋僞乕僒儘儞 2020/10; 64 (11): 863-6.
521005. [夝愢] 儔僋僫峓嵡偵峈寣彫斅栻搳梌偼昁梫偐丠惣嶳榓棙 (擼恄宱撪): 擔杮堛帠怴曬 2021/1; 5048: 51.
522038. [島嵗]亂摿廤: 寖摦偡傞擼懖拞恌椕亅擼懖拞丒弞娐婍昦懳嶔婎杮朄偲偼?亃G. 奺榑5: 偦偺懠偺擼寣娗忈奞偺恌椕偺摦岦丂MELAS/CADASIL/CARASIL. 斞捤崅峗 (擼恄宱撪): Clinical Neuroscience 2020/5; 38 (5): 643-6.
522039. [島嵗]亂埾堳夛採尵 (戞60夞擔杮恄宱妛夛妛弍戝夛丂嬞媫僔儞億僕僂儉彺榐廤)亃恄宱撪壢愱栧堛婎杮椞堟壔偵壗偑昁梫偐: 梙傟傞愱栧堛惂搙偲婎杮椞堟愱栧堛偺巊柦. 墍惗夒峅1, 敆堜惓怺1, 搉曈丂寷1, 晊杮廏榓1, 埨摗揘楴1, 惣嶳榓棙1,2, 崅嫶椙曘1, 屗揷払巎1 (1擔杮恄宱妛夛恄宱撪壢愱栧堛婎杮椞堟壔悇恑懳嶔杮晹, 2擼恄宱撪): 椪彴恄宱妛 2020/8; 60 (8): 515-9.
522040. [島嵗]亂摿廤: 恄宱徢岓妛偲恄宱恌抐妛亅?AI偼枴曽偐揋偐?亃C. 摿堎揑徢忬偺徢岓妛丒恌抐妛偲AI丂暋帇. 斞捤崅峗 (擼恄宱撪): Clinical Neuroscience 2020/11; 38 (11): 1417-20.
522041. [島嵗]亂楢嵹: 尒摝偟偰偼偄偗側偄恎懱強尒亃15. 恄宱偺恌偐偨亅堄幆忈奞.惣嶳榓棙 (擼恄宱撪): 擔杮堛巘夛嶨帍 2020/12; 149 (9): 1604-5.
522042. [島嵗]亂摿廤: 僄僀僕儞僌亃C. 壛楊偲恄宱幘姵丂帺屓柶塽惈擼墛. 斞捤崅峗1, 桍揷撝巕1, 嬥郪捈旤2 (1擼恄宱撪, 2昦懺丒恌椕宯): Clinical Neuroscience 2021/1; 39 (1): 103-6.
522043. [島嵗] 僐儘僫壭帪戙偵偐偐傝偮偗堛偑拲堄偟偨偄擼懖拞恌椕偺嵟怴忣曬.惣嶳榓棙 (擼恄宱撪): 恄撧愳導撪壢堛妛夛嶨帍 2021/1; 84: 10.
540022. [偦偺懠]亂楢嵹: 僐儘僫壭, 堛椕昇敆偲儚僋僠儞偺搊応偱怴偨側僼僃乕僘傊亃1. 姫摢尵.惣嶳榓棙 (擼恄宱撪): MMJ 2021/2; 2丒3寧崋: 1.
[挊丂彂]
620029. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓 2021擭斉丂巹偼偙偆帯椕偟偰偄傞亃戞15復 恄宱丒嬝幘姵丂擼寣娗忈奞偺崌暪徢 (岆殝惈攛墛傪拞怱偵), p.950-1. 惣嶳榓棙 (擼恄宱撪), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒堦惉, 堛妛彂堾, 搶嫗, 2021/1敪峴.
[妛夛丒尋媶夛摍]
713023. [妛夛 (崙嵺)] (Virtual Session) Status epilepticus suspected autoimmune: antibody frequency and main clinical features. Suga H1, Iizuka T1, Kaneko J1, Yanagida A2, Kaneko A1, Kitamura E1, Kanazawa N3, Dalmau J, Nishiyama K1: AAN 2020 (The 72nd AAN Annual Meeting) (2020/4/26), Toronto, Canada. (恵夑桾庽1, 斞捤崅峗1, 嬥巕弤懢榊1, 桍揷撝巕2, 嬥巕丂岤1, 杒懞塸擇1, 嬥郪捈旤3, 惣嶳榓棙1: 1擼恄宱撪, 2戝妛堾堛椕宯尋媶壢, 3昦懺丒恌椕宯)
713024. [妛夛 (崙嵺)] (堦斒島墘) Bilaterally synchronized faciobrachial dystonic seizures in anti-LGI1 Encephalitis: a case report. Mikami T, Amano E, Iizuka T1, Machida A: AAN 2020 (2020/4/25-5/1), Web奐嵜. (斞捤崅峗1: 1擼恄宱撪)
713025. [妛夛 (崙嵺)] (堦斒島墘) Clinical features, immunotherapy, and outcome in patients with cryptogenic NORSE. Iizuka T1, Yanagida A2, Kaneko J1, Nonoda Y3, Iwase R1, Suga H1, Koizumi K, Nakamura T, Ueno H, Shishido T, Sakamoto M, Imai K, Terasawa Y, Itagaki Y, Hattori K, Ayano M, Hosoi Y, Ohara H, Kanazawa N4, Nishiyama K1: AAN 2020 (2020/4/26), Web奐嵜. (斞捤崅峗1, 桍揷撝巕2, 嬥巕弤懢榊1, 栰乆揷朙3, 娾悾椚巕1, 恵夑桾庽1, 嬥郪捈旤4, 惣嶳榓棙1: 1擼恄宱撪, 2戝妛堾堛椕宯尋媶壢, 3彫帣, 4昦懺丒恌椕宯)
713026. [妛夛 (崙嵺)] (堦斒島墘) Clinical and immunological investigation in patients with suspected autoimmune post-herpes simplex encephalitis. Kaneko J1, Iizuka T1, Iwase R1, Nagai T1, Kaneko A1, Kitamura E1, Tomita H, Igarashi S, Irioka T, Arai M, Kanazawa K2, Nishiyama K1: AAN 2020 (2020/4/25-5/1), Web奐嵜. (嬥巕弤懢榊1, 斞捤崅峗1, 娾悾椚巕1, 塱堜弐峴1, 嬥巕丂岤1, 杒懞塸擇1, 嬥郪捈旤2, 惣嶳榓棙1: 1擼恄宱撪, 2昦懺丒恌椕宯)
722040. [妛夛 (慡崙)] (彽懸島墘摍) 帺屓柶塽惈擼墛偵偍偗傞塣摦堎忢徢偲偰傫偐傫敪嶌偺敪尰婡峔. 斞捤崅峗 (擼恄宱撪): 戞61夞擔杮恄宱妛夛妛弍戝夛 (2020/9/1), 壀嶳.
722041. [妛夛 (慡崙)] (彽懸島墘摍) 枹棃 (30擭屻) 偺恄宱柶塽幘姵偺帯椕I-3 帺屓柶塽惈擼墛偺帯椕偺枹棃. 斞捤崅峗 (擼恄宱撪): 戞32夞擔杮恄宱柶塽妛夛妛弍廤夛 (2020/10/1), 嬥戲.
722042. [妛夛 (慡崙)] (彽懸島墘摍) 擼恄宱撪壢堛偑恌傞傋偒僒儖僐僀僪乕僔僗. 惣嶳榓棙 (擼恄宱撪): 戞38夞擔杮恄宱帯椕妛夛妛弍廤夛 (2020/10/28), 搶嫗 (僴僀僽儕僢僪奐嵜).
722043. [妛夛 (慡崙)] (嫵堢島墘) 帺屓柶塽惈擼墛偍傛傃偦偺椶墢幘姵偵偍偗傞Up to Date. 斞捤崅峗 (擼恄宱撪): 戞38夞擔杮恄宱帯椕妛夛妛弍廤夛 (2020/10/29), 搶嫗 (僴僀僽儕僢僪奐嵜).
722044. [妛夛 (慡崙)] (彽懸島墘摍) 媫惈婜偺峈寣愷椕朄. 惣嶳榓棙 (擼恄宱撪): 戞46夞擔杮擼懖拞妛夛妛弍廤夛 (2021/3/11), 暉壀 (僴僀僽儕僢僪奐嵜).
723151. [妛夛 (慡崙)] (堦斒島墘) 屻愐悜摦柆徢岓孮偺1椺. 栘壓嵷乆, 恄嶈恀幚1, 娾悾椚巕1, 崅丂媊庽, 杒懞塸擇1, 垻媣捗擇晇1, 惣嶳榓棙1 (1擼恄宱撪): 堛妛惗丒尋廋堛偺擔杮撪壢妛夛偙偲偼偠傔 2020 (戞117夞擔杮撪壢妛夛憤夛丒島墘夛) (2020/8/8), Web奐嵜.
723152. [妛夛 (慡崙)] (堦斒島墘) 擼掙摦柆嵡愷徢偵偍偗傞屻戝擼摦柆偺昤弌偲拞擼丒嫶峓嵡偲偺娭學. 垻媣捗擇晇1, 塒堜峩懢榊1, 栘懞暥彨1, 恵夑桾庽1, 孖揷塴棟巕1, 塐堜丂椛1, 堜搰戝曘1, 杒懞塸擇1, 斞捤崅峗1, 惣嶳榓棙1 (1擼恄宱撪): STROKE 2020 (2020/8/24), Web奐嵜.
723153. [妛夛 (慡崙)] (堦斒島墘) 媫惈婜擼弌寣偵崌暪偡傞媫惈婜擼峓嵡偵偮偄偰偺専摙. 塱堜弐峴 (擼恄宱撪): STROKE 2020 (2020/8/24), Web奐嵜.
723154. [妛夛 (慡崙)] (堦斒島墘) Status epilepticus suspected autoimmune: antibody frequency and its main clinical features. 恵夑桾庽1, 斞捤崅峗1, 嬥巕弤懢榊1, 桍揷撝巕2, 嬥巕丂岤1, 杒懞塸擇1, 嬥郪捈旤3, 垻媣捗擇晇1, 惣嶳榓棙1 (1擼恄宱撪, 2戝妛堾堛椕宯尋媶壢, 3昦懺丒恌椕宯): 戞61夞擔杮恄宱妛夛妛弍戝夛 (2020/8/31), 壀嶳.
723155. [妛夛 (慡崙)] (堦斒島墘) Association between low body temperature and cortical spreading depression. 杒懞塸擇1, 嬥郪捈旤2, 斞捤崅峗1, 惣嶳榓棙1 (1擼恄宱撪, 2昦懺丒恌椕宯): 戞61夞擔杮恄宱妛夛妛弍戝夛 (2020/8/31), 壀嶳.
723156. [妛夛 (慡崙)] (堦斒島墘) 敪徢屻媫懍偵徢忬偑夵慞偡傞擼弌寣偺摿挜. 垻媣捗擇晇1, 塱堜弐峴1, 塒堜峩懢榊1, 栘懞暥彨1, 垻晹桳婲1, 嬥巕丂岤1, 恵夑桾庽1, 塐堜丂椛1, 孖揷塴棟巕1, 堜搰戝曘1, 嬥巕弤懢榊1, 杒懞塸擇1, 斞捤崅峗1, 惣嶳榓棙1 (1擼恄宱撪): 戞61夞擔杮恄宱妛夛妛弍戝夛 (2020/9/2), 壀嶳.
723157. [妛夛 (慡崙)] (堦斒島墘) 懱壏曄壔偲cortical spreading depression偺娭學. 杒懞塸擇1, 嬥郪捈旤2, 斞捤崅峗1, 惣嶳榓棙1 (1擼恄宱撪, 2昦懺丒恌椕宯): 戞48夞擔杮摢捝妛夛憤夛 (2020/11/7-8), Web奐嵜.
731012. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) COVID-19偲恄宱撪壢幘姵丆恄宱擄昦. 惣嶳榓棙 (擼恄宱撪): 戞35夞恄撧愳導恄宱擄昦尋廋夛 (2020/12/7), 憡柾尨.
732011. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 偙偺徢椺偺恌抐偲帯椕偼?亂忋媺曇亃. 惣嶳榓棙 (擼恄宱撪): 戞3夞擔杮恄宱妛夛擼懖拞摿暿嫵堢尋廋夛 (2020/9/20), 戝嶃 (僴僀僽儕僢僪奐嵜).
733032. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) Parry-Romberg徢岓孮偵傕傗傕傗昦傪崌暪偟昿夞偵堦夁惈擼嫊寣敪嶌傪孞傝曉偟偨44嵨彈惈椺. 娾悾椚巕1, 堜搰戝曘1, 塒堜峩懢榊1, 栘懞暥彨1, 塐堜丂椛1, 憹郪恀旤巕2, 嶳杮戝曘3, 垻媣捗擇晇1, 惣嶳榓棙1 (1擼恄宱撪, 2旂晢, 3擼奜): 戞235夞擔杮恄宱妛夛娭搶峛怣墇抧曽夛 (2020/12/5), Web奐嵜.
733033. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僾儕僆儞抈敀堚揱巕偵120bp偺憓擖曄堎傪擣傔偨壠懓惈僾儕僆儞昦偺53嵨彈惈椺. 栘懞暥彨1, 塱堜恀婱巕1, 斞捤夒婱1, 挿揷撧弿旤1, 垻媣捗擇晇1, 斞捤崅峗1, 惣嶳榓棙1 (1擼恄宱撪): 戞236夞擔杮恄宱妛夛娭搶峛怣墇抧曽夛 (2021/3/6), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-110016. [尨挊] Hashimoto encephalopathy in the 21st century. Mattozzi S, Sabater L, Escudero D, Arino H, Armangue T, Simabukuro M, Iizuka T1, Hara M, Saiz A, Sotgiu S, Dalmau J, Graus F: Neurology 2020/1; 94 (2): e217-24. (斞捤崅峗1: 1擼恄宱撪)
'19-310001. [徢椺曬崘] Infantile Refsum Disease Associated with Hypobetalipoproteinemia. Matsuo M, Akutsu T1, Kanazawa N2, Shimozawa N: J Pediatr Neurol 2019; 17 (6): 210-2. (垻媣捗擇晇1, 嬥郪捈旤2: 1擼恄宱撪, 2昦懺丒恌椕宯)
'19-310002. [徢椺曬崘] Anti-HMGCR myopathy following acute Epstein-Barr virus infection. Shimizu T, Kondo Y1, Kanazawa N2, Kaneko A1, Tominaga N1, Nagai M1, Iizuka T1, Nishino I, Nishiyama K1: Muscle Nerve 2020/1; 61 (1): E5-8. (嬤摗桾巕1, 嬥郪捈旤2, 嬥巕丂岤1, 晉塱撧曐旤1, 塱堜恀婱巕1, 斞捤崅峗1, 惣嶳榓棙1: 1擼恄宱撪, 2昦懺丒恌椕宯)
'19-310003. [徢椺曬崘] A Case of Bilaterally Synchronized Faciobrachial Dystonic Seizures in Anti-Leucine-Rich Glioma Inactivated-1 Encephalitis. Mikami T, Amano E, Iizuka T1, Machida A: Mov Disord Clin Pract 2020/3; 7 (4): 470-1. (斞捤崅峗1: 1擼恄宱撪)
'19-540003. [偦偺懠]亂姫摢尵亃MMJ偺曇廤埾堳傪攓柦偟偰.惣嶳榓棙 (擼恄宱撪): MMJ 2019/4; 4寧崋: 33.
'19-540004. [偦偺懠]亂姫摢尵亃椷榓偲偲傕偵擼懖拞崕暈偺枊偑奐偔.惣嶳榓棙 (擼恄宱撪): MMJ 2020/2; 2丒3寧崋: 1.
[挊丂彂]
'19-620005. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓 2020擭斉丂巹偼偙偆帯椕偟偰偄傞亃戞15復 恄宱丒嬝幘姵丂堦夁惈擼嫊寣敪嶌偺撪壢揑帯椕, p.929-30. 惣嶳榓棙 (擼恄宱撪), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒堦惉, 堛妛彂堾, 搶嫗, 2020/1敪峴.
[妛夛丒尋媶夛摍]
'18-722004. [妛夛 (慡崙)] (彽懸島墘摍) 擼峓嵡偺擇師梊杊: 婋尟場巕偺娗棟. 惣嶳榓棙 (擼恄宱撪): 戞44夞擔杮擼懖拞妛夛妛弍廤夛 (2019/3/22), 墶昹.
寣塼撪壢妛
[妛弍榑暥]
110193. [尨挊] Changes in estimate glomerular filtration rate associated with long-term tyrosine kinase inhibitor treatment in patinets with chronic myelogenous leukemia. Motohashi T1, Kamata H2, Hayama K1, Michishita Y2, Horigome Y2, Tadera N2, Okina S2, Suzuki T2: Kitasato Med J 2021/3; 51 (1): 32-41. (杮嫶抦旤1, 姍揷峗柅2, 塇嶳宒埲1, 摴壓梇夘2, 杧暷桟堦2, 揷帥斖峴2, 墺丂慶惤2, 楅栘棽峗2: 1戝妛堾堛椕宯尋媶壢, 2寣塼撪)
320002. [徢椺曬崘] 擠怭戞2婜偵敪徢偟偨媫惈敀寣昦. 杧暷桟堦1, 揷帥斖峴1, 摴壓梇夘1, 杮嫶抦旤2, 愇揷丂棽3, 墺丂慶惤1, 姍揷峗柅1, 媨鴵峗擇3, 楅栘棽峗1 (1寣塼撪, 2戝妛堾堛椕宯尋媶壢, 3桝寣丒嵶朎堏怉): 椪彴寣塼 2020/8; 61 (8): 865-9.
522044. [島嵗]亂摿廤: 椪彴寣塼妛亅恌抐偲帯椕偵偍偗傞僷儔僟僀儉僔僼僩2020 (愒寣媴宯幘姵)亅亃揝戙幱偲揝嵻晄墳惈揝寚朢惈昻寣. 楅栘棽峗 (寣塼撪): 椪彴寣塼 2020/5; 61 (5): 475-83.
522045. [島嵗]亂戞82夞擔杮寣塼妛夛妛弍廤夛嫵堢島墘摿廤亃桝寣屻揝夁忚徢偺恌椕. 楅栘棽峗 (寣塼撪): 椪彴寣塼 2020/9; 61 (9): 1205-11.
522046. [島嵗]亂摿廤: 昻寣丂嵟怴偺栻暔帯椕愴棯偲幚慔億僀儞僩亃仭偙傫側偲偒偳偆偡傞? 僾儘偑嫵偊傞幚慔億僀儞僩Q&A!丂揝夁忚偺偲偒偵偼偳偆懳墳偡傞偐?丂揝僉儗乕僩嵻偼偳偺姵幰偵偳偆巊偆? 楅栘棽峗 (寣塼撪): 栻嬊 2020/9; 71 (10): 3181-6.
522047. [島嵗]亂摿廤: 寣嶼傪嬌傔傞亃<寣嶼偺堎忢偺娪暿恌抐>丂昻寣偺娪暿恌抐. 楅栘棽峗 (寣塼撪): 撪壢 2020/10: 126 (4): 705-9.
[挊丂彂]
620030. [妛弍彂 (暘扴幏昅)]亂擖栧庮釃撪壢妛 夵掶戞3斉亃II 奺榑丂13 憿寣婍丂3. 崪悜堎宍惉徢岓孮, p.251-4. 楅栘棽峗 (寣塼撪), 曇: 擔杮椪彴庮釃妛夛, 撿峕摪, 搶嫗, 2020/7敪峴.
620031. [妛弍彂 (暘扴幏昅)]亂憿寣婍庮釃妛 (戞2斉)亅婎慴偲椪彴偺嵟怴尋媶摦岦亅(擔杮椪喱78姫憹姧崋3)亃IV. 崪悜宯庮釃偺椪彴丂6. 崪悜堎宍惉徢岓孮丂(3) 崪悜堎宍惉徢岓孮偺梊屻場巕, p.389-94. 楅栘棽峗 (寣塼撪), 擔杮椪喱幮, 搶嫗, 2020/8敪峴.
620032. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓丂2021擭搙斉亃11. 戙幱幘姵丂揝夁忚徢 (僿儌僋儘儅僩乕僔僗), p.789-90. 楅栘棽峗 (寣塼撪), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒堦惉, 堛妛彂堾, 搶嫗, 2021/1敪峴.
[妛夛丒尋媶夛摍]
713027. [妛夛 (崙嵺)] (堦斒島墘) Real-World Assessment of Nationwide Health Economic Burden and Treatment-Based Survival for Current Myelodysplastic Syndromes Treatment Practice in Japan. Tsutsue S, Suzuki T1, Kim H, Kuan YH W, Crawford B: The American Society of Hematology 62nd Annual Meeting and Exposition (2020/12/5-8), Web奐嵜. (楅栘棽峗1: 1寣塼撪)
722045. [妛夛 (慡崙)] (嫵堢島墘) 桝寣屻揝夁忚徢偺帯椕巜恓偲崱屻偺揥奐. 楅栘棽峗 (寣塼撪): 戞68夞擔杮桝寣丒嵶朎帯椕妛夛妛弍憤夛 (2020/5/28-30), 帍忋奐嵜, 擔杮桝寣嵶朎帯椕妛夛帍 2020/4; 66 (2): 127.
722046. [妛夛 (慡崙)] (僔儞億僕僂儉) 憿寣婍幘姵偲桝寣屻揝夁忚徢. 楅栘棽峗 (寣塼撪): 戞44夞擔杮揝僶僀僆僒僀僄儞僗妛夛妛弍廤夛 (2020/9/5-6), 帍忋奐嵜, 擔杮揝僶僀僆僒僀僄儞僗妛夛WEB; 戞44夞擔杮揝僶僀僆僒僀僄儞僗妛夛妛弍廤夛僾儘僌儔儉: 僔儞億僕僂儉1.
722047. [妛夛 (慡崙)] (嫵堢島墘) 桝寣屻揝夁忚徢偺恌椕. 楅栘棽峗 (寣塼撪): 戞82夞擔杮寣塼妛夛妛弍廤夛 (2020/10/10-11/8), Web奐嵜, 椪彴寣塼 2020/8; 61 (8): 戞82夞擔杮寣塼妛夛妛弍廤夛僾儘僌儔儉: 嫵堢島墘11.2-5D.
723158. [妛夛 (慡崙)] (堦斒島墘) 姦椻嬅廤慺徢偱偼儕儞僷惈庮釃偑崅棪偵崌暪偡傞: 扨巤愝屻曽帇揑夝愅偺寢壥. 揷帥斖峴1, 塇嶳宒埲2, 墶嶳恀婌1, 愹嶳榓媣1, 峕敤峎堦1, 摴壓梇夘1, 杧暷桟堦1, 姍揷峗柅1, 墺丂慶惤1, 媨峗擇3, 楅栘棽峗1 (1寣塼撪, 2戝妛堾堛椕宯尋媶壢, 3桝寣丒嵶朎堏怉): 戞82夞擔杮寣塼妛夛妛弍廤夛 (2020/10/10-11/8), Web奐嵜, 戞82夞擔杮寣塼妛夛妛弍廤夛僾儘僌儔儉 2020; WEB.
723159. [妛夛 (慡崙)] (堦斒島墘) 僟僒僠僯僽娭楢挵墛偺敪徢偲帯椕偵偮偄偰偺扨巤愝屻曽帇揑夝愅. 愹嶳榓媣1, 墺丂慶惤1, 峕敤峎堦1, 塇嶳宒埲2, 墶嶳恀婌1, 揷帥斖峴1, 杧暷桟堦1, 摴壓梇夘1, 姍揷峗柅1, 媨峗擇3, 楅栘棽峗1 (1寣塼撪, 2戝妛堾堛椕宯尋媶壢, 3桝寣丒嵶朎堏怉): 戞82夞擔杮寣塼妛夛妛弍廤夛 (2020/10/10-11/8), Web奐嵜, 戞82夞擔杮寣塼妛夛妛弍廤夛僾儘僌儔儉 2020; WEB.
723160. [妛夛 (慡崙)] (堦斒島墘) 嵞敪丒擄帯惈懡敪惈崪悜庮偵偍偗傞掅梡検奐巒僀僉僒僝儈僽椕朄偺桳梡惈偵偮偄偰偺屻曽帇揑専摙. 杧暷桟堦1, 墺丂慶惤1, 姍揷峗柅1, 揷帥斖峴1, 塇嶳宒埲2, 墶嶳恀婌1, 摴壓梇夘1, 愹嶳榓媣1, 峕敤峎堦1, 楅栘棽峗1 (1寣塼撪, 2戝妛堾堛椕宯尋媶壢): 戞82夞擔杮寣塼妛夛妛弍廤夛 (2020/10/10-11/8), Web奐嵜, 戞82夞擔杮寣塼妛夛妛弍廤夛僾儘僌儔儉 2020; WEB.
723161. [妛夛 (慡崙)] (堦斒島墘) 僄儈僔僘儅僽掕婜搳梌姵幰偺廳撃側弌寣惈帠徾偵懳偟偰rFVIII惢嵻偺曗廩椕朄偱娗棟偟偨徢椺偵偮偄偰. 墶嶳恀婌1, 怴堜隳懢1, 峕敤峎堦1, 愹嶳榓媣1, 塇嶳宒埲2, 杧暷桟堦1, 揷帥斖峴1, 姍揷峗柅1, 墺丂慶惤1, 楅栘棽峗1, 媨峗擇3 (1寣塼撪, 2戝妛堾堛椕宯尋媶壢, 3桝寣丒嵶朎堏怉): 戞82夞擔杮寣塼妛夛妛弍廤夛 (2020/10/10-11/8), Web奐嵜, 戞82夞擔杮寣塼妛夛妛弍廤夛僾儘僌儔儉 2020; WEB.
723162. [妛夛 (慡崙)] (堦斒島墘) 5q-傪彍偔FAB-RA徢椺偱偺奺寣媴宯摑偺堎宍惉偑梌偊傞梊屻傊偺塭嬁: 摿敪惈憿寣忈奞挷嵏尋媶斍曬崘. 慜揷抭栫, 徏揷丂峎, 鎩揷弤栫, 愳抂丂峗, 愇愳棽擵, 捠嶳丂孫, 峳娭偐傗偺, 怴曐丂宧, 攇懡抭巕, 楅栘棽峗1, 姖栰廏堦, 塒媙寷桽, 怴摪恀婭, 桳攏桋壚, 捈愳嫥惏, 懢揷徎巕, 愮梩丂帬, 媨嶈懽巌, 拞旜崃擇, 彫郪宧栫, 峳堜弐栫, 崟愳曯晇, 崅愜峎巎, 嶰扟對巕 (1寣塼撪): 戞82夞擔杮寣塼妛夛妛弍廤夛 (2020/10/10-11/8), Web奐嵜, 戞82夞擔杮寣塼妛夛妛弍廤夛僾儘僌儔儉 2020; WEB.
733034. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 壜媡惈屻摢梩敀幙擼徢 (PRES) 傪敪徢偟偨Ph梲惈媫惈儕儞僷夎媴惈敀寣昦 (Ph + ALL). 怴堜隳懢1, 杧暷桟堦1, 墺丂慶惤1, 姍揷峗柅1, 揷帥斖峴1, 摴壓梇夘1, 墶嶳恀婭1, 塇嶳宒埲2, 愹嶳榓媣1, 峕敤峎堦1, 彫惣岹柧1, 嶰塝媣媂1, 媨峗擇3, 楅栘棽峗1 (1寣塼撪, 2戝妛堾堛椕宯尋媶壢, 3桝寣丒嵶朎堏怉): 戞14夞擔杮寣塼妛夛娭搶峛怣墇抧曽夛 (2021/3/20), 搶嫗, 椪彴寣塼 2021; 62 (6): 673.
屇媧婍撪壢妛
[妛弍榑暥]
110194. [尨挊] Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer. Igawa S1, Ono T1, Kasajima M1, Manabe H1, Fukui T1, Mitsufuji H2, Yokoba M3, Kubota M3, Katagiri M3, Sasaki J1,4, Naoki K1: Cancer Manag Res 2020/6; 12: 4911-21. (堜愳丂憦1, 彫栰懽暯1, 妢搰恀巙1, 崃绯塸柧1, 暉堜朁栫1, 嶰摗丂媣2, 墶応惓揟3, 媣曐揷彑3, 曅嬎恀恖3, 嵅乆栘帯堦榊1,4, 桺栘崕旻1: 1屇媧婍撪, 2娕岇妛晹, 3堛椕塹惗妛晹, 4怴悽婭堛椕丒墶抐揑堛椕)
110195. [尨挊] Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma. Nagashio R1, Kuchitsu Y1, Igawa S2, Kusuhara S2, Naoki K2, Satoh Y3, Ichinoe M4, Murakumo Y4, Saegusa M4, Sato Y1: Biomed Res 2020/6; 41 (3): 149-59. (挿墫丂椇1, 媭捗桳婭1, 堜愳丂憦2, 擁尨惌堦榊2, 桺栘崕旻2, 嵅摗擵弐3, 堦屗徆柧4, 懞塤朏庽4, 嶰巬丂怣4, 嵅摗梇堦1: 1堛椕塹惗妛晹, 2屇媧婍撪, 3屇媧婍奜, 4昦棟)
110196. [尨挊] Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors. Ono T1, Igawa S1, Kurahayashi S1, Okuma Y1, Sugimoto A1, Kusuhara S1, Ozawa T1, Fukui T1, Sasaki J1,2, Mitsufuji H3, Yokoba M4, Kubota M4, Katagiri M4, Naoki K1: Invest New Drugs 2020/6; 38 (3): 885-93. (彫栰懽暯1, 堜愳丂憦1, 憅椦怲懢榊1, 戝孎桭棞巕1, 悪杮丂棔1, 擁尨惌堦榊1, 彫郪婱桾1, 暉堜朁栫1, 嵅乆栘帯堦榊1,2, 嶰摗丂媣3, 墶応惓揟4, 媣曐揷彑4, 曅嬎恀恖4, 桺栘崕旻1: 1屇媧婍撪, 2怴悽婭堛椕丒墶抐揑堛椕, 3娕岇妛晹, 4堛椕塹惗妛晹)
110197. [尨挊] Survival and prognostic factors in elderly patients receiving second-line chemotherapy for relapsed small-cell lung cancer: Results from the Japanese Joint Committee of Lung Cancer Registry. Igawa S1, Naoki K1, Shintani Y, Sekine I, Shukuya T, Takayama K, Inoue A, Okamoto I, Kiura K, Takahashi K, Yamamoto N, Takiguchi Y, Miyaoka E, Okumura M, Yoshino I: Lung Cancer 2020/8; 146: 160-4. (堜愳丂憦1, 桺栘崕旻1: 1屇媧婍撪)
110198. [尨挊] Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab. Fukui T1, Hosotani S1, Soda I2, Ozawa T1, Kusuhara S1, Kakegawa-I M1, Kasajima M1, Hiyoshi Y1, Igawa S1, Yokoba M3, Mitsufuji H4, Kubota M3, Katagiri M3, Sasaki J1,5, Ishiyama H2, Naoki K3: Thorac Cancer 2020/8; 11 (4): 1005-14. (暉堜朁栫1, 嵶扟恀巌1, 憗揷丂奿2, 彫郪婱桾1, 擁尨惌堦榊1, 妡愳枹婓巕1, 妢搰恀巙1, 擔媑峃峅1, 堜愳丂憦1, 墶応惓揟3, 嶰摗丂媣4, 媣曐揷彑3, 曅嬎恀恖3, 嵅乆栘帯堦榊1,5, 愇嶳攷瀶2, 桺栘崕旻1: 3屇媧婍撪, 2曻幩慄 (庮釃), 3堛椕塹惗妛晹, 4娕岇妛晹, 5怴悽婭堛椕丒墶抐揑堛椕)
110199. [尨挊] Intracellular levels of reactive oxygen species correlate with ABT-263 sensitivity in non-small-cell lung cancer cells. Ohgino K, Terai H, Yasuda H, Nukaga S, Hamamoto J, Tani T, Kuroda A, Arai D, Ishioka K, Masuzawa K, Ikemura S, Kawada I, Naoki K1, Fukunaga K, Soejima K: Cancer Sci 2020/10; 111 (10): 3793-801. (桺栘崕旻1: 1屇媧婍撪)
110200. [尨挊] MET amplification results in heterogeneous responses to osimertinib in EGFR-mutant lung cancer treated with erlotinib. Nishiyama A, Takeuchi S, Adachi Y, Otani S1, Tanimoto A, Sasaki M, Matsumoto S, Goto K, Yano S: Cancer Sci 2020/10; 111 (10): 3813-23. (戝扟嶇巕1: 1屇媧婍撪)
110201. [尨挊] Comparison between quantitative computed tomography, scintigraphy, and anatomical methods for prediction of postoperative FEV 1 and DLCO: effects of chronic obstructive pulmonary disease status and resected lobes. Yokoba M1, Ichikawa T, Harada S2, Shiomi K3, Mikubo M3, Ono M3, Sonoda D2, Satoh Y3, Hanawa H, Naoki K4, Katagiri M1: J Thorac Dis 2020/10; 12 (10): 5269-80. (墶応惓揟1, 尨揷恀栫2, 墫尒丂榓3, 嶰孍彨巎3, 彫栰尦巏3, 墍揷丂戝3, 嵅摗擵弐3, 桺栘崕旻4, 曅嬎恀恖1: 1堛椕塹惗妛晹, 2戝妛堾堛椕宯尋媶壢, 3屇媧婍奜, 4屇媧婍撪)
110202. [尨挊] Serum immune modulators during the first cycle of anti-PD-1 antibody therapy in non-small cell lung cancer: Perforin as a biomarker. Ota T, Fukui T1, Nakahara Y1, Takeda T, Uchino J, Mouri T, Kudo K, Nakajima S, Suzumura T, Fukuoka M: Thorac Cancer 2020/11; 11 (11): 3223-33. (暉堜朁栫1, 拞尨慞楴1: 1屇媧婍撪)
110203. [尨挊] Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer. Igawa S1, Ono T1, Kasajima M1, Kusuhara S1, Otani S1, Fukui T1, Yokoba M2, Kubota M2, Katagiri M2, Mitsufuji H3, Sasaki J1,4, Naoki K1: Invest New Drugs 2020/12; 38 (6): 1906-14. (堜愳丂憦1, 彫栰懽暯1, 妢搰恀巙1, 擁尨惌堦榊1, 戝扟嶇巕1, 暉堜朁栫1, 墶応惓揟2, 媣曐揷彑2, 曅嬎恀恖2, 嶰摗丂媣3, 嵅乆栘帯堦榊1,4, 桺栘崕旻1: 1屇媧婍撪, 2堛椕塹惗妛晹, 3娕岇妛晹, 4怴悽婭堛椕丒墶抐揑堛椕)
110204. [尨挊] Suppression of interleukin-6 gene expression and protein production by mechanical stretching combined with weak, PEEP-like stretching of human pulmonary artery endothelial cells. Kobayashi K1, Kokubo K2, Inaoka H2, Noshiro M, Kubota M1, Kobayashi H1: Kitasato Med J 2021/3; 51 (1): 24-31. (彫椦偙偢宐1, 彫媣曐尓堦2, 堫壀廏烕2, 栰忛恀棟2, 媣曐揷彑1, 彫椦峅桽1: 1堛椕塹惗妛晹, 2戝妛堾堛椕宯尋媶壢)
520006. [憤愢] 彫嵶朎攛娻偺帯椕. 堜愳丂憦1, 埳摗峅婭1, 娫拞攷栫1, 彫栰懽暯1, 桺栘崕旻1 (1屇媧婍撪): 杒棦堛妛 2020/12; 50 (2): 69-75.
[挊丂彂]
620033. [妛弍彂 (暘扴幏昅)]亂恌抐偲帯椕偺庤媄亅恌嶡幒偙傟1嶜亅(恌抐偲帯椕 2021擭 Vol.109 No.憹姧崋)亃戞1晹恌抐丂戞3復椪彴専嵏丂13 嫻悈強尒, p.184-7. 桺栘崕旻 (屇媧婍撪), 恌抐偲帯椕幮, 搶嫗, 2021/3敪峴.
[妛夛丒尋媶夛摍]
713028. [妛夛 (崙嵺)] (堦斒島墘) Evaluation of blood cell adhesion and solute removal performance by an ex vivo experiment of a polysulfone hemofilter using an NV polymer membrane for continuous renal replacement therapy. Kurihara Y, Ueki S, Kobayashi K, Kokubo K, Kobayashi H, Kubota M1: 57th ERA-EDTA Virtual Congress (2020/6/6), Web奐嵜. (媣曐揷彑1: 1堛椕塹惗妛晹)
713029. [妛夛 (崙嵺)] (堦斒島墘) Lung expansion and alternation of low attenuation volume in lobectomized patients. Yokoba M1, Ichikawa T, Harada S2, Ozawa T3, Kusuhara S3, Fukui T3, Igawa S3, Mitsufuji H4, Kubota M1, Sasaki J3,5, Naoki K3, Sato Y1, Katagiri M1: ERS International Congress 2020 (2020/9/5-9), WEB奐嵜, European Respiratory Journal 2020; 56: (Suppl 64): 3129. (墶応惓揟1, 尨揷恀栫2, 彫郪婱桾3, 擁尨惌堦榊3, 暉堜朁栫3, 堜愳丂憦3, 嶰摗丂媣4, 媣曐揷彑1, 嵅乆栘帯堦榊3,5, 桺栘崕旻3, 嵅摗梇堦1, 曅嬎恀恖1: 1堛椕塹惗妛晹, 2戝妛堾堛椕宯尋媶壢, 3屇媧婍撪, 4娕岇妛晹, 5怴悽婭堛椕丒墶抐揑堛椕)
713030. [妛夛 (崙嵺)] (堦斒島墘) A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, nonsmall cell lung cancer (TORG1632). Igawa S1, Noro R, Kubota K, Naoki K, Bessho A, Hirose T, Shimokawa T, Nakashima M, Minato K, Seki N, Tokito T, Harada T, Sasada S, Miyamoto S, Tanaka Y, Furuya N, Kaburagi T, Hayashi H, Lihara H, Okamoto H: ESMO Asia Virtual Congress 2020 (2020/11/20), Web奐嵜. (堜愳丂憦1: 1屇媧婍撪)
713031. [妛夛 (崙嵺)] (堦斒島墘) Impact of Neutrophil-to-Lymphocyte Ratio in Patients with EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibitors. Ono T1, Igawa S1, Yamada K1, Kameda A1, Oguri A1, Yamamoto H1, Manabe H1, Ozawa T1, Kusuhara S1, Kasajima M1, Kakegawa M1, Otani S1, Fukui T1, Sasaki J1,2, Naoki K1: IASLC 2020 WCLC World Conference on Lung Cancer (2021/1/28-31), WEB奐嵜. (彫栰懽暯1, 堜愳丂憦1, 嶳揷孫棞1, 婽揷杻嵤幚1, 彫孖柧恖1, 嶳杮峗婱1, 崃绯塸柧1, 彫郪婱桾1, 擁尨惌堦榊1, 妢搰恀巙1, 妡愳枹婓巕1, 戝扟嶇巕1, 暉堜朁栫1, 嵅乆栘帯堦榊1,2, 桺栘崕旻1: 1屇媧婍撪, 2怴悽婭堛椕丒墶抐揑堛椕)
713032. [妛夛 (崙嵺)] (堦斒島墘) Dynamic Risk Prediction for Disease Control With Nivolumab in Advanced or Recurrent Non-Small Cell Lung Cancer Patients (NewEpoch). Fukui T1, Igawa S1, Goto Y, Yoh K, Hosomi Y, Kato T, Usui K, Hirano K, Tanaka H, Saito R, Bessho A, Aono H, Tamura A, Ohashi Y, Taguri M, Sasaki J1,2, Naoki K1, Kunitoh H: IASLC 2020 WCLC World Conference on Lung Cancer (2021/1/28-31), WEB奐嵜. (暉堜朁栫1, 堜愳丂憦1, 嵅乆栘帯堦榊1,2, 桺栘崕旻1: 1屇媧婍撪, 2怴悽婭堛椕丒墶抐揑堛椕)
713033. [妛夛 (崙嵺)] (堦斒島墘) Real-world experience of the utility in afatinib therapy for patients with EGFR-mutant advanced NSCLC. Igawa S1, Ono T1, Kasajima M1, Yamada K1, Oguri A1, Kameda A1, Yamamoto H1, Kakegawa M1, Hiyoshi Y1, Kusuhara S1, Ozawa T1, Otani S1, Fukui T1, Kubota M2, Yokoba M2, Katagiri M2, Mitsufuji H3, Sasaki J1,4, Naoki K1: IASLC 2021 World Conference on Lung Cancer (2021/1/29), Singapore. (堜愳丂憦1, 彫栰懽暯1, 妢搰恀巙1, 嶳揷孫棞1, 彫孖柧恖1, 婽揷杻嵤幚1, 嶳杮峗婱1, 妡愳枹婓巕1, 擔媑峃峅1, 擁尨惌堦榊1, 彫郪婱桾1, 戝扟嶇巕1, 暉堜朁栫1, 媣曐揷彑2, 墶応惓揟2, 曅嬎恀恖2, 嶰摗丂媣3, 嵅乆栘帯堦榊1,4, 桺栘崕旻1: 1屇媧婍撪, 2堛椕塹惗妛晹, 3娕岇妛晹, 4怴悽婭堛椕丒墶抐揑堛椕)
722048. [妛夛 (慡崙)] (嫵堢島墘) 攛娻. 桺栘崕旻 (屇媧婍撪): 戞58夞擔杮娻帯椕妛夛妛弍廤夛 (2020/10/23), 嫗搒 (僴僀僽儕僢僪奐嵜).
722049. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) PS晄椙徢椺偵懳偡傞栻暔椕朄乣嵶朎忈奞惈峈偑傫嵻偺娤揰偐傜乣. 巗愳桋巕, 暿強徍岹, 壀杮峗柧, 桺栘崕旻1, 嵶尒岾惗, 娾郪弐堦榊, 帪擟崅復, 娭丂弴旻 (1屇媧婍撪): 戞61夞擔杮攛娻妛夛妛弍廤夛 (2020/11/14), 壀嶳 (僴僀僽儕僢僪奐嵜).
723163. [妛夛 (慡崙)] (堦斒島墘) EGFR-TKI掞峈惈偺T790M梲惈NSCLC偵偍偗傞僆僔儊儖僠僯僽偺堚揱巕曄堎僞僀僾暿偺岠壥偺専摙 (慜岦偒娤嶡尋媶). 憅椦怲懢榊1, 堜愳丂憦1, 戝孎桭棞巕1, 悪揷宨桟1, 彫栰懽暯1, 悪杮丂棔1, 慮崻塸擵1, 嵶扟恀巌1, 暉堜朁栫1, 媣曐揷彑2, 嶰摗丂媣3, 桺栘崕旻1 (1屇媧婍撪, 2堛椕塹惗妛晹, 3娕岇妛晹): 戞43夞擔杮屇媧婍撪帇嬀妛夛妛弍廤夛 (2020/6/26), 巻忋奐嵜.
723164. [妛夛 (慡崙)] (堦斒島墘) 擕娻弍屻曻幩慄徠幩屻偵敪徢偟TBLB偵偰恌抐偟偨婍幙壔攛墛偺堦椺. 彫栰懽暯1, 嶰摗丂媣2, 崃绯塸柧1, 嶳杮峗婱1, 敧忋桳棦1, 埳摗峅婭1, 彫郪婱桾1, 擁尨惌堦榊1, 擔媑峃峅1, 妢搰恀巙1, 妡愳枹婓巕1, 暉堜朁栫1, 堜愳丂憦1, 媣曐揷彑3, 桺栘崕旻1 (1屇媧婍撪, 2娕岇妛晹, 3堛椕塹惗妛晹): 戞43夞擔杮屇媧婍撪帇嬀妛夛妛弍廤夛 (2020/6/27), 巻忋奐嵜.
723165. [妛夛 (慡崙)] (堦斒島墘) 僆僔儊儖僠僯僽搳梌屻偺怱寣娗僀儀儞僩偵娭偡傞専摙. 崃绯塸柧1, 妡愳枹婓巕1, 嶳杮峗婱1, 敧忋桳棦1, 埳摗峅婭1, 擔媑峃岹1, 暉堜朁栫1, 堜愳丂憦1, 嵅乆栘帯堦榊1,2, 桺栘崕旻1 (1屇媧婍撪, 2怴悽婭堛椕丒墶抐揑堛椕): 堛妛惗丒尋廋堛偺擔杮撪壢妛夛偙偲偼偠傔2020 (戞117夞擔杮撪壢妛夛憤夛丒島墘夛), (2020/8/8), Web奐嵜.
723166. [妛夛 (慡崙)] (堦斒島墘) EGFR-TKI掞峈惈偺T790M梲惈NSCLC偵偍偗傞僆僔儊儖僠僯僽偺堚揱巕曄堎僞僀僾暿偺岠壥偺専摙 (慜岦偒娤嶡尋媶). 埳摗峅婭1, 彫栰懽暯1, 堜愳丂憦1, 敧忋桳棦1, 崃绮塸柧1, 嶳杮峗婱1, 暉堜朁栫1, 嶰摗丂媣2, 嵅乆栘帯堦榊1,3, 媣曐揷彑4, 桺栘崕旻1 (1屇媧婍撪, 2娕岇妛晹, 3怴悽婭堛椕丒墶抐揑堛椕, 4堛椕塹惗妛晹): 戞60夞擔杮屇媧婍妛夛妛弍島墘夛 (2020/9/21), Web奐嵜.
723167. [妛夛 (慡崙)] (堦斒島墘) 攛梩愗彍弍巤峴攛娻姵幰偺巆懚攛婡擻梊應抣偺愗彍攛梩暿斾妑. 墶応惓揟1, 巗愳丂婤, 尨揷恀栫2, 嵅摗擵弐3, 桺栘崕旻4, 曅嬎恀恖1 (1堛椕塹惗妛晹, 2戝妛堾堛椕宯尋媶壢, 3屇媧婍奜, 4屇媧婍撪): 戞60夞擔杮屇媧婍妛夛妛弍島墘夛, (2020/9/21), WEB奐嵜.
723168. [妛夛 (慡崙)] (堦斒島墘) 僟僀傾儔僀僓偺in vitro惈擻昡壙偵偍偗傞暘巕検3枩椞堟偺儅乕僇暔幙偺専摙. 彫媣曐尓堦1, 孖尨壚岶, 廳揷岲旤, 嬥揷捈恖, 彫椦偙偢宐1, 媣曐揷彑1 (1堛椕塹惗妛晹): 戞26夞擔杮HDF堛妛夛妛弍廤夛丒憤夛 (2020/10/10), Web奐嵜.
723169. [妛夛 (慡崙)] (堦斒島墘) 寢妀惈嫻枌墛偱偺攟梴梲惈棪岦忋偵偍偗傞嬊強杻悓壓嫻峯嬀専嵏偺桳梡惈. 彫郪婱桾1, 嶰摗丂媣2, 崃绯塸柧1, 嶳杮峗婱1, 敧忋桳棦1, 奓捤愰庽1, 埳摗峅婭1, 戝峕弐懢榊, 戝孎桭棞巕1, 悪杮丂棔1, 憅椦怲懢榊1, 彫栰懽暯1, 尨揷恀栫3, 擁尨惌堦榊1, 擔媑峃峅1, 妢搰恀巙1, 妡愳枹婓巕1, 暉堜朁栫1, 堜愳丂憦1, 墶応惓揟4, 嵅乆栘帯堦榊1,5, 媣曐揷彑4, 曅嬎恀恖4, 桺栘崕旻1 (1屇媧婍撪, 2娕岇妛晹, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹, 5怴悽婭堛椕丒墶抐揑堛椕): 戞95夞擔杮寢妀丒旕寢妀惈峈巁嬠徢妛夛憤夛丒妛弍島墘夛 (2020/10/11-12), Web奐嵜.
723170. [妛夛 (慡崙)] (堦斒島墘) 婛帯椕崅楊恑揥宆彫嵶朎攛娻姵幰傊偺傾儉儖價僔儞扨嵻椕朄偺椪彴岠壥偵偮偄偰偺専摙. 崃绯塸柧1, 堜愳丂憦1, 嶳杮峗婱1, 敧忋桳棦1, 戝扟嶇巕1, 暉堜朁栫1, 墶応惓揟2, 嶰摗丂媣3, 媣曐揷彑2, 曅嬎恀恖2, 嵅乆栘帯堦榊1,4, 桺栘崕旻1 (1屇媧婍撪, 2堛椕塹惗妛晹, 3娕岇妛晹, 4怴悽婭堛椕丒墶抐揑堛椕): 戞61夞擔杮攛娻妛夛妛弍廤夛 (2020/11/12), 壀嶳 (僴僀僽儕僢僪奐嵜).
723171. [妛夛 (慡崙)] (堦斒島墘) EGFR堚揱巕曄堎梲惈恑峴旕彫嵶朎攛娻偵懳偡傞掅梡検傾僼傽僠僯僽偺戞嘦憡帋尡: TORG1632帋尡. 暿強徍岹, 栰楥椦懢榊, 攡栰婱桾, 桺栘崕旻1, 堜愳丂憦1, 淎悾丂宧, 懞揷懽婯, 壓愳峆惗, 拞浉尗彯, 柀丂峗堦, 娭丂弴旻, 帪擟崅復, 尨揷晀擵, 嶚揷恀帬, 椦丂廏庽, 斞尨戝柅, 壀杮峗柧, 媣曐揷奭 (1屇媧婍撪): 戞61夞擔杮攛娻妛夛妛弍廤夛 (2020/11/12), 壀嶳 (僴僀僽儕僢僪奐嵜).
723172. [妛夛 (慡崙)] (堦斒島墘) 嬊強恑峴旕彫嵶朎攛娻姵幰偵偍偗傞壔妛曻幩慄椕朄屻偺憗婜憹埆偍傛傃挿婜惗懚偵娭傢傞場巕偺専摙. 嶳杮峗婱1, 暉堜朁栫1, 戝孎桭棞巕1, 彫栰懽暯1, 憅椦怲懢榊1, 悪杮丂棔1, 悪揷宨桟1, 彫郪婱桾1, 擁尨惌堦榊1, 尨揷恀栫2, 妡愳枹婓巕1, 妢搰恀巙1, 戝扟嶇巕1, 堜愳丂憦1, 嵅乆栘帯堦榊1,3, 桺栘崕旻1 (1屇媧婍撪, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞61夞擔杮攛娻妛夛妛弍廤夛 (2020/11/12), 壀嶳 (僴僀僽儕僢僪奐嵜).
723173. [妛夛 (慡崙)] (堦斒島墘) Impact of EGFR genotype on efficacy of Osimertinib in patients with NSCLC: A prospective observational study. 嶳揷孫棞1, 堜愳丂憦1, 彫栰懽暯1, 妢搰恀巙1, 彫孖柧恖1, 婽揷杻嵤幚1, 嶳杮峗婱1, 妡愳枹婓巕1, 擔媑峃峅1, 擁尨惌堦榊1, 彫郪婱桾1, 戝扟嶇巕1, 暉堜朁栫1, 墶応惓揟2, 媣曐揷彑2, 曅嬎恀恖2, 嶰摗丂媣3, 嵅乆栘帯堦榊1,4, 桺栘崕旻1 (1屇媧婍撪, 2堛椕塹惗妛晹, 3娕岇妛晹, 4怴悽婭堛椕丒墶抐揑堛椕): 戞18夞擔杮椪彴庮釃妛夛妛弍廤夛 (2021/2/18), Web奐嵜.
733035. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 峔壒忈奞丒殝壓忈奞偱敪尒偝傟偨Collett-Sicard Syndrome崌暪攛態娻偺堦椺. 戝孎桭棞巕1, 擁尨惌堦榊1, 婽揷杻嵤幚1, 嶳杮峗婱1, 慮崻塸擵1, 彫栰懽暯1, 憅椦怲懢榊1, 妡愳枹婓巕1, 戝扟嶇巕1, 暉堜朁栫1, 堜愳丂憦1, 墶応惓揟2, 嵅乆栘帯堦榊1,3, 嶰摗丂媣4, 媣曐揷彑2, 曅嬎恀恖2, 桺栘崕旻1 (1屇媧婍撪, 2堛椕塹惗妛晹, 3怴悽婭堛椕丒墶抐揑堛椕, 4娕岇妛晹): 戞179夞擔杮寢妀丒旕寢妀惈峈巁嬠徢妛夛娭搶巟晹妛夛/戞243夞擔杮屇媧婍妛夛娭搶抧曽夛崌摨妛夛 (2021/2/13), Web奐嵜.
733036. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 鋁旜晹鋁娻偵懳偡傞EUS-FNA屻偵鋁惈嫻悈傪偒偨偟偨1椺. 彫孖柧恖1, 嶳揷孫棞1, 敧忋桳棦1, 悪揷宨桟1, 悪杮丂棔1, 彫郪婱桾1, 妡愳枹婓巕1, 妢搰恀巙1, 戝扟嶇巕1, 暉堜朁栫1, 堜愳丂憦1, 墶応惓揟2, 嵅乆栘帯堦榊1,3, 嶰摗丂媣4, 媣曐揷彑2, 曅嬎恀恖2, 桺栘崕旻1 (1屇媧婍撪, 2堛椕塹惗妛晹, 3怴悽婭堛椕丒墶抐揑堛椕, 4娕岇妛晹): 戞179夞擔杮寢妀丒旕寢妀惈峈巁嬠徢妛夛娭搶巟晹妛夛/戞243夞擔杮屇媧婍妛夛娭搶抧曽夛崌摨妛夛 (2021/2/13), Web奐嵜.
733037. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 暊枌攄庬偱弍屻嵞敪偟偨BRAF堚揱巕曄堎梲惈攛娻偵懳偟僟僽儔僼僃僯僽/僩儔儊僠僯僽暪梡椕朄偑憈岠偟偨1椺. 敧忋桳棦1, 戝扟嶇巕1, 慮崻塸擵1, 悪杮丂棔1, 彫栰懽暯1, 暉堜朁栫1, 堜愳丂憦1, 媣曐揷彑2, 嵅乆栘帯堦榊1,3, 桺栘崕旻1 (1屇媧婍撪, 2堛椕塹惗妛晹, 3怴悽婭堛椕丒墶抐揑堛椕): 戞189夞擔杮攛娻妛夛娭搶巟晹妛弍廤夛 (2021/3/27), Web奐嵜.
撪暘斿戙幱撪壢妛
[妛弍榑暥]
110205. [尨挊] Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial. Johannsson G, Gordon MB, Rasmussen MH, Haokonsson IH, Karges W, Sv緍ke C, Tahara S, Takano K1, Biller BMK: J Clin Endocrinol Metab 2020/4; 105 (4): e1358-76. (崅栰岾楬1: 1撪暘斿戙幱撪)
110206. [尨挊] Use of Noncontact Infrared Skin Thermometer for Peripheral Arterial Disease Screening in Patients With and Without Diabetes. Hayashi A1, Shichiri M1: Angiology 2020/8; 71 (7): 650-7. (椦丂揘斖1, 幍棦崃媊1: 1撪暘斿戙幱撪)
110207. [尨挊] Short-term Change in Resting Energy Expenditure and Body Compositions in Therapeutic Process for Graves' Disease. Hayashi A1, Takano K1, Kawakami Y2, Hitomi M2, Ohata Y1, Suzuki A1, Kamata Y1, Shichiri M1: Intern Med 2020/8; 59 (15): 1827-33. (椦丂揘斖1, 崅栰岾楬1, 愳忋桰巕2, 恖尒杻旤巕2, 戝敥峃岹1, 楅栘峍柤1, 姍揷桾擇1, 幍棦崃媊1: 1撪暘斿戙幱撪, 2塰梴晹)
110208. [尨挊] Comparison of accuracy between flash glucose monitoring and continuous glucose monitoring in patients with type 2 diabetes mellitus undergoing hemodialysis. Matoba K1,2, Hayashi A1, Shimizu N1, Moriguchi I, Kobayashi N, Shichiri M1: J Diabetes Complications 2020/11; 34 (11): 107680. (揑応寬懢1,2, 椦丂揘斖1, 惔悈弴栫1, 幍棦崃媊1: 1撪暘斿戙幱撪, 2椪専妛)
110209. [尨挊] The effectiveness of growth hormone replacement on energy expenditure and body composition in patients with adult growth hormone deficiency. Momozono A1, Hayashi A2, Takano K1, Shichiri M1: Endocr J 2021/4; 68 (4): 469-75. doi: 10.1507/endocrj.EJ20-0644. Epub 2020 Dec 22. (搷墍丂柧1, 椦丂揘斖2, 崅栰岾楬1, 幍棦崃媊1: 1撪暘斿戙幱撪壢妛, 2椪専妛)
110210. [尨挊] Suprabasin-derived bioactive peptides identified by plasma peptidomics. Taguchi T1, Kodera Y, Oba K2, Saito T, Nakagawa Y, Kawashima Y, Shichiri M2: Sci Rep 2021/1; 11 (1): 1047. (揷岥丂朁1, 戝掚榓恖2, 幍棦崃媊2: 1戝妛堾堛椕宯尋媶壢, 2撪暘斿戙幱撪)
110211. [尨挊] Circulating prorenin: its molecular forms and plasma concentrations. Fujimoto K1, Kawamura S2, Bando S2, Kamata Y1, Kodera Y, Shichiri M1: Hypertens Res 2021/6; 44 (6): 674-684. doi: 10.1038/s41440-020-00610-0. Epub 2021 Feb 10. (摗杮榓幚1, 愳懞嵐桭婓2, 嶁搶丂宒2, 姍揷桾擇1, 幍棦崃媊1: 1撪暘斿戙幱撪, 2戝妛堾堛椕宯尋媶壢)
110212. [尨挊] Glucose-dependent insulinotropic polypeptide stimulates the release of a spectrum of biologically active proteins in human endothelial cells. Masaki T1, Shichiri M2: Kitasato Med J 2021/3; 51 (1): 42-8. (惓栘巏恖1, 幍棦崃媊2: 1戝妛堾堛椕宯尋媶壢, 2撪暘斿戙幱撪)
110213. [尨挊] Molecular components and concentrations of human serum prorenin. Kawamura S1, Fujimoto K2, Kamata Y2, Shichiri M2: Kitasato Med J 2021/3; 51 (1): 63-9. (愳懞嵐桭婓1, 摗杮榓幚2, 姍揷桾擇2, 幍棦崃媊2: 1戝妛堾堛椕宯尋媶壢, 2撪暘斿戙幱撪)
110214. [尨挊] Isolation and detection of cell surface angiotensin II receptor using chemical crosslinking. Sasaki S1, Taguchi T1, Kodera Y, Shichiri M2: Kitasato Med J 2021/3; 51 (1): 70-5. (嵅乆栘幯栫壛1, 揷岥丂朁1, 彫帥媊抝, 幍棦崃媊2: 1戝妛堾堛椕宯尋媶壢, 2撪暘斿戙幱撪)
521006. [夝愢] 婡擻惈恄宱撪暘斿庮釃偺恌抐偲撪暘斿徢忬偺撪壢帯椕. 崅栰岾楬 (撪暘斿戙幱撪): 徚壔婍丒娞憻撪壢 2020/7; 8 (1): 107-12.
[挊丂彂]
620034. [妛弍彂 (暘扴幏昅)]亂昦婥偲偔偡傝2020 婎慴偲幚慔Expert乫s Guide (栻嬊2020擭憹姧崋)亃10. 戙幱宯偺昦婥偲偔偡傝丂丒摐擜昦 (崌暪徢傪娷傓), p.886-900. 椦丂揘斖1, 幍棦崃媊1 (1撪暘斿戙幱撪), 撿嶳摪, 搶嫗, 2020/4敪峴.
[妛夛丒尋媶夛摍]
713034. [妛夛 (崙嵺)] (堦斒島墘) Once-weekly somapacitan in Japanese adults with growth hormone deficiency was well tolerated, with similar efficacy to daily growth hormone: a randomised trial. Otsuka F, Takahashi Y, Tahara S, Michael H?jby Rasmussen, Ogawa Y, Takano K1: 22nd European Congress of Endocrinology (ECE) 2020 (2020/9/5), WEB奐嵜. (崅栰岾楬1: 1撪暘斿戙幱撪)
722050. [妛夛 (慡崙)] (僔儞億僕僂儉) 鋁丒徚壔娗恄宱撪暘斿庮釃偵懳偡傞僜儅僩僗僞僠儞傾僫儘僌帯椕. 崅栰岾楬 (撪暘斿戙幱撪): 戞93夞擔杮撪暘斿妛夛妛弍憤夛 (2020/7/20), Web奐嵜.
723174. [妛夛 (慡崙)] (堦斒島墘) 慡恎偺嬝堔弅傪擣傔偨峛忬態拞撆惈儈僆僷僠乕偺堦椺. 摗搱丂椸1, 搚婒戩栫1, 巗愳棆巘1, 姍揷桾擇1, 崅栰岾楬1, 幍棦崃媊1 (1撪暘斿戙幱撪): 戞93夞擔杮撪暘斿妛夛妛弍憤夛 (2020/7/20-8/31), 昹徏 (Web奐嵜), 擔杮撪暘斿妛夛嶨帍 2020; 96 (1): 311.
723175. [妛夛 (慡崙)] (堦斒島墘) 僶僙僪僂昦偺壛椕拞偵懡敪惈娭愡墛偲僪働儖僶儞昦傪敪徢偟偨堦椺. 揷岥丂朁1, 惔悈弴栫2, 姍揷棞堖撨, 姍揷桾擇2, 崅栰岾楬2, 幍棦崃媊2 (1戝妛堾堛椕宯尋媶壢, 2撪暘斿戙幱撪): 戞63夞擔杮峛忬態妛夛妛弍廤夛 (2020/11/19-12/15), 撧椙 (Web奐嵜), 擔杮撪暘斿妛夛嶨帍 2020; 96 (1): 385.
723176. [妛夛 (慡崙)] (堦斒島墘) 峛忬態拞撆徢惈敀幙擼徢傪棃偟偨Basedow昦偺堦椺. 惔悈弴栫1, 搚婒戩栫1, 恵夑桾庽2, 揷岥丂朁3, 姍揷桾擇1, 崅栰岾楬1, 幍棦崃媊1 (1撪暘斿戙幱撪, 2擼恄宱撪, 3戝妛堾堛椕宯尋媶壢): 戞63夞擔杮峛忬態妛夛妛弍廤夛 (2020/11/19-12/15), 撧椙 (Web奐嵜), 擔杮撪暘斿妛夛嶨帍 2020; 96 (1): 385.
723177. [妛夛 (慡崙)] (堦斒島墘) 懕敪惈峛忬態婡擻掅壓徢傪摉弶媈偭偨桳捝惈嬝醶澒傪敽偆TSBAb梲惈偺尨敪惈峛忬態婡擻掅壓徢偺堦椺. 姍揷桾擇1, 惔悈弴栫1, 揷岥丂朁2, 姍揷棞堖撨, 巗愳棆巘1, 崅栰岾楬1, 幍棦崃媊1 (1撪暘斿戙幱撪, 2戝妛堾堛椕宯尋媶壢): 戞63夞擔杮峛忬態妛夛妛弍廤夛 (2020/11/19-12/15), 撧椙 (Web奐嵜), 擔杮撪暘斿妛夛嶨帍 2020; 96 (1): 385.
723178. [妛夛 (慡崙)] (堦斒島墘) GH曗廩椕朄偵傛傞娞憻撪帀朾傊偺岠壥傪IDEAL IQ朄傪梡偄偰昡壙偟偨専摙. 揷岥丂朁1, 崅栰岾楬2, 幍棦崃媊2 (1戝妛堾堛椕宯尋媶壢, 2撪暘斿戙幱撪): 戞31夞擔杮娫擼壓悅懱庮釃妛夛, (2021/2/19-28), 搶嫗 (Web奐嵜), 擔杮撪暘斿妛夛嶨帍 2021; 97 (1): 311.
733038. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 扽巁儕僠僂儉偵傛傞恡惈擜曵徢偑媈傢傟偨偑拞悤惈擜曵徢偲恌抐偟偨1椺. 捯丂丂桜1, 堦搰桼壛巕1, 栘懞崄棦1, 彫揷丂宒1, 淎悾惓弐1, 摗搱丂椸1, 楅栘峍柤1, 惔悈弴栫1, 巗愳棆巘1, 姍揷桾擇1, 崅栰岾楬1, 幍棦崃媊1 (1撪暘斿戙幱撪): 戞21夞擔杮撪暘斿妛夛娭搶峛怣墇巟晹妛弍廤夛 (2020/9/18-19), 怴妰 (Web奐嵜), 擔杮撪暘斿妛夛嶨帍 2020; 96 (1): 385.
733039. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僀儞僼儖僄儞僓僂僀儖僗A宆姶愼偵傛傞傕偺偑帵嵈偝傟偨寑徢1宆摐擜昦偺堦椺. 淎悾惓弐1, 楅栘梲旻1, 堦搰桼壛巕1, 巗愳棆巘1, 姍揷桾擇1, 崅栰岾楬1, 幍棦崃媊1 (1撪暘斿戙幱撪): 戞58夞擔杮摐擜昦妛夛娭搶峛怣墇抧曽夛 (2021/1/30-31), 搶嫗 (Web奐嵜), 摐擜昦 2021; 64 (8): 579.
733040. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 夝朥妛揑側堎忢傪擣傔偢恡擽釃傪偔傝曉偟偨2宆摐擜昦偺堦椺. 捯丂丂桜1, 搚婒戩栫1, 崅嫶樞巕, 摗搱丂椸1, 惔悈弴栫1, 楅栘峍柤1, 姍揷桾擇1, 崅栰岾楬1, 幍棦崃媊1 (1撪暘斿戙幱撪): 戞58夞擔杮摐擜昦妛夛娭搶峛怣墇抧曽夛 (2021/1/30-31), 搶嫗 (Web奐嵜), 摐擜昦 2021; 64 (8): 579.
'19擭搙埲慜暘
[挊丂彂]
'19-620006. [妛弍彂 (暘扴幏昅)]亂寣摐娗棟偺偨傔偺摐擜昦帯椕栻妶梡儅僯儏傾儖亃6復 僀儞僗儕儞偺巊偄曽丂6-7 帺屓寣摐應掕婍, CGM, CSII, SAP偺巊偄曽, p.185-90. 椦丂揘斖1, 幍棦崃媊1 (1撪暘斿戙幱撪), 曇: 帥撪峃晇, 敀愳丂弮, 拞奜堛妛幮, 搶嫗, 2020/3敪峴.
恡憻撪壢妛
[妛弍榑暥]
310019. [徢椺曬崘] A case of hemodialysis and steroid therapy for carbamazepine-induced eosinophilic granulomatosis with polyangiitis: a case report with literature review. Abe T1, Nishiyama K1, Yamazaki T1, Miyasaka R1, Honma Y1, Tominaga T1, Hashimoto K1, Masaki T1, Kamata F2, Kamata M1, Aoyama T1, Sano T1, Takeuchi Y1, Naito S1: Renal Replacement Therapy 2020/5; 26: Article number 6. (垻晹揘栫1, 惣嶳宨巕1, 嶳嶈戱栫1, 媨嶁棾攏1, 杮娫桭崄棦1, 晉塱戝巙1, 嫶杮宐巕1, 惓栘婱嫵1, 姍揷晣旤2, 姍揷恀棟巕1, 惵嶳搶屲1, 嵅栰丂棽1, 抾撪峃梇1, 撪摗惓媑1: 1恡憻撪, 2戝妛堾堛椕宯尋媶壢)
310020. [徢椺曬崘] Initiation of peritoneal dialysis in a patient with chronic renal failure associated with tetralogy of Fallot: a case report. Abe T1, Aoyama T1, Sano K1, Miyasaka R1, Yamazaki T1, Honma Y1, Tominaga H1, Ida M1, Arao A1, Sakakibara M1, Hashimoto K1, Takahashi H1, Sakai T1, Naito S1, Koitabashi T2, Sano T1, Takeuchi Y1: BMC Nephrol 2020/7; 21 (1): 277. (垻晹揘栫1, 惵嶳搶屲1, 嵅栰宨巕1, 媨嶁棾攏1, 嶳嶈戱栫1, 杮娫桭崄棦1, 晉塱戝巙1, 堜揷恀惗巕1, 峳旜丂嵤1, 嶅尨杻桭巕1, 嫶杮宐巕1, 崅嫶丂梱1, 庰堜寬巙1, 撪摗惓媑1, 彫斅嫶弐旤2, 嵅栰丂棽1, 抾撪峃梇1: 1恡憻撪, 2弞娐婍撪)
320003. [徢椺曬崘] COVID-19傪敪徢偟偨摐擜昦崌暪堐帩摟愅姵幰偺堦椺. 撪摗惓媑1, 愳懞嵐桼旤2, 榓揷払旻3, 嶳嶈戱栫1, 媨嶁棾攏1, 嵅栰宨巕1, 嶅尨杻桭巕1, 崅嫶丂椛1, 塱壀枹棃1, 惵嶳搶屲1, 嵅栰丂棽1, 崅嶳梲巕4, 抾撪峃梇1 (1恡憻撪, 2戝妛堾堛椕宯尋媶壢, 3銹尨昦丒姶愼撪, 4怴悽婭堛椕丒墶抐揑堛椕): 摟愅夛帍 2020/11; 53 (11): 567-72.
540023. [偦偺懠 (妛夛彺榐)]亂戞25夞擔杮暊枌摟愅堛妛夛亃崌暪徢 (姶愼徢): 暊枌摟愅娭楢姶愼徢偺憗婜敪徢偲摿挜. 垻晹揘栫1, 惵嶳搶屲1, 庰堜寬巎1, 撪摗惓媑1, 嵅栰丂棽1, 抾撪峃梇1 (1恡憻撪): 堓偲摟愅 2020/9; 89 (暿嶜): 220-1.
挊丂彂]
620035. [妛弍彂 (暘扴幏昅)]亂専嵏抣傪撉傓2020 (撪壢 Vol.125 No.4 2020擭4寧憹戝崋)亃19復帺屓柶塽専嵏丂峈巺媴懱婎掙枌峈懱 (峈GBM峈懱), p.878. 嵅栰丂棽1, 嶁杮彯搊2 (1恡憻撪, 2堛椕媄弍嫵堢), 撿峕摪, 搶嫗, 2020/4敪峴.
[妛夛丒尋媶夛摍]
723179. [妛夛 (慡崙)] (堦斒島墘) 摐帀幙GM3偵傛傞億僪僒僀僩曐岇岠壥. 嶳岥榓壴, 愳搰塱巕1, 嶳壓丂嫥, 撪摗惓媑1 (1恡憻撪): 戞63夞擔杮恡憻妛夛妛弍憤夛 (2020/8/20), 墶昹 (僴僀僽儕僢僪奐嵜).
723180. [妛夛 (慡崙)] (堦斒島墘) 僶儖僾儘巁偺峈僱僼儕儞峈懱桿摫惈FSGS梊杊丒帯椕岠壥. 撪摗惓媑1, 愇奯捈巕, 拠嶳尗堦, 愳搰塱巕1 (1恡憻撪): 戞63夞擔杮恡憻妛夛妛弍憤夛 (2020/8/20), 墶昹 (僴僀僽儕僢僪奐嵜).
723181. [妛夛 (慡崙)] (堦斒島墘) 僶儖僾儘巁偺峈懱桿摫惈憙忬巺媴懱峝壔徢 (FSGS) 梊杊丒帯椕岠壥偺専摙. 愳搰塱巕1, 愇奯捈巕, 拠嶳尗堦, 撪摗惓媑1 (1恡憻撪): 戞93夞擔杮惗壔妛夛戝夛 (2020/9/14), Web奐嵜.
723182. [妛夛 (慡崙)] (堦斒島墘) 怴婯枬惈恡憻昦儌僨儖摦暔偺夝愅. 嶳岥榓壴, 愳搰塱巕1, 愇奯捈巕, 塱崻戝姴, 嶳壓丂嫥, 撪摗惓媑1 (1恡憻撪): 戞93夞擔杮惗壔妛夛戝夛 (2020/9/16), Web奐嵜.
723183. [妛夛 (慡崙)] (堦斒島墘) 寣燋岎姺椕朄偲傾僫僼傿儔僉僔乕偵娭偡傞専摙. 垻晹揘栫1, 惵嶳搶屲1, 愳懞嵐桼旤2, 嶳嶈戱栫1, 嵅栰宨巕1, 媨嶁棾攏1, 嶅尨杻桭巕1, 庰堜寬巎1, 撪摗惓媑1, 嵅栰丂棽1, 抾撪峃梇1 (1恡憻撪, 2戝妛堾堛椕宯尋媶壢): 戞65夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2020/11/2), Web奐嵜.
723184. [妛夛 (慡崙)] (堦斒島墘) 暋悢嬠偵傛傞暊枌摟愅娭楢暊枌墛偺堦椺. 惣嶳宨巕1, 垻晹揘栫1, 愳懞嵐桼旤2, 嶅尨杻桭巕1, 媨嶁棾攏1, 嶳嶈戱栫1, 堜揷恀惗巕1, 庰堜寬巎1, 撪摗惓媑1, 惵嶳搶屲1, 嵅栰丂棽1, 抾撪峃梇1 (1恡憻撪, 2戝妛堾堛椕宯尋媶壢): 戞65夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2020/11/2), Web奐嵜.
733041. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 岲巁媴憹懡徢傪敽偆摟愅崲擄徢偺懳墳偵嬯椂偟偨堦椺. 嵅栰宨巕1, 崅嫶丂椛1, 愳懞嵐桼旤2, 嶅尨杻桭巕1, 媨嶁棾攏1, 嶳嶈戱栫1, 塱壀枹棃1, 庰堜寬巎1, 撪摗惓媑1, 惵嶳搶屲1, 嵅栰丂棽1, 抾撪峃梇1 (1恡憻撪, 2戝妛堾堛椕宯尋媶壢): 戞50夞擔杮恡憻妛夛搶晹妛弍戝夛 (2020/9/26-27), Web奐嵜.
733042. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 崅僩儕僌儕僙儕僪 (TG) 寣徢偵傛傞廳徢媫惈鋁墛偵懳偟偰寣燋岎姺椕朄偑桳岠偱偁偭偨3椺. 媨嶁棾攏1, 崅嫶丂椛1, 愳懞嵐桼旤2, 嶅尨杻桭巕1, 嵅栰宨巕1, 嶳嶈戱栫1, 塱壀枹棃1, 撪摗惓媑1, 惵嶳搶屲1, 嵅栰丂棽1, 抾撪峃梇1 (1恡憻撪, 2戝妛堾堛椕宯尋媶壢): 戞50夞擔杮恡憻妛夛搶晹妛弍戝夛 (2020/9/26-27), Web奐嵜.
733043. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 峈惗嵻娷桳僗僥儘僀僪奜梡栻偵偰擜嵶娗娫幙惈恡墛傪棃偟偨堦椺. 嶅尨杻桭巕1, 嵅栰丂棽1, 愳懞嵐桼旤2, 嵅栰宨巕1, 嶳嶈戱栫1, 媨嶁棾攏1, 塱壀枹棃1, 崅嫶丂椛1, 撪摗惓媑1, 惵嶳搶屲1, 抾撪峃梇1 (1恡憻撪, 2戝妛堾堛椕宯尋媶壢): 戞50夞擔杮恡憻妛夛搶晹妛弍戝夛 (2020/9/26-27), Web奐嵜.
733044. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 姡釢偺帯椕偱夵慞偟偨枌惈憹怋惈巺媴懱恡墛偺1椺. 嶳嶈戱栫1, 崅嫶丂椛1, 庰堜寬巎1, 愳懞嵐桼旤2, 嶅尨杻桭巕1, 嵅栰宨巕1, 媨嶁棾攏1, 塱壀枹棃1, 撪摗惓媑1, 惵嶳搶屲1, 嵅栰丂棽1, 抾撪峃梇1 (1恡憻撪, 2戝妛堾堛椕宯尋媶壢): 戞50夞擔杮恡憻妛夛搶晹妛弍戝夛 (2020/9/26-27), Web奐嵜.
733045. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怴婯億僪僒僀僩忈奞儌僨儖傪梡偄偨怴栻憂弌傊岦偗偰. 撪摗惓媑1, 愳搰塱巕1 (1恡憻撪): 2020擭搙戞8夞棟妛晹僙儈僫乕 (2020/12/22), 憡柾尨.
'19擭搙埲慜暘
[妛夛丒尋媶夛摍]
'19-733007. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怴婯抈敀擜帯椕栻奐敪偵岦偗偰乣怴偨側儌僨儖摦暔庽棫偐傜憂栻傪栚巜偡乣. 撪摗惓媑1, 愳搰塱巕1 (1恡憻撪): 戞12夞僾儘僌儗僗儗億乕僩夛媍 (2019/11/20), 憡柾尨.
銹尨昦丒姶愼撪壢妛
[妛弍榑暥]
110215. [尨挊] Serological comparison of systemic lupus erythematosus with neuropsychiatric lupus using synthetic nucleic acid antigens. Khatri S, Psaraftis N, Funaro A, Arinuma Y1, Fujieda Y, Mader S, J況gensen CD, Astakhova K: J Transl Autoimmun 2020/10; 3: 100068. (桳徖椙岾1: 1銹尨昦磹鯎�)
110216. [尨挊] Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study. Kameda H, Takeuchi T, Yamaoka K1, Oribe M, Kawano M, Zhou Y, Othman AA, Pangan AL, Asabe S, Kitamura S, Meerwein S, Tanaka Y: Rheumatology (Oxford) 2020/11; 59 (11): 3303-13. (嶳壀朚岹1: 1銹尨昦磹鯎�)
110217. [尨挊] Clinical and Microbiological Features of Asymptomatic SARS-CoV-2 Infection and Mild COVID-19 in Seven Crewmembers of a Cruise Ship. Hoshiyama T1, Wada T1, Nihonyanagi S2, Kameda R3, Yamaoka-Tojo M4, Fukuda M4, Ako J3, Yamaoka K1, Takayama Y5: Intern Med 2020/12; 59 (24): 3135-40. (惎嶳棽峴1, 榓揷払旻1, 擇杮桍怢2, 婽揷丂椙3, 搶瀶旤撧巕4, 暉揷椣栫4, 垻屆弫嵠3, 嶳壀朚岹1, 崅嶳梲巕5: 1銹尨昦丒姶愼撪, 2姶愼娗棟幒, 3弞娐婍撪, 4堛椕塹惗妛晹, 5怴悽婭堛椕丒墶抐揑堛椕)
310021. [徢椺曬崘] Three Novel COVID-19 Pneumonia Cases Successfully Treated With Lopinavir/Ritonavir. Wada T1, Shimode K1, Hoshiyama T1, Takayama Y2, Yamaoka K1: Front Med (Lausanne) 2020/5; 7: 241. (榓揷払旻1, 壓庤岞夘1, 惎嶳棽峴1, 崅嶳梲巕2, 嶳壀朚岹1: 1銹尨昦丒姶愼撪, 2怴悽婭堛椕丒墶抐揑堛椕)
310022. [徢椺曬崘] Haemophilus influenzae Non-type b Infection in an Adult Patient with Systemic Lupus Erythematosus. Hasegawa Y1, Arinuma Y2, Tanaka S2, Tono T2, Tanaka T2, Muramatsu T1, Kondo J1, Matsueda Y2, Hoshiyama T2, Wada T2, Takayama Y3, Yamaoka K2: Intern Med 2020/12; 59 (23): 3097-101. (挿扟愳桋峗1, 桳徖椙岾2, 揷拞廧柧2, 搶栰弐梞2, 揷拞抦庽2, 懞徏丂彔1, 嬤摗撜堦1, 徏巬丂桟2, 惎嶳棽峴2, 榓揷払旻2, 崅嶳梲巕3, 嶳壀朚岹2: 1戝妛堾堛椕宯尋媶壢, 2銹尨昦磹鯎�, 3怴悽婭堛椕丒墶抐揑堛椕)
310023. [徢椺曬崘] A case of anti-MDA5 antibody-positive dermatomyositis developing reversible cerebral vasospasm syndrome successfully treated by multi-immunosuppressant combination including mycophenolate mofetil. Muramatsu T1, Tono T2, Kanayama Y1, Hasegawa Y1, Kondo J1, Hoshiyama T2, Wada T2, Arinuma Y2, Tanaka S2, Yamaoka K2: Mod Rheumatol Case Rep 2021/1; 5 (1): 69-75. (懞徏丂彔1, 搶栰弐梞2, 嬥嶳朏榊1, 挿扟愳桋峗1, 嬤摗撜堦1, 惎嶳棽峴2, 榓揷払旻2, 桳徖椙岾2, 揷拞廧柧2, 嶳壀朚岹2: 1戝妛堾堛椕宯尋媶壢, 2銹尨昦磹鯎�)
510009. [憤愢] Developmental process in diffuse psychological/neuropsychiatric manifestations of neuropsychiatric systemic lupus erythematosus. Arinuma Y1, Yamaoka K1: Immunol Med 2021/3; 44 (1): 16-22. (桳徖椙岾1, 嶳壀朚岹1: 1銹尨昦磹鯎�)
522048. [島嵗]亂摿廤: 帺屓柶塽幘姵丒AIDS 偲DDS: 柶塽堎忢丒柶塽晄慡傊偺怴偟偄挧愴亃3. 帺屓柶塽幘姵帯椕偺敪揥偲壽戣. 嶳壀朚岹 (銹尨昦丒姶愼撪): Drug Delivery System 2020/11; 35 (5): 376-83.
522049. [島嵗]亂楢嵹: 巹偺帯椕亃儕僂儅僠惈懡敪嬝捝徢 (PMR). 嶳壀朚岹 (銹尨昦丒姶愼撪): 擔杮堛帠怴曬 2020/4; 5009: 47.
[挊丂彂]
620036. [妛弍彂 (暘扴幏昅)]亂娫幙惈攛幘姵恌椕儅僯儏傾儖 夵掶戞3斉亃IV 娫幙惈攛幘姵偺昦懺偲帯椕儅僯儏傾儖丂B 銹尨昦攛偲椶墢幘姵丂6. 崿崌惈寢崌慻怐昦 (MCTD), p.367-70. 榓揷払旻 (銹尨昦丒姶愼撪), 娔廋: 媣曐湪巏, 曇: 摗揷師榊, 婌幧応挬梇, 撿峕摪, 搶嫗, 2020/6敪峴.
[妛夛丒尋媶夛摍]
722051. [妛夛 (慡崙)] (僔儞億僕僂儉) COVID-19僷儞僨儈僢僋娐嫬壓偵偍偗傞僀儀儖儊僋僠儞堛巘庡摫帯尡偐傜尒偊偰偒偨壽戣. 嶳壀朚岹1, 榓揷払旻1, 栰拞旤榓2, 慜揷幚壴3, 孎扟梇帯4 (1銹尨昦丒姶愼撪, 2僌儘乕僶儖椪彴尋媶巟墖僙, 3栻嵻晹, 4椪彴尋媶丒僾儘僕僃僋僩): 擔杮椪彴帋尡妛夛戞12夞妛弍廤夛憤夛 (2021/2/12-13), WEB奐嵜, 僾儘僌儔儉丒彺榐廤 2021; p.72.
'19擭搙埲慜暘
[挊丂彂]
'19-620007. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓 2020擭斉丂巹偼偙偆帯椕偟偰偄傞亃戞14復 銹尨昦偍傛傃椶墢幘姵丂IgG4娭楢幘姵, p.903-4. 嶳壀朚岹 (銹尨昦丒姶愼撪), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒堦惉, 堛妛彂堾, 搶嫗, 2020/1敪峴.
擕態丒峛忬態奜壢妛
[妛弍榑暥]
110218. [尨挊] Anti-HER2 antibody therapy using gene-transduced adipocytes for HER2-positive breast cancer. Masuda T, Fujimoto H, Teranaka R, Kuroda M, Aoyagi Y, Nagashima T, Sangai T1, Takada M, Nakagawa A, Kubota Y, Yokote K, Ohtsuka M: Breast Cancer Res Treat 2020/4; 180 (3): 625-34. (嶰奒婱巎1: 1擕態丒峛忬態奜)
110219. [尨挊] The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs. Iwamoto T, Fujisawa T, Shien T, Araki K, Sakamaki K, Sangai T1, Kikawa Y, Takao S, Nishimura R, Takahashi M, Aihara T, Mukai H, Taira N: Breast Cancer 2020/9; 27 (5): 973-81. (嶰奒婱巎1: 1擕態丒峛忬態奜)
110220. [尨挊] Detection of Nonpalpable Tiny Axillary Lymph Nodes Surrounded by Adipose Tissue Using a Near-Infrared Camera. Akita S, Yamaji Y, Takeuchi N, Wakai K, Azuma K, Nakagawa A, Fujimoto H, Sangai T1, Nagashima T, Mitsukawa N, Ikehara Y: Lymphat Res Biol 2020/10; 18 (5): 455-63. (嶰奒婱巎1: 1擕態丒峛忬態奜)
[妛夛丒尋媶夛摍]
723185. [妛夛 (慡崙)] (堦斒島墘) AIRSEAL system巊梡偵傛傞姰慡嬀帇壓峛忬態庤弍偵偍偗傞帇栰僗僩儗僗寉尭岠壥. 抮揷壚巎, 釼摗宑岾, 墶揷岝墰1, 愬愇婭旻2, 搉绮徆旻3 (1戝妛堾堛椕宯尋媶壢, 2擕態丒峛忬態奜, 3杒棦戝妛杒棦尋媶強昦堾): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13-15), Web奐嵜.
723186. [妛夛 (慡崙)] (堦斒島墘) 弍慜壔妛椕朄傪巤峴偟偨僩儕僾儖僱僈僥傿僽擕娻偺嵞敪丒梊屻場巕偺専摙. 媏抮恀棟巕1, 彫嶁桖尗1, 揷拞梪巕, 墶揷岝墰2, 惣媨梞巎1, 壛摗丂峅1, 愬愇婭旻1 (1擕態丒峛忬態奜, 2戝妛堾堛椕宯尋媶壢): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13-15), Web奐嵜.
723187. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞BRACAnalysis偺専摙 The experience of BRACAnalysis system in our hospital. 榤扟旤撧1, 彫嶁桖尗1, 揷拞梪巕, 媏抮恀棟巕1, 惣媨梞巎1, 彫浉宑懢, 塇淎寬恗, 椦丂嫗巕1, 搰捗丂彨, 捗懞廏峃2, 崅揷巎抝3, 愬愇婭旻1 (1擕態丒峛忬態奜, 2斿擜婍, 3戝妛堾堛椕宯尋媶壢): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723188. [妛夛 (慡崙)] (堦斒島墘) 専恌僙儞僞乕偵偍偗傞愇奃壔昦曄偺昡壙偵偮偄偰偺専摙. 壀杮棽塸, 塇旜媊婸, 抸崻梲巕, 恄嶳懢榊, 垻晹丂朙, 埳搶柧旤, 崟娾旤奊, 撪嶳拤惗, 墱杮拤擵, 愬愇婭旻1 (1擕態丒峛忬態奜): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723189. [妛夛 (慡崙)] (堦斒島墘) 抝惈旕怹弫惈擷朎撪擕娻偺1椺. 斞捤旤崄, 堜忋弨恖, 媏抮恀棟巕1, 彫嶁桖尗1, 愬愇婭旻1 (1擕態丒峛忬態奜): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723190. [妛夛 (慡崙)] (堦斒島墘) 擕偑傫弍屻BMI30埲忋偺懳懁擕娻偺専摙. 椦丂嫗巕1, 榤扟旤撧1, 塇淎寬恗, 彫浉宑懢, 愬愇婭旻1 (1擕態丒峛忬態奜): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723191. [妛夛 (慡崙)] (堦斒島墘) 弍屻泓鈢儕儞僷愡嵞敪傪掓偟偨BRCA堚揱巕曄堎梲惈姵幰偵僆儔僷儕僽傪巊梡偟偨1椺. 惣媨梞巎1, 揷拞梪巕, 墶揷岝墰2, 媏抮恀棟巕1, 搰捗丂彨, 捗懞廏峃3, 壛摗丂峅1, 彫嶁桖尗1, 崅揷巎抝2, 愬愇婭旻1 (1擕態丒峛忬態奜, 2戝妛堾堛椕宯尋媶壢, 3斿擜婍): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723192. [妛夛 (慡崙)] (堦斒島墘) 懳懁儕僗僋掅尭擕朳愗彍弍傪峴偄丆旕怹弫惈擕娗娻偑敪尒偝傟偨堚揱惈擕娻棏憙娻徢岓孮偺1椺. 彫嶁桖尗1, 墶揷岝墰2, 揷拞梪巕, 媏抮恀棟巕1, 惣媨梞巎1, 榤扟旤撧1, 壛摗丂峅1, 妬揷嶇旤擳3, 搰捗丂彨, 捗懞廏峃4, 崅揷巎抝2, 愬愇婭旻1 (1擕態丒峛忬態奜, 2戝妛堾堛椕宯尋媶壢, 3昦棟, 4斿擜婍): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723193. [妛夛 (慡崙)] (堦斒島墘) TDM1 (僩儔僗僣僘儅僽僄儉僞儞僔儞) 偑挿婜憈岟偟偰偄傞1徢椺. 愬愇婭旻1, 撪摗壜撧巕2, 摗栰巎怐3, 揷拞梪巕, 媏抮恀棟巕1, 惣媨梞巎1, 壛摗丂峅1, 彫嶁桖尗1 (1擕態丒峛忬態奜, 2壓晹徚壔娗奜, 3戝妛堾堛椕宯尋媶壢): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723194. [妛夛 (慡崙)] (堦斒島墘) 傾儀儅僔僋儕僽偵傛傞娫幙惈攛墛傪擣傔偨1椺. 撪摗壜撧巕1, 媏抮恀棟巕2, 戝栘宑巕1, 墶揷岝墰3, 揷拞梪巕, 惣媨梞巎2, 壛摗丂峅2, 彫嶁桖尗2, 愬愇婭旻2 (1壓晹徚壔娗奜, 2擕態丒峛忬態奜, 3戝妛堾堛椕宯尋媶壢): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723195. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞傾儀儅僔僋儕僽偺巊梡宱尡. 戝栘宑巕1, 媏抮恀棟巕2, 撪摗壜撧巕1, 墶揷岝墰3, 揷拞梪巕, 惣媨梞巎2, 壛摗丂峅2, 彫嶁桖尗2, 愬愇婭旻2 (1壓晹徚壔娗奜, 2擕態丒峛忬態奜,3戝妛堾堛椕宯尋媶壢): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723196. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞擕娻弍慜壔妛椕朄偺岠壥丆嵞敪丆梊屻偵娭偡傞専摙. 媏抮恀棟巕1, 彫嶁桖尗1, 撪摗壜撧巕2, 戝栘宑巕2, 墶揷岝墰3, 揷拞梪巕, 惣媨梞巎1, 壛摗丂峅1, 愬愇婭旻1, 嶰奒婱巎1 (1擕態丒峛忬態奜, 2壓晹徚壔娗奜, 3戝妛堾堛椕宯尋媶壢): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723197. [妛夛 (慡崙)] (堦斒島墘) 僴僀儕僗僋偵弨偠偨僒乕儀僀儔儞僗夋憸専嵏偱嬊強嵞敪傪恌抐偟偨BRCA1 VUS曐帩幰擕娻偺徢椺. 拞捗愳抭巕, 嶰奒婱巎1, 摗杮峗巌, 崅揷丂岇, 嶅尨弤懢, 帥拞椇懢榊, 嶁揷帯恖, 挿搱丂寬 (1擕態丒峛忬態奜): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723198. [妛夛 (慡崙)] (堦斒島墘) 弍屻挿婜娫柍嵞敪惗懚拞偺恑峴婜擠怭娭楢擕娻偺1椺. 嶁杮梲夘, 崅揷丂岇, 帥拞椇懢榊, 嶅尨弤懢, 摗杮峗巌, 嶰奒婱巎1, 挿搱丂寬, 戝捤彨擵 (1擕態丒峛忬態奜): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723199. [妛夛 (慡崙)] (堦斒島墘) nab-PTX偺枛徑恄宱忈奞梊杊偵懳偡傞僼儘乕僘儞僌儘乕僽丆抏惈僗僩僢僉儞僌偵傛傞戞II憡帋尡 (SPOT帋尡). 攼梩嫥姲, 拞嶳婱姲, 嶰奒婱巎1, 怷杮丂戩, 敧廫搰岹峴, 嶳杮丂朙, 孎扟恀悷, 埨尨壛撧, 媑揷儈僫, 壀杮懽巕, 嶳拞抾弔, 戝栰恀巌, 憹揷怲嶰 (1擕態丒峛忬態奜): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723200. [妛夛 (慡崙)] (堦斒島墘) 擕娻廃弍婜壔妛椕朄偵偍偗傞敪擬惈岲拞媴悢尭彮徢偵娭偡傞慜岦偒挷嵏: CSPOR-BC Study. 惣懞廏婭, 愇愳丂岶, 嶁姫尠懢榊, 惉堜堦棽, 嶰奒婱巎1, 嬍忛尋懢榊, 挿扟愳慞巬, 搉绮寬堦, 悰徖怢峃, 岦堜攷暥 (1擕態丒峛忬態奜): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
堦斒丒彫帣丒娞抇鋁奜壢妛
[妛弍榑暥]
110027. [尨挊] EP3 signaling in dendritic cells promotes liver repair by inducing IL-13-mediated macrophage differentiation in mice. Nakamoto S1, Ito Y2, Nishizawa N3, Goto T1, Kojo K4, Kumamoto Y3, Watanabe M5, Narumiya S, Majima M2: FASEB J 2020/4; 34 (4): 5610-27. (拞杮廋巌1, 埳摗媊栫2, 惣郪怢嫳3, 屻摗戩栫1, 屆忛丂寷4, 孏尦梇夘3, 搉绮徆旻5, 攏搱惓棽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3堦斒丒彫帣丒娞抇鋁奜, 4壓晹徚壔娗奜, 5杒棦戝妛杒棦尋媶強昦堾)
110221. [尨挊] Validation and performance of three-level procedure-based classification for laparoscopic liver resection. Kawaguchi Y, Tanaka S, Fuks D, Kanazawa A, Takeda Y, Hirokawa F, Nitta H, Nakajima T, Kaizu T1, Kaibori M, Kojima T, Otsuka Y, Kubo S, Hasegawa K, Kokudo N, Kaneko H, Wakabayashi G, Gayet B: Surg Endosc 2020/5; 34 (5): 2056-66. (奀捗婱巎1: 1堦斒丒彫帣丒娞抇鋁奜)
110031. [尨挊] Lymphangiogenesis and accumulation of reparative macrophages contribute to liver repair after hepatic ischemia-reperfusion injury. Nakamoto S1, Ito Y2, Nishizawa N3, Goto T1, Kojo K4, Kumamoto Y3, Watanabe M5, Majima M2: Angiogenesis 2020/8; 23 (3): 395-410. (拞杮廋巌1, 埳摗媊栫2, 惣郪怢嫳3, 屻摗戩栫1, 屆忛丂寷4, 孏尦梇夘3, 搉绮徆旻5, 攏搱惓棽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3堦斒丒彫帣丒娞抇鋁奜, 4壓晹徚壔娗奜, 5杒棦戝妛杒棦尋媶強昦堾)
110222. [尨挊] Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN). Fujiyama Y1, Kumamoto Y2, Nishizawa N2, Nakamoto S1, Harada H3, Yokota K4, Tanaka Y, Igarashi K2, Oiki H, Okuwaki K5, Iwai T5, Kajita S6, Takahashi H7, Tajima H2, Kaizu T2, Sasaki J8, Watanabe M9, Yamashita K8: Ann Surg Oncol 2020/10; 27 (10): 4007-16. (摗嶳朏庽1, 孏尦梇夘2, 惣郪怢嫳2, 拞杮廋巌1, 尨揷岹婸3, 墶揷榓巕4, 屲廫棐堦惏2, 墱榚嫽夘5, 娾堜抦媣5, 妬揷嶇旤擳6, 崅嫶攷擵7, 揷搰丂峅2, 奀捗婱巎2, 嵅乆栘帯堦榊8, 搉绮徆旻9, 嶳壓宲巎8: 1戝妛堾堛椕宯尋媶壢, 2堦斒丒彫帣丒娞抇鋁奜, 3忋晹徚壔娗奜, 4壓晹徚壔娗奜, 5徚壔婍撪, 6昦棟, 7堛椕塹惗妛晹, 8怴悽婭堛椕丒墶抐揑堛椕, 9杒棦戝妛杒棦尋媶強昦堾)
110223. [尨挊] Assembling a library of typical surgery video clips to construct a system for assessing the surgical difficulty of laparoscopic cholecystectomy. Kurata M, Iwashita Y, Ohyama T, Endo I, Hibi T, Umezawa A, Suzuki K, Watanabe M, Asai K, Mori Y, Higashida M, Kumamoto Y1, Shindoh J, Yoshida M, Honda G, Misawa T, Abe Y, Nagakawa Y, Toyota N, Yamada S, Norimizu S, Matsumura N, Sata N, Sunagawa H, Ito M, Takeda Y, Nakamura Y, Rikiyama T, Higuchi R, Gocho T, Ueno K, Kumagai Y, Kanaji S, Takada T, Yamamoto M: J Hepatobiliary Pancreat Sci 2021/3; 28 (3): 255-62. (孏尦梇夘1: 1堦斒丒彫帣丒娞抇鋁奜)
120007. [尨挊] 嬌丒挻掅弌惗懱廳帣偺彫挵僗僩乕儅暵嵔弍偺帄揔帪婜偵娭偡傞専摙. 嶳杮桾婸1, 揷拞丂寜1,2, 弌壠嫓堦1, 捛栘岹愰1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 擔杮彫帣奜壢妛夛帍 2020/8; 56 (4): 365-9.
522050. [島嵗]亂摿廤: 彫帣奜壢堛偑廗摼偡傋偒専嵏亅庤媄偲恌抐亃媫惈拵悅墛 (暊晹扨弮X慄, 挻壒攇). 揷拞丂寜1,2, 弌壠嫓堦2, 搉晹桋榊2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 彫帣奜壢 2020/8; 52 (8): 841-5.
522051. [島嵗]亂摿廤: 彫帣奜壢傪傔偖傞偝傑偞傑側栤戣偲彨棃偺揥朷亃僩儔儞僕僔儑儞堛椕偺尰嫷偲壽戣. 旜壴榓巕, 揷晬桾巕, 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 彫帣奜壢 2021/1; 53 (1): 61-6.
522052. [島嵗]亂摿廤: 昁実! 奜彎偲奜壢幘姵傊偺懳墳亃[奺榑] 恦懍側敾抐傪昁梫偲偡傞幘姵丂媫惈拵悅墛: 嬞媫庤弍 vs interval appendectomy (慂岴惈, 擽釃宍惉惈). 揷拞丂寜1,2, 弌壠嫓堦2, 搉晹桋榊2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 彫帣撪壢 2021/2; 53 (2): 217-22.
540024. [偦偺懠 (捛搲暥)] 庤屗堦榊愭惗傪幟傫偱. 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 擔杮彫帣奜壢妛夛嶨帍 2020/8; 56 (4): 339-41.
[挊丂彂]
620037. [妛弍彂 (暘扴幏昅)]亂憗傢偐傝朌崌丒暙崌偺偡傋偰 (椪彴奜壢 Vol.75 No.11 2020擭10寧崋 (憹姧崋))亃仭4復弍幃暿偺朌崌丒暙崌朄丂鋁憻丂鋁亅嬻挵暙崌 奰揷朄, p.289-93. 孏尦梇夘1, 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 屲廫棐堦惏1, 拞杮廋巌2, 摗嶳朏庽2, 壀杮岝婩巕1, 嫜丂桾椇2 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢), 堛妛彂堾, 搶嫗, 2020/10敪峴.
620038. [妛弍彂 (暘扴幏昅)]亂僨傿儀乕僩偐傜妛傇弍幃偺墱媊丒庤媄偺旈實乵抇摴丒鋁憻曇乶亃僒乕僕僇儖僨傿儀乕僩6鋁嬻挵暙崌丂(2) 奰揷朄, p.155-64. 孏尦梇夘 (堦斒丒彫帣丒娞抇鋁奜), 曇: 敀愇寷抝 (庡姴), 杒愳桾媣, 怴揷峗岾, 嶳岥栁庽, 儊僕僇儖價儏乕幮 搶嫗, 2020/12敪峴.
620039. [妛弍彂 (暘扴幏昅)]亂崱擔偺彫帣帯椕巜恓 戞17斉亃戞13復 徚壔婍幘姵, 娞幘姵丂徚壔娗億儕乕僾丒億儕億乕僔僗, p.457-8. 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜), 憤曇廤: 悈岥丂夒, 巗嫶丂岝, 嶈嶳丂峅, 埳摗廏堦, 堛妛彂堾, 搶嫗, 2020/12敪峴.
620040. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓 2021擭斉丂巹偼偙偆帯椕偟偰偄傞亃戞23復 彫帣壢幘姵丂憀宎僿儖僯傾, 鋊僿儖僯傾, p.1485-6. 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒堦惉, 堛妛彂堾, 搶嫗, 2021/1敪峴.
[妛夛丒尋媶夛摍]
722052. [妛夛 (慡崙)] (彽懸島墘摍) 暊峯嬀壓宯摑揑娞愗彍偺昗弨壔偍傛傃偦偺埨慡惈. 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723201. [妛夛 (慡崙)] (堦斒島墘) CDO1堚揱巕DNA儊僠儖壔偵傛傞鋁娻怴婯恌抐朄偺桳梡惈偺専摙. 惣郪怢嫳1, 嶳壓宲巎2,3, 摗嶳朏庽4, 拞杮廋巌4, 媣曐擟巎1, 揷搰丂峅1, 奀捗婱巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3忋晹徚壔娗奜, 4戝妛堾堛椕宯尋媶壢): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/15), Web奐嵜.
723202. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓娞愗彍偵偍偗傞垷嬫堟埲忋娞愗彍偺埨慡惈亅扨巤愝450椺偺専摙. 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/15), Web奐嵜.
723203. [妛夛 (慡崙)] (堦斒島墘) 戝挵娻娞揮堏徢椺偵懳偡傞暊峯嬀壓庤弍偺埨慡惈亅117椺偺専摙亅. 摗嶳朏庽1, 奀捗婱巎2, 塱丂帬嫵, 拞杮廋巌1, 惣郪怢嫳2, 媣曐擟巎2, 揷搰丂峅2, 孏尦梇夘2 (1戝妛堾堛椕宯尋媶壢, 2堦斒丒彫帣丒娞抇鋁奜): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/15), Web奐嵜.
723204. [妛夛 (慡崙)] (堦斒島墘) 徚壔娗慂岴弍屻, 恖岺汨栧暵嵔弍屻偵恖岺汨栧汨栧懁偺彫挵嫹嶓偱嵞庤弍偑昁梫偲側偭偨挻掅弌惗懱廳帣偺1椺. 捛栘岹愰1, 揷拞丂寜1,2, 嶳杮桾婸1, 弌壠嫓堦1, 忋徏桼徆1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞57夞擔杮彫帣奜壢妛夛妛弍廤夛 (2020/9/19), 搶嫗 (僴僀僽儕僢僪奐嵜).
723205. [妛夛 (慡崙)] (堦斒島墘) 廃弍婜梊杊揑峈嬠栻偺搳梌婜娫偵偮偄偰偺専摙乣愭揤惈抇摴奼挘徢偵傛傞専徹乣. 弌壠嫓堦1, 揷拞丂寜1,2, 嶳杮桾婸1, 捛栘岹愰1, 忋徏桼徆1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞57夞擔杮彫帣奜壢妛夛妛弍廤夛 (2020/9/20), 搶嫗 (僴僀僽儕僢僪奐嵜).
723206. [妛夛 (慡崙)] (堦斒島墘) 怘摴暵嵔徢弍屻偺暙崌晹嫹嶓偺僽僕乕偱怘摴攛釕傪棃偟偨堦椺. 嶳杮桾婸1, 揷拞丂寜1,2, 弌壠嫓堦1, 捛栘岹愰1, 僂僢僪僴儉僗楁巕3 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕, 3曻幩慄 (夋憸)): 戞57夞擔杮彫帣奜壢妛夛妛弍廤夛 (2020/9/21), 搶嫗 (僴僀僽儕僢僪奐嵜).
723207. [妛夛 (慡崙)] (堦斒島墘) 擔楊49, 懱廳950g偱妺惣庤弍傪巤峴偟偨挻掅弌惗懱廳帣抇摴暵嵔徢偺1椺. 忋徏桼徆1, 揷拞丂寜1,2, 嶳杮桾婸1, 弌壠嫓堦1, 捛栘岹愰1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞57夞擔杮彫帣奜壢妛夛妛弍廤夛 (2020/9/21), 搶嫗 (僴僀僽儕僢僪奐嵜).
723208. [妛夛 (慡崙)] (堦斒島墘) 戝挵娻娫幙偵偍偗傞SPARC敪尰傪夘偟偨Wnt/兝-catenin宱楬妶惈壔偲墦妘揮堏婡彉偺夝柧. 摗嶳朏庽1, 拞杮廋巌1, 惣郪怢嫳2, 嫜丂桾椇1, 摗栰巎怐1, 屻摗戩栫1, 墶揷岝墰1, 揧栰岶暥1, 峛斻揷晲巙1, 墶揷榓巕, 彫浉宑懢, 撪摗丂崉3, 孏尦梇夘2, 嶳壓宲巎4,5 (1戝妛堾堛椕宯尋媶壢, 2堦斒丒彫帣丒娞抇鋁奜, 3壓晹徚壔娗奜, 4怴悽婭堛椕丒墶抐揑堛椕, 5忋晹徚壔娗奜): 戞79夞擔杮娻妛夛妛弍憤夛 (2020/10/1), 峀搰 (僴僀僽儕僢僪奐嵜).
723209. [妛夛 (慡崙)] (堦斒島墘) 挵夞揮堎忢徢拞挵幉擯揮傪敽偭偨怴惗帣堓攋楐偺堦椺. 懢揷丂椊1, 揷拞丂寜2,3, 嶳杮桾婸3, 弌壠嫓堦3, 捛栘岹愰3, 搉晹桋榊3 (1壓晹徚壔娗奜, 2怴悽婭堛椕丒愭抂堛椕, 3堦斒丒彫帣丒娞抇鋁奜): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/29-31), Web奐嵜.
723210. [妛夛 (慡崙)] (堦斒島墘) 戝挵娻娞揮堏偵懳偡傞暊峯嬀壓庤弍偺揔墳偵娭偡傞専摙. 摗嶳朏庽1, 奀捗婱巎2, 拞杮廋巌1, 塱丂帬嫵, 惣郪怢嫳2, 媣曐擟巎2, 揷搰丂峅2, 孏尦梇夘2 (1戝妛堾堛椕宯尋媶壢, 2堦斒丒彫帣丒娞抇鋁奜): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723211. [妛夛 (慡崙)] (堦斒島墘) 鋁娻偵懳偡傞暊峯嬀壓鋁懱旜晹愗彍偺帯椕惉愌偲庤弍庤媄偺岺晇. 惣郪怢嫳1, 揷搰丂峅1, 嫜丂桾椇2, 壀杮岝婩巕1, 摗嶳朏庽2, 媣曐擟巎1, 奀捗婱巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723212. [妛夛 (慡崙)] (堦斒島墘) C tube drainage against bile leakage in laparoscopic liver resection. 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞32夞擔杮娞抇鋁奜壢妛夛妛弍廤夛 (2021/2/24), Web奐嵜.
723213. [妛夛 (慡崙)] (堦斒島墘) Standardized of laparoscopic distal pancreatectomy and the ingenuity of the procedure. 揷搰丂峅1, 奀捗婱巎1, 惣郪怢嫳1, 媣曐擟巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞32夞擔杮娞抇鋁奜壢妛夛妛弍廤夛 (2021/2/24), Web奐嵜.
723214. [妛夛 (慡崙)] (堦斒島墘) Three anatomical landmarks in laparoscopic distal pancreatectomy for pancreatic cancer. 惣郪怢嫳1, 揷搰丂峅1, 摗嶳朏庽2, 拞杮廋巌2, 媣曐擟巎1, 奀捗婱巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜, 2戝妛堾堛椕宯尋媶壢): 戞32夞擔杮娞抇鋁奜壢妛夛妛弍廤夛 (2021/2/24), Web奐嵜.
723215. [妛夛 (慡崙)] (堦斒島墘) A Case of Isolated Abscess after Laparoscopic Hepatectomy. 媣曐擟巎1, 惣郪怢嫳1, 揷搰丂峅1, 奀捗婱巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞32夞擔杮娞抇鋁奜壢妛夛妛弍廤夛 (2021/2/24), Web奐嵜.
723033. [妛夛 (慡崙)] (億僗僞乕) 媫惈娞忈奞屻偺娞廋暅偵偼儕儞僷娗怴惗偲儅僋儘僼傽乕僕偑婑梌偡傞. 拞杮廋巌1, 埳摗媊栫2, 屻摗戩栫1, 嵶栰壛撧巕2, 敤拞丂岞2, 攏搱惓棽2, 揤栰塸庽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟): 戞94夞擔杮栻棟妛夛擭夛 (2021/3/8-10), 嶥杫 (僴僀僽儕僢僪奐嵜).
723216. [妛夛 (慡崙)] (堦斒島墘) 媫惈鋁墛傪敪徢偟丆暊峯嬀壓銪憻屌掕弍偵擄廰偟偨梀憱銪丒堓幉擯偺1椺. 揷拞丂寜1,2, 嶳杮桾婸2, 弌壠嫓堦2, 捛栘岹愰2 (1怴悽婭堛椕丒愭抂堛椕, 2堦斒丒彫帣丒娞抇鋁奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10-13), 墶昹 (僴僀僽儕僢僪奐嵜).
732012. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 暊峯嬀壓鋁摢廫擇巜挵愗彍弍偺摫擖偲岺晇. 揷搰丂峅1, 奀捗婱巎1, 壀杮岝婩巕1, 惣郪怢嫳1, 媣曐擟巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞14夞娞憻撪帇嬀奜壢尋媶夛丒戞12夞鋁憻撪帇嬀奜壢尋媶夛 (2020/10/28), Web奐嵜.
732013. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) Caudal view傪棙梡偟偨傾僾儘乕僠偺棙揰偲寚揰傪峫偊傞. 惣郪怢嫳1, 揷搰丂峅1, 壀杮岝婩巕1, 媣曐擟巎1, 奀捗婱巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞14夞娞憻撪帇嬀奜壢尋媶夛丒戞12夞鋁憻撪帇嬀奜壢尋媶夛 (2020/10/28), Web奐嵜.
733046. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 挵娗尭埑梡僇僥乕僥儖挵釕偺宱尡. 揷拞丂寜1,2, 嶳杮桾婸2, 弌壠嫓堦2, 捛栘岹愰2 (1怴悽婭堛椕丒愭抂抐揑堛椕, 2堦斒丒彫帣丒娞抇鋁): 戞34夞擔杮彫帣僗僩乕儅丒攔煏丒憂彎娗棟尋媶夛 (2020/6/13), 帍忋奐嵜.
733047. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僗僩乕儅傪曐桳偡傞彫帣傗娫寚摫擜傪昁梫偲偡傞彫帣偺廇墍丒廇妛偵偍偗傞壽戣偺柧妋壔亅堛椕幰偺宱尡偵婎偯偔幚懺挷嵏: 僗僩乕儅亅. 曐姞怢戙, 墱揷桾旤, 垻晹丂孫, 姍揷捈巕, 崅尒郪帬, 搶娫枹棃, 徏栰戝曘, 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂抐揑堛椕, 2堦斒丒彫帣丒娞抇鋁): 戞34夞擔杮彫帣僗僩乕儅丒攔煏丒憂彎娗棟尋媶夛 (2020/6/13), 帍忋奐嵜.
733048. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僗僩乕儅傪曐桳偡傞彫帣傗娫寚摫擜傪昁梫偲偡傞彫帣偺廇墍丒廇妛偵偍偗傞壽戣偺柧妋壔亅堛椕幰偺宱尡偵婎偯偔幚懺挷嵏: 娫寚摫擜亅. 姍揷捈巕, 曐姞怢戙, 垻晹丂孫, 墱揷桾旤, 崅尒郪帬, 搶娫枹棃, 徏栰戝曘, 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂抐揑堛椕, 2堦斒丒彫帣丒娞抇鋁): 戞34夞擔杮彫帣僗僩乕儅丒攔煏丒憂彎娗棟尋媶夛 (2020/6/13), 帍忋奐嵜.
733049. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 曐堢墍丒梒抰墍丒彫妛峑偵偍偗傞僗僩乕儅働傾丒帺屓摫擜働傾幚巤偺偨傔偺曌嫮夛偵庢傝擖傟傞撪梕偺専摙偲島媊帒椏偺嶌惉. 墱揷桾旤, 曐姞怢戙, 垻晹丂孫, 姍揷捈巕, 崅尒郪帬, 搶娫枹棃, 徏栰戝曘, 揷拞丂寜1,2 (1怴悽婭堛椕丒愭抂抐揑堛椕, 2堦斒丒彫帣丒娞抇鋁): 戞34夞擔杮彫帣僗僩乕儅丒攔煏丒憂彎娗棟尋媶夛 (2020/6/13), 帍忋奐嵜.
733050. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 扙弌憻婍偺娨擺偑崲擄側嫄戝鋊懷僿儖僯傾偵懳偟偰曐懚揑側壛椕傪峴偭偨偑梊婜偟側偄宱夁傪扝偭偨堦椺. 弌壠嫓堦1, 揷拞丂寜1,2, 嶳杮桾婸1, 捛栘岹愰1, 忋徏桼徆1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞6夞擔杮彫帣傊偦尋媶夛 (2020/8/14), Web奐嵜.
733051. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 娻娫幙慄堐夎嵶朎偵偍偗傞SPARC敪尰傪夘偟偨Wnt/兝-catenin宱楬妶惈壔偲戝挵娻墦妘揮堏婡彉偺夝柧. 摗嶳朏庽1, 拞杮廋巌1, 惣郪怢嫳2, 嫜丂桾椇1, 摗栰巎怐1, 屻摗戩栫1, 墶揷岝墰1, 揧栰岶暥1, 峛斻揷晲巙1, 墶揷榓巕, 彫浉宑懢, 撪摗丂崉3, 孏尦梇夘2, 嶳壓宲巎4,5 (1戝妛堾堛椕宯尋媶壢, 2堦斒丒彫帣丒娞抇鋁奜, 3壓晹徚壔娗奜, 4怴悽婭堛椕丒墶抐揑堛椕, 5忋晹徚壔娗奜): 戞40夞擔杮暘巕庮釃儅乕僇乕尋媶夛 (2020/9/30), Web奐嵜.
733052. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 暊峯嬀壓娞愗彍偵偍偗傞懱撪幃Pringle朄. 壀杮岝婩巕1, 奀捗婱巎1, 惣郪怢嫳1, 揷搰丂峅1, 媣曐擟巎1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞14夞娞憻撪帇嬀奜壢尋媶夛丒戞12夞鋁憻撪帇嬀奜壢尋媶夛 (2020/10/28), Web奐嵜.
733053. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 暊峯嬀壓娞S7丒S8垷嬫堟愗彍偺庤弍庤媄偍傛傃偦偺埨慡惈. 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳1, 媣曐擟巎1, 壀杮岝婩巕1, 孏尦梇夘1 (1堦斒丒彫帣丒娞抇鋁奜): 戞14夞娞憻撪帇嬀奜壢尋媶夛丒戞12夞鋁憻撪帇嬀奜壢尋媶夛 (2020/10/28), Web奐嵜.
733054. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擔楊49丆懱廳950 g偱妺惣庤弍傪巤峴偟偨挻掅弌惗懱廳帣抇摴暵嵔徢偺1椺. 忋徏桼徆1, 揷拞丂寜1,2, 弌壠嫓堦1, 搉晹桋榊1 (1堦斒丒彫帣丒娞抇鋁奜, 2怴悽婭堛椕丒愭抂堛椕): 戞47夞擔杮抇摴暵嵔徢尋媶夛 (2020/12/5), 愬戜 (僴僀僽儕僢僪奐嵜).
'19擭搙埲慜暘
[妛弍榑暥]
'19-110017. [尨挊] A multicenter prospective registration study on laparoscopic pancreatectomy in Japan: report on the assessment of 1,429 patients. Ohtsuka T, Nagakawa Y, Toyama H, Takeda Y, Maeda A, Kumamoto Y1, Nakamura Y, Hashida K, Honda G, Fukuzawa K, Toyoda E, Tanabe M, Gotohda N, Matsumoto I, Ryu T, Uyama I, Kojima T, Unno M, Ichikawa D, Inoue Y, Matsukawa H, Sudo T, Takaori K, Yamaue H, Eguchi S, Tahara M, Shinzeki M, Eguchi H, Kurata M, Morimoto M, Hayashi H, Marubashi S, Inomata M, Kimura K, Amaya K, Sho M, Yoshida R, Murata A, Yoshitomi H, Hakamada K, Yasunaga M, Abe N, Hioki M, Tsuchiya M, Misawa T, Seyama Y, Noshiro H, Sakamoto E, Hasegawa K, Kawabata Y, Uchida Y, Kameyama S, Ko S, Takao T, Kitahara K, Nakahira S, Baba H, Watanabe M, Yamamoto M, Nakamura M: J Hepatobiliary Pancreat Sci 2020/2; 27 (2): 47-55. (孏尦梇夘1: 1堦斒丒彫帣丒娞抇鋁奜)
忋晹徚壔娗奜壢妛
[妛弍榑暥]
110224. [尨挊] Intraoperative conversion from laparoscopic gastrectomy to an open procedure: a decade of experience in a Japanese high-volume center. Kumagai K, Hiki N1, Nunobe S, Jiang X, Makuuchi R, Ida S, Ohashi M, Yamaguchi T, Sano T: Surg Endosc 2021/4; 35 (4): 1834-42. doi: 10.1007/s00464-020-07584-7. Epub 2020 Apr 30. (斾婇捈庽1: 1忋晹徚壔娗奜)
110225. [尨挊] Prevention of intra-thoracic recurrent laryngeal nerve injury with robot-assisted esophagectomy. Hosoda K1, Niihara M1, Ushiku H1, Harada H1, Sakuraya M1, Washio M1, Yamashita K1,2, Hiki N1: Langenbecks Arch Surg 2020/6; 405 (4): 533-40. (嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 尨揷岹婸1, 烴扟旤婱巕1, 榟旜恀棟垽1, 嶳壓宲巎1,2, 斾婇捈庽1: 1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕)
110226. [尨挊] A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction. Hosoda K1, Azuma M2, Katada C2, Ishido K2, Niihara M1, Ushiku H1, Sakuraya M1, WashioM1, Wada T2, Watanabe A2, Harada H1, Tanabe S2,3, Koizumi W2, Yamashita K1,4, Hiki N1: Int J Clin Oncol 2020/6; 25 (6): 1090-7. (嵶揷丂宩1, 搶丂悙抭2, 寴揷恊棙2, 愇屗尓師2, 怴尨惓戝1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 榓揷戱栫2, 搉绯峎幆2, 尨揷岹婸1, 揷绯丂憦2,3, 彫愹榓嶰榊2, 嶳壓宲巎1,4, 斾婇捈庽1: 1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒愭抂堛椕, 4怴悽婭堛椕丒墶抐揑堛椕)
110227. [尨挊] Delta-shaped anastomosis vs circular stapler anastomosis after laparoscopic distal gastrectomy with Billroth I reconstruction: A randomized controlled trial. Hosoda K1, Mieno H1, Ema A1, Ushiku H1, Washio M1, Song I, Watanabe M2, Yamashita K1,3, Hiki N1: Asian J Endosc Surg 2020/7; 13 (3): 301-10. (嵶揷丂宩1, 嶰廳栰峗楴1, 峕娫丂楁1, 媿媣廏庽1, 榟旜恀棟垽1, 搉绮徆旻2, 嶳壓宲巎1,3, 斾婇捈庽1: 1忋晹徚壔娗奜, 2杒棦戝妛杒棦尋媶強昦堾, 3怴悽婭堛椕丒墶抐揑堛椕)
110228. [尨挊] Risk factors and prognosis of gastric stasis, a crucial problem after laparoscopic pylorus-preserving gastrectomy for early middle-third gastric cancer. Takahashi R, Ohashi M, Hiki N1, Makuuchi R, Ida S, Kumagai K, Sano T, Nunobe S: Gastric Cancer 2020/7; 23 (4): 707-15. (斾婇捈庽1: 1忋晹徚壔娗奜)
110229. [尨挊] Neoadjuvant chemotherapy plus surgery for high-risk advanced gastric cancer: long-term results of KDOG1001 trial. Hosoda K1, Katada C2, Ishido K2, Niihara M1, Ushiku H1, Sakuraya M1, Washio M1, Wada T2, Watanabe A2, Harada H1, Sato T3, Tajima H1, Kaizu T1, Kosaka Y4, Kato H4, Sengoku N4, Tanaka K5,6, Naito T3, Kumamoto Y6, Sangai T4, Tanabe S2,5, Koizumi W2, Yamashita K1,7, Hiki N1: Langenbecks Arch Surg 2020/9; 40 5 (6): 777-85. (嵶揷丂宩1, 寴揷恊棙2, 愇屗尓師2, 怴尨惓戝1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 榓揷戱栫2, 搉绯峎怐2, 尨揷岹婸1, 嵅摗晲榊3, 揷搰丂峅1, 奀捗婱巎1, 彫嶁桖尗4, 壛摗丂峅4, 愬愇婭旻4, 揷拞丂寜5,6, 撪摗丂崉3, 孏尦梇夘6, 嶰奒婱巎4, 揷绯丂憦2,5, 嶳壓宲巎1,7, 彫愹榓嶰榊2, 斾婇捈庽1: 1忋晹徚壔娗奜, 2徚壔婍撪, 3壓晹徚壔娗奜, 4擕態丒峛忬態奜, 5怴悽婭堛椕丒愭抂堛椕, 6堦斒丒彫帣丒娞抇鋁奜, 7怴悽婭堛椕丒墶抐揑堛椕)
110230. [尨挊] Patient selection for salvage surgery after definitive chemoradiotherapy in esophageal squamous cell carcinoma. Harada H1, Yamashita K1,2, Katada C3, Ishiyama H4, Soeno T5, Washio M1, Sakuraya M1, Ushiku H1, Niihara M1, Hosoda K1, Hiki N1: Langenbecks Arch Surg 2020/9; 405 (6): 767-76. (尨揷岹婸1, 嶳壓宲巎1,2, 寴揷恊棙3, 愇嶳攷瀶4, 揧栰岶暥5, 榟旜恀棟垽1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1: 1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3徚壔婍撪, 4曻幩慄 (庮釃), 5戝妛堾堛椕宯尋媶壢)
110231. [尨挊] Therapeutic value of splenectomy to dissect splenic hilar lymph nodes for type 4 gastric cancer involving the greater curvature, compared with other types. Kano Y, Ohashi M, Ida S, Kumagai K, Makuuchi R, Sano T, Hiki N1, Nunobe S: Gastric Cancer 2020/9; 23 (5): 927-36. (斾婇捈庽1: 1忋晹徚壔娗奜)
110232. [尨挊] An Unmodulated Very-Low-Voltage Electrosurgical Technology Creates Predictable and Ultimate Tissue Coagulation: From Experimental Data to Clinical Use. Watanabe Y, Fuchshuber P, Homma T, Bilgic E, Madani A, Hiki N1, Cammack I, Noji T, Kurashima Y, Shichinohe T, Hirano S: Surg Innov 2020/10; 27 (5): 492-8. (斾婇捈庽1: 1忋晹徚壔娗奜)
110233. [尨挊] Comparison of Postoperative Quality of Life among Three Different Reconstruction Methods After Proximal Gastrectomy: Insights From the PGSAS Study. Yabusaki H, Kodera Y, Fukushima N, Hiki N1, Kinami S, Yoshida M, Aoyagi K, Ota S, Hata H, Noro H, Oshio A, Nakada K: World J Surg 2020/10; 44 (10): 3433-40. (斾婇捈庽1: 1忋晹徚壔娗奜)
110234. [尨挊] Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists. Kano Y, Ohashi M, Hiki N1, Takahari D, Chin K, Yamaguchi K, Ida S, Kumagai K, Sano T, Nunobe S: Surg Today 2020/10; 50 (10): 1197-205. (斾婇捈庽1: 1忋晹徚壔娗奜)
110235. [尨挊] Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer. Takahashi R, Nunobe S, Osumi H, Takahari D, Yamamoto N, Ida S, Kumagai K, Ohashi M, Sano T, Hiki N1: Surg Today 2020/10; 50 (10): 1240-8. (斾婇捈庽1: 1忋晹徚壔娗奜)
110236. [尨挊] Prediction of Efficacy of Postoperative Chemotherapy by DNA Methylation of CDO1 in Gastric Cancer. Harada H1, Soeno T2, Yokoi K3, Nishizawa N4, Ushiku H1, Hosoda K1, Hiki N1, Yamashita K1,5: J Surg Res 2020/12; 256: 404-12. (尨揷岹婸1, 揧栰岶暥2, 墶堜孿屽3, 惣郪怢嫳4, 媿媣廏庽1, 嵶揷丂宩1, 斾婇捈庽1, 嶳壓宲巎1,5: 1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4堦斒丒彫帣丒娞抇鋁奜, 5怴悽婭堛椕丒墶抐揑堛椕)
110237. [尨挊] Size-dependent differences in the proximal remnant stomach: how much does a small remnant stomach after subtotal gastrectomy work? Yasufuku I, Ohashi M, Eto K, Ida S, Kumagai K, Nunobe S, Sano T, Hiki N1: Surg Endosc 2020/12; 34 (12): 5540-9. (斾婇捈庽1: 1忋晹徚壔娗奜)
110238. [尨挊] The incidences of metachronous multiple gastric cancer after various types of gastrectomy: analysis of data from a nationwide Japanese survey. Kinami S, Aizawa M, Yamashita H, Kumagai K, Kamiya S, Toda M, Takahata T, Fujisaki M, Miyamoto H, Kusanagi H, Kobayashi K, Washio M1, Hosoda K1, Kosaka T: Gastric Cancer 2021/1; 24 (1): 22-30. (榟旜恀棟垽1, 嵶揷丂宩1: 1忋晹徚壔娗奜)
120008. [尨挊] 恄撧愳導壓偺崅楊幰堓娻徢椺偵懳偡傞暊峯嬀堓愗彍弍偺尰忬. 嵅摗丂徛, 殸嶈庡惻, 崅嫶惓弮, 戝搰丂婱, 斾婇捈庽1, 戝捸婤恖, 彫郪氠帯, 墦摗丂奿 (1忋晹徚壔娗奜): 擔杮撪帇嬀奜壢妛夛嶨帍 2020/7; 25 (4): 254-62.
320004. [徢椺曬崘] Nab-PTX + RAM暪梡椕朄屻偵暊峯嬀壓娞晹暘愗彍弍傪巤峴偟偨嵞敪堓娻偺1椺. 拞攏婎攷1,2, 崅嫶掯恖2,3, 帪擟悞憦, 娵嶳惓桾2,3, 愮栰怲堦榊2,4, 媿媣廏庽1, 拞懞榓摽2,3, 撪摗惓婯2,4, 嬤摗峃巎2,5, 嶳嶈丂摍2,6, 惣丂敧巏, 斾婇捈庽1 (1忋晹徚壔娗奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3堦斒丒彫帣丒娞抇鋁奜, 4壓晹徚壔娗奜, 5擕態丒峛忬態奜, 6昦棟): 娻偲壔妛椕朄 2020/12; 47 (13): 2065-7.
320005. [徢椺曬崘] 忎偺崅偄擲枌壓庮釃條棽婲傪掓偟偨堓掙態宆堓娻偺1椺. 搚曽堦斖, 桼梇晀擵, 壨撪丂梞, 媑悈徦堦, 杧撪桾夘, 愇嶳峎悽巙, 暯郪弐柧, 搚揷抦岹, 彲巌壚峎, 斾婇捈庽1, 摗嶈弴巕 (1忋晹徚壔娗奜): 堓偲挵 2020/9; 55 (10): 1313-22.
510010. [憤愢] Robot-assisted minimally invasive esophagectomy for esophageal cancer: Meticulous surgery minimizing postoperative complications. Hosoda K1, Niihara M1, Harada H1, Yamashita K1,2, Hiki N1: Ann Gastroenterol Surg 2020/8; 4 (6): 608-17. (嵶揷丂宩1, 怴尨惓戝1, 尨揷岹婸1, 嶳壓宲巏1,2, 斾婇捈庽1: 1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕)
510011. [憤愢] Postoperative pancreatic fistula after gastrectomy for gastric cancer. Washio M1, Yamashita K1,2, Niihara M1, Hosoda K1, Hiki N1: Ann Gastroenterol Surg 2020/9; 4 (6): 618-27. (榟旜恀棟垽1, 嶳壓宲巏1,2, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1: 1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕)
510012. [憤愢] History and emerging trends in chemotherapy for gastric cancer. Yamashita K1,2, Hosoda K2, Niihara M2, Hiki N2: Ann Gastroenterol Surg 2021/2; 5 (4): 446-56. (嶳壓宲巎1,2, 嵶揷丂宩2, 怴尨惓戝2, 斾婇捈庽2: 1怴悽婭堛椕丒墶抐揑堛椕, 2忋晹徚壔娗奜)
520007. [憤愢] III. 徚壔婍撪帇嬀偺敪揥丂暊峯嬀帯椕偺怴揥奐丂暊峯嬀丒撪帇嬀崌摨堓愗彍 (LECS) 偺尰嵼偲枹棃. 斾婇捈庽 (忋晹徚壔娗奜): 擔杮徚壔婍撪帇嬀妛夛嶨帍 2020/11; 62 (Suppl.3): 2440-6.
522053. [島嵗]亂摿廤: 幚慔! 庤弍偑忋払偡傞僩儗乕僯儞僌朄亅Off the Job Training偺嵟怴摦岦亃仭庤弍偺榬傪杹偔偨傔偵昁梫側價僨僆夋憸偵傛傞妛廗丂妛夛傗web側偳偱採嫙偝傟傞柾斖揑價僨僆夋憸偺妶梡朄. 媿媣廏庽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1, 榟旜恀棟垽1, 尨揷岹婸1, 拞攏婎攷1,2, 揧栰岶暥3, 嶳壓宲巎1,4: 1忋晹徚壔娗奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3戝妛堾堛椕宯尋媶壢, 4怴悽婭堛椕丒墶抐揑): 椪彴奜壢 2020/4; 75 (4): 388-92.
522054. [島嵗]亂戞1摿廤: 備傞乣偔, 偱傕偪傖傫偲妛傃偨偄僫乕僗偺偨傔偺33偺徚壔婍幘姵&帯椕 乬傢傞乭偒傖傜 偢偐傫亃2. 堓偺幘姵&帯椕丂傢傞偒傖傜偢偐傫. 烴扟旤婱巕1, 斾婇捈庽1, 嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 榟旜恀棟垽1, 尨揷岹婸1, 嶳壓宲巎1,2 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑): 徚壔婍僫乕僔儞僌 2020/5; 25 (5): 402-10.
530011. [偦偺懠 (Editorial)] Why minimally invasive surgery for esophageal cancer is minimally invasive? Hiki N1: Ann Gastroenterol Surg 2020/5; 4 (3): 188-9. (斾婇捈庽1: 1忋晹徚壔娗奜)
[挊丂彂]
620041. [妛弍彂 (暘扴幏昅)]亂僉乕儚乕僪偱傢偐傞椪彴塰梴 椷榓斉丂塰梴偱帯偡! 婎慴偐傜幚慔傑偱亃戞10復 奺幘姵偺塰梴娗棟丂16. 偑傫, p.344-54. 怴尨惓戝1, 斾婇捈庽1 (1忋晹徚壔娗奜), 曇: 壀揷怶屷, 梤搚幮, 搶嫗, 2020/4敪峴.
620042. [妛弍彂 (暘扴幏昅)]亂弍慜丒弍屻娗棟昁実2020 (徚壔婍奜壢2020擭4寧憹姧崋)亃ii. 弍慜専嵏丂7. 塰梴傾僙僗儊儞僩, p.581-4. 怴尨惓戝1, 斾婇捈庽1 (1忋晹徚壔娗奜), 傊傞偡弌斉, 搶嫗, 2020/4敪峴.
620043. [妛弍彂 (暘扴幏昅)]亂撪帇嬀奜壢庤弍丂栶棫偮僥僋僯僢僋100 [Web摦夋晅] 戞1斉亃億乕僩偺憓擖埵抲丂02忋晹徚壔娗嘇 (堓), p.203-5. 尨揷岹婸1, 斾婇捈庽1 (1忋晹徚壔娗奜). 曇: 媨郪岝抝, 堛妛彂堾, 搶嫗, 2020/10敪峴.
[妛夛丒尋媶夛摍]
721011. [妛夛 (慡崙)] (摿暿島墘) 廃弍婜Patient selection偵傛傞怘摴娻帯椕嵟揔壔傊偺挧愴. 嶳壓宲巎1,2, 尨揷岹婸2, 怴尨惓戝2, 嵶揷丂宩2, 媿媣廏庽2, 榟旜恀棟垽2, 烴扟旤婱巕2, 寴揷恊棙3, 愇嶳攷瀶4, 斾婇捈庽2 (1怴悽婭堛椕丒墶抐揑堛椕, 2忋晹徚壔娗奜, 3徚壔婍撪, 4曻幩慄 (庮釃)): 戞74夞擔杮怘摴妛夛妛弍廤夛 (2020/12/10), 摽搰 (僴僀僽儕僢僪奐嵜).
722053. [妛夛 (慡崙)] (僔儞億僕僂儉) A phase I study of DOS neoadjuvant chemotherapy for esophagogastric junction cancer. 嵶揷丂宩1, 搶丂悙抭2, 尨揷岹婸1, 烴扟旤婱巕1, 榟旜恀棟垽1, 媿媣廏庽1, 怴尨惓戝1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒墶抐揑堛椕): 戞92夞擔杮堓娻妛夛憤夛 (2020/7/1-31), Web奐嵜, 擔杮堓娻妛夛憤夛婰帠 2020/3; 92: 199.
722054. [妛夛 (慡崙)] (僔儞億僕僂儉) Intrathoracic double flap technique for esophagogastric cancer. 怴尨惓戝1, 媿媣廏庽1, 嵶揷丂宩1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 揧栰岶暥2, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞92夞擔杮堓娻妛夛憤夛 (2020/7/1-31), Web奐嵜, 擔杮堓娻妛夛憤夛婰帠 2020/3; 92: 201.
722055. [妛夛 (慡崙)] (僔儞億僕僂儉) 崅搙恑峴堓娻偵懳偡傞撪帇嬀奜壢庤弍: 恑峴怘摴堓愙崌晹娻偵懳偡傞撪帇嬀奜壢庤弍. 嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 嵅摗晲榊2, 奀捗婱巎1, 壛摗丂峅3, 揷拞丂寜4,5, 撪摗丂崉2, 孏尦梇夘5, 嶰奒婱巎3, 嶳壓宲巎1,6, 斾婇捈庽1 (1忋晹徚壔娗奜, 2壓晹徚壔娗奜, 3擕態丒峛忬態奜, 4怴悽婭堛椕丒愭抂堛椕, 5堦斒丒彫帣丒娞抇鋁奜, 6怴悽婭堛椕丒墶抐揑堛椕): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/30), Web奐嵜, 擔杮椪彴奜壢妛夛嶨帍 2020/10; 81 (憹姧崋): 214.
722056. [妛夛 (慡崙)] (僔儞億僕僂儉) 儘儃僢僩巟墖壓堓愗彍弍偺掕宆壔偲帯椕惉愌: 儘儃僢僩巟墖堓娻庤弍偺抁婜挿婜惉愌. 嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 嵅摗晲榊2, 奀捗婱巎3, 壛摗丂峅4, 揷拞丂寜3,5, 撪摗丂崉2, 孏尦梇夘3, 嶰奒婱巎4, 嶳壓宲巎1,6, 斾婇捈庽1 (1忋晹徚壔娗奜, 2壓晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4擕態丒峛忬態奜, 5怴悽婭堛椕丒愭抂堛椕, 6怴悽婭堛椕丒墶抐揑堛椕): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/31), Web奐嵜, 擔杮椪彴奜壢妛夛嶨帍 2020/10; 81 (憹姧崋): 237.
722057. [妛夛 (慡崙)] (僔儞億僕僂儉) Thoracoscopic double-flap reconstruction for esophagogastric junction cancer. 嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
722058. [妛夛 (慡崙)] (僔儞億僕僂儉) Feasibility of laparoscopic gastrectomy for gastric cancer in multicenter prospective studies. Etoh E, 斾婇捈庽1, Honda M, Shiraishi N, Kitano S, Inomata M (1忋晹徚壔娗奜): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
722059. [妛夛 (慡崙)] (僔儞億僕僂儉) 奺椞堟偵偍偗傞儘儃僢僩巟墖庤弍亅堓娻偵懳偡傞儘儃僢僩巟墖庤弍亅. 嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞45夞擔杮奜壢宯楢崌妛夛妛弍廤夛 (2020/12/23), Web奐嵜, 擔杮奜壢宯楢崌夛妛夛妛弍廤夛彺榐廤 2020/12; 45 (5): 539.
723217. [妛夛 (慡崙)] (堦斒島墘) 崅楊幰堓娻偺奜壢帯椕惉愌. 榟旜恀棟垽1, 嶳壓宲巎1,2, 揧栰岶暥3, 尨揷岹婸1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3戝妛堾堛椕宯尋媶壢): 戞92夞擔杮堓娻妛夛憤夛 (2020/7/1-31), Web奐嵜.
723218. [妛夛 (慡崙)] (堦斒島墘) 怴婯堓娻DNA暊悈愻忩嵶朎恌偺妋棫亅CDO1堚揱巕儊僠儖壔傪梡偄偰亅 . 尨揷岹婸1, 揧栰岶暥2, 榟旜恀棟垽1, 媿媣廏庽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞92夞擔杮堓娻妛夛憤夛 (2020/7/1-31), Web奐嵜.
723219. [妛夛 (慡崙)] (堦斒島墘) 娙曋側暊峯嬀壓堓愗彍弍偺擄搙梊應場巕偲偟偰偺恡晜梀僒僀儞. 搉晹峎巕1, 嵶揷丂宩2, 怴尨惓戝2, 媿媣廏庽2, 烴扟旤婱巕2, 榟旜恀棟垽2, 尨揷岹婸2, 嶳壓宲巎2,3, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞92夞擔杮堓娻妛夛憤夛 (2020/7/1-31), Web奐嵜.
723220. [妛夛 (慡崙)] (堦斒島墘) 堓怘摴媡棳偺杊巭偵偍偗傞Double-flap朄嵞寶偲Orvil朄嵞寶偺専摙. 媿媣廏庽1, 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 揧栰岶暥2, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞92夞擔杮堓娻妛夛憤夛 (2020/7/1-31), Web奐嵜.
723221. [妛夛 (慡崙)] (堦斒島墘) 怴偟偄弍慜壔妛椕朄偵傛傞conversion surgery偺惉愌. 烴扟旤婱巕1, 嶳壓宲巎1,2, 揧栰岶暥3, 尨揷岹婸1, 榟旜恀棟垽1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3戝妛堾堛椕宯尋媶壢): 戞92夞擔杮堓娻妛夛憤夛 (2020/7/1-31), Web奐嵜.
723222. [妛夛 (慡崙)] (堦斒島墘) 嫄戝堓擲枌壓庮釃偵懳偟偰奐暊丒撪帇嬀崌摨堓嬊強愗彍傪峴偄憻婍丒婡擻壏懚偑壜擻偱偁偭偨堦椺. 懢揷丂椊1, 尨揷岹婸2, 揧栰岶暥3, 榟旜恀棟垽2, 媿媣廏庽2, 烴扟旤婱巕2, 怴尨惓戝2, 嵶揷丂宩2, 嶳壓宲巎2,4, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3戝妛堾堛椕宯尋媶壢, 4怴悽婭堛椕丒墶抐揑堛椕): 戞92夞擔杮堓娻妛夛憤夛 (2020/7/1-31), Web奐嵜.
723223. [妛夛 (慡崙)] (堦斒島墘) Digital droplet PCR傪梡偄偨堓娻暊枌攄庬偵懳偟偰偺怴婯恌抐朄. 揧栰岶暥1, 尨揷岹婸2, 烴扟旤婱巕2, 榟旜恀棟垽2, 媿媣廏庽2, 怴尨惓戝2, 嵶揷丂宩2, 嶳壓宲巎2,3, 斾婇捈庽2 (1戝妛堾堛椕宯尋媶壢, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞92夞擔杮堓娻妛夛憤夛 (2020/7/1-31), Web奐嵜.
723224. [妛夛 (慡崙)] (堦斒島墘) 堓娻偵偍偗傞MutL homolog 1 (MLH1) 堚揱巕DNA儊僠儖壔偺椪彴揑堄媊. 尨揷岹婸1, 揧栰岶暥2, 榟旜恀棟垽1, 媿媣廏庽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞106夞擔杮徚壔婍昦妛夛憤夛 (2020/8/13), 帍忋奐嵜 (堦晹Web奐嵜).
723225. [妛夛 (慡崙)] (堦斒島墘) 娗峯撪帇嬀丒暊峯嬀崌摨庤弍偺嵟慜慄丂崅楊幰堓娻姵幰偵懳偡傞optional LECS. 榟旜恀棟垽1, 斾婇捈庽1, 揧栰岶暥2, 尨揷岹婸1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13), Web奐嵜.
723226. [妛夛 (慡崙)] (堦斒島墘) DCF傪帯椕愴棯偵慻傒擖傟偨T4嫻晹怘摴娻偺帯椕惉愌偐傜傒偊傞崱屻偺壽戣. 怴尨惓戝1, 尨揷岹婸1, 嵶揷丂宩1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13), Web奐嵜.
723227. [妛夛 (慡崙)] (堦斒島墘) 堓娻偵偍偗傞SSI儕僗僋儌僨儖偲梊屻丒嵞敪宍幃偵偮偄偰. 烴扟旤婱巕1, 嶳壓宲巎1,2, 揧栰岶暥3, 尨揷岹婸1, 榟旜恀棟垽1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3戝妛堾堛椕宯尋媶壢): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13), Web奐嵜.
723228. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀堓愗彍偵偍偗傞鋁忋墢妔惔帪偺鋁揮偑偟朄偺岺晇. 搉晹峎巕1, 媿媣廏庽2, 嵶揷丂宩2, 怴尨惓戝2, 烴扟旤婱巕2, 榟旜恀棟垽2, 尨揷岹婸2, 嶳壓宲巎2,3, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/14), Web奐嵜.
723229. [妛夛 (慡崙)] (堦斒島墘) 怘摴娻庤弍偵偍偗傞塰梴帺屓昡壙僔乕僩傪梡偄偨廃弍婜塰梴娗棟偺専摙. 尨揷岹婸1, 揧栰岶暥2, 榟旜恀棟垽1, 媿媣廏庽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/14), Web奐嵜.
723230. [妛夛 (慡崙)] (堦斒島墘) 忋晹徚壔娗婡擻壏懚弍幃偺僄價僨儞僗丂堓怘摴媡棳偺杊巭偵偍偗傞Double-flap朄嵞寶偲Orvil朄嵞寶偺専摙. 媿媣廏庽1, 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/15), Web奐嵜.
723231. [妛夛 (慡崙)] (堦斒島墘) 怘摴娻庤弍偵偍偗傞僟價儞僠偑傕偨傜偡棙揰丂惡懷杻醿寉尭偺壜擻惈. 嵶揷丂宩1, 媿媣廏庽1, 怴尨惓戝1, 尨揷岹婸1, 榟旜恀棟垽1, 烴扟旤婱巕1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/15), Web奐嵜.
723232. [妛夛 (慡崙)] (堦斒島墘) 堓娻偵偍偗傞慜娻儅乕僇乕偲偟偰偺KKLC-1偺桳梡惈偵偮偄偰. 拞攏婎攷1,2, 暉嶳丂棽1, 戝捤弐榓3, 擇搉怣峕, 巗棃壝怢, 帪擟悞憦4, 娵嶳惓桾1,5, 拞懞榓摽1,5, 撪摗惓婯1,4, 嬤摗峃巎1,6, 惣丂敧巏1, 崅嫶掯恖1,5, 彫椦寷拤1, 嶳嶈丂摍1,7, 斾婇捈庽2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2忋晹徚壔娗奜, 3徚壔婍撪, 4壓晹徚壔娗奜, 5堦斒丒彫帣丒娞抇鋁奜, 6擕態丒峛忬態奜, 7昦棟): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/15), Web奐嵜.
723233. [妛夛 (慡崙)] (堦斒島墘) 怘摴娻姵幰偵偍偗傞帯椕慜寣惔CRP抣偑惗懚棪偵梌偊傞塭嬁. 屻摗戩栫1, 揧栰岶暥1, 嵶揷丂宩2, 斾婇捈庽2, 嶳壓宲巎2,3 (1戝妛堾堛椕宯尋媶壢, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞79夞擔杮娻妛夛妛弍憤夛 (2020/10/1), 峀搰 (僴僀僽儕僢僪奐嵜).
723234. [妛夛 (慡崙)] (堦斒島墘) 怘摴滸暯忋旂娻偵偍偗傞摨帪堚揱巕憹暆偺壔妛椕朄掞峈惈傊偺婑梌. 揧栰岶暥1, 尨揷岹婸2, 嵶揷丂宩2, 斾婇捈庽2, 嶳壓宲巎2,3 (1戝妛堾堛椕宯尋媶壢, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞79夞擔杮娻妛夛妛弍憤夛 (2020/10/1), 峀搰 (僴僀僽儕僢僪奐嵜).
723235. [妛夛 (慡崙)] (堦斒島墘) 堓娻偺怺払搙恌抐偵偍偗傞CT偺桳梡惈偵偮偄偰. 墱栰峎懢1, 尨揷岹婸2, 榟旜恀棟垽2, 烴扟旤婱巕2, 媿媣廏庽2, 怴尨惓戝2, 嵶揷丂宩2, 嶳壓宲巎2,3, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/29), Web奐嵜.
723236. [妛夛 (慡崙)] (堦斒島墘) 嫄戝堓擲枌壓庮釃偵懳偟偰奐暊丒撪帇嬀崌摨堓嬊強愗彍 (Open Endoscopic CooperativeSurgery; OECS) 傪峴偄憻婍丒婡擻壏懚偑壜擻偱偁偭偨堦椺. 懢揷丂椊1, 尨揷岹婸2, 揧栰岶暥3, 榟旜恀棟垽2, 媿媣廏庽2, 烴扟旤婱巕2, 怴尨惓戝2, 嵶揷丂宩2, 嶳壓宲巎2,4, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3戝妛堾堛椕宯尋媶壢, 4怴悽婭堛椕丒墶抐揑堛椕): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/29), Web奐嵜.
723237. [妛夛 (慡崙)] (堦斒島墘) 桯栧壓寣娗傪Tree偺傛偆偵帇栰揥奐偡傞怴偟偄No.6儕儞僷愡妔惔朄. 媿媣廏庽1, 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 揧栰岶暥2, 撪摗丂崉3, 孏尦梇夘4, 揷拞丂寜4,5, 嶰奒婱巎6, 嵅摗晲榊3, 奀捗婱巎1, 嶳壓宲巎1,7, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3壓晹徚壔娗奜, 4堦斒丒彫帣丒娞抇鋁奜, 5怴悽婭堛椕丒愭抂堛椕, 6擕態丒峛忬態奜, 7怴悽婭堛椕丒墶抐揑堛椕): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/29), Web奐嵜.
723238. [妛夛 (慡崙)] (堦斒島墘) 娞抇鋁椞堟偵偍偗傞Reduced port庤弍偺岺晇偲揥朷: 暊峯嬀壓宯摑揑娞愗彍偵偍偗傞Reduced Port Surgery (RPS) 偺岺晇. 奀捗婱巎1, 揷搰丂峅1, 惣郪怢嫳2, 壀杮岝婩巕2, 嫜丂桾椇3, 摗嶳朏庽3, 媣曐擟巎2, 嵅摗晲榊4, 嵶揷丂宩1, 嶳壓宲巎1,5, 揷拞丂寜2,6, 斾婇捈庽1, 撪摗丂崉4, 嶰奒婱巎7, 孏尦梇夘2 (1忋晹徚壔娗奜, 2堦斒丒彫帣丒娞抇鋁奜, 3戝妛堾堛椕宯尋媶壢, 4壓晹徚壔娗奜, 5怴悽婭堛椕丒墶抐揑堛椕, 6怴悽婭堛椕丒愭抂堛椕, 7擕態丒峛忬態奜): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/29), Web奐嵜.
723239. [妛夛 (慡崙)] (堦斒島墘) 娞抇鋁椞堟偵偍偗傞Reduced port庤弍偺岺晇偲揥朷: 暊峯嬀壓旜懁鋁愗彍偱偺reduced port surgery. 揷搰丂峅1, 奀捗婱巎1, 媣曐擟巎1, 惣郪怢嫳2, 壀杮岝婩巕2, 摗嶳朏庽3, 嫜丂桾椇3, 嵅摗晲榊4, 嵶揷丂宩1, 嶳壓宲巎1,5, 揷拞丂寜2,6, 斾婇捈庽1, 撪摗丂崉4, 嶰奒婱巎7, 孏尦梇夘2 (1忋晹徚壔娗奜, 2堦斒丒彫帣丒娞抇鋁奜, 3戝妛堾堛椕宯尋媶壢, 4壓晹徚壔娗奜, 5怴悽婭堛椕丒墶抐揑堛椕, 6怴悽婭堛椕丒愭抂堛椕, 7擕態丒峛忬態奜): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/29), Web奐嵜.
723240. [妛夛 (慡崙)] (堦斒島墘) Minimally invasive surgery傊-埨慡側庤弍庤媄偺宲彸偲憂憿亅鋁憻傪怗傜側偄暊峯嬀壓堓愗彍亅. 榟旜恀棟垽1, 斾婇捈庽1, 揧栰岶暥2, 尨揷岹婸1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/29), Web奐嵜.
723241. [妛夛 (慡崙)] (堦斒島墘) 嵟揔側弍屻娗棟傪栚巜偟偨庢傝慻傒 (徚壔娗) Stage I堓娻弍屻偵偍偗傞懠昦巰梊應場巕偺摨掕. 烴扟旤婱巕1, 嶳壓宲巎1,2, 揧栰岶暥3, 尨揷岹婸1, 榟旜恀棟垽1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3戝妛堾堛椕宯尋媶壢): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/29), Web奐嵜.
723242. [妛夛 (慡崙)] (堦斒島墘) 暊枌攄庬偵懳偡傞帯椕愴棯: CDO1堚揱巕DNA儊僠儖壔傪梡偄偨怴婯堓娻DNA暊悈愻忩嵶朎恌偺妋棫. 尨揷岹婸1, 揧栰岶暥2, 榟旜恀棟垽1, 媿媣廏庽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/29), Web奐嵜.
723243. [妛夛 (慡崙)] (堦斒島墘) 崅搙恑峴堓娻丆嵞敪堓娻偵懳偡傞帯椕愴棯-栻暔椕朄偲庤弍偲偺梈崌-愗彍晄擻恑峴堓娻偵懳偡傞conversion庤弍徢椺偺挿婜梊屻. 尨揷岹婸1, 揧栰岶暥2, 榟旜恀棟垽1, 媿媣廏庽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/31), Web奐嵜.
723244. [妛夛 (慡崙)] (堦斒島墘) 堓愗彍屻偺嵞寶曽朄傪嵞峫偡傞-埨慡惈偲QOL偺娤揰偐傜-桯栧懁堓愗彍弍偲堓慡揈弍偵偍偗傞挿婜梊屻偵偮偄偰偺専摙. 戝栘宑巕1, 尨揷岹婸2, 揧栰岶暥3, 榟旜恀棟垽2, 烴扟旤婱巕2, 媿媣廏庽2, 怴尨惓戝2, 嵶揷丂宩2, 嶳壓宲巎2,4, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3戝妛堾堛椕宯尋媶壢, 4怴悽婭堛椕丒墶抐揑堛椕): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/31), Web奐嵜.
723245. [妛夛 (慡崙)] (堦斒島墘) Organ touchless偵婎偯偔堓慡揈屻偺怘摴嬻挵暙崌. 怴尨惓戝1, 嵶揷丂宩1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 揧栰岶暥2, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/31), Web奐嵜.
723246. [妛夛 (慡崙)] (堦斒島墘) 鋁娻偵懳偡傞暊峯嬀壓鋁懱旜晹愗彍: 鋁娻偵懳偡傞暊峯嬀壓旜懁鋁愗彍偺掕宆壔. 揷搰丂峅1, 奀捗婱巎1, 媣曐擟巎1, 惣郪怢嫳2, 壀杮岝婩巕2, 摗嶳朏庽3, 嫜丂桾椇3, 嵅摗晲榊4, 嵶揷丂宩1, 嶳壓宲巎1,5, 揷拞丂寜2,6, 斾婇捈庽1, 撪摗丂崉4, 嶰奒婱巎7, 孏尦梇夘2 (1忋晹徚壔娗奜, 2堦斒丒彫帣丒娞抇鋁奜, 3戝妛堾堛椕宯尋媶壢, 4壓晹徚壔娗奜, 5怴悽婭堛椕丒墶抐揑堛椕, 6怴悽婭堛椕丒愭抂堛椕, 7擕態丒峛忬態奜): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/31), Web奐嵜.
723247. [妛夛 (慡崙)] (堦斒島墘) 怘摴堓愙崌晹娻偵懳偡傞暊峯嬀壓怘摴暚栧懁堓愗彍, 嫻峯嬀壓娤壒奐偒朄嵞寶. 嵶揷丂宩1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞28夞擔杮徚壔婍娭楢妛夛廡娫 (2020/11/6), 暫屔 (僴僀僽儕僢僪奐嵜).
723248. [妛夛 (慡崙)] (堦斒島墘) 崻帯揑壢妛曻幩慄帯椕屻偺怘摴僒儖儀乕僕庤弍偵偍偗傞梊屻梊應場巕偺専摙. 媿媣廏庽1, 尨揷岹婸1, 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榟旜恀棟垽1, 揧栰岶暥2, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞74夞擔杮怘摴妛夛妛弍廤夛 (2020/12/10), 摽搰 (僴僀僽儕僢僪奐嵜).
723249. [妛夛 (慡崙)] (堦斒島墘) 怘摴娻弍慜寣塼僈僗CO-Hb偲朌崌晄慡丆攛墛偲偺娭楢. 揧栰岶暥1, 尨揷岹婸2, 烴扟旤婱巕2, 榟旜恀棟垽2, 媿媣廏庽2, 怴尨惓戝2, 嵶揷丂宩2, 嶳壓宲巎2,3, 斾婇捈庽2 (1戝妛堾堛椕宯尋媶壢, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞74夞擔杮怘摴妛夛妛弍廤夛 (2020/12/10), 摽搰 (僴僀僽儕僢僪奐嵜).
723250. [妛夛 (慡崙)] (堦斒島墘) 怘摴娻弍屻偺朌崌晄慡夵慞傪栚巜偟偨嵞寶堓娗偍傛傃嵞寶宱楬嶌惉. 怴尨惓戝1, 嵶揷丂宩1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 揧栰岶暥2, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞74夞擔杮怘摴妛夛妛弍廤夛 (2020/12/10), 摽搰 (僴僀僽儕僢僪奐嵜).
723251. [妛夛 (慡崙)] (堦斒島墘) 怘摴娻偵偍偗傞栻嵻懴惈偵娭梌偡傞儮Np63/SOX2堚揱巕偺梊應儅乕僇乕偲偟偰偺専摙. 尨揷岹婸1, 戝愹梲夘, 揧栰岶暥2, 榟旜恀棟垽1, 媿媣廏庽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞74夞擔杮怘摴妛夛妛弍廤夛 (2020/12/10), 摽搰 (僴僀僽儕僢僪奐嵜).
723252. [妛夛 (慡崙)] (堦斒島墘) 怘摴尨敪GIST偵懳偡傞庤弍愴棯偵偮偄偰偺専摙. 摗旜弐堯1, 尨揷岹婸2, 榟旜恀棟垽2, 烴扟旤婱巕2, 媿媣廏庽2, 怴尨惓戝2, 嵶揷丂宩2, 嶳壓宲巎2,3, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞74夞擔杮怘摴妛夛妛弍廤夛 (2020/12/10), 摽搰 (僴僀僽儕僢僪奐嵜).
723253. [妛夛 (慡崙)] (堦斒島墘) 怘摴娻愗彍屻崌暪徢梊杊偺偨傔偺庤弍帪儘儃僢僩棙梡. 嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 揧栰岶暥2, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞74夞擔杮怘摴妛夛妛弍廤夛 (2020/12/10), 摽搰 (僴僀僽儕僢僪奐嵜).
723254. [妛夛 (慡崙)] (堦斒岥墘) 廃弍婜Patient selection偵傛傞怘摴娻帯椕嵟揔壔傊偺挧愴. 嶳壓宲巎1,2, 尨揷岹婸2, 怴尨惓戝2, 嵶揷丂宩2, 媿媣廏庽2, 榟旜恀棟垽2, 烴扟旤婱巕2, 寴揷恊棙3, 愇嶳攷瀶4, 斾婇捈庽2 (1怴悽婭堛椕丒墶抐揑堛椕, 2忋晹徚壔娗奜, 3徚壔婍撪, 4曻幩慄 (庮釃)): 戞74夞擔杮怘摪妛夛妛弍廤夛 (2020/12/10-11), 摽搰 (僴僀僽儕僢僪奐嵜), 擔杮怘摴妛夛妛弍廤夛僾儘僌儔儉丒彺榐廤 2020/12; 74: 18.
723255. [妛夛 (慡崙)] (堦斒島墘) 崅楊幰恑峴堓娻姵幰偵懳偡傞optional LECS. 榟旜恀棟垽1, 斾婇捈庽1, 揧栰岶暥2, 尨揷岹婸1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723256. [妛夛 (慡崙)] (堦斒島墘) 桯栧懁堓愗彍屻偺Roux-en-Y嵞寶偲Billroth-I朄嵞寶偺挿婜梊屻偺専摙. 戝栘宑巕1, 尨揷岹婸2, 揧栰岶暥3, 榟旜恀棟垽2, 烴扟旤婱巕2, 媿媣廏庽2, 怴尨惓戝2, 嵶揷丂宩2, 嶳壓宲巎2,4, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3戝妛堾堛椕宯尋媶壢, 4怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723257. [妛夛 (慡崙)] (堦斒島墘) 堓愗彍屻偺巆堓奼挘傪梊應偡傞暊晹扨弮儗儞僩僎儞偺桳梡側巜昗. 搉晹峎巕1, 尨揷岹婸2, 揧栰岶暥3, 榟旜恀棟垽2, 烴扟旤婱巕2, 媿媣廏庽2, 怴尨惓戝2, 嵶揷丂宩2, 嶳壓宲巎2,4, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3戝妛堾堛椕宯尋媶壢, 4怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723258. [妛夛 (慡崙)] (堦斒島墘) 弍慜壔妛椕朄傪巤峴偟偨堓娻弍屻崌暪徢椺偺梊屻傊偺塭嬁. 尨揷岹婸1, 媿媣廏庽1, 揧栰岶暥2, 榟旜恀棟垽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723259. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓堓愗彍偵偍偗傞鋁忋墢妔惔帪偺鋁揮偑偟朄偺岺晇. 摗旜弐堯1, 媿媣廏庽2, 嵶揷丂宩2, 怴尨惓戝2, 烴扟旤婱巕2, 榟旜恀棟垽2, 尨揷岹婸2, 揧栰岶暥3, 嶳壓宲巎2,4, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3戝妛堾堛椕宯尋媶壢, 4怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723260. [妛夛 (慡崙)] (堦斒島墘) 愗彍晄擻恑峴堓娻偵懳偡傞丆摉堾偵偍偗傞怴偟偄弍慜壔妛椕朄偵傛傞Conversion surgery偺惉愌. 烴扟旤婱巕1, 嶳壓宲巎1,2, 揧栰岶暥3, 尨揷岹婸1, 榟旜恀棟垽1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕, 3戝妛堾堛椕宯尋媶壢): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723261. [妛夛 (慡崙)] (堦斒島墘) 怘摴堓愙崌晹娻偵懳偡傞暊峯嬀壓暚栧懁堓愗彍丒嫻峯撪忋愳朄嵞寶偺桳梡惈. 媿媣廏庽1, 嵶揷丂宩1, 怴尨惓戝1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 揧栰岶暥2, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723262. [妛夛 (慡崙)] (堦斒島墘) 儘儃僢僩巟墖嫻峯嬀壓怘摴愗彍弍偺埵抲偯偗. 怴尨惓戝1, 嵶揷丂宩1, 媿媣廏庽1, 榟旜恀棟垽1, 烴扟旤婱巕1, 尨揷岹婸1, 揧栰岶暥2, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723263. [妛夛 (慡崙)] (堦斒島墘) 鈛鈨晹愗彍偵拝栚偟偨堓愗彍朄暿懱廳丒崪奿嬝検尭彮棪偺専摙亅摉堾偺尰忬傪摜傑偊偰亅. 烴扟旤婱巕1, 斾婇捈庽1, 揧栰岶暥2, 尨揷岹婸1, 榟旜恀棟垽1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 擔杮奜壢戙幱塰梴妛夛戞57夞妛弍廤夛 (2020/12/24-26), Web奐嵜.
723264. [妛夛 (慡崙)] (堦斒島墘) 崅楊幰怘摴偑傫庤弍徢椺偵偍偗傞塰梴愛庢検帺屓昡壙僔乕僩偺桳梡惈偺専摙. 怴尨惓戝1, 媿媣廏庽1, 尨揷岹婸1, 媏抮撧曚巕2, 榟旜恀棟垽1, 烴扟旤婱巕1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2塰梴晹, 3怴悽婭堛椕丒墶抐揑堛椕): 擔杮奜壢戙幱塰梴妛夛戞57夞妛弍廤夛 (2020/12/24-26), Web奐嵜.
723265. [妛夛 (慡崙)] (堦斒島墘) 鈛鈨晹愗彍偵拝栚偟偨堓愗彍朄暿懱廳丒崪奿嬝検尭彮棪偺専摙. 烴扟旤婱巕1, 斾婇捈庽1, 揧栰岶暥2, 尨揷岹婸1, 榟旜恀棟垽1, 媿媣廏庽1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞93夞擔杮堓娻妛夛憤夛 (2021/3/3), Web奐嵜.
723266. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓堓愗彍偵偍偗傞鋁傪埑攔偟側偄揥奐. 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞93夞擔杮堓娻妛夛憤夛 (2021/3/3), Web奐嵜.
723267. [妛夛 (慡崙)] (堦斒島墘) 鋁憻旕埑攔鋁忋墢儕儞僷愡妔惔傪敽偭偨儘儃僢僩巟墖堓愗彍弍. 嵶揷丂宩1, 尨揷岹婸1, 榟旜恀棟垽1, 烴扟旤婱巕1, 媿媣廏庽1, 怴尨惓戝1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞93夞擔杮堓娻妛夛憤夛 (2021/3/3), Web奐嵜.
723268. [妛夛 (慡崙)] (堦斒島墘) QOL偺柺偐傜傒偨堓娻帯椕偺岺晇亅寣摐曄摦偵敽偆堓愗彍屻僟儞僺儞僌徢忬偺夵慞偺宱尡偲屄暿壔塰梴椕朄偺夘擖偺帋傒亅. 怴尨惓戝1, 媿媣廏庽1, 嵶揷丂宩1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞93夞擔杮堓娻妛夛憤夛 (2021/3/3), Web奐嵜.
723269. [妛夛 (慡崙)] (堦斒島墘) 堓娻偵懳偡傞撪帇嬀傪棙梡偟偨帯椕 (ESD, LECS) 偺尰忬偲揥朷亅崅楊幰堓娻姵幰偵懳偡傞optional LECS亅. 榟旜恀棟垽1, 斾婇捈庽1, 嵶揷丂宩1, 怴尨惓戝1, 媿媣廏庽1, 烴扟旤婱巕1, 榓揷戱栫2, 尨揷岹婸1, 揧栰岶暥3, 揷绯丂憦2,4, 嶳壓宲巎1,5 (1忋晹徚壔娗奜, 2徚壔婍撪, 3戝妛堾堛椕宯尋媶壢, 4怴悽婭堛椕丒愭抂堛椕, 5怴悽婭堛椕丒墶抐揑堛椕): 戞93夞擔杮堓娻妛夛憤夛 (2021/3/3), Web奐嵜.
723270. [妛夛 (慡崙)] (堦斒島墘) 暚栧懁堓愗彍弍偵偍偗傞庤弍庤媄偺岺晇丂暚栧懁堓愗彍弍偵偍偗傞嵟揔側嵞寶朄偵偮偄偰偺専摙. 尨揷岹婸1, 揧栰岶暥2, 榟旜恀棟垽1, 媿媣廏庽1, 烴扟旤婱巕1, 怴尨惓戝1, 嵶揷丂宩1, 嶳壓宲巎1,3, 斾婇捈庽1 (1忋晹徚壔娗奜, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞93夞擔杮堓娻妛夛憤夛 (2021/3/3), Web奐嵜.
723271. [妛夛 (慡崙)] (堦斒島墘) 堓娻夋憸恌抐偺怴悽奅丂堓娻偺CT偵傛傞晹埵暿怺払搙恌昡壙偵偮偄偰. 墱栰峎懢1, 尨揷岹婸2, 榟旜恀棟垽2, 媿媣廏庽2, 烴扟旤婱巕2, 怴尨惓戝2, 嵶揷丂宩2, 嶳壓宲巎2,3, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞93夞擔杮堓娻妛夛憤夛 (2021/3/3), Web奐嵜.
733055. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怘摴滸暯忋旂娻偺摨帪堚揱巕憹暆偵傛傞壔妛椕朄掞峈惈偺妉摼. 揧栰岶暥1, 尨揷岹婸2, 烴扟旤婱巕2, 媿媣廏庽2, 榟旜恀棟垽2, 怴尨惓戝2, 嵶揷丂宩2, 斾婇捈庽2, 嶳壓宲巎2,3 (1戝妛堾堛椕宯尋媶壢, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞40夞擔杮暘巕庮釃儅乕僇乕尋媶夛 (2020/9/30), Web奐嵜.
733056. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怘摴娻偵偍偗傞梊屻場巕偲偟偰帯椕慜C-reactive protein抣偺専摙. 屻摗戩栫1, 揧栰岶暥1, 尨揷岹婸2, 榟旜恀棟垽2, 烴扟旤婱巕2, 媿媣廏庽2, 怴尨惓戝2, 嵶揷丂宩2, 斾婇捈庽2, 嶳壓宲巎2,3 (1戝妛堾堛椕宯尋媶壢, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞40夞擔杮暘巕庮釃儅乕僇乕尋媶夛 (2020/9/30), Web奐嵜.
733057. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 戝挵娻徢椺偵偍偗傞Ascl2/Wnt2堚揱巕敪尰偵娭偡傞椪彴昦棟妛揑専摙. 峛斻揷晲巙1, 摗嶳朏庽1, 揧栰岶暥1, 墶揷岝墰1, 屻摗戩栫1, 嫜丂桾椇1, 摗栰帊怐1, 嶳壓宲巎2,3 (1戝妛堾堛椕宯尋媶壢, 2怴悽婭堛椕丒墶抐揑堛椕, 3忋晹徚壔娗奜): 戞40夞擔杮暘巕庮釃儅乕僇乕尋媶夛 (2020/9/30), Web奐嵜.
733058. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 暊峯嬀壓暚栧懁堓愗彍偵偍偗傞Double-flap朄嵞寶偲Orvil朄嵞寶偺専摙 斾婇捈庽 (忋晹徚壔娗奜): 戞50夞堓奜壢丒弍屻忈奞尋媶夛 (2020/11/14), Web奐嵜.
733059. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 崅楊幰堓娻姵幰偵懳偟娚榓LECS傪巤峴偟偨4椺偺専摙. 榟旜恀棟垽1, 斾婇捈庽1, 榓揷戱栫2, 怴尨惓戝1, 揷绯丂憦2,3 (1忋晹徚壔娗奜, 2徚壔婍撪, 3怴悽婭堛椕丒愭抂堛椕): 戞111夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/12/19), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-110018. [尨挊] Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy. Yasufuku I, Nunobe S, Ida S, Kumagai K, Manabu Ohashi M1, Hiki N1, Sano T: Gastric Cancer 2020/3; 23 (2): 319-27. (斾婇捈庽1: 1忋晹徚壔娗奜)
[挊丂彂]
'19-620008. [妛弍彂 (暘扴幏昅)]亂椷榓僗僞僀儖 嬀帇壓堓庤弍偺偡傋偰亃彉暥, p.iii. 憤榑: 暊峯嬀壓庤弍偱弌寣偝偣側偄僐僣, p.2-6. 僐儔儉: 桯栧壓摦惷柆廃埻偺妔惔傪娙扨偵偡傞怴偟偄No.6 妔惔, p.92-9. 斾婇捈庽 (忋晹徚壔娗奜), 曇: 斾婇捈庽, 晍巤憂栫, 儊僕僇儖價儏乕幮, 搶嫗, 2019/12敪峴.
'19-620009. [妛弍彂 (暘扴幏昅)]亂椷榓僗僞僀儖 嬀帇壓堓庤弍偺偡傋偰亃僐儔儉: 儘儃僢僩庤弍偼杮摉偵崌暪徢傪寉尭偡傞偐?, p.157-9. 嵶揷丂宩 (忋晹徚壔娗奜), 曇: 斾婇捈庽, 晍巤憂栫, 儊僕僇儖價儏乕幮, 搶嫗, 2019/12敪峴.
'19-620010. [妛弍彂 (暘扴幏昅)]亂徚壔婍奜壢愱栧堛偺怱摼 忋姫亃1. 徚壔婍奜壢妛憤榑丂2. 塰梴偲戙幱丂4. 塰梴娗棟丂廃弍婜偺塰梴娗棟, p.12-6. 斾婇捈庽 (忋晹徚壔娗奜), 堦斒幮抍朄恖 擔杮徚壔婍奜壢妛夛 搶嫗, 2020/2敪峴.
[妛夛丒尋媶夛摍]
'19-723019. [妛夛 (慡崙)] (堦斒島墘) 偑傫壔妛椕朄丒曻幩慄椕朄偵偍偗傞塰梴巟帩椕朄偺栶妱丂忋晹徚壔娗庤弍屻偺塰梴巟帩椕朄. 怴尨惓戝1, 嵶揷丂宩1, 媿媣廏庽1, 烴扟旤婱巕1, 榟旜恀棟垽1, 尨揷岹婸1, 嶳壓宲巎1,2, 斾婇捈庽1 (1忋晹徚壔娗奜, 2怴悽婭堛椕丒墶抐揑堛椕): 戞35夞擔杮椪彴塰梴戙幱妛夛妛弍廤夛 (2020/2/27), 帍忋奐嵜.
'19-723020. [妛夛 (慡崙)] (堦斒島墘) 堓愗彍弍屻偺憗婜塰梴偍傛傃塣摦夘擖偺岠壥. 堜揷丂抭, 孎扟岤巙, 徏旜岹旤, 晍晹憂栫, 斾婇捈庽1 (1忋晹徚壔娗奜): 戞35夞擔杮椪彴塰梴戙幱妛夛妛弍廤夛 (2020/2/27), 帍忋奐嵜.
壓晹徚壔娗奜壢妛
[妛弍榑暥]
110239. [尨挊] The Function and Prognostic Significance of Cripto-1 in Colorectal Cancer. Sato J, Karasawa H, Suzuki T, Nakayama S, Katagiri M, Maeda S, Ohnuma S, Motoi F, Naitoh T1, Unno M: Cancer Invest 2020/4; 38 (4): 214-27. (撪摗丂崉1: 1壓晹徚壔娗奜)
110240. [尨挊] Prognostic indicators in pancreatic cancer patients undergoing total pancreatectomy. Maeda S, Ariake K, Iseki M, Ohtsuka H, Mizuma M, Nakagawa K, Morikawa T, Hayashi H, Motoi F, Kamei T, Naitoh T1, Unno M: Surg Today 2020/5; 50 (5): 490-8. (撪摗丂崉1: 1壓晹徚壔娗奜)
110241. [尨挊] Mechanism of Bile Acid Reabsorption in the Biliopancreatic Limb After Duodenal-Jejunal Bypass in Rats. Ueno T, Tanaka N, Imoto H, Maekawa M, Kohyama A, Watanabe K, Motoi F, Kamei T, Unno M, Naitoh T1: Obes Surg 2020/7; 30 (7): 2528-37. (撪摗丂崉1: 1壓晹徚壔娗奜)
110242. [尨挊] Influence of chemoradiotherapy on nutritional status in locally advanced rectal cancer: Prospective multicenter study. Yamano T, Tomita N, Sato T1, Hayakawa K, Kamikonya N, Matoba S, Uki A, Baba H, Oya N, Hasegawa H, Shigematsu N, Hiraoka M, Shimada M, Noda M, Sakai Y, Sato H, Saegusa M2, Takeuchi M, Oguchi M, Oya M, Watanabe M1,3: Nutrition 2020/9; 77: 110807. (嵅摗晲榊1, 嶰巬丂怣2, 搉绮徆旻1,3: 1壓晹徚壔娗奜, 2昦棟, 3杒棦戝妛杒棦尋媶強昦堾)
110243. [尨挊] Current status of laparoscopic bariatric/metabolic surgery in Japan: The sixth nationwide survey by the Japan Consortium of Obesity and Metabolic Surgery. Ohta M1, Kasama K1, Sasaki A1, Naitoh T1,2, Seki Y1, Inamine S1, Oshiro T1, Doki Y1, Seto Y1, Hayashi H1, Uyama I1, Takiguchi S1, Kojima K1, Mori T1, Inomata M1, Kitagawa Y1, Kitano S1 (1Japan Consortium of Obesity and Metabolic Surgery (JCOMS)): Asian J Endosc Surg 2021/4; 14 (2): 170-7. doi: 10.1111/ases.12836. Epub 2020 Jul 21. (撪摗丂崉1,2: 2壓晹徚壔娗奜)
320006. [徢椺曬崘] 鋁娻壔妛椕朄拞偵梓棻媴僐儘僯乕巋寖場巕惢嵻偵傛傞戝摦柆墛傪敪徢偟偨1椺. 媨嶈寬恖, 崅娳払擵, 尦堜搤旻, 婽堜丂彯, 撪摗丂崉1, 奀栰椣柧 (1壓晹徚壔娗奜): 娻偲壔妛椕朄 2020/5; 47 (5): 851-3.
320007. [徢椺曬崘] 嬊強壓晹恑峴捈挵娻偵懳偟弍慜壔妛曻幩慄椕朄偱cCR 偲側傝挿婜Watch and Wait偺1椺. 彫浉宑懢1, 拞懞棽弐1, 嵅摗晲榊1, 搉绮徆旻2 (1壓晹徚壔娗奜, 2杒棦戝妛杒棦尋媶強昦堾): 娻偲壔妛椕朄 2020/8; 47 (8): 1241-13.
320008. [徢椺曬崘] 崅搙旍枮傪崌暪偟偨S忬寢挵娻銷泖怹弫徢椺偵懳偟壔妛椕朄丒尭検屻崻帯愗彍偟摼偨1椺. 揷嶳曚崅, 搨郪廏柧, 妬尨戝婸, 楅栘廏岾, 嶳懞柧姲, 恄嶳撃巎, 搉曈榓岹, 戝徖丂擡, 婽堜丂彯, 撪摗丂崉1, 奀栰椣柧 (1壓晹徚壔娗奜): 娻偲壔妛椕朄 2020/12; 47 (13): 2320-2.
320009. [徢椺曬崘] 暊晹戝摦柆釒僗僥儞僩僌儔僼僩撪憓弍屻偵暊峯嬀壓捈挵愗彍弍傪巤峴偟偨堦椺. 彫浉宑懢1, 塇淎寬恗2, 嶰塝孾氭1, 墴揷彫昐崌3, 榤扟旤撧3, 椦丂嫗巕3, 拞懞棽弐1, 撪摗丂崉1, 愇堜寬堦榊2 (1壓晹徚壔娗奜, 2憡柾栰昦堾, 3擕態丒峛忬態奜): 杒棦堛妛 2020/12; 50 (2): 125-8.
521007. [夝愢]亂夝愢4亃colitic cancer. 嵅摗晲榊1, 嶳棞崅峀1, 嶰塝孾氭1, 屆忛丂寷1, 墶堜孿屽1, 揷拞弐摴1, 攱尨愮宐1, 撪摗丂崉1 (1壓晹徚壔娗奜): 徚壔婍奜壢 2020/7; 43 (8): 1277-80.
522055. [島嵗]亂楢嵹: 巹偺帯椕亃恑峴戝挵娻. 愇堜椙岾1,2, 搉绮徆旻2 (1壓晹徚壔娗奜, 2杒棦戝妛杒棦尋媶強昦堾): 擔杮堛帠怴曬 2020/4; 5007: 39.
522056. [島嵗]亂摿廤: 幚慔! 庤弍偑忋払偡傞僩儗乕僯儞僌朄亅Off the Job Training偺嵟怴摦岦亃仭庤弍偺榬傪杹偔偨傔偵昁梫側價僨僆夋憸偵傛傞妛廗丂庤弍摦夋偺曐懚僔僗僥儉: 摦夋偺夋幙偲曐懚曽朄,屄恖忣曬曐岇偺娤揰偐傜. 撪摗丂崉 (壓晹徚壔娗奜): 椪彴奜壢 2020/4; 75 (4): 397-401.
522057. [島嵗]亂摿廤: 撪帇嬀奜壢庤弍偵昁梫側嬊強夝朥亅寢挵丒捈挵亃暊峯嬀壓寢挵塃敿愗彍弍偵昁梫側嬊強夝朥. 屆忛丂寷1, 嵅摗晲榊1, 嶰塝孾氭1, 墶堜孿屷1, 揷拞弐摴1, 撪摗丂崉1 (1壓晹徚壔娗奜): 庤弍 2020/12; 74 (13): 1805-13.
522058. [島嵗]亂摿廤: 娞撪抇娗娻傪嬌傔傞亃II. 娞撪抇娗娻偺椪彴丂娞撪抇娗娻偺奜壢揑帯椕亅愗彍壜擻惈偐傜帯桙壜擻惈傊: 鉱枾側庤弍愴棯偲transplant oncology偑傕偨傜偡僷儔僟僀儉僔僼僩亅. 抾懞桾夘1, 垻晹梇懢, 愇堜椙岾1,2, 搉绮徆旻1, 擔斾懽憿 (1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜): 娞抇鋁 2021/2; 82 (2): 215-23.
[挊丂彂]
620044. [妛弍彂 (暘扴幏昅)]亂弍慜丒弍屻娗棟昁実2020 (徚壔婍奜壢2020擭4寧憹姧崋)亃III. 弍幃暿弍慜丒弍屻娗棟丂3. 彫挵丒戝挵丂5) 戝挵娻挵暵嵡, p.651-5. 棊崌戝庽1, 愇堜椙岾1,2, 搉绮徆旻1 (1杒棦戝妛杒棦尋媶強昦堾, 2壓晹徚壔娗奜), 傊傞偡弌斉, 搶嫗, 2020/4敪峴.
620045. [妛弍彂 (暘扴幏昅)]亂暿嶜擔杮椪喱 椞堟暿徢岓孮僔儕乕僘 No.12丂徚壔娗徢岓孮 (戞3斉) IV亅偦偺懠偺徚壔娗幘姵傪娷傔偰亅亃3. 挵暵嵡丂(2) 桙拝惈挵暵嵡, p.304-10. 愇堜椙岾1,2, 棊崌戝庽2, 敆丂桾擵2, 搉绮徆旻2 (1壓晹徚壔娗奜, 2杒棦戝妛杒棦尋媶強昦堾), 擔杮椪喱幮, 搶嫗, 2020/5敪峴.
620046. [妛弍彂 (暘扴幏昅)]亂戝挵奜壢庤弍偵偍偗傞僩儔僽儖僔儏乕僥傿儞僌 (庤弍2020擭7寧憹戝崋)亃I. 弍拞弌寣丂6) 暊峯嬀壓捈挵娻庤弍偵偍偗傞弍拞弌寣偺梊杊偲懳張朄, p.1113-20. 愇堜椙岾1,2, 棊崌戝庽2, 敆丂桾擵2, 搉绮徆旻2 (1壓晹徚壔娗奜, 2杒棦戝妛杒棦尋媶強昦堾), 嬥尨弌斉, 搶嫗, 2020/7敪峴.
620047. [妛弍彂 (暘扴幏昅)]亂戝挵奜壢庤弍偵偍偗傞僩儔僽儖僔儏乕僥傿儞僌 (庤弍2020擭7寧憹戝崋)亃III. 徚壔娗朌崌丒暙崌丂1) 朌崌晄慡傪杊偖庤朌偄暙崌偺岺晇偲僩儔僽儖僔儏乕僥傿儞僌, p.1185-90. 撪摗丂崉1, 嵅摗晲榊1, 嶰塝孾氭1, 屆忛丂寷1, 墶堜孿屽1, 揷拞弐摴1 (1壓晹徚壔娗奜), 嬥尨弌斉, 搶嫗, 2020/7敪峴.
620048. [妛弍彂 (暘扴幏昅)]亂旍枮徢奜壢帯椕偺嵟慜慄 (BIO Clinica 2020擭11寧椪帪憹姧崋)亃尭検丒戙幱夵慞庤弍偺暘巕婡峔亅徚壔娗偵傛傞摐戙幱惂屼亅, p.1224-8. 撪摗丂崉 (壓晹徚壔娗奜), 杒棽娰, 搶嫗, 2020/10敪峴.
620049. [妛弍彂 (暘扴幏昅)]亂憗傢偐傝朌崌丒暙崌偺偡傋偰 (椪彴奜壢2020擭10寧憹姧崋)亃1復 朌崌丒暙崌朄偺婎杮丂寢鉌 (巺寢傃) 偺曽朄丂撪帇嬀壓, p.28-31. 撪摗丂崉1, 媿媣廏庽2, 墶堜孿屽1, 屆忛丂寷1, 揷拞弐摴1, 嶰塝孾氭1, 揷搰丂峅3, 嶳棞崅峀1, 嵅摗晲榊1, 奀捗婱巎3, 嵶揷丂宩2, 嶳壓宲巎2,4, 孏尦梇夘3, 斾婇捈庽 (1壓晹徚壔娗, 2忋晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4怴悽婭堛椕丒墶抐揑堛椕), 堛妛彂堾, 搶嫗, 2020/10敪峴.
[妛夛丒尋媶夛摍]
713035. [妛夛 (崙嵺)] (堦斒島墘) Laparoscopic right colectomy with co-axial port setting. Naitoh T1: Elsa 2020 Virtual Congress (2020/9/11), Web奐嵜. (撪摗丂崉1: 1壓晹徚壔娗奜)
722060. [妛夛 (慡崙)] (彽懸島墘摍) 戙幱夵慞庤弍偲偟偰偺徚壔娗僶僀僷僗晅壛庤弍摫擖偵偍偗傞壽戣. 撪摗丂崉1, 揷拞捈庽1, 堜杮攷暥, 媿媣廏庽2, 怴尨惓戝2, 榟旜恀棟垽2, 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1, 嵶揷丂宩2, 嶳壓宲巎2,3, 斾婇捈庽2 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10), 墶昹 (僴僀僽儕僢僪奐嵜).
722061. [妛夛 (慡崙)] (彽懸島墘摍) 旍枮2宆摐擜昦姵幰偵懳偡傞尭検丒戙幱夵慞庤弍偺姲夝梊應場巕偺専徹 撪摗丂崉1, 妢娫榓揟, 堫奯挩栫, 摗憅弮擇, 彫愳丂徛, 淎揷桬巑, 懢揷惓擵, 彫嶳塸懃, 塊栘丂抭, 嶳岥丂悞 (1壓晹徚壔娗奜): 戞41夞擔杮旍枮妛夛丒戞38夞擔杮旍枮徢帯椕妛夛妛弍廤夛 (2021/3/21), Web奐嵜.
723272. [妛夛 (慡崙)] (堦斒島墘) 壔妛椕朄偵傛傝娞揮堏偑徚幐偟挿婜惗懚傪摼偨捈挵娻摨帪惈懡敪娞揮堏偺1椺. 攱尨愮宐1, 拞懞棽弐1, 墶堜孿屽1, 屆忛丂寷1, 嶰塝孾氭1, 嵅摗晲榊1 (1壓晹徚壔娗奜): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13), Web奐嵜.
723273. [妛夛 (慡崙)] (堦斒島墘) BMI偼寢挵娻庤弍偺抁婜惉愌偱儕僗僋場巕偵側傝摼傞偐. 墶堜孿屽1, 拞懞棽弐1, 攱尨愮宐1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1 (1壓晹徚壔娗奜): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/14), Web奐嵜.
723274. [妛夛 (慡崙)] (堦斒島墘) 嬊強恑峴捈挵娻偵懳偡傞弍慜壔妛曻幩慄帯椕屻偺Watch-and-wait approach偲Salvage庤弍. 屆忛丂寷1, 拞懞棽弐1, 嵅摗晲榊1, 嶳棞崅峀1, 嶰塝孾氭1, 墶堜孿屽1, 攱尨愮宐1 (1壓晹徚壔娗奜): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/14), Web奐嵜.
723275. [妛夛 (慡崙)] (堦斒島墘) 嬊強恑峴捈挵娻偵懳偡傞曻幩慄姶庴惈傪憹嫮偡傞TS-1傪梡偄偨帯椕愴棯偺挿婜梊屻. 拞懞棽弐1, 嵅摗晲榊1, 搉绮徆旻2 (1壓晹徚壔娗奜, 2杒棦戝妛杒棦尋媶強昦堾): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/14), Web奐嵜.
723276. [妛夛 (慡崙)] (堦斒島墘) 堓娻庤弍偵偍偗傞僒儖僐儁僯傾偲梊屻偲偺専摙. 敆丂桾擵1, 戝嶌徆媊1, 杒丂塸揟1, 慜揷擔嵷巕1, 塉媨棽夘1, 棊崌戝庽1, 愇堜椙岾1,2, 恄扟婭婸1,3, 屲寧彈宐堦1, 媏抮巎榊1,4, 搉绮徆旻1 (1杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3屇媧婍奜, 4昦堾楢実嫵堢): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13-15), Web奐嵜.
723277. [妛夛 (慡崙)] (堦斒島墘) 摉壢偵偍偗傞媫惈拵悅墛偺帯椕愴棯. 塉媨棽夘1, 愇堜椙岾1,2, 杒丂塸揟1, 慜揷擔嵷巕1, 敆丂桾擵1, 棊崌戝庽1, 屲寧彈宐堦1, 恄扟婭婸1,3, 搉绮徆旻1 (1杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3屇媧婍奜): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13-15), Web奐嵜.
723278. [妛夛 (慡崙)] (堦斒島墘) 擕娻惗専慻怐偲愗彍昗杮偵偍偗傞昦棟慻怐妛揑場巕偺堦抳偺専摙. 屲寧彈宐堦1, 慜揷擔嵷巕1, 抮揷丂惓1, 桍郪婱巕1, 杒丂塸揟1, 塉媨棽夘1, 敆丂桾擵1, 棊崌戝庽1, 戝嶌徆媊1, 恄扟婭婸1,2, 愇堜椙岾1,3, 戝晹丂惤1, 慜揷堦榊1, 搉绮徆旻1 (1杒棦尋媶強昦堾, 2屇媧婍奜, 3壓晹徚壔娗奜): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13-15), Web奐嵜.
723279. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞HER2梲惈擕娻偺帯椕惉愌偐傜傒偨廃弍婜Pertuzumab偺揔墳偵偮偄偰偺専摙. 慜揷擔嵷巕1, 抮揷丂惓1, 杒丂塸揟1, 塉媨棽夘1, 桍郪婱巕1, 敆丂桾擵1, 棊崌戝庽1, 恄扟婭婸1,2, 屲寧彈宐堦1, 戝嶌徆媊1, 愇堜椙岾1,3, 搉绮徆旻1, 戝晹丂惤1, 慜揷堦榊1,4 (1杒棦尋媶強昦堾, 2屇媧婍奜, 3壓晹徚壔娗奜, 4昦棟): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13-15), Web奐嵜.
723280. [妛夛 (慡崙)] (堦斒島墘) 恖岺汨栧憿愝弍偑桳岠偩偭偨枬惈媇惖挵暵嵡偺堦椺. 彫浉宑懢, 攱尨愮宐1, 嵅摗晲榊1, 拞懞棽弐1 (1壓晹徚壔娗奜): 戞56夞擔杮暊晹媬媫堛妛夛憤夛 (2020/10/8), 柤屆壆 (僴僀僽儕僢僪奐嵜).
723281. [妛夛 (慡崙)] (堦斒島墘) 弍屻挵暵嵡偵懳偟偰暊峯嬀壓庤弍偼桳梡偐丂奐暊堏峴徢椺偺専摙. 拞懞棽弐1, 嵅摗晲榊1, 攱尨愮宐1, 搉绮徆旻2 (1壓晹徚壔娗奜, 2杒棦戝妛杒棦尋媶強昦堾): 戞56夞擔杮暊晹媬媫堛妛夛憤夛 (2020/10/8), 柤屆壆 (僴僀僽儕僢僪奐嵜).
723282. [妛夛 (慡崙)] (堦斒島墘) 擕摢壏懚擕朳愗彍弍+帀朾拲擖嵞寶屻偵嵞敪傪偒偨偟偨1徢椺. 摗栰巎怐1, 錟暲丂彑, 拞媨婭巕, 抾壓棙晇, 壀杮丂棨1, 悈栰枩棦, 戝愹梲夘, 揷拞弐摴1, 崻杮徆擵, 彫憅捈恖1 (1壓晹徚壔娗奜): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723283. [妛夛 (慡崙)] (堦斒島墘) 擕娻偵偍偗傞Ki67偺椪彴昦棟妛揑場巕偲偺娭學, 梊屻場巕偲偟偰偺廳梫惈. 屲寧彈宐堦1, 慜揷擔嵷巕1, 桍郪婱巕1, 杒丂塸揟1, 塉媨棽夘1, 棊崌戝庽1, 敆丂桾擵1, 戝嶌徆媊1, 恄扟婭婸1,2, 愇堜椙岾1,3, 愺徖巎庽1, 搉绮徆旻1, 慜揷堦榊1,4, 抮揷丂惓1 (1杒棦尋媶強昦堾, 2屇媧婍奜, 3壓晹徚壔娗奜, 4昦棟): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/9-31), Web奐嵜.
723284. [妛夛 (慡崙)] (堦斒島墘) 恌抐偵嬯椂偟偨壓峴寢挵娻挵暵嵡偺宱尡. 棊崌戝庽1, 愇堜椙岾1,2, 敆丂桾擵1, 塉媨棽夘1, 慜揷擔嵷巕1, 杒丂塸揟1, 屲寧彈宐堦1, 戝嶌徆媊1, 恄扟婭婸1,3, 搉绮徆旻1 (1杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3屇媧婍奜): 戞56夞擔杮暊晹媬媫堛妛夛憤夛 (2020/10/8-11/2), 柤屆壆 (僴僀僽儕僢僪奐嵜).
723285. [妛夛 (慡崙)] (堦斒島墘) 朤恄宱愡庮釃偲偺娪暿偵擄廰偟偨彫挵恄宱撪暘斿庮釃 (NET) 偺堦椺. 崅嫶丂朑1, 屆忛丂寷1, 墶堜孿屽1, 揷拞弐摴1, 嶰塝孾氭1, 嵅摗晲榊1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/29), Web奐嵜.
723286. [妛夛 (慡崙)] (堦斒島墘) 嬊強恑峴捈挵偑傫偵懳偟偰弍慜壔妛曻幩慄帯椕屻偺Watch-and wait approach偲偟偨宱尡. 棊崌戝庽1, 愇堜椙岾1,2, 敆丂桾擵1, 塉媨棽夘1, 慜揷擔嵷巕1, 彫嬎夒悽1, 搉绮徆旻1 (1杒棦尋媶強昦堾, 2壓晹徚壔娗奜): 戞75夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2020/11/13-14), Web奐嵜.
723287. [妛夛 (慡崙)] (堦斒島墘) 奺壢偵偍偗傞儘儃僢僩巟墖壓庤弍偺岺晇: 捈挵娻偵懳偡傞暊峯嬀壓庤弍偲儘儃僢僩巟墖壓庤弍偺斾妑専摙. 嶰塝孾氭1, 嵅摗晲榊1, 揷拞弐摴1, 墶堜孿屽1, 屆忛丂寷1, 嵶揷丂宩2, 嶳壓宲巎2,3, 揷拞丂寜4,5, 嶰奒婱巎6, 孏尦梇夘5, 斾婇捈庽2, 撪摗丂崉1 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕, 4怴悽婭堛椕丒愭抂堛椕, 5堦斒丒彫帣丒娞抇鋁奜, 6擕態丒峛忬態奜): 戞58夞擔杮娻帯椕妛夛妛弍廤夛 (2020/10/22), 嫗搒 (僴僀僽儕僢僪奐嵜).
723288. [妛夛 (慡崙)] (堦斒島墘) Stage III戝挵娻偵偍偗傞CT傪梡偄偨崪奿嬝検應掕偵傛傞抁婜媦傃挿婜梊屻偺梊應. 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嶰塝孾氭1, 壛摗丂峅2, 奀捗婱巎3, 嵅摗晲榊1, 嵶揷丂宩4, 嶳壓宲巎4,5, 揷拞丂寜3,6, 嶰奒婱巎2, 孏尦梇夘3, 斾婇捈庽4, 撪摗丂崉1 (1壓晹徚壔娗奜, 2擕態丒峛忬態奜, 3堦斒丒彫帣丒娞抇鋁奜, 4忋晹徚壔娗奜, 5怴悽婭堛椕丒墶抐揑堛椕, 6怴悽婭堛椕丒愭抂堛椕): 戞58夞擔杮娻帯椕妛夛妛弍廤夛 (2020/10/22), 嫗搒 (僴僀僽儕僢僪奐嵜).
723289. [妛夛 (慡崙)] (堦斒島墘) 戝挵娻偵偍偗傞弍慜CT傪梡偄偨崪奿嬝検應掕偵傛傞抁婜媦傃挿婜梊屻偺梊應. 墶堜孿屽1, 揷拞弐摴1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1, 嵶揷丂宩2, 嶳壓宲巎2,3, 揷拞丂寜4,5, 嶰奒婱巎6, 孏尦梇夘5, 斾婇捈庽2, 撪摗丂崉1 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3怴悽婭堛椕丒墶抐揑堛椕, 4怴悽婭堛椕丒愭抂堛椕, 5堦斒丒彫帣丒娞抇鋁奜, 6擕態丒峛忬態奜): 戞82夞擔杮椪彴奜壢妛夛憤夛 (2020/10/29), Web奐嵜.
723290. [妛夛 (慡崙)] (堦斒島墘) 嬊強恑峴捈挵娻偵懳偡傞弍慜壔妛曻幩慄帯椕屻偺Watch-and-wait approach偺壜擻惈偲栤戣揰. 屆忛丂寷1, 嵅摗晲榊1, 嶳棞崅峀1, 嶰塝孾氭1, 墶堜孿屽1, 揷拞弐摴1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞75夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2020/11/13), Web奐嵜.
723291. [妛夛 (慡崙)] (堦斒島墘) 恑峴墶峴寢挵娻偵懳偡傞暊峯嬀壓庤弍偺抁婜媦傃挿婜惉愌. 嶰塝孾氭1, 屆忛丂寷1, 墶堜孿屽1, 揷拞弐摴1, 嵅摗晲榊1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞75夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2020/11/13), Web奐嵜.
723292. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞忋峴寢挵娻偵懳偡傞弍幃偺専摙. 墶堜孿屽1, 撪摗丂崉1, 嵅摗晲榊1, 嶰塝孾氭1, 屆忛丂寷1, 揷拞弐摴1 (1壓晹徚壔娗奜): 戞75夞擔杮戝挵汨栧昦妛夛妛弍廤夛 (2020/11/13), Web奐嵜.
723293. [妛夛 (慡崙)] (堦斒島墘) 恑峴捈挵娻偵懳偡傞壔妛曻幩慄帯椕屻偺Watch-and-wait approach偵偍偗傞Clinical complete response偺敾掕. 屆忛丂寷1, 攱尨愮宐1, 墶堜孿屽1, 嶰塝孾氭1, 嶳棞崅峀1, 嵅摗晲榊1, 拞懞棽弐1 (1壓晹徚壔娗奜): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723294. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓寢挵娻偵偍偗傞BMI偺抁婜惉愌偵懳偡傞塭嬁偺専摙. 墶堜孿屽1, 拞懞棽弐1, 攱尨愮宐1, 屆忛丂寷1, 嶰塝孾氭1, 嵅摗晲榊1 (1壓晹徚壔娗奜): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723295. [妛夛 (慡崙)] (堦斒島墘) 摉堾偺捈挵娻偵懳偡傞儘儃僢僩巟墖壓庤弍. 嶰塝孾氭1, 拞懞棽弐1, 攱尨愮宐1, 墶堜孿屽1, 屆忛丂寷1, 嵅摗晲榊1, 撪摗丂崉1, 搉绮徆旻2 (1壓晹徚壔娗奜, 2杒棦戝妛杒棦尋媶強昦堾): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723296. [妛夛 (慡崙)] (堦斒島墘) 曻幩慄帯椕屻7擭栚偵挵暵嵡傪宊婡偵恌抐偝傟偨曻幩惈彫挵墛偺1椺. 杒丂塸揟1, 棊崌戝庽1, 愇堜椙岾1,2, 塉媨棽夘1, 敆丂桾擵1, 慜揷擔嵷巕1, 戝嶌徆媊1, 屲寧彈宐堦1, 恄扟婭婸1,3, 搉绮徆旻1 (1杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3屇媧婍奜): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723297. [妛夛 (慡崙)] (堦斒島墘) 弍慜嬝擏検偑弍屻曗彆壔妛椕朄偵媦傏偡塭嬁. 敆丂桾擵1, 戝嶌徆媊1, 杒丂塸揟1, 慜揷擔嵷巕1, 塉媨棽夘1, 棊崌戝庽1, 愇堜椙岾1,2, 恄扟婭婸1,3, 屲寧彈宐堦1, 搉绮徆旻1 (1杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3屇媧婍奜): 戞75夞擔杮徚壔婍奜壢妛夛憤夛 (2020/12/15-17), 榓壧嶳 (僴僀僽儕僢僪奐嵜).
723298. [妛夛 (慡崙)] (堦斒島墘) 戝挵娻娞揮堏偵傛傞抇摴弌寣偵懳偟撪帇嬀, 曻幩慄帯椕偵傛傝媬柦偟摼偨1椺. 壀丂懽廈1, 抾懞桾夘1, 愇堜椙岾1,2, 敆丂桾擵1, 棊崌戝庽1, 搉绮徆旻1 (1杒棦尋媶強昦堾, 2壓晹徚壔娗奜): 戞57夞擔杮暊晹媬媫堛妛夛憤夛 (2021/3/11-12), Web奐嵜.
723299. [妛夛 (慡崙)] (堦斒島墘) 暊峯嬀壓庤弍偐傜儘儃僢僩巟墖壓暊峯嬀壓庤弍傊亅捈挵娻 庤弍庤媄偺僀僲儀乕僔儑儞亅. 嶳棞崅峀1, 嵅摗晲榊1, 嶰塝孾氭1, 屆忛丂寷1, 墶堜孿屽1, 揷拞弐摴1, 嵶揷丂宩2, 奀捗婱巎3, 愬愇婭旻4, 嶳壓宲巎2,5, 揷拞丂寜3,6, 斾婇捈庽2, 孏尦梇夘3, 嶰奒婱巎4, 撪摗丂崉1 (1壓晹徚壔娗奜, 2忋晹徚壔娗奜, 3堦斒丒彫帣丒娞抇鋁奜, 4擕態丒峛忬態奜, 5怴悽婭堛椕丒墶抐揑堛椕, 6怴悽婭堛椕丒愭抂堛椕): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10), 墶昹 (僴僀僽儕僢僪奐嵜).
723300. [妛夛 (慡崙)] (堦斒島墘) Safety and validity of laparoscopic surgery after NCRT for advanced lower rectal cancer. 屆忛丂寷1, 拞懞棽弐1, 嵅摗晲榊1, 嶳棞崅峀1, 嶰塝孾氭1, 墶堜孿屽1, 揷拞弐摴1, 攱尨愮宐1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10), 墶昹 (僴僀僽儕僢僪奐嵜).
723301. [妛夛 (慡崙)] (堦斒島墘) Surgical and Survival Outcomes of Surgery Alone for pT3-T4 Rectal Cancer. 攱尨愮宐1, 墶堜孿屽1, 屆忛丂寷1, 嶰塝孾氭1, 嵅摗晲榊1, 拞懞棽弐1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10), 墶昹 (僴僀僽儕僢僪奐嵜).
723302. [妛夛 (慡崙)] (堦斒島墘) The analysis of short- and long-term prognosis in laparoscopic right-side colectomy in our hospital. 墶堜孿屽1, 攱尨愮宐1, 屆忛丂寷1, 嶰塝孾氭1, 嵅摗晲榊1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/12), 墶昹 (僴僀僽儕僢僪奐嵜).
723303. [妛夛 (慡崙)] (堦斒島墘) 嬊強恑峴壓晹捈挵娻偵懳偡傞弍慜壔妛曻幩慄椕朄屻偺暊峯嬀/儘儃僢僩巟墖壓庤弍偺桳梡惈. 嵅摗晲榊1, 屆忛丂寷1, 嶰塝孾氭1, 揷拞弐摴1, 墶堜孿屽1, 嶳棞崅峀1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/12), 墶昹 (僴僀僽儕僢僪奐嵜).
723304. [妛夛 (慡崙)] (堦斒島墘) Evaluation of outlet obstruction after ileostomy in our hospital. 峛斻揷晲巙1, 屆忛丂寷2, 屻摗戩栫1, 攱尨愮宐2, 墶堜孿屽2, 揷拞弐摴2, 嶰塝孾氭2, 嶳棞崅峀2, 嵅摗晲榊2, 拞懞棽弐2, 撪摗丂崉2 (1戝妛堾堛椕宯尋媶壢, 2壓晹徚壔娗奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10-13), 墶昹 (僴僀僽儕僢僪奐嵜).
723305. [妛夛 (慡崙)] (堦斒島墘) The impact of body mass index on short-term outcome in laparoscopic colectomy. 屻摗戩栫1, 墶堜孿屽2, 攱尨愮宐2, 屆忛丂寷2, 嶰塝孾氭2, 嵅摗晲榊2, 撪摗丂崉2 (1戝妛堾堛椕宯尋媶壢, 2壓晹徚壔娗奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10-13), 墶昹 (僴僀僽儕僢僪奐嵜).
723306. [妛夛 (慡崙)] (堦斒島墘) A case of cCR after preoperative chemoradiotherapy for rectal cancer with watch and wait approach. 彫浉宑懢, 拞懞棽弐1, 嵅摗晲榊1, 搉绮徆旻2 (1壓晹徚壔娗奜, 2杒棦戝妛杒棦尋媶強昦堾): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10-13), 墶昹 (僴僀僽儕僢僪奐嵜).
723307. [妛夛 (慡崙)] (堦斒島墘) Ischemic necrosis of colorectal anastomosis at oral side after RALS-LAR. 搉晹峎巕1, 嵅摗晲榊1, 攱尨愮宐1, 墶堜孿屽1, 屆忛丂寷1, 嶰塝孾氭1, 嶳棞崅峀1, 拞懞棽弐1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10-13), 墶昹 (僴僀僽儕僢僪奐嵜).
723308. [妛夛 (慡崙)] (堦斒島墘) Rectal Cancer who Received TS1, which Enhances Radiosensitivity. 拞懞棽弐1, 嵅摗晲榊1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10-13), 墶昹 (僴僀僽儕僢僪奐嵜).
723309. [妛夛 (慡崙)] (堦斒島墘) Verification of the safety of robot-assisted laparoscopic surgery for rectal cancer. 嶰塝孾氭1, 嵅摗晲榊1, 攱尨愮宐1, 墶堜孿屽1, 屆忛丂寷1, 拞懞棽弐1, 撪摗丂崉1 (1壓晹徚壔娗奜): 戞33夞擔杮撪帇嬀奜壢妛夛憤夛 (JSES 2020) (2021/3/10-13), 墶昹 (僴僀僽儕僢僪奐嵜).
733060. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 寢挵宔幒嬤朤偵偱偒偨昦曄偵懳偡傞撪帇嬀帯宱尡. 棊崌戝庽1, 愇堜椙岾1,2, 敆丂桾擵1, 慜揷擔嵷巕1, 抾懞桾夘1, 屲寧彈宐堦1, 恄扟婭婸1,3, 忢徏丂椷1, 惣懞丂尗1,4, 拞栰丂夒1, 搉绮徆旻1 (1杒棦尋媶強昦堾, 2壓晹徚壔娗奜, 3屇媧婍奜, 4徚壔婍撪): 戞111夞擔杮徚壔婍撪帇嬀妛夛娭搶巟晹椺夛 (2020/12/19-20), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-320001. [徢椺曬崘] 屻暊枌庮釃愗彍屻捙崪摦柆釒攋楐偵傛傞婥摴暵嵡偐傜怱攛掆巭傪偒偨偟偨恄宱慄堐庮徢I宆偺1媬柦椺. 嶰塝岶擵, 悈娫惓摴, 尦堜搤旻, 撪摗丂崉1, 婽堜丂 彯, 崅悾丂孿, 奀栰椣柧 (1壓晹徚壔娗奜): Japanese Journal of Acute Care Surgery 2019; 9 (2): 254-7.
'19-320002. [徢椺曬崘] 媬柦偟摼偢朥専偱CMV姶愼偑敾柧偟偨懡敪彫挵捵釃偺1椺. 堜杮攷暥, 揷拞捈庽, 晲幰岹徍, 戝徖丂擡, 尦堜搤旻, 撪摗丂崉1, 婽堜丂彯, 奀栰椣柧 (1壓晹徚壔娗奜): Japanese Journal of Acute Care Surgery 2019; 9 (2): 272-6.
怱憻寣娗奜壢妛
[妛弍榑暥]
110244. [尨挊] Preoperative skeletal muscle density is associated with postoperative mortality in patients with cardiovascular disease. Yamashita M1, Kamiya K2, Matsunaga A2, Kitamura T3, Hamazaki N4, Matsuzawa R, Nozaki K4, Ichikawa T4, Nakamura T1, Yamamoto S1, Kariya H4, Maekawa E5, Meguro K5, Ogura M2, Yamaoka-Tojo M2, Ako J5, Miyaji K3: Interact Cardiovasc Thorac Surg 2020/4; 30 (4): 515-22. (嶳壓恀巌1, 恄扟寬懢榊2, 徏塱撃旻2, 杒懞丂棩3, 郷嶈怢柧4, 栰嶈峃暯4, 巗愳婱暥4, 拞懞妜巎1, 嶳杮彯暯1, 姟扟塸婭4, 慜愳宐旤5, 栚崟寬懢榊5, 彫憅丂嵤2, 搶瀶旤撧巕2, 垻屆弫嵠5, 媨抧丂娪3: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3怱憻寣娗奜, 4儕僴價儕晹, 5弞娐婍撪)
110245. [尨挊] Risk Factors for Progression of Distal Deep Vein Thrombosis. Fujioka S1, Ohkubo H1, Kitamura T1, Mishima T1, Onishi Y1, Tadokoro Y1, Araki H1, Matsushiro T1, Yakuwa K1, Miyamoto T1, Torii S1,2, Miyaji K1: Circ J 2020/9; 84 (10): 1862-5. (摗壀弐堦榊1, 戝媣曐攷悽1, 杒懞丂棩1, 旤搰棙徍1, 戝惣媊旻1, 揷強桽婭1, 峳婰弔撧1, 徏戙戩栫1, 敧孡堦婱1, 媨杮棽巌1, 捁堜怶嶰1,2, 媨抧丂娪1: 1怱憻寣娗奜, 2抧堟堛椕嫵堢)
110246. [尨挊] Risk Factors for Mid-Term Liver Disease After the Fontan Procedure. Oka N1, Miyamoto T1, Tomoyasu T1, Hayashi H1, Miyaji K1: Int Heart J 2020/9; 61 (5): 979-83. (壀丂摽旻1, 媨杮棽巌1, 桭曐婱攷1, 椦丂廏寷1, 媨抧丂娪1: 1怱憻寣娗奜)
110247. [尨挊] Watch-and-wait strategy for type A intramural haematoma and acute aortic dissection with thrombosed false lumen of the ascending aorta: a Japanese single-centre experience. Kitamura T1, Torii S1,2, Miyamoto T1, Mishima T1, Ohkubo H1, Fujioka S1, Yakuwa K1, Araki H1, Kondo S, Tamura Y1, Tadokoro Y1, Onishi Y1, Miyaji K1: Eur J Cardiothorac Surg 2020/9; 58 (3): 590-7. (杒懞丂棩1, 捁堜怶嶰1,2, 媨杮棽巌1, 旤搰棙徍1, 戝媣曐攷悽1, 摗壀弐堦榊1, 敧孡堦婱1, 峳婰弔撧1, 揷懞壚旤1, 揷強桽婭1, 戝惣媊旻1, 媨抧丂娪1: 1怱憻寣娗奜, 2抧堟堛椕嫵堢)
110248. [尨挊] Regional thigh tissue oxygen saturation during cardiopulmonary bypass predicts acute kidney injury after cardiac surgery. Sakaki K, Kitamura T1, Kohira S2, Torii S1,3, Mishima T1, Hanayama N1, Kobayashi K1, Ohkubo H1, Miyaji K1: J Artif Organs 2020/12; 23 (4): 315-20. (杒懞丂棩1, 彫暯丂憦2, 捁堜怶嶰1,3, 旤搰棙徍1, 壺嶳捈擇1, 彫椦寬夘1, 戝媣曐攷悽1, 媨抧丂娪1 (1怱憻寣娗奜, 2堛椕塹惗妛晹, 3抧堟堛椕嫵堢)
110249. [尨挊] Gluteal Blood Flow Monitoring in Endovascular Aneurysm Repair With Internal Iliac Artery Embolization. Fujioka S1, Kitamura T1, Mishima T1, Nakajima R1, Tamura Y1, Horikoshi R1, Araki H1, Yakuwa K1, Tomoyasu T1, Okamura T1, Miyamoto T1, Torii S1,2, Miyaji K1: Circ J 2021/3; 85 (4): 345-50. (摗壀弐堦榊1, 杒懞丂棩1, 旤搰棙徍1, 拞搰棟巕1, 揷懞壚旤1, 杧墇棟恗1, 峳婰弔撧1, 敧孡堦婱1, 桭曐婱攷1, 壀懞丂鐫1, 媨杮棽巌1, 捁堜怶嶰1,2, 媨抧丂娪1: 1怱憻寣娗奜, 2抧堟堛椕嫵堢)
310024. [徢椺曬崘] Aortic atresia with transposition of the great arteries. Fukunishi T1, Miyaji K1, Miyamoto T1, Inoue N1, Kitamura T1: Gen Thorac Cardiovasc Surg 2020/12; 68 (12): 1492-4. (暉惣戶恀1, 媨抧丂娪1, 媨杮棽巌1, 堜忋怣岾1, 杒懞丂棩1: 1怱憻寣娗奜)
310025. [徢椺曬崘] Spontaneous splenic rupture, mesenteric ischemia and spinal infarction after aortic repair for acute type A dissection in a patient with sickle cell trait. Toyoda M1, Kitamura T1, Nakashima K1, Matsunaga Y1, Nie M1, Miyaji K1: Gen Thorac Cardiovasc Surg 2021/3; 69 (3): 560-3. (朙揷恀庻1, 杒懞丂棩1, 拞搰岝婱1, 徏塱宑楑1, 嫜丂惓婎1, 媨抧丂娪1: 1怱憻寣娗奜)
320010. [徢椺曬崘] 壓巿寣棳忈奞傪敽偆B宆戝摦柆夝棧偵懳偡傞EVAR帯椕偺1椺. 拞搰岝婱1, 攇棦梲夘1, 崅栘庻恖, 杒懞丂棩1, 媨抧丂 娪1 (1怱憻寣娗奜): 擔杮怱憻寣娗奜壢妛夛嶨帍 2021/1; 50 (1): 69-72.
[妛夛丒尋媶夛摍]
723310. [妛夛 (慡崙)] (堦斒島墘) 撪挵崪摦柆嵡愷傪暪梡偟偨暊晹僗僥儞僩僌儔僼僩撪憓弍偵偍偗傞鋅嬝寣棳儌僯僞儕儞僌庤朄偺専摙. 摗壀弐堦榊1, 戝媣曐攷悽1, 旤搰棙徍1, 捁堜怶嶰1,2, 媨杮棽巌1, 敧孡堦婱1, 峳婰弔撧1, 戝惣媊旻1, 揷強桽婭1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13-15), web奐嵜, 擔杮奜壢妛夛掕婜妛弍廤夛彺榐廤 2020/8; 120: SF-035-2.
723311. [妛夛 (慡崙)] (堦斒島墘) 惉恖奐怱弍偵偍偗傞慻怐巁慺朞榓搙偲恖岺怱攛娭楢媫惈恡忈奞偺娭楢惈. 嶅寬巌楴1, 屆暯丂憦2, 杒懞丂棩1, 捁堜怶嶰1,3, 媨杮棽巌1, 旤搰棙徍1, 戝媣曐攷悽1, 摗壀弐堦榊1, 敧孡堦婱1, 峳婰弔撧1, 戝惣媊旻1, 揷強桾婭1, 媨抧丂娪1 (1怱憻寣娗奜, 2堛椕塹惗妛晹, 3抧堟堛椕嫵堢): 戞120夞擔杮奜壢妛夛掕婜妛弍廤夛 (2020/8/13-15), web奐嵜, 擔杮奜壢妛夛掕婜妛弍廤夛彺榐廤 2020/8; 120: SF-070-6.
723312. [妛夛 (慡崙)] (堦斒島墘) 愭揤惈怱幘姵庤弍僔儈儏儗乕僔儑儞偺椪彴墳梡 (4D MRI, 3D) 僐儞僺儏乕僞乕僔儈儏儗乕僔儑儞偵傛傞壖憐庤弍偵婎偯偄偨攛摦柆宍惉弍. 媨抧丂娪1, 媨杮棽巌1, 徏戙戩栫1, 戝惣媊旻1, 捁堜怶嶰1,2, 杒懞丂棩1, 旤搰棙徍1, 戝媣曐攷悽1, 摗壀弐堦榊1, 敧孡堦婱1, 峳婰弔撧1, 揷強桾婭1, 媨嶈隳暯3, 斅扟宑堦4 (1怱憻寣娗奜, 2抧堟堛椕嫵堢, 3戝妛堾堛椕宯尋媶壢, 4嫗搒晎棫戝妛): 戞50夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2020/8/17-19), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2020/8; 50: PD3-2.
723313. [妛夛 (慡崙)] (堦斒島墘) 枛徑寣岲拞媴/儕儞僷媴斾偼愭揤惈怱幘姵弍屻偺戝検嫻悈帯椕岠壥梊應場巕偲側傝偆傞. 敧孡堦婱1, 晲堜揘棟2, 怷壓姲擵2, 媨抧丂娪1, 媨杮棽巌1, 杒懞丂棩1, 嬥巕岾桾2 (1怱憻寣娗奜, 2搶嫗戝妛): 戞50夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2020/8/17-19), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2020/8; 50: PR4-4.
723314. [妛夛 (慡崙)] (堦斒島墘) 枬惈戝摦柆夝棧偵懳偡傞奜壢揑帯椕愴棯乣Crawford extent 2偵懳偡傞擇婜揑帯椕乣. 摗壀弐堦榊1, 杒懞丂棩1, 捁堜怶嶰1,2, 媨杮棽巌1, 旤搰棙徍1, 戝媣曐攷悽1, 敧孡堦婱1, 峳婰弔撧1, 戝惣媊旻1, 揷強桽婭1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞50夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2020/8/17-19), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2020/8; 50: PR9-5.
723315. [妛夛 (慡崙)] (堦斒島墘) 彫帣婜枹帯椕惉恖愭揤惈怱幘姵姵幰偺弍屻婋尟梊應場巕偺専摙. 媨杮棽巌1, 敧孡堦婱1, 揷強桽婭1, 戝惣媊旻1, 揷懞壚旤1, 嬤摗丂恀1, 峳婰弔撧1, 摗壀弐堦榊1, 戝媣曐攷悽1, 旤搰棙徍1, 杒懞丂棩1, 捁堜怶嶰1,2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞50夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2020/8/17-19), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2020/8; 50: PR17-4.
723316. [妛夛 (慡崙)] (堦斒島墘) Iliac Branch Endoprosthesis (IBE) 傪梡偄偨EVAR偺専摙. 戝媣曐攷悽1, 摗壀弐堦榊1, 旤搰棙徍1, 戝惣媊旻1, 揷強桽婭1, 峳婰弔撧1, 敧孡堦婱1, 杒懞丂棩1, 媨杮棽巌1, 捁堜怶嶰1,2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞50夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2020/8/17-19), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2020/8; 50: PR21-4.
723317. [妛夛 (慡崙)] (堦斒島墘) Contegra conduit傪梡偄偨憤摦柆姴徢廋暅弍. 媨抧丂娪1, 媨杮棽巌1, 敧孡堦婱1, 揷強桽婭1, 捁堜怶嶰1,2, 杒懞丂棩1, 旤搰棙徍1, 戝媣曐攷悽1, 摗壀弐堦榊1, 峳婰弔撧1, 嬤摗丂恀1, 揷懞壚旤1, 戝惣媊旻1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞50夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2020/8/17-19), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2020/8; 50: V2-2.
723318. [妛夛 (慡崙)] (堦斒島墘) 戝摦柆媩廋暅弍帪偵梡偄傞斀夞恄宱僗働儖僩儞壔朄偺桳梡惈偵偮偄偰. 媨杮棽巌1, 桭曐婱攷1, 戝惣媊旻1, 揷強桽婭1, 敧孡堦婱1, 椦丂廏寷1, 壀丂摽旻1, 媨抧丂娪1 (1怱憻寣娗奜): 戞50夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2020/8/17-19), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2020/8; 50: V2-4.
723319. [妛夛 (慡崙)] (堦斒島墘) 姶愼惈怱撪枌墛丆憁朮曎暵嵔晄慡徢偵懳偡傞帺屓怱枌傪梡偄偨憁朮曎宍惉弍偺抁拞婜惉愌. 峳婰弔撧1, 戝惣媊旻1, 揷強桽婭1, 敧孡堦婱1, 徏戙戩栫1, 摗壀弐堦榊1, 戝媣曐攷悽1, 旤搰棙徍1, 杒懞丂棩1, 媨杮棽巌1, 捁堜怶嶰1,2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞50夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2020/8/17-19), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2020/8; 50: O21-4.
723320. [妛夛 (慡崙)] (堦斒島墘) 擕帣抳巰惈晄惍柆偵懳偡傞怉偊崬傒宆彍嵶摦婍偺桳梡惈. 揷強桽婭1, 媨杮棽巌1, 敧孡堦婱1, 捁堜怶嶰1,2, 杒懞丂棩1, 徏壓丂峅1, 摗壀弐堦榊1, 峳婰弔撧1, 嬤摗丂恀1, 揷懞壚旤1, 戝惣媊旻1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞50夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2020/8/17-19), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2020/8; 50: P3-2.
723321. [妛夛 (慡崙)] (堦斒島墘) B孮梟寣惈楢嵔媴嬠姶愼徢崌暪偺戝摦柆弅弅嶓暋崌偵懳偟偰廋暅弍傪巤峴偟偨堦椺. 敧孡堦婱1, 媨杮棽巌1, 揷強桽婭1, 戝惣媊旻1, 揷懞壚旤1, 嬤摗丂恀1, 峳婰弔撧1, 摗壀弐堦榊1, 戝媣曐攷悽1, 旤搰棙徍1, 杒懞丂棩1, 捁堜怶嶰1,2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞50夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2020/8/17-19), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2020/8; 50: P27-5.
723322. [妛夛 (慡崙)] (堦斒島墘) 僴僀儕僗僋姵幰偵偍偗傞嫻暊晹戝摦柆釒偵懳偡傞帯椕愴棯. 戝惣媊旻1, 摗壀弐堦榊1, 杒懞丂棩1, 捁堜怶嶰1,2, 媨杮棽巌1, 旤搰棙徍1, 戝媣曐攷悽1, 敧孡堦婱1, 峳婰弔撧1, 嬤摗丂恀1, 揷懞壚旤1, 揷強桽婭1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞50夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2020/8/17-19), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2020/8; 50: P52-4.
723323. [妛夛 (慡崙)] (堦斒島墘) 嵍攛摦柆嫄戝壖惈釒偵懳偟廋暅弍傪巤峴偟偨堦椺. 揷懞壚旤1, 媨抧丂娪1, 媨杮棽巌1, 壀懞丂払1, 徏戙戩栫1, 杧墇棟恗1, 捁堜怶嶰1,2, 杒懞丂棩1, 敧孡堦婱1, 峳婰弔撧1, 拞搰棟巕1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞73夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2020/10/29-11/1), web奐嵜, 擔杮嫻晹奜壢妛夛嶨帍 2020/10; suppl: 118.
723324. [妛夛 (慡崙)] (堦斒島墘) 掅儕僗僋崅楊AS姵幰偵偍偗傞TAVI, SAVR慖戰偺巜昗偵娭偡傞専摙. 拞搰棟巕1, 杒懞丂棩1, 捁堜怶嶰1, 媨杮棽巌1, 旤搰棙徍1, 壀懞丂払1, 戝媣曐攷悽1, 桭曐婱攷1, 摗壀弐堦榊1, 敧孡堦婱1, 峳婰弔撧1, 杧墇棟恗1, 揷懞壚旤1 (1怱憻寣娗奜): 戞73夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2020/10/29-11/1), web奐嵜, 擔杮嫻晹奜壢妛夛嶨帍 2020/10; suppl: 147.
723325. [妛夛 (慡崙)] (堦斒島墘) 僼傽儘乕巐挜徢偵偍偗傞懱攛抁棈庤弍偵傛傞攛摦柆曎椫惉挿偺岠壥. 揷懞壚旤1, 媨抧丂娪1, 媨杮棽巌1, 壀懞丂払1, 桭曐婱攷1, 杒懞丂棩1, 捁堜怶嶰1,2, 摗壀弐堦榊1, 敧孡堦婱1, 峳婰弔撧1, 杧墇棟恗1, 拞搰棟巕1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞73夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2020/10/29-11/1), web奐嵜, 擔杮嫻晹奜壢妛夛嶨帍 2020/10; suppl: 210.
723326. [妛夛 (慡崙)] (堦斒島墘) Fallot巐挜徢弍屻攛摦柆曎抲姺弍偵偍偗傞嶰愲曎椫宍惉弍偺拞婜墦妘婜惉愌. 杧墇棟恗1, 媨抧丂娪1, 媨杮棽巌1, 壀懞丂払1, 桭曐婱攷1, 揷懞壚旤1, 杒懞丂棩1, 捁堜怶嶰1,2, 摗壀弐堦榊1, 敧孡堦婱1, 峳婰弔撧1, 拞搰棟巕1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞73夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2020/10/29-11/1), web奐嵜, 擔杮嫻晹奜壢妛夛嶨帍 2020/10; suppl: 229.
723327. [妛夛 (慡崙)] (堦斒島墘) 65嵨埲忋怱憻庤弍姵幰偵懳偡傞戅堾屻儕僴價儕僥乕僔儑儞宲懕偺巜昗. 杒懞丂棩1, 捁堜怶嶰1,2, 媨杮棽巌1, 旤搰棙徍1, 壀懞丂払1, 戝媣曐攷悽1, 桭曐婱攷1, 摗壀弐堦榊1, 敧孡堦婱1, 峳婰弔撧1, 杧墇棟恗1, 揷懞壚旤1, 拞搰棟巕1, 郷嶈怢柧3, 嶳壓恀巌4, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢, 3儕僴價儕晹, 4戝妛堾堛椕宯尋媶壢): 戞73夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2020/10/29-11/1), web奐嵜, 擔杮嫻晹奜壢妛夛嶨帍 2020/10; suppl: 247.
723328. [妛夛 (慡崙)] (堦斒島墘) 惉恖奐怱弍姵幰偵偍偗傞弍慜枛徑嬤愒奜慄慻怐巁慺朞榓搙偺應掕婡庬偵傛傞憡堘亅弍慜場巕偲偺娭楢惈亅. 屆暯丂憦1, 媨抧丂娪2, 杒懞丂棩2, 捁堜怶嶰2,3, 摗壀弐堦榊2, 媨杮棽巌2, 壀懞丂払2, 峳婰弔撧2, 桭曐婱攷2, 杧墇棟恗2, 揷懞壚旤2, 拞搰棟巕2 (1堛椕塹惗妛晹, 2怱憻寣娗奜, 3抧堟堛椕嫵堢): 戞73夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2020/10/29-11/1), web奐嵜, 擔杮嫻晹奜壢妛夛嶨帍 2020/10; suppl: 249.
723329. [妛夛 (慡崙)] (堦斒島墘) 奜壢帯椕乽婡擻揑扨怱幒偵懳偡傞僔儍儞僩庤弍乿弶夞庤弍偵懱攛摦柆抁棈庤弍傪梫偡傞婡擻揑扨怱幒偺帯椕愴棯. 壀丂摽旻1, 椦丂廏寷1, 桭曐婱攷1, 媨杮棽巌1, 媨抧丂娪1 (1怱憻寣娗奜): 戞56夞擔杮彫帣弞娐婍妛夛憤夛丒妛弍廤夛 (2020/11/22-24), 嫗搒 (web奐嵜), 擔杮彫帣弞娐婍妛夛嶨帍 2020/11; 36 (Suppl 2): s2-122.
723330. [妛夛 (慡崙)] (堦斒島墘) bulging sinus晅ePTFE mono-cusp patch傪梡偄偨RVOTR偺拞婜墦妘惉愌. 徏戙戩栫1, 媨抧丂娪1, 媨杮棽巌1, 壀丂摽旻1, 桭曐婱攷1, 椦丂廏寷1, 杒懞丂棩1, 敧孡堦婱1, 峳婰弔撧1, 戝惣媊旻1, 揷強桾婭1 (1怱憻寣娗奜): 戞56夞擔杮彫帣弞娐婍妛夛憤夛丒妛弍廤夛 (2020/11/22-24), 嫗搒 (web奐嵜), 擔杮彫帣弞娐婍妛夛嶨帍 2020/11; 36 (Suppl 2): s2-331.
723331. [妛夛 (慡崙)] (堦斒島墘) 怴惗帣媦傃擕帣婜憰拝偺怱憻儁乕僗儊乕僇乕偺墦妘婜惉愌偵偮偄偰. 媨杮棽巌1, 徏戙戩栫1, 戝惣媊旻1, 怺挰捈擵2, 桭曐婱攷1, 椦丂廏寷1, 壀丂摽旻1, 媨抧丂娪1 (1怱憻寣娗奜, 2孮攏導棫彫帣堛椕僙儞僞乕): 戞56夞擔杮彫帣弞娐婍妛夛憤夛丒妛弍廤夛 (2020/11/22-24), 嫗搒 (web奐嵜), 擔杮彫帣弞娐婍妛夛嶨帍 2020/11; 36 (Suppl 2): s2-400.
723332. [妛夛 (慡崙)] (堦斒島墘) Samurai Cannulation (Direct True Lumen Cannulation) for Acute Stanford Type A AorticDissection. 杒懞丂棩1, 捁堜怶嶰1,2, 媨杮棽巌1, 旤搰棙徍1, 壀懞丂払1, 桭曐婱攷1, 摗壀弐堦榊1, 敧孡堦婱1, 峳婰弔撧1, 揷懞壚旤1, 拞搰棟巕1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞48夞擔杮寣娗奜壢妛夛妛弍憤夛 (2020/11/27-29), web奐嵜, 擔杮寣娗奜壢妛夛嶨帍 2020/11; 29 (Suppl): 11.
723333. [妛夛 (慡崙)] (堦斒島墘) 偑傫娭楢惷柆寣愷徢偺帯椕惉愌. 摗壀弐堦榊1, 旤搰棙徍1, 拞搰棟巕1, 揷懞壚旤1, 峳婰弔撧1, 敧孡堦婱1, 桭曐婱攷1, 壀懞丂払1, 杒懞丂棩1, 媨杮棽巌1, 捁堜怶嶰1,2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞48夞擔杮寣娗奜壢妛夛妛弍憤夛 (2020/11/27-29), web奐嵜, 擔杮寣娗奜壢妛夛嶨帍 2020/11; 29 (Suppl): 23.
723334. [妛夛 (慡崙)] (堦斒島墘) 媫惈A宆夝棧偵懳偡傞慡媩晹抲姺亄Frozen Elephant Trunk偲戝摦柆儕儌僨儕儞僌偺専摙. 摗壀弐堦榊1, 杒懞丂棩1, 揷懞壚旤1, 峳婰弔撧1, 敧孡堦婱1, 桭曐婱攷1, 旤搰棙徍1, 捁堜怶嶰1,2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞51夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2021/2/19-21), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2021/2; 51: 38.
723335. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞抜奒揑Yasui庤弍 (Norwood-Rastelli庤弍) 偺帯椕惉愌偺専摙. 揷懞壚旤1, 媨抧丂娪1, 媨杮棽巌1, 壀懞丂鐫1, 拞搰棟巕1, 捁堜怶嶰1,2, 旤搰棙徍1, 杒懞丂棩1, 摗壀弐堦榊1, 敧孡堦婱1, 峳婰弔撧1, 桭曐婱攷1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞51夞擔杮怱憻寣娗奜壢妛夛妛弍憤夛 (2021/2/19-21), web奐嵜, 擔杮怱憻寣娗奜壢妛夛妛弍憤夛彺榐廤 2021/2; 51: 64.
733061. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嵍攛摦柆嫄戝壖惈釒偵懳偟廋暅弍傪巤峴偟偨堦椺. 揷懞壚旤1, 媨抧丂娪1, 媨杮棽巌1, 壀懞丂払1, 徏戙戩栫1, 杧墇棟恗1, 捁堜怶嶰1,2, 杒懞丂棩1, 敧孡堦婱1, 峳婰弔撧1, 拞搰棟巕1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞183夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2020/7/16-8/7), web奐嵜, 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2020/7; 183: 18.
733062. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 戝摦柆曎暵嵔晄慡徢弍慜偵嬼敪揑偵恌抐偝傟偨戝摦柆4愲曎偺1椺. 徏塱宑楑1, 彫椦寬夘1, 揷懞岾曚1, 彫尨朚媊, 嫜丂惓婎1, 媨抧丂娪1 (1怱憻寣娗奜): 戞183夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2020/7/16-8/7), web奐嵜, 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2020/7; 183: 28.
733063. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 壓峴戝摦柆抲姺弍屻壖惈釒亅攛慂攋偵懳偟偰, 嬞媫TEVAR偐傜偺bridgesurgery偱媬柦偟摼偨1椺. 拞搰棟巕1, 摗壀弐堦榊1, 峳婰弔撧1, 敧孡堦婱1, 杒懞丂棩1, 捁堜怶嶰1,2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞183夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2020/7/16-8/7), web奐嵜, 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2020/7; 183: 33.
733064. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 媫惈怱嬝峓嵡屻擕摢嬝抐楐偵傛傞憁朮曎暵嵔晄慡徢偵懳偡傞憁朮曎宍惉弍偺堦椺. 揷懞壚旤1, 杒懞丂棩1, 捁堜怶嶰1,2, 媨杮棽巌1, 旤搰棙徍1, 壀懞丂払1, 摗壀弐堦榊1, 桭曐婱攷1, 敧孡堦婱1, 峳婰弔撧1, 杧墇棟恗1, 拞搰棟巕1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞184夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2020/11/28), 搶嫗 (web奐嵜) 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2020/11; 184: 13.
733065. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 惉恖Valsalva摯摦柆釒攋楐偵懳偡傞庤弍椺. 拞搰棟巕1, 壀懞丂払1, 揷懞壚旤1, 媨杮棽巌1, 杧墇棟恗1, 峳婰弔撧1, 敧孡堦婱1, 桭曐婱攷1, 摗壀弐堦榊1, 旤搰棙徍1, 杒懞丂棩1, 捁堜怶嶰1,2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞184夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2020/11/28), 搶嫗 (web奐嵜) 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2020/11; 184: 25.
733066. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怱嬝峓嵡屻擕摢嬝抐楐偵懳偡傞憁朮曎宍惉弍屻偵憁朮曎抲姺弍傪巤峴偟偨堦椺. 揷懞壚旤1, 杒懞丂棩1, 捁堜怶嶰1,2, 壀懞丂払1, 敧孡堦婱1, 峳婰弔撧1, 徏塱宑楑1, 拞搰棟巕1, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞185夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2021/3/13), web奐嵜, 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2021/3; 185: 13.
733067. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 寑徢宆怱嬝墛屻偺怱愲晹怱幒釒偺帯椕宱尡. 朙揷恀庻1, 徏塱宑楑1, 擖郪桭曘1, 彫尨朚媊, 嫜丂惓婎1, 媨抧丂娪1 (1怱憻寣娗奜): 戞185夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2021/3/13), web奐嵜, 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2021/3; 185: 14.
733068. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 妛峑寬恌偱敪尒偝傟偨塃幒擲塼庮偵懳偟偰庮釃愗彍Cryoablation偵傛傞嵞敪梊杊傪峴側偭偨1椺. 懞堜桟懢1, 揷拞桟婱1, 拞搰岝婱1, 杒懞丂棩1, 媨抧丂娪1 (1怱憻寣娗奜): 戞185夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2021/3/13), web奐嵜, 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2021/3; 185: 32.
733069. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) MA丆DORV, AS, Hypoarch, PDA偵懳偡傞rapid two staged modified Norwood庤弍椺. 徏塱宑楑1, 壀懞丂払1, 拞搰棟巕1, 揷懞壚旤1, 敧孡堦婱1, 峳婰弔撧1, 摗壀弐堦榊1, 旤搰棙徍1, 杒懞丂棩1, 捁堜怶嶰1,2, 媨抧丂娪1 (1怱憻寣娗奜, 2抧堟堛椕嫵堢): 戞185夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2021/3/13), web奐嵜, 擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛梫巪廤 2021/3; 185: 34.
屇媧婍奜壢妛
[妛弍榑暥]
110250. [尨挊] EGFR mutation genotyping and ALK status determination in liquid-based cytology samples of non-small cell lung cancer. Satoh Y1, Matsuo Y2, Kuba T3, Yamashita K3, Sawano M, Tozaka S, Yamazaki H1, Sonoda D4, Mikubo M1, Naito M1, Matsui Y1, Shiomi K1, Yoshida T5, Murakumo Y5: Virchows Arch 2020/5; 476 (5): 753-62. (嵅摗擵弐1, 徏旜桼婭巕2, 媣応丂庽3, 嶳壓榓栫3, 嶳嶈岹宲1, 墍揷丂戝4, 嶰孍彨巎1, 撪摗夒恗1, 徏堜孾晇1, 墫尒丂榓1, 媑揷丂岟5, 懞塤朏庽5: 1屇媧婍奜, 2昦懺丒恌椕宯, 3昦棟晹, 4戝妛堾堛椕宯尋媶壢, 5昦棟)
110251. [尨挊] Cytology Reporting System for Lung Cancer from the Japan Lung Cancer Society and Japanese Society of Clinical Cytology: An Interobserver Reproducibility Study and Risk of Malignancy Evaluation on Cytology Specimens. Hiroshima K, Yoshizawa A, Takenaka A, Haba R, Kawahara K, Minami Y, Kakinuma H1, Shibuki Y, Miyake A, Kajio K, Miyamoto K, Nagatomo M, Nishimura S, Mano M, Matsubayashi J, Motoi N, Nagao T, Nakatsuka S, Yoshida T2, Satoh Y3: Acta Cytol 2020/9-10; 64 (5): 452-62. (奰徖淎朚1, 媑揷丂岟2, 嵅摗擵弐3: 1昦棟晹, 2昦棟, 3屇媧婍奜)
110252. [尨挊] Characteristics of surgically resected non-small cell lung cancer patients with post-recurrence cure. Sonoda D1, Matsuura Y, Kondo Y2, Ichinose J, Nakao M, Ninomiya H, Ishikawa Y, Nishio M, Okumura S, Satoh Y2, Mun M: Thorac Cancer 2020/11; 11 (11): 3280-8. (墍揷丂戝1, 嬤摗懽恖2, 嵅摗擵弐2: 1戝妛堾堛椕宯尋媶壢, 2屇媧婍奜)
110253. [尨挊] Prognostic impact of preoperative FDG-PET positive lymph nodes in lung cancer. Endoh H, Ichikawa A, Yamamoto R, Shiozawa S, Nishizawa N, Satoh Y1, Oriuchi: Int J Clin Oncol 2021/1; 26 (1): 87-94. (嵅摗擵弐1: 1屇媧婍奜)
110254. [尨挊] Method for preservation of DNA stability of liquid-based cytology specimens from a lung adenocarcinoma cell line. Matsuo Y1, Yamashita K2, Yoshida T3, Satoh Y4: Virchows Arch 2021/3; 478 (3): 507-16. (徏旜桼婭巕1, 嶳壓榓栫2, 媑揷丂岟3, 嵅摗擵弐4: 1昦懺丒恌椕宯, 2昦棟晹, 3昦棟, 4屇媧婍奜)
310026. [徢椺曬崘] Resection of intra-pulmonary endometriosis by video-assisted thoracoscopic surgery under pre-operative CT-guided marking synchronized with menstrual cycle. Matsushima K1, Ono M1, Hayashi S1, Sonoda D2, Matsui Y1, Shiomi K1, Satoh Y1, Ohbu M3: Gen Thorac Cardiovasc Surg 2020/5; 68 (5): 549-53. (徏搰孿屷1, 彫栰尦巏1, 椦丂徦巕1, 墍揷丂戝2, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1, 戝晹丂惤3: 1屇媧婍奜, 2戝妛堾堛椕宯尋媶壢, 3杒棦戝妛杒棦尋媶強昦堾)
310027. [徢椺曬崘] Subxiphoid dual-port thymectomy for thymoma in a patient with post-aortic left brachiocephalic vein. Naito M1, Ono M1, Hayashi S1, Mastui Y1, Shiomi K1, Satoh Y1: Gen Thorac Cardiovasc Surg 2021/1; 69 (1): 151-4. (撪摗夒恗1, 彫栰尦巏1, 椦丂徦巕1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1: 1屇媧婍奜)
320011. [徢椺曬崘] 柍娋惈奜泱梩宍惉晄慡徢偵敽偆姶愼惈攛鵑朎偺1愗彍椺. 娵嶳棃婸1, 徏搰孿屷1, 嶰孍彨巎1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1 (1屇媧婍奜): 擔杮屇媧婍奜壢妛夛嶨帍 2020/5; 34 (4): 275-80.
520008. [憤愢] 屇媧婍嵶朎恌updata亅恌抐偍傛傃僶僀僆儅乕僇乕傊偺妶梡偲壽戣亅. 墍揷丂戝1, 嵅摗擵弐2 (1戝妛堾堛椕宯尋媶壢, 2屇媧婍奜): 攛娻 2020/10; 60 (5): 373-8.
522059. [島嵗]亂摿廤: 攛廲妘偺嫻峯嬀丒儘儃僢僩巟墖庤弍偺恑曕亃2. 庤媄丒婡婍丂慜廲妘庤弍偵偍偗傞掅怤廝惈庤弍偺摫擖偐傜峫偊傞偙偲亅寱忬撍婲壓庤媄偲儘儃僢僩巟墖庤弍. 嵅摗擵弐1, 椦丂徦巕1, 撪摗夒恗1, 徏堜孾晇1 (1屇媧婍奜): 嫻晹奜壢 2020/4; 73 (4): 274-9.
522060. [島嵗]亂摿廤: 攛丒嫻態恄宱撪暘斿庮釃偺帯椕亃2. 恄宱撪暘斿庮釃偵偍偗傞嵶朎恌偺栶妱亅帯椕慜恌抐傪拞怱偵亅. 嵅摗擵弐 (屇媧婍奜): 擔奜夛帍 2021/1; 122 (1): 10-7.
[挊丂彂]
620050. [妛弍彂 (暘扴幏昅)]亂僴僀儕僗僋嫻晹奜壢庤弍 (嫻晹奜壢2020擭9寧憹姧崋)亃II. 屇媧婍椞堟丂26. 恡晄慡崌暪徢椺偵偍偗傞攛丒廲妘庤弍偲廃弍婜娗棟, p. 866-9. 撪摗夒恗1, 嵅摗擵弐1 (1屇媧婍奜), 撿峕摪, 搶嫗, 2020/9敪峴.
620051. [妛弍彂 (暘扴幏昅)]亂攛娻恌椕僈僀僪儔僀儞亅埆惈嫻枌拞旂庮丒嫻態庮釃娷傓亅2020擭斉 戞6斉亃戞1晹 攛娻恌椕僈僀僪儔僀儞2020擭斉丂I. 攛娻偺恌抐丂4. 昦棟嵶朎恌抐, p.34-46. 嵅摗擵弐 (屇媧婍奜), 曇: 擔杮攛娻妛夛, 嬥尨弌斉, 搶嫗, 2021/1敪峴.
620052. [妛弍彂 (暘扴幏昅)]亂屇媧婍幘姵嵟怴偺帯椕2021-2022亃XIII 愭揤惈堎忢丒宍惉晄慡丂2 攛摦惷柆釕 (攛摦惷柆婏宍), p.405-7. 椦丂徦巕1, 嵅摗擵弐1 (1屇媧婍奜), 曇: 栧揷弤堦, 尫娫徍旻, 惣壀埨旻, 撿峕摪, 搶嫗, 2021/3敪峴.
620053. [妛弍彂 (嫟挊)]亂椪彴丒昦棟丂攛娻庢埖偄婯栺丂戞8斉曗掶斉亃4. 昦棟恌抐, p68-124. 5. 嵶朎恌, p.126-48. 8. 尨敪惈攛庮釃偺帯椕岠壥偺慻怐妛揑敾掕婎弨, p.184-6. 嵅摗擵弐 (屇媧婍奜), 曇: 擔杮攛娻妛夛, 嬥尨弌斉, 搶嫗, 2021/3敪峴.
[妛夛丒尋媶夛摍]
721012. [妛夛 (慡崙)] (摿暿島墘) 嵶朎恌偺僲僽儗僗丒僆僽儕乕僕儏乣巹偨偪偺栚巜偡傕偺乣. 嵅摗擵弐 (屇媧婍奜): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20), Web奐嵜.
722062. [妛夛 (慡崙)] (彽懸島墘摍) 擔杮偵偍偗傞屇媧婍嵶朎恌敾掕婎弨: 崙嵺壔傪栚巜偟偰. 媑郪柧旻, 淎搰寬嶰, 嵅摗擵弐1 (1屇媧婍奜): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20), Web奐嵜.
722063. [妛夛 (慡崙)] (彽懸島墘摍) JSCC-JLCS怴曬崘條幃偵偍偗傞atypical cells偵偮偄偰. 壨尨朚岝, 淎搰寬嶰, 抾拞柧旤, 嵅摗擵弐1 (1屇媧婍奜): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20), Web奐嵜.
722064. [妛夛 (慡崙)] (僔儞億僕僂儉) 屇媧婍嵶朎恌偺揥朷 乣敾掕婎弨偺崙嵺壔傪栚巜偟偰乣. 嵅摗擵弐 (屇媧婍奜): 戞59夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2020/11/22), 墶昹.
723336. [妛夛 (慡崙)] (堦斒島墘) 尨敪惈攛娻偲偺娪暿偵嬯椂偟偨攛怹弫傪敽偆嫻態滸暯忋旂娻偺堦椺. 堜弌怢栫, 拞嶳朁廐, 娾徏峅暥, 拞嶳孭巕, 嵅摗寷弐, 惣梇堦婱, 惵桍戝庽, 墫郪丂揘, 愇婽淎庽, 嵅摗擵弐1 (1屇媧婍奜): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20), Web奐嵜.
723337. [妛夛 (慡崙)] (堦斒島墘) 懡妀嫄嵶朎撪偵Asteroid body傪擣傔偨攛尨敪惈僋儕僾僩僢僐僢僇僗徢偺1椺. 娾徏峅暥, 拞嶳朁廐, 嵅摗寷弐, 堜弌怢栫, 惣梇堦婱, 愇婽淎庽, 峳愳垽巕, 惵桍戝庽, 墫郪丂揘, 嵅摗擵弐1 (1屇媧婍奜): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20), Web奐嵜.
723338. [妛夛 (慡崙)] (堦斒島墘) 尨敪惈旕彫嵶朎攛娻偺堚揱巕夝愅偵偍偗傞塼忬壔専懱嵶朎恌偺桳岠惈. 徏旜桼婭巕1, 嶳壓榓栫2, 媑揷丂岟3, 媣応丂庽2, 郪栰恀棟巕, 懞塤朏庽3, 嵅摗擵弐4 (1昦懺丒恌椕宯, 2昦棟晹, 3昦棟, 4屇媧婍奜): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20), Web奐嵜.
723339. [妛夛 (慡崙)] (堦斒島墘) 攛娻弍慜偵偍偗傞懴弍擻専嵏偲偟偰偺晧壸怱揹恾専嵏揔墳偺専摙. 嬍愳丂払1, 嶰堜丂垽1, 椦丂徦巕1, 撪摗夒恗1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1 (1屇媧婍奜): 戞37夞擔杮屇媧婍奜壢妛夛妛弍廤夛 (2020/9/29-10/12), Web奐嵜.
723340. [妛夛 (慡崙)] (堦斒島墘) 僗僥乕僾儔乕屻偺寣娗抐抂偺愗棧憖嶌偵傛傝攛摦柆弌寣傪棃偟偨堦椺. 恄扟婭婸1,2, 杒丂塸揟2, 慜揷擔嵷巕2, 塉媨棽夘2, 敆丂桾擵2, 棊崌戝庽2, 屲寧彈宐堦2, 愇堜椙岾1,3 (1屇媧婍奜, 2杒棦尋媶強昦堾, 3壓晹徚壔娗奜): 戞37夞擔杮屇媧婍奜壢妛夛妛弍廤夛 (2020/9/29-10/12), Web奐嵜.
723341. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞奜彎惈寣婥嫻偺庤弍徢椺偺専摙. 椦丂徦巕1, 嶰堜丂垽1, 嬍愳丂払1, 徏搰孿屷1, 撪摗夒恗1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1 (1屇媧婍奜): 戞73夞擔杮嫻晹奜壢妛夛掕婜妛弍廤夛 (2020/10/29-11/1), Web奐嵜.
723342. [妛夛 (慡崙)] (堦斒島墘) 塃攛拞梩掅宍惉偵敪惗偟偨掕宆僇儖僠僲僀僪3椺偺専摙. 嶰堜丂垽1, 嬍愳丂払1, 徏搰孿屷1, 椦丂徦巕1, 撪摗夒恗1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1, 堦屗徆柧2 (1屇媧婍奜, 2昦棟): 戞61夞擔杮攛娻妛夛妛弍廤夛 (2020/11/12), 壀嶳 (僴僀僽儕僢僪奐嵜).
723343. [妛夛 (慡崙)] (堦斒島墘) 弍屻21擭栚偵嫻枌攄庬嵞敪傪擣傔偨嫻態尨敪擲昞旂娻偺1椺. 徏搰孿屷1, 嶰堜丂垽1, 嬍愳丂払1, 椦丂徦巕1, 撪摗夒恗1, 徏堜孾晇1, 墫尒丂榓1, 撊杮徆岶2, 堦屗徆柧2,丂徲丂悽埉, 嵅摗擵弐1 (1屇媧婍奜, 2昦棟): 戞61夞擔杮攛娻妛夛妛弍廤夛 (2020/11/12), 壀嶳 (僴僀僽儕僢僪奐嵜).
723344. [妛夛 (慡崙)] (堦斒島墘) 旝彫擕摢宆態娻偵偍偗傞嵶朎姅傪梡偄偨埆惈搙偺専摙. 墍揷丂戝1, 徏旜桼婭巕2, 徏搰孿屷3, 嶰孍彨巎3, 撪摗夒恗3, 嵅摗擵弐3 (1戝妛堾堛椕宯尋媶壢, 2昦懺丒恌椕宯, 3屇媧婍奜): 戞59夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2020/11/22), 墶昹.
733070. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 揮堏惈墶妘枌庮釃偺堦愗彍椺. 嬍愳丂払1, 嶰堜丂垽1, 徏搰孿屷1, 椦丂徦巕1, 撪摗夒恗1, 徏堜孾晇1, 墫尒丂榓1, 嵅摗擵弐1 (1屇媧婍奜): 戞184夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2020/11/28), 搶嫗.
733071. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摿敪惈怱擷悈挋棷偵懳偟怱枌奐憢弍傪巤峴偟偨1椺. 嶰堜丂垽1, 嬍愳丂払1, 椦丂徦巕1, 撪摗夒恗1, 徏堜孾晇1, 墫尒丂榓1, 摗揷揝暯2, 嵅摗擵弐1 (1屇媧婍奜, 2屇媧婍撪): 戞185夞擔杮嫻晹奜壢妛夛娭搶峛怣墇抧曽夛 (2021/3/13), Web奐嵜.
擼恄宱奜壢妛
[妛弍榑暥]
110255. [尨挊] Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone. Natsume A1, Aoki K1, Ohka F1, Maeda S1, Hirano M1, Adilijiang A1, Motomura K1, Sumi M1, Nishikawa R1, Narita Y1, Muragaki Y1, Maruyama T1, Ito T1, Beppu T1, Nakamura H1, Kayama T1, Sato S1, Nagane M1, Mishima K1, Nakasu Y1, Kurisu K1, Yamasaki F1, Sugiyama K1, Onishi T1, Iwadate Y1, Terasaki M1, Kobayashi H1, Matsumura A1, Ishikawa E1, Sasaki H1, Mukasa A1, Matsuo T1, Hirano H1, Kumabe T1,2, Shinoura N1, Hashimoto N1, Aoki T1, Asai A1, Abe T1, Yoshino A1, Arakawa Y1, Asano K1, Yoshimoto K1, Shibui S1, Okuno Y1, Wakabayashi T1 (1Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG): J Neurooncol 2020/5; 148 (1): 17-27. (孏晹弐岹1,2: 2擼奜)
110256. [尨挊] Ergonomics-based Positioning of the Operating Handle of Surgical Microscopes. Shimizu S1, Kuroda H1, Mochizuki T, Kumabe T1: Neurol Med Chir (Tokyo) 2020/6; 60 (6): 313-6. (惔悈丂濟1, 崟揷攷婭1, 朷寧悞峅, 孏晹弐岹1: 1擼奜)
110257. [尨挊] Ribosomal protein S6 promotes stem-like characters in glioma cells. Shirakawa Y, Hide T1, Yamaoka M, Ito Y, Ito N, Ohta K, Shinojima N, Mukasa A, Saito H, Jono H: Cancer Sci 2020/6; 111 (6): 2041-51. (廏戱堦榊1: 1擼奜)
110258. [尨挊] TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma. Kikuchi Z, Shibahara I1, Yamaki T, Yoshioka E, Shofuda T, Ohe R, Matsuda K, Saito R, Kanamori M, Kanemura Y, Kumabe T1, Tominaga T, Sonoda Y: Neurooncol Adv 2020/9; 2 (1): vdaa114. (幠尨堦梲1, 孏晹弐岹1: 1擼奜)
110259. [尨挊] H3K27M and TERT promoter mutations are poor prognostic factors in surgical cases of adult thalamic high-grade glioma. Osada Y, Saito R, Shibahara I1, Sasaki K, Shoji T, Kanamori M, Sonoda Y, Kumabe T1, Watanabe M, Tominaga T: Neurooncol Adv 2021/2; 3 (1): vdab038. (幠尨堦梲1, 孏晹弐岹1: 1擼奜)
110260. [尨挊] So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma? Kanamori M, Takami H, Yamaguchi S, Sasayama T, Yoshimoto K, Tominaga T, Inoue A, Ikeda N, Kambe A, Kumabe T1, Matsuda M, Tanaka S, Natsumeda M, Matsuda K, Nonaka M, Kurihara J, Yamaoka M, Kagawa N, Shinojima N, Negoto T, Nakahara Y, Arakawa Y, Hatazaki S, Shimizu H, Yoshino A, Abe H, Akimoto J, Kawanishi Y, Suzuki T, Natsume A, Nagane M, Akiyama Y, Keino D, Fukami T, Tomita T, Kanaya K, Tokuyama T, Izumoto S, Nakada M, Kuga D, Yamamoto S, Anei R, Uzuka T, Fukai J, Kijima N, Terashima K, Ichimura K, Nishikawa R: Neuro Oncol 2021/2; 23 (2): 295-303. (孏晹弐岹1: 1擼奜)
110261. [尨挊] Electron microscopic study of the median structure of the posterior column of the spinal cord of the adult rat with a special reference to the posterior median septum. Mii K, Yagishita S, Kumabe T1: Anat Rec (Hoboken) 2021/3; 304 (3): 625-30. (嶰堜岞旻, 桍壓嶰榊, 孏晹弐岹1: 1擼奜)
310028. [徢椺曬崘] Frequent Clinical and Radiological Progression of Optic Pathway/Hypothalamic Pilocytic Astrocytoma in Adolescents and Young Adults. Shoji T, Kanamori M, Saito R, Watanabe Y, Watanabe M, Fujimura M, Ogawa Y, Sonoda Y, Kumabe T1, Kure S, Tominaga T: Neurol Med Chir (Tokyo) 2020/6; 60 (6): 277-85. (孏晹弐岹1: 1擼奜)
320012. [徢椺曬崘] 暋悢夞偺戝戁嬝枌嵦庢晹偵儕儞僷楻傪惗偠偨1椺. 惔悈丂濟1, 朷寧悞峅1, 崟揷攷婭1, 崻尦丂廩2, 孏晹弐岹1 (1擼奜, 2宍惉丒旤奜): 擼恄宱奜壢 2020/7; 48 (7): 621-5.
320013. [徢椺曬崘] 擼寣娗憿塭偱 early venous filling 傪掓偟偨擼傾儈儘僀僪傾儞僊僆僷僠乕娭楢墛徢偺1椺. 嶳杮戝曘1, 堜搰戝曘2, 將帞丂墌1, 恗栘丂弤1, 塐堜丂椛2, 彫愹姲擵1, 嶰巬丂怣3, 惣嶳榓棙2, 孏晹弐岹1 (1擼奜, 2擼恄宱撪, 3昦棟): 擼恄宱奜壢 2020/7; 48 (7): 641-7.
320014. [徢椺曬崘] 拞擼惓拞晹奀柸忬寣娗庮偵懳偟anterior interhemispheric transcallosal transforaminal approach傪梡偄偰揈弌偟偨1椺. 墡揷榓婱巕1, 幠尨堦梲1, 忹尨岝恖, 孏晹弐岹1 (1擼奜) 擼恄宱奜壢 2020/8; 48 (8): 717-23.
320015. [徢椺曬崘] 摢奧撪泱庮曻幩慄屻帯椕挿婜娤嶡婜娫拞偵偍偗傞僺僢僩僼僅乕儖: 戞1寊恄宱恄宱忊庮偺1恌抐抶墑椺. 堜忋抭晇1, 幠尨堦梲1, 將帞丂墌1, 敿揷丂敚1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜) 擼恄宱奜壢懍曬 2020/9; 30 (9): 1010-5.
320016. [徢椺曬崘] 曣巜傑偨偼帵巜偺傒偺孅嬋忈奞傪弶婜徢忬偲偟偨慜崪娫恄宱杻醿偺2徢椺. 惔悈丂濟1, 朷寧悞峅, 崟揷攷婭1, 戝郪惉擵, 揷拞丂棟, 崻杮丂廩2, 孏晹弐岹1 (1擼奜, 2宍惉丒旤奜): 擼恄宱奜壢 2021/2; 49 (2): 452-3.
522061. [島嵗]亂嫵孭揑徢椺偵妛傇僔儕乕僘亃椉懁懳徧惈枛徑惈慜戝擼摦柆釒偵懳偟偰寣娗撪帯椕傪峴偭偨1椺. 嶳杮戝曘1, 彫愹姲擵1, 堜搰戝曘2, 恗栘丂弤 1, 塐堜丂椛2, 媨嶁榓峅1, 孏晹弐岹1 (1擼奜, 2擼恄宱撪): 擼恄宱奜壢 2020/4; 48 (4): 349-53.
530012. [偦偺懠 (Comment)] In Reply to the Letter to the Editor Regarding ""A Case of Calcifying Pseudoneoplasms of the Neuraxis Coexisting with Interhemispheric Lipoma and Agenesis of the Corpus Callosum: Involvement of Infiltrating Macrophages"". Inukai M1, Shibahara I1, Kumabe T1: World Neurosurg 2020/7; 139: 670-1. (將帞丂墌1, 幠尨堦梲1, 孏晹弐岹1: 1擼奜)
530013. [偦偺懠 (Comment)] Letter to the Editor Regarding ""Failure of Surgery in Idiopathic Spinal Cord Herniation: Case Report and Review of the Literature"". Shimizu S1: World Neurosurg 2020/10; 142: 556-7. (惔悈丂濟1: 1擼奜)
[挊丂彂]
620054. [妛弍彂 (暘扴幏昅)] 亂埆惈擼庮釃偺偡傋偰亅Neuro-Oncology偺嫵壢彂亅堚揱巕恌抐帪戙偺椪彴儕傾儖儚乕儖僪 (擼恄宱奜壢懍曬2020擭憹姧崋)亃[V復 庤弍] 1. 銹夎庮 (GBM) 偺庤弍亅変乆偺棳媀1: 懁摢梩撪懁銹夎庮傪拞怱偵, p.74-83. 幠尨堦梲1, 孏晹弐岹1 (1擼奜), 曇: 悪嶳堦旻, 嫶杮捈嵠, 儊僨傿僇弌斉, 戝嶃, 2020/9敪峴.
620055. [妛弍彂 (暘扴幏昅)]亂埆惈擼庮釃偺偡傋偰亅Neuro-Oncology偺嫵壢彂亅(擼恄宱奜壢懍曬2020擭憹姧崋)亃[V復 庤弍] 12. 泱嵶朎庮釃 (germ cell tumor) 偺庤弍, p.184-94. 嬥怷惌擵, 孏晹弐岹1, 晊塱掝擇 (1擼奜), 曇: 悪嶳堦旻, 嫶杮捈嵠, 儊僨傿僇弌斉, 戝嶃, 2020/9敪峴.
[妛夛丒尋媶夛摍]
722065. [妛夛 (慡崙)] (僔儞億僕僂儉摍) 恄宱銹庮偵偍偗傞愭払幰偺嫵偊偲巹偺傾儗儞僕. 孏晹弐岹1, 幠尨堦梲1 (1擼奜): 戞25夞擔杮擼庮釃偺奜壢妛夛 (2020/9/11), 柤屆壆 (僴僀僽儕僢僪奐嵜).
722066. [妛夛 (慡崙)] (僔儞億僕僂儉摍) 夝朥妛偵婎偯偄偨懁摢梩撪懁屻曽 (屻曽奀攏/奀攏朤夞) 恄宱銹庮採弌弍: 摢捀屻摢峚丒彫擼僥儞僩丒撪戝擼惷柆傪尒傞. 幠尨堦梲1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞25夞擔杮擼庮釃偺奜壢妛夛 (2020/9/11), 柤屆壆 (僴僀僽儕僢僪奐嵜).
722067. [妛夛 (慡崙)] (僔儞億僕僂儉摍) 僩儖僐埰嬤朤庮釃庤弍偵偍偗傞壎巘偺嫵偊偲巹偺傾儗儞僕亅壎巘偼悽奅拞偵偄傞!亅. 壀丂廏岹1, 媣恵旤恀棟1, 嬤摗岹帯1, 僔儍僀僩僴僂傾乕丒僶乕儞僪2, 儘僀僪丒儕僇儖僪2, 儕儏乕僨僢僋丒僟僀僄僞乕3, 儁儖僱僣僉乕丒傾僋僙儖4, 僶儖僩儔儞僼傿乕丒僿儖儉儞僩5, 堃懞岞堣1, 摗堜惔岶6 (1擼奜, 2儊僀儓乕僋儕僯僢僋丒儊僀儓乕堛壢戝妛昦棟, 3僴儞僽儖僌戝妛擼恄宱奜壢, 4儅僀儞僣戝妛擼恄宱奜壢, 5僠儏乕儕僢僸戝妛擼恄宱奜壢, 6暉壀摽廎夛昦堾擼恄宱奜壢): 戞25夞擔杮擼庮釃偺奜壢妛夛 (2020/9/12), 柤屆壆 (僴僀僽儕僢僪奐嵜).
722068. [妛夛 (慡崙)] (彽懸島墘摍) 婄柺恄宱慜摢巬杻醿傪弌偝側偄宱悕懱朄偺旂晢愗奐. 媣恵旤恀棟1,2, 壀丂廏岹1,2, 嬤摗岹帯1,2, 堃懞岞堣1,2, 孏晹弐岹2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2擼奜): 戞29夞擼恄宱奜壢庤弍偲婡婍妛夛 (CNTT2020) (2020/9/29), 墶昹.
722069. [妛夛 (慡崙)] (僔儞億僕僂儉摍) 戝岥宎媧堷僇僥乕僥儖偺愴崙帪戙乣SOFIAFLOW Plus傪巊偄偙側偣!乣. 嶳杮戝曘 (擼奜): 戞29夞擼恄宱奜壢庤弍偲婡婍妛夛 (CNTT2020) (2020/9/30), 墶昹.
722070. [妛夛 (慡崙)] (彽懸島墘摍) 僠僞儞僾儗乕僩傪巊梡偟側偄偨傔偺奐摢岺晇: 摿偵枹攋楐擼摦柆釒僋儕僢僺儞僌弍偵偍偄偰. 彫愹姲擵1,2, 嶳杮戝曘2, 敿揷丂敚2, 媨嶁榓峅2, 墡揷榓婱巕2, 惔悈丂濟2, 孏晹弐岹2 (1媬柦, 2擼奜): 戞13夞擔杮惍梕擼恄宱奜壢妛夛 (JSAN2020) (2020/9/30), 墶昹.
722071. [妛夛 (慡崙)] (僔儞億僕僂儉摍) 崙奜棷妛偐傜妛傫偩庤弍偺怱摼偲嬀帇壓庤弍嫵堢亅姵幰拞怱庤弍嫵堢亅. 壀丂廏岹1, 儁儖僱僣僉乕丒傾僋僙儖2, 儕儏乕僨僋丒僨僀僄僞乕3, 僶儖僩儔儞僼傿乕丒僿儖儉儞僩4, 儘僀僪丒儕僇儖僪5, 僔儍僀僩僴僂傾乕丒僶乕儞僪5, 摗堜惔岶6 (1擼奜, 2儅僀儞僣戝妛擼恄宱奜壢, 3僴儞僽儖僌戝妛擼恄宱奜壢, 4僠儏乕儕僢僸戝妛擼恄宱奜壢, 5儊僀儓乕僋儕僯僢僋丒儊僀儓乕堛壢戝妛昦棟, 6暉壀摽廎夛昦堾擼恄宱奜壢): 戞29夞擼恄宱奜壢庤弍偲婡婍妛夛 (CNTT2020) (2020/9/30), 墶昹.
722072. [妛夛 (慡崙)] (僔儞億僕僂儉摍) 摿敪惈丒堛尨惈屻摢恄宱捝偺夝朥妛揑峫嶡. 惔悈丂濟1, 壀丂廏岹1, 孏晹弐岹1 (1擼奜): 戞27夞擔杮愐捙丒愐悜恄宱庤弍庤媄妛夛妛弍廤夛 (2020/10/3), web奐嵜.
722073. [妛夛 (慡崙)] (僔儞億僕僂儉摍) 嵍Brodamnn 22, 41, 42栰偵懚嵼偡傞恄宱銹庮偵懳偡傞妎惲壓恄宱惗棟妛儌僯僞儕儞僌傪暪梡偟偨壜媦揑揈弌弍. 幠尨堦梲1, 忋揷埢巕2, 搾杮丂摰2, 媨嶁榓峅1, 嵅摗悷恖1, 廏戱堦榊1, 釼摗棾懢3, 娾嶈恀庽4, 塱徏尓堦3, 嬥怷惌擵3, 墍揷弴旻5, 楅栘嫥巕6, 拞棦怣榓7, 晊塱掝擇3, 孏晹弐岹1 (1擼奜, 2儕僴價儕晹, 3搶杒戝妛擼恄宱奜壢, 4崙棫惛恄丒恄宱堛椕尋媶僙儞僞乕擼恄宱奜壢, 5嶳宍戝妛擼恄宱奜壢, 6搶杒戝妛崅師婡擻忈奞妛暘栰, 7搶杒戝妛偰傫偐傫妛暘栰): 戞18夞擔杮Awake Surgery妛夛 (2020/10/3), web奐嵜.
722074. [妛夛 (慡崙)] (僔儞億僕僂儉摍) 彫帣擼庮釃偵懳偡傞懡妏揑傾僾儘乕僠: 嬊強庮釃僐儞僩儘乕儖偵偍偗傞嵞庤弍偺昁梫惈. 孏晹弐岹 (擼奜): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛 戞79夞妛弍憤夛 (2020/10/16), 壀嶳 (僴僀僽儕僢僪奐嵜).
722075. [妛夛 (慡崙)] (彽懸島墘摍) 嵞敪泱庮偵懳偡傞掅慄検慡擼丒愐悜徠幩. 嬥怷惌擵, 釼摗棾懢, 墍揷弴旻, 孏晹弐岹1, 徏壓惏梇, 晊塱掝擇 (1擼奜): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/16), 壀嶳 (僴僀僽儕僢僪奐嵜).
722076. [妛夛 (慡崙)] (僔儞億僕僂儉摍) 彫帣擼庮釃偵懳偡傞嵞庤弍帪偺弍屻姶愼梊杊朄. 幠尨堦梲1, 敿揷丂敚1, 媨嶁榓峅1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞48夞擔杮彫帣恄宱奜壢妛夛 (2020/11/22-23), web奐嵜.
722077. [妛夛 (慡崙)] (彽懸島墘摍) 嵞敪泱庮偵懳偡傞慡擼丒愐悜徠幩. 嬥怷惌擵, 釼摗棾懢, 墍揷弴旻, 孏晹弐岹1, 晊塱掝擇 (1擼奜): 戞48夞擔杮彫帣恄宱奜壢妛夛 (2020/11/23), Web奐嵜.
722078. [妛夛 (慡崙)] (僔儞億僕僂儉摍) 銹夎庮姴嵶朎僯僢僠偱偺嵶朎娫僐儈儏僯働乕僔儑儞. 廏戱堦榊1, 敀愳桾婱2, 忛栰攷巎2, 幠尨堦梲1, 將帞丂墌1, 幝搰捈庽3, 晲妢峎忎3, 孏晹弐岹1 (1擼奜, 2孎杮戝妛惗柦壢妛尋媶晹椪彴栻暔摦懺妛, 3孎杮戝妛惗柦壢妛尋媶晹擼恄宱奜壢): 戞38夞擔杮擼庮釃妛夛妛弍廤夛 (2020/11/30), 峀搰 (僴僀僽儕僢僪奐嵜).
723345. [妛夛 (慡崙)] (堦斒島墘) 娽鈢撪恄宱忊庮偵偰恌抐偝傟偨壠懓惈schwannomatosis偺1椺. 媨嶁榓峅1, 幠尨堦梲1, 廏戱堦榊1, 將帞丂墌1, 嶰巬丂怣2, 拞栰壝巕, 巗懞岾堦, 崅憡徎巑3, 孏晹弐岹1 (1擼奜, 2昦棟, 3惍奜): 戞38夞擔杮擼庮釃昦棟妛夛 (2020/8/6), Web奐嵜.
723346. [妛夛 (慡崙)] (堦斒島墘) Optic hypothalamic pilocytic astrocytoma偺宱帪揑昦棟強尒偺曄壔. 嬥怷惌擵, 搉曈傒偐, 釼摗棾懢, 孏晹弐岹1, 晊塱掝擇 (1擼奜): 戞38夞擔杮擼庮釃昦棟妛夛 (2020/8/6), Web奐嵜.
723347. [妛夛 (慡崙)] (堦斒島墘) 帇彴崅埆惈搙恄宱銹庮偵偍偗傞僸僗僩儞曄堎偲梊屻偵偮偄偰偺専摙. 挿揷壚惍, 釼摗棾懢, 彲巌戱戝, 挿撿夒巙, 幠尨堦梲1, 嬥怷惌擵, 墍揷弴旻, 孏晹弐岹1, 搉曈傒偐, 晊塱掝擇 (1擼奜): 戞38夞擔杮擼庮釃昦棟妛夛 (2020/8/7), Web奐嵜.
723348. [妛夛 (慡崙)] (億僗僞乕) 巰偵帄偭偨娽鈢愭抂徢岓孮偺堦椺乣怤廝惈傾僗儁儖僊儖僗徢偺嫼埿乣. 將帞丂墌1, 敿揷丂敚1, 廏戱堦榊1, 墡揷榓婱巕1, 媨嶁榓峅1, 媑揷丂岟2, 嶰巬丂怣2, 孏晹弐岹1 (1擼奜, 2昦棟): 戞38夞擔杮擼庮釃昦棟妛夛 (2020/8/7), 搶嫗.
723349. [妛夛 (慡崙)] (億僗僞乕) 攋楐摦柆釒偵懳偡傞奜壢帯椕屻偵旕暵嵡惈挵娗嫊寣傪敪徢偟偨2椺. 彫愹姲擵1,2, 嶳杮戝曘1, 愺棙丂桋2, 孏晹弐岹1 (1擼奜, 2媬柦): 戞45夞擔杮擼懖拞妛夛憤夛 (2020/8/23), web奐嵜.
723350. [妛夛 (慡崙)] (億僗僞乕) 撦揑摢晹奜彎偵傛傝拞戝擼摦柆M2婲巒晹偵壖惈摦柆釒傪惗偠偨1椺. 惔悈丂濟1, 崟揷攷婭1, 壀丂廏岹1, 孏晹弐岹1 (1擼奜): 戞49夞擔杮擼懖拞偺奜壢妛夛 (2020/8/23), web奐嵜.
723351. [妛夛 (慡崙)] (堦斒島墘) 崅埵寊摦柆崅搙嫹嶓徢偵懳偡傞帯椕曽恓: high cervical approach偐傜専徹. 媣恵旤恀棟1, 堃懞岞堣1, 嬤摗岹帯1, 壀丂廏岹1 (1擼奜): 戞49夞擔杮擼懖拞偺奜壢妛夛 (2020/8/23), web奐嵜.
723352. [妛夛 (慡崙)] (堦斒島墘) 擼寣娗憿塭偵傛傞奜寊摦柆暘婒條幃偺暘椶偲摿挜. 嶳杮戝曘1, 幠尨堦梲1, 彫愹姲擵1,2, 搉绯丂悞3, 堜搰戝曘4, 崟揷攷婭1, 恗栘丂弤1, 媨嶁榓峅1, 嬤摗棾巎5, 孏晹弐岹1 (1擼奜, 2媬柦, 3愬戜昦堾憤崌恌椕壢, 4擼恄宱撪, 5嶉嬍愇怱夛昦堾擼寣娗撪帯椕壢): 戞49夞擔杮擼懖拞偺奜壢妛夛 (2020/8/23), web奐嵜.
723353. [妛夛 (慡崙)] (堦斒島墘) 夝朥妛偵婎偯偄偨奀攏/奀攏朤夞屻曽銹夎庮揈弌弍: 摢捀屻摢峚丒彫擼僥儞僩丒撪戝擼惷柆丒僈儗儞戝惷柆傪尒傞. 幠尨堦梲1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞29夞擼恄宱奜壢庤弍偲婡婍妛夛 (CNTT2020) (2020/9/29), 墶昹.
723354. [妛夛 (慡崙)] (堦斒島墘) 恄宱銹夎庮採弌偵偍偗傞Sonopet覀苾o僀億乕儔摨帪暪梡偺桳梡惈. 孏晹弐岹1, 幠尨堦梲1, 廏戱堦榊1 (1擼奜): 戞29夞擼恄宱奜壢庤弍偲婡婍妛夛 (CNTT2020) (2020/9/29), 墶昹.
723355. [妛夛 (慡崙)] (堦斒島墘) 婄柺恄宱杻醿傪弌偝側偄彫擼嫶妏晹庮釃庤弍. 媣恵旤恀棟1,2, 壀丂廏岹1,2, 嬤摗岹帯1,2, 孏晹弐岹2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2擼奜): 戞43夞擔杮婄柺恄宱妛夛 (2020/9/30), 垽昋.
723356. [妛夛 (慡崙)] (堦斒島墘) 暋悢夞偺戝戁嬝枌嵦庢晹偵儕儞僷楻傪惗偠偨1椺. 惔悈丂濟1, 朷寧悞峅, 崟揷攷婭1, 崻尦丂廩2, 孏晹弐岹1 (1擼奜, 2宍惉丒旤奜): 戞13夞擔杮惍梕擼恄宱奜壢妛夛 (JSAN2020) (2020/9/30), 墶昹.
723357. [妛夛 (慡崙)] (堦斒島墘) 恖娫岺妛偵婎偯偔庤弍尠旝嬀憖嶌僴儞僪儖偺愝掕: 弍拞旀楯掅尭偺帋傒. 惔悈丂濟1, 崟揷攷婭1, 朷寧悞峅, 孏晹弐岹1 (1擼奜): 戞27夞擔杮愐捙丒愐悜恄宱庤弍庤媄妛夛妛弍廤夛 (2020/10/2), web奐嵜.
723358. [妛夛 (慡崙)] (堦斒島墘) 愐悜屻惓拞恑擖朄偺夝朥妛揑専摙: 儔僢僩屻惓拞拞妘偺挻旝嵶峔憿偐傜. 嶰堜岞旻, 桍壓嶰榊, 孏晹弐岹1 (1擼奜): 戞27夞擔杮愐捙丒愐悜恄宱庤弍庤媄妛夛妛弍廤夛 (2020/10/3), web奐嵜.
723359. [妛夛 (慡崙)] (堦斒島墘) 儀僶僕僘儅僽摫擖屻偺銹夎庮帯椕惉愌. 釼摗棾懢, 嬥怷惌擵, 幠尨堦梲1, 挿揷壚惍, 墍揷弴旻, 孏晹弐岹1, 搉曈傒偐, 晊塱掝擇 (1擼奜): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/15), 壀嶳 (僴僀僽儕僢僪奐嵜).
723360. [妛夛 (慡崙)] (堦斒島墘) 銹夎庮偵偍偗傞TERTp曄堎偺椪彴揑堄媊. 媏抧慞彶, 嶳杮丂揘, 幠尨堦梲1, 徏揷寷堦楴, 嬥懞暷攷, 戝峕椣懢榊, 嬥怷惌擵, 孏晹弐岹1, 晊塱掝擇, 墍揷弴旻 (1擼奜): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/15), 壀嶳 (僴僀僽儕僢僪奐嵜).
723361. [妛夛 (慡崙)] (堦斒島墘) 帇彴崅埆惈搙恄宱銹庮採弌椺偵偍偗傞僸僗僩儞曄堎偲梊屻偵偮偄偰偺専摙. 挿揷宩惍, 釼摗棾懢, 幠尨堦梲1, 彲巌戱戝, 挿撿夒巙, 嬥怷惌擵, 墍揷弴旻, 孏晹弐岹1, 搉绯傒偐, 晊塱掝擇 (1擼奜): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/15), 壀嶳 (僴僀僽儕僢僪奐嵜).
723362. [妛夛 (慡崙)] (堦斒島墘) 拞宆偺挳恄宱庮釃偵懳偡傞挳椡壏懚庤弍. 媣恵旤恀棟1, 壀丂廏岹1, 嬤摗岹帯1, 堃懞岞堣1, 孏晹弐岹1 (1擼奜): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/15-11/30), 壀嶳 (僴僀僽儕僢僪奐嵜).
723363. [妛夛 (慡崙)] (堦斒島墘) 旕揟宆揑夋憸強尒傪帵偡尨敪惈拞悤恄宱宯埆惈儕儞僷庮偺昦棟慻怐妛揑摿挜. 將帞丂墌1, 幠尨堦梲1, 敿揷丂敚1, 墡揷榓婱巕1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/15-11/30), 壀嶳 (僴僀僽儕僢僪奐嵜).
723364. [妛夛 (慡崙)] (堦斒島墘) 崅楊幰偺傃傑傫惈幉嶕懝彎偺椪彴揑摿挜. 廏戱堦榊1, 嶳杮戝曘1, 彫愹姲擵1,2, 嵅摗悷恖1, 愺棙丂桋2, 孏晹弐岹1 (1擼奜, 2媬柦): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/15-11/30), 壀嶳 (僴僀僽儕僢僪奐嵜).
723365. [妛夛 (慡崙)] (堦斒島墘) 暘婒條幃偵拲栚偟偨擼寣娗嶣塭偵傛傞奜栩摦柆偺摿挜夝愅. 嶳杮戝曘1, 彫愹姲擵1,2, 堜搰戝曘3, 崟揷攷婭1, 幠尨堦梲1, 恗栘丂弤1, 媨嶁榓峅1, 搉绯丂悞4, 嬤摗棾巎5, 孏晹弐岹1 (1擼奜, 2媬柦, 3擼恄宱撪, 4JCHO愬戜昦堾憤崌恌椕壢, 5嶉嬍愇怱夛昦堾擼寣娗撪帯椕壢): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/15-11/30), 壀嶳 (僴僀僽儕僢僪奐嵜).
723366. [妛夛 (慡崙)] (億僗僞乕) 嵞敪銹夎庮偵懳偡傞Bevacizumab偺帯椕惉愌偲摿挜揑側夋憸強尒偵娭偡傞専摙. 敿揷丂敚1, 幠尨堦梲1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/15-11/30), 壀嶳 (僴僀僽儕僢僪奐嵜).
723367. [妛夛 (慡崙)] (億僗僞乕) 慜摢摢捀曎奧晹恄宱銹庮揈弌屻偺塣摦婡擻忈奞偵娭偡傞婋尟場巕偺専摙. 幠尨堦梲1, 嵅摗悷恖1, 栘壓丂妛2, 搉绯丂悞3, 廏戱堦榊1, 釼摗棾懢4, 嬥怷惌擵4, 墍揷弴旻5, 晊塱掝擇4, 孏晹弐岹1 (1擼奜, 2戝嶃戝妛戝妛堾堛妛宯尋媶壢擼恄宱奜壢, 3JCHO愬戜昦堾憤崌恌椕壢, 4搶杒戝妛戝妛堾堛妛宯尋媶壢恄宱奜壢妛暘栰, 5嶳宍戝妛堛妛晹擼恄宱奜壢): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/15-11/30), 壀嶳 (僴僀僽儕僢僪奐嵜).
723368. [妛夛 (慡崙)] (億僗僞乕) 帴応幃僫價僎乕僔儑儞僈僀僪壓撪帇嬀壓晹寣庮揈弌弍傪慻傒崬傫偩寣庮傪敽偆攋楐擼摦惷柆婏宍偵懳偡傞媫惈婜帯椕愴棯. 彫愹姲擵1,2, 嶳杮戝曘2, 廏戱堦榊2, 愺棙丂桋1, 孏晹弐岹2 (1媬柦, 2擼奜): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/15-11/30), 壀嶳 (僴僀僽儕僢僪奐嵜).
723369. [妛夛 (慡崙)] (億僗僞乕) 恖娫岺妛偵婎偯偔庤弍尠旝嬀憖嶌僴儞僪儖偺愝掕: 弍拞旀楯掅尭偺帋傒. 惔悈丂濟1, 崟揷攷婭1, 朷寧悞峅, 孏晹弐岹1 (1擼奜): 堦斒幮抍朄恖擔杮擼恄宱奜壢妛夛戞79夞妛弍憤夛 (2020/10/15-11/30), 壀嶳 (僴僀僽儕僢僪奐嵜).
723370. [妛夛 (慡崙)] (億僗僞乕) 旕揟宆揑夋憸強尒傪帵偡尨敪惈拞悤恄宱宯埆惈儕儞僷庮偺昦棟慻怐妛揑摿挜. 將帞丂墌1, 幠尨堦梲1, 敿揷丂敚1, 墡揷榓婱巕1, 嵅摗悷恖1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞38夞擔杮擼庮釃妛夛妛弍廤夛 (2020/11/29), 峀搰 (僴僀僽儕僢僪奐嵜).
723371. [妛夛 (慡崙)] (億僗僞乕) 嵞敪銹夎庮偵懳偡傞Bevacizmab偺帯椕惉愌偲摿挜揑側夋憸強尒偵娭偡傞専摙. 敿揷丂敚1, 幠尨堦梲1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞38夞擔杮擼庮釃妛夛妛弍廤夛 (2020/11/29), 峀搰 (僴僀僽儕僢僪奐嵜).
723372. [妛夛 (慡崙)] (億僗僞乕) 彫帣丒AYA悽戙偺嵞敪埆惈擼庮釃偵懳偡傞堚揱巕僷僱儖専嵏偺椪彴墳梡. 幠尨堦梲1, 孏晹弐岹1, 廏戱堦榊1, 嶚旜椇懢2, 嵅乆栘岝2, 嵅乆栘帯堦榊3 (1擼奜, 2宑滀媊弇戝妛堛妛晹擼恄宱奜壢, 3怴悽婭堛椕丒墶抐揑堛椕): 戞38夞擔杮擼庮釃妛夛妛弍廤夛 (2020/11/30), 峀搰 (僴僀僽儕僢僪奐嵜).
723373. [妛夛 (慡崙)] (億僗僞乕) Extra-parenchymal (Peripheral) Atypical Teratoid/Rhabdoid Tumors. 壀丂廏岹1, 媣恵旤恀棟1, 堃懞岞堣1, 嬤摗峗帯1 (1擼奜): 戞38夞擔杮擼庮釃妛夛妛弍廤夛 (2020/12/1), 峀搰 (僴僀僽儕僢僪奐嵜).
723374. [妛夛 (慡崙)] (堦斒島墘) 12p gain偼崅埆惈搙偺旕僕儍乕儈僲乕儅惈泱嵶朎庮偱崅昿搙偵擣傔傜傟傞. 棦尒夘巎, 崅尒峗悢, 暉搰怲懢榊, 拞棦梞堦, 揷拞洅懢, 釼摗墑恖, 嬥怷惌擵, 孏晹弐岹1, 彫椦孾堦, 塱崻婎梇, 堜撪弐旻, 峚岥徆峅, 揷懞丂堣, 慜尨寬庻, 庰堜孿堦, 悪嶳堦旻, 墶忋惞婱, 抾搰廏梇, 擶拞惓攷, 熐堜徍梇, 惣愳丂椇, 徏扟惌惗, 巗懞岾堦 (1擼奜): 戞38夞擔杮擼庮釃妛夛妛弍廤夛 (2020/12/1), 峀搰 (僴僀僽儕僢僪奐嵜).
723375. [妛夛 (慡崙)] (堦斒島墘) 戞巐擼幒忋堖庮偺夝朥暘椶丒暘巕暘椶偐傜傒偨揈弌搙丒婡擻壏懚丒庮釃惂屼. 嬥怷惌擵, 釼摗棾懢, 搉曈傒偐, 墍揷弴旻, 孏晹弐岹1, 晊塱掝擇 (1擼奜): 戞38夞擔杮擼庮釃妛夛妛弍廤夛 (2020/12/1), 峀搰 (僴僀僽儕僢僪奐嵜).
723376. [妛夛 (慡崙)] (堦斒島墘) 擼寣娗忈奞庤弍偵偍偗傞摢奧掙庤媄偺桳梡惈. 媣恵旤恀棟1, 嬤摗岹帯1, 堃懞岞堣1, 壀丂廏岹1 (1擼奜): 戞50夞擔杮擼懖拞偺奜壢妛夛妛弍廤夛 (STROKE 2021) (2021/3/12), 暉壀 (僴僀僽儕僢僪奐嵜).
723377. [妛夛 (慡崙)] (堦斒島墘) M1-2摦柆釒僩儔僢僺儞僌弍偵暪梡偡傞傾僔僗僩僶僀僷僗弍偵偍偗傞recipient artery慖戰偺岺晇亅徢椺曬崘. 崟揷攷婭1, 拞嫃峃揥, 朷寧悞峅, 惔悈丂濟1, 孏晹弐岹1 (1擼奜): 戞50夞擔杮擼懖拞偺奜壢妛夛妛弍廤夛 (STROKE 2021) (2021/3/11-4/12), 暉壀 (僴僀僽儕僢僪奐嵜).
723378. [妛夛 (慡崙)] (堦斒島墘) 捙崪擼掙摦柆paramedian longitudinal axis偺堚巆摦柆偵惗偠偨夝棧惈摦柆釒偺1椺. 惔悈丂濟1, 崟揷攷婭1, 娒棙榓岝, 拞嫃峃揥, 將帞丂墌1, 孏晹弐岹1 (1擼奜): 戞50夞擔杮擼懖拞偺奜壢妛夛妛弍廤夛 (STROKE 2021) (2021/3/11-4/12), 暉壀 (僴僀僽儕僢僪奐嵜).
731013. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) eloquent area偵偍偗傞銹夎庮偺庤弍愴棯. 孏晹弐岹 (擼奜): 怣廈擼庮釃Web僇儞僼傽儗儞僗 (2020/10/6), web奐嵜.
731014. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 彫帣擼庮釃偺憗婜恌抐偵偍偗傞拲堄帠崁. 孏晹弐岹 (擼奜): 戞230夞擔杮彫帣壢妛夛媨忛抧曽夛 (2020/11/15), Web奐嵜.
733072. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 彫擼堎宍惉傪攚宨偵敪惗偟偨惉恖悜夎庮偺1椺. 朙揷錆棞巕1, 幠尨堦梲1, 敿揷丂敚1, 昐晲桟棟1, 將帞丂墌1, 廏戱堦榊1, 孏晹弐岹1 (1擼奜): 戞143夞擔杮擼恄宱奜壢妛夛娭搶巟晹夛 (2020/12/12), 搶嫗 (僴僀僽儕僢僪奐嵜).
733073. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摢奧撪germinoma偵慡恖惈sarcoidosis傪崌暪偟偨堦椺. 昐晲桟棟1, 幠尨堦梲1, 堜忋抭晇1, 彫愹姲擵1,2, 巘揷怣恖1, 廏戱堦榊1, 將帞丂墌1, 媑揷丂岟3, 嵅乆栘帯堦榊4, 孏晹弐岹1 (1擼奜, 2媬柦, 3昦棟, 4怴悽婭堛椕丒墶抐揑堛椕): 戞143夞擔杮擼恄宱奜壢妛夛娭搶巟晹夛 (2020/12/12), 搶嫗 (僴僀僽儕僢僪奐嵜).
'19擭搙埲慜暘
[挊丂彂]
'19-620011. [妛弍彂 (暘扴幏昅)]亂僀儔僗僩偲夋憸偱傒傞寣娗撪帯椕偵昁梫側慡恎寣娗 (儊僨傿僇儖僗僞僢僼偺偨傔偺寣娗撪帯椕僔儕乕僘 儊僨傿僇僥匓)亃1復 摢晹偺寣娗, p.15-56. 嶳杮戝曘1, 愇揷峅婤2, 摗壀弐堦榊3, 戝媣曐攷悽3, 抮揷桽婤4, 僂僢僪僴儉僗楁巕5, 徏塱宧擇5, 尨丂晀彨, 摗堜丂奭5, 垻屆弫嵠2 (1擼奜, 2弞娐婍撪, 3怱憻寣娗奜, 4媬柦, 5曻幩慄 (夋憸)) 曇: 垻屆弫嵠, 儊僨傿僇弌斉, 戝嶃, 2019/10敪峴.
彫帣壢妛
[妛弍榑暥]
110262. [尨挊] Hypoxic activation of glucose-6-phosphate dehydrogenase controls the expression of genes involved in the pathogenesis of pulmonary hypertension through the regulation of DNA methylation. Joshi SR, Kitagawa A1, Jacob C, Hashimoto R, Dhagia V, Ramesh A, Zheng C, Zhang H, Jordan A, Waddell I, Leopold J, Hu C-J, McMurtry IF, D'Alessandro A, Stenmark KR, Gupte SA: Am J Physiol Lung Cell Mol Physiol 2020/4; 318 (4): L773-86. (杒愳撃巎1: 1彫帣)
110263. [尨挊] Primary causes of kidney disease and mortality in dialysis-dependent children. Okuda Y1, Soohoo M, Ishikura K1, Tang Y, Obi Y, Laster M, Rhee CM, Streja E, Kalantar-Zadeh K: Pediatr Nephrol 2020/5; 35 (5): 851-60. (墱揷梇夘1, 愇憅寬巌1: 1彫帣)
110264. [尨挊] CRISPR-Mediated Single Nucleotide Polymorphism Modeling in Rats Reveals Insight Into Reduced Cardiovascular Risk Associated With Mediterranean G6PD Variant. Kitagawa A1, Kizub I, Jacob C, Michael K, D'Alessandro A, Reisz JA, Grzybowski M, Geurts AM, Rocic P, Gupte R, Miano JM, Gupte SA: Hypertension 2020/8; 76 (2): 523-32. (杒愳撃巎1: 1彫帣)
110265. [尨挊] A cross-sectional nationwide survey of congenital and infantile nephrotic syndrome in Japan. Hamasaki Y, Hamada R, Muramatsu M, Matsumoto S, Aya K, Ishikura K1, Kaneko T, Iijima K: BMC Nephrol 2020/8; 21 (1): 363. (愇憅寬巌1: 1彫帣)
110266. [尨挊] A simple, refined approach to diagnosing renovascular hypertension in children: A 10-year study. Saida K, Kamei K, Hamada R, Yoshikawa T, Kano Y, Nagata H, Sato M, Ogura M, Harada R, Hataya H, Miyazaki O, Nosaka S, Ito S, Ishikura K1: Pediatr Int 2020/8; 62 (8): 937-43. (愇憅寬巌1: 1彫帣)
110267. [尨挊] Refractory Hypertension in Infantile-Onset Denys-Drash Syndrome. Nishi K, Kamei K, Ogura M, Sato M, Murakoshi M,Kamae C,Suzuki R , Kanamori T, Nagano C, Nozu K, Ishikura K1, Ito S: Tohoku J Exp Med 2020/9; 252 (1): 45-51. (愇憅寬巌1: 1彫帣)
110268. [尨挊] Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents. Kamei K, Miyairi I, Ishikura K1, Ogura M, Shoji K, Arai K, Ito R, Kawai T, Ito S: PLoS One 2020/10; 15 (10): e0240217. (愇憅寬巌1: 1彫帣)
110269. [尨挊] Dietary Potassium Intake and Mortality in a Prospective Hemodialysis Cohort. Narasaki Y, Okuda Y1, Kalantar SS, You AS, Novoa A, Nguyen T, Streja E, Nakata T, Colman S, Kalantar-Zadeh K, Nguyen DV, Rhee CM: J Ren Nutr 2021/7; 31 (4): 411-20. doi: 10.1053/j.jrn.2020.05.008. Epub 2020 Oct 27. (墱揷梇夘1: 1彫帣)
110270. [尨挊] Perinatal factors contributing to chronic kidney disease in a cohort of Japanese children with very low birth weight. Uemura O, Ishikura K1, Kaneko T, Hirano D, Hamasaki Y, Ogura M, Mikami N, Gotoh Y, Sahashi T, Fujita N, Yamamoto M, Hibino S, Nakano M, Wakano Y, Honda M: Pediatr Nephrol 2021/4; 36 (4): 953-60. doi: 10.1007/s00467-020-04791-1. Epub 2020 Oct 17. (愇憅寬巌1: 1彫帣)
110271. [尨挊] Association of age with risk of first and subsequent allograft failure and mortality among young kidney transplant recipients in the USA - a retrospective cohort study. Okuda Y1, Streja E, Rhee CM, Tantisattamo E, Reddy U, Laster M, Tang Y, Rajpoot D, Molnar MZ, Ichii H, Obi Y, Kalantar-Zadeh K: Transpl Int 2020/11; 33 (11): 1503-15. (墱揷梇夘1: 1彫帣)
110272. [尨挊] Influenza virus vaccination in children with nephrotic syndrome: insignificant risk of relapse. Ishimori S, Kamei K, Ando T, Yoshikawa T, Kano Y, Nagata H, Saida K, Sato M, Ogura M, Ito S, Ishikura K1: Clin Exp Nephrol 2020/11; 24 (11): 1069-76. (愇憅寬巌1: 1彫帣)
110273. [尨挊] Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome. Jia X , Yamamura T , Gbadegesin R, McNulty MT, Song K, Nagano C, Hitomi Y, Lee D, Aiba Y, Khor S-S, Ueno K, Kawai Y, Nagasaki M, Noiri E, Horinouchi T, Kaito H, Hamada R, Okamoto T, Kamei K, Kaku Y, Fujimaru R, Tanaka R , Shima Y, Research Consortium on Genetics of Childhood Idiopathic Nephrotic Syndrome in Japan; Baek J, Kang HG, Ha I-S, Han KH, Yang EM, Korean Consortium of Hereditary Renal Diseases in Children; Abeyagunawardena A, Lane B, Chryst-Stangl M, Esezobor C, Solarin A, Midwest Pediatric Nephrology Consortium (Genetics of nephrotic syndrome study group); Dossier C, Desch恘es G, NEPHROVIR; Vivarelli M, Debiec H, Ishikura K1, Matsuo M, Nozu K, Ronco P, Cheong HI, Sampson MG, Tokunaga K, Iijima K: Kidney Int 2020/11; 98 (5): 1308-22. (愇憅寬巌1: 1彫帣)
110274. [尨挊] A faster decline of residual kidney function and erythropoietin stimulating agent hyporesponsiveness in incident hemodialysis patients. Kimura H, Sy J, Okuda Y1, Wenziger C, Hanna R, Obi Y, Rhee CM, Kovesdy CP, Kalantar-Zadeh K, Streja E: Hemodial Int 2021/1; 25 (1): 60-70. (墱揷梇夘1: 1彫帣)
110275. [尨挊] Hyperglycemic Crisis in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS). Toki T1, Shimizu-Motohashi Y, Komaki H, Takeshita E, Ishiyama A, Saito T, Mori-Yoshimura M, Sumitomo N, Hirasawa-Inoue A, Nakagawa E, Nishino I, Goto Y, Sasaki M: Pediatr Neurol 2021/1; 114: 1-4. (搚婒丂暯1: 1彫帣)
110276. [尨挊] A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) study. Prusakov P1, Goff DA1, Wozniak PS1, Cassim A1, Scipion CEA1, Urz渁 S1, Ronchi A1, Zeng L1, Ladipo-Ajayi O1, Aviles-Otero N1, Udeigwe-Okeke CR1, Melamed R1, Silveira RC1, Auriti C1, Beltr噉-Arroyave C1, Zamora-Flores E1, Sanchez-Codez M1, Donkor ES1, Kekom妅i S1, Mainini N1, Trochez RV1, Casey J1, Graus JM1, Muller M1, Singh S1, Loeffen Y1, P巖ez MET1, Ferreyra GI1, Lima-Rogel V1, Perrone B1, Izquierdo G1, Cernada M1, Stoffella S1, Ekenze SO1, de Alba-Romero C1, Tzialla C1, Pham JT1, Hosoi K1, Consuegra MCCC1, Betta P1, Hoyos OA1, Roilides E1, Naranjo-Zu杋ga G1, Oshiro M1, Garay V1, Mond� V1, Mazzeo D1, Stahl JA1, Cantey JB1, Monsalve JGM1, Normann E1, Landgrave LC1, Mazouri A1, Avila CA1, Piersigilli F1, Trujillo M1, Kolman S1, DelgadoV1, Guzman V1, Abdellatif M1, Monterrosa L1, Tina LG1, Yunis K1, Rodriguez MAB1, Le Saux N1, Leonardi V1, Porta A1, Latorre G1, Nakanishi H1,2,3, Meir M1, Manzoni P1, Norero X1, Hoyos A1, Arias D1, S噉chez RG1, Medoro AK1, S噉chez PJ1 (1Global NEO-ASP Study Group): EClinicalMedicine 2021/1; 32: 100727. (拞惣廏旻1,2,3: 2怴悽婭堛椕丒愭抂堛椕, 3彫帣)
110277. [尨挊] Race and Ethnicity Predict Bone Markers and Fracture in Pediatric Patients With Chronic Kidney Disease. Laster M, Denburg M, Okuda Y1, Kumar J, Furth S, Warady B, Kalantar-Zadeh K, Norris K, Salusky IB: J Bone Miner Res 2021/2; 36 (2): 298-304. (墱揷梇夘1: 1彫帣)
110278. [尨挊] Prognosis and acute complications at the first onset of idiopathic nephrotic syndrome in children: a nationwide survey in Japan (JP-SHINE study). Sato M1, Ishikura K1,2, Ando T1, Kikunaga K1, Terano C1, Hamada R1, Ishimori S1, Hamasaki Y1, Araki Y1, Gotoh Y1, Nakanishi K1, Nakazato H1, Matsuyama T1, Iijima K1, Yoshikawa N1, Ito S1, Honda M1 (1Japanese Pediatric Survey Holding Information of Nephrotic Syndrome (JP-SHINE) study of the Japanese Study Group of Renal Disease in Children): Nephrol Dial Transplant 2021/2; 36 (3): 475-81. (愇憅寬巌1,2: 2彫帣)
110279. [尨挊] A Retrospective Cohort Study on Mortality and Neurodevelopmental Outcomes of Preterm Very Low Birth Weight Infants Born to Mothers with Hypertensive Disorders of Pregnancy. Kono Y1, Yonemoto N1, Nakanishi H1,2,3, Hosono S1, Hirano S1, Kusuda S1, Fujimura M1 (1Neonatal Research Network Japan): Am J Perinatol 2021/2. doi: 10.1055/s-0041-1722874. Online ahead of print. (拞惣廏旻1,2,3: 2怴悽婭堛椕丒愭抂堛椕, 3彫帣)
110280. [尨挊] Development and validation of a Japanese version of the TRANSITION-Q. Morisaki-Nakamura M, Suzuki S, Kobayashi A, Kita S, Sato I, Iwasaki M, Hirata Y1, Sato A, Oka A, Kamibeppu K: Pediatr Int 2021/3; 63 (3): 270-8. (暯揷梲堦榊1: 1彫帣)
110281. [尨挊] G6PD activity contributes to the regulation of histone acetylation and gene expression in smooth muscle cells and to the pathogenesis of vascular diseases. Dhagia V, Kitagawa A1, Jacob C, Zheng C, D'Alessandro A, Edwards JG, Rocic P, Gupte R, Gupte SA: Am J Physiol Heart Circ Physiol 2021/3; 320 (3): H999-1016. (杒愳撃巎1: 1彫帣)
110282. [尨挊] Prophylactic rituximab administration in children with complicated nephrotic syndrome. Okutsu M, Kamei K, Sato M, Kanamori T, Nishi K, Ishiwa S, Ogura M, Sako M, Ito S, Ishikura K1: Pediatr Nephrol 2021/3; 36 (3): 611-9. (愇憅寬巌1: 1彫帣)
120009. [尨挊] 嶉嬍導偵偍偗傞僟僯傾儗儖僊乕偵娭偡傞堄幆挷嵏偺寢壥. 媀摨惔崄, 嵅摗廏旤, 嶰戭掕柧, 嶁搶桼婭1,2, 崅壀惓晀, 戝応廋堦, 懞揷丂岝 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2彫帣): 嶉嬍導塹惗尋媶強曬 2021/1; 54: 116-21.
120010. [尨挊] YS1402旂壓搳梌, 偍傛傃怱嬝搳梌偵偍偗傞嫊寣惈怱嬝徢偵懳偡傞岠壥偺専摙. 暯揷梲堦榊1, 嵅揷惌棽 (1彫帣): 寧姧Bio Industry 2020/8; 37 (8): 38-45.
120011. [尨挊] 擕帣憗婜偵怉崬傒宆彍嵶摦婍 (ICD) 怉崬傒傪峴偭偨愭揤惈QT墑挿徢岓孮偺1椺. 搚婒旤媣1, 埨摗丂庻1, 曯旜宐棞1, 栘懞弮恖1, 崅棞丂妛1, 杮揷丂悞1, 暯揷梲堦榊1, 媨抧丂娪2, 愇憅寬巌1 (1彫帣, 2怱憻寣娗奜): 擔杮彫帣媬媫堛妛夛嶨帍 2021/2; 20 (1): 39-42.
310029. [徢椺曬崘] Successful angioplasties using high pressure large balloons in a patient with severe anastomotic pulmonary artery stenosis soon after single-lung transplantation. Shiraga K, Hirata Y1, Saito A, Ozcelik N, Asakai H, Inuzuka R, Soma K, Sato M, Hirata Y, Oka A: J Cardiol Cases 2020/5; 22 (1): 22-5. (暯揷梲堦榊1: 1彫帣)
310030. [徢椺曬崘] Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy. Nishi K, Sato M, Ogura M, Okutsu M, Ishikura K1, Kamei K: BMC Nephrol 2020/8; 21 (1): 323. (愇憅寬巌1: 1彫帣)
310031. [徢椺曬崘] A girl with MIRAGE syndrome who developed steroid-resistant nephrotic syndrome: a case report. Ishiwa S, Koichi Kamei K, Tanase-Nakao K, Shibata S, Matsunami K, Takeuchi I, Sato M, Ishikura K1, Narumi S: BMC Nephrol 2020/8; 21 (1): 340. (愇憅寬巌1: 1彫帣)
310032. [徢椺曬崘] Poor Myocardial Compaction in a Patient with Recessive MYL2 Myopathy. Monoi-Tamamitsu A, Nakagama Y, Domoto Y, Yoshida K, Ogawa S, Hirono K, Shindo T, Ogawa Y, Nakano K, Asakai H, Hirata Y1, Matsui H, Inuzuka R: Int Heart J 2021/3; 62 (2): 445-7. (暯揷梲堦榊1: 1彫帣)
310033. [徢椺曬崘] Echocardiogram Unmasked Hemodynamic Advantage of Atrial Pacing in Securing Ventricular Preload in a Fontan Patient with Junctional Rhythm. Saiki H, Kawada K1, Kuwata S1, Takanashi M1, Fukunishi T2, Miyaji K2, Senzaki H: Int Heart J 2021/3; 62 (2): 448-52. (愳揷岶暯1, 鴚揷惞巕1, 崅棞丂妛1, 暉惣戶恀2, 媨抧丂娪2: 1彫帣, 2怱憻寣娗奜)
320017. [徢椺曬崘] 怱幒拞妘寚懝傪崌暪偟憗婜偵奜壢揑帯椕夘擖傪梫偟偨懡岴惈嶰怱朳怱偺擕帣椺. 愳揷岶暯1, 栘懞弮恖1, 暯揷梲堦榊1, 杮揷丂悞1, 崅棞丂妛1, 嶁搶桼
婭1,2, 怷丂慞庽, 愇憅寬巌1 (1彫帣, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 彫帣壢 2021/2; 62 (2): 193-8.
510013. [憤愢] Inherited salt-losing tubulopathy: An old condition but a new category of tubulopathy. Nozu K, Yamamura T, Horinouchi T, Nagano C, Sakakibara N, Ishikura K1, Hamada R, Morisada N, Iijima K: Pediatr Int 2020/4; 62 (4): 428-37. (愇憅寬巌1: 1彫帣)
520009. [憤愢] 椪彴堛偑庤偑偗傞塽妛尋媶. 墱揷梇夘1, 愇憅寬巌1 (1彫帣): 杒棦堛妛 2020/12; 50 82): 93-103.
522062. [島嵗]亂摿廤: 廃嶻婜偲弞娐娗棟亃怴惗帣婜偺弞娐娗棟丂斢婜弞娐晄慡偺昦懺偲娗棟. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 廃嶻婜堛妛 2020/7; 50 (7): 1133-8.
522063. [島嵗]亂摿廤: 彫帣偺銹尨昦亃[椪彴椺] 彫帣婜偵敪徢偟偨microgeodic disease偺2徢椺. 峕攇屗岶曘1, 嬥巕夒婭1, 嶁搶桼婭1, 愇憅寬巌1 (1彫帣): 旂晢昦恌椕 2021/3; 43 (3): 260-3.
530014. [偦偺懠 (Letter to the Editor)] Toward co-production of research in 22q11.2 deletion syndrome: Research needs from the caregiver's perspective. Tamune H, Kumakura Y, Morishima R, Kanehara A, Tanaka M, Okochi N, Nakajima N, Hamada J, Ogawa T, Nakahara M, Jinde S, Kano Y, Tanaka K, Hirata Y1, Oka A, Kasai K: Psychiatry Clin Neurosci 2020/11; 74 (11): 626-7. (暯揷梲堦榊1: 1彫帣)
540025. [偦偺懠 (儚乕僉儞僌僌儖乕僾曬崘)]亂擔杮彫帣壢妛夛摥偒曽夵妚専摙儚乕僉儞僌僌儖乕僾曬崘亃偙傟偐傜偺彫帣壢堛偑栚巜偡彫帣曐寬丒堛椕偺曽岦惈偵偮偄偰. 戝嶳徃堦1, 愒椾梲巕1, 暉尨棦宐1, 峳杧恗旤1, 愇栄丂悞1, 愇嶈桪巕1, 埳摗桭栱1, 峕尨丂楴1, 擔壓丂棽1, 庬巗恞拡1, 郷揷梞捠1, 暯杮棿屷1, 樤揷岝榓1, 摴抂怢柧1, 嶁搶桼婭1,2,3, 嬥忛婭巕1, 徏尨抦戙1, 暯嶳夒峗1 (1擔杮彫帣壢妛夛摥偒曽夵妚専摙儚乕僉儞僌僌儖乕僾, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3彫帣): 擔杮彫帣壢妛夛嶨帍 2021/3; 125 (3): 540-4.
[挊丂彂]
610002. [妛弍彂 (暘扴幏昅)]亂Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension亃11. Morphological Characterization of Pulmonary Microvascular Disease in Bronchopulmonary Dysplasia Caused by Hyperoxia in Newborn Mice, p.91-3. Nakanishi H1,2, Morikawa S, Kitahara S, Yoshii A, Uchiyama A, Kusuda S, Ezaki T, Editors: Nakanishi T, Baldwin HS, Fineman JR, Yamagishi H, Springer, Singapore, 2020/10. (拞惣廏旻1,2: 1怴悽婭堛椕丒愭抂堛椕, 2彫帣)
620056. [妛弍彂 (暘扴幏昅)]亂彫帣幘姵偺栻暔帯椕僈僀僪儔僀儞憤傑偲傔丂昗弨帯椕傪傑傞偛偲夝愢! (寧姧栻帠2020擭5寧椪帪憹姧崋)亃戞V復 恡幘姵丂愭揤惈恡擜楬堎忢, p.1388-92. 愇憅寬巌 (彫帣), 曇廤戙昞: 屲廫棐棽, 曇: 陰摗弴暯, 嶳扟柧惓, 偠傎偆, 搶嫗, 2020/5敪峴.
620057. [妛弍彂 (暘扴幏昅)]亂彫帣儕僂儅僠妛亃戞I晹 憤榑丂彫帣儕僂儅僠惈幘姵偺棟夝偵昁梫側柶塽妛偺婎慴抦幆, p.10-4. 嶁搶桼婭1,2, 怉徏悞擵 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2彫帣), 娔廋: 埳摗廏堦, 怷丂夒椇, 曇: 擔杮彫帣儕僂儅僠妛夛, 挬憅彂揦, 搶嫗, 2020/5敪峴.
620058. [妛弍彂 (暘扴幏昅)]亂崅寣埑妛丂壓亅崅寣埑惂埑偺尰忬偲揥朷亅(擔杮椪喱78姫憹姧崋2)亃XIII. 儔僀僼僗僥乕僕丒儔僀僼僀儀儞僩偐傜傒偨崅寣埑偺帯椕偲娗棟2. 彫帣偐傜巚弔婜偺崅寣埑偺恌抐丒帯椕丒梊屻, p.244-51. 墱揷梇夘1, 愇憅寬巌1, 斞搰堦惤 (1彫帣, 擔杮椪喱幮, 搶嫗, 2020/7敪峴.
620059. [妛弍彂 (暘扴幏昅)]亂崱擔偺彫帣帯椕巜恓 戞17斉亃16. 恡丒斿擜婍幘姵丂枛婜恡晄慡, p.594-9. 愇憅寬巌 (彫帣), 憤曇廤: 悈岥丂夒, 巗嫶丂岝, 嶈嶳丂峅, 埳摗 廏堦, 堛妛彂堾, 搶嫗, 2020/12敪峴.
[妛夛丒尋媶夛摍]
713036. [妛夛 (崙嵺)] (堦斒岥墘) Racial-ethnic differences in bone and mineral outcomes in children with CKD. Marciana Laster, Michelle Denburg, Okuda Y1, Juhi Kumar, Susan Furth, Keith Norris, Kamyar Kalantar-Zadeh, Bradley Warady, Isidro Salusky Pediatric Academic Societies (PAS) Meeting 2020 (2020/4/29-5/6), Philadelphia, USA. (墱揷梇夘1: 1彫帣)
713037. [妛夛 (崙嵺)] (堦斒島墘) Kidney Transplant Access Among Children and Young Adults on Dialysis in the United States. Okuda Y1, Ekamol Tantisattamo, Elani Streja, Marciana Laster, Connie M Rhee, Kamyar Kalantar-Zadeh American Society of Nephrology Kidney Week 2020 (2020/10/19-12/4), Web奐嵜. (墱揷梇夘1: 1彫帣)
713038. [妛夛 (崙嵺)] (堦斒岥墘) Secular Trends in the Incidence and Prevalence of Dialysis Therapy among Children and Young Adults in JAPAN Compared with the USA, Europe and Oceania. Okuda Y1, Harada R, Hamada R, Hamasaki Y, Ishikura K1 14th Asian Congress of Pediatric Nephrology (2021/3/29-4/2), Taipei, Taiwan. Asian J Pediatr Nephrol 2021; 4 (Suppl S1): 1-67. (墱揷梇夘1, 愇憅寬巌1: 1彫帣)
713039. [妛夛 (崙嵺)] (堦斒島墘) Polyhydramnios as a symptom of antenatal Bartter syndrome. Kawada K1, Okuda Y1, Kon S1,2, Serizawa H, Ishida S, Nozu K, Ishikura K1: 14th Asian Congress of Pediatric Nephrology (2021/3/29-4/2), Taipei, Taiwan. (愳揷岶暯1, 墱揷梇夘1, 崺 怢栫1,2, 愇憅寬巌1: 1彫帣, 2媬柦)
721013. [妛夛 (慡崙)] (摿暿島墘) 庼擕拞偺曣恊偵懳偡傞栻暔帯椕偺峫偊曽. 拞惣廏旻1,2, 懞搰壏巕 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 戞123夞擔杮彫帣壢妛夛妛弍廤夛 (2020/8/21), Web奐嵜.
721014. [妛夛 (慡崙)] (摿暿島墘) 憗嶻帣RS僂僀儖僗姶愼偺廳徢壔梷惂偵偍偗傞僺僢僩僼僅乕儖乣僷儕價僘儅僽偺壎宐傪庴偗傞傋偒懳徾幰乣. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 戞56夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2020/11/28-12/4), Web奐嵜.
722079. [妛夛 (慡崙)] (嫵堢島墘) 僱僼儘儞釘亅椪彴宆偲堚揱巕堎忢亅. 墱揷梇夘1, 愇憅寬巌1 (1彫帣): 戞55夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/1/9), Web奐嵜.
722080. [妛夛 (慡崙)] (僉乕億僀儞僩儗僋僠儍乕)亂僈僀僪儔僀儞偐傜妛傇CAKUT偺恌椕亃CAKUT偺撪壢揑娗棟: 僈僀僪儔僀儞偵婎偯偄偰. 愇憅寬巌 (彫帣): 戞29夞擔杮彫帣斿擜婍壢妛夛憤夛丒妛弍廤夛 (2021/2/1), Web奐嵜.
723379. [妛夛 (慡崙)] (堦斒岥墘) TSH扨撈寚懝徢偺暘巕婎斦: 彫帣姵幰13椺偺宯摑揑堚揱巕夝愅偲暥專儗價儏乕. 悪郪愮曚, 垻晹惔旤, 巙夑寬懢榊, 悰尨廏揟, 戝悪峃巌, 幒扟峗擇, 挬憅桼旤巕, 埨払徆岟, 戝捠丂彯, 徖憅廃旻, 彫抮柧旤, 捴丂弤巕, 媖揷堦婸1, 徏塝怣晇, 扟嶳徏梇, 挿扟愳曭墑, 柭奀妎巙 (1彫帣): 戞93夞擔杮撪暘斿妛夛妛弍憤夛 (2020/7/20-8/31), Web奐嵜, 擔杮彫帣恡憻昦妛夛嶨帍 2020/12; 33 (Suppl 1): 53.
723380. [妛夛 (慡崙)] (堦斒岥墘) 摉壢偵偍偗傞彫帣婜敪徢偺僕僗僩僯傾偵娭偡傞恌椕榐挷嵏. 搚婒丂暯1, 抾壓奊棦, 廧桭揟巕, 杮嫶桾巕, 愇嶳徍旻, 釼摗婱巙, 彫杚岹暥, 拞愳塰擇, 恵奓尋巌, 嵅乆栘惇峴 (1彫帣): 戞62夞擔杮彫帣恄宱妛夛妛弍廤夛 (2020/8/18-20, 9/1-30), Web奐嵜.
723381. [妛夛 (慡崙)] (堦斒岥墘) 娞惷柆, 栧柆寣愷徢傪暪敪偟偨壔擽惈娞擽釃偺4嵨彈帣椺. 愳揷岶暯1, 媖揷堦婸1, 塝揷夎媣旤1, 峕攇屗岶曘1, 摗晲媊恖1, 埳摗彯巙1, 嶁搶桼婭1,2, 愇憅寬巌1 (1彫帣, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞123夞擔杮彫帣壢妛夛妛弍廤夛 (2020/8/21-23), Web奐嵜, 擔杮撪暘斿妛夛嶨帍 2020; 95 (4): 1333.
723382. [妛夛 (慡崙)] (堦斒岥墘) 彫帣摟愅姵幰偵偍偗傞擭楊, 尨幘姵偲崅寣埑偺娭楢. 墱揷梇夘1, 崺丂怢栫1,2, 愇憅寬巌1 (1彫帣, 2媬柦): 戞123夞擔杮彫帣壢妛夛妛弍廤夛 (2020/8/21-23), Web奐嵜, 擔杮彫帣壢妛夛嶨帍 2020/2; 124 (2): 225.
723383. [妛夛 (慡崙)] (堦斒岥墘) 攕寣徢惈僔儑僢僋偲偺娪暿偑崲擄偱偁偭偨Clarkson徢岓孮偲巚傢傟傞惗屻7儠寧偺抝帣. 峕攇屗岶曘1, 嬥巕夒婭1, 愇憅寬巌1 (1彫帣): 戞123夞擔杮彫帣壢妛夛妛弍廤夛 (2020/8/21-23), Web奐嵜,
723384. [妛夛 (慡崙)] (堦斒岥墘) 憗嶻EXIT徢椺偵偍偗傞揔惓側曍弌帪婜偲儕僗僋場巕. 娭扟棦壚1, 愇揷廆巌1, 嶳岥埢擳1, 戝壀杻棟1, 巛帩丂妛1, 拞惣廏旻1,2, 愇憅寬巌1 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕): 戞123夞擔杮彫帣壢妛夛妛弍廤夛 (2020/8/21-23), Web奐嵜.
723385. [妛夛 (慡崙)] (堦斒岥墘) 摉堾弌惗偺挻憗嶻帣廇妛忬嫷傾儞働乕僩挷嵏. 巛帩丂妛1, 戝壀杻棟1, 嶳岥埢擳1, 墶娭桽堦榊1, 愇揷廆巌1, 拞惣廏旻1,2, 愇憅寬巌1 (1彫帣, 2怴悽婭堛椕丒愭抂揑堛椕): 戞123夞擔杮彫帣壢妛夛妛弍廤夛 (2020/8/21-23), Web奐嵜.
723386. [妛夛 (慡崙)] (堦斒島墘) 彫帣偵偍偗傞愭峴揑擇師恡堏怉偲堏怉恡惗懚棪偺娭楢. 墱揷梇夘1, 愇憅寬巌1, Elani Streja, Kamyar Kalantar-Zadeh (1彫帣): 戞56夞擔杮堏怉妛夛憤夛 (2020/11/5), Web奐嵜.
723387. [妛夛 (慡崙)] (堦斒岥墘) 摉堾偱巤峴偟偨Fontan庤弍姵幰偺fenestration偺帺慠楌. 崅棞丂妛1, 杮揷丂悞1, 栘懞弮恖1, 媨杮棽巌2, 媨抧丂娪2, 暯揷梲堦榊1, 愇憅寬巌1 (1彫帣, 2怱憻寣娗奜): 戞56夞擔杮彫帣弞娐婍妛夛憤夛丒妛弍廤夛 (2020/11/22-24), 嫗搒 (僴僀僽儕僢僪奐嵜), 擔杮彫帣弞娐婍妛夛嶨帍 2020/11; 36 (Suppl 2): s2-326.
723388. [妛夛 (慡崙)] (堦斒岥墘) 旍戝宆怱嬝徢傪崌暪偟偨愭揤惈僒僀僩儊僈儘僂僀儖僗姶愼徢偺1椺. 搉绯椱旤1, 杮揷丂悞1, 崅棞丂妛1, 栘懞弮恖1, 嶳岥埢擳1, 暯揷梲堦榊1, 愇憅寬巌1 (1彫帣): 戞56夞擔杮彫帣弞娐婍妛夛憤夛丒妛弍廤夛 (2020/11/22-24), 嫗搒 (僴僀僽儕僢僪奐嵜).
723389. [妛夛 (慡崙)] (堦斒島墘) Lowe徢岓孮偺挿婜揑側恡梊屻偵娭偡傞専摙. 桏撪抭楴, 嶰塝寬堦榊, 挘揷丂朙, 愇捤婌悽怢, 恄揷徦堦榊, 嵅摗撝巙, 堥搰丂崑, 郷揷丂棨, 愇憅寬巌1, 屲廫棐棽, 暈晹尦巎 (1彫帣): 戞55夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/1/9), Web奐嵜,
723390. [妛夛 (慡崙)] (堦斒島墘) 彫帣婜敪徢偺僱僼儘儞釘姵帣28椺偺椪彴憸. 堜岥抭梞, 郷揷丂棨, 撿丂桾壚, 埬擺偁偮偙, 搰戃丂搉, 敀崻惓堦榊, 攽丂峅婤, 愒曯宧帯, 帥栰愮崄巕, 尨揷椓巕, 郷嶈桽巕, 愇憅寬巌1, 敠扟峗巎, 杮揷夒宧 (1彫帣): 戞55夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/1/9), Web奐嵜,
723391. [妛夛 (慡崙)] (堦斒島墘) 扨堦巤愝偵偍偗傞僱僼儘儞釘16柤偺椪彴憸偺専摙. 姌峕抭壚巕, 彫柛夒晇, 懞墇枹婓, 惣寬懢楴, 嬥怷丂摟, 楅栘棾懢榊, 嵅摗丂晳, 愇憅寬巌1, 婽堜岹堦 (1彫帣): 戞55夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/1/9), Web奐嵜, 擔杮彫帣恡憻昦妛夛嶨帍 2020/12; 33 (Suppl 1): 82.
723392. [妛夛 (慡崙)] (堦斒島墘) 彫帣恡椞堟偺婓彮丒擄帯惈幘姵偺敪尒帪婜偍傛傃宊婡偵娭偡傞慡崙挷嵏尋媶. 郷揷丂棨, 郷嶈桽巕, 忋懞丂帯, 暈晹尦巎, 拞惣峗堦, 娵嶳彶堦, 埳摗廏堦, 怷掑捈嵠, 栰捗姲戝, 挘揷丂朙, 尨揷椓巕, 嬥巕揙帯, 杮揷夒宧, 愇憅寬巌1 (1彫帣): 戞55夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/1/9), Web奐嵜, 擔杮彫帣恡憻昦妛夛嶨帍 2020/12; 33 (Suppl 1): 129.
723393. [妛夛 (慡崙)] (堦斒島墘) 彫帣恡幘姵偵偍偗傞摟愅摫擖慜偺恡婡擻掅壓懍搙偺幘姵枅偺斾妑. 嬥怷丂摟, 嵅摗丂晳, 楅栘棾懢榊, 懞墇枹婓, 惣寬懢楴, 姌峕抭壚巕, 彫柛夒晇, 愇憅寬巌1, 婽堜岹堦 (1彫帣): 戞55夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/1/9), Web奐嵜, 擔杮彫帣恡憻昦妛夛嶨帍 2020/12; 33 (Suppl 1): 150.
723394. [妛夛 (慡崙)] (堦斒島墘) 專恡堏怉搊榐偟偰偄偨偑PD儔僗僩傪慖戰偟偨僟僂儞徢岓孮偺31嵨彈惈椺. 崺丂怢栫1,2, 拞懞怣栫2, 崅棞丂妛2, 愇堜戝曘3, 墶撪嬇巕2, 墱揷梇夘2, 娾攇捈旤, 戝孎峗峕, 庣壆弐夘, 壨惣婭徍, 媑揷堦惉3,4, 愇憅寬巌2 (1媬柦, 2彫帣, 3斿擜婍, 4怴悽婭堛椕丒愭抂堛椕): 戞55夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/1/9), Web奐嵜, 擔杮彫帣恡憻昦妛夛嶨帍 2020/12; 33 (Suppl 1): 158.
723395. [妛夛 (慡崙)] (堦斒島墘) 杮朚彫帣偺挻壒攇抐憌朄偵傛傞恡挿幉宎偺婎弨抣偺嶌惉. 摗揷捈栫, 屻摗朏廩, 尨揷椓巕, 徏懞愮宐巕, 嶁堜抭峴, 郷嶈桽巕, 惣寬懢楴, 嬥巕揙帯, 忋懞丂帯, 愇憅寬巌1 (1彫帣): 戞55夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/1/9), Web奐嵜, 擔杮彫帣恡憻昦妛夛嶨帍 2020/12; 33 (Suppl 1): 159.
723396. [妛夛 (慡崙)] (堦斒島墘) 摉僙儞僞乕奐愝埲棃偺宱旂揑恡惗専1045審偺儗價儏乕. 婽堜岹堦, 彫柛夒晇, 嵅摗丂晳, 懞墇枹婓, 楅栘棾懢榊, 姌峕抭壚巕, 嬥怷丂摟, 惣寬懢楴, 媊壀岶巕, 愇憅寬巌1, 埳摗廏堦, 斞搰堦惤 (1彫帣): 戞55夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/1/9), Web奐嵜, 擔杮彫帣恡憻昦妛夛嶨帍 2020/12; 33 (Suppl 1): 161.
723397. [妛夛 (慡崙)] (堦斒島墘) 彫帣媫惈幘姵偛偲偺掅僫僩儕僂儉寣徢偺昿搙偲掱搙. 敀崻惓堦榊, 郷揷丂棨, 怷愳榓旻, 埬擺偁偮偙, 搰戃丂搉, 攽丂峅婤, 愒曯宧帯, 堜岥抭梞, 帥栰愮崄巕, 尨揷椓巕, 郷嶈桽巕, 愇憅寬巌1, 敠扟峗巎, 杮揷夒宧 (1彫帣): 戞55夞擔杮彫帣恡憻昦妛夛妛弍廤夛 (2021/1/9), Web奐嵜, 擔杮彫帣恡憻昦妛夛嶨帍 2020/12; 33 (Suppl 1): 173.
731015. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) I倗Y; 峈懱偐傜妛傇惗暔偺恑壔偲姶愼徢. 嶁搶桼婭 (彫帣): 戞180夞擔杮彫帣壢妛夛嶉嬍抧曽夛妛弍廤夛 (2020/9/13), Web奐嵜.
731016. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 憗嶻帣偵懳偡傞堦巁壔拏慺媧擖椕朄偺幚嵺. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 儅儕儞僋儘僢僩僼傽乕儅WEB僙儈僫乕 (2020/11/17), 搶嫗.
731017. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 嵞峫: 屻婜憗嶻帣 (Late-preterm) 偼Near term偱偼側偄乣嶻晈恖壢恌椕僈僀僪儔僀儞夵掕屻偺RSV姶愼懳嶔偵偮偄偰峫偊傞乣. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): Japan Experts' Meeting (2021/1/16), 搶嫗.
731018. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 懴惈妉摼傪栚巜偟偨怘暔傾儗儖僊乕帯椕偺幚嵺. 嶁搶桼婭1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2彫帣): 嶉嬍導墰傾儗儖僊乕僼僅乕儔儉 (2021/1/27), 偝偄偨傑巗 (Web).
731019. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 彫帣摿敪惈僱僼儘乕僛徢岓孮丗杮朚偺椪彴尋媶偲嵟怴偺僈僀僪儔僀儞. 愇憅寬巌 (彫帣): 戞62夞戝嶃彫帣恡尋媶夛 (2021/2/25), 戝嶃.
731020. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘)乽怴惗帣慼惗乿乣幚嵺偺尰応偱偺宱尡偐傜乣. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 戞9夞杻悓壢堛偺偨傔偺嶻壢杻悓僾儘僼僃僢僔儑僫儖僙儈僫乕 (2021/2/27), Web奐嵜.
731021. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘)亂偙傟偐傜偺愗敆憗嶻娗棟偵偮偄偰峫偊傞亃怴惗帣壢堛偐傜傒偨愗敆憗嶻娗棟乣挿婜梊屻傕尒悩偊偰乣. 拞惣廏旻1,2 (1怴悽婭堛椕丒愭抂堛椕, 2彫帣): 崅抦嶻壢僙儈僫乕 (2021/2/28), 崅抦.
731022. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 惉恖堏峴堛椕亅杮朚偵墬偗傞恡憻昦椞堟偱偺偁備傒偲崱屻偺杒棦戝妛昦堾偵偍偗傞庢傝慻傒亅. 愇憅寬巌 (彫帣): 彫帣婜敪徢枬惈恡幘姵傪傕偮姵幰偝傫偺惉恖堏峴堛椕傪峫偊傞夛 (2021/3/25), 岤栘.
732014. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 杒棦戝妛昦堾彫帣壢偺COVID-19偲偺摤偄. 愇憅寬巌 (彫帣): 惷壀導棫惔悈昦堾彫帣壢島墘夛 (2020/5/22), 惷壀.
732015. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 彫帣壢偐傜恡憻撪壢傊偺恡幘姵姵幰偺堏峴堛椕懱惂偺峔抸. 崺丂怢栫1,2 (1媬柦, 2彫帣): 憡柾尨CKD web僙儈僫乕 (2020/10/20), 憡柾尨.
732016. [妛夛 (抧曽夛丒尋媶夛)] (巗柉岞奐島嵗) 彫帣姵幰偝傫偺帺棫偲偼乣惉恖堏峴巟墖偺尰忬偲壽戣乣. 暯揷梲堦榊 (彫帣): 戞177夞姖儢嶈彫帣堛椕僙儈僫乗 (2020/10/20), 姖儢嶈.
732017. [妛夛 (抧曽夛丒尋媶夛)] (嫵堢島墘) 椪彴尋媶偺弶妛幰偑娮傝傗偡偄僺僢僩僼僅乕儖. 愇憅寬巌 (彫帣): 2020擭搙椪彴尋媶僙儈僫乕乽椪彴尋媶嵟弶偺堦曕乿 (2021/3/16), 恄撧愳.
733074. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 杮徢椺偼愳嶈昦偩偭偨偺偐? 峕攇屗岶曘 (彫帣): 戞15夞恄撧愳導愳嶈昦尋媶夛 (2020/9/14), Web奐嵜.
733075. [妛夛 (慡崙)] (堦斒岥墘) 怱掆巭偺堦場偲偟偰峈僸僗僞儈儞栻偺夁検搳梌偑媈傢傟偨擕帣椺. 愳揷岶暯1, 曯旜宐棞1, 惣揷彯巎1, 埨摗丂庻1, 巛帩丂妛1, 愇憅寬巌1 (1彫帣): 戞362夞擔杮彫帣壢妛夛恄撧愳導抧曽夛 (2020/11/21), 墶昹.
733076. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 敪嶌惈幐挷傪庡徢忬偲偡傞僌儖僐乕僗僩儔儞僗億乕僞乕1寚懝徢 (GLUT1DS). 搚婒丂暯1, 釼摗婱巙, 廧桭揟巕, 抾壓奊棦, 杮嫶桾巕, 愇嶳徍旻, 彫杚岹暥, 拞愳塰擇, 惎栰淎庽, 媨杮梇嶔, 愇堜撝巑, 淎悾怢堦, 嵅乆栘惇峴 (1彫帣): 戞74夞擔杮彫帣恄宱妛夛娭搶抧曽夛 (2021/3/20), 搶嫗.
'19擭搙埲慜暘
[妛夛丒尋媶夛摍]
H29-723001. [妛夛 (慡崙)] (堦斒島墘) 曣懱傾僫僼傿儔僉僔乕僔儑僢僋偵傛傝怴惗帣壖巰偱弌惗偟偨堦椺. 懡揷嬘巌, 巛帩丂妛1, 拞嬥楴巕2, 朷寧弮巕2, 嶳岥埢擳1, 戝壀杻棦1, 愇堜惓峗1 (1彫帣, 2嶻壢): 戞53夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2017/7/17), 墶昹.
'19-723021. [妛夛 (慡崙)] (堦斒岥墘) 廤妛揑帯椕偵傛傝媬柦偟偊偨媫惈拵悅墛偺1椺. 揷懞桟暯1, 曯旜宐棞1, 埨摗丂庻1, 揷拞丂寜2,3, 愇憅寬巌1 (1彫帣, 2怴悽婭堛椕丒愭抂堛椕, 3堦斒丒彫帣丒娞抇鋁奜): 戞47夞擔杮廤拞帯椕堛妛夛妛弍廤夛 (2020/3/6-8), 柤屆壆.
'19-733008. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) Microgeodic disease偲峫偊傜傟偨2徢椺. 峕攇屗岶曘1, 嶁搶桼婭1,2, 愇憅寬巌1 (1彫帣, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞357夞擔杮彫帣壢妛夛恄撧愳導抧曽夛 (2019/6/22), 墶昹.
'19-733009. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 愳嶈昦偺庡梫徢忬傪掓偟偨杻怾偺1抝帣椺. 揷懞桟暯1, 嵅摗壛戙巕1, 栘懞弮恖1, 枼塝崕懃1, 峕攇屗岶曘1 (1彫帣): 戞358夞擔杮彫帣壢妛夛恄撧愳導抧曽夛 (2019/9/21), 墶昹.
'19-733010. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 壠懓楌傛傝媈偄, 孞傝曉偡専嵏偐傜恌抐偟摼偨掅儕儞寣惈偔傞昦偺1徢椺. 媖揷堦婸1, 塝揷夎媣旤1, 戝捗惉擵, 愇憅寬巌1 (1彫帣): 戞358夞擔杮彫帣壢妛夛恄撧愳導抧曽夛 (2019/9/21) 墶昹.
'19-733011. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 怴惗帣嬃湵昦偺2徢椺. 敀堜岹捈1, 栰乆揷朙1, 娾嶈弐擵1, 巛帩丂妛1, 愇憅寬巌1 (1彫帣): 戞360夞擔杮彫帣壢妛夛恄撧愳抧曽夛 (2020/2/5), 墶昹.
嶻壢妛乛晈恖壢妛
[妛弍榑暥]
110283. [尨挊] Inhibition of autophagy in theca cells induces CYP17A1 and PAI-1 expression via ROS/p38 and JNK signalling during the development of polycystic ovary syndrome. Kobayashi M, Yoshino O1,2, Nakashima A, Ito M, Nishio K, Ono Y, Kusabiraki T, Kunitomi C, Takahashi N, Harada M, Hattori K, Orisaka M, Osuga Y, Saito S: Mol Cell Endocrinol 2020/5; 508: 110792. (媑栰丂廋1,2: 1嶻壢, 2晈恖)
110284. [尨挊] Low Bone Mineral Density in Elite Female Athletes With a History of Secondary Amenorrhea in Their Teens. Nose-Ogura S, Yoshino O1,2, Dohi M, Kigawa M, Harada M, Kawahara T, Osuga Y, Saito S: Amenorrhea in Their Teens. Clin J Sport Med 2020/5; 30 (3): 245-50. (媑栰丂廋1,2: 1嶻壢, 2晈恖)
110285. [尨挊] Acquired contractile ability in human endometrial stromal cells by passive loading of cyclic tensile stretch. Kim J, Ushida T, Montagne K, Hirota Y, Yoshino O1,2, Hiraoka T2, Osuga Y, Furuakwa KS: Sci Rep 2020/6; 10 (1): 9014. (媑栰丂廋1,2, 暯壀婤戝2: 1嶻壢, 2晈恖)
110029. [尨挊] Lymphangiogenesis induced by vascular endothelial growth factor receptor 1 signaling contributes to the progression of endometriosis in mice. Hattori K1, Ito Y2, Honda M1, Sekiguchi K3, Hosono K2, Shibuya M, Unno N3, Majima M2: J Pharmacol Sci 2020/8; 143 (4): 255-63. (暈晹嬁巕1, 埳摗媊栫2, 杮揷夒巕1, 娭岥榓婇3, 嵶栰壛撧巕2, 奀栰怣栫3, 攏搱惓棽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3嶻壢)
110286. [尨挊] Effect of transdermal estradiol therapy on bone mineral density of amenorrheic female athletes. Nose-Ogura S, Yoshino O1,2, Kanatani M, Dohi M, Tabei K, Harada M, Hiraike O, Kawahara T, Osuga Y, Fujii T: Scand J Med Sci Sports 2020/8; 30 (8): 1379-86. (媑栰丂廋1,2: 1嶻壢, 2晈恖)
110287. [尨挊] Relationship between tartrate-resistant acid phosphatase 5b and stress fractures in female athletes. Nose-Ogura S, Yoshino O1,2, Dohi M, Torii S, Kigawa M, Harada M, Hiraike O, Kawahara T, Osuga Y, Fujii T, Saito S: J Obstet Gynaecol Res 2020/8; 46 (8): 1436-42. (媑栰丂廋1,2: 1嶻壢, 2晈恖)
110288. [尨挊] Differential roles of uterine epithelial and stromal STAT3 coordinate uterine receptivity and embryo attachment. Hiraoka T1, Hirota Y, Fukui Y, Gebril M, Kaku T, Aikawa S, Hirata T, Akaeda S, Matsuo M, Haraguchi H, Saito-Kanatani M, Shimizu-Hirota R, Takeda N, Yoshino O1,2, Fujii T, Osuga Y: Sci Rep 2020/9; 10 (1): 15523. (暯壀婤戝1, 媑栰丂廋1,2: 1晈恖, 2嶻壢)
110289. [尨挊] Uterine CD11c+ cells induce the development of paternal antigen-specific Tregs via seminal plasma priming. Shima T, Nakashima A, Yasuda I, Ushijima A, Inada K, Tsuda S, Yoshino O1,2, Tomura M, Saito S: J Reprod Immunol 2020/9; 141: 103165. (媑栰丂廋1,2: 1嶻壢, 2晈恖)
110290. [尨挊] Relaxin-2 May Suppress Endometriosis by Reducing Fibrosis, Scar Formation, and Inflammation. Yoshino O1,2, Ono Y, Honda M3, Hattori K3, Sato E4, Hiraoka T2, Ito M, Kobayashi M, Arai K, Katayama H, Tsuchida H, Yamada-Nomoto K, Iwahata S1, Fukushi Y, Wada S, Iwase H2, Koga K, Osuga Y, Iwaoka M, Unno N1: Biomedicines 2020/10; 8 (11): 467. (媑栰丂廋1,2, 杮揷夒巕3, 暈晹嬁巕3, 嵅摗奊棦撧4, 暯壀婤戝2, 娾抂弐曘1, 娾悾弔巕2, 奀栰怣栫1: 1嶻壢, 2晈恖, 3戝妛堾堛椕宯尋媶壢, 4昦懺丒恌椕宯)
110032. [尨挊] Inhibition of receptor activity-modifying protein 1 suppresses the development of endometriosis and the formation of blood and lymphatic vessels. Honda M1, Ito Y2, Hattori K1, Hosono K2, Sekiguchi K3, Unno N3, Majima M2: J Cell Mol Med 2020/10; 24 (20): 11984-97. (杮揷夒巕1, 埳摗媊栫2, 暈晹嬁巕1, 嵶栰壛撧巕2, 娭岥榓婇3, 奀栰怣栫3, 攏搱惓棽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3嶻壢)
110291. [尨挊] Uterine Epithelial Progesterone Receptor Governs Uterine Receptivity Through Epithelial Cell Differentiation. Gebril M, Hirota Y, Aikawa S, Fukui Y, Kaku T, Matsuo M, Hirata T, Akaeda S, Hiraoka T1, Shimizu-Hirota R, Takeda N, Taha T, Balah OAl , Elnoury MAH, Fujii T, Osuga Y: Endocrinology 2020/12; 161 (12): bqaa195. (暯壀婤戝1: 1晈恖)
110292. [尨挊] CD206+ macrophage is an accelerator of endometriotic-like lesion via promoting angiogenesis in the endometriosis mouse model. Ono Y, Yoshino O1,2, Hiraoka T2, Sato E3, Furue A2, Nawaz A, Hatta H, Fukushi Y, Wada S, Tobe K, Hirota Y, Osuga Y, Unno N1, Saito S: Sci Rep 2021/1; 11 (1): 853. (媑栰丂廋1,2, 暯壀婤戝2, 嵅摗奊棦撧3, 屆峕柧巕2, 奀栰怣栫1: 1嶻壢, 2晈恖, 3昦懺丒恌椕宯)
110293. [尨挊] Retinoblastoma protein promotes uterine epithelial cell cycle arrest and necroptosis for embryo invasion. Akaeda S, Hirota Y, Fukui Y, Aikawa S, Shimizu-Hirota R, Kaku T, Gebril M, Hirata T, Hiraoka T1, Matsuo M, Haraguchi H, Saito-Kanatani M, Takeda N, Fujii T, Osuga Y: EMBO Rep 2021/2; 22 (2): e50927. (暯壀婤戝1: 1晈恖)
110294. [尨挊] Perinatal outcomes associated with the positional relationship between the placenta and the adenomyosis lesion. Ono Y, Ota H, Takimoto K, Tsuzuki Y, Ayako Nakajima A,Yoshino O1,2, Unno N1, Fujino T, Fukushi Y, Shinichiro Wada S: J Gynecol Obstet Hum Reprod 2021/3; 50 (7): 102114. (媑栰丂廋1,2, 奀栰怣栫1: 1嶻壢, 2晈恖)
110295. [尨挊] Surgical margin status and recurrence pattern in invasive vulvar Paget's disease: A Japanese Gynecologic Oncology Group study. Matsuo K, Nishio S, Matsuzaki S, Iwase H1, Kagami S, Soeda S, Usui H, Nishikawa R, Mikami M, Enomoto T: Gynecol Oncol 2021/3; 160 (3): 748-54. (娾悾弔巕1: 1晈恖)
110296. [尨挊] Attitudes toward overtime work and self-training: A survey on obstetricians and gynecologists in Japan. Mayama M, Sekine M, Onodera Y, Suemitsu T, Maeda Y, Nakano K, Sugita Y, Ogura J, Ohsuga T, Kodera C, Murakami T, Kido M, Suzuki Y, Shibata A, Nishijima K, Umazume T, Nakagawa S, Unno N1, Komatsu H, Shozu M, Enomoto T, Watari H: J Obstet Gynaecol Res 2021/5; 47 (5): 1666-74. doi: 10.1111/jog.14735. Epub 2021 Mar 10. (奀栰怣栫1: 1嶻壢)
120012. [尨挊] 晈恖壢埆惈庮釃擼揮堏徢椺偺椪彴揑摿挜偵偮偄偰偺屻曽帇揑専摙. 屆愳惓媊1, 娾悾弔巕1, 墦摗恀堦1, 戝惣尗恖1, 揷嶨桳婭1, 崅揷嫳恇1, 怴堜惓廏1, 媑栰丂廋1,2, 壎揷婱巙1 (1晈恖, 2嶻壢): 擔杮晈恖壢庮釃妛夛嶨帍 2020/4; 38 (2): 182-92.
310034. [徢椺曬崘] First report in Japan of a delivery of a woman with the 2019 novel coronavirus disease. Mochizuki J1, Nakamura M2, Iwahata S2, Nishijima J1, Ito T3, Wada T4, Takayama Y5, Unno N1: J Obstet Gynaecol Res 2021/1; 47 (1): 407-10. (朷寧弮巕1, 拞懞婎姲2, 娾抂弐曘2, 惣搰弮堦1, 埳摗彯巙3, 榓揷払旻4, 崅嶳梲巕5, 奀栰怣栫1: 1嶻壢, 2晈恖, 3彫帣, 4銹尨昦丒姶愼撪, 5怴悽婭堛椕丒墶抐揑堛椕)
320018. [徢椺曬崘] Massive ovarian edema偵懳偟偰暊峯嬀壓庤弍傪巤峴偟懳徠揑側揮婡傪偲偭偨2徢椺. 嶳嶈丂桪1, 媣搱懃峴2, 崻捗岾曚1, 拞懞婎姲3, 廐嶳奊棦巕, 愇堜奊浠巕, 搰壀嫕惗1, 埳摗幚崄1,2, 屲搰桾擵1, 嶁搶桼婭2,4, 嶰栘柧摽1,2 (1嶻壢, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3晈恖, 4彫帣): 嶉嬍導嶻壢晈恖壢妛夛嶨帍 2020/9; 50 (2): 107-13.
320019. [徢椺曬崘] 弍慜偺庮釃撪梕僪儗僫乕僕屻埨慡偵庤弍傪巤峴偟偊偨栺75 kg偺嫄戝棏憙娻偺堦椺. 惣嶳崄怐1, 怴堜惓廏1, 忋朧晀巕, 墦摗恀堦1, 屆愳惓媊1, 揷嶨桳婭1, 崅揷嫳恇1, 娾悾弔巕1, 壎揷婱巙1 (1晈恖): 擔杮晈恖壢庮釃妛夛嶨帍 2020/10; 38 (4): 348-55.
320020. [徢椺曬崘] 摉堾偱宱尡偟偨婬彮晹埵擠怭5椺. 拞懞婎姲1, 崻捗岾曚2, 彫搰丂堣2, 嶳嶈丂桪2, 屲搰桾擵2, 埳摗幚崄2,3, 墦摗恀堦1, 屆愳惓媊1, 搰壀嫕惗2, 媣搱懃峴3, 嶰栘柧摽2,3 (1晈恖, 2嶻壢, 3杒棦戝妛儊僨傿僇儖僙儞僞乕): 嶉嬍嶻壢晈恖壢妛夛嶨帍 2021/3; 51 (1): 35-40.
320021. [徢椺曬崘] 姰慡拞妘巕媨偺塃懁巕媨偵敪惗偟偨巕媨懱娻偺1椺. 垻晹丂悏1, 娾悾弔巕1, 揷嶨桳婭1, 拞懞婎姲1, 墦摗恀堦1, 屆愳惓媊1, 戝惣尗恖1, 崅揷嫳恇1, 怴堜惓廏1, 媑栰丂廋1,2, 壎揷婱巙1 (1晈恖, 2嶻壢): 娭搶楢崌嶻壢晈恖壢妛夛嶨帍 2021/3; 58 (1): 101-8.
522064. [島嵗]亂傂偲偔偪儊儌亃埨慡丒埨怱側柍捝暘曍偼. 奀栰怣栫 (嶻壢) 擔杮堛巘夛嶨帍 2020/4; 149 (1): 68.
522065. [島嵗]亂摿廤: 怴 宱銽暘曍傪惉岟偝偣傞29偺採尵亃媧堷曍弌弍亅嬥懏僇僢僾, 僜僼僩僇僢僾, 庤摦幃媧堷婍側偳偺巊偄暘偗. 嬥堜梇擇 (嶻壢): 廃嶻婜堛妛 2021/1; 51 (1): 63-8.
522066. [島嵗]亂摿廤: QOL傪峫偊傞亃4. 巕媨撪枌徢偲QOL. 媑栰丂廋1,2, 峛夑偐傪傝, 楅姏傛偟傒, 娾悾弔巕2 (1嶻壢, 2晈恖): 嶻壢偲晈恖壢 2021/2; 88 (3): 291-6.
522067. [島嵗]亂摿廤: 怴嫽丒嵞嫽姶愼徢, 桝擖姶愼徢偲廃嶻婜堛妛亃[奺榑] 怴宆僐儘僫僂僀儖僗丂COVID-19偲擠嶻晈娗棟. 奀栰怣栫 (嶻壢): 廃嶻婜堛妛 2021/3; 51 (3): 330-8.
540026. [偦偺懠 (妛夛彺榐)]亂戞139夞 娭搶楢崌嶻壢晈恖壢妛夛 憤夛丒妛弍廤夛 彺榐崋亃屻堚徢側偔媬柦偟摼偨怱攛嫊扙宆梤悈嵡愷徢偺堦椺. 屲搰桾擵1, 戝惣梖巕1, 媑懞壝峀1, 拞嬥楴巕1, 暈晹嬁巕1, 娭岥榓婇1, 愇愳棽嶰1, 嬥堜梇擇1, 朷寧弴巕1, 奀栰怣栫1 (1嶻壢): 娭搶楢崌嶻壢晈恖壢妛夛夛帍 2020/6; 57 (2): 235.
540027. [偦偺懠 妶摦曬崘)] JALA乽柍捝暘曍娭學妛夛丒抍懱楢棈嫤媍夛乿妶摦曬崘 (2019擭搙). 奀栰怣栫 (嶻壢): 暘曍偲杻悓 2020/10; 102: 38-46.
[挊丂彂]
620060. [妛弍彂 (暘扴幏昅)]亂専嵏抣傪撉傓2020 (椪彴嶨帍撪壢2020擭4寧憹戝崋)亃<17復 墛徢儅乕僇乕専嵏>巕媨栩娗擲塼拞梓棻媴僄儔僗僞乕僛, p.818. 奀栰怣栫 (嶻壢), 撿峕摪, 搶嫗, 2020/4敪峴.
620061. [妛弍彂 (暘扴幏昅)]亂専嵏抣傪撉傓2020 (椪彴嶨帍撪壢2020擭4寧憹戝崋)亃<17復 墛徢儅乕僇乕専嵏> APR僗僐傾, p.819-20. 奀栰怣栫 (嶻壢), 撿峕摪, 搶嫗, 2020/4敪峴.
620062. [妛弍彂 (暘扴幏昅)]亂専嵏抣傪撉傓2020 (椪彴嶨帍撪壢2020擭4寧憹戝崋)亃<17復 墛徢儅乕僇乕専嵏>銽暘斿塼拞僀儞僗儕儞條惉挿場巕寢崌抈敀1宆 (IGF-BP1), p.821. 奀栰怣栫 (嶻壢), 撿峕摪, 搶嫗, 2020/4敪峴.
620063. [妛弍彂 (暘扴幏昅)]亂杻悓壢僾儔僋僥傿僗 1丂嶻壢杻悓All in One亃V. 宱銽暘曍偺杻悓丂2. 柍捝暘曍偺弨旛丂[T] 柍捝暘曍帠屘傪庴偗偨柍捝暘曍偺埨慡惈岦忋偺偨傔偺懳墳亅JALA: 敪懌偵帄傞傑偱偺宱夁偲偦偺妶摦撪梕亅, p.119-21. 奀栰怣栫 (嶻壢), 暥岝摪, 搶嫗, 2020/7敪峴.
620064. [妛弍彂 (暘扴幏昅)]亂嶻晈恖壢愱栧堛偺偨傔偺昁廋抦幆丂2020擭搙斉亃嶻晈恖壢娭楢偺摑寁, A28-33. 奀栰怣栫 (嶻壢), 曇廤丒娔廋: 擔杮嶻壢晈恖壢妛夛, 擔杮嶻壢晈恖壢妛夛帠柋嬊, 搶嫗, 2020/12敪峴.
620065. [妛弍彂 (暘扴幏昅)]亂崱寧偺椪彴丂惗怋堛椕偺婎慴抦幆傾僢僾僨乕僩丂姵幰愢柧偵栶棫偮嵟怴僄價僨儞僗丒嵟怴僨乕僞 (椪彴晈恖壢嶻壢Vol.75 No.1崌暪憹戝崋)亃仭[堦斒晄擠帯椕] 晄擠徢偵懳偡傞堦斒揑側専嵏丒帯椕丂愽嵼惈崅僾儘儔僋僠儞寣徢, p.43-8. 媑栰丂廋1,2, 屆峕柧巕2, 暯壀婤戝2 (1嶻壢, 2晈恖): 堛妛彂堾, 搶嫗, 2021/1敪峴.
620066. [妛弍彂 (暘扴幏昅)]亂昗弨嶻壢晈恖壢妛丂戞5斉亃嶻壢曇丂戞21復 擠怭偺娗棟丂A 擠怭偵娭偡傞梡岅, B 擠怭偺挜岓偲恌抐, C 擠晈寬恌 (擠嶻晈寬峃恌嵏), D 僴僀儕僗僋擠怭, p.483-92. 奀栰怣栫 (嶻壢), 曇: 埢晹戶嵠, 斅憅撝晇, 堛妛彂堾, 搶嫗, 2021/3敪峴.
[妛夛丒尋媶夛摍]
721015. [妛夛 (慡崙)] (摿暿島墘) 寧宱崲擄徢丒巕媨撪枌徢偑姵幰偵梌偊傞恎懱揑丒惛恄揑塭嬁 (HR-QOL). 媑栰丂廋1,2 (1嶻壢, 2晈恖): 戞72夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2020/4/24), Web奐嵜.
721016. [妛夛 (慡崙)] (摿暿島墘) 傢偑崙偺柍捝暘曍偺偁傝曽亅柍捝暘曍娭學妛夛丒抍懱楢棈嫤媍夛偺庢慻亅. 奀栰怣栫 (嶻壢): 擔杮嬫堟杻悓妛夛戞7夞妛弍廤夛 (2020/8/9-22), Web奐嵜.
721017. [妛夛 (慡崙)] (摿暿島墘) 嫵堢僾儘僌儔儉C (C-5) 棏憙娻丒棏娗娻丒暊枌娻偺庤弍椕朄. 娾悾弔巕 (晈恖): 戞62夞擔杮晈恖壢庮釃妛夛妛弍島墘夛 (2021/1/29-30), Web奐嵜.
722081. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 嵞敪棏憙娻廔枛婜偵CART傪巤峴偟偨1椺. 揷嶨桳婭1, 拞懞婎姲1, 墦摗恀堦1, 屆愳惓媊1, 戝惣尗恖1, 崅揷嫳恇1, 娾悾弔巕1 (1晈恖): 戞9夞晈恖壢庮釃偺娚榓堛椕傪峫偊傞夛妛弍廤夛 (2020/10/10), 墶昹 (僴僀僽儕僢僪奐嵜).
722082. [妛夛 (慡崙)] (嫵堢島墘) 柍捝暘曍偺埨慡惈妋曐偵岦偗偨庢慻亅柍捝暘曍娭學妛夛丒抍懱楢棈嫤媍夛偺妶摦偐傜亅. 奀栰怣栫 (嶻壢): 戞56夞擔杮廃嶻婜丒怴惗帣堛妛夛妛弍廤夛 (2020/11/28-12/4), Web奐嵜.
722083. [妛夛 (慡崙)] (嫵堢島墘) 棏憙娻丒棏娗娻丒暊枌娻偺庤弍椕朄. 娾悾弔巕 (晈恖): 戞62夞擔杮晈恖壢庮釃妛夛妛弍島墘夛 (2021/1/29-2/11), Web奐嵜.
722084. [妛夛 (慡崙)] (摿暿婇夋) 嵭奞帪彫帣廃嶻婜儕僄僝儞偺惉傝棫偪偐傜僐儘僫懳墳傑偱. 暈晹嬁巕 (戝妛堾堛椕宯尋媶壢): 戞26夞擔杮嵭奞堛妛夛憤夛丒妛弍廤夛 (2021/3/15-17), Web奐嵜.
723398. [妛夛 (慡崙)] (億僗僞乕) 恄撧愳導偵偍偗傞嵭奞帪彫帣廃嶻婜儕僄僝儞偺戝婯柾抧恔帪堛椕妶摦孭楙嶲壛曬崘. 暈晹嬁巕1, 憅郪寬懢榊2, 墊杮婭旤巕3, 暯悂抦梇4, 愇杮恖巑5, 奀栰怣栫6 (1戝妛堾堛椕宯尋媶壢, 2墶昹巗棫戝晬懏昦堾, 3墶昹巗棫戝僙儞僞乕昦堾, 4彫揷尨巗棫昦堾, 5搶奀戝晅懏昦堾, 6嶻壢): 戞72夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2020/4/23-28), Web奐嵜.
723399. [妛夛 (慡崙)] (億僗僞乕) 巕媨嬀庤弍慜偵宱岥GnRH antagonist (relugolix) 傪搳梌偟偨徢椺偺専摙. 埳摗幚崄1, 媑栰丂廋1,2, 娾抂弐曘1, 暯壀婤戝1, 壓揷棽恗1, 杮揷夒巕3, 壎揷婱巙1 (1晈恖, 2嶻壢, 3戝妛堾堛椕宯尋媶壢): 戞72夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2020/4/23-28), Web奐嵜.
723400. [妛夛 (慡崙)] (億僗僞乕) 戀帣栩晹婏宍庮4椺偺宱尡. 戝惣梖巕1, 媑懞壝峀1, 暈晹嬁巕2, 拞嬥楴巕1, 娭岥榓婇1, 愇愳棽嶰1, 嬥堜梇擇1, 朷寧弮巕1, 奀栰怣栫1 (1嶻壢, 2戝妛堾堛椕宯尋媶壢): 戞72夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2020/4/23-28), Web奐嵜.
723401. [妛夛 (慡崙)] (億僗僞乕) 銽暻偵敪惗偟偨儊僩僩儗僉僒乕僩娭楢儕儞僷憹怋惈幘姵偺堦椺. 屲廫敤恗巙1, 崅揷嫳恇1, 屆愳惓媊1, 戝惣尗恖1, 揷嶨桳婭1, 娾悾弔巕1, 壎揷婱巙1 (1晈恖): 戞72夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2020/4/23-28), Web奐嵜.
723402. [妛夛 (慡崙)] (億僗僞乕) pT1偍傛傃pT2偺忋旂惈棏憙娻偵偍偗傞屻暊枌儕儞僷愡妔惔偺堄媊偵娭偡傞専摙. 戝惣尗恖1, 娾悾弔巕1, 屆愳惓媊1, 揷嶨桳婭1, 崅揷嫳恇1, 媑栰丂廋1,2, 壎揷婱巙1 (1晈恖, 2嶻壢): 戞72夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2020/4/23-28), Web奐嵜.
723403. [妛夛 (慡崙)] (億僗僞乕) 巕媨撪枌徢偵偍偗傞寣娗丒儕儞僷娗怴惗傪惂屼偡傞恄宱儁僾僠僪CGRP偺栶妱. 杮揷夒巕1, 暈晹嬁巕1, 娭岥榓婇2, 媑栰丂廋2,3, 壎揷婱巙3, 奀栰怣栫2 (1戝妛堾堛椕宯尋媶壢, 2嶻壢, 3晈恖): 戞72夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2020/4/23-28), Web奐嵜.
723404. [妛夛 (慡崙)] (億僗僞乕) Investigation of the functional role of ovarian hormone receptors in the carcinogenic process from ovarian endometrioma to ovarian cancer. 暯壀婤戝1, 媑栰丂廋1,2, 娾抂弐曘1, 埳摗幚崄1, 杮揷夒巕3, 娾悾弔巕1, 帪擟愹屛2, 壎揷婱巙1, Osuga Y (1晈恖, 2嶻壢, 3戝妛堾堛椕宯尋媶壢): 戞72夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2020/4/23-28), Web奐嵜.
723405. [妛夛 (慡崙)] (億僗僞乕) 抩娚弌寣徢椺偺廳徢壔傪梊應偡傞巜昗偵娭偡傞専摙. 拞嬥楴巕1, 朷寧弮巕1, 戝惣梖巕1, 暈晹嬁巕1, 媑懞壝峀1, 娭岥榓婇1, 愇愳棽嶰1, 嬥堜梇擇1, 奀栰怣栫1 (1嶻壢): 戞72夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2020/4/23-28), Web奐嵜.
723406. [妛夛 (慡崙)] (億僗僞乕) 摉堾偱儕僗僋掅尭棏娗棏憙揈弌弍 (RRSO) 傪峴偭偨1徢椺. 楅栘桼棞撧, 懌棫崕擵, 墦摗恀堦1, 惣搰丂柧, 媨嶁槺婓, 媨杮恀崑, 杧峕峅擇, 墶揷帯廳 (1晈恖): 戞72夞擔杮嶻壢晈恖壢妛夛妛弍島墘夛 (2020/4/23-28), Web奐嵜.
723407. [妛夛 (慡崙)] (堦斒岥墘) 暊悈嵶朎恌偱偼恌抐崲擄偱偁偭偨棏憙尨敪埆惈崟怓庮偺堦椺. 戝惣尗恖1, 娾悾弔巕1, 嶁岥丂擡2, 屆愳惓媊1, 揷嶨桳婭1, 崅揷嫳恇1, 壎揷婱巙1 (1晈恖, 2昦棟晹): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20-7/19), Web奐嵜.
723024. [妛夛 (慡崙)] (億僗僞乕) 儅僂僗巕媨撪枌徢偵偍偗傞RAMP1偺寣娗丒儕儞僷娗怴惗懀恑嶌梡. 杮揷夒巕1, 埳摗媊栫2, 暈晹嬁巕1, 嵶栰壛撧巕2, 拞杮廋巌1, 戝崅巎惞1, 捗棷悽棦3, 攏搱惓棽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟, 3杻悓): 戞41夞擔杮墛徢丒嵞惗堛妛夛 (2020/7/8-9), Web奐嵜.
723027. [妛夛 (慡崙)] (堦斒岥墘) 儅僂僗巕媨撪枌徢偵偍偗傞RAMP1偺儕儞僷娗怴惗懀恑嶌梡. 杮揷夒巕1, 埳摗媊栫2, 暈晹嬁巕1, 嵶栰壛撧巕2, 戝崅巎惞1, 攏搱惓棽2 (1戝妛堾堛椕宯尋媶壢, 2栻棟): 戞44夞擔杮儕儞僷妛夛憤夛 (2020/9/11-12), 戝媨.
723408. [妛夛 (慡崙)] (億僗僞乕) 棏憙枹暘壔泱嵶朎庮偺暊悈拞偵弌尰偟偨庮釃嵶朎憸偺摿挜. 揷嶨桳婭1, 拞懞婎姲1, 墦摗恀堦1, 屆愳惓媊1, 戝惣尗恖1, 崅揷嫳恇1, 娾悾弔巕1 (1晈恖): 戞59夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2020/11/21-22, 12/11-27), 墶昹/Web奐嵜.
723409. [妛夛 (慡崙)] (堦斒岥墘) 巕媨栩娻偵偍偗傞弍屻嵞敪崅儕僗僋孮徢椺偺椪彴揑専摙. 嶳嶈丂桪1, 屆愳惓媊2, 拞懞婎姲2, 墦摗恀堦2, 戝惣尗恖2, 揷嶨桳婭2, 崅揷嫳恇2, 媑栰丂廋1,2, 娾悾弔巕2, 壎揷婱巙2 (1嶻壢, 2晈恖): 戞62夞擔杮晈恖壢庮釃妛夛妛弍島墘夛 (2021/1/29-2/11), Web奐嵜.
723410. [妛夛 (慡崙)] (億僗僞乕) 棏憙尨敪惈埆惈崟怓庮偵懳偟偰柶塽僠僃僢僋億僀儞僩慾奞栻傪巊梡偟偨2椺. 扟丂戩栫1, 戝惣尗恖1, 拞懞婎姲1, 屆愳惓媊1, 揷嶨桳婭1, 崅揷嫳恇1, 媑栰丂廋1,2, 娾悾弔巕1, 壎揷婱巙1 (1晈恖, 2嶻壢): 戞62夞擔杮晈恖壢庮釃妛夛妛弍島墘夛 (2021/1/29-2/11), Web奐嵜.
732018. [妛夛 (抧曽夛丒尋媶夛)] (巜摫堛島廗夛) 嶻晈恖壢堛偺楯摥娐嫬傪夵慞偝偣傛偆. 奀栰怣栫 (嶻壢): 戞139夞 娭搶楢崌嶻壢晈恖壢妛夛憤夛丒妛弍廤夛 (2020/6/23-7/6), Web奐嵜.
732019. [妛夛 (抧曽夛丒尋媶夛)] (岞奐島嵗) 堛椕惌嶔偲尰応亅嶻壢丒廃嶻婜堛椕暘栰奺榑亅. 奀栰怣栫 (嶻壢): 搶嫗戝妛堛妛晹妛惗丒嫵怑堳懳徾堛妛彉榑楢懕島嵗僔儕乕僘XX戞2夞 (2020/10/1-11/26), Web奐嵜.
732020. [妛夛 (抧曽夛丒尋媶夛)] (僙儈僫乕) 柍捝暘曍娭學妛夛丒抍懱楢棈嫤媍夛 (JALA) 偺妶摦忬嫷亅柍捝暘曍偺埨慡惈妋曐偺偨傔偵亅. 奀栰怣栫 (嶻壢): 擔杮嶻壢杻悓妛夛庡嵜戞1夞WEB僙儈僫乕 (2020/12/14-2021/1/11), Web奐嵜.
732021. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 嵭奞帪偵偍偗傞恄撧愳導偺彫帣丒廃嶻婜堛椕懱惂: 嵭奞帪偺擠嶻晈丒曣巕傪庣傞偨傔偺巟墖曽朄偺幚嵺偲懳嶔偺偡傋偰. 奀栰怣栫 (嶻壢): 恄撧愳導彆嶻巘夛尋廋夛 (2021/2/27), Web奐嵜.
732022. [妛夛 (抧曽夛丒尋媶夛)] (巗柉岞奐島嵗) 儕僾儘僟僋僥傿僽僿儖僗: 擔杮偺幮夛偑書偊傞壽戣丂彈惈偺寬峃廡娫. 奀栰怣栫 (嶻壢): 娵偺撪僉儍儕傾弇僗儁僔儍儖僙儈僫乕丂彈惈偺儔僀僼僨僓僀儞偲儕僾儘僟僋僥傿僽僿儖僗亅崱偙偦峫偊偨偄僩乕僞儖僿儖僗働傾亅 (2021/3/3), Web奐嵜.
732023. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 屻堚徢側偔媬柦偟摼偨怱攛嫊扙宆梤悈嵡愷徢偺堦椺. 屲搰桾擵1, 戝惣梖巕1, 媑懞壝峀1, 拞嬥楴巕1, 暈晹嬁巕2, 娭岥榓婇1, 愇愳棽嶰1, 嬥堜梇擇1, 朷寧弴巕1, 奀栰怣栫1 (1嶻壢, 2戝妛堾堛椕宯尋媶壢): 戞139夞 娭搶楢崌嶻壢晈恖壢妛夛憤夛丒妛弍廤夛 (2020/6/23-7/6), Web奐嵜.
733077. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) COVID-19僼儖PPE憰旛偱懳墳偟偨枹庴恌擠晈偺1椺. 屲廫敤恗巙1, 媑懞壝峀1, 惣搰弮堦1, 暈晹嬁巕2, 拞嬥楴巕1, 娭岥榓婇1, 愇愳棽嶰1, 戝惣梖巕1, 嬥堜梇擇1, 朷寧弮巕1, 奀栰怣栫1 (1嶻壢, 2戝妛堾堛椕宯尋媶壢): 戞429�430夞恄撧愳嶻壢晈恖壢妛夛妛弍島墘夛 (2020/7/12), Web奐嵜.
733078. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 巕媨嬝庮擯揮偺堦椺. 墦摗撧弿旤1, 屲廫敤恗巙1, 搰壀嫕惗1, 扚丂塸庽, 怴堜丂搘2 (1嶻壢, 2晈恖): 戞429�430夞恄撧愳嶻壢晈恖壢妛夛妛弍島墘夛 (2020/7/12), Web奐嵜.
733079. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 儁儉僽儘儕僘儅僽偑挊岠偟偨MSI専嵏梲惈巕媨懱娻偺堦椺. 悾屗嵐寧1, 崅揷嫳恇1, 拞懞婎姲1, 屆愳惓媊1, 戝惣尗恖1, 揷嶨桳婭1, 娾悾弔巕1, 壎揷婱巙1 (1晈恖): 戞429�430夞恄撧愳嶻壢晈恖壢妛夛妛弍島墘夛 (2020/7/12), Web奐嵜.
733080. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 暯惉31擭搙恄撧愳嶻壢晈恖壢堛夛晈恖壢埆惈庮釃搊榐廤寁曬崘. 堥嶈懢堦, 徖嶈椷巕, 怴堜丂搘1, 儖僀僘墶揷撧朁, 媑揷丂峗, 悪塝丂尗, 戝尨丂庽, 崅揷嫳恇1, 栘斠峷帨, 嵅乆栘峃, 暷嶳崉堦, 椦丂峃巕, 暯郪丂栆, 敧戙棔巕, 搚壆丂憦, 拞揷偝偔傜, 怷壀丂姴, 嶰忋姴抝, 壛摗媣惙, 拞栰崃嵅抝, 媨忛墄巕, 崅嫶峆抝 (1晈恖): 戞429�430夞恄撧愳嶻壢晈恖壢妛夛妛弍島墘夛 (2020/7/12), Web奐嵜.
733081. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 棳嶻張抲傪宊婡偵septic shock傪棃偨偟偨堦椺. 暯揷妜巎1, 媑懞壝峀1, 暈晹嬁巕1, 拞嬥楴巕1, 娭岥榓婇1, 愇愳棽嶰1, 戝惣梖巕1, 嬥堜梇擇1, 奀栰怣栫1 (1嶻壢, 2戝妛堾堛椕宯尋媶壢): 戞431夞恄撧愳嶻壢晈恖壢妛夛妛弍島墘夛 (2020/9/26), Web奐嵜.
733082. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 13嵨偺弶宱慜偺彮彈偵敪惗偟偨棏憙擲塼惈娻偺堦椺. 墦摗撧弿旤1, 崅揷嫳恇1, 拞懞婎姲1, 墦摗恀堦1, 戝惣尗恖1, 揷嶨桳婭1, 媑栰丂廋1,2, 娾悾弔巕1 (1晈恖, 2嶻壢): 戞140夞娭搶楢崌嶻壢晈恖壢妛夛憤夛丒妛弍廤夛 (2020/11/12-18): Web奐嵜.
733083. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 摉堾偺峀斈巕媨慡揈弍屻攔擜忈奞偺娗棟. 垻晹丂悏1, 崅揷嫳恇2, 拞懞婎姲2, 墦摗恀堦2, 屆愳惓媊2, 戝惣尗恖2, 揷嶨桳婭2, 媑栰丂廋1,2, 娾悾弔巕2, 奀栰怣栫1 (1嶻壢, 2晈恖): 戞383夞巐悈夛 (2020/11/18), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'18-110001. [尨挊] HIF2兛 in the uterine stroma permits embryo invasion and luminal epithelium detachment. Matsumoto L, Hirota Y, Saito-Fujita T, Takeda N, Tanaka T, Hiraoka T1, Akaeda S, Fujita H, Shimizu-Hirota R, Igaue S, Matsuo M, Haraguchi H, Saito-Kanatani M, Fujii T, Osuga Y: J Clin Invest 2018/7; 128 (7): 3186-97. (暯壀婤戝1: 1晈恖)
'18-110002. [尨挊] Mdm2-p53-SF1 pathway in ovarian granulosa cells directs ovulation and fertilization by conditioning oocyte quality. Haraguchi H, Hirota Y, Saito-Fujita T, Tanaka T, Shimizu-Hirota R, Harada M, Akaeda S, Hiraoka T1, Matsuo M, Matsumoto L, Hirata T, Koga K, Wada-Hiraike O, Fujii T, Osuga Y: FASEB J 2019/2; 33 (2): 2610-20. (暯壀婤戝1: 1晈恖)
[妛夛丒尋媶夛摍]
H28-723001. [妛夛 (慡崙)] (堦斒島墘) 摉巤愝偵偍偗傞廃嶻婜椞堟偺挋寣幃帺屓寣桝寣幚巤娗棟懱惂偵偮偄偰. 娭岥榓婇1, 朷寧弮巕1, 奀栰怣栫1 (1嶻壢): 戞30夞擔杮帺屓寣桝寣妛夛妛弍憤夛 (2017/3/10-11), 墶昹.
'19-733012. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) Massive ovarian edema偵懳偟偰暊峯嬀壓庤弍傪巤峴偟懳徠揑側揮婡傪偲偭偨2徢椺. 嶳嶈丂桪1, 媣搱懃峴2, 拞懞婎姲3, 廐嶳奊棦巕1, 愇堜奊浠巕, 埳摗幚崄1,2, 屲搰桾擵1, 搰壀嫕惗1, 崻捗岾曚, 嶁搶桼婭2,4, 嶰栘柧摽1,2 (1嶻壢, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3晈恖, 4彫帣): 戞57夞嶉嬍導堛妛夛憤夛 (2020/2/22), 嶉嬍.
惍宍奜壢妛
[妛弍榑暥]
110297. [尨挊] A portable pneumatic compression device to prevent venous thromboembolism in orthopedic patients with the highest risks of both venous thrombosis and bleeding: A case series study. Takahashi Y, Takahira N1, Shibuya M, Uchiyama K2, Fukushima K3, Iwase D3, Kawamura T3, Miyagi M3, Higashiyama R3, Moriya M3, Sakai K, Tsuda K, Sakamoto M, Akamine A4, Takaso M3: J Orthop Surg (Hong Kong) 2020/1-4; 28 (1): 2309499020905711. (崅暯彯怢1, 撪嶳彑暥2, 暉搰寬夘3, 娾悾丂戝3, 壨懞丂捈3, 媨忛惓峴3, 搶嶳楃帯3, 怷扟岝弐3, 愒椾憦旻4, 崅憡徎巑3: 1堛椕塹惗妛晹, 2堛椕埨慡丒娗棟, 3惍奜, 4栻嵻晹)
110298. [尨挊] Sequential CCL2 Expression Profile After Disc Injury in Mice. Nakawaki M1, Uchida K1, Miyagi M1, Inoue G1, Kawakubo A1, Kuroda A2, Satoh M3, Takaso M1: J Orthop Res 2020/4; 38 (4): 895-901. (拞榚廩復1, 撪揷寬懢榊1, 媨忛惓峴1, 堜忋丂尯1, 愳媣曐曕1, 崟揷峎媊2, 嵅摗丂夒3, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢, 3柶塽)
110299. [尨挊] Increase in Tryptase and Its Role in the Synovial Membrane of Overweight and Obese Patients with Osteoarthritis of the Knee. Takata K1, Uchida K2, Mukai M1, Takano S2, Aikawa J2, Iwase D2, Sekiguchi H2, Miyagi M2, Inoue G2, Takaso M2: Diabetes Metab Syndr Obes 2020/5; 13: 1491-7. (崅揷丂尋1, 撪揷寬懢榊2, 寎丂丂妛1, 崅栰徃懢榊2, 憡愳丂弤2, 娾悾丂戝2, 娭岥桾擵2, 媨忛惓峴2, 堜忋丂尯2, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜)
110300. [尨挊] Arthroscopic tenodesis using a bioabsorbable interference screw and soft anchor: A case series of 60 patients. Sasaki Y, Ochiai N, Kenmoku T1, Yamaguchi T Kijima T, Hashimoto E, Ohtori S: J Orthop Sci 2020/5; 25 (3): 410-5. (尒栚抭婭1: 1惍奜)
110301. [尨挊] Risk factors associated with prolonged intensive care unit stay after posterior spinal fusion for Duchenne muscular dystrophy. Saito W1, Inoue G1, Shirasawa E1, Imura T1, Nakazawa T1, Miyagi M1, Uchida K1, Matsuda H2, Akazawa T, Takaso M1: J Orthop Sci 2021/5; 26 (3): 332-6. (釼摗丂榡1, 堜忋丂尯1, 敀郪塰庽1, 堜懞婱擵1, 拞郪弐擵1, 媨忛惓峴1, 撪揷寬懢榊1, 徏揷峅旤2, 崅憡徎巑1: 1惍奜, 2杻悓)
110302. [尨挊] Arthroscopic tenodesis using a bioabsorbable interference screw and soft anchor: A case series of 60 patients. Sasaki Y, Ochiai N, Kenmoku T1,2, Yamaguchi T, Kijima T, Hashimoto E, Ohtori S: J Orthop Sci 2020/5; 25 (3): 410-5. (擔曽抭岹1,2: 1杒棦戝妛杒棦尋媶強昦堾, 2惍奜)
110303. [尨挊] Loop-Mediated Isothermal Amplification Screening for COVID-19 in Asymptomatic Preoperative Orthopedic Patients in a General Hospital in Kanagawa, Japan. Uchida K1, Sekiguchi H1, Higashiyama R1, Endo T, Yokozeki Y2, Inoue G1, Miyagi M1, Fujino S1, Yoshida N, Takaso M1: Cureus 2020/7; 12 (7): e9331. (撪揷寬懢榊1, 娭岥桾擵1, 搶嶳楃帯1, 墶娭梇巌2, 堜忋丂尯1, 媨忛惓峴1, 摗栰彲懢榊1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
110304. [尨挊] Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study. Kawabata A, Yoshii T, Hirai T, Ushio S, Kaito T, Yamashita T, Fujiwara H, Nagamoto Y, Matsuoka Y, Suzuki H, Nishimura H, Terai H, Tamai K, Tagami A, Yamada S, Adachi S, Watanabe K, Katsumi K, Ohashi M, Shibuya Y, Harimaya K, Kawaguchi K, Yokoyama N, Oishi H, Doi T, Kimura A, Inoue H, Inoue G1, Miyagi M1, Saito W1, Nakano A, Sakai D, Nukaga T, Ikegami S, Shimizu M, Futatsugi T, Ohtori S, Furuya T, Orita S, Imagama S, Ando K, Kobayashi K, Kiyasu K, Murakami H, Yoshioka K, Seki S, Hongo M, Kakutani K, Yurube T, Aoki Y, Oshima M, Takahata M, Iwata A, Endo H, Abe T, Tsukanishi T, Nakanishi K, Watanabe K, Hikata T, Suzuki S, Isogai N, Okada E, Funao H, Ueda S, Shiono Y, Nojiri K, Hosogane N, Ishii K: BMC Musculoskelet Disord 2020/7; 21 (1): 420. (堜忋丂尯1, 媨忛惓峴1, 釼摗丂榡1: 1惍奜)
110305. [尨挊] Prediction tool for high risk of surgical site infection in spinal surgery. Namba T, Ueno M, Inoue G1, Imura T1, Saito W1, Nakazawa T1, Miyagi M1, Shirasawa E1, Takahashi O, Takaso M1: Infect Control Hosp Epidemiol 2020/7; 41 (7): 799-804. (堜忋丂尯1, 堜懞婱擵1, 釼摗丂榡1, 拞郪弐擵1, 媨忛惓峴1, 敀郪塰庽1, 崅憡徎巑1: 1惍奜)
110306. [尨挊] Body Composition in Japanese Girls with Adolescent Idiopathic Scoliosis. Miyagi M1, Saito W1, Imura T1, Nakazawa T1, Shirasawa E1, Kawakubo A1, Uchida K1, Akazawa T, Inage K, Ohtori S, Inoue G1, Takaso M1: Spine Surg Relat Res 2020/8; 5 (2): 68-74. (媨忛惓峴1, 釼摗丂榡1, 堜懞婱擵1, 拞郪弐擵1, 敀郪塰庽1, 愳媣曐曕1, 撪揷寬懢榊1, 堜忋丂尯1, 崅憡徎巑1: 1惍奜)
110307. [尨挊] Posterior Spinal Correction and Fusion Surgery in Patients with Spinal Muscular Atrophy-Associated Scoliosis for Whom Treatment with Nusinersen Was Planned. Machida S1, Miyagi M1, Saito W1, Matsui A, Imura T1, Inoue G1, Nakazawa T1, Shirasawa E1, Ikeda S1, Kawakubo A1, Kuroda A2, Yokozeki Y2, Mimura Y, Uchida K1, Akazawa T, Takaso M1: Spine Surg Relat Res 2020/8; 5 (2): 109-13. (挰揷廃暯1, 媨忛惓峴1, 釼摗丂榡1, 堜懞婱擵1, 堜忋丂尯1, 拞郪弐擵1, 敀郪塰庽1, 抮揷怣夘1, 愳媣曐曕1, 崟揷峎媊2, 墶娭梇巌2, 撪揷寬懢榊1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
110308. [尨挊] Acceleration of Bone Healing by In Situ-Forming Dextran-Tyramine Conjugates Containing Basic Fibroblast Growth Factor in Mice. Shoji S1, Uchida K2, Saito W2, Sekiguchi H2, Inoue G2, Miyagi M2, Kuroda A1, Takaso M2: Cureus 2020/8; 12 (8): e10085. (彲巌恀懢榊1, 撪揷寬懢榊2, 釼摗丂榡2, 娭岥桾擵2, 堜忋丂尯2, 媨忛惓峴2, 崟揷峎媊1, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜)
110309. [尨挊] Investigation of resident and recruited macrophages following disc injury in mice. Kawakubo A1, Uchida K1, Miyagi M1, Nakawaki M1, Satoh M2, Sekiguchi H1, Yokozeki Y3, Inoue G1, Takaso M1: J Orthop Res 2020/8; 38 (8): 1703-9. (愳媣曐曕1, 撪揷寬懢榊1, 媨忛惓峴1, 拞榚廩復1, 嵅摗丂夒2, 娭岥桾擵1, 墶娭梇巌3, 堜忋丂尯1, 崅憡徎巑1: 1惍奜, 2柶塽, 3戝妛堾堛椕宯尋媶壢)
110310. [尨挊] Short- versus long-segment posterior spinal fusion with vertebroplasty for osteoporotic vertebral collapse with neurological impairment in thoracolumbar spine: a multicenter study. Ishikawa Y, Watanabe K, Katsumi K, Ohashi M, Shibuya Y, Izumi T, Hirano T, Endo N, Kaito T, Yamashita T, Fujiwara H, Nagamoto Y, Matsuoka Y, Suzuki H, Nishimura H, Terai H, Tamai K, Tagami A, Yamada S, Adachi S, Yoshii T, Ushio S, Harimaya K, Kawaguchi K, Yokoyama N, Oishi H, Doi T, Kimura A, Inoue H, Inoue G1, Miyagi M1, Saito W1, Nakano A, Sakai D, Nukaga T, Ikegami S, Shimizu M, Futatsugi T, Ohtori S, Furuya T, Orita S, Imagama S, Ando K, Kobayashi K, Kiyasu K, Murakami H, Yoshioka K, Seki S, Hongo M, Kakutani K, Yurube T, Aoki Y, Oshima M, Takahata M, Iwata A, Endo H, Abe T, Tsukanishi T, Nakanishi K, Watanabe K, Hikata T, Suzuki S, Isogai N, Okada E, Funao H, Ueda S, Shiono Y, Nojiri K, Hosogane N, Ishii K: BMC Musculoskelet Disord 2020/8; 21 (1): 513. (堜忋丂尯1, 媨忛惓峴1, 釼摗丂榡1: 1惍奜)
110311. [尨挊] Pulmonary Function Improves in Patients with Adolescent Idiopathic Scoliosis who Undergo Posterior Spinal Fusion Regardless of Thoracoplasty: A Mid-Term Follow-Up. Akazawa T, Kotani T, Sakuma T, Nakayama K, Iijima Y, Torii Y, Iinuma M, Kuroya S, Asano K, Ueno J, Yoshida A, Murakami K, Minami S, Orita S, Inage K, Shiga Y, Nakamura J, Inoue G1, Miyagi M1, Saito W1, Eguchi Y, Fujimoto K, Takahashi H, Ohtori S, Niki H: Spine Surg Relat Res 2020/8; 5 (1): 22-7. (堜忋丂尯1, 媨忛惓峴1, 釼摗丂榡1: 1惍奜)
110312. [尨挊] Central sensitization inventory scores correlate with pain at rest in patients with hip osteoarthritis: a retrospective study. Ohashi Y1, Fukushima K2, Inoue G2, Uchida K2, Koyama T1, Tsuchiya M2, Uchiyama K3, Takahira N4, Takaso M2: BMC Musculoskelet Disord 2020/9; 21 (1): 595. (戝嫶宑媣1, 暉搰寬夘2, 堜忋丂尯2, 撪揷寬懢榊2, 彫嶳抭媣1, 搚壆恀曚2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹)
110313. [尨挊] Sports activity participation after curved periacetabular osteotomy for acetabular dysplasia. Takahashi Y1, Takahira N2, Uchiyama K3, Fukushima K4, Moriya M4, Shibuya M1, Tsuda K1, Tozaki K1, Kudo S1, Kaneda H1, Sekita J1, Takaso M4: BMC Musculoskelet Disord 2020/9; 21 (1): 637. (崅嫶壚濘1, 崅暯彯怢2, 撪嶳彑暥3, 暉搰寬夘4, 怷扟岝弐4, 廰扟恀崄1, 捗揷峎巌1, 屗嶈丂惛1, 岺摗丂彨1, 嬥揷峗柧1, 娭揷撜栫1, 崅憡徎巑4: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3堛椕埨慡丒娗棟, 4惍奜)
110314. [尨挊] Short-Term Impact of Staying Home on Bone Health in Patients With Osteoporosis During a State of Emergency Declaration Due to COVID-19 in Kanagawa, Japan. Yokozeki Y1, Uchida K2, Miyagi M2, Murata K1, Koyama T1, Kuroda A1, Kawakubo A2, Nannri Y3, Inoue G2, Takaso M2: Cureus 2020/9; 12 (9): e10278. (墶娭梇巌1, 撪揷寬懢榊2, 媨忛惓峴2, 懞揷岾桟1, 彫嶳抭媣1, 崟揷峎媊1, 愳媣曐曕2, 撿棦桟懢3, 堜忋丂尯2, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜, 3儕僴價儕晹)
110315. [尨挊] Acceleration of bone union by in situ-formed hydrogel containing bone morphogenetic protein-2 in a mouse refractory fracture model. Shoji S1, Uchida K2, Saito W2, Sekiguchi H2, Inoue G2, Miyagi M2, Takata K1, Yokozeki Y1, Takaso M2: J Orthop Surg Res 2020/9; 15 (1): 426. (彲巌恀懢榊1, 撪揷寬懢榊2, 釼摗丂榡2, 娭岥桾擵2, 堜忋丂尯2, 媨忛惓峴2, 崅揷丂尋1, 墶娭梇巌1, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜)
110316. [尨挊] Experience of an Orthopaedic Surgery Department Early During the COVID-19 Outbreak in Japan Including Real-Time Polymerase Chain Reaction Assay Results for SARS-CoV-2. Inoue G1, Uchida K1, Fukushima K1, Uchiyama K2, Nakazawa T1, Aikawa J1, Matsuura T1, Miyagi M1, Takahira N3, Takaso M1: Cureus 2020/10; 12 (10): e11140. (堜忋丂尯1, 撪揷寬懢榊1, 暉搰寬夘1, 撪嶳彑暥2, 拞郪弐擵1, 憡愳丂弤1, 徏塝峎惓1, 媨忛惓峴1, 崅暯彯怢3, 崅憡徎巑1: 1惍奜, 2堛椕埨慡丒娗棟, 3堛椕塹惗妛晹)
110317. [尨挊] Poly(POG)n loaded with recombinant human bone morphogenetic protein-2 accelerates new bone formation in a critical-sized bone defect mouse model. Tazawa R1, Uchida K1, Minehra H1, Matsuura T1, Kawamura T1, Sekiguchi H1, Muneshige K2, Inoue S2, Inoue G1, Takaso M1: J Orthop Surg Res 2020/10; 15 (1): 471. (揷郪丂椚1, 撪揷寬懢榊1, 曯尨岹徆1, 徏塝峎惓1, 壨懞丂捈1, 娭岥桾擵1, 廆廳嬁巕2, 堜忋丂隳2, 堜忋丂尯1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
110318. [尨挊] Evaluation of myeloperoxidase in synovial fluid as a biomarker for chronic periprosthetic joint infection. Ikeda S1, Uchiyama K2, Minegishi Y1, Nakamura M3, Takaso M1: Int Orthop 2020/10; 44 (10): 1915-20. (抮揷怣夘1, 撪嶳彑暥2, 曱娸梞師榊1, 拞懞惓庽3, 崅憡徎巑1: 1惍奜, 2堛椕埨慡丒娗棟, 3堛椕塹惗妛晹)
110319. [尨挊] Unilateral-dominant reduction in muscle volume in female knee osteoarthritis patients: computed tomography-based analysis of bilateral sides. Tsukada A1, Uchida K1, Aikawa J1, Takano S1, Iwase D1, Mukai M2 Miyagi M1, Nanri Y3, Inoue G1, Takaso M1: J Orthop Surg Res 2020/11; 15 (1): 543. (捤揷垷桾旤1, 撪揷寬懢榊1, 憡愳丂弤1, 崅栰徃懢榊1, 娾悾丂戝1, 寎丂丂妛2, 媨忛惓峴1, 撿棦桟懢3, 堜忋丂尯1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢, 3儕僴價儕晹)
110320. [尨挊] Effects of Tissue Flossing and Dynamic Stretching on Hamstring Muscles Function. Kaneda H1, Takahira N2, Tsuda K1, Tozaki K1, Kudo S1, Takahashi Y1, Sasaaki S3, Kenmoku T4: J Sports Sci Med 2020/11; 19 (4): 681-9. (嬥揷峗柧1, 崅暯彯怢2, 捗揷峎巌1, 屗嶈丂惛1, 岺摗丂彨1, 崅嫶壚濘1, 嵅乆栘廏堦3, 尒栚抭婭4: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3儕僴價儕晹, 4惍奜)
110321. [尨挊] In Vivo Evaluation of the Mechanical Strength of a Slide Lengthening Technique With a Locking Mechanism Using a Rabbit Model. Iwase D1, Uchida K1, Metoki Y1, Sekiguchi H1, Aikawa J1 Matsuo T, Matsuo A, Takaso M1: Cureus 2020/12; 12 (12): e12387. (娾悾丂戝1, 撪揷寬懢榊1, 栚帪桳婓宐1, 娭岥桾擵1, 憡愳丂弤1, 崅憡徎巑1: 1惍奜)
110322. [尨挊] Influence of outer geometry on primary stability for uncemented acetabular shells in developmental dysplasia of the hip. Yoshida K1, Fukushima K2, Sakai R1, Uchiyama K3, Takahira N1, Ujihira M1: Proc Inst Mech Eng H 2021/1; 235 (1): 65-72. (媑揷榓峅1, 暉搰寬夘2, 庰堜棙撧1, 撪嶳彑暥3, 崅暯彯怢1, 巵暯惌怢1: 1堛椕塹惗妛晹, 2惍奜, 3堛椕埨慡丒娗棟)
110323. [尨挊] Elevated levels of TNF-兛, IL-1兝 and IL-6 in the synovial tissue of patients with labral tear: a comparative study with hip osteoarthritis. Koyama T1, Uchida K2, Fukushima K2, Ohashi Y1, Uchiyama K3, Inoue G2, Takahira N4, Takaso M2: BMC Musculoskelet Disord 2021/1; 22 (1): 33. (彫嶳抭媣1, 撪揷寬懢榊2, 暉搰寬夘2, 戝嫶宑媣1, 撪嶳彑暥3, 堜忋丂尯2, 崅暯彯怢4, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹)
110324. [尨挊] Assessment of the duration and effectiveness of intra-articular lidocaine injections for groin pain in patients with labral tears involving early osteoarthritis. Fukushima K1, Inoue G1, Kawakubo A2, Uchida K1, Koyama T2, Ohashi Y2, Uchiyama K3, Takahira N4, Takaso M1: SICOT J 2021; 7: 4. doi: 10.1051/sicotj/2020049. Epub 2021 Jan 12. (暉搰寬夘1, 堜忋丂尯1, 愳媣曐曕2, 撪揷寬懢榊1, 彫嶳抭媣2, 戝嫶宑媣2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹)
110325. [尨挊] Management of regional bone bank during declaration of a state of emergency concerning the COVID-19 in Japan. Uchida K1, Mukai M2, Miyagi M1, Fukushima K1, Uchiyama K3, Nakayama A1, Matsumoto M1, Takahira N4, Urabe K1, Takaso M1, Inoue G1: Cell Tissue Bank 2021/12; 22 (4): 703-9. doi: 10.1007/s10561-021-09908-w. Epub 2021 Feb 20. (撪揷寬懢榊1, 寎丂丂妛2, 媨忛惓峴1, 暉搰寬夘1, 撪嶳彑暥3, 拞嶳徎巕1, 徏杮丂晳1, 崅暯彯怢4, 愯晹丂寷1, 崅憡徎巑1, 堜忋丂尯1: 1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹)
110326. [尨挊] Limitations of posterior spinal fusion to L5 for flaccid neuromuscular scoliosis focusing on pelvic obliquity. Saito W1, Inoue G1, Shirasawa E1, Imura T1, Nakazawa T1, Miyagi M1, Kawakubo A2, Uchida K1, Kotani T, Akazawa T, Takaso M1: Spine Deform 2021/3; 9 (2): 559-65. (釼摗丂榡1, 堜忋丂尯1, 敀郪塰庽1, 堜懞婱擵1, 拞郪弐擵1, 媨忛惓峴1, 愳媣曐曕2, 撪揷寬懢榊1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
120013. [尨挊] 枬惈恡憻昦偑崪慹闋徢姵幰偺椪彴強尒偵媦傏偡塭嬁. 愇堜戝曘1, 媨忛惓峴1, 徏杮岝孿1, 晲堜惓堦榊1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜): 搶擔杮惍宍嵭奞奜壢妛夛嶨帍 2020/4; 32 (1): 38-44.
120014. [尨挊] 慻怐傪柾媅偟偨戝戁崪崪姴晹偵偍偗傞億儕僄僠儗儞働乕僽儖偲僠僞儞働乕僽儖偺柺埑偺斾妑. 栴揷摗濘1, 庰堜棙撧2, 媑揷榓峅2, 巵暯惌怢2, 撪嶳彑暥3, 崅憡徎巑4 (1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3堛椕埨慡丒娗棟, 4惍奜): 崪愜 2020/5; 42 (3): 981-4.
120015. [尨挊] 恖岺屢娭愡抲姺弍偵偍偗傞僴儞儅儕儞僌壒偺廃攇悢夝愅偲戝戁崪偺墳椡偺悇掕. 庰堜棙撧1, 媑揷榓峅1, 巵暯惌怢1, 杒棦庽惗2, 撪嶳彑暥3, 崅暯彯怢1 (1堛椕塹惗妛晹, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟): 崪愜 2020/5; 42 (3): 1087-90.
120016. [尨挊] 崅楊崪慹闋徢姵幰偵偍偗傞寬峃娭楢QOL偺専摙. 嶰懞桰桽1, 媨忛惓峴1, 揷搰廏堦榊1, 懞揷岾桟2, 彫嶳抭媣2, 愳媣曐曕2, 撪揷寬懢榊1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): Journal of Spine Research 2020/9; 11 (9): 1114-9.
120017. [尨挊] 擔杮恖偵偍偗傞CORAIL� stem偺巊梡僒僀僘偺孹岦. 堜忋岹夘1, 暉搰寬夘1, 彫嶳抭媣2, 戝嫶宑媣2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 娭愡奜壢 2020/10; 39 (10): 1135-41.
120018. [尨挊] 姲崪塒宍惉晄慡偵偍偗傞弶婜屌掕惈偵懳偡傞敿懭墌媴宆僙儊儞僩儗僗恖岺屢娭愡僔僃儖偺岠壥. 媑揷榓峅1, 暉搰寬夘2, 庰堜棙撧1, 撪嶳彑暥3, 崅暯彯怢1, 巵暯惌怢1 (1堛椕塹惗妛晹, 2惍奜, 3堛椕埨慡丒娗棟): 椪彴僶僀僆儊僇僯僋僗 2020/10; 41: 43-8.
120019. [尨挊] 挻崅暘巕検億儕僄僠儗儞惢働乕僽儖偲嬥懏惢働乕僽儖偺戝戁崪崪姴晹偵偍偗傞柺埑偺斾妑. 庰堜棙撧1, 栴揷摗濘2, 媑揷榓峅1, 撪嶳彑暥3, 崅暯彯怢1, 巵暯惌怢1 (1堛椕塹惗妛晹, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟): 椪彴僶僀僆儊僇僯僋僗 2020/10; 41: 381-4.
120020. [尨挊] 嬄夌埵億乕僞僽儖僫價僎乕僔儑儞HipAlign偺摫擖慜屻偵偍偗傞僇僢僾愝抲惛搙偺専摙. 幠揷捈栱1, 撪嶳彑暥2, 暉搰寬夘1, 釼摗峀庽3, 怷扟岝弐1, 崅暯彯怢4, 崅憡徎巑1 (1惍奜, 2堛椕埨慡丒娗棟, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): Hip joint 2020/8; 46 (1): 404-5.
120021. [尨挊] 戝戁崪揮巕晹崪愜偵傛傞彫揮巕崪曅揮埵偑曕峴宍懺偵梌偊傞塭嬁. 彫桍壚戙, 暉搰寬夘1, 惸摗宑懢 (1惍奜): Hip joint 2020/8; 46 (2): S219-22.
310035. [徢椺曬崘] Cervical Hyperextension Treated by Posterior Spinal Correction and Fusion in A Patient with Ullrich Congenital Muscular Dystrophy: A Case Report. Saito W1, Imura T1, Miyagi M1, Nakazawa T1, Takaso M1, Inoue G1: JBJS Case Connect 2020/4-6; 10 (2): e0392. (釼摗丂榡1, 堜懞婱擵1, 媨忛惓峴1, 拞郪弐擵1, 崅憡徎巑1, 堜忋丂尯1: 1惍奜)
310036. [尨挊] Impact of Jiggling Exercise as Conservative Treatment for Hip Osteoarthritis: A Report of Two Cases. Teramoto Y1, Fukushima K1, Koyama T2, Ohashi Y2, Uchiyama K3, Takahira N2, Takaso M1: Case Rep Orthop 2020/5; 2020: 2804193. doi: 10.1155/2020/2804193. eCollection 2020. (帥杮梞暯1, 暉搰寬夘1, 彫嶳抭媣2, 戝嫶宑媣2, 撪嶳彑暥3, 崅暯彯怢2, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟)
310037. [徢椺曬崘] Bilateral Solitary Osteochondroma of the Bicipital Tuberosity Accompanied with Painful Clicking: A Case Report and Literature Review. Metoki Y1, Sukegawa 1, Onuma K1, Otake Y1, Yokozeki Y2, Miyata T1, Kenmoku T1, Takaso M1: J Hand Surg Asian Pac Vol 2020/6; 25 (2): 245-50. (栚帪桳婓宐1, 彆愳峗巑1, 彫徖尗帯1, 戝抾桰嵠1, 墶娭梇巌2, 媨揷丂庽1, 尒栚抭岹1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
310038. [徢椺曬崘] Flexor Tenosynovitis Caused by Mycobacterium arupense: A Case Report and Review of the Literature. Yokozeki Y1, Sukegawa K2, Onuma K2, Otake Y2, Wada T3, Takaso M2: JBJS Case Connect 2020/7-9; 10 (3): e2000033. (墶娭梇巌1, 彆愳峗巑2, 彫徖尗帯2, 戝抾桰嵠2, 榓揷払旻3, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜, 3銹尨昦丒姶愼撪)
310039. [徢椺曬崘] Arthroscopic Superior Capsule Reconstruction for Cuff Tear Arthropathy (Hamada Grade 5): A Case Report. Inoue K1, Kenmoku T1, Nakawaki M1, Tazawa R1, Matsumoto M1, Takaso M1: JBJS Case Connect 2020/12; 10 (4): e20.00511. (堜忋岹夘1, 尒栚抭婭1, 拞榚廩復1, 揷郪丂椚1, 徏杮岝孿1, 崅憡徎巑1: 1惍奜)
310040. [徢椺曬崘] A dorsal approach for the distal-to-proximal internal fixation of oblique scaphoid fractures. Tada T1, Onuma K1, Sukegawa K1, Otake Y1, Kenmoku T1, Takaso M1: J Orthop Case Rep 2020/12; 10 (9): 98-101. (懡揷戱栴1, 彫徖尗帯1, 彆愳峗巑1, 戝抾桰嵠1, 尒栚抭岹1, 崅憡徎巑1: 1惍奜)
320022. [徢椺曬崘] 20擭埲忋晄埨掕惈傪桳偟偰偄偨捖媽惈旾娭愡屻奜懁夞慁晄埨掕徢亅挿彾嬝銯偲旾嬝曎傪梡偄偰旾娭愡傪嵞寶偟偨1椺亅. 挰揷廃暯1, 彆愳峗巑1, 彫徖尗帯1, 戝抾桰嵠1, 尒栚抭婭1, 崅憡徎巑1 (1惍奜): 擔杮旾娭愡妛夛嶨帍 2020; 27 (2): 184-8.
320023. [徢椺曬崘] 栩捙扙塒崪愜弍屻偵惗偠偨擼姴峓嵡偺1椺. 捤揷垷桾旤1, 媨忛惓峴1, 敀郪塰庽1, 釼摗丂榡1, 堜懞婱擵1, 拞郪弐擵1, 堜忋丂尯1, 崅暯彯怢2, 崅憡徎巑1 (1惍奜, 2堛椕塹惗妛晹): 娭搶惍宍嵭奞奜壢妛夛嶨帍 2020/4; 51 (2): 45-9.
320024. [徢椺曬崘] 愐捙屻孅塣摦傪宊婡偵敪徢偟偨彫帣spinal cord injury without radiographic abnormality偺2椺. 墶娭梇巌1, 媨忛惓峴2, 堜忋丂尯2, 拞郪弐擵2, 堜懞婱擵2, 釼摗丂榡2, 敀郪塰庽2, 崅暯彯怢3, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3堛椕塹惗妛晹): 娭搶惍宍嵭奞奜壢妛夛嶨帍 2020/6; 51 (3): 138-44.
320025. [徢椺曬崘] 戝戁崪摢偡傋傝徢偺寬懁梊杊揑pinning帪偺夁擬偵傛傝崪夡巰傪惗偠偨1椺. 愳堜峗暯1, 撪嶳彑暥2, 暉搰寬夘1, 怷扟岝弐1, 崅暯彯怢3, 崅憡徎巑1, 嶳杮崑柧 (1惍奜, 2堛椕埨慡丒娗棟, 3堛椕塹惗妛晹): 娭搶惍宍嵭奞奜壢妛夛嶨帍 2020/6; 51 (3): 171-6.
320026. [徢椺曬崘] 屻曽嫺惓屌掕弍屻偵寣婥嫻傪偒偨偟偨恄宱嬝尨惈懁淽徢偺1椺. 堜忋丂隳1, 媨忛惓峴2, 拞郪弐擵2, 堜忋丂尯2, 堜懞婱擵2, 崅暯彯怢3, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3堛椕塹惗妛晹): 娭搶惍宍嵭奞奜壢妛夛嶨帍 2020/6; 51 (3): 234-8.
320027. [徢椺曬崘] 戝戁崪奜斀崪愗傝屻11擭宱夁偟偰傕崪桙崌偣偢THA巤峴偵擄廰偟偨1椺. 嫶捾岶揟1, 撪嶳彑暥2, 暉搰寬夘1, 戝嫶宑媣3, 彫嶳抭媣3, 怷扟岝弐1, 崅暯彯怢4, 崅憡徎巑1 (1惍奜, 2堛椕埨慡丒娗棟, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): Hip Joint 2020/8; 46 (2): 1019-24.
320028. [徢椺曬崘] 捙懱偵捈愙怹弫偟偨旕彫嵶朎攛娻偵懳偟晹暘捙懱愗彍傪暪梡偟庮釃傪堦夠偵揈弌偟偊偨1椺. 暷揷徆峀1, 敀郪塰庽1, 堜忋丂尯1, 媨忛惓峴1, 釼摗丂榡1, 崅憡徎巑1 (1惍奜): 搶擔杮惍宍嵭奞奜壢妛夛嶨帍 2020/8; 32 (2): 221-226.
320029. [徢椺曬崘] A孮兝梟楢嬠偵傛傞曣巜夡巰惈擃晹慻怐姶愼徢偺1椺. 媨揷丂庽1, 彆愳峗巑1, 彫徖尗帯1, 愳媣曐曕2, 戝抾桰嵠1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 惍宍奜壢 2020/9; 71 (10): 1087-9.
320030. [徢椺曬崘] 僒僢僇乕偺僑乕儖僉乕僷乕偵惗偠偨忋榬嶰摢嬝旂壓抐楐偺1椺. 幠揷捈栱1, 彫徖尗帯1, 彆愳峗巑1, 戝抾桰嵠1, 尒栚抭婭1, 崅憡徎巑1 (1惍奜): 娭搶惍宍嵭奞奜壢妛夛嶨帍 2020/10; 51 (5): 420-5.
510014. [憤愢] Technical and Conceptual Review on the L5-S1 Oblique Lateral Interbody Fusion Surgery (OLIF51). Orita S, Shiga Y, Inage K, Eguchi Y, Maki S, Furuya T, Aoki Y, Inoue M, Hynes RA, Koda M, Takahashi H, Akazawa T, Nakamura J, Hagiwara S, Inoue G1, Miyagi M1, Fujibayashi S, Iida T, Kotani Y, Tanaka M, Nakajima T, Ohtori S: Spine Surg Relat Res 2020/6; 5 (1): 1-9. (堜忋丂尯1, 媨忛惓峴1: 1惍奜)
520015. [憤愢] 捙娫斅惈崢捝偺枬惈壔婡彉偵娭偡傞峫嶡. 媨忛惓峴1, 撪揷寬懢榊1, 拞榚廩復1, 愳媣曐曕2, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): Journal of Spine Research 2020/; 11 (6): 878-82.
522068. [島嵗]亂摿廤: 恖岺娭愡廃埻姶愼偺尰忬偲揥朷丂崙嵺僐儞僙儞僒僗傪摜傑偊偰亃帯椕Debridement, Antibiotics, and Implant Retention (DAIR)亅堦婜揑嵞抲姺弍傑偨偼擇婜揑嵞抲姺弍亅. 撪嶳彑暥1, 抮揷怣夘2, 嶳杮崑柧, 暉搰寬夘2, 怷扟岝弐2, 崅暯彯怢3, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3堛椕塹惗妛晹): 椪彴惍宍奜壢 2020/4; 55 (4): 345-51.
522069. [島嵗]亂摿廤: 屢娭愡椞堟偺弍慜丒弍拞巟墖媄弍Up to date亃II. 弍拞庤弍巟墖丂億乕僞僽儖僫價僎乕僔儑儞僔僗僥儉傪梡偄偨嬄夌埵THA. 枼揷峴廏, 埳摗夒擵, 娾愗寬懢榊, 撪嶳彑暥1, 愳嶈夒巎, 恄揷復抝, 恄栰揘栫, 廎姍丂椇, 愮梩戝夘, 挿扟愳惓桾, 摗戙崅柧, 媨晲榓惓 (1堛椕埨慡丒娗棟): 娭愡奜壢 2020/6; 39 (6): 642乚51.
522070. [島嵗]亂摿廤: 屢娭愡椞堟偺弍慜丒弍拞巟墖媄弍Up to date亃II. 弍拞庤弍巟墖丂HipGrid� DRONE偵傛傞嬄夌埵THA偺弍拞巟墖. 暉搰寬夘1, 崅暯彯怢2, 崅憡徎巑1 (1惍奜, 2堛椕塹惗妛晹): 娭愡奜壢 2020/6; 39 (6): 652-6.
522071. [島嵗]亂庒庤堛巘偺偨傔偺 宱尡偡傋偒乬椞堟暿乭庤弍島嵗亃[屢娭愡] (PART 1) 娭愡嬀帇壓庤弍丂屢娭愡怬朌崌弍 (宍惉弍). 暉搰寬夘1, 崅暯彯怢2, 崅憡徎巑1 (1惍奜, 2堛椕塹惗妛晹): 惍宍奜壢Surgical Technique 2020/6; 10 (3): 328-34.
522072. [島嵗]亂摿廤: 崅楊幰偺醬捝娗棟偲娚榓働傾亃2. 崢晹愐拰娗嫹嶓徢偲崢捝娭楢幘姵. 堜忋丂尯 (惍奜): 擔杮榁擭堛妛夛嶨帍 2020/7; 57 (3): 243-53.
522073. [島嵗]亂摿廤: 僀儞僾儔儞僩廃埻崪愜偺帯椕愴棯丂THA丒TKA丒崪愜屻偺僾儗乕僩丒悜撪揃亃仭僐儔儉丂僀儞僾儔儞僩廃埻崪愜偵偍偗傞戝戁崪僗僥儉嵞抲姺弍偺僥僋僯僢僋. 撪嶳彑暥1, 暉搰寬夘2, 怷扟岝弐2, 彫嶳抭媣3, 戝嫶宑媣3, 崅暯彯怢4, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): 椪彴惍宍奜壢 2020/9; 55 (9): 1037-46.
522074. [島嵗]亂摿廤: 掅怤廝庤弍偵偍偗傞姶愼懳嶔儅僯儏傾儖亃I. Surgical Site Infection (SSI) 偺梊杊丂峈MRSA栻偺梊杊峈嬠栻搳梌偲帯椕搳梌偺峫偊曽. 撪嶳彑暥1, 暉搰寬夘2, 怷扟岝弐2, 彫嶳抭媣3, 戝嫶宑媣3, 崅暯彯怢4, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): 惍宍奜壢嵟彫怤廝庤弍僕儍乕僫儖 2021/2; 98: 44422.
522075. [島嵗]亂摿廤: 恖岺屢娭愡嵞抲姺弍丂嵟慜慄偐傜擄堈搙偺崅偄徢椺傑偱亃僀儞僾儔儞僩攋懝偵傛傞恖岺屢娭愡嵞抲姺弍. 嶳杮崑柧, 撪嶳彑暥1, 崅暯彯怢2 (1堛椕埨慡丒娗棟, 2堛椕塹惗妛晹): 娭愡奜壢 2021/2; 40 (2): 175-85.
522076. [島嵗]亂摿廤: 恖岺屢娭愡嵞抲姺弍丂嵟慜慄偐傜擄堈搙偺崅偄徢椺傑偱亃崪寚懝傊偺懳墳亅摨庬崪傪梡偄偨嵞寶. 暉搰寬夘1, 撪嶳彑暥2, 堜忋丂尯1, 崅暯彯怢3, 崅憡徎巑1 (1惍奜, 2堛椕埨慡丒娗棟, 3堛椕塹惗妛晹): 娭愡奜壢 2021/2; 40 (2): 205-12.
[挊丂彂]
620067. [妛弍彂 (暘扴幏昅)]亂Save the Athlete 屢娭愡僗億乕僣懝彎亃II丂屢娭愡丒崪斦偺僗億乕僣懝彎丂A. 幘姵曇丂1. 戝戁崪姲崪塒僀儞僺儞僕儊儞僩 (FAI), p.34-44. 暉搰寬夘 (惍奜), 曇: 崅暯彯怢, 儊僕僇儖價儏乕幮, 搶嫗, 2020/10敪峴.
620068. [妛弍彂 (暘扴幏昅)]亂僷乕僼僃僋僩丂慜廫帤恱懷嵞寶弍 (ACL)亃戞4復帯椕丂6. 摨庬銯偵傛傞ACL嵞寶, p.138-44. 搶嶳楃帯 (惍奜), 曇: 愇嫶嫳擵, 崟揷椙桽, 慜丂払梇, 嬥朏摪, 嫗搒, 2020/10敪峴.
620069. [妛弍彂 (暘扴幏昅)]亂惍宍奜壢儗僕僨儞僩偺偨傔偺愐捙偺儀乕僔僢僋庤弍亃1復夝朥, 専嵏朄丂2. 堦斒揑側専嵏朄 (愐悜峯憿塭専嵏, 恄宱崻僽儘僢僋, 捙娫斅拲幩丒憿塭専嵏), p.16. 媨忛惓峴1, 嶰懞桰桽1 (1惍奜), 曇挊: 慏旜梲惗, 擔杮堛帠怴曬幮, 搶嫗, 2020/12敪峴.
[妛夛丒尋媶夛摍]
711001. [妛夛 (崙嵺)] (摿暿島墘) Bone allograft: What can they offer? Urabe K1: Asia Pacific Association of Surgical Tissue Banking 2021 (2021/3/19), Web奐嵜. (愯晹丂寷1: 1惍奜)
711002. [妛夛 (崙嵺)] (摿暿島墘) Meniscal allograft. Urabe K1: Asia Pacific Association of Surgical Tissue Banking 2021 (2021/3/19), Web奐嵜. (愯晹丂寷1: 1惍奜)
712005. [妛夛 (崙嵺)] (彽懸島墘摍) Curved Periacebular Osteotomy. Fukushima K1, Koyama T2, Ohashi Y2, Uchiyama K3, Takahira N4, Takaso M1: The 2nd Annual Congress of Asia Society of Hip Arthroscopy & Preservation (2020/4/4), Web奐嵜. (暉搰寬夘1, 彫嶳抭媣2, 戝嫶宑媣2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹)
713040. [妛夛 (崙嵺)] (堦斒島墘) Prevalence and characteristics of a spinal sagittal imbalance in patients with osteoporosis. Miyagi M1, Matsunaga T1, Murata K2, Koyama T2, Kawakubo A2, Yokozeki Y2, Uchida K1, Inoue G1, Takaso M1: The World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases 2020 (WCO-IOF-ESCEO 2020) (2020/8/20-22), Web奐嵜. (媨忛惓峴1, 徏塱濄擵1, 懞揷岾桟2, 彫嶳抭媣2, 愳媣曐曕2, 墶娭梇巌2, 撪揷寬懢榊1, 堜忋丂尯1, 崅憡徎巑1: 1惍奜, 2戝妛堾堛椕宯尋媶壢)
713041. [妛夛 (崙嵺)] (堦斒島墘) Poor general condition, low trunk muscle mass, and spinal sagittal imbalance affect the health-related quality of life in osteoporosis patients. Koyama T1, Miyagi M2, Murata K1, Kuroda A1, Kawakubo A1, Ohtori S, Inage K, Uhida K2, Inoue G2, Takaso M2: The World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases 2020 (WCO-IOF-ESCEO 2020) (2020/8/20-22), Web奐嵜. (彫嶳抭媣1, 媨忛惓峴2, 懞揷岾桟1, 崟揷峎媊1, 愳媣曐曕1, 撪揷寬懢榊2, 堜忋丂尯2, 崅憡徎巑2: 1戝妛堾堛椕宯尋媶壢, 2惍奜)
721018. [妛夛 (慡崙)] (摿暿島墘) Vertebral osteotomy in patients with adult spinal deformity. 堜忋丂尯 (惍奜): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/8), 恄屗 (僴僀僽儕僢僪奐嵜).
721019. [妛夛 (慡崙)] (摿暿島墘) 儕僂儅僠惈幘姵偵惗偠偨恖岺屢娭愡廃埻姶愼偺帯椕. 撪嶳彑暥1, 抮揷怣夘2, 怷扟岝弐2, 暉搰寬夘2, 崅暯彯怢3, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3堛椕塹惗妛晹): 戞49夞擔杮儕僂儅僠偺奜壢妛夛 (2020/9/11), Web奐嵜.
721020. [妛夛 (慡崙)] (摿暿島墘) Avenir Complete: Full HA coated stem偺僨僓僀儞僐儞僙僾僩偲椪彴宱尡. 暉搰寬夘 (惍奜): 戞47夞擔杮屢娭愡妛夛妛弍廤夛 (2020/10/24), 巐擔巗 (僴僀僽儕僢僪奐嵜).
722085. [妛夛 (慡崙)] (彽懸島墘摍) 曐懚椕朄偲屢娭愡嬀帇壓庤弍. 暉搰寬夘1, 彫嶳抭媣2, 戝嫶宑媣2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 戞93夞擔杮惍宍奜壢妛夛妛弍憤夛 (2020/6/11-8/31), Web奐嵜.
722086. [妛夛 (慡崙)] (彽懸島墘摍) 摨庬崪傪梡偄偨恖岺屢娭愡抲嵞抲姺弍偺婎杮庤媄. 撪嶳彑暥1, 暉搰寬夘2, 怷扟岝弐2, 崅暯彯怢3, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3堛椕塹惗妛晹): 戞93夞擔杮惍宍奜壢妛夛妛弍憤夛 (2020/6/11-8/31), Web奐嵜,擔杮惍宍奜壢妛夛帍彺榐廤 p. S391.
722087. [妛夛 (慡崙)] (彽懸島墘摍) 崙嵺僐儞僙儞僒僗偺傢偑崙偱偺墳梡. 嶳揷峗巌, 揷拞峃恗, 搚壆峅峴, 堫梩丂桾, 彫椦捈幚, 浟丂尗柉, 怷堜寬巌, 撪嶳彑暥1, 堜忋戝曘, 徏壓榓旻 (1堛椕埨慡丒娗棟): 戞93夞擔杮惍宍奜壢妛夛妛弍憤夛 (2020/6/11-8/31), Web奐嵜,擔杮惍宍奜壢妛夛帍 p. S477.
722088. [妛夛 (慡崙)] (彽懸島墘摍) 屢娭愡PJI偺帯椕偺岺晇. 撪嶳彑暥1, 抮揷怣夘2, 怷扟岝弐2, 暉搰寬夘2, 崅暯彯怢3, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3堛椕塹惗妛晹): 戞93夞擔杮惍宍奜壢妛夛妛弍憤夛 (2020/6/11-8/31), Web奐嵜,戞93夞擔杮惍宍奜壢妛夛妛弍憤夛彺榐廤嘦 p. S602.
722089. [妛夛 (慡崙)] (彽懸島墘摍) 崪愗傝弍偵偍偗傞嫺惓憖嶌偱惗偠偨恄宱懝彎偺専摙. 堜忋丂尯1, 堜懞婱擵1, 媨忛惓峴1, 陰摗丂榡1, 敀郪塰庽1, 愳媣曐曕2, 拞郪弐擵1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞10夞擔杮惉恖愐拰曄宍妛夛 (2020/8/15), 柤屆壆 (僴僀僽儕僢僪奐嵜).
722090. [妛夛 (慡崙)] (彽懸島墘摍) 惉恖愐拰曄宍偵偍偗傞崪慹闋徢帯椕偺枹棃. 媨忛惓峴 (惍奜): 戞10夞擔杮惉恖愐拰曄宍妛夛 (2020/8/15), 柤屆壆 (僴僀僽儕僢僪奐嵜).
722091. [妛夛 (慡崙)] (彽懸島墘摍) 崪慹闋徢姵幰偺""崢嬋偑傝""偲崢捝. 媨忛惓峴1, 崅憡徎巑1 (1惍奜): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/7), 恄屗 (僴僀僽儕僢僪奐嵜).
722092. [妛夛 (慡崙)] (彽懸島墘摍) 屢娭愡傪拞怱偲偟偨嶰師尦傾儔僀儊儞僩Hip-Spine-Knee. 媨忛惓峴1, 暉搰寬夘1, 撪嶳彑暥2, 堜忋丂尯1, 拞郪弐擵1, 堜懞婱擵1, 陰摗丂榡1, 敀郪塰庽1, 崅暯彯怢3, 崅憡徎巑1 (1惍奜, 2堛椕埨慡丒娗棟, 3堛椕塹惗妛晹): 戞47夞擔杮屢娭愡妛夛妛弍廤夛 (2020/10/23), 巐擔巗 (僴僀僽儕僢僪奐嵜).
722093. [妛夛 (慡崙)] (彽懸島墘摍) 愐捙庤弍偵偍偗傞弌寣掅尭偺岺晇. 堜忋丂尯 (惍奜): 戞29夞擔杮愐捙僀儞僗僩僁儖儊儞僥乕僔儑儞妛夛 (2020/11/18), Web奐嵜.
722094. [妛夛 (慡崙)] (彽懸島墘摍) Surgical technique and clinical results for patients of Femoroacetabular impingement syndrome (FAIS). 暉搰寬夘1, 戝嫶宑媣2, 彫嶳抭媣2, 崅暯彯怢3, 撪嶳彑暥4, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹, 4堛椕埨慡丒娗棟): 戞12夞擔杮娭愡嬀丒旼丒僗億乕僣惍宍奜壢妛夛/戞46夞擔杮惍宍奜壢僗億乕僣堛妛夛妛弍廤夛崌摨妛夛 (JOSKAS-JOSSM 2020) (2020/12/17), 恄屗 (僴僀僽儕僢僪奐嵜).
722095. [妛夛 (慡崙)] (彽懸島墘摍) 恖岺娭愡弍屻姶愼徢偺憗婜専弌偺偨傔偺僶僀僆儅乕僇乕偲PCR朄亅MPO偲Tm mapping朄亅. 撪嶳彑暥1, 抮揷怣夘2, 烴堜宑憿3, 恗堜尒塸庽, 曱娸梞師榊2, 怷扟岝弐2, 暉搰寬夘2, 崅暯彯怢4, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3椪専晹, 4堛椕塹惗妛晹): 戞43夞擔杮崪丒娭愡姶愼徢妛夛 (2020/12/25), Web奐嵜.
722096. [妛夛 (慡崙)] (彽懸島墘摍) 崪丒娭愡姶愼徢弍屻 SSI梊杊偺偨傔偺庤弍婡婍庢傝埖偄忋偺拲堄揰. 撪嶳彑暥1, 暉搰寬夘2, 怷扟岝弐2, 抮揷怣夘2, 搉绯丂揙, 嬥尨弮巌3, 崅暯彯怢4, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3娕岇晹, 4堛椕塹惗妛晹): 戞43夞擔杮崪丒娭愡姶愼徢妛夛 (2020/12/26), Web奐嵜.
723411. [妛夛 (慡崙)] (堦斒島墘) 娭愡儕僂儅僠偺娪暿偵偍偔傋偒庤晹旕寢妀惈峈巁嬠徢亅帯椕奐巒傑偱婜娫傪梫偟偨嫵堢揑側2徢椺亅. 戝抾桰嵠1, 彆愳峗巑1, 墶娭梇巌2, 媨揷丂庽1, 挰揷廃暯1, 娾悾丂戝1, 尒栚抭婭1, 彫徖尗帯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞93夞擔杮惍宍奜壢妛夛妛弍憤夛 (2020/6/11-8/31), Web奐嵜.
723412. [妛夛 (慡崙)] (堦斒島墘) 曣巜CM娭愡徢偵懳偡傞儘僢僉儞僌僾儗乕僩傪巊梡偟偨曣巜CM娭愡屌掕弍偺帯椕宱尡. 彫徖尗帯1, 彆愳峗巑1, 戝抾桰嵠1, 尒栚抭婭1, 崅憡徎巑1 (1惍奜): 戞93夞擔杮惍宍奜壢妛夛妛弍憤夛 (2020/6/11-8/31), Web奐嵜.
723413. [妛夛 (慡崙)] (堦斒島墘) 愐拰栴忬柺傾儔僀儊儞僩偵塭嬁傪梌偊傞場巕偺専摙丂嬝検丒嬝椡掅壓偑愐拰栴忬柺傾儔僀儊儞僩堎忢偵娭梌偡傞. 媨忛惓峴1, 惎栰夒弐, 堫栄堦廏, 懞揷岾桟2, 彫嶳抭媣2, 愳媣曐曕2, 杧丂桰夘, 愜揷弮媣, 堜忋丂尯1, 戝捁惛巌, 拞懞攷椇, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞93夞擔杮惍宍奜壢妛夛妛弍憤夛 (2020/6/11-8/31), Web奐嵜.
723414. [妛夛 (慡崙)] (堦斒島墘) 壛楊惈嬝擏尭彮徢僒儖僐儁僯傾傪崌暪偟偨尨敪惈崪慹闋徢姵幰偺摿挜. 栴栰攷擵1, 媨忛惓峴1, 懞揷岾桟2, 彫嶳抭媣2, 戝捁惛巌, 堫栄堦廏, 娭岥桾擵1, 撪揷寬懢榊1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞93夞擔杮惍宍奜壢妛夛妛弍憤夛 (2020/6/11-8/31), Web奐嵜.
723415. [妛夛 (慡崙)] (堦斒島墘) 崅楊幰屻淽徢偵懳偡傞儗僕僗僞儞僗僩儗乕僯儞僌偺桳岠惈偵娭偡傞専摙. 堫栄堦廏, 媨忛惓峴1, 峕岥丂榓, 搉绮塸堦榊, 朙岥丂摟, 悪塝巎榊, 愜揷弮媣, 巙夑峃峗, 戝捁惛巌 (1惍奜): 戞93夞擔杮惍宍奜壢妛夛妛弍憤夛 (2020/6/11-8/31), Web奐嵜.
723416. [妛夛 (慡崙)] (堦斒島墘) 屢娭愡庤弍姵幰偵偍偗傞拞悤惈姶嶌偺懚嵼. 戝嫶宑媣1, 暉搰寬夘2, 堜忋丂尯2, 媨忛惓峴2, 撪揷寬懢榊2, 彫嶳抭媣1, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 戞93夞擔杮惍宍奜壢妛夛妛弍憤夛 (2020/6/11-8/31), Web奐嵜.
723417. [妛夛 (慡崙)] (堦斒島墘) 崢晹愐拰娗嫹嶓徢庤弍偵偍偗傞嬝擏検偺塭嬁偺専摙. 愳媣曐曕1, 媨忛惓峴2, 拞郪弐擵2, 堜懞婱擵2, 釼摗丂榡2, 敀郪塰庽2, 戝捁惛巌, 堫栄堦廏, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞93夞擔杮惍宍奜壢妛夛妛弍憤夛 (2020/6/11-8/31), Web奐嵜.
723418. [妛夛 (慡崙)] (堦斒島墘) 旕惗懱摨庬挵泺恱懷傪梡偄偨奜彎惈慜榬夞慁忈奞偺帯椕宱尡亅奜彎惈烎広崪桙崌徢偺2椺亅. 戝抾桰嵠1, 彆愳峗巑1, 彫徖尗帯1, 墶娭梇巌2, 媨揷丂庽1, 挰揷廃暯1, 娾悾丂戝1, 尒栚抭婭1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞63夞擔杮庤奜壢妛夛妛弍廤夛 (2020/6/25-8/17), Web奐嵜.
723419. [妛夛 (慡崙)] (堦斒島墘) 忋榬晹烎崪恄宱偺憱峴偲忋榬嶰摢嬝奜懁摢銯亅奜懁嬝娫拞妘暋崌懱偺娭學惈. 彆愳峗巑1, 斞揷浠梌, 彫徖尗帯1, 戝抾桰嵠1, 栚帪桳婓宐1, 嬍栘塸柧2, 彫愳尦擵3, 崅憡徎巑1 (1惍奜, 2椪彴夝朥嫵堢, 3夝朥): 戞63夞擔杮庤奜壢妛夛妛弍廤夛 (2020/6/25-8/17), Web奐嵜.
723420. [妛夛 (慡崙)] (堦斒島墘) 愐拰栴忬柺傾儔僀儊儞僩堎忢, 懱姴嬝検掅壓偑崪慹闋徢姵幰偺寬峃娭楢QOL偵塭嬁傪媦傏偡. 媑揷捈恖1, 彫嶳抭媣2, 媨忛惓峴1, 懞揷岾桟2, 愳媣曐曕2, 戝捁惛巌, 堫栄堦廏, 陰摗丂榡1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞10夞擔杮惉恖愐拰曄宍妛夛 (2020/8/15), 柤屆壆 (僴僀僽儕僢僪奐嵜).
723421. [妛夛 (慡崙)] (堦斒島墘) Development of general check-up system using smartphone application to detect the adolescent idiopathic scoliosis. 堜忋丂尯1, 媨忛惓峴1, 陰摗丂榡1, 堜懞婱擵1, 彫扟弐柧, 愒郪丂搘, 嵅媣娫婤, 捁嫃椙徍, 堫栄堦廏, 拞嶳宧懢, 斞搰丂桋, 斞徖夒墰, 墦摗垷嵐巕, 敀郪塰庽1, 拞郪弐擵1, 崅憡徎巑1 (1惍奜): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/8), 恄屗 (僴僀僽儕僢僪奐嵜).
723422. [妛夛 (慡崙)] (堦斒島墘) Radiological and clinical results of corrective surgery for spinal deformity in patients with Parkinson disease. 堜忋丂尯1, 陰摗丂榡1, 媨忛惓峴1, 堜懞婱擵1, 敀郪塰庽1, 崟揷峎媊2, 愳媣曐曕2, 墶娭梇巌2, 拞郪弐擵1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/8), 恄屗 (僴僀僽儕僢僪奐嵜).
723423. [妛夛 (慡崙)] (堦斒島墘) 恄宱嬝尨惈愐拰懁淽徢庤弍偵偍偗傞廃弍婜崌暪徢偺専摙 (戞2曬). 媨忛惓峴1, 徏杮岝孿1, 釼摗丂榡1, 堜懞婱擵1, 堜忋丂尯1, 拞郪弐擵1, 敀郪塰庽1, 崟揷峎媊2, 愳媣曐曕2, 墶娭梇巌2, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/7-9), 恄屗 (僴僀僽儕僢僪奐嵜).
723424. [妛夛 (慡崙)] (堦斒島墘) GFP崪悜僉儊儔儅僂僗傪梡偄偨捙娫斅彎奞屻偵憹壛偡傞儅僋儘僼傽乕僕偺婲尮夝愅. 愳媣曐曕1, 撪揷寬懢榊2, 媨忛惓峴2, 拞榚廩復2, 拞郪弐擵2, 堜懞婱擵2, 釼摗丂榡2, 敀郪塰庽2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/7-9), 恄屗 (僴僀僽儕僢僪奐嵜).
723425. [妛夛 (慡崙)] (堦斒島墘) 崢晹愐拰娗嫹嶓徢庤弍偵偍偗傞嬝擏検偺塭嬁偺専摙. 愳媣曐曕1, 媨忛惓峴2, 拞郪弐擵2, 堜懞婱擵2, 釼摗丂榡2, 敀郪塰庽2, 戝捁惛巌, 堫栄堦廏, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/7-9), 恄屗 (僴僀僽儕僢僪奐嵜).
723426. [妛夛 (慡崙)] (堦斒島墘) 彫帣懁淽徢庤弍偵偍偗傞弍拞掅懱壏徢偺儕僗僋場巕. 釼摗丂榡1, 堜忋丂尯1, 媨忛惓峴1, 堜懞婱擵1, 敀郪塰庽1, 拞郪弐擵1, 崅憡徎巑1 (1惍奜): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/7-9), 恄屗 (僴僀僽儕僢僪奐嵜).
723427. [妛夛 (慡崙)] (堦斒島墘) 彫帣婜懁淽徢庤弍偵偍偗傞奺庤弍庤媄抜奒偱偺寣塼懝幐偺専摙. 敀郪塰庽1, 釼摗丂榡1, 堜忋丂尯1, 媨忛惓峴1, 堜懞婱擵1, 拞郪弐擵1, 崅憡徎巑1 (1惍奜): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/7-9), 恄屗 (僴僀僽儕僢僪奐嵜).
723428. [妛夛 (慡崙)] (堦斒島墘) 僋儔僗僞乕夝愅傪梡偄偨愐拰栴忬柺傾儔僀儊儞僩偺暘椶: 愐捙奜棃姵幰1,378椺偱偺専摙. 杧丂桰夘, 朙揷岹岝, 惎栰夒弐, 崅嫶恀帯, 戝嶳隳堦楴, 楅栘嫓挩, 捯旜桞梇, 帥堜廏晉, 摪墍丂彨, 堫栄堦廏, 愜揷弮媣, 媨忛惓峴1, 堜忋丂尯1, 戝捁惛巌, 崅憡徎巑1, 拞懞攷椇 (1惍奜): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/7-9), 恄屗 (僴僀僽儕僢僪奐嵜).
723429. [妛夛 (慡崙)] (堦斒島墘) 摨庬崪扨撈偱峴偭偨懁曽恑擖崢捙捙懱娫屌掕弍偺崪桙崌棪. 堜懞婱擵1, 堜忋丂尯1, 拞郪弐擵1, 釼摗丂榡1, 媨忛惓峴1, 敀郪塰庽1, 崅憡徎巑1 (1惍奜): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/7-9), 恄屗 (僴僀僽儕僢僪奐嵜).
723430. [妛夛 (慡崙)] (堦斒島墘) 崅僄僱儖僊乕奜彎偵傛傞愬崪晄埨掕宆崪愜偵懳偡傞掅怤廝屻曽屌掕弍偺桳梡惈. 墶娭梇巌1, 媨忛惓峴2, 堜懞婱擵2, 釼摗丂榡2, 敀郪塰庽2, 摗栰彲懢榊2, 拞郪弐擵2, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/7-9), 恄屗 (僴僀僽儕僢僪奐嵜).
723431. [妛夛 (慡崙)] (堦斒島墘) 僗儅乕僩僼僅儞傾僾儕傪梡偄偨懁淽徢専恌僔僗僥儉偺奐敪. 堜忋丂尯1, 媨忛惓峴1, 釼摗丂榡1, 堜懞婱擵1, 彫扟弐柧, 愒郪丂搘, 嵅媣娫婤, 捁嫃椙徍, 堫栄堦廏, 拞嶳宧懢, 斞搰丂桋, 斞徖夒墰, 墦摗垷嵐巕, 敀郪塰庽1, 拞郪弐擵1, 崅憡徎巑1 (1惍奜): 戞49夞擔杮愐捙愐悜昦妛夛妛弍廤夛 (2020/9/7-9), 恄屗 (僴僀僽儕僢僪奐嵜).
723432. [妛夛 (慡崙)] (堦斒島墘) 崪慹闋徢姵幰偺枬惈崢捝偵懳偡傞僨儏儘僉僙僠儞墫巁墫偺桳岠惈偲埨慡惈. 媨忛惓峴1, 懞揷岾桟2, 彫嶳抭媣2, 崟揷峎媊2, 愳媣曐曕2, 墶娭梇巌2, 嶰懞桰夘1, 恀暻婎庽1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞22夞擔杮崪慹闋徢妛夛 (2020/10/9-11), Web奐嵜.
723433. [妛夛 (慡崙)] (堦斒島墘) 崪慹闋徢姵幰偵偍偗傞堓怘摴媡棳徢忬偲愐拰栴忬柺傾儔僀儊儞僩堎忢. 媑郪丂懽1, 徏杮岝孿1, 晲堜惓堦榊1, 媨忛惓峴1, 懞揷岾桟2, 彫嶳抭媣2, 愳媣曐曕2, 撪揷寬懢榊1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞22夞擔杮崪慹闋徢妛夛 (2020/10/9-11), Web奐嵜.
723434. [妛夛 (慡崙)] (堦斒島墘) 崪慹闋徢姵幰偵偍偗傞塰梴忬懺偲崪幙儅乕僇乕丒儁儞僩僔僕儞, 儂儌僔僗僥僀儞抣偺娭學. 愇堜戝曘1, 媨忛惓峴1, 懞揷岾桟2, 彫嶳抭媣2, 愳媣曐曕2, 崟揷峎媊2, 墶娭梇巌2, 恀暻婎庽1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞22夞擔杮崪慹闋徢妛夛 (2020/10/9-11), Web奐嵜.
723435. [妛夛 (慡崙)] (堦斒島墘) 崪慹闋徢姵幰偵偍偗傞捙懱崪愜偺婋尟場巕偺専摙丂壓埵崢捙崪愜偵拝栚偟偰. 媨揷丂庽1, 媨忛惓峴1, 墶娭梇巌2, 懞揷岾桟2, 彫嶳抭媣2, 崟揷峎媊2, 愳媣曐曕2, 恀暻婎庽1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞22夞擔杮崪慹闋徢妛夛 (2020/10/9-11), Web奐嵜.
723436. [妛夛 (慡崙)] (堦斒島墘) 愐拰栴忬柺傾儔僀儊儞僩堎忢偲懱姴嬝検掅壓偑崪慹闋徢姵幰偵偍偗傞崢捝偵娭梌偡傞. 懞忋岍懃1, 媨忛惓峴1, 懞揷岾桟2, 彫嶳抭媣2, 愳媣曐曕2, 嶰懞桰桟1, 堫栄堦廏, 戝搰惛巌, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞22夞擔杮崪慹闋徢妛夛 (2020/10/9-11), Web奐嵜.
723437. [妛夛 (慡崙)] (堦斒島墘) 廳徢崪慹闋徢姵幰偵懳偡傞儘儌僜僘儅僽搳梌偺抁婜惉愌. 懞揷岾桟1, 媨忛惓峴2, 暉搰愰柧, 彫椦柧惓, 崅栰徃懢榊2, 彫嶳抭媣1, 崟揷峎媊1, 愳媣曐曕1, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞22夞擔杮崪慹闋徢妛夛 (2020/10/9-11), Web奐嵜.
723438. [妛夛 (慡崙)] (堦斒島墘) 崪慹闋徢拲幩嵻偑恡婡擻偵梌偊傞塭嬁偵娭偡傞専摙. 恄晹抭旻1, 媨忛惓峴1, 懞揷岾桟2, 彫嶳抭媣2, 崟揷峎媊2, 愳媣曐曕2, 墶娭梇巌2, 恀暻婎庽1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞22夞擔杮崪慹闋徢妛夛 (2020/10/9-11), Web奐嵜.
723439. [妛夛 (慡崙)] (堦斒島墘) 恖岺娭愡廃埻姶愼偵偍偗傞尨場嬠庬摨掕偺偨傔偺Tm mapping朄偵傛傞嬠悢掕検朄偺専摙. 撪嶳彑暥1, 烴堜宑憿2, 恗堜尒塸庽, 抮揷怣夘3, 暉搰寬夘3, 怷扟岝弐3, 崅暯彯怢4, 崅憡徎巑3 (1堛椕埨慡丒娗棟, 2椪専晹, 3惍奜, 4堛椕塹惗妛晹): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/16), Web奐嵜,擔杮惍宍奜壢妛夛婎慴妛弍廤夛丂彺榐廤p.55
723440. [妛夛 (慡崙)] (堦斒島墘) 捙娫斅彎奞屻偺M1, M2儅僋儘僼傽乕僕偺婲尮偺夝愅. 愳媣曐曕1, 撪揷寬懢榊2, 媨忛惓峴2, 拞榚廩復2, 堜忋丂尯2, 釼摗 榡2, 娭岥桾擵2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723441. [妛夛 (慡崙)] (堦斒島墘) CD206梲惈捙娫斅撪嵼惈儅僋儘僼傽乕僕偼尭彮偡傞. 愳媣曐曕1, 撪揷寬懢榊2, 媨忛惓峴2, 拞榚廩復2, 堜忋丂尯2, 釼摗 榡2, 娭岥桾擵2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723442. [妛夛 (慡崙)] (堦斒島墘) 曄宍惈旼娭愡徢姵幰偺妸枌慻怐偵偍偗傞Peptide Lv偺敪尰偲醬捝傊偺娭梌偺専摙. 寎丂丂妛1, 撪揷寬懢榊2, 崅栰徃懢榊2, 崅揷丂尋1, 娾悾丂戝2, 憡愳丂弤2, 戝娧桾巕3, 娭岥桾擵2, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3昦懺丒恌椕宯): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723443. [妛夛 (慡崙)] (堦斒島墘) 僶儞僐儅僀僔儞娷桳儕儞巁僇儖僔僂儉僙儊儞僩偼杽擖屻6僇寧偵搉傝惗懱撪偱偺彊曻摿惈偲峈嬠妶惈傪堐帩偟偰偄傞. 寎丂丂妛1, 撪揷寬懢榊2, 悰惗丂寬, 拞搰晲旻, 憡愳丂弤2, 娾悾丂戝2, 崅栰徃懢榊2, 娭岥桾擵2, 崅憡徎巑2, 愯晹丂寷2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723444. [妛夛 (慡崙)] (堦斒島墘) TNF-兛偼捙娫斅慻怐撪偺iNOS敪尰傪惂屼偟偰偄傞. 拞榚廩復1, 撪揷寬懢榊1, 愳媣曐曕2, 媨忛惓峴1, 戝媣曐捈3, 墶娭梇巌2, 娭岥桾擵1, 堜忋丂尯1, 釼摗丂榡1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3幚摦): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723445. [妛夛 (慡崙)] (堦斒島墘) 暃峛忬態儂儖儌儞搳梌偼崪慹闋徢儌僨儖儅僂僗偵偍偗傞NGF忋徃傪梷惂偡傞. 懞揷岾桟1, 撪揷寬懢榊2, 媨忛惓峴2, 揷郪丂椚2, 堜忋丂尯2, 彫嶳抭媣1, 愳媣曐曕1, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723446. [妛夛 (慡崙)] (堦斒島墘) 旍枮傪敽偆曄宍惈旼娭愡徢姵幰偺妸枌慻怐偱偼CD5L偑憹壛偡傞. 彲巌恀懢榊1, 撪揷寬懢榊2, 堜忋丂尯2, 崅揷丂尋1, 寎丂丂妛1, 憡愳丂弤2, 娾悾丂戝2, 崅栰徃懢榊2, 娭岥桾擵2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723447. [妛夛 (慡崙)] (堦斒島墘) 壛楊偵敽偆嬝慻怐偵偍偗傞Apelin庴梕懱敪尰偺掅壓偵偼TNF-兛偑娭梌偡傞. 彫嶳抭媣1, 撪揷寬懢榊2, 媨忛惓峴2, 揷郪丂椚2, 堜忋丂尯2, 摗姫庻巕, 戝嫶宑媣1, 娭岥桾擵2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723448. [妛夛 (慡崙)] (堦斒島墘) 曄宍惈屢娭愡徢姵幰偵偍偗傞CD163偲埨惷帪捝偺娭楢. 戝嫶宑媣1, 暉搰寬夘2, 撪揷寬懢榊2, 彫嶳抭媣1, 撪嶳彑暥3, 崅暯彯怢4, 戝娧桾巕5, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹, 5昦懺丒恌椕宯): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723449. [妛夛 (慡崙)] (堦斒島墘) 峣漀惈恄宱忈奞儌僨儖儔僢僩偺枛徑恄宱偵偍偗傞Apelin偺敪尰摦懺偺専摙. 墶娭梇巌1, 撪揷寬懢榊2, 岦堜峎柋, 淎郪捈栫, 堜忋丂尯2, 媨忛惓峴2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723450. [妛夛 (慡崙)] (堦斒島墘) 曄宍惈旼娭愡徢偺妸枌慻怐偵偍偗傞Adrenomedullin偲旍枮嵶朎偲偺娭楢惈偺専摙. 崅栰徃懢榊1, 撪揷寬懢榊1, 崅揷丂尋2, 寎丂丂妛2, 憡愳丂弤1, 娾悾丂戝1, 堜忋丂尯1, 戝娧桾巕3, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3昦懺丒恌椕宯): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723451. [妛夛 (慡崙)] (堦斒島墘) 捙娫斅慻怐偵偍偗傞恄宱惉挿場巕偺敪尰惂屼婡峔偺専摙. 墶娭梇巌1, 撪揷寬懢榊2, 愳媣曐曕1, 媨忛惓峴2, 戝媣曐捈3, 拞榚廩復2, 堜忋丂尯2, 釼摗丂榡2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3幚摦): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723452. [妛夛 (慡崙)] (堦斒島墘) Peptide Lv偼捙娫斅彎奞屻偺Macrophage polarization傪惂屼偡傞. 撪揷寬懢榊1, 愳媣曐曕2, 戝媣曐捈3, 媨忛惓峴1, 堜忋丂尯1, 墶娭梇巌2, 寎丂丂妛2, 娭岥桾擵1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3幚摦): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723453. [妛夛 (慡崙)] (堦斒島墘) 娭愡儕僂儅僠姵幰偱偼妸枌慄堐夎嵶朎偵偍偗傞C宆儗僋僠儞庴梕懱Macrophage inducible C-type lectin偺敪尰偼槾恑偟偰偄傞. 崅揷 丂尋1, 撪揷寬懢榊2, 崅栰徃懢榊2, 娾悾丂戝2, 堜忋丂尯2, 媨忛惓峴2, 憡愳丂弤2, 娭岥桾擵2, 戝娧桾巕3, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3昦懺丒恌椕宯): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723454. [妛夛 (慡崙)] (堦斒島墘) 嫄戝崪寚懝偵懳偡傞BMP-2娷桳恖岺僐儔乕僎儞僎儖偺桳岠惈偺専摙. 揷郪丂椚1, 撪揷寬懢榊1, 曯尨岹徆, 徏塝峎惓2, 壨懞丂捈1, 堜忋丂尯1, 彲巌恀懢榊3, 嶁岥幍奀, 戝娧桾巕4, 崅憡徎巑1 (1惍奜, 2媬柦, 3戝妛堾堛椕宯尋媶壢, 4昦懺丒恌椕宯): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723455. [妛夛 (慡崙)] (堦斒島墘) BMP-2娷桳嬊強峝壔僸傾儖儘儞巁僎儖傪梡偄偨擄帯惈崪愜帯椕朄偺桳梡惈. 彲巌恀懢榊1, 撪揷寬懢榊2, 娭岥桾擵2, 堜忋丂尯2, 釼摗丂榡2, 媨忛惓峴2, 懞揷岾桟1, 愳媣曐曕1, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723456. [妛夛 (慡崙)] (堦斒島墘) 庤崻娗徢岓孮姵幰偺妸枌壓寢崌慻怐偵偍偗傞HIF-1兛敪尰偲慄堐壔娭楢場巕偲偺娭楢惈偺専摙. 墶娭梇巌1, 撪揷寬懢榊2, 拞榚廩復2, 彫徖尗帯2, 彆愳峗巑2, 尒栚抭婭2, 戝娧桾巕3, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3昦懺丒恌椕宯): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723457. [妛夛 (慡崙)] (堦斒島墘) 彈惈偺曄宍惈旼娭愡徢姵幰偺妸枌慻怐偱偼抝惈偵斾傋僇儖僔僩僯儞堚揱巕娭楢儁僾僠僪庴梕懱RAMP1偺敪尰偑崅偄. 撪揷寬懢榊1, 崅栰徃懢榊1, 崅揷丂尋2, 寎丂丂妛2, 憡愳丂弤1, 娾悾丂戝1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723458. [妛夛 (慡崙)] (堦斒島墘) 彈惈庤崻娗徢岓孮姵幰偺妸枌壓寢崌慻怐偱偼COL3A1偺敪尰偑槾恑偟偰偄傞. 崟揷峎媊1, 墶娭梇巌1, 撪揷寬懢榊2, 拞榚廩復2, 彫徖尗帯2, 彆愳峗巑2, 尒栚抭婭2, 戝娧桾巕3, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜, 3昦懺丒恌椕宯): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723459. [妛夛 (慡崙)] (堦斒島墘) 儔僢僩恄宱懝彎儌僨儖偵懳偡傞platelet-rich plasma揧壛僐儔乕僎儞僔乕僩偺捝妎夁晀梷惂岠壥偲偦偺婡彉偵娭偡傞専摙. 岦堜柋峎, 撪揷寬懢榊1, 巙夑峃峗, 堫栄堦廏, 愜揷弮媣, 徏塝桟夘, 峕岥丂榓, 媨忛惓峴1, 堜忋丂尯1, 崅憡徎巑1, 戝捁惛巌 (1惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723460. [妛夛 (慡崙)] (堦斒島墘) 儔僢僩嵖崪恄宱懝彎儌僨儖偵懳偡傞椻搥曐懚偟偨vein 偵傛傞wrapping偺捝妎夁晀梷惂岠壥偲heme oxygenase-1 (HO-1) 桿摫擻偺専摙. 岦堜柋峎, 撪揷寬懢榊1, 巙夑峃峗, 堫栄堦廏, 愜揷弮媣, 徏塝桟夘, 峕岥丂榓, 媨忛惓峴1, 堜忋丂尯1, 崅憡徎巑1, 戝捁惛巌 (1惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723461. [妛夛 (慡崙)] (堦斒島墘) Chronic constriction injury (CCI) 儌僨儖偵懳偡傞彍埑弍屻偺T嵶朎偺曄壔偵娭偡傞専摙. 岦堜柋峎, 撪揷寬懢榊1, 巙夑峃峗, 堫栄堦廏, 愜揷弮媣, 徏塝桟夘, 峕岥丂榓, 堜忋丂尯1, 崅憡徎巑1, 戝捁惛巌 (1惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723462. [妛夛 (慡崙)] (堦斒島墘) 椉懁壓巿CT夋憸傪梡偄偨曄宍惈旼娭愡徢偵偍偗傞曅懁惈偺嬝検曄壔偺専摙. 寎丂丂妛1, 撪揷寬懢榊2, 捤揷垷桽旤2, 憡愳丂弤2, 娾悾丂戝2, 崅栰徃懢榊2, 媨忛惓峴2, 娭岥桾擵2, 堜忋 尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723463. [妛夛 (慡崙)] (堦斒島墘) 崪慹闋徢偵敽偆崢捝偵懳偡傞 Weekly PTH惢嵻偺桳岠惈. 懞揷岾桟1, 媨忛惓峴2, 彫嶳抭媣1, 愳媣曐曕1, 徏杮岝孿2, 暷揷徆峀2, 崅壀弮堦2, 撪揷寬懢榊2, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723464. [妛夛 (慡崙)] (堦斒島墘) 崪慹闋徢姵幰偵偍偗傞塰梴忬懺偲儁儞僩僔僕儞, 儂儌僔僗僥僀儞抣偺娭學. 媨忛惓峴1, 撪揷寬懢榊1, 懞揷岾桟2, 彫嶳抭媣2, 愳媣曐曕2, 崟揷峎媊2, 墶娭梇巌2, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723465. [妛夛 (慡崙)] (堦斒島墘) Schwann嵶朎桼棃僄僋僜僜乕儉偑TNF兛偺 乬decoy乭偲偟偰嶌梡偡傞. 淎郪捈栫, Wendy Campana, Hyojun Kwon, 撪揷寬懢榊1, 棊崌怣桋, 嫶杮塴巕, 峕岥丂榓, 戝捁惛巌 (1惍奜): 戞35夞擔杮惍宍奜壢妛夛婎慴妛弍廤夛 (2020/10/15-16), Web奐嵜.
723466. [妛夛 (慡崙)] (堦斒島墘) 惉恖愐拰曄宍庤弍偵偍偗傞LLIF働乕僕偱惗偠傞廔斅懝彎偵娭偡傞専摙. 堜忋丂尯1, 釼摗丂榡1, 敀郪塰庽1, 媨忛惓峴1, 堜懞婱擵1, 嶰懞桰桽1, 愳媣曐曕2, 崟揷峎媊2, 墶娭梇巌2, 拞郪弐擵1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞29夞擔杮愐捙僀儞僗僩僁儖儊儞僥乕僔儑儞妛夛 (2020/10/24), Web奐嵜.
723467. [妛夛 (慡崙)] (堦斒島墘) 崪慹闋徢姵幰偺枬惈崢捝偵懳偡傞僨儏儘僉僙僠儞墫巁墫偺岠壥. 媨忛惓峴1, 懞揷岾桟2, 彫嶳抭媣2, 崟揷峎媊2, 愳媣曐曕2, 墶娭梇巌2, 嶰懞桰夘1, 恀暻婎庽1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞28夞擔杮崢捝妛夛 (2020/10/30-11/29), Web奐嵜.
723468. [妛夛 (慡崙)] (堦斒島墘) 巚弔婜摿敪惈懁淾徢姵幰偵懳偡傞屻曽嫺惓屌掕弍偵偍偗傞弍拞憤弌寣検. 敀郪塰庽1, 陰摗丂榡1, 媨忛惓峴1, 堜忋丂尯1, 堜懞婱擵1, 拞郪弐擵1, 崟揷峎媊2, 愳媣曐曕2, 墶娭梇巌2, 嶰懞桰桽1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞54夞擔杮懁淽徢妛夛 (2020/11/6-8), Web奐嵜.
723469. [妛夛 (慡崙)] (堦斒島墘) Cluster 夝愅傪梡偄偨愐拰栴忬柺傾儔僀儊儞僩偺暘椶:愐捙奜棃姵幰1,378椺偱偺専摙. 杧丂桰夘, 朙揷岹岝, 惎栰夒弐, 崅嫶恀帯, 戝嶳隳堦楴, 楅栘嫓挩, 帥堜廏晉, 堫栄堦廏, 愜揷弮媣, 媨忛惓峴1, 堜忋丂尯1, 戝捁惛巌, 崅憡徎巑1, 拞懞攷椇 (1惍奜): 戞54夞擔杮懁淽徢妛夛 (2020/11/6-8), Web奐嵜.
723470. [妛夛 (慡崙)] (堦斒島墘) Type1 AIS偵偍偗傞弍慜CT偱偺弍拞儘僢僪挿偺惓妋側梊應曽朄偺専摙. 愳媣曐曕1, 釼摗丂榡2, 拞郪弐擵2, 堜懞婱擵2, 媨忛惓峴2, 敀郪塰庽2, 堜忋丂尯2, 崅憡徎巑2 (1戝妛堾堛椕宯尋媶壢, 2惍奜): 戞54夞擔杮懁淽徢妛夛 (2020/11/6-8), Web奐嵜.
731023. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 崢捙曄惈幘姵偺恌抐偲帯椕嘥. 堜忋丂尯 (惍奜): 戞18夞擔杮惍宍奜壢妛夛愐捙愐悜昦堛尋廋夛 (2020/8/30), Web奐嵜.
731024. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 僗儅乕僩僼僅儞傪梡偄偨巚弔婜摿敪惈懁淾徢僗僋儕乕僯儞僌僣乕儖偺奐敪. 堜忋丂尯1, 堜懞婱擵1, 彫扟弐柧, 斞搰丂桋, 嵅媣娫婤, 拞嶳宧懢, 愒郪丂搘, 墦摗垷嵐巕, 捁嫃椙徍, 堫栄堦廏, 戝捁惛巌, 崅憡徎巑1 (1惍奜): 戞69夞搶擔杮惍宍嵭奞奜壢妛夛 (2020/9/19), Web奐嵜.
731025. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 嵟怴偺弍屻姶愼徢恌椕. 撪嶳彑暥1, 抮揷怣夘2, 怷扟岝弐2, 暉搰寬夘2, 崅暯彯怢3, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3堛椕塹惗妛晹): 戞69夞搶擔杮惍宍嵭奞奜壢妛夛 (2020/9/19), Web奐嵜.
731026. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 昦懺儊僇僯僘儉傪峫椂偟偨曄宍惈屢娭愡徢偺恌椕偲僨儏儘僉僙僠儞偺埵抲偯偗. 暉搰寬夘 (惍奜): 僔僆僲僊web僙儈僫乕 in 恄撧愳 (2020/9/24), Web奐嵜.
731027. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 恖岺屢娭愡廃埻姶愼偺恌抐丒帯椕偺嵟怴忣曬. 撪嶳彑暥 (堛椕埨慡丒娗棟): Zimmer Biomet幮 Web僙儈僫乕 (2020/9/29), Web奐嵜.
731028. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 昦懺儊僇僯僘儉傪峫椂偟偨曄宍惈屢娭愡徢偺恌椕偲僨儏儘僉僙僠儞偺埵抲偯偗. 暉搰寬夘 (惍奜): 懡杸娭愡僼僅乕儔儉 (2020/12/10), Web奐嵜.
731029. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 屢娭愡恌椕偺幚嵺 (恌抐). 暉搰寬夘 (惍奜): S&N webinar 屢娭愡捝傪僒儓僫儔偡傞偨傔偵 (2021/1/29), Web奐嵜.
731030. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 擔忢奜棃偵偍偗傞陭宎晹捝偺恌椕乣恎懱強尒傪拞怱偵乣. 暉搰寬夘 (惍奜): Johnson & Johnson HIP Total Solution Seminar (2021/2/20), Web奐嵜.
731031. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 曄宍惈屢娭愡徢帯椕偵偍偗傞醬捝偺昡壙偲偦偺懳張. 暉搰寬夘 (惍奜): 憡柾尨Pain Forum Online 2021 (2021/3/11), Web奐嵜.
732024. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 15嵨埲壓偺庒擭幰偵懳偡傞屢娭愡嬀帇壓庤弍丂暯嬒3擭埲忋偺椪彴惉愌. 暉搰寬夘1, 戝嫶宑媣2, 彫嶳抭媣2, 搚壆恀曚1, 惔悈寬巎1, 撪嶳彑暥3, 崅憡徎巑, 崅暯彯怢4 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 戞69夞搶擔杮惍宍嵭奞奜壢妛夛 (2020/9/19), Web奐嵜.
732025. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 嫄戝崪寚懝偵懳偡傞摨庬崪傪梡偄偨懳張朄. 撪嶳彑暥1, 暉搰寬夘2, 怷扟岝弐2, 彫嶳抭媣3, 戝嫶宑媣3, 崅暯彯怢4, 崅憡徎巑2 (1堛椕埨慡丒娗棟, 2惍奜, 3戝妛堾堛椕宯尋媶壢, 4堛椕塹惗妛晹): Johnson & Johnson HIP Total Solution Seminar (2021/2/21), Web奐嵜.
732026. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 恖岺娭愡廃埻姶愼偵偍偗傞恌抐偺恑曕亅怴婯僶僀僆儅乕僇乕MPO偲Tm mapping朄亅. 撪嶳彑暥1, 烴堜宑憿2, 恗堜尒塸庽, 抮揷怣夘3, 暉搰寬夘3, 怷扟岝弐3, 崅暯彯怢4, 崅憡徎巑3 (1堛椕埨慡丒娗棟, 2椪専晹, 3惍奜, 4堛椕塹惗妛晹): 戞61夞娭搶惍宍嵭奞奜壢妛夛 (2021/3/26), Web奐嵜.
732027. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) Full HA stem (Corail stem) 偺抁婜帯椕惉愌. 暉搰寬夘1, 搚壆恀曚1, 釼摗峀庽1, 彫嶳抭媣2, 戝嫶宑媣2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹): 戞61夞娭搶惍宍嵭奞奜壢妛夛 (2021/3/27), Web奐嵜.
733084. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僀僰欩彎屻偵敪徢偟偨Mycobacterium chelonae偵傛傞庤晹怢嬝銯銯忊妸枌墛偺堦椺. 柀嵅戙巕1, 彆愳峗巑1, 彫徖尗帯1, 戝抾桰嵠1, 挰揷廃暯1, 尒栚抭婭1, 崅憡徎巑1 (1惍奜): 戞69夞搶擔杮惍宍嵭奞奜壢妛夛妛弍廤夛 (2020/9/18), web奐嵜.
733085. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僑乕儖僉乕僷乕偑儃乕儖傪庤彾晹偱僙乕僽偟偨嵺偵庴彎偟偨偲峫偊傜傟偨廙忬崪崪愜偺2椺. 懡揷戱栴1, 彫徖尗帯1, 彆愳峗巑1, 戝抾桰嵠1, 尒栚抭婭1, 崅憡徎巑1 (1惍奜): 戞69夞搶擔杮惍宍嵭奞奜壢妛夛 (2020/9/19), Web奐嵜.
733086. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 愐拰栴忬柺傾儔僀儊儞僩堎忢偲懱姴嬝検掅壓偑崪慹闋徢姵幰偵偍偗傞崢捝偵娭梌偡傞. 栰姟壠弚1, 媨忛惓峴1, 懞揷岾桟2, 彫嶳抭媣2, 愳媣曐曕2, 嶰懞桰夘1, 堫栄堦廏, 戝捁惛巌, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞69夞搶擔杮惍宍嵭奞奜壢妛夛 (2020/9/19), Web奐嵜.
733087. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 媫懍恑峴惈偺杻醿傪掓偟偨娐捙屻摢崪桙崌徢偺1椺. 崱栰梇懢1, 堜懞婱擵1, 堜忋丂尯1, 拞郪弐擵1, 媨忛惓峴1, 陰摗丂榡1, 敀郪塰庽1, 崅憡徎巑1 (1惍奜): 戞69夞搶擔杮惍宍嵭奞奜壢妛夛 (2020/9/19), Web奐嵜.
733088. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 崪慹闋徢姵幰偵偍偗傞醬捝偺桳昦棪偲恄宱忈奞惈醬捝. 堦瀶桭岶1, 媨忛惓峴1, 崟揷峎媊2, 懞揷岾桟2, 彫嶳抭媣2, 愳媣曐曕2, 墶娭梇巌2, 恀暻婎庽1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 戞69夞搶擔杮惍宍嵭奞奜壢妛夛 (2020/9/19), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-110019. [尨挊] The Surgical Outcomes of Spinal Fusion for Osteoporotic Vertebral Fractures in the Lower Lumbar Spine with a Neurological Deficit. Isogai N, Hosogane N, Funao H, Nojiri K, Suzuki S, Okada E, Ueda S, Hikata T, Shiono Y, Watanabe K, Watanabe K, Kaito T, Yamashita T, Fujiwara H, Nagamoto Y, Terai H, Tamai K, Matsuoka Y, Suzuki H, Nishimura H, Tagami A, Yamada S, Adachi S, Ohtori S, Orita S, Furuya T, Yoshii T, Ushio S, Inoue G1, Miyagi M1, Saito W1, Imagama S, Ando K, Sakai D, Nukaga T, Kiyasu K, Kimura A, Inoue H, Nakano A, Harimaya K, Kawaguchi K, Yokoyama N, Oishi H, Doi T, Ikegami S, Shimizu M, Futatsugi T, Kakutani K, Yurube T, Oshima M, Uei H, Aoki Y, Takahata M, Iwata A, Seki S, Murakami H, Yoshioka K, Endo H, Hongo M, Nakanishi K, Abe T, Tsukanishi T, Ishii K: Spine Surg Relat Res 2020/1; 4 (3): 199-207. (堜忋丂尯1, 媨忛惓峴1, 釼摗丂榡1: 1惍奜)
'19-120002. [尨挊] 晄埨掕宆戝戁崪揮巕晹崪愜偺弍屻惍暅埵偵偍偗傞椡妛揑専摙. 壨懞丂捈1, 曯尨岹徆1, 徏塝峎惓1, 彲巌恀懢榊1, 揷郪丂椚1, 崅憡徎巑1, 庰堜棙撧2, 媑揷榓峅2, 巵暯惌怢2 (1惍奜, 2堛椕塹惗妛晹): 崪愜 2019/4; 41 (2): 522-4.
'19-120003. [尨挊] 僝儗僪儘儞巁悈榓暔擭1夞搳梌惢嵻媫惈婜斀墳偵懳偡傞僇儖僔僩僯儞惢嵻愭峴搳梌偺岠壥. 搚壆恀曚1, 媨忛惓峴1, 懞揷岾桟2, 彫嶳抭媣2, 愳媣曐曕2, 堜忋丂尯1, 撪揷寬懢榊1, 崅憡徎巑1 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 恄撧愳惍宍嵭奞奜壢尋媶夛嶨帍 2019/11; 32 (4): 121-4.
'19-320003. [徢椺曬崘] 旾孅嬋埵偱偺MRI嶣憸偱昡壙偟偨旾娭愡懁曽扙塒偺1椺. 揷拞宑廏1, 尒栚抭婭1, 釼摗峀庽1, 柤憅捈廳, 拞榚廩復1, 揷郪丂椚1, 彫徖尗帯1, 彆愳峗巑1, 崅憡徎巑1 (1惍奜): 恄撧愳惍宍嵭奞奜壢妛夛帍 2019/11; 32 (4): 89-92.
'19-522005. [島嵗]亂恄宱嬝幘姵, 怴偨側帯椕偺帪戙傊亃III. 崌暪徢傊偺夘擖丂愐拰曄宍傊偺傾僾儘乕僠 崅憡徎巑1, 釼摗丂榡1, 媨忛惓峴1, 堜忋丂尯1, 拞郪弐擵1, 堜懞婱擵1, 敀郪塰庽1, 愳媣曐曕2 (1惍奜, 2戝妛堾堛椕宯尋媶壢): 彫帣壢恌椕 2019/12; 83 (1): 113-22.
[挊丂彂]
H27-620001. [妛弍彂 (暘扴幏昅)]亂奜彎奜壢庤弍僷乕僼僃僋僩丂廳徢姵幰媬柦偺偨傔偺儀僗僩傾僾儘乕僠亃戞3復奺榑丂4. 崪斦崪愜, p.2-9. 曯尨岹徆, 徏塝峎惓1, 怴摗惓婸 (1媬柦), 曇: 妺惣丂栆, 恌抐偲帯椕幮, 搶嫗, 2015/8敪峴.
H27-620002. [妛弍彂 (暘扴幏昅)]亂壓巿椪彴徢岓偺恌偐偨丒峫偊曽亃戞3復屢娭愡丒崪斦晹偺椪彴恌抐奺榑丂仠巚弔婜丒惵擭婜 (僗億乕僣忈奞丒奜彎娷傓)丂8. 棞忬嬝徢岓孮, 9. 崪斦崪愜丒屢娭愡扙塒, p.70-3. 徏塝峎惓1, 曯尨岹徆, 怴摗惓婸 (1媬柦), 曇: 媑栴怶堦, 挓嵅墄抝, 揷拞峃恗, 撿嶳摪, 搶嫗, 2015/11敪峴.
H29-620001. [妛弍彂 (暘扴幏昅)]亂愱栧堛偺惍宍奜壢奜棃恌椕丂嵟怴偺恌抐丒帯椕亃II. 幘姵奺榑丂5) 僐儞僷乕僩儊儞僩徢岓孮, p.84-7. 曯尨岹徆, 徏塝峎惓1, 怴摗惓婸 (1媬柦), 曇: 晊巑晲巎, 揷曈廏庽, 戝愳丂弤, 撿峕摪, 搶嫗, 2017/4敪峴.
'18-620002. [妛弍彂 (暘扴幏昅)]亂寛掕斉!傕偆嬯庤偲偼尵傢偣側偄丂傑傞偛偲崪愜偙傟1嶜 (惍宍奜壢娕岇2018擭弔婫憹姧)亃戞4復壓巿偺崪愜丂5. 泺崪崪姴晹崪愜, p.142-5. 徏塝峎惓 (媬柦), 曇: 墫揷捈巎, 儊僨傿僇弌斉, 戝嶃, 2018/5敪峴.
[妛夛丒尋媶夛摍]
'18-723002. [妛夛 (慡崙)] (堦斒島墘) 晄埨掕宆戝戁崪揮巕晹崪愜偵偍偗傞弍屻惍暅昡壙偲sliding偵偮偄偰偺専摙. 徏塝峎惓1, 曯尨岹徆, 壨懞丂捈2, 撪嶳彑暥3, 暉搰寬夘2, 彲巌恀懢榊4, 揷郪丂椚2, 戝抾桰嵠2, 崅暯彯怢5, 崅憡徎巑2 (1媬柦, 2惍奜, 3堛椕埨慡丒娗棟, 4戝妛堾堛椕宯尋媶壢, 5堛椕塹惗妛晹): 戞44夞擔杮崪愜帯椕妛夛 (2018/7/6-7), 壀嶳.
'19-713011. [妛夛 (崙嵺)] (堦斒島墘) Stability of internal fixation for distal clavicular fractures. Kawai K1, Matsuura T2, Minehara H, Kawamura T1, Takaso M1: 27th Annual Meeting of the European Orthopaedic Research Society (2019/10/2-5), Maastricht, Netherlands. (愳堜峗暯1, 徏塝峎惓2, 壨懞丂捈1, 崅憡徎巑1: 1惍奜, 2媬柦)
'19-723022. [妛夛 (慡崙)] (堦斒島墘) 奜彎惈峀斖埻戝戁崪崪寚懝偵懳偟偰Masquelet 朄傪梡偄偨帯椕宱尡. 柀丂崉庽1, 徏塝峎惓2, 曯尨岹徆, 壨懞丂捈1, 彲巌恀懢榊3, 揷郪丂椚1, 釼摗峀庽1, 摗桼悞擵, 崅憡徎巑1 (1惍奜, 2媬柦, 3戝妛堾堛椕宯尋媶壢): 戞45夞擔杮崪愜帯椕妛夛 (2019/6/28), 暉壀.
'19-723023. [妛夛 (慡崙)] (堦斒島墘) Suicidal jumper乫s fracture偵敽偆愬崪晹偺妏忬曄宍偵懳偟偰娤寣揑惍暅屌掕弍傪巤峴偟偨1椺. 暷揷徆峀1, 壨懞丂捈1, 曯尨岹徆, 徏塝峎惓2, 彲巌恀懢榊3, 揷郪丂椚1, 嶰懞桰桟1, 崅憡徎巑1 (1惍奜, 2媬柦, 3戝妛堾堛椕宯尋媶壢): 戞45夞擔杮崪愜帯椕妛夛 (2019/6/28), 暉壀.
'19-723024. [妛夛 (慡崙)] (堦斒島墘) 崅僄僱儖僊乕奜彎偵傛傞晄埨掕宆愬崪崪愜偵懳偡傞掅怤廝屻曽屌掕弍偺桳梡惈. 媨忛惓峴1, 堜懞婱擵1, 曯尨岹徆, 徏塝峎惓2, 壨懞丂捈1, 堜忋丂尯1, 崅憡徎巑1 (1惍奜, 2媬柦): 戞45夞擔杮崪愜帯椕妛夛 (2019/6/29), 暉壀.
'19-723025. [妛夛 (慡崙)] (堦斒島墘) 懡敪奜彎姵幰偵懳偟偰Early Appropriate Care傪峴偭偨1椺. 釼摗峀庽1, 徏塝峎惓2, 曯尨岹徆, 壨懞丂捈1, 彲巌恀懢榊3, 揷郪丂椚1, 墶娭梇巌3, 崅憡徎巑1 (1惍奜, 2媬柦, 3戝妛堾堛椕宯尋媶壢): 戞45夞擔杮崪愜帯椕妛夛 (2019/6/29), 暉壀.
'19-723026. [妛夛 (慡崙)] (堦斒島墘) 崪堏摦弍偵偍偗傞崪堏摦懍搙偑docking site偺崪桙崌偵媦傏偡塭嬁. 揷郪丂椚1, 曯尨岹徆, 徏塝峎惓2, 壨懞丂捈1, 撪揷寬懢榊1, 堜忋丂尯1, 彲巌恀懢榊3, 愳媣曐曕3, 崅憡徎巑1 (1惍奜, 2媬柦, 3戝妛堾堛椕宯尋媶壢): 戞45夞擔杮崪愜帯椕妛夛 (2019/6/29), 暉壀.
'19-723027. [妛夛 (慡崙)] (堦斒島墘) 20擭埲忋晄埨掕惈傪桳偟偰偄偨旾娭愡屻奜懁夞慁晄埨掕徢亅挿彾嬝銯偲旾嬝傪梡偄偰嵞寶偟偨1椺亅. 挰揷廃暯1, 彆愳峗巑1, 彫徖尗帯1, 戝抾桰嵠1, 尒栚抭婭1, 崅憡徎巑1 (1惍奜): 戞32夞擔杮旾娭愡妛夛妛弍廤夛 (2020/2/7), 撧椙.
'19-723028. [妛夛 (慡崙)] (堦斒島墘) 忋榬晹烎崪恄宱偺憱峴偲忋榬嶰摢嬝奜懁摢銯亅奜懁嬝娫拞妘暋崌懱偺娭學偵偮偄偰偺夝朥妛揑尋媶 (戞1曬)亅. 彆愳峗巑1, 挰揷廃暯1, 彫徖尗帯1, 戝抾桰嵠1, 尒栚抭婭1, 崅憡徎巑1 (1惍奜): 戞32夞擔杮旾娭愡妛夛妛弍廤夛 (2020/2/7), 撧椙.
'19-733013. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉堾偵偍偗傞崪斦椫崪愜偵懳偡傞憂奜屌掕朄偺帯椕宱尡. 帥杮梞暯1, 曯尨岹徆, 徏塝峎惓2, 壨懞丂捈1, 彲巌恀懢榊3, 揷郪丂椚1, 妢尨丂弒2, 愺棙丂桋2, 崅憡徎巑1 (1惍奜, 2媬柦, 3戝妛堾堛椕宯尋媶壢): 戞68夞搶擔杮惍宍嵭奞奜壢妛夛 (2019/9/5-6), 搶嫗.
'19-733014. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 奜彎惈峀斖埻崪寚懝偵懳偟偰Masquelet朄傪梡偄偨帯椕彫宱尡. 朙懞梖巌1, 徏塝峎惓2, 曯尨岹徆, 壨懞丂捈1, 彲巌恀懢榊3, 揷郪丂椚1, 釼摗峀庽1, 崅憡徎巑1 (1惍奜, 2媬柦, 3戝妛堾堛椕宯尋媶壢): 戞167夞恄撧愳惍宍嵭奞奜壢尋媶夛 (2019/10/5), 墶昹.
'19-733015. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 壓巿偺僀儞僾儔儞僩廃埻崪愜偺帯椕: 恖岺旼娭愡抲姺弍屻偺僀儞僾儔儞僩廃埻崪愜偺帯椕. 憡愳丂弤1, 娾悾丂戝1, 媑揷捈恖1, 曯尨岹徆, 柀嵅戙巕1, 晲堜惓堦榊1, 寎丂丂妛2, 崅栰徃懢榊1, 壨懞丂捈1, 徏塝峎惓3, 崅憡徎巑1, 搶嶳楃帯1 (1惍奜, 2戝妛堾堛椕宯尋媶壢, 3媬柦): 戞167夞恄撧愳惍宍嵭奞奜壢尋媶夛 (2019/10/5), 墶昹.
'19-733016. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 3師尦憿宍儌僨儖傪梡偄偰弍慜僔儈儏儗乕僔儑儞傪峴偭偨Madelung曄宍偺帯椕宱尡. 栚帪桳婓宐1, 彆愳峗巑1, 彫徖尗帯1, 戝抾桰嵠1, 挰揷廃暯1, 崅憡徎巑1 (1惍奜): 戞34夞搶擔杮庤奜壢尋媶夛 (2020/2/1), 搶嫗.
宍惉奜壢丒旤梕奜壢妛
[妛弍榑暥]
522077. [島嵗] 廬棃偺帯椕偱夵慞偵擄廰偡傞憂彎傊偺帯椕愴棯亅嬊強堿埑暵嵔椕朄亅. 攏応崄巕1,2, 嶁搶桼婭1,3 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜, 3彫帣): 嶉嬍導堛巘夛帍 2020; 839: 36-9.
522078. [島嵗] 宍惉奜壢堛偑揱偊偨偄憂彎偺偍榖偟亅宍惉奜壢偺偛徯夘偐傜嵟嬤偺僩僺僢僋傑偱亅. 攏応崄巕1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜): 杒懌棫孲堛巘夛夛曬 2020; 308: 37-41.
540028. [偦偺懠 (壢尋旓曬崘彂)]亂暥晹壢妛徣壢妛尋媶旓曗彆嬥婎斦尋媶C: 怴偨側怬妠岥奧楐帯椕愴棯偺奐敪偵岦偗偨鋊懷丒鋊懷寣偲庤弍梋忚慻怐偵傛傞慻怐嵞惗亃攏応崄巕1,2, 嶳嶈埨惏2, 晲揷丂孾2, 悪杮岶擵2, 孎郪寷堦2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜): 暥晹壢妛徣壢妛尋媶旓曗彆嬥婎斦尋媶C: 怴偨側怬妠岥奧楐帯椕愴棯偺奐敪偵岦偗偨鋊懷丒鋊懷寣偲庤弍梋忚慻怐偵傛傞慻怐嵞惗丂尋媶惉壥曬崘彂 2020/6; https://kaken.nii.ac.jp/ja/file/KAKENHI-PROJECT-16K11376/16K11376seika.pdf.
540029. [偦偺懠 (壢尋旓曬崘彂)]亂暥晹壢妛徣壢妛尋媶旓曗彆嬥婎斦尋媶C: 敪惗曣抧偵埶懚偡傞崪慻怐桼棃娫梩宯嵶朎偺懡暘壔擻偺夝柧偲偦偺椪彴揑堄媊亃嶳嶈埨惏1, 悪杮岶擵1, 攏応崄巕1,2, 悪杮壚崄1, 怷嶳榓偺1 (1宍惉丒旤奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 暥晹壢妛徣壢妛尋媶旓曗彆嬥婎斦尋媶C: 敪惗曣抧偵埶懚偡傞崪慻怐桼棃娫梩宯嵶朎偺懡暘壔擻偺夝柧偲偦偺椪彴揑堄媊丂尋媶惉壥曬崘彂 2020/5; https://kaken.nii.ac.jp/ja/file/KAKENHI-PROJECT-17K11852/17K11852seika.pdf.
[妛夛丒尋媶夛摍]
713042. [妛夛 (崙嵺)] (堦斒島墘) Co-culture of Umbilical Cord derived Mesenchymal Stem Cells (UCMSCs) and Chondrocytes improved Chondrogenic differentiation. Baba K1,2, Yamazaki Y2, Sone Y3, Sugimoto Y2, Moriyama K2, Sugimoto T2, Kumazawa K2, Takeda A2: 11th WORLD BIOMATERIALS CONGRESS (2020/12/11-15), WEB奐嵜. (攏応崄巕1,2, 嶳嶈埨惏2, 慮崻桼旤巕3, 悪杮壚崄2, 怷嶳榓偺2, 悪杮岶擵2, 孎郪寷堦2, 晲揷丂孾2: 1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜, 3昦懺丒恌椕宯)
713043. [妛夛 (崙嵺)] (堦斒島墘) Differentiation and proliferation potencies of human bone tissue-derived mesenchymal stromal cells (hBT-MSCs) after long-term cryopreservation -Comparison among cells stored for 1, 5, 10, 15, and 20 years-. Sugimoto Y1, Yamazaki Y1, Moriyama K1, Sugimoto T1, Kumazawa K1, Baba K1,2, Sone Y3, Takeda A1: 11th WORLD BIOMATERIALS CONGRESS (2020/12/11-15), WEB奐嵜. (悪杮壚崄1, 嶳嶈埨惏1, 怷嶳榓偺1, 悪杮岶擵1, 孎郪寷堦1, 攏応崄巕1,2, 慮崻桼旤巕3, 晲揷丂孾1: 1宍惉丒旤奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3昦懺丒恌椕宯)
713044. [妛夛 (崙嵺)] (堦斒島墘) The bone differenciation inducibility by exosome of the mescenchymal cells from human ilium bone (hBMCs). Yamazaki Y1, Sone Y2, Sugimoto Y1, Baba K1,3, Moriyama K1: 11th WORLD BIOMATERIALS CONGRESS (2020/12/11-15), WEB奐嵜. (嶳嶈埨惏1, 慮崻桼旤巕2, 悪杮壚崄1, 攏応崄巕1,3, 怷嶳榓偺1: 1宍惉丒旤奜, 2昦懺丒恌椕宯, 3杒棦戝妛儊僨傿僇儖僙儞僞乕)
713045. [妛夛 (崙嵺)] (堦斒島墘) Differences in pluripotency of jawbone- and iliac bone-derived mesenchymal cells. Moriyama K1, Yamazaki Y1, Sugimoto Y1, Sugimoto T1, Kumazawa K1, Baba K1,2, Sone Y3, Takeda A1丗11th WORLD BIOMATERIALS CONGRESS (2020/12/11-15), WEB奐嵜. (怷嶳榓偺1, 嶳嶈埨惏1, 悪杮壚崄1, 悪杮岶擵1, 孎郪寷堦1, 攏応崄巕1,2, 慮崻桼旤巕3, 晲揷丂孾1: 1宍惉丒旤奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3昦懺丒恌椕宯)
723471. [妛夛 (慡崙)] (堦斒島墘) 僔儏儚儞嵶朎偲偺嫟攟梴偵傛傞僸僩鋊懷桼棃娫梩宯嵶朎偺暘壔擻偺専摙. 攏応崄巕1,2, 嶳嶈埨惏2, 慮崻桼旤巕3, 悪杮壚崄2, 怷嶳榓偺2, 孎郪寷堦2,4, 悪杮岶擵2, 晲揷丂孾2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜, 3昦懺丒恌椕宯, 4媬柦): 戞19夞擔杮嵞惗堛椕妛夛憤夛 (2020/5/18-29), WEB奐嵜.
723472. [妛夛 (慡崙)] (堦斒島墘) 20擭挿婜搥寢曐懚偟偨崪桼棃娫梩宯嵶朎偺暘壔擻媦傃挿婜宲戙傪孞傝曉偟偨嵶朎偲偺榁壔愼怓偺専摙. 悪杮壚崄1, 嶳嶈埨惏1, 怷嶳榓偺1, 悪杮岶擵1, 孎郪寷堦1,2, 攏応崄巕1,3, 慮崻桼旤巕4, 晲揷丂孾1 (1宍惉丒旤奜, 2媬柦, 3杒棦戝妛儊僨傿僇儖僙儞僞乕, 4昦懺丒恌椕宯): 戞19夞擔杮嵞惗堛椕妛夛憤夛 (2020/5/18-29), WEB奐嵜.
723473. [妛夛 (慡崙)] (堦斒島墘) 奜棃恌椕偵偍偗傞擄帯惈捵釃偲掅垷墧寣徢. 攏応崄巕1,2, 戝孏嵤壛2, 嬥巕桭婭2, 暫摢揙栫, 崻杮丂廩2, 愇崟嫥巎, 晲揷丂孾2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜): 戞63夞擔杮宍惉奜壢妛夛憤夛丒妛弍廤夛 (2020/8/26-28), 柤屆壆 (WEB奐嵜).
723474. [妛夛 (慡崙)] (堦斒島墘) 暊枌摟愅僇僥乕僥儖弌岥晹擽釃偵懳偟偰峴偭偨帩懕燇棳暪梡嬊強堿埑暵嵔椕朄 (NPWTi-d) 偺帯椕宱尡. 戝孏嵤壛1, 攏応崄巕1,2, 崻杮丂廩1, 暫摢揙栫, 晲揷丂孾1 (1宍惉丒旤奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞63夞擔杮宍惉奜壢妛夛憤夛丒妛弍廤夛 (2020/8/26-28), 柤屆壆 (WEB奐嵜).
723475. [妛夛 (慡崙)] (堦斒島墘) 擬彎姵幰偵偍偗傞徚壔婍崌暪徢偺専摙. 孎郪寷堦1, 崻杮丂廩1, 攼栘怲栫1, 娾愳偝偍傝2, 榓搨弮暯1, 怴旤梇戝1, 晲揷丂孾1, 娵嫶岶徍2, 憹揷抭惉2, 壴搰丂帒2, 曅壀桽堦2, 愺棙丂桋2 (1宍惉丒旤奜, 2媬柦): 戞46夞擔杮擬彎妛夛憤夛丒妛弍廤夛 (2020/9/2-3), 戝嶃.
723476. [妛夛 (慡崙)] (堦斒島墘) 廳徢擬彎偵崌暪偟偨柍愇惈夡醩惈抇鵑墛偵懳偟, 擬彎憂偐傜奐暊庤弍傪巤峴偟偨堦椺. 怴旤梇戝1, 孎郪寷堦1, 娾愳偝偍傝2, 攼栘怲栫1, 崻杮丂廩1, 晲揷丂孾1, 娵嫶岶徍2, 愺棙丂桋2 (1宍惉丒旤奜, 2媬柦): 戞46夞擔杮擬彎妛夛憤夛丒妛弍廤夛 (2020/9/2-3), 戝嶃.
723477. [妛夛 (慡崙)] (堦斒島墘) 僔儏儚儞嵶朎偲偺旕愙怗宆嫟攟梴偵偍偗傞鋊懷桼棃娫梩宯嵶朎偺僌儕傾宯嵶朎傊偺暘壔擻偺専摙. 攏応崄巕1,2, 嶳嶈埨惏2, 悪杮壚崄2, 怷嶳榓偺2, 孎郪寷堦2, 悪杮岶擵2, 晲揷丂孾2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜): 戞29夞擔杮宍惉奜壢妛夛婎慴妛弍廤夛 (2020/10/8-9), 墶昹 (WEB奐嵜).
723478. [妛夛 (慡崙)] (堦斒島墘) micrograft偺扴懱偲偟偰梡偄偨恖岺恀旂偺慻怐妛揑専摙. 怴旤梇戝1, 攏応崄巕1,2, 崻杮丂廩1, 晲揷丂孾1 (1宍惉丒旤奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞29夞擔杮宍惉奜壢妛夛婎慴妛弍廤夛 (2020/10/8-9), 墶昹 (WEB奐嵜).
723479. [妛夛 (慡崙)] (堦斒島墘) 怴宆僐儘僫僂僀儖僗姶愼徢棳峴婜偵墑婜丒拞巭偟偨宍惉奜壢庤弍徢椺偺専摙. 攏応崄巕1,2, 怴旤梇戝2, 揷拞悙婓2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜): 戞68夞擔杮怑嬈丒嵭奞堛妛夛妛弍戝夛 (2020/12/5), 昹徏 (帍忋奐嵜).
723480. [妛夛 (慡崙)] (堦斒島墘) 暊枌摟愅僇僥乕僥儖弌岥晹擽釃偵懳偡傞, 僇僥乕僥儖傪壏懚偟偨庤弍曽朄媦傃弍屻娗棟偵偮偄偰. 揷拞悙婓1, 攏応崄巕1,2, 怴旤梇戝1 (1宍惉丒旤奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞68夞擔杮怑嬈丒嵭奞堛妛夛妛弍戝夛 (2020/12/5), 昹徏 (帍忋奐嵜).
723481. [妛夛 (慡崙)] (堦斒島墘) 倣icrograft傪梡偄偨擄帯惈捵釃偵懳偡傞怴偨側帯椕愴棯-姶愼徢棳峴婜偺惂尷壓偱帯椕偟偨4徢椺偺曬崘. 怴旤梇戝1, 攏応崄巕1,2, 揷拞悙婓1 (1宍惉丒旤奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞68夞擔杮怑嬈丒嵭奞堛妛夛妛弍戝夛 (2020/12/5), 昹徏 (帍忋奐嵜).
723482. [妛夛 (慡崙)] (堦斒島墘) 僔儏儚儞嵶朎偲偺旕愙怗宆嫟攟梴偵傛傞僸僩鋊懷桼棃娫梩宯嵶朎偺恄宱宯嵶朎傊偺暘壔擻偺専摙. 攏応崄巕1,2, 嶳嶈埨惏2, 慮崻桼旤巕3, 悪杮壚崄2, 孎郪寷堦2, 悪杮岶擵2, 晲揷丂孾2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜, 3昦懺丒恌椕宯): 戞20夞擔杮嵞惗堛椕妛夛憤夛 (2021/3/11-13), WEB奐嵜.
723483. [妛夛 (慡崙)] (堦斒島墘) 僄僋僜僜乕儉偵傛偭偰僸僩崪慻怐桼棃娫梩宯嵶朎偼崪暘壔桿摫偝傟傞偐丠 嶳嶈埨惏1, 悪杮壚崄1, 孎郪寷堦1, 攏応崄巕1,2, 悪杮岶擵1, 慮崻桼旤巕3, 晲揷丂孾1 (1宍惉丒旤奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕, 3昦懺丒恌椕宯): 戞20夞擔杮嵞惗堛椕妛夛憤夛 (2021/3/11-13), WEB奐嵜.
733089. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉壢偱帯椕夘擖偟偨姤摦柆僗僥儞僩烎崪摦柆巆棷偺堦椺. 搚揷棟巕1, 怴旤梇戝1, 攏応崄巕1,2 (1宍惉丒旤奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞23夞杒棦宍惉奜壢僼僅乕儔儉 (2020/10/18-24), WEB奐嵜.
733090. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 鋊晹栄憙摯偺1椺. 戝娭椇夘1,2, 搚揷棟巕2, 攏応崄巕1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2宍惉丒旤奜): 娭搶宍惉奜壢妛夛戞299夞搶嫗抧曽夛 (2021/3/6), WEB奐嵜.
旂晢壢妛
[妛弍榑暥]
110327. [尨挊] Inhibition of Endoglin Exerts Antitumor Effects through the Regulation of Non-Smad TGF-兝 Signaling in Angiosarcoma. Sakamoto R, Kajihara I, Miyauchi H, Maeda-Otsuka S, Yamada-Kanazawa S, Sawamura S, Kanemaru H, Makino K, Aoi J, Makino T, Fukushima S, Masuzawa M1, Masuzawa M, Amoh Y1, Hoshina D, Abe R, Ihn H: J Invest Dermatol 2020/10; 140 (10): 2060-72.e6. (憹郪恀幚巕1, 揤塇峃擵1: 1旂晢)
320031. [徢椺曬崘] 擽醰惈姡釢偲娪暿傪梫偟偨媫惈斈敪惈敪怾惈擽醰徢偲峫偊傜傟偨1椺. 奆愳戝曘1, 戝媣曐巙偢偐1, 敀堜嫗旤1, 埨錣椙堦1, 揤塇峃擵1 (1旂晢): 旂晢壢偺椪彴 2020/11; 62 (12): 1703-7.
522079. [島嵗]亂摿廤: 娫梩宯庮釃亃摢晹扨敪庮釒偐傜恌抐偵帄偭偨媫惈扨媴惈敀寣昦. 帞徖幚桪1, 憹郪恀幚巕1, 杧暷桽堦, 揤塇峃擵1 (1旂晢): 旂晢壢偺椪彴 2020/5; 62 (5): 583-6.
522080. [島嵗]亂摿廤: 擏夎庮徢亃偍傓偮廃埻偵怘昳曐懚梡偺儔僢僾傪姫偄偰偄偨Diaper Area Granuloma of the Age偺1椺. 嵅乆栘埐1, 宩丂桭棟1, 敀堜嫗旤1, 忋揷嫪巑1 (1旂晢: 旂晢壢偺椪彴 2020/8; 62 (9): 1294-5.
[妛夛丒尋媶夛摍]
723484. [妛夛 (慡崙)] (堦斒島墘) 壓戁捵釃傪掓偟偨枹暘壔懡宍擏庮偺1椺. 彫嶳旤曚1, 憹郪恀幚巕1, 崅壀撧撨巕, 釼摗嫳巕1, 敀堜嫗旤1, 昹揷桽巕2, 榓搨弮暯3, 棫愇桪旤奊, 揤塇峃擵1 (1旂晢, 2昦懺丒恌椕宯, 3宍惉丒旤奜): 戞119夞擔杮旂晢壢妛夛憤夛 (2020/6/4), Web奐嵜.
723485. [妛夛 (慡崙)] (堦斒島墘) 旂晢昦曄偐傜尒嬌傔傞戙幱堎忢幘姵丂戙幱堎忢徢偵敽偆旂晢昦曄丂柍婡暔幙丆價僞儈儞, 儉僠儞摍. 敀堜嫗旤 (旂晢): 戞119夞擔杮旂晢壢妛夛憤夛 (2020/6/4-7), Web奐嵜.
723486. [妛夛 (慡崙)] (堦斒島墘) 摢晹寣娗擏庮偺敄暻嬻摯宆攛揮堏偵傛傞嵞敪惈婥嫻偵懳偟偰僷僝僷僯僽偲攛晹暘愗彍偑憈岟偟偨1椺. 憹郪恀幚巕1, 椦丂徦巕2, 墫尒丂榓2, 嬥暎桪庽1, 崅壀撧撨巕, 敀堜嫗旤1, 揤塇峃擵1 (1旂晢, 2屇媧婍奜): 戞119夞擔杮旂晢壢妛夛憤夛 (2020/6/4-7), Web奐嵜.
723487. [妛夛 (慡崙)] (堦斒島墘) 醡釢僩儞僱儖偵傒傜傟傞尞乽崟墢乿強尒偵偮偄偰偺専摙 怴婯僟乕儌僗僐僺乕強尒偺採埬. 忋揷嫪巑1, 嵅乆栘埐1, 宩丂桭棟1, 敀堜嫗旤1 (1旂晢): 戞119夞擔杮旂晢壢妛夛憤夛 (2020/6/4-7), Web奐嵜.
723488. [妛夛 (慡崙)] (堦斒島墘) 摢晹寣娗擏庮偵懳偟僪僉僜儖價僔儞搳梌偑堦帪憈岟偟偨1椺. 帞徖幚桪1, 憹郪恀幚巕1, 崅壀撧撨巕, 敀堜嫗旤1, 憗揷丂奿2, 桍郪岹恖, 揤塇峃擵1 (1旂晢, 2曻幩慄 (庮釃)): 戞36夞擔杮旂晢埆惈庮釃妛夛妛弍戝夛 (2021/1/8-9), 墶昹.
733091. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 塃憀宎晹偵朓鈢怐墛條偺椪彴傪掓偟偨ALK堿惈枹暘壔戝嵶朎宆儕儞僷庮偺1椺. 帞徖幚桪1, 憹郪恀幚巕1, 嬥暎桪庽1, 敀堜嫗旤1, 揤塇峃擵1, 悪杮壚崄2 (1旂晢, 2宍惉丒旤奜): 擔杮旂晢壢妛夛戞891夞搶嫗抧曽夛 (2020/9/5), Web奐嵜.
733092. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 枬惈儕儞僷惈敀寣昦偵崌暪偟偨悈醰惈椶揤醰釋偺1椺. 嬥嶳傑傝偐1, 嬥暎桪庽1, 埨錣椙堦1, 敀堜嫗旤1, 姍揷峗柅2, 嶰堜弮愥1, 揤塇峃擵1 (1旂晢, 2寣塼撪): 戞84夞擔杮旂晢壢妛夛搶嫗巟晹妛弍戝夛 (2020/11/21-22), Web奐嵜.
733093. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 栄曪姴嵶朎傪梡偄偨僪乕僷儈儞嶻惗嵶朎偺桿摫. 嶳崻旤抭巕, 崅壀撧撨巕, 彫尨岹嵠1, 敀堜嫗旤1, 埨錣椙堦1, 昹揷桽巕2, 峳愳怢巕, Robert M Hoffman, 揤塇峃擵1 (1旂晢, 2昦懺丒恌椕宯): 戞28夞栄敮壢妛尋媶夛 (2020/12/5), 搶嫗 (僴僀僽儕僢僪奐嵜).
733094. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 戝挵宔幒慂岴傪崌暪偟偨夡醩惈擽旂徢偺1椺. 悈岥棾擵夘1, 敀堜嫗旤1, 崅栰揘榊1, 嬥暎桪庽1, 嵅乆栘埐1, 揤塇峃擵1, 搉晹峎巕2, 旙岥摴惗 (1旂晢, 2壓晹徚壔娗奜): 擔杮旂晢壢妛夛戞893夞搶嫗抧曽夛 (2020/12/19), Web奐嵜.
733095. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 栩晹偵懡敪鵑朎惈儕儞僷愡揮堏傪偒偨偟偨栩晹儕儞僷娗擏庮偺1椺. 斾棷娫壚撧1, 憹郪恀幚巕1, 嵅乆栘埐1, 敀堜嫗旤1, 揤塇峃擵1, 徏栘丂悞2, 揷峐嬶帇 (1旂晢, 2帹旲堲岮丒摢栩奜): 擔杮旂晢壢妛夛戞893夞搶嫗抧曽夛 (2020/12/19), Web奐嵜.
733096. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) IgG/IgA揤醰釋偺1椺. 嬥嶳傑傝偐1, 嬥暎桪庽1, 憹郪恀幚巕1, 敀堜嫗旤1, 揤塇峃擵1, 搚堜婓暥, 愇堜巎恖 (1旂晢): 擔杮旂晢壢妛夛戞894夞搶嫗抧曽夛 (2021/1/16), Web奐嵜.
'19擭搙埲慜暘
[妛夛丒尋媶夛摍]
'19-733017. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 崪悜堎宍惉徢岓孮偺宱夁拞偵敪徢偟偨夡醩惈擽旂徢偺1椺. 彫嶳旤曚1, 崅壀撧撨巕, 崅栰揘榊1, 敀堜嫗旤1, 揤塇峃擵1, 姍揷峗柅2, 壆戙惓峎 (1旂晢, 2寣塼撪): 擔杮旂晢壢妛夛戞886夞搶嫗抧曽夛 (2019/10/19), 恄撧愳.
'19-733018. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) HPV16宆偑専弌偝傟偨Queyrat峠怓旍岤徢偺1椺. 奆愳戝曘1, 彫尨岹嵠1, 敀堜嫗旤1, 揤塇峃擵1, 揷曈寬堦 (1旂晢): 擔杮旂晢壢妛夛戞889夞搶嫗抧曽夛 (2020/2/15), 恄撧愳.
斿擜婍壢妛
[妛弍榑暥]
110328. [尨挊] Electronic nose to distinguish bladder cancer by urinary odour feature: A pilot study. Matsumoto K1, Murakami Y1, Shimizu Y, Hirayama T1, Ishikawa W, Iwamura M1: Cancer Biomark 2020/4; 28 (1): 33-9. (徏杮榓彨1, 懞忋懽惔1, 暯嶳婱攷1, 娾懞惓巏1: 1斿擜婍)
110329. [尨挊] Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study. Koguchi D1, Murakami Y1, Ikeda M1, Dobashi M, Ishii J: BMC Urol 2020/4; 20 (1): 38. (崅岥丂戝1, 懞忋懽惔1, 抮揷彑恇1: 1斿擜婍)
110330. [尨挊] The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients. Kobayashi K, Yamamoto S2, Takahashi S, Ishikawa K, Yasuda M, Wada K, Hamasuna R, Hayami H, Minamitani S, Matsumoto T, Kiyota H, Tateda K, SatoJ, Hanaki H1, Masumori N, Hiyama Y, Yamada H, Egawa S, Kimura T, Nishiyama H, Miyazaki J, Matsumoto K2, Homma Y, Kamei J, Fujimoto K, Torimoto K, Tanaka K, Togo Y, Uehara S, Matsubara A, Shoji K, Goto H, Komeda H, Ito T, Katsuhisa K, Mita K, Kato M, Fujimoto Y, Masue T, Inatomi H, Takahashi Y, Ishihara S, Nishimura K, Mitsumori K, Ito N, Kanamaru S, Yamada D, Maeda H, Yamashita M, Tsugawa M, Takenaka T, Takahashi K, Oka Y, Yasufuku T, Watanabe S, Chihara Y, Okumura K, Kawanishi H, Matsukawa M, Shigeta M, Koda S: J Infect Chemother 2020/5; 26 (5): 418-28. (壴栘廏柧1, 徏杮榓彨2: 1杒棦戝妛戝懞抭婰擮尋媶強, 2斿擜婍)
110331. [尨挊] Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial. Noguchi M, Arai G, Egawa S, Ohyama C, Naito S, Matsumoto K1, Uemura H, Nakagawa M, Nasu Y, Eto M, Suekane S, Sasada T, Shichijo S, Yamada A, Kakuma T, Itoh K: Cancer Immunol Immunother 2020/5; 69 (5): 847-57. (徏杮榓彨1: 1斿擜婍)
110332. [尨挊] Renal functional outcome after laparoscopic partial nephrectomy using dynamic renal scintigraphy. Fujita T1, Nishi M1, Ishii D1, Matsumoto K1, Yoshida K2, Iwamura M1: Can J Urol 2020/10; 27 (5): 10402-6. (摗揷揘晇1, 惣丂惙岹1, 愇堜戝曘1, 徏杮榓彨1, 媑揷堦惉2, 娾懞惓巏1: 1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕)
110333. [尨挊] Efficacy of Exercise Therapy Initiated in the Early Phase After Kidney Transplantation: A Pilot Study. Yamamoto S1, Matsuzawa R, Kamitani T, Hoshi K2, Ishii D3, Noguchi F4, Hamazaki N5, Nozaki K5, Ichikawa T5, Maekawa E6, Matsunaga A7, Yoshida K8: J Ren Nutr 2020/11; 30 (6): 518-25. (嶳杮彯暯1, 惎丂壚朏2, 愇堜戝曘3, 栰岥暥擳4, 郷嶈怢柧5, 栰嶈峃暯5, 巗愳懜暥5, 慜愳宐旤6, 徏塱撃旻7, 媑揷堦惉8: 1戝妛堾堛椕宯尋媶壢, 2塹惗, 3斿擜婍, 4娕岇晹, 5儕僴價儕晹, 6弞娐婍撪, 7堛椕塹惗妛晹, 8怴悽婭堛椕丒愭抂抐揑堛椕)
110334. [尨挊] Prognostic impact of preoperative renal function in patients treated with radical cystectomy: a multi-institutional retrospective study. Koguchi D, Matsumoto K1, Ikeda M1, Taoka Y1, Hirayama T1, Murakami Y1, Utsunomiya T, Matsuda D, Okuno N, Irie A, Iwamura M1: Int J Clin Oncol 2020/11; 25 (11): 1969-76. (崅岥丂戝1, 徏杮榓彨1, 抮揷彑恇1, 揷壀壚寷1, 暯嶳婱攷1, 懞忋懽惔1, 娾懞惓巏1: 1斿擜婍)
110335. [尨挊] The usefulness of ultrasound examination in detecting testicular nubbin in Japanese boys with non-palpable testes. Mori K1, Hamano A, Yamamoto S, Kawamura H, Koyama M, Fujishita M: J Pediatr Urol 2020/12; 16 (6): 816.e1-e4. (怷丂榡暯1: 1斿擜婍)
110336. [尨挊] PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy. Murakami Y1, Matsumoto K1, Shimizu Y, Ikeda M1, Amano N2, Shimura S1, Ishii D1, Sato Y3, Iwamura M1: Urol Oncol 2021/3; 39 (3): 195.e15-e23. (懞忋懽惔1, 徏杮榓彨1, 抮揷彑恇1, 揤栰摑擵2, 巙懞憇堦楴1, 愇堜戝曘1, 嵅摗梇堦3, 娾懞惓巏1: 1斿擜婍, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹)
110337. [尨挊] Impact of maintenance therapy using a half dose of the bacillus Calmette-Gu?rin Tokyo strain on recurrence of intermediate and high-risk nonmuscle invasive bladder cancer: a retrospective single-center study. single-center stud Koguchi D1, Matsumoto K1, Hirayama T1, Moroo S1, Kobayashi M1, Katsumata H2, Ikeda M1, Iwamura M1: BMC Urol 2020/12; 20 (1): 194. (崅岥丂戝1, 徏杮榓彨1, 暯嶳婱攷1, 巘旜斏岶1, 彫椦搷巕1, 彑枖梞庽2, 抮揷彑恇1, 娾懞惓巏1: 1斿擜婍, 2戝妛堾堛椕宯尋媶壢)
110338. [尨挊] Oncologic Outcomes of Salvage Chemotherapy in Patients with Recurrent or Metastatic Lesions after Radical Nephroureterectomy: A Multi-Institutional Retrospective Study. Ikeda M1, Matsumoto K1, Hirayama T1, Koguchi D1, Murakami Y1, Matsuda D, Okuno N, Utsunomiya T, Taoka Y1, Irie A, Iwamura M1: Chemotherapy 2020; 65 (5-6): 134-40. (抮揷彑恇1, 徏杮榓彨1, 暯嶳婱攷1, 崅岥丂戝1, 懞忋懽惔1, 揷壀壚寷1, 娾懞惓巏1: 1斿擜婍)
110339. [尨挊] Non-maintenance intravesical Bacillus Calmette-Gu?rin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study. Miyake M1, Iida K1, Nishimura N1, Miyamoto T1, Fujimoto K1, Tomida R1, Matsumoto K1,2, Numakura K1, Inokuchi J1, Morizane S1, Yoneyama T1, Matsumura Y1, Abe T1, Inoue M1, Yamada T1, Terada N1, Hirao S1, Uemura M1, Matsushita Y1, Taoka R1, Kobayashi T1, Kojima T1, Matsui Y1, Kitamura H1, Nishiyama H1 (1Japanese Urological Oncology Group): BMC Cancer 2021/3; 21 (1): 266. (徏杮榓彨1,2: 2斿擜婍)
110340. [尨挊] High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy. Amano N1, Matsumoto K2, Shimizu Y, Nakamura M2, Tsumura H2, Ishii D2, Sato Y3, Iwamura M2: Urol Oncol 2021/3; 39 (3): 196.e1-e7. (揤栰摑擵1, 徏杮榓彨2, 拞懞恀棙峕2, 捗懞廏峃2, 愇堜戝曘2, 嵅摗梇堦3, 娾懞惓巏2: 1戝妛堾堛椕宯尋媶壢, 2斿擜婍, 3堛椕塹惗妛晹)
310041. [徢椺曬崘] Complete biochemical response following metastasis-directed radiotherapy for oligometastatic prostate cancer: A case report. Okuda S1, Tabata K1, Shimura S1, Harano T1, Shiba I1, Iwamura M1: Urol Case Rep 2020/6; 33: 101315. (墱揷抦巎1, 揷敤寬堦1, 巙懞憇堦楴1, 尨栰婱峅1, 巌攏丂弌1, 娾懞惓巏1: 1斿擜婍)
520010. [憤愢] 嵼棷丒朘擔奜崙恖懳墳偺堛椕僠乕儉. 抮揷惉峕1, 揷懞弮恖, 愇堜戝曘1, 娾懞惓巏1, 媑揷堦惉2 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕愭抂): 擔杮椪彴恡堏怉妛夛嶨帍 2020/5; 8 (1): 26-32.
520011. [憤愢] 恡嵶朎娻偲C斀墳惈抈敀. 摗揷揘晇1, 娾懞惓巏1 (1斿擜婍): 杒棦堛妛 2020/12; 50 (2): 87-91.
522081. [島嵗]亂摿廤: 僆儕僑揮堏丒僆儕僑嵞敪慜棫態娻傪弰傞彅栤戣亃揮堏憙昗揑嬊強帯椕. 揷敤寬堦1, 娾懞惓巏1, 捗懞廏峃1 (1斿擜婍): 斿擜婍奜壢 2020/7; 33 (7): 953-8.
522082. [島嵗]亂嵗択夛: 慜棫態娻恌椕偵娭偡傞嵟怴僐儞僙儞僒僗亅APCCC 2019傪庴偗偰亅亃 楅栘孾墄, 揷敤寬堦1, 愒徏廏曘, 忋懞攷巌 (1斿擜婍): ESPOIR 2020/8; 3 (1): 44391.
522083. [島嵗]亂摿廤: 巒傔傛偆! 怴偨偵2020擭曐尟廂嵹偝傟偨庤弍丒専嵏丒娗棟巜摫亃儘儃僢僩巟墖恡岜宍惉弍亅儘儃僢僩偼懱峯撪朌崌偺僴乕僪儖傪壓偘傜傟傞偐亅. 娾懞惓巏 (斿擜婍): 斿擜婍奜壢 2020/10; 33 (10): 1267-73.
540030. [偦偺懠 (妛夛彺榐)]亂戞84夞擔杮斿擜婍壢妛夛搶晹憤夛婰榐廤亃僔儞億僕僂儉5: 揮堏惈擜楬忋旂娻偺堦師壔妛椕朄屻偺帯椕巜恓丂擇師帯椕偲偟偰偺壔妛椕朄. 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍): 斿擜婍奜壢 2020/6; 33 (椪帪憹姧): 728.
540031. [偦偺懠 (怴暦婰帠)] 擼巰恡堏怉僴僀儁乕僗. 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍): 搶墱擔曬 2020/7; p.7.
[挊丂彂]
620070. [妛弍彂 (暘扴幏昅)]亂恡堏怉偲偔偡傝亃戞1復 恡堏怉偲柶塽梷惂栻丂1. 恡堏怉偲嫅愨斀墳亅嫅愨斀墳偺偟偔傒亅, p.2-6. 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍), 曇: 媑揷堦惉, 彫椦徆岹, 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
620071. [妛弍彂 (暘扴幏昅)]亂恡堏怉偲偔偡傝亃戞1復 恡堏怉偲柶塽梷惂栻丂3. 柶塽梷惂栻偵偮偄偰偔傢偟偔抦傠偆 (傾僓僠僆僾儕儞), p.25-6. 愇堜戝曘1 (1斿擜婍), 曇: 媑揷堦惉, 彫椦徆岹 (2怴悽婭堛椕丒愭抂堛椕), 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
620072. [妛弍彂 (暘扴幏昅)]亂恡堏怉偲偔偡傝亃戞1復 恡堏怉偲柶塽梷惂栻丂3. 柶塽梷惂栻偵偮偄偰偔傢偟偔抦傠偆 (儊僠儖僾儗僪僯僝儘儞, 僾儗僪僯僝儘儞), p.29-31. 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍), 曇: 媑揷堦惉1,2, 彫椦徆岹, 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
620073. [妛弍彂 (暘扴幏昅)]亂恡堏怉偲偔偡傝亃戞1復 恡堏怉偲柶塽梷惂栻丂4. 柶塽梷惂栻偺暈梡拞偵婥傪晅偗傞偙偲 (姶愼徢偺帯椕栻), p.48-50. 杒搰榓庽1 (1斿擜婍), 曇: 媑揷堦惉1,2, 彫椦徆岹 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍), 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
620074. [妛弍彂 (暘扴幏昅)]亂恡堏怉偲偔偡傝亃戞1復 恡堏怉偲柶塽梷惂栻丂4. 柶塽梷惂栻偺暈梡拞偵婥傪晅偗傞偙偲 (Column 恡堏怉幰偲怴宆僐儘僫僂僀儖僗姶愼徢), p.50. 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍), 曇: 媑揷堦惉1,2, 彫椦徆岹, 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
620075. [妛弍彂 (暘扴幏昅)]亂恡堏怉偲偔偡傝亃戞1復 恡堏怉偲柶塽梷惂栻丂4. 柶塽梷惂栻偺暈梡拞偵婥傪晅偗傞偙偲 (崅擜巁寣徢), p.66-7. 愇堜戝曘1 (1斿擜婍), 曇: 媑揷堦惉1,2, 彫椦徆岹 (2怴悽婭堛椕丒愭抂堛椕), 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
620076. [妛弍彂 (暘扴幏昅)]亂恡堏怉偲偔偡傝亃戞2復 栻傪惓偟偔堸傒懕偗傞偨傔偵丂柶塽梷惂栻丂堸傒崌傢偣偺拲堄揰亂怘帠亃(偍庰傪堸傓偲偒偵偼, 偳偺僞僀儈儞僌偱暈梡偡傟偽傛偄偱偡偐?), p.132. 愇堜戝曘1 (1斿擜婍), 曇: 媑揷堦惉1,2, 彫椦徆岹 (2怴悽婭堛椕丒愭抂堛椕), 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
620077. [妛弍彂 (暘扴幏昅)]亂彫帣斿擜婍壢妛亃II彫帣斿擜婍壢妛憤榑丂B帯椕憤榑丂3. 彫帣偺暊峯嬀庤弍, p.84-7. 娾懞惓巏 (斿擜婍), 曇: 擔杮彫帣斿擜婍壢妛夛, 恌抐偲帯椕幮, 搶嫗, 2021/2敪峴.
621001. [妛弍彂 (娔廋丒曇廤丒偦偺懠)]亂恡堏怉偲偔偡傝亃偼偠傔偵, p.1. 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍), 曇: 媑揷堦惉1,2, 彫椦徆岹, 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
[妛夛丒尋媶夛摍]
722097. [妛夛 (慡崙)] (僔儞億僕僂儉) 恡堏怉屻摟愅嵞摫擖帪偺働傾偲梊屻. 愇堜戝曘1, 栰岥暥擳2 (1斿擜婍, 2娕岇晹): 戞56夞擔杮堏怉妛夛憤夛 (2020/11/1-30), web奐嵜, 堏怉 2020/10; 55 (憤夛椪帪): 301.
722098. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 恡堏怉屻偺摟愅傾僋僙僗偵偮偄偰: 堏怉帪乣嵞摫擖傊傓偗偰. 愇堜戝曘1, 杒搰榓庽1, 媑揷堦惉1,2 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕): 戞24夞擔杮摟愅傾僋僙僗堛妛夛妛弍廤夛丒憤夛 (2020/11/28), 戝嶃 (僴僀僽儕僢僪奐嵜).
722099. [妛夛 (慡崙)] (僀僽僯儞僌僙儈僫乕) 壡暘妱徠幩偵偍偗傞 SpaceOARTM偺栶妱. 捗懞廏峃 (斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
722100. [妛夛 (慡崙)] (僔儞億僕僂儉) 嬊強慜棫態娻偵懳偡傞HDR brachytherapy傪梡偄偨帯椕愴棯乣偦偺尷奅偲崱屻偺揥朷乣. 捗懞廏峃1, 揷敤寬堦1, 嵅摗埿暥, 杒栰夒巎, 愇嶳攷瀶2, 娾懞惓巏1 (1斿擜婍, 2曻幩慄 (庮釃)): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
722101. [妛夛 (慡崙)] (僔儞億僕僂儉) 傾僢僾僼儘儞僩丒僪僙僞僉僙儖+ADT. 揷敤寬堦 (斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/24), 恄屗 (僴僀僽儕僢僪奐嵜).
722102. [妛夛 (慡崙)] (彽懸島墘摍) 崅楊幰偺專恡堏怉搊榐. 愇堜戝曘1, 媑揷堦惉1,2 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕): 戞54夞擔杮椪彴恡堏怉妛夛 (2021/2/18), Web奐嵜.
723489. [妛夛 (慡崙)] (堦斒島墘) 帯椕偵嬯椂偟偨Mycobacterium abscessus偵傛傝暊枌摟愅僇僥乕僥儖僩儞僱儖姶愼偺堦椺. 彑枖梞庽1, 愇堜戝曘1, 墱揷抦巎1, 巘旜斏岶1, 巙懞憇堦楴1, 娾懞惓巏1, 媑揷堦惉1,2 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕): 戞26夞擔杮暊枌摟愅堛妛夛妛弍廤夛丒憤夛 (2020/9/19), 怴廻.
723490. [妛夛 (慡崙)] (堦斒島墘) 拞娫儕僗僋孮偵偍偗傞儓僂慺125枾晻彫慄尮椕朄扨撈偲奜徠幩暪梡枾晻彫慄尮椕朄偺斾妑. 捗懞廏峃1, 揷拞愰摴2, 彫岥抭旻3, 旜挘戱栫, 拞堜丂桋2, 愺愳桬梇4, 斞搰榓朏5, 壛摗惏楴5, 嫶揷丂娹5, 揷敤寬堦1, 嵅摗埿暥, 愇嶳攷瀶6, 娾懞惓巏1 (1斿擜婍, 2撧椙導棫堛壢戝妛, 3偑傫尋桳柧昦堾, 4撧椙導棫堛壢戝曻幩慄帯椕壢, 5挿栰巗柉昦堾, 6曻幩慄 (庮釃)): 戞58夞擔杮娻帯椕妛夛妛弍廤夛 (2020/10/22-24), 嫗搒 (僴僀僽儕僢僪奐嵜), 擔杮娻帯椕妛夛妛弍廤夛彺榐廤58夞 2020; 58: O66-2.
723491. [妛夛 (慡崙)] (堦斒島墘) 拞娫儕僗僋孮偵偍偗傞儓僂慺125枾晻彫慄尮椕朄扨撈偲奜徠幩暪梡枾晻彫慄尮椕朄偺斾妑. 捗懞廏峃1, 揷拞愰摴, 彫岥抭旻, 旜挘戱栫, 拞堜丂桋, 愺愳桬梇, 斞搰榓朏, 壛摗惏楴, 嫶揷丂娹, 揷敤寬堦1, 嵅摗埿暥, 愇嶳攷瀶2, 娾懞惓巏1 (1斿擜婍, 2曻幩慄 (庮釃)): 戞58夞擔杮娻帯椕妛夛妛弍廤夛 (2020/10/24), 嫗搒 (僴僀僽儕僢僪奐嵜).
723492. [妛夛 (慡崙)] (堦斒島墘) 慜棫態慡揈彍弍偵偍偄偰恄宱壏懚庤弍偑愗彍抐抂偵梌偊傞塭嬁偵娭偡傞専摙. 巙懞憇堦楴1, 揷敤寬堦1, 捗懞廏峃1, 抮揷彑恇1, 杒搰榓庽1, 怷丂榡暯1, 暯栰廋暯1, 愇堜戝曘1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍): 戞34夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2020/11/19), Web奐嵜.
723493. [妛夛 (慡崙)] (堦斒島墘) 摉壢偵偍偗傞儘儃僢僩巟墖恡岜宍惉弍偺弶婜惉愌偲暊峯嬀壓恡岜宍惉弍偲偺斾妑専摙. 怷丂榡暯1, 惣丂惙岹, 抮揷彑恇1, 娾懞惓巏1, 愇堜戝曘1 (1斿擜婍): 戞34夞擔杮斿擜婍撪帇嬀妛夛憤夛 (2020/11/19), Web奐嵜.
723494. [妛夛 (慡崙)] (億僗僞乕) The usefulness of ultrasound examination in detecting testicular nubbin in Japanese boys with nonpalpable testes. 怷丂榡暯1, Hamano A, Yamamoto S, Kawamura H, Koyama M, Fujishita M (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723495. [妛夛 (慡崙)] (億僗僞乕) 僾儔僠僫惢嵻懴惈嵞敪擜楬忋旂娻偵懳偡傞gemcitabine/paclitaxel椕朄偺帯椕惉愌. 抮揷彑恇1, 徏杮榓彨1, 揤栰摑擵2, 巙懞憇堦楴1, 暯栰廋暯1, 揷敤寬堦1, 摗揷揘晇1, 媑揷堦惉1,3, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒愭抂堛椕): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723496. [妛夛 (慡崙)] (憤夛徿億僗僞乕) 儕僗僋偺崅偄揮堏惈嫀惃掞峈惈慜棫態娻偵懳偡傞拃師椕朄偱僪僙僞僉僙儖傪愭峴偝偣傞堄媊偼彮側偄: 懡巤愝嫟摨屻傠岦偒尋媶. 栴栰徎戝, 愳忋丂棟, 捗懞廏峃1, 揷敤寬堦1, 恄扟捈恖, 楅栘孾墄, 壨尨悞巌, 忋懞攷巌, 摗杮桽枹, 徏尨怢峎 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723497. [妛夛 (慡崙)] (億僗僞乕) 宱擜摴揑慜棫態儗乕僓乕妀弌弍 (HoLEP) 屻偺嬼敪慜棫態娻偺専摙. 朷寧峃暯1, 嶁揷桾夘1, 崅岥丂戝1, 搚嫶惓恖, 愇堜弤堦榊 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723498. [妛夛 (慡崙)] (億僗僞乕) 崻帯帯椕屻偺揮堏惈慜棫態娻偵懳偡傞揮堏晹徠幩偺弶婜帯椕宱尡. 揷敤寬堦1, 捗懞廏峃1, 懞忋懽惔1, 杒搰榓庽1, 巙懞憇堦楴1, 暯栰廋暯1, 抮揷彑恇1, 愇堜戝曘1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723499. [妛夛 (慡崙)] (億僗僞乕) 忋晹擜楬娻偵懳偡傞恡岜擜娗慡揈彍弍丒銷泖晹暘愗彍弍屻偺銷泖嵞敪偵偍偗傞椪彴昦棟妛揑場巕偺専摙. 巙懞憇堦楴1, 徏杮榓彨1, 抮揷彑恇1, 崅岥丂戝1, 揷壀壚寷1, 暯嶳婱攷1, 懞忋懽惔1, 塅搒媨戱帯, 徏揷戝夘1, 墱栰婭旻, 擖峕丂孾, 娾懞惓巏1 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723500. [妛夛 (慡崙)] (堦斒岥墘) 尷嬊慜棫態娻帯椕乣僄價僨儞僗偲巹偺偙偩傢傝乣嬊強慜棫態娻偵懳偡傞HDR brachytherapy傪梡偄偨帯椕愴棯: 偦偺尷奅偲崱屻偺揥朷. 捗懞廏峃1, 揷敤寬堦1, 嵅摗埿暥1, 杒栰夒巎2, 愇嶳攷瀶3, 娾懞惓巏1 (1斿擜婍, 2崙棫昦堾婡峔憡柾尨昦堾, 3曻幩慄 (庮釃)): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜), 擔杮斿擜婍壢妛夛憤夛108夞 2020; 108: 308.
723501. [妛夛 (慡崙)] (億僗僞乕) 拞娫儕僗僋孮偵偍偗傞慜棫態慡揈彍弍偲Low-dose-rate brachytherapy偺帯椕惉愌斾妑: 懡巤愝嫟摨屻岦偒尋媶. 捗懞廏峃1, 揷拞愰摴2, 彫岥抭旻3, 拞堜丂桋2, 旜挘戱栫, 愺愳桬梇4, 斞搰榓朏5, 壛摗惏楴5, 嫶揷丂娹5, 揷敤寬堦1, 嵅摗埿暥1, 愇嶳攷瀶6 (1斿擜婍, 2撧椙導棫堛壢戝妛, 3偑傫尋桳柧昦堾, 4撧椙導棫堛壢戝曻幩慄帯椕壢, 5挿栰巗柉昦堾, 6曻幩慄 (庮釃)): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜), 擔杮斿擜婍壢妛夛憤夛108夞 2020; 108: 869.
723502. [妛夛 (慡崙)] (堦斒島墘) 怴婯梊屻梊應儌僨儖偐傜尒偨僆儕僑儊僞慜棫態娻偺梊屻. 埨堜彨恖, 嶰岲峃廏, 暷嶳泫巕, 壨尨悞巌, 拞恄媊峅, 戝栰朏惓, 斞捤弤暯, 嫶杮嫳怢, 捗懞廏峃1, 揷敤寬堦1, 忋懞攷巌 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/23), 恄屗 (僴僀僽儕僢僪奐嵜).
723503. [妛夛 (慡崙)] (億僗僞乕) 慜棫態慡揈彍弍偵偍偗傞恄宱壏懚庤弍偑愗彍抐抂偵梌偊傞塭嬁偵娭偡傞専摙. 尨栰婱峅1, 揷敤寬堦1, 捗懞廏峃1, 懞忋懽惔1, 巌攏丂弌1, 墱揷抦巎1, 柸娧丂隳1, 巘旜斏岶1, 摗揷揘晇1, 娾懞惓巏1 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723504. [妛夛 (慡崙)] (憤夛徿億僗僞乕) 拞娫儕僗僋孮偵偍偗傞慜棫態慡揈彍弍偲Low-dose-rate brachytherapy偺帯椕惉愌斾妑: 懡巤愝嫟摨屻岦偒尋媶. 捗懞廏峃1, 揷拞愰摴, 彫岥抭旻, 拞堜丂桋, 旜挘戱栫, 愺愳桬梇, 斞搰榓朏, 壛摗惏楴, 嫶揷丂娹, 揷敤寬堦1, 嵅摗埿暥, 愇嶳攷瀶2 (1斿擜婍, 2曻幩慄 (庮釃)): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723505. [妛夛 (慡崙)] (億僗僞乕) 揮堏惈恡娻偵懳偟僯儃儖儅僽傪娷傓廤妛揑帯椕傪巤峴偟挿婜惗懚傪摼偨1椺. 墫栰丂桾1, 撿揷丂桜, 棫壴婱巎1, 揷壀壚寷1 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723506. [妛夛 (慡崙)] (憤夛徿億僗僞乕) 擇暘愐捙徢姵幰偵偍偗傞恡釐嵀偺宱帪揑悇堏偵偮偄偰偺専摙. 壓栘尨峲懢, 彫椦搷巕1, 嫿尨埡巕, 惣丂惙岹, 嶳嶈梇堦榊 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723507. [妛夛 (慡崙)] (億僗僞乕) 擜摴壓楐弍屻偺姤忬峚晹擜摴旂晢釕偵懳偟偰PATIO (乬preserve the tract and turn it inside out乭) 朄偼桳岠偐? 彫椦搷巕1, 壓栘尨峲懢, 嫿尨埡巕, 惣丂惙岹, 嶳嶈梇堦榊, 娾懞惓巏1 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723508. [妛夛 (慡崙)] (堦斒島墘) 擜楬寢愇摍偺徢忬傪庴恌宊婡偲偟偰徚壔婍墛徢惈幘姵偑嵟廔恌抐偲側偭偨徢椺偺椪彴揑専摙. 垻晹婭擵, 嶳岥丂憦, 戝嶳揘暯1, 摽岝惓峴, 憹堜懃徍, 愇揷桾懃, 奀榁郪椙徍, 悈塱岝攷, 嬥愳嫥堦 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/24), 恄屗 (僴僀僽儕僢僪奐嵜).
723509. [妛夛 (慡崙)] (億僗僞乕) 杒棦戝妛昦堾偵偍偗傞Pembrolizumab偺弶婜巊梡宱尡. 揤栰摑擵1, 徏杮榓彨2, 柸娧丂隳2, 嶁揷桾夘2, 懞忋懽惔2, 暯嶳婱攷2, 捗懞廏峃2, 愇堜戝曘2, 娾懞惓巏2 (1戝妛堾堛椕宯尋媶壢, 2斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723510. [妛夛 (慡崙)] (堦斒島墘) 銷泖娻偵偍偗傞PD-L1敪尰偲梊屻偵娭偡傞専摙. 懞忋懽惔1, 徏杮榓彨1, 巙懞憇堦楴1, 捗懞廏峃1, 揷敤寬堦1, 愇堜戝曘1, 摗揷揘晇1, 嵅摗梇堦, 娾懞惓巏1 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/24), 恄屗 (僴僀僽儕僢僪奐嵜).
723511. [妛夛 (慡崙)] (億僗僞乕) 銷泖娻姵幰偵偍偗傞寣惔拞DJ僞儞僷僋幙敪尰儗儀儖偺専摙. 暯栰廋暯1, 徏杮榓彨1, 揷拞丂孿, 揤栰摑擵2, 捗懞廏峃1, 揷敤寬堦1, 愇堜戝曘1, 挿墫丂椇3, 嵅摗梇堦3, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723512. [妛夛 (慡崙)] (億僗僞乕) 銷泖慡揈徢椺偵偍偗傞擜楬曄岦弍偍傛傃弍慜恡婡擻偲梊屻偵娭偡傞専摙. 崅岥丂戝1, 徏杮榓彨1, 抮揷彑恇1, 揷壀壚寷1, 暯嶳婱攷1, 懞忋懽惔1, 塅搒媨戱帯, 徏揷戝夘1, 墱栰婭旻, 擖峕丂孾, 娾懞惓巏1 (1斿擜婍): 戞108夞擔杮斿擜婍壢妛夛憤夛 (JUA2020) (2020/12/22), 恄屗 (僴僀僽儕僢僪奐嵜).
723513. [妛夛 (慡崙)] (堦斒島墘) 摉壢偵偍偗傞儘儃僢僩巟墖恡岜宍惉弍偺弶婜惉愌偲暊峯嬀壓恡岜宍惉弍偲偺斾妑専摙. 怷丂榡暯1, 暯栰廋暯1, 杒搰榓庽1, 惣丂惙岹, 抮揷彑恇1, 愇堜戝曘1, 娾懞惓巏1 (1斿擜婍): 戞13夞擔杮儘儃僢僩奜壢妛夛妛弍廤夛 (2021/1/23), Web奐嵜.
723514. [妛夛 (慡崙)] (億僗僞乕) 椉懁徚幐惛憙偺1椺. 怷丂榡暯1, 嶳杮復懢榊, 郷栰丂撝 (1斿擜婍): 戞29夞擔杮彫帣斿擜婍壢妛夛憤夛丒妛弍廤夛 (2021/1/31), Web奐嵜.
723515. [妛夛 (慡崙)] (億僗僞乕) 摉堾偵偍偗傞恡堏怉屻儕儞僷憹怋惈幘姵 (PTLD) 偺専摙. 拞懞恀棙峕1, 愇堜戝曘1, 彫椦搷巕1, 杒搰榓庽1, 堜懞梉昉2, 栰岥暥擳2, 娾懞惓巏1, 媑揷堦惉1,3 (1斿擜婍, 2娕岇晹, 3怴悽婭堛椕丒愭抂堛椕): 戞54夞擔杮椪彴恡堏怉妛夛 (2021/2/18), Web奐嵜.
723516. [妛夛 (慡崙)] (億僗僞乕) 杒棦戝妛偺憙忬巺媴懱峝壔徢傪尨幘姵偲偡傞儗僔僺僄儞僩16椺. 杒搰榓庽1, 愇堜戝曘1, 垻晹揘栫2, 拞懞恀棙峕1, 彫椦搷巕1, 栰岥暥擳3, 堜懞梉昉3, 媑揷堦惉1,4, 娾懞惓巏1 (1斿擜婍, 2恡憻撪, 3娕岇晹, 4怴悽婭堛椕丒愭抂堛椕): 戞54夞擔杮椪彴恡堏怉妛夛 (2021/2/19), Web奐嵜.
731032. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 悑師帯椕偵偍偗傞壔妛椕朄偺埵抲晅偗亅暃嶌梡娗棟偱岠壥傪嵟戝偵!亅. 揷敤寬堦 (斿擜婍): WEB僇儞僼傽儗儞僗 (2020/8/5), Web奐嵜.
731033. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 摉壢偵偍偗傞CRPC帯椕曽恓. 揷敤寬堦 (斿擜婍): JEVTANA Interactive Webinar (2020/8/6), Web奐嵜.
731034. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 堏怉堛椕偵偍偗傞COVID-19懳嶔. 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍): Novartis Pharma Web Symposium (2020/8/6), 怴廻 (僴僀僽儕僢僪奐嵜).
731035. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 墦妘揮堏傪桳偡傞慜棫態娻帯椕偺僷儔僟僀儉僔僼僩乣栻嵻椕朄偲嬊強帯椕偺巊偄偳偙傠乣. 揷敤寬堦 (斿擜婍): Prostate Cancer Skype Symposium in Sagamihara (2020/9/2), Web奐嵜.
731036. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 曻幩慄帯椕偐傜峫偊傞Low Vol. (Oligo) mCSPC偺帯椕愴棯. 捗懞廏峃 (斿擜婍): Prostate Cancer Academy Web僙儈僫乕 (2020/9/7), Web奐嵜.
731037. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) M1HSPC偺嵟怴栻暔帯椕. 揷敤寬堦 (斿擜婍): 椪彴斿擜婍僙儈僫乕 (2020/11/6), Web奐嵜.
731038. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) Low volume and high volume mCSPC丂栻暔椕朄偲曻幩慄椕朄: 偦傟偧傟偐傜傒偨帯椕愴棯. 捗懞廏峃 (斿擜婍): 慜棫態WEB僙儈僫乕 (2020/11/12), Web奐嵜.
731039. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mCSPC帯椕偺嵟怴挭棳偵懳偡傞Clinical question. 揷敤寬堦 (斿擜婍): 慜棫態娻嵟怴CQ Web僙儈僫乕 (2020/11/18), Web奐嵜.
731040. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) CRPC偵偍偗傞僞僉僒儞宯栻嵻偺FN儅僱僕儊儞僩 揷敤寬堦 (斿擜婍): WEB僇儞僼傽儗儞僗 (2020/12/11), Web奐嵜.
731041. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 墦妘揮堏傪桳偡傞慜棫態娻偺僷儔僟僀儉僔僼僩. 揷敤寬堦 (斿擜婍): Niigata Urology Seminar 2020 (2020/12/12), 怴妰.
731042. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) ARAMIS帋尡擇尵僨乕僞偐傜杮朚偵偍偗傞MOCRPC帯椕傪峫偊傞. 揷敤寬堦 (斿擜婍): 僯儏儀僋僆WEB conference (2021/1/28), Web奐嵜.
731043. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) mCRPC偵偍偗傞儕儉僷乕僓偺巊梡宱尡. 揷敤寬堦 (斿擜婍): CRPC Precision Medicine Online Seminar (2021/2/3), Web奐嵜.
731044. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 嵼戭堛椕偲偟偰偺恡晄慡帯椕偵偍偗傞撪壢帯椕偺廳梫惈. 媑揷堦惉1,2 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍): 搶戝榓巗堛巘夛妛弍島墘夛Web攝怣 (2021/2/26), Web奐嵜.
731045. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 乽mCSPC偺昗弨帯椕乿乣栻暔椕朄偲曻幩慄帯椕偺僄價僨儞僗偲崱屻偺揥朷乣. 捗懞廏峃 (斿擜婍): 慜棫態偑傫Web僙儈僫乕 in KANAGAWA (2021/3/11), Web奐嵜.
732028. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 愭峴揑恡堏怉偺尰忬. 愇堜戝曘1, 杒搰榓庽1, 媑揷堦惉1,2 (1斿擜婍, 2怴悽婭堛椕丒愭抂堛椕): 戞85夞擔杮斿擜婍壢妛夛搶晹憤夛 (2020/9/25), Web奐嵜.
732029. [妛夛 (抧曽夛丒尋媶夛)] (嫟嵜僙儈僫乕) 恑峴惈慜棫態娻帯椕偺嵟慜慄乣嵟怴僄價僨儞僗傪庴偗偰偳偆曄傢傞偺偐?乣. 揷敤寬堦 (斿擜婍): 戞85夞擔杮斿擜婍壢妛夛搶晹憤夛 (2020/10/10), Web奐嵜.
732030. [妛夛 (抧曽夛丒尋媶夛)] (嫟嵜僙儈僫乕) mCSPC帯椕傪峫嶡偡傞. 揷敤寬堦 (斿擜婍): 戞3夞憡柾尨丒惣屛僄儕傾CSPC島墘夛 (2020/11/12), Web奐嵜.
733097. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉堾偵偍偗傞慜棫態娻偺僽儔僉僙儔僺乕乣僽儔僉 (撪徠幩) 偺桳岠惈偵偮偄偰乣. 捗懞廏峃 (斿擜婍): 戞2夞恄撧愳導惣晹Urology Web Seminar (2020/9/1), 奀榁柤.
733098. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 壓晹擜楬徢忬偍傛傃寣擜傪崌暪偟偨銷泖僿儖僯傾偺2椺. 媏抧戝庽, 嶳岥丂憦, 戝嶳揘暯1, 摽岝惓峴, 憹堜懃徍, 愇揷桾懃 (1斿擜婍): 戞410夞擔杮斿擜婍壢妛夛杒奀摴抧曽夛 (2020/9/12), 嶥杫.
733099. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 慜棫態娻偺僆儕僑揮堏偵懳偡傞揮堏晹埵曻幩慄帯椕 (MDRT) 偺専摙. 揷敤寬堦1, 捗懞廏峃1, 懞忋懽惔1, 揤栰峢擵2, 巙懞憇堦楴1, 暯栰廋暯1, 杒搰榓庽1, 抮揷彑恇1, 怷丂榡暯1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢): 戞85夞擔杮斿擜婍壢妛夛搶晹憤夛 (2020/9/25), Web奐嵜.
733100. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 恑峴惈擜楬忋旂娻偵懳偡傞Pembrolizumab偺巊梡宱尡. 揤栰峢擵1, 徏杮榓彨2, 抮揷彑恇2, 暯栰廋暯2, 怷丂榡暯2, 捗懞廏峃2, 揷敤寬堦2, 愇堜戝曘2, 娾懞惓巏2 (1戝妛堾堛椕宯尋媶壢, 2斿擜婍): 戞85夞擔杮斿擜婍壢妛夛搶晹憤夛 (2020/9/25), Web奐嵜.
733101. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 銷泖娻偱偺PD-L1敪尰晹埵偲偦偺梊屻梊應場巕偲偟偰偺栶妱偵偮偄偰. 懞忋懽惔1, 徏杮榓彨1, 抮揷彑恇1, 暯栰廋暯1, 杒搰榓庽1, 愇堜戝曘1, 嵅摗梇堦2, 娾懞惓巏1 (1斿擜婍, 2堛椕塹惗妛晹): 戞85夞擔杮斿擜婍壢妛夛搶晹憤夛 (2020/9/25), Web奐嵜.
733102. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擜楬忋旂娻偵懳偡傞gemcitabine/paclitaxel 2師壔妛椕朄偺帯椕惉愌. 抮揷彑恇1, 徏杮榓彨1, 揤栰峢擵2, 巙懞憇堦楴1, 捗懞廏峃1, 揷敤寬堦1, 媑揷堦惉1,3, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢, 3怴悽婭堛椕丒愭抂堛椕): 戞85夞擔杮斿擜婍壢妛夛搶晹憤夛 (2020/9/25), Web奐嵜.
733103. [妛夛 (抧曽夛丒尋媶夛)] (億僗僞乕) 娞丒擼揮堏恡娻徢椺偵懳偡傞僀僺儕儉儅僽亄僯儃儖儅僽 (Ipi亄Nivo) 暪梡椕朄偺宱尡. 杒搰榓庽1, 愇堜戝曘1, 摗揷揘晇1, 墱揷抦巎1, 巌攏丂弌1, 拞懞恀棙峕1, 彑枖梞庽1, 巘旜斏岶1, 巙懞憇堦楴1, 揤栰峢擵2, 懞忋懽惔1, 暯栰廋暯1, 抮揷彑恇1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍, 2戝妛堾堛椕宯尋媶壢): 戞85夞擔杮斿擜婍壢妛夛搶晹憤夛 (2020/9/25), Web奐嵜.
733104. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恡岜擜娗慡揈弌弍屻偺銷泖嵞敪偵偍偗傞椪彴昦棟妛揑場巕偺専摙. 巙懞憇堦楴1, 徏杮榓彨1, 抮揷彑恇1, 巘旜斏岶1, 崅岥丂戝1, 揷壀壚寷1, 暯嶳婱攷1, 懞忋懽惔1, 塅搒媨戱帯, 徏揷戝夘1, 墱栰婭旻, 擖峕丂孾, 娾懞惓巏1 (1斿擜婍): 戞85夞擔杮斿擜婍壢妛夛搶晹憤夛 (2020/9/25), Web奐嵜.
733105. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 慜棫態慡揈屻偵擜娗揮堏傪棃偟偨堦椺. 崅岥丂戝1, 抮揷彑恇1, 墿丂塸栁 (1斿擜婍): 戞72夞惣擔杮斿擜婍壢妛夛憤夛 (2020/11/7), Web奐嵜.
733106. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 怋惈銷泖墛偲崪斦帀朾徢傪崌暪偟偨椉懁悈恡徢傪掓偟偨1椺. 朷寧峃暯1, 嶁揷桾夘1, 崅岥丂戝1, 愇堜弮堦榊, 抮揷彑恇1 (1斿擜婍): 戞72夞惣擔杮斿擜婍壢妛夛憤夛 (2020/11/7), Web奐嵜.
733107. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 憹怋惈銷泖墛偲崪斦帀朾庮徢傪崌暪偟椉懁悈恡徢傪掓偟偨1椺. 朷寧峃暯1, 嶁揷桾夘1, 嬥峧桭栘巕, 愇堜弤堦榊 (1斿擜婍): 戞72夞惣擔杮斿擜婍壢妛夛憤夛 (2020/11/7), Web奐嵜.
733108. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) OLEP偵偍偗傞夁妶摦銷泖夵慞岠壥. 嶁揷桾夘1, 朷寧峃暯1, 崅岥丂戝1, 搚嫶惓恖, 愇堜弮堦榊 (1斿擜婍): 戞70夞擔杮斿擜婍壢妛夛拞晹憤夛 (2020/11/12-14), 愇愳 (僴僀僽儕僢僪奐嵜).
733109. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 慜棫態娻丒恡娻偺儘儃僢僩庤弍偵婜懸偝傟傞偙偲. 杒搰榓庽 (斿擜婍): SKYT2021 WEB Conference (2021/2/4), Web奐嵜.
733110. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 塃恡岜娻弍捈屻偵寣惔娞峺慺丆鋁峺慺偑媫懍偵憹埆偟偨堦椺. 尨栰婱峅1, 庒揷晹梲巌1, 墱栰婭旻, 娾懞惓巏1 (1斿擜婍): 戞62夞擔杮斿擜婍壢妛夛恄撧愳抧曽夛 (2021/2/25), Web奐嵜,斿擜婍奜壢 2021; 34 (8): 1013.
733111. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 埆惈崟怓庮偺椉懁暃恡揮堏偵懳偟偰椉懁暃恡揈彍弍傪巤峴偟偨堦椺. 朙揷徆旤1, 抮揷彑恇1, 烴堜丂梫1, 懞栘晀榊1, 戝怷庨榓擳1, 拞懞恀棙峕1, 彫椦搷巕1, 彑枖梞庽1, 徏杮榓彨1, 娾懞惓巏1 (1斿擜婍): 戞62夞擔杮斿擜婍壢妛夛恄撧愳抧曽夛 (2021/2/25), Web奐嵜,斿擜婍奜壢 2021; 34 (8): 1015.
娽壢妛
[妛弍榑暥]
110341. [尨挊] Relationship between novel intraocular pressure measurement from Corvis ST and central corneal thickness and corneal hysteresis. Matsuura M1, Murata H, Fujino Y2, Yanagisawa M, Nakao Y, Tokumo K, Nakakura S, Kiuchi Y, Asaoka R: Br J Ophthalmol 2020/4; 104 (4): 563-8. (徏塝彨恖1, 摗栰桭棦2: 1戝妛堾堛椕宯尋媶壢, 2娽壢)
110342. [尨挊] Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database. Asano S, Murata H, Matsuura M1, Fujino Y2, Miki A, Tanito M, Mizoue S, Mori K, Suzuki K, Yamashita T, Kashiwagi K, Shoji N2, Zangwill LM, Asaoka R: Br J Ophthalmol 2020/4; 104 (4): 569-74. (徏塝彨恖1, 摗栰桭棦2, 彲巌怣峴2: 1戝妛堾堛椕宯尋媶壢, 2娽壢)
110343. [尨挊] Effect of corneal cross-linking on endothelial cell density and morphology in the peripheral cornea. Goukon H1, Kamiya K2, Takahashi M1, Shoji N1: BMC Ophthalmol 2020/4; 20 (1): 139. (嫿塃嬤攷峃1, 恄扟榓岶2, 崅嫶惓塸1, 彲巌怣峴1: 1娽壢, 2堛椕塹惗妛晹)
110344. [尨挊] Comparison of Conventional Keratometry and Total Keratometry in Normal Eyes. Hoshikawa R1, Kamiya K1, Fujimura F1, Shoji N2: Biomed Res Int 2020/4; 2020: 8075924. (姳愳棦奊1, 恄扟榓岶1, 摗懞晣嵅巕1, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110345. [尨挊] The usefulness of the Deep Learning method of variational autoencoder to reduce measurement noise in glaucomatous visual fields. Asaoka R, Murata H, Asano S, Matsuura M, Fujino Y, Miki A, Tanito M, Mizoue S, Mori K, Suzuki K, Yamashita T, Kashiwagi K, Shoji N1: Sci Rep 2020/5; 10 (1): 7893. (彲巌怣峴1: 1娽壢)
110346. [尨挊] Comparison of angle-to-angle distance using three devices in normal eyes. Saito A1, Kamiya K2, Fujimura F2, Takahashi M1, Shoji N1: Eye (Lond) 2020/6; 34 (6): 1116-20. (釼摗丂嵤1, 恄扟榓岶2, 摗懞晣嵅巕2, 崅嫶惓塸1, 彲巌怣峴1: 1娽壢, 2堛椕塹惗妛晹)
110347. [尨挊] Comparison of Predictability Using Barrett Universal II and SRK/T Formulas according to Keratometry. Iijima K1, Kamiya K2, Iida Y1, Shoji N1: J Ophthalmol 2020/6; 2020: 7625725. (斞搰丂宧1, 恄扟榓岶2, 斞揷壝旻1, 彲巌怣峴1: 1娽壢, 2堛椕塹惗妛晹)
110348. [尨挊] Effect of Angle Opening Parameters on Corneal Endothelial Cell Density and Intraocular Pressure after Posterior Chamber Phakic Intraocular Lens Implantation. Kamiya K1, Ando W2, Tsujisawa T2, Takahashi M2, Shoji N2: J Clin Med 2020/8; 9 (9): 2704. (恄扟榓岶1, 埨摗榓壧巕2, 捯戲扖旻2, 崅嫶惓塸2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110349. [尨挊] Standard coronal orbital magnetic resonance imaging is an effective technique for diagnosing sagging eye syndrome. Kawai M1, Goseki T2, Ishikawa H1, Tatsui S2, Shoji N2: Graefes Arch Clin Exp Ophthalmol 2020/9; 258 (9): 1983-9. (壨崌垽幚1, 屻娭棙柧2, 愇愳丂嬒1, 棿堜墤巕2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110350. [尨挊] Visual and Topographic Improvement with Epithelium-On, Oxygen-Supplemented, Customized Corneal Cross-Linking for Progressive Keratoconus. Kamiya K1, Kanayama S2, Takahashi M2, Shoji N2: J Clin Med 2020/10; 9 (10): 3222.
(恄扟榓岶1, 嬥嶳弐夘2, 崅嫶惓塸2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110351. [尨挊] Objective measurement of nine gaze-directions using an eye-tracking device. Iwata Y1, Handa T1, Ishikawa H1: J Eye Mov Res 2020/10; 13 (6): 10.16910/jemr.13.6.4. (娾揷丂梱1, 敿揷抦栫1, 愇愳丂嬒1: 1堛椕塹惗妛晹)
110352. [尨挊] The Effects of Chewing Gum in Preventing Eyestrain. Asakawa K1, Kanno S, Ando T, Osawa K, Ishikawa H1: Biomed Res Int 2020/11; 2020: 2470473. (愺愳丂尗1, 愇愳丂嬒1: 1堛椕塹惗妛晹)
110353. [尨挊] Long-term clinical results of trabectome surgery in patients with open-angle glaucoma. Kono Y1, Kasahara M2, Hirasawa K2, Tsujisawa T1, Kanayama S1, Matsumura K2, Morita T, Shoji N2: Graefes Arch Clin Exp Ophthalmol 2020/11; 258 (11): 2467-76. (壨栰梇椇1, 妢尨惓峴2, 暯郪堦朄2, 捯戲扖旻1, 嬥嶳弐夘1, 徏懞堦峅2, 彲巌怣峴2: 1戝妛堾堛椕宯尋媶壢, 2娽壢)
110354. [尨挊] Usefulness of data augmentation for visual field trend analyses in patients with glaucoma. Asaoka R, Murata H, Matsuura M1, Fujino Y2, Miki A, Tanito M, Mizoue S, Mori K, Suzuki K, Yamashita T, Kashiwagi K, Shoji N2: Br J Ophthalmol 2020/12; 104 (12): 1697-703. (徏塝彨恖1, 摗栰桭棦2, 彲巌怣峴2: 1戝妛堾堛椕宯尋媶壢, 2娽壢)
110355. [尨挊] Comparison of Phakic Intraocular Lens Vault Using Conventional Nomogram and Prediction Formulas. Ando W1, Kamiya K2, Hayakawa H1, Takahashi M1, Shoji N1: J Clin Med 2020/12; 9 (12): 4090. (埨摗榓壧巕1, 恄扟榓岶2, 憗愳廏婸1, 崅嫶惓塸1, 彲巌怣峴1: 1娽壢, 2堛椕塹惗妛晹)
110356. [尨挊] Etiology and outcomes of current posterior chamber phakic intraocular lens extraction. Hayakawa H1, Kamiya K2, Ando W1, Takahashi M1, Shoji N1: Sci Rep 2020/12; 10 (1): 21686. (憗愳廏婸1, 恄扟榓岶2, 埨摗榓壧巕1, 崅嫶惓塸1, 彲巌怣峴1: 1娽壢, 2堛椕塹惗妛晹)
110357. [尨挊] Discrepancy in Loss of Macular Perfusion Density and Ganglion Cell Layer Thickness in Early Glaucoma. Hirasawa K1, Smith CA, West ME, Sharpe GP, Shuba LM, Rafuse PE, Nicolela MT, Vianna JR, Chauhan BC: Am J Ophthalmol 2021/1; 221: 39-47. (暯郪堦朄1: 1娽壢)
110358. [尨挊] Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study. Ishikawa H, Masuda Y, Ishikawa H1, Shikisima K, Goseki T2, Kezuka T, Terao M, Miyazaki A, Matsumoto K, Nishikawa H, Gomi F, Mimura O: Jpn J Ophthalmol 2021/1; 65 (1): 133-142. (愇愳丂嬒1, 屻娭棙柧2: 1堛椕塹惗妛晹, 2娽壢)
110359. [尨挊] Ocular and Systemic Factors Affecting Laser Speckle Flowgraphy Measurements in the Optic Nerve Head. Anraku A, Enomoto N, Tomita G, Iwase A, Sato T, Shoji N1, Shiba T, Nakazawa T, Sugiyama K, Nitta K, Araie M: Transl Vis Sci Technol 2021/1; 10 (1): 13. (彲巌怣峴1: 1娽壢)
110360. [尨挊] Intravenous immunoglobulin treatment for steroid-resistant optic neuritis: a multicenter, double-blind, randomized, controlled phase III study. Mimura O, Ishikawa H1, Kezuka T, Shikishima K, Suzuki T, Nakamura M, Chuman H, Inoue K, Kimura A, Yamagami A, Mihoya M, Nakao Y: Jpn J Ophthalmol 2021/1; 65 (1): 122-32. ( 愇愳丂嬒1: 1堛椕塹惗妛晹)
110361. [尨挊] Strabismus After Ahmed Glaucoma Valve Implantation. Robbins L, Goseki T1, Law SK, Nouri-Mahdavi K, Caprioli J, Coleman AL, Giaconi JA, Demer JL, Velez FG, Pineles SL: Am J Ophthalmol 2021/2; 222: 1-5. (屻娭棙柧1: 1娽壢)
110362. [尨挊] Prediction of distance visual acuity in presbyopic astigmatic subjects. Hoshikawa R1, Kamiya K1, Fujimura F1, Shoji N2: Sci Rep 2021/3; 11 (1): 6958. (姳愳棦奊1, 恄扟榓岶1, 摗懞晣嵅巕1, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
110363. [尨挊] Characterization of the position of the extraocular muscles and orbit in acquired esotropia both at distance and near using orbital magnetic resonance imaging. Kawai M1, Goseki T2, Ishikawa H3, Tatsui S2, Li H, Ukisu R4, Shoji N2: PLoS One 2021/3; 16 (3): e0248497. (壨崌垽幚1, 屻娭棙柧2, 愇愳丂嬒3, 棿堜墤巕2, 晜廎棿懢榊4, 彲巌怣峴2: 1戝妛堾堛椕宯尋媶壢, 2娽壢, 3堛椕塹惗妛晹, 4曻幩慄 (夋憸))
120022. [尨挊]亂妛夛尨挊: 戞73夞擔杮椪彴娽壢妛夛島墘廤 [3]亃島墘21-1 娽豳醶澒姵幰偺擔忢惗妶偺晄帺桼搙偲婋尟搙. 壨杮傂傠旤1, 娾嵅恀媩1, 嶳忋柧巕1,2, 堜忋尗帯1, 庒憅夒搊1 (1堜忋娽壢昦堾, 2娽壢): 椪彴娽壢2020/5; 74 (5): 577-81.
120023. [尨挊]亂妛夛尨挊: 戞73夞擔杮椪彴娽壢妛夛島墘廤 [4]亃揥帵6-037 悈徎懱嵞寶弍屻偺娽撪儗儞僘岝妛晹偺孹幬曽岦偲掱搙傪娤嶡偡傞怴偟偄曽朄. 攏搱惔擛1, 巗愳丂宑2, 庰堜岾峅3, 撪摗彯媣3, 堥扟彯婸4, 曅壀悡攷4, 拞懞桭徍4, 嬍抲柧栰5, 巗愳堦晇3,6 (1娽壢柧娽堾, 2憤崌惵嶳昦堾娽壢, 3拞嫗娽壢, 4柤屆壆傾僀僋儕僯僢僋, 5抧堟堛椕婡擻悇恑婡峔拞嫗昦堾娽壢, 6娽壢): 椪彴娽壢 2020/6; 74 (6): 735-45.
120024. [尨挊]亂戞58夞擔杮敀撪忈妛夛妛弍徿庴徿婰擮榑暥亅椪彴亅亃敀撪忈娽偵偍偗傞懠妎慜曽嶶棎偺娭楢場巕偲庤弍慜屻偵偍偗傞曄壔. 恄扟榓岶 (堛椕塹惗妛晹): 擔杮敀撪忈妛夛帍 2020/6; 32: 11-5.
120025. [尨挊] 3D Visual Function Trainer-ORTe偲戝宆庛帇嬀偺夞慁梈憸堟偺斾妑. 屗捤榓巕1,2, 屻娭棙柧1, 愇愳丂嬒3, 敿揷抦栫3, 弿曽抭宐巕2, 彲巌怣峴1 (1娽壢, 2弿曽堛堾, 3堛椕塹惗妛晹): 恄宱娽壢 2020/6; 37 (2): 154-9.
120026. [尨挊] 傾僶儞僔傿�1P偺鵑撪屌掕忬懺偺昡壙. 斞揷壝旻1, 惔悈岞栫2, 彲巌怣峴1 (1娽壢, 2嶳墹昦堾傾僀僙儞僞乕): IOL&RS 2020/9; 34 (3): 475-80.
120027. [尨挊]亂妛夛尨挊: 戞60夞擔杮帇擻嫺惓妛夛僔儞億僕僂儉I丂僋儘乕僘傾僢僾乣嬤帇乣亃妛峑寬峃恌抐偲彫帣偺嬤帇 摗懞晣嵅巕 (堛椕塹惗妛晹): 擔杮帇擻孭楙巑嫤夛帍 2020/12; 49: 1-6.
120028. [尨挊]亂妛夛尨挊: 戞60夞擔杮帇擻嫺惓妛夛堦斒島墘亃徟揰怺搙奼挘宆3徟揰娽撪儗儞僘偲掅壛擖夞愜宆2徟揰娽撪儗儞僘偺弍屻惉愌偺斾妑. 姖栰隳屽1, 彫搰棽巌2, 塅懮宐巕1, 庰堜岾峅1, 壛摗岾恗1, 嶰揷懞杻棦1, 撪摗彯媣1, 嬍抲柧栰3, 巗愳堦晇1,4 (1拞嫗娽壢, 2宑墳媊弇戝妛, 3JCHO拞嫗昦堾, 4娽壢): 擔杮帇擻孭楙巑嫤夛帍 2020/12; 49: 21-30.
120029. [尨挊]亂妛夛尨挊: 戞60夞擔杮帇擻嫺惓妛夛堦斒島墘亃岝妛幃惗懱寁應憰抲偲慜娽晹OCT偵傛傞僩乕儕僢僋娽撪儗儞僘偺棎帇嫺惓岠壥偺斾妑. 梋揷愮宐1, 庰堜岾峅1, 彫搰棽巌2, 嬍抲柧栰3, 壛摗岾恗1, 塅懮宐巕1, 姖栰隳屽1, 嶳杮恀嵷3, 撪摗彯媣1, 巗愳堦晇1,4 (1拞嫗娽壢, 2宑墳媊弇戝妛, 3JCHO拞嫗昦堾, 4娽壢): 擔杮帇擻孭楙巑嫤夛帍 2020/12; 49: 31-8.
120030. [尨挊]亂妛夛尨挊: 戞60夞擔杮帇擻嫺惓妛夛堦斒島墘亃彫妛4丒5擭惗偵偍偗傞娍帤彂帤偵塭嬁偡傞帇妎揑梫場偺専摙. 壀栰恀媩1, 撪愳媊榓1, 揷懞徣屽2, 釼摗恀擵夘2, 怴堜揷岶桾1,3 (1崙嵺堛椕暉巸戝妛曐寬堛椕妛晹帇婡擻椕朄妛壢, 2嬨廈曐寬暉巸戝妛曐寬壢妛晹帇婡擻椕朄妛壢, 3娽壢): 擔杮帇擻孭楙巑嫤夛帍 2020/12; 49: 119-25.
120031. [尨挊]亂妛夛尨挊: 戞60夞擔杮帇擻嫺惓妛夛堦斒島墘亃徴摦惈娽媴塣摦偍傛傃妸摦惈捛廬塣摦偑惷揑棫埵帪偺廳怱摦梙偵媦傏偡塭嬁. 撪愳媊榓1, 壀幚擳棦1, 嵵摗愮桾1, 拞揷浠撧1, 懞壀幍奀1, 壀栰恀媩1, 怴堜揷岶桾1,2 (1崙嵺堛椕暉巸戝妛曐寬堛椕妛晹帇婡擻椕朄妛壢, 2娽壢): 擔杮帇擻孭楙巑嫤夛帍 2020/12; 49: 147-54.
120032. [尨挊] 慜娽晹岝姳徛抐憌寁傪梡偄偨妏枌岤偺晹埵暿斾妑偲擭楊曄壔. 釼摗埱撧1, 埳摗旤嵐奊1, 抮揷揘栫1,2, 屲廫棐復巎1,2, 惔悈岞栫1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): 偁偨傜偟偄娽壢 2021/2; 38 (2): 197-201.
120033. [尨挊] 崅師擼婡擻偺娭梌偑媈傢傟傞愕柧丒娽捝. 庒憅夒搊1, 慮変晹桼崄2, 尨丂捈恖3, 嶳忋柧巕1,4, 壛栁弮巕5, 暉懞旤斂6, 墱丂塸峅7, 拠攽丂憦8, 嶰懞丂帯9 (1堜忋娽壢昦堾, 2嶰朙憤崌昦堾, 3崙嵺堛椕暉巸戝妛曐寬堛椕妛晹帇婡擻椕朄妛, 4娽壢, 5峛晎嫟棫昦堾, 6壓娭堛椕僙儞僞乕, 7戝嶃堛壢戝妛, 8棟壔妛尋媶強, 9暫屔堛壢戝妛): 恄宱娽壢 2021/3; 38 (1): 7-13.
310042. [徢椺曬崘] Two cases of epithelial ingrowth after small incision lenticule extraction. Kamiya K1, Takahashi M2, Shoji N2, Naruse S: Am J Ophthalmol Case Rep 2020/7; 19: 100819. (恄扟榓岶1, 崅嫶惓塸2, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
320032. [徢椺曬崘] 嫮搙嬤帇傪敽傢側偄屌掕撪幬帇偵懳偟, 忋奜捈嬝寢崌弍偑桳梡偱偁偭偨堦椺. 尨揷桪巕1, 屻娭棙柧2, 嬥揷榓朙1, 愇愳丂嬒3, 拞嶈廏擇1 (1媨嶈拞墰娽壢昦堾, 2娽壢, 3堛椕塹惗妛晹): 恄宱娽壢 2020/6; 37 (2): 160-4.
320033. [徢椺曬崘] 娽媴塣摦忈奞傪敽偭偨帇椡夞暅晄椙偺峈MOG峈懱梲惈帇恄宱墛偺1椺. 愇愳戝婲1, 愇愳丂嬒2, 棿堜墤巕1, 屻娭棙柧1, 嬥嶳弐夘3, 斞揷壝旻1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢): 恄宱娽壢 2020/12; 37 (4): 413-7.
320034. [徢椺曬崘] 僗僥儘僀僪僷儖僗偍傛傃寣燋岎姺椕朄偵柍斀墳偱偁偭偨儈僩僐儞僪儕傾堚揱巕曄堎傪桳偡傞帇恄宱墛偺1椺. 棿堜墤巕1, 嬥嶳弐夘2, 屻娭棙柧1, 愇愳丂嬒3, 彲巌怣峴1 (1娽壢, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹): 恄宱娽壢 2020/12; 37 (4): 418-22.
320035. [徢椺曬崘] 價僞儈儞A寚朢徢偑尨場偲峫偊傜傟傞廳彎妏枌姶愼徢傪惗偠偨彫帣帺暵徢僗儁僋僩儔儉忈奞偺1椺. 崅嫶壺巕1, 恄扟榓岶2, 崅嫶惓塸1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 娽壢 2021/3; 63 (3): 267-73.
510016. [憤愢] Effectiveness and limitations of minimally invasive glaucoma surgery targeting Schlemm's canal. Kasahara M1, Shoji N1: Jpn J Ophthalmol 2021/1; 65 (1): 6-22. (妢尨惓峴1, 彲巌怣峴1: 1娽壢)
520012. [憤愢] Sagging Eye Syndrome. 屻娭棙柧 (娽壢): 擔杮偺娽壢 2020/6; 91 (6): 60-5.
520013. [憤愢] 2020JSCRS Clinical Survey. 嵅摗惓庽1, 恄扟榓岶1,2, 彫搰棽巌1, 屻摗寷恗1, 揷暎恗巙1, 弶嶁撧捗巕1, 椦丂丂尋1 (1JSCRS僨乕僞夝愅埾堳夛, 2堛椕塹惗妛晹): IOL&RS 2020/9; 34 (3): 412-32.
520014. [憤愢] JSCRS COVID-19嬞媫傾儞働乕僩. 恄扟榓岶1,2, 嵅摗惓庽1, 椦丂丂尋1, 彫搰棽巌1, 屻摗寷恗1, 揷暎恗巙1, 弶嶁撧捗巕1 (1JSCRS僨乕僞夝愅埾堳夛, 2堛椕塹惗妛晹): IOL&RS 2020/9; 34 (3): 441-6.
521008. [夝愢]亂婡婍丒栻嵻徯夘亃庤弍偺僐僣偲僩儔僽儖僔儏乕僥傿儞僌: 椢撪忈曇1. 慇堐拰懷愗彍弍. 彲巌怣峴 (娽壢): 娽壢 2020/4; 62 (4): 383-9.
521009. [夝愢]亂婡婍丒栻嵻徯夘亃46. 懠妎揑帇婡擻専嵏憰抲ORTe EYENAC. 敿揷抦栫 (堛椕塹惗妛晹): 娽壢 2020/5; 62 (5): 482-8.
521010. [夝愢]亂僐儞僒儖僥乕僔儑儞僐乕僫乕亃僄僉僗僷乕僩偵暦偔 (榖戣採嫙幰). 屲廫棐復巎1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): IOL&RS 2020/6; 34 (2): 329-36.
521011. [夝愢]亂娽壢堛偺庤堷 <967>亃幬帇傊偺儃僣儕僰僗撆慺帯椕. 屻娭棙柧 (娽壢): 擔杮偺娽壢 2020/9; 91 (9): 1322-3.
521012. [夝愢]亂Clinical Challenge亃帇恄宱擕摢敪愒丒庮挴偐傜峫偊傞娪暿恌抐. 愇愳丂嬒1, 棿堜墤巕2 (1堛椕塹惗妛晹, 2娽壢): 椪彴娽壢 2020/10; 74 (10): 1182-5.
521013. [夝愢]亂栚偱尒傞僔儕乕僘 夋憸偱尒傞椢撪忈偺昦懺 戞15夞亃朳悈惷柆偵拲栚偟偨棳弌楬嵞寶弍. 暷嶳丂椚1, 妢尨惓峴1 (1娽壢): Frontiers in Glaucoma 2020/10; 60: 1-6.
521014. [夝愢]亂偙偩傢傝偺恌椕婍嬶亃巗愳幃僟僽儖僄儞僪儅僯僺儏儗乕僞乕. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): IOL&RS 2021/3; 35 (1): 166-8.
522084. [島嵗]亂摿廤 (1): 怴偟偄妏枌庤弍亃僼僃儉僩僙僇儞僪儗乕僓乕妏枌庤弍. 恄扟榓岶 (堛椕塹惗妛晹): 娽壢僌儔僼傿僢僋 2020/4; 9 (2): 124-30.
522085. [島嵗]亂摿廤: 傛偔傢偐傞孅愜嫺惓庤弍亃儗乕僔僢僋, 昞柺徠幩偺弍屻恌嶡偲挿婜宱夁. 屲廫棐復巎1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): OCULISTA 2020/4; 85: 59-66.
522086. [島嵗]亂摿廤: 娽壢偵偍偗傞儕僗僋儅僱僕儊儞僩偺億僀儞僩亃摐擜昦栐枌徢, 崅寣埑惈娽掙恌椕偺儕僗僋儅僱僕儊儞僩. 巗绯媊復1,2 (1恄撧愳帟壢戝妛晅懏墶昹僋儕僯僢僋, 2娽壢): OCULISTA 2020/5; 86: 47-56.
522087. [島嵗]亂摿廤匒: 墌悕妏枌恌椕偺恑曕亃墌悕妏枌偵懳偡傞娤寣揑帇椡嫺惓朄. 恄扟榓岶 (堛椕塹惗妛晹): 娽壢僌儔僼傿僢僋 2020/6; 9 (3): 307-13.
522088. [島嵗]亂摿廤: 墌悕妏枌帯椕偺弍屻昡壙亃僇僗僞儉妏枌僋儘僗儕儞僉儞僌偺弍屻帇婡擻. 崅嫶惓塸 (娽壢): 娽壢庤弍 2020/4; 33 (2): 198-206.
522089. [島嵗]亂傢偐傝傗偡偄椪彴島嵗亃敀撪忈庤弍偵偍偗傞儌僲價僕儑儞. 屲廫棐復巎1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): 擔杮偺娽壢 2020/8; 91 (8): 1187-92.
522090. [島嵗]亂崱寧偺榖戣亃AI偺妏枌宍忬夝愅傊偺墳梡. 恄扟榓岶 (堛椕塹惗妛晹): 椪彴娽壢 2020/9; 74 (9): 1077-83.
522091. [島嵗]亂NEWS&TOPICS崱寧偺堦榖亃峈庮釃栻偵傛傞娽暃嶌梡. 攼栘峀嵠1,2 (1惷壀導棫惷壀偑傫僙儞僞乕娽壢, 2娽壢): 擔杮偺娽壢 2020/9; 91 (9): 1282-3.
522092. [島嵗]亂傢偐傝傗偡偄椪彴島嵗亃怓僐儞僩儔僗僩偲帇擣惈. 愳庣揷戱巙 (堛椕塹惗妛晹): 擔杮偺娽壢 2020/9; 91 (9): 1298-302.
522093. [島嵗]亂摿廤: 孅愜嫺惓庤弍偺僩儔僽儖僔儏乕僥傿儞僌亃屻朳宆桳悈徎懱娽撪儗儞僘偺僩儔僽儖僔儏乕僥傿儞僌. 屲廫棐復巎1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): IOL&RS 2020/9; 34 (3): 400-6.
522094. [島嵗]亂摿廤: 怑嬈惈娽忈奞偺儅僱乕僕儊儞僩亃嶐崱偺儌僶僀儖僨僶僀僗巊梡偵傛傞帇婡擻傊偺塭嬁. 娾揷丂梱1, 愇愳丂嬒1 (1堛椕塹惗妛晹): OCULISTA 2020/10; 91: 69-76.
522095. [島嵗]亂娽壢儗儞僘僙儈僫乕 407亃僿僢僘傾僢僾 (heads-up) 敀撪忈庤弍. 巗愳堦晇1,2, 巗愳丂宑1 (1拞嫗娽壢, 2娽壢): 偁偨傜偟偄娽壢 2020/10; 37 (10): 1269-70.
522096. [島嵗]亂椢撪忈僙儈僫乕 楢嵹245亃椢撪忈庤弍MIGS偺摦岦. 彲巌怣峴 (娽壢): 偁偨傜偟偄娽壢 2020/11; 37 (11): 1425-6.
522097. [島嵗]亂摿廤: 幬帇亅婎杮偐傜幚慔傑偱亃Sagging eye syndrome. 屻娭棙柧 (娽壢): OCULISTA 2020/12; 93: 52-8.
522098. [島嵗]亂摿廤: 娽鈢幘姵偲恄宱娽壢亃娽鈢埆惈庮釃偲恄宱娽壢. 攼栘峀嵠1,2 (1惷壀導棫惷壀偑傫僙儞僞乕, 2娽壢): 恄宱娽壢 2020/12; 37 (4): 362-9.
522099. [島嵗]亂娽撪儗儞僘僙儈僫乕 楢嵹410亃儌儖僈乕僯敀撪忈偵偍偗傞慜鵑愗奐Viscoexpansion Technique. 斞揷壝旻 (娽壢): 偁偨傜偟偄娽壢 2021/1; 38 (1): 71-2.
522100. [島嵗]亂堛夛Pick Up丂戞74夞擔杮椪彴娽壢妛夛丂擔杮娽壢幮夛曐尟夛媍僔儞億僕僂儉乽怴偟偄娽壢堛弍乿亃2. MIGS偺嵶暘壔偲椢撪忈庤弍偺妚怴. 彲巌怣峴 (娽壢): 擔杮偺娽壢 2021/2; 92 (2): 54-5.
522101. [島嵗]亂摿廤: 慜娽晹専嵏偺僐僣嫵偊傑偡亃慜娽晹OCT偺巊偄曽. 恄扟榓岶 (堛椕塹惗妛晹): 椪彴娽壢 2021/2; 75 (2): 163-70.
522102. [島嵗]亂摿廤: 妋偐傔傛偆! 棎帇偺婎慴丂尒捈偦偆! 棎帇偺恌椕亃桳悈徎懱娽撪儗儞僘偵傛傞棎帇嫺惓. 屲廫棐復巎1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): OCULISTA 2021/2; 95: 25-32.
522103. [島嵗]亂摿廤: 怴偟偄帪戙偺IOL搙悢寁嶼亃Hill-RBF朄偺梊應惈. 斞搰丂宧 (娽壢): IOL&RS 2021/3; 35 (1): 10-4.
530015. [偦偺懠 (Letter)] Crosslinking of near responses in healthy young subjects. Asakawa K1, Tomioka M, Nakayama J, Hayama M, Hinata M, Ishikawa H1: Acta Ophthalmol 2020/9; 98 (6): e791-3. (愺愳丂尗1, 愇愳丂嬒1: 1堛椕塹惗妛晹)
530016. [偦偺懠 (Erratum)] Correction to: Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study. Ishikawa H, Masuda Y, Ishikawa H1, Shikisima K, Goseki T2, Kezuka T, Terao M, Miyazaki A, Matsumoto K, Nishikawa H, Gomi F, Mimura O: Jpn J Ophthalmol 2021/1; 65 (1): 143. (愇愳丂嬒1, 屻娭棙柧2: 1堛椕塹惗妛晹, 2娽壢)
530017. [偦偺懠 (Comment)] Reply to: Comment on Prevalence of Sagging Eye Syndrome in Adults with Binocular Diplopia. Goseki T1, Suh SY, Robbins L, Pineles SL, Demer JL, Velez FG: Am J Ophthalmol 2021/1; 221: 324-5. (屻娭棙柧1: 1娽壢)
530018. [偦偺懠 (Letter to the Editor)] Pupil fields in patients with Leber hereditary optic neuropathy. Asakawa K1, Matsuno M2, Ishikawa H1, Shoji N2: Graefes Arch Clin Exp Ophthalmol 2021/3; 259 (3): 791-3. (愺愳丂尗1, 徏栰朑堖2, 愇愳丂嬒1, 彲巌怣峴2: 1堛椕塹惗妛晹, 2娽壢)
540032. [偦偺懠 (崱寧偺昞巻)]亂崱寧偺昞巻亃奜彎惈擑嵤棧抐. 塱栰岾堦1, 堜忋岾師2 (1娽壢, 2捁庢戝妛): 椪彴娽壢 2020/4; 74 (4): 374.
540033. [偦偺懠 (僩僺僢僋僗)] 孅愜嫺惓庤弍偺僈僀僪儔僀儞夵惓. 恄扟榓岶 (堛椕塹惗妛晹): 娽壢庤弍 2020/4; 33 (2): 229-32.
540034. [偦偺懠] 摿廤偵偁偨偭偰. 恄扟榓岶1, 拞懞桭徍2 (1堛椕塹惗妛晹, 2柤屆壆傾僀僋儕僯僢僋): IOL&RS 2020/6; 34 (2): 220.
540035. [偦偺懠 (朄恖偐傜偺偍抦傜偣)] 僐儘僫棳峴壓偺娽壢恌椕. 巗愳堦晇1,2,3 (1JSCRS暃棟帠挿, 2拞嫗娽壢, 3娽壢): IOL&RS 2020/6; 34 (2): 347.
540036. [偦偺懠 (奀奜堛妛忣曬)]亂奀奜堛妛忣曬亃Heavy eye syndrome偲Sagging eye syndrome偺壓捈嬝埵抲曄壔. 屻娭棙柧 (娽壢): 擔杮偺娽壢 2020/7; 91 (7): 994-5.
540037. [偦偺懠 (彉榑)]亂摿廤: Imaging偺恑曕偲恄宱娽壢幘姵亃彉榑. 愇愳丂嬒 (堛椕塹惗妛晹): 娽壢 2020/8; 62 (8): 731.
540038. [偦偺懠 (朄恖偐傜偺偍抦傜偣)] 棟帠挿廇擟偵傛偣偰. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): IOL&RS 2020/9; 34 (3): 548-9.
540039. [偦偺懠 (怴暦婰帠)]乽2偮偵尒偊傞?乿暋帇偺尨場偲帯椕. 屻娭棙柧 (娽壢): 擬奀怴暦 2020/10; p.3.
540040. [偦偺懠 (彉榑)]亂摿廤: 暋帇亃彉榑. 愇愳丂嬒 (堛椕塹惗妛晹): 娽壢 2021/2; 63 (2): 105.
540041. [偦偺懠 (娔廋)] 40嵨夁偓偨傜拲堄偑昁梫! 幐柧尨場戞1埵偺乽椢撪忈乿. 彲巌怣峴 (娽壢): 偡偙傗偐寬曐 2021/3; 3 (868): 2.
540042. [偦偺懠] 摿廤偵偁偨偭偰. 恄扟榓岶1, 彫搰棽巌2 (1堛椕塹惗妛晹, 2宑滀媊弇戝妛): IOL&RS 2021/3; 35 (1): 2.
540043. [偦偺懠 (曇廤幰傊偺庤巻)] 嫮搙嬤帇偵敽偆撪幬帇偺梡岅偺崿棎偵偮偄偰. 嶳忋柧巕1,2, 娾嵅恀媩1, 庒憅夒搊1, 怉栘抭巙3, 揷戲埢巕3, 惔壨丂帨3, 塇擖婱巕3, 敤悾揘彯3, 暉抧寬榊3 (1堜忋娽壢昦堾, 2娽壢, 3怴妰戝妛戝妛堾堛帟妛憤崌尋媶壢娽壢妛暘栰): 恄宱娽壢 2021/3; 38 (1): 65-7.
[挊丂彂]
620078. [妛弍彂 (暘扴幏昅)]亂娽壢僗僑媄 椢撪忈偺恌抐丒帯椕丒庤弍 (娽壢僌儔僼傿僢僋2020擭暿嶜)亃5復 椢撪忈偺帯椕 (庤弍)丂2 偳偙偱庤弍偵摜傒偒傞? 暵嵡嬿妏椢撪忈, p.175-80. 彲巌怣峴 (娽壢), 娔廋: 拞郪丂揙, 儊僨傿僇弌斉, 戝嶃, 2020/5敪峴.
620079. [妛弍彂 (暘扴幏昅)]亂娽壢妛 戞3斉亃I. 峔憿偲偦偺昦懺丂K. 帇恄宱丂3. 帇恄宱偺昦懺丂2) 帇恄宱偺墛徢丂匔帇恄宱栐枌墛, 匘帺屓柶塽惈帇恄宱墛, p.494-5. 屻娭棙柧 (娽壢), 曇廤庡姴: 戝幁揘榊, 暥岝摪, 搶嫗, 2020/4敪峴.
620080. [妛弍彂 (暘扴幏昅)]亂娽壢妛 戞3斉亃I. 峔憿偲偦偺昦懺丂K. 帇恄宱丂3. 帇恄宱偺昦懺丂3) 帇恄宱徢丂匘埑敆帇恄宱徢, p.500-2. 屻娭棙柧 (娽壢), 曇廤庡姴: 戝幁揘榊, 暥岝摪, 搶嫗, 2020/4敪峴.
620081. [妛弍彂 (暘扴幏昅)]亂娽壢妛 戞3斉亃I. 峔憿偲偦偺昦懺丂K. 帇恄宱丂3. 帇恄宱偺昦懺丂3) 帇恄宱徢丂匛拞撆惈帇恄宱徢, p.502-4. 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢), 曇廤庡姴: 戝幁揘榊, 暥岝摪, 搶嫗, 2020/4敪峴.
620082. [妛弍彂 (暘扴幏昅)]亂娽壢妛 戞3斉亃II. 婡擻偲偦偺昦懺丂E. 娽媴塣摦丒幬帇丂2. 専嵏丂4) 椉娽帇婡擻専嵏丂匑Bagolini帋尡, 匒Worth4摂専嵏, 匓戝宆庛帇嬀, 匔afterimage test, 匘幚梡棫懱帇専嵏, 匛Lang stereo test, 匜Titmus stereo test (TST), 匞TNO stereo test, 匟Frisby stereo test, 匢嶰濿朄, 匤3D Visual Function Trainer-ORTe, 5) 夋憸専嵏, p.750-8. 屻娭棙柧 (娽壢), 曇廤庡姴: 戝幁揘榊, 暥岝摪, 搶嫗, 2020/4敪峴.
620083. [妛弍彂 (暘扴幏昅)]亂崙帋114 戞114夞堛巘崙壠帋尡栤戣夝愢彂亃A-27. 挷愡惈撪幬帇偺帯椕曽恓, p.35-6. B-12. 暋帇偲埆怱傪偒偨偡婄柺崪愜晹埵, p.144-5. B-29. 娽奜彎惈帇恄宱徢偺忈奞晹埵, p.165-6. 屻娭棙柧 (娽壢), 曇: 堛巘崙壠帋尡栤戣夝愢彂曇廤埾堳夛, 僥僐儉弌斉帠嬈杮晹, 搶嫗, 2020/4敪峴.
620084. [妛弍彂 (暘扴幏昅)]亂娽壢恌椕價僕儏傾儖儔乕僯儞僌 4丂悈徎懱偲孅愜亃3. 恌椕曇丂娽撪儗儞僘偵傛傞儌僲價僕儑儞丂敀撪忈庤弍帪偵曅娽墦曽嫺惓, 椈娽嬤曽嫺惓傪峴偄, 椙岲側慡嫍棧帇椡偑摼傜傟偨徢椺, p.194-7. 恄扟榓岶 (堛椕塹惗妛晹), 曇: 戝幁揘榊, 拞嶳彂揦, 搶嫗, 2020/5敪峴.
620085. [妛弍彂 (暘扴幏昅)]亂娽壢恌椕價僕儏傾儖儔乕僯儞僌 4丂悈徎懱偲孅愜亃3. 恌椕曇丂娽撪儗儞僘搙悢偢傟偵懳偡傞piggyback朄丂敀撪忈庤弍屻偺孅愜岆嵎偵懳偟偰secondary piggyback傪巤峴偟偨徢椺, p.198-201. 斞揷壝旻 (娽壢), 曇: 戝幁揘榊, 拞嶳彂揦, 搶嫗, 2020/5敪峴.
620086. [妛弍彂 (暘扴幏昅)]亂娽壢媬媫幘姵2020 (娽壢2020擭10寧椪帪憹姧崋)亃姫摢尵, p.1029. 愇愳丂嬒1 (1堛椕塹惗妛晹), 曇: 晉揷崉巌, 捸揷堦抝, 屻摗丂峗, 斞揷抦峅, 嶨夑巌庫栫, 栧擵墍堦柧, 愇愳丂嬒1, 嬥尨弌斉, 搶嫗, 2020/10敪峴.
620087. [妛弍彂 (暘扴幏昅)]亂娽壢媬媫幘姵2020 (娽壢2020擭10寧椪帪憹姧崋)亃V 椢撪忈丂4. 悈徎懱偵婲場偡傞崅娽埑, p.1183-8. 彲巌怣峴1 (1娽壢), 曇: 晉揷崉巌, 捸揷堦抝, 屻摗丂峗, 斞揷抦峅, 嶨夑巌庫栫, 栧擵墍堦柧, 愇愳丂嬒2 (2堛椕塹惗妛晹), 嬥尨弌斉, 搶嫗, 2020/10敪峴.
620088. [妛弍彂 (暘扴幏昅)]亂娽壢媬媫幘姵2020 (娽壢2020擭10寧椪帪憹姧崋)亃VI 恄宱娽壢丂6. 娽鈢嬝墛, p.1215-9. 娾嵅恀媩1,2 (1堜忋娽壢昦堾, 2娽壢), 曇: 晉揷崉巌, 捸揷堦抝, 屻摗丂峗, 斞揷抦峅, 嶨夑巌庫栫, 栧擵墍堦柧, 愇愳丂嬒3 (3堛椕塹惗妛晹), 嬥尨弌斉, 搶嫗, 2020/10敪峴.
620089. [妛弍彂 (暘扴幏昅)]亂摿廤: 偡傋偰尒偣傑偡!丂姵幰愢柧丒摨堄彂儅僯儏傾儖 (椪彴娽壢2020擭10寧憹姧崋)亃7 孅愜嫺惓丂ICL (捠忢宆), 112-3. 忢淎弐懢榊1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢), 堛妛彂堾, 搶嫗, 2020/10敪峴.
620090. [妛弍彂 (暘扴幏昅)]亂摿廤: 偡傋偰尒偣傑偡!丂姵幰愢柧丒摨堄彂儅僯儏傾儖 (椪彴娽壢2020擭10寧憹姧崋)亃8 妏枌丂DMEK, p.131-3. 恊愳丂奿1, 椦丂岶旻2,3 (1僴乕僩儔僀僼昦堾, 2墶昹撿嫟嵪昦堾, 3娽壢), 堛妛彂堾, 搶嫗, 2020/10敪峴.
620091. [妛弍彂 (暘扴幏昅)]亂娽壢僀儊乕僕儞僌2020Q&A (偁偨傜偟偄娽壢Vol.37椪帪憹姧崋)亃1. 妏枌丂Q9 僂僃乕僽僼儘儞僩傾僫儔僀僓乕偵傛傞妏枌廂嵎偲慡娽媴廂嵎偺夝愅偵偮偄偰嫵偊偰偔偩偝偄, p.46-51. 恄扟榓岶 (堛椕塹惗妛晹), 儊僨傿僇儖埁弌斉, 搶嫗, 2020/11敪峴.
620092. [妛弍彂 (暘扴幏昅)]亂娽壢僀儊乕僕儞僌2020Q&A (偁偨傜偟偄娽壢Vol.37椪帪憹姧崋)亃5. 庛帇幬帇丂Q2 Sagging eye Syndrome偲嬤帇惈幬帇偺MRI夋憸恌抐傪嫵偊偰偔偩偝偄, p.406-9. 壨崌垽幚1, 屻娭棙柧2 (1戝妛堾堛椕宯尋媶壢, 2娽壢), 儊僨傿僇儖埁弌斉, 搶嫗, 2020/11敪峴.
620093. [妛弍彂 (暘扴幏昅)]亂偍堛幰偝傫僆儞儔僀儞亃棎帇: 尒偊曽偼? 尨場偼? 儊僈僱傗僐儞僞僋僩偱嫺惓偱偒傞? 帯椕偼偁傞偺?, web儁乕僕. 恄扟榓岶 (堛椕塹惗妛晹), 僾儗僔僕儑儞, 搶嫗, 2021/1.
620094. [妛弍彂 (暘扴幏昅)]亂偍堛幰偝傫僆儞儔僀儞亃墦帇: 嬤帇傗榁娽偲偺堘偄偼? 尨場偼? 嫺惓傗帯椕偺曽朄偼?, web儁乕僕. 恄扟榓岶 (堛椕塹惗妛晹), 僾儗僔僕儑儞, 搶嫗, 2021/1.
620095. [妛弍彂 (暘扴幏昅)]亂偍堛幰偝傫僆儞儔僀儞亃嬤帇: 尨場偼? 堚揱傗惗妶廗姷偲偺娭學偼? 嫺惓傗帯椕偺曽朄偼?, web儁乕僕. 恄扟榓岶 (堛椕塹惗妛晹), 僾儗僔僕儑儞, 搶嫗, 2021/1.
621002. [妛弍彂 (曇廤)]亂娽壢媬媫幘姵2020 (娽壢2020擭10寧椪帪憹姧崋)亃曇: 晉揷崉巌, 捸揷堦抝, 屻摗丂峗, 斞揷抦峅, 嶨夑巌庫栫, 栧擵墍堦柧, 愇愳丂嬒1 (1堛椕塹惗妛晹), 嬥尨弌斉, 搶嫗, 2020/10敪峴.
621003. [妛弍彂 (曇廤)]亂擔杮娽壢妛夛愱栧堛惂搙丂娽壢尋廋堛僈僀僪儔僀儞丂椷榓2擭搙斉亃曇: 擔杮娽壢妛夛愱栧堛惂搙埾堳夛 (埾堳挿: 彲巌怣峴 (娽壢)), 搶嫗, 擔杮娽壢妛夛, 2020/12敪峴.
[妛夛丒尋媶夛摍]
712006. [妛夛 (崙嵺)] (彽懸島墘) Micro-incisional : Trabectome and Kahook Dual Blade. Shoji N1: WGA Global Webinars (2020/10/10), Web奐嵜. (彲巌怣峴1: 1娽壢)
713046. [妛夛 (崙嵺)] (億僗僞乕) Morphological change and possible mechanism of intraocular pressure reduction after MP-TSCPC in rabbits. Tsujisawa T1, Shoji N1, Ishikawa H2, Asakawa K2, Uga S1: World Ophthalmology Congress (WOC 2020) (2020/6/26), Web奐嵜. (捯戲扖旻1, 彲巌怣峴1, 愇愳丂嬒2, 愺愳丂尗2, 塅夑栁嶰1: 1娽壢, 2堛椕塹惗妛晹)
721021. [妛夛 (慡崙)] (摿暿島墘) 拞嫗僌儖乕僾偺奀奜堛椕峷專. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
721022. [妛夛 (慡崙)] (摿暿島墘)亂嵗挿亃摿暿島墘. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722103. [妛夛 (慡崙)] (嫵堢僙儈僫乕)亂僆乕僈僫僀僓乕亃娽豳醶澒偺恌抐丒帯椕丒昦懺惗棟. 愇愳丂嬒 (堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722104. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 傢偐傝偵偔偄娽豳醶澒徢椺 Cases of blepharospasm that is difficult to diagnose. 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722105. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 娽豳醶澒偺帯椕朄 How to treat blepharospasm. 屻娭棙柧 (娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722106. [妛夛 (慡崙)] (嫵堢僙儈僫乕)亂僆乕僈僫僀僓乕亃夵傔偰妛傇帇婡擻専嵏朄乣懡妏揑偵昡壙偡傞偨傔偵乣. 恄扟榓岶 (堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722107. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 孅愜偲帇椡専嵏 refraction and visual acuity test. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722108. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 妏枌撪旂嵶朎尭彮椺偵懳偡傞敀撪忈庤弍 Cataract surgery in patients with corneal endothelial cell loss. 斞揷壝旻 (娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722109. [妛夛 (慡崙)] (僒僽僗儁僔儍儕僥傿僒儞僨乕)亂僨傿儗僋僞乕亃帇恄宱幘姵偲娫堘偊傗偡偄娽昦曄. 愇愳丂嬒 (堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722110. [妛夛 (慡崙)] (僒僽僗儁僔儍儕僥傿僒儞僨乕) 帇恄宱幘姵偵帡偨娽掙幘姵 Fundus Diseases Resembling Optic Neuropathy 巗绮媊復1,2 (1恄撧愳帟壢戝妛墶昹僋儕僯僢僋, 2娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722111. [妛夛 (慡崙)] (僒僽僗儁僔儍儕僥傿僒儞僨乕)亂僨傿儗僋僞乕亃嵟怴偺椢撪忈恌抐 (The latest diagnosis methods of glaucoma). 愇愳丂嬒 (堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722112. [妛夛 (慡崙)] (僒僽僗儁僔儍儕僥傿僒儞僨乕)亂僨傿儗僋僞乕亃奺庬椢撪忈帯椕偺揔墳 (Indication of various glaucoma therapies). 愇愳丂嬒 (堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722113. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃ACUVUE乬尒偊傞乭傪捛媮偡傞. 恄扟榓岶 (堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722114. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) ACUVUE乬尒偊傞乭傪捛媮偡傞. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
722115. [妛夛 (慡崙)] (僔儞億僕僂儉)亂僆乕僈僫僀僓乕亃帇栰寁2020. 彲巌怣峴 (娽壢): 戞9夞擔杮帇栰夋憸妛夛妛弍廤夛 (2020/6/17), Web奐嵜.
722116. [妛夛 (慡崙)] (夛挿婇夋) 奐娽庤弍偐傜孅愜嫺惓庤弍傊. 惔悈岞栫1,2,3 (1嶳墹昦堾, 2崙嵺堛椕暉巸戝, 3娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722117. [妛夛 (慡崙)] (摿暿曬崘) JSCRS丂COVID-19 嬞媫傾儞働乕僩. 恄扟榓岶1, 椦丂丂尋2, 嵅摗惓庽3, 彫搰棽巌4, 屻摗寷恗5, 弶嶁撧捗巕6, 揷暎恗巙7,8 (1堛椕塹惗妛晹, 2椦娽壢昦堾, 3僒僩僂娽壢, 4宑墳戝, 5屗揷偛偲偆娽壢, 6嬥戲堛戝, 7峀搰戝婑晬島嵗DTM, 8僣僇僓僉昦堾): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722118. [妛夛 (慡崙)] (摿暿曬崘) 2020 JSCRS clinical survey. 嵅摗惓庽1, 恄扟榓岶2, 彫搰棽巌3, 屻摗寷恗4, 揷暎恗巙5,6, 弶嶁撧捗巕7, 椦丂丂尋8 (1僒僩僂娽壢, 2堛椕塹惗妛晹, 3宑墳戝, 4屗揷偛偲偆娽壢, 5峀搰戝婑晬島嵗DTM, 6僣僇僓僉昦堾, 7嬥戲堛戝, 8椦娽壢昦堾): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722119. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃榁帇嫺惓娽撪儗儞僘偺帇婡擻. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722120. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃ICL崱抦偭偰偍偔傋偒嵟怴忣曬. 恄扟榓岶 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722121. [妛夛 (慡崙)] (僔儞億僕僂儉) 拞崅擭幰傊偺懳墳. 屲廫棐復巎1,2 (1嶳墹昦堾, 2娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722122. [妛夛 (慡崙)] (僔儞億僕僂儉) AI傪梡偄偨桳悈徎懱娽撪儗儞僘偺嵟揔壔. 恄扟榓岶 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722123. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃怴偟偄帪戙偺IOL搙悢寁嶼乣SRK/TK幃偺岟嵾傪峫偊傞乣. 恄扟榓岶 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722124. [妛夛 (慡崙)] (僔儞億僕僂儉) Hill-RBF朄偺梊應惈. 斞搰丂宧1, 恄扟榓岶2, 斞揷壝旻1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722125. [妛夛 (慡崙)] (僔儞億僕僂儉) MIGS揔墳偺拲堄揰. 彲巌怣峴 (娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722126. [妛夛 (慡崙)] (僔儞億僕僂儉) 妏枌宍忬夝愅AI傾僢僾僨乕僩. 恄扟榓岶 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722127. [妛夛 (慡崙)] (僔儞億僕僂儉) 3D價僕儏傾儖僔僗僥儉偺嫵堢岠壥偐傜尒偨棙揰偲寚揰. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722128. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 僩乕儕僢僋娽撪儗儞僘庤弍偺幚嵺. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722129. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 弍屻崌暪徢傊偺懳墳. 恄扟榓岶 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722130. [妛夛 (慡崙)] (帇擻孭楙巑僾儘僌儔儉)亂僆乕僈僫僀僓乕亃帇擻孭楙巑偑抦偭偰偍偔傋偒敀撪忈丒孅愜嫺惓庤弍偺暆峀偄抦幆乣弍幃, 娽岝妛, 寁嶼幃, 娽撪儗儞僘偺抦幆乣. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722131. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗)亂島巘亃墌悕妏枌傾僢僾僨乕僩. 恄扟榓岶 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722132. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗)亂僆乕僈僫僀僓乕亃悽奅偺嵟怴僩儗儞僪傪抦傠偆! ""What's New in 2022"". 恄扟榓岶 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722133. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗)亂僆乕僈僫僀僓乕亃亂ORT偵傛傞ORT偺偨傔偺IC亃挌擩偵懍偔専嵏傪峴偆偨傔偺巹偺岺晇. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722134. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗)亂島巘亃亂ORT偵傛傞ORT偺偨傔偺IC亃挌擩偵懍偔専嵏傪峴偆偨傔偺巹偺岺晇. 埨摗榓壧巕 (娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722135. [妛夛 (慡崙)] (働乕僗儗億乕僩) 儌儖僈僯敀撪忈偵偍偗傞慜鵑愗奐乣viscoexpansion technique. 斞揷壝旻1, 彲巌怣峴1 (1娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722136. [妛夛 (慡崙)] (嫟嵜僙儈僫乕)亂嵗挿亃偙偙傑偱偒偨偐! 敀撪忈庤弍. 恄扟榓岶 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722137. [妛夛 (慡崙)] (嫟嵜僙儈僫乕) 娽撪儗儞僘摿惈傪惇偡傞幰偼丒丒丒. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722138. [妛夛 (慡崙)] (嫟嵜僙儈僫乕) NGENUITY覀虊聰\惈傪扵傞. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722139. [妛夛 (慡崙)] (嫟嵜僙儈僫乕)亂嵗挿亃QOL傪偮側偖懡徟揰SCL偺壜擻惈偲尷奅乣扨徟揰IOL憓擖屻偵乣. 恄扟榓岶 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722140. [妛夛 (慡崙)] (嫟嵜僙儈僫乕) QOL傪偮側偖懡徟揰SCL偺壜擻惈偲尷奅. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722141. [妛夛 (慡崙)] (嫟嵜僙儈僫乕) 懡徟揰SCL偺椪彴巊梡. 恄扟榓岶 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
722142. [妛夛 (慡崙)] (僔儞億僕僂儉)亂僆乕僈僫僀僓乕亃帇婡擻尋媶偺怴揥奐. 怴堜揷岶桾1,2 (1崙嵺堛椕暉巸戝妛, 2娽壢): 戞76夞擔杮庛帇幬帇妛夛憤夛丒戞45夞擔杮彫帣娽壢妛夛憤夛崌摨妛夛 (2020/7/3), Web奐嵜.
722143. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃怴宆僐儘僫僂僀儖僗偲摤偆岝妛偲堛妛. 彲巌怣峴 (娽壢): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722144. [妛夛 (慡崙)] (婰擮島墘)亂嵗挿亃妛弍彠椼徿庴徿婰擮島墘. 恄扟榓岶 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722145. [妛夛 (慡崙)] (婰擮島墘)亂嵗挿亃妛弍榑暥徿庴徿婰擮島墘. 恄扟榓岶 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722146. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃INTERSECT OF VISION. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722147. [妛夛 (慡崙)] (僔儞億僕僂儉) 巕偳傕偺娽傪庣傞妛峑寬恌. 摗懞晣嵅巕 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722148. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃娽壢庤弍偺Priority. 惔悈岞栫1,2 (1嶳墹昦堾, 2娽壢): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722149. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃娽壢庤弍偺Priority. 恄扟榓岶 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722150. [妛夛 (慡崙)] (僔儞億僕僂儉) 敀撪忈庤弍偺Priority 屲廫棐復巎1,2 (1嶳墹昦堾, 2娽壢): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722151. [妛夛 (慡崙)] (僔儞億僕僂儉) 僩乕儕僢僋娽撪儗儞僘偺Priority 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722152. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃椉娽帇嫺惓偺娽岝妛. 敿揷抦栫 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722153. [妛夛 (慡崙)] (僔儞億僕僂儉) 孅愜嫺惓偲椉娽帇傪VEP偱懠妎揑偵懆偊傞. 嵅摗丂巌1, 怴堜揷岶桾1,2 (1崙嵺堛椕暉巸戝, 2娽壢): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722154. [妛夛 (慡崙)] (僔儞億僕僂儉) 尒偊曽昡壙偺捛媮. 敿揷抦栫 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722155. [妛夛 (慡崙)] (嫵堢僙儈僫乕) 怴恖堛巘傗尋廋堛, 妛惗偺偨傔偺椪彴娤嶡娽. 斞揷壝旻 (娽壢): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722156. [妛夛 (慡崙)] (僙儈僫乕)亂嵗挿亃師悽戙偺Cataract Refractive Surgery傪扵傞. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722157. [妛夛 (慡崙)] (僙儈僫乕) PanOptix覀虒鯅w摿惈偲拞娫嫍棧偑尒偊傞偙偲偺廳梫惈. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722158. [妛夛 (慡崙)] (僙儈僫乕)亂嵗挿亃傑傕側偔! 儗儞僥傿僗僐儞僼僅乕僩僩乕儕僢僋覕瓟�! 娽岝妛偐傜恌偨娽撪儗儞僘慖戰. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722159. [妛夛 (慡崙)] (僙儈僫乕) 棎帇傪桳偡傞娽偵懳偡傞敀撪忈庤弍愴棯. 斞揷壝旻 (娽壢): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722160. [妛夛 (慡崙)] (僙儈僫乕) 僩乕儕僢僋娽撪儗儞僘傪惉岟偵摫偔億僀儞僩偲拲堄偡傋偒徢椺. 恄扟榓岶 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722161. [妛夛 (慡崙)] (僙儈僫乕)亂嵗挿亃墦嬤椉梡僐儞僞僋僩儗儞僘乣岝妛摿惈偲擭戙暿張曽偺幚嵺乣. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722162. [妛夛 (慡崙)] (僙儈僫乕) 岝偺拞偱惗偒傞乣愕柧偺椪彴尰応, 擔忢惗妶偱偺尒偊曽傊偺塭嬁乣傾僉儏價儏乕覂I傾僔僗覂g儔儞僕僔儑儞僘 僗儅乕僩挷岝TM. 敿揷抦栫 (堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
722163. [妛夛 (慡崙)] (摿暿僙僢僔儑儞) Annual report from blood flow study group寣棳斍妶摦曬崘. 彲巌怣峴 (娽壢): 戞31夞擔杮椢撪忈妛夛 (2020/10/2), Web奐嵜.
722164. [妛夛 (慡崙)] (摿暿僙僢僔儑儞) Multicenter study evaluating non-inferiority of microhook ab interno trabeculotomy to Trabectome Microhook (慄堐拰懷愗奐弍娽撪朄偲Trabectome偺旕楎惈傪専摙偡傞懡巤愝椪彴尋媶). 拞懞丂惤1, 峚忋巙楴2, 搶弌朁枻3, 彲巌怣峴4, 愒栘拤摴5, 彲巌戱暯6, 墶嶳丂桰7, 怉揷弐旻8, 釼摗梇懢9, 扟屗惓庽10, 堜忋尗帯11 (1恄屗戝, 2垽昋戝, 3嬥戲戝, 4娽壢, 5嫗搒戝, 6嶉嬍堛戝, 7搶杒戝, 8擇杮徏娽壢昦堾, 9徍榓戝, 10搰崻戝, 11堜忋娽壢昦堾): 戞31夞擔杮椢撪忈妛夛 (2020/10/2), Web奐嵜.
722165. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃庤弍帯椕偺恑曕偲昡壙. 彲巌怣峴 (娽壢): 戞31夞擔杮椢撪忈妛夛 (2020/10/2), Web奐嵜.
722166. [妛夛 (慡崙)] (僔儞億僕僂儉) Complication management and drug management after outoflow reconstructive surgery (棳弌楬嵞寶弍屻偺崌暪徢娗棟偲栻暔娗棟). 妢尨惓峴 (娽壢): 戞31夞擔杮椢撪忈妛夛 (2020/10/2), Web奐嵜.
722167. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 椢撪忈僩儕價傾. 彲巌怣峴 (娽壢): 戞31夞擔杮椢撪忈妛夛 (2020/10/2), Web奐嵜.
722168. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗) 幬帇庤弍偺僌儘乕僶儖僗僞儞僟乕僪傪峫偊傞丂偦偺2. 挿扟晹憦1, 崻娸婱巙2, 屻娭棙柧3,4, 椦丂岶梇5, 栴働嶈掝巌6 (1愳嶈堛戝, 2弴揤戝, 3崙嵺堛椕暉巸戝, 4娽壢, 5掗嫗戝丒堛椕媄弍, 6娽壢傗偑偝偒堛堾): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722169. [妛夛 (慡崙)] (僔儞億僕僂儉)亂嵗挿亃懡徟揰娽撪儗儞僘偺揔惓巊梡. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722170. [妛夛 (慡崙)] (僔儞億僕僂儉) 妏枌僋儘僗儕儞僉儞僌偺恑壔 (Evolution of Corneal Cross-linking). 恄扟榓岶 (堛椕塹惗妛晹): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722171. [妛夛 (慡崙)] (僔儞億僕僂儉) MIGS偺嵶暘壔偲椢撪忈庤弍偺妚怴 (Subdivision of MIGS and innovations in glaucoma surgery). 彲巌怣峴 (娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722172. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗) 妏枌撪旂堏怉弍 (DSAEK/DMEK): 婎杮偲墳梡. 彫椦丂尠1, 揤栰巎榊2, 堫晉丂曌3, 怸懞廳恖4, 椦丂岶旻5,6, 惣揷岾擇7, 栧揷丂梀8 (1嬥戲戝, 2堜忋娽壢, 3崙棫挿庻堛椕僙儞僞乕, 4宑滀戝, 5墶昹撿嫟嵪昦堾, 6娽壢, 7戝嶃戝, 8媣棷暷戝): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722173. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗) 怓妎堎忢偺恌抐偲巜摫, 壛楊偵傛傞怓妎堎忢傕娷傓. 巗愳堦晇1,2, 拞懞偐偍傞3, 懞栘憗昪4, 栛栰媣旤巕5, 娾嵅恀婭6, 拞懞塸庽7, 攼堜恀棟巕8 (1拞嫗娽壢, 2娽壢, 3彈巕堛戝, 4傓傜偒娽壢, 5姞扟朙揷憤崌昦堾, 6帬夑堛壢戝, 7柤搶娽壢, 8娽壢攼堜堛堾): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722174. [妛夛 (慡崙)] (僀儞僗僩儔僋僔儑儞僐乕僗) 幚慔偐傜妛傇桳悈徎懱娽撪儗儞僘. 惔悈岞栫1,2, 恄扟榓岶3, 巗愳堦晇2,4, 拞懞桭徍5, 杒郪悽巙攷6, 屲廫棐復巎1,2 (1嶳墹昦堾傾僀僙儞僞乕, 1,2娽壢, 3堛椕塹惗妛晹, 4拞嫗娽壢, 5柤屆壆傾僀僋儕僯僢僋, 6僒僺傾僞儚乕傾僀僋儕僯僢僋搶嫗): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722175. [妛夛 (慡崙)] (僔儞億僕僂儉) 娽鈢僾儕乕堎忢偑堷偒婲偙偡暋帇Diplopia caused by orbital pulley disorder. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722176. [妛夛 (慡崙)] (妛弍揥帵僔儑乕僩僩乕僋) 娽豳醶澒徢椺偺儃僣儕僰僗帯椕屻偺BUT, 弖栚僗僐傾, 帺妎徢忬偺専摙. 挬斾撧桾旤1, 娾嵅恀媩1,2, 嶳忋柧巕1,2, 揤栰巎榊1, 堜忋尗帯1, 庒憅夒搊1 (1堜忋娽壢昦堾, 2娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722177. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 僗儅乕僩挷岝僐儞僞僋僩儗儞僘偺幚嵺偲壜擻惈, 婎慴偲椪彴偐傜. 敿揷抦栫 (堛椕塹惗妛晹): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722178. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃儔儞僠儑儞僙儈僫乕27. 彲巌怣峴 (娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722179. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 懡寣彫斅寣燋 (Platelet-rich plasma: PRP) 偺帯椕偺尰忬偲枹棃. 恄扟榓岶 (堛椕塹惗妛晹): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722180. [妛夛 (慡崙)] (僀僽僯儞僌僙儈僫乕) 僆儞儔僀儞恌椕偵偮偄偰抦偭偰偍偔傋偒偙偲偼? 屲廫棐復巎1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722181. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕) 僋儘乕僕儞僌儕儅乕僋僗. 惔悈岞栫1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722182. [妛夛 (慡崙)] (儌乕僯儞僌僙儈僫乕) 敀撪忈偺僄價僨儞僗 嫮搙嬤帇傊偺妏枌棎帇嫺惓. 恄扟榓岶 (堛椕塹惗妛晹): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722183. [妛夛 (慡崙)] (儌乕僯儞僌僙儈僫乕)亂僩乕儕僢僋IOL堄尒岎姺夛亃棎帇傪偳偆巆偡偐, 巆偝側偄偐乣棎帇偼慞偐埆偐乣. 恄扟榓岶 (堛椕塹惗妛晹): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
722184. [妛夛 (慡崙)] (幚慔僙儈僫乕)亂嵗挿亃幚慔僙儈僫乕1. 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
722185. [妛夛 (慡崙)] (幚慔僙儈僫乕) 傗偝偟偄幬帇帯椕偲儃僩僢僋僗偺墳梡亅懳択曇亅. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
722186. [妛夛 (慡崙)] (摙榑夛) Nationwide epidemiological and clinical survey of optic neuritis in Japan. 愇愳丂嬒 (堛椕塹惗妛晹): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
722187. [妛夛 (慡崙)] (徢椺専摙夛) 偆偭寣擕摢傪偒偨偟偨Camurati-Engelmann徢岓孮偺1椺 墶嶳垻巕1,2, 屻娭棙柧1,3, 棿堜墤巕1, 愇愳丂嬒4, 彲巌怣峴1 (1娽壢, 2奀榁柤憤崌昦堾, 3崙嵺堛椕暉巸戝妛擬奀昦堾, 4堛椕塹惗妛晹): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
722188. [妛夛 (慡崙)] (徢椺専摙夛) MRI偵偰戝擼敀幙偵峀斈側崅怣崋椞堟傪擣傔偨m11778揰曄堎梲惈帇恄宱徢偺堦椺. 嬥嶳弐夘1, 愇愳丂嬒2, 屻娭棙柧1,3, 棿堜墤巕1, 廐嶳媣彯4, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹, 3崙嵺堛椕暉巸戝妛擬奀昦堾, 4惞儅儕傾儞僫堛壢戝妛擼恄宱撪壢): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
722189. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃帇恄宱墛恌椕偺嵟慜慄. 愇愳丂嬒 (堛椕塹惗妛晹): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
722190. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃傾僼僞僰乕儞僙儈僫乕2. 愇愳丂嬒 (堛椕塹惗妛晹): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
723517. [妛夛 (慡崙)] (堦斒島墘) 桳怓壠揺偵偍偗傞MP-TSCPC徠幩屻偺慻怐曄壔偲娽埑壓崀偺嶌梡婡彉偺専摙. 捯戲扖旻1, 彲巌怣峴1, 愺愳丂尗2, 壨栰梇椇1, 愇愳丂嬒2 (1娽壢, 2堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723518. [妛夛 (慡崙)] (堦斒島墘) Variational Bayes傪梡偄偨帇栰應掕傾儖僑儕僘儉. 懞揷攷巎1, 摗栰桭棦1,2, 徏塝彨恖1,2, 搰揷丂尗3, 挬壀丂椇1 (1搶嫗戝, 2娽壢, 3嫽榓): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723519. [妛夛 (慡崙)] (堦斒島墘) 扨徟揰娽撪儗儞僘憓擖弍屻偺懡徟揰僐儞僞僋僩儗儞僘偺帇婡擻偲枮懌搙偺専摙. 恄扟榓岶1, 摗懞晣嵅巕1, 埨摗榓壧巕2, 斞搰丂宧2, 彲巌怣峴2 (1堛椕塹惗妛晹, 2娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723520. [妛夛 (慡崙)] (堦斒島墘) 僸僩悈徎懱偺愒摴晹傪専弌偡傞怴偟偄夋憸夝愅朄. 攏搱惔擛1, 巗愳丂宑2, 撪摗彯媣3, 庰堜岾峅3, 曅壀悡攷4, 堥扟彯庽4, 拞懞桭徍4, 嬍抲柧栰5, 巗愳堦晇3,6 (1娽壢柧娽堾, 2婒晫愒廫帤昦堾, 3拞嫗娽壢, 4柤屆壆傾僀僋儕僯僢僋, 5JCHO拞嫗昦堾, 6娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723521. [妛夛 (慡崙)] (堦斒島墘) Hill-RBF朄Version1.0偲Version2.0偺梊應惈偺斾妑. 斞搰丂宧1, 恄扟榓岶2, 斞揷壝旻1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723522. [妛夛 (慡崙)] (堦斒島墘) 僇僗僞儅僀僘僪妏枌僋儘僗儕儞僉儞僌偵傛傞妏枌慜屻柺孅愜椡曄壔. 崅嫶惓塸 (娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723523. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃掅怤廝椢撪忈庤弍. 彲巌怣峴 (娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723524. [妛夛 (慡崙)] (堦斒島墘) 僩儔儀僋僩乕儉庤弍婛墲娽偵懳偡傞捛壛兪僼僢僋僩儔儀僋儘僩儈乕偺惉愌. 壨栰梇椇1, 妢尨惓峴1, 捯戲扖旻1, 暷嶳丂椚1, 墶嶳垻巕1, 彲巌怣峴1 (1娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723525. [妛夛 (慡崙)] (堦斒島墘) 僩儔儀僋僩乕儉庤弍屻偺峈椢撪忈揰娽栻巊梡暿偺惉愌. 妢尨惓峴1, 壨栰梇椇1, 捯戲扖旻1, 暷嶳丂椚1, 墶嶳垻巕1, 彲巌怣峴1 (1娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723526. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃惗懱寁應. 恄扟榓岶 (堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723527. [妛夛 (慡崙)] (堦斒島墘) 敀撪忈庤弍慜屻偵偍偗傞娽埵偺専摙. 埳摗旤嵐奊1, 抮揷揘栫1, 釼摗埱撧1, 屲廫棐復巎1,2, 惔悈岞栫1,2 (1嶳墹昦堾, 2娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723528. [妛夛 (慡崙)] (堦斒島墘) Vault梊應夞婣偺3幃儗儞僘僒僀僘暿斾妑. 埨摗榓壧巕1, 恄扟榓岶2, 崅嫶惓塸1, 嬥嶳弐夘1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723529. [妛夛 (慡崙)] (堦斒島墘) 暘岝摟夁棪偺堎側傞墿怓拝怓儗儞僘偑僐儞僩儔僗僩姶搙偵媦傏偡塭嬁偺専摙. 摗懞晣嵅巕1, 恄扟榓岶1, 尨岥隳懢2, 愳庣揷戱巙1, 斞揷壝旻2, 姳愳棦奊1, 彲巌怣峴2 (1堛椕塹惗妛晹, 2娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723530. [妛夛 (慡崙)] (堦斒島墘) 峈僸僗僞儈儞揰娽栻 (僄僺僫僗僠儞墫巁墫) 偺摰岴偵懳偡傞嶌梡. 棿堜墤巕1, 愇愳丂嬒2, 崃壓婭旤戙1, 愺愳丂尗2, 媑晉寬巙3, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹, 3暉壀崙嵺堛椕暉巸戝妛): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723531. [妛夛 (慡崙)] (堦斒島墘) 慜娽晹嶰師尦夋憸夝愅憰抲傪梡偄偨寬忢娽偵偍偗傞嬿妏宍忬夝愅. 暯栰怲堦榊1, 屲廫棐復巎1,2,3, 嶳愳愮壚2, 惔悈岞栫1,2,3, 塒堜抭旻1 (1崙嵺堛椕暉巸戝, 2嶳墹昦堾傾僀僙儞僞乕, 3娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723532. [妛夛 (慡崙)] (堦斒島墘) 恖岺抦擻傪梡偄偨Hess僠儍乕僩偺帺摦恌抐. 屻娭棙柧1, 揷暎恗巙3,4, 彙杮峗婭3, 愇旘捈巎3, 壨崌垽幚1, 彲巌怣峴1, 巗绮媊復1,2, 媨揷榓揟5, 拞郪桽懃6, 椦丂丂尋7, 栘撪椙柧4, 壂杮憦巙8 (1娽壢, 2恄撧愳帟壢戝丒墶昹僋儕僯僢僋, 3僣僇僓僉昦堾, 4峀搰戝, 5媨揷娽壢昦堾, 6幁帣搰戝, 7椦娽壢昦堾, 8峀搰愒廫帤丒尨敋昦堾): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723533. [妛夛 (慡崙)] (堦斒島墘) 娽豳醶澒姵幰偵偍偗傞僪儔僀傾僀恌抐婎弨偵傛傞専摙. 拞柎揷憉巎1, 娾嵅恀媩1,2, 嶳忋柧巕1,2, 揤栰巎榊1, 堜忋尗帯1, 庒憅夒搊1 (1堜忋娽壢昦堾, 2娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723534. [妛夛 (慡崙)] (妛弍揥帵) 攝崌嵻儔僞僲僾儘僗僩/僠儌儘乕儖傪儔僞僲僾儘僗僩/僇儖僥僆儘乕儖傊12儠寧娫曄峏. 嬥尨嵍嫗1,2, 堜忋尗帯1, 娾嵅恀媩1,3, 殸徏巙曐4, 愇揷嫳巕5, 晉揷崉巌5 (1堜忋娽壢昦堾, 2弴揤戝丒塝埨, 3娽壢, 4惣妺惣丒堜忋娽壢昦堾, 5搶朚戝丒戝嫶): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723535. [妛夛 (慡崙)] (妛弍揥帵) 僑僯僆僗僐乕僾乽GS-1乿偺桳梡惈媦傃埨慡惈偺専摙. 崅栘桬婱1,2, 搉绯嶰孭2, 庰堜岾峅2, 崅栘朏宐2, 梋揷愮宐2, 巗愳堦晇2,3 (1斞揷巗棫昦堾, 2拞嫗娽壢, 3娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723536. [妛夛 (慡崙)] (妛弍揥帵) 忋曽妏枌愗奐, 悅捈屌掕傪偟偨娧捠岴晅偒桳悈徎懱屻朳儗儞僘偺椪彴惉愌. 屲廫棐復巎1,2, 惔悈岞栫1,2, 壛摗幯栴崄1 (1嶳墹昦堾, 2娽壢): 戞124夞擔杮娽壢妛夛憤夛 (2020/4/27), Web奐嵜.
723537. [妛夛 (慡崙)] (堦斒島墘) 墦嬤椉梡僜僼僩僐儞僞僋僩儗儞僘憰梡桳柍偵傛傞OCT夝愅寢壥偺斾妑専摙. 摗懞晣嵅巕1, 寢懇塸棙撧1, 搰捗晣桪1, 栰嶈壺栯1, 埨揷憗婓1, 愇愳丂嬒1, 彲巌怣峴2 (1堛椕塹惗妛晹, 2娽壢): 戞9夞擔杮帇栰夋憸妛夛妛弍廤夛 (2020/6/17), Web奐嵜.
723538. [妛夛 (慡崙)] (堦斒島墘) Discrepancy between patterns of deterioration in macular perfusion density and ganglion cell thickness in early glaucoma. 暯郪堦朄1,2, Corey A Smith1, Michael E West1, Jayme R Vianna1, Lesya M Shuba1, Paul E Rafuse1, Marcelo T Nicolela1, Balwantray C Chauhan1 (1Dalhousie University, 2娽壢): 戞9夞擔杮帇栰夋憸妛夛妛弍廤夛 (2020/6/17), Web奐嵜.
723539. [妛夛 (慡崙)] (堦斒島墘) Corvis ST偵傛傞惗懱椡妛揑椢撪忈場巕偺椢撪忈幆暿擻偍傛傃帇栰恑峴偲偺娭楢. 惵栘廋堦榊1, 栘撪椙柧2, 摽栄壴嵷2, 摗栰桭棦3,4, 徏塝彨恖3,4, 懞揷攷巎3, 拞憅弐桽5, 挬壀丂椇3 (1巗棫嶥杫昦堾, 2峀搰戝, 3搶嫗戝, 4娽壢, 5嶰塰夛僣僇僓僉昦堾): 戞9夞擔杮帇栰夋憸妛夛妛弍廤夛 (2020/6/17), Web奐嵜.
723540. [妛夛 (慡崙)] (堦斒島墘) A deep learning model to predict visual field in central 10 degrees from optical coherence tomography measurement in glaucoma. Fujino Y1, Hashimoto Y1, Asaoka R1, Kiwaki T2, Sugiura H2, Asano S1, Murata H1, 徏塝彨恖1,3, Miki A4, Mori K5, Ikeda Y5,6, Kanamoto T7, Yamagami J8, Inoue K9, Tanito M10, Yamanishi K2 (1搶嫗戝, 2搶嫗戝妛忣曬棟岺妛, 3戝妛堾堛椕宯尋媶壢, 4戝嶃戝, 5嫗搒晎堛戝, 6屼抮娽壢, 7峀搰婰擮昦堾, 8JR搶嫗憤崌昦堾, 9堜忋娽壢, 10搰崻戝): 戞9夞擔杮帇栰夋憸妛夛妛弍廤夛 (2020/6/17), Web奐嵜.
723541. [妛夛 (慡崙)] (堦斒島墘) 儗乕儀儖堚揱惈帇恄宱徢偵偍偗傞僿僢僪儅僂儞僩宆帇栰寁偵傛傞摰岴帇栰應掕. 徏栰朑堖1, 埳摗庨棟1, 屗捤丂屽1, 愺愳丂尗2, 愇愳丂嬒2, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞9夞擔杮帇栰夋憸妛夛妛弍廤夛 (2020/6/17), Web奐嵜.
723542. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃懡徟揰丒僩乕儕僢僋2. 巗愳堦晇1,2 (1拞嫗娽壢, 2娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723543. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃惗懱寁應. 愳庣揷戱巙 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723544. [妛夛 (慡崙)] (堦斒島墘) 慜娽晹岝姳徛抐憌寁傪巊梡偟偨僸僩悈徎懱妀偺怴偟偄暘椶. 攏搱惔擛1, 巗愳丂宑2, 庰堜岾峅3, 壛摗岾恗3, 撪摗彯媣3, 嬍抲柧栰4, 巗愳堦晇3,5 (1娽壢柧娽堾, 2憤崌惵嶳昦堾, 3拞嫗娽壢, 4JCHO拞嫗昦堾, 5娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723545. [妛夛 (慡崙)] (堦斒島墘) 慜娽晹OCT Anterion覀艻OL-Master700覀虋e庬應掕抣偺斾妑. 巗愳丂宑1,2, 彫搰棽巌2,3, 揷懞尗惗2, 庰堜岾峅2, 壛摗岾恗2, 巗愳楁巕2, 郪栘埢巕4, 嬍抲柧栰4, 巗愳堦晇2,4,5 (1憤崌惵嶳昦堾, 2拞嫗娽壢, 3宑滀戝, 4拞嫗昦堾, 5娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723546. [妛夛 (慡崙)] (堦斒島墘) 拞崅擭幰偵偍偗傞棎帇検偑帇椡偵梌偊傞塭嬁. 姳愳棦奊1, 恄扟榓岶1, 斞揷壝旻2, 墶娭桽壚巕2, 嬥嶳弐夘2, 彲巌怣峴2 (1堛椕塹惗妛晹, 2娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723547. [妛夛 (慡崙)] (堦斒島墘) 娽豳壓悅偵懳偡傞忋娽豳庤弍慜屻偺妏枌宍忬曄壔偺専摙. 愇愳宐棦1, 屲廫棐復巎2,3, 彫郪拤旻1 (1彫戲娽壢撪壢昦堾, 2嶳墹昦堾, 3娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723548. [妛夛 (慡崙)] (堦斒島墘) 儗乕僔僢僋挿婜宱夁屻偺奜彎惈僼儔僢僾曃埵偵懳偟偰惍暅傪梫偟偨4徢椺. 烴堜棔巕1, 崅嫶惓塸1, 恄扟榓岶2, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723549. [妛夛 (慡崙)] (堦斒島墘) 墌悕妏枌娽偵偍偗傞僇僗僞儉妏枌僋儘僗儕儞僉儞僌慜屻偺stress-strain index偺斾妑. 郪栘埢巕1, 挿扟愳垷棦1, 彫搰棽巌2, 惣揷抦栫3, 拞懞桭徍3, 巗愳堦晇4,5 (1JCHO拞嫗昦堾, 2宑滀戝, 3柤屆壆傾僀僋儕僯僢僋, 4拞嫗娽壢, 5娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723550. [妛夛 (慡崙)] (堦斒島墘) 儁儖乕僔僪妏枌曈墢曄惈偵懳偡傞僇僗僞儅僀僘僪妏枌僋儘僗儕儞僉儞僌偺憗婜椪彴惉愌. 崅嫶惓塸1, 恄扟榓岶2, 嬥嶳弐夘1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723551. [妛夛 (慡崙)] (堦斒島墘) 恑峴惈墌悕妏枌偵懳偡傞僇僗僞儅僀僘僪妏枌僋儘僗儕儞僉儞僌偺弍屻1擭惉愌偺専摙. 嬥嶳弐夘1, 恄扟榓岶2, 崅嫶惓塸1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723552. [妛夛 (慡崙)] (堦斒島墘) 妏枌僋儘僗儕儞僉儞僌偺僇僗僞儉朄偲旕僇僗僞儉朄偺斾妑. 彫搰棽巌1,2, 惣揷抦栫1, 拞懞桭徍1, 搉晹丂娐3, 敀堜桪懢3, 嵅摗桾栫3, 巗愳堦晇4,5 (1柤屆壆傾僀僋儕僯僢僋, 2宑滀戝, 3嵅摗桾栫娽壢堛堾, 4拞嫗娽壢, 5娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723553. [妛夛 (慡崙)] (堦斒島墘) NX70CH傪梡偄偨僟僽儖儂乕儖僯乕僪儖偵傛傞僟僽儖僯乕僪儖朄. 媑揷懃旻1, 巗愳堦晇2,3 (1婒晫愒廫帤昦堾, 2拞嫗娽壢, 3娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723554. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃ICL. 恄扟榓岶 (堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723555. [妛夛 (慡崙)] (堦斒島墘) 慜娽晹3師尦岝姳徛抐憌寁偵偍偗傞壛嶼暯嬒夋憸傪梡偄偨嬿妏娫嫍棧偺嵞尰惈. 壛摗幯栴崄1, 惔悈岞栫1,2, 屲廫棐復巎1,2 (1嶳墹昦堾, 2娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723556. [妛夛 (慡崙)] (堦斒島墘) ICL僒僀僘偺梊應幃NK2幃偺夵椙. 拞懞桭徍1, 媑揷梲巕1, 悈栰懽巕1, 堥扟彯婸1, 惣揷抦栫1, 悪嶳峃梇1, 彫搰棽巌1,2, 巗愳堦晇3,4 (1柤屆壆傾僀僋儕僯僢僋, 2宑滀戝, 3拞嫗娽壢, 4娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723557. [妛夛 (慡崙)] (堦斒島墘) 桳悈徎懱娽撪儗儞僘偺嵟揔僒僀僘梊應偺晄堦抳棪偲偦偺尨場偺専摙. 埨摗榓壧巕1, 恄扟榓岶2, 崅嫶惓塸1, 嬥嶳弐夘1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723558. [妛夛 (慡崙)] (堦斒島墘) 桳悈徎懱娽撪儗儞僘偺悅捈屌掕偵傛傞vault偺宱帪曄壔. 崅尨桼堖1, 恄扟榓岶2, 埨摗榓壧巕1, 崅嫶惓塸1, 嬥嶳弐夘1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723559. [妛夛 (慡崙)] (堦斒島墘) 屻朳宆僼僃僀僉僢僋娽撪儗儞僘 (ICL) 憓擖弍屻憗婜偺Irido-Trabecular Contact (ITC) 偺敪惗棪偲偦偺梫場偺専摙. 崅栘桬婱1, 惣揷抦栫2, 彫搰棽巌2,3, 揷拞朏庽4, 拞懞桭徍2, 巗愳堦晇4,5 (1斞揷巗棫昦堾, 2柤屆壆傾僀僋儕僯僢僋, 3宑墳戝, 4拞嫗娽壢, 5娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723560. [妛夛 (慡崙)] (堦斒島墘) 桳悈徎懱娽撪儗儞僘偺弍屻僴儘乕偺昡壙. 峕攇屗旤榓1, 屲廫棐復巎2,3, 壛摗幯栴崄2, 彫郪拤旻1 (1彫戲娽壢撪壢昦堾, 2嶳墹昦堾, 3娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723561. [妛夛 (慡崙)] (妛弍揥帵) 墦帇丒墦帇惈棎帇偵懳偡傞Implantable Collamer Lens (ICH) 偺弍屻惉愌. 媑揷梲巕1, 惣揷抦栫1, 堥扟彯婸1, 摯堜棦奊1,2, 悈栰懽巕1, 彫搰棽巌1,3, 拞懞桭徍1, 嵅摗桾栫4, 巗愳堦晇2,5 (1柤屆壆傾僀僋儕僯僢僋, 2拞嫗娽壢, 3宑滀戝, 4嵅摗桾栫娽壢堛堾, 5娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723562. [妛夛 (慡崙)] (妛弍揥帵) 廬棃偺尠旝嬀敀撪忈庤弍偲僨僕僞儖尠旝嬀傪梡偄偨Heads-up cataract surgery偺弶婜惉愌偺専摙. 屆愳桭戝1, 巗愳丂宑2, 墶嶳丂隳3, 彫搰棽巌4, 揷拞朏庽5, 忢斦惞巌5, 摯堜棦奊5, 巗愳堦晇5,6 (1戝梇夛戞堦昦堾, 2憤崌惵嶳昦堾, 3JCHO拞嫗昦堾, 4宑墳戝, 5拞嫗娽壢, 6娽壢): 戞35夞JSCRS妛弍憤夛 (2020/7/1), Web奐嵜.
723563. [妛夛 (慡崙)] (堦斒岥墘) Virtual Reality僔儏乕僥傿儞僌僎乕儉偵傛傞娽埵丒挷愡婡擻偍傛傃塮憸悓偄傊偺塭嬁. 尨丂捈恖1, 姍揷懽彶1, 屻摗孿桽1, 崅栛旤峕1, 慜揷恀婓1, 嶳嶈悙婭1, 怴堜揷岶桾1,2 (1崙嵺堛椕暉巸戝丒曐寬堛椕妛晹帇婡擻椕朄妛壢, 2娽壢): 戞76夞擔杮庛帇幬帇妛夛憤夛丒戞45夞擔杮彫帣娽壢妛夛憤夛崌摨妛夛 (2020/7/3), Web奐嵜.
723564. [妛夛 (慡崙)] (堦斒岥墘) Spot vision screener傪梡偄偨娫寚惈奜幬帇偺椉娽奐曻壓偲曅娽幷暵壓偱偺孅愜抣曄壔. 徖郪桬婸1, 屻娭棙柧2, 屗捤丂屽1, 棿堜墤巕2, 愇愳丂嬒3, 彲巌怣峴2 (1ORT, 2娽壢, 3堛椕塹惗妛晹): 戞76夞擔杮庛帇幬帇妛夛憤夛丒戞45夞擔杮彫帣娽壢妛夛憤夛崌摨妛夛 (2020/7/3), Web奐嵜.
723565. [妛夛 (慡崙)] (堦斒岥墘)亂嵗挿亃夋憸夝愅. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝丒擬奀, 2娽壢): 戞76夞擔杮庛帇幬帇妛夛憤夛丒戞45夞擔杮彫帣娽壢妛夛憤夛崌摨妛夛 (2020/7/3), Web奐嵜.
723566. [妛夛 (慡崙)] (堦斒岥墘) 庛帇娽偵偍偗傞LSFG偲SS-OCT傪梡偄偨寣棳摦懺偲柆棈枌岤偺昡壙. 屗捤丂屽1, 屻娭棙柧2, 愇愳丂嬒3, 棿堜墤巕2, 彲巌怣峴2 (1ORT, 2娽壢, 3堛椕塹惗妛晹): 戞76夞擔杮庛帇幬帇妛夛憤夛丒戞45夞擔杮彫帣娽壢妛夛憤夛崌摨妛夛 (2020/7/3), Web奐嵜.
723567. [妛夛 (慡崙)] (堦斒岥墘) 僨僕僞儖僨僶僀僗偵傛偭偰惗偠傞屻揤嫟摨惈撪幬帇偺摿挜偲帯椕惉愌. 愇愳戝婲1, 屻娭棙柧1, 棿堜墤巕1, 愇愳丂嬒2, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞76夞擔杮庛帇幬帇妛夛憤夛丒戞45夞擔杮彫帣娽壢妛夛憤夛崌摨妛夛 (2020/7/3), Web奐嵜.
723568. [妛夛 (慡崙)] (妛弍揥帵) 帇慄夝愅憰抲偵傛傞ASD帣偺徴摦惈娽媴塣摦偵娭偡傞専摙. 巐擵媨桟攏1, 楅栘尗帯1, 彫栰媩奊2, 宭忋嫳旻1, 嵅摗柇巕1, 嶰怷愮庬1, 怴堜揷岶桾1,3 (1崙嵺堛椕暉巸戝, 2柧帯戝, 3娽壢): 戞76夞擔杮庛帇幬帇妛夛憤夛丒戞45夞擔杮彫帣娽壢妛夛憤夛崌摨妛夛 (2020/7/3), Web奐嵜.
723569. [妛夛 (慡崙)] (妛弍揥帵) 娽鈢MRI偵傛傞屻揤撪幬帇偺奜娽嬝埵抲昡壙. 壨崌垽幚1, 屻娭棙柧2, 愇愳丂嬒3, 棿堜墤巕2, 彲巌怣峴2 (1戝妛堾堛椕宯尋媶壢, 2娽壢, 3堛椕塹惗妛晹): 戞76夞擔杮庛帇幬帇妛夛憤夛丒戞45夞擔杮彫帣娽壢妛夛憤夛崌摨妛夛 (2020/7/3), Web奐嵜.
723570. [妛夛 (慡崙)] (堦斒島墘) 怓妎堎忢幰偵偍偗傞敄曢壓偺帇擣惈偵媦傏偡怓偺塭嬁. 斞捤払栫1, 愳庣揷戱巙2, 抾拞丂捈3, 捯丂丂憂4, 嬥堜攷岾5, 暯堜棙攷6, 楅栘桾惗7, 敿揷抦栫2, 愇愳丂嬒2 (1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3僯僢僙儞働儞昳幙昡壙僙儞僞乕, 4僇働儞僥僗僩僙儞僞乕, 5怣廈戝慇堐妛晹, 6怣廈戝, 7傾僛傾僗 (姅)): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
723571. [妛夛 (慡崙)] (堦斒島墘) 曅娽惈偺怱場惈帇椡忈奞偵懳偡傞Occlu-pad傪梡偄偨椉娽奐曻壓偵偍偗傞扨娽帇椡専嵏. 娾揷丂梱1, 敿揷抦栫1, 愇愳丂嬒1, 彲巌怣峴2 (1堛椕塹惗妛晹, 2娽壢): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
723572. [妛夛 (慡崙)] (堦斒島墘) Waterclefts偺嬊嵼偺堘偄偑帇婡擻傊媦傏偡塭嬁亅岝妛僔儈儏儗乕僔儑儞偵傛傞夝愅亅. 娭丂桽夘1, 愳庣揷戱巙2, 嶰揷揘戝1, 媣曐峕棟1, 嵅乆栘梞1 (1嬥戲堛戝, 2堛椕塹惗妛晹): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
723573. [妛夛 (慡崙)] (堦斒島墘) 暘岝摟夁棪偺堎側傞墿怓拝怓儗儞僘偺僌儗傾壓偵偍偗傞僐儞僩儔僗僩姶搙傊偺塭嬁. 尨岥隳懢1, 愳庣揷戱巙2, 摗懞晣嵅巕2, 彲巌怣峴3 (1搶杒暥壔妛墍戝, 2堛椕塹惗妛晹, 3娽壢): 戞56夞擔杮娽岝妛妛夛憤夛乣FOCUS 2020乣 (2020/9/5), Web奐嵜.
723574. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃椢撪忈庤弍. 彲巌怣峴 (娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723575. [妛夛 (慡崙)] (堦斒島墘) 媫惈尨敪暵嵡嬿妏徢偵懳偡傞帯椕偺椪彴惉愌. 斞搰丂宧1, 恄扟榓岶2, 斞揷壝旻1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723576. [妛夛 (慡崙)] (堦斒島墘) 娧捠岴晅偒桳悈徎懱娽撪儗儞僘揈弌偵帄偭偨徢椺偺尨場偲梊屻偺専摙. 憗愳廏婸1, 恄扟榓岶2, 崅嫶惓塸1, 埨摗榓壧巕1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723577. [妛夛 (慡崙)] (堦斒島墘) 儊乕僇乕僲儌僌儔儉偲梊應幃傪梡偄偨桳悈徎懱娽撪儗儞僘弍屻Vault偺斾妑. 埨摗榓壧巕1, 恄扟榓岶2, 崅嫶惓塸1, 憗愳廏婸1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723578. [妛夛 (慡崙)] (堦斒島墘) 僇僗僞儅僀僘僪妏枌僋儘僗儕儞僉儞僌偺僐乕儞宍忬暿偺弍屻惉愌. 崅嫶惓塸1, 恄扟榓岶2, 憗愳廏婸1, 埨摗榓壧巕1, 彲巌怣峴1 (1娽壢, 2堛椕塹惗妛晹): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723579. [妛夛 (慡崙)] (堦斒島墘) Corneal Cross-Linking for Pediatric Keratoconus: A Meta-Analysis. 彫嫶塸挿1,2, 旴揷丂杚1,3, 巺堜慺孾1,3, 恄扟榓岶1,4, 壛摗捈巕1,2, 捸揷堦抝2, 搰丂弫1,5 (1墌悕妏枌尋媶夛, 2宑滀戝, 3嫗搒晎堛戝, 4堛椕塹惗妛晹, 5搶嫗帟戝丒巗愳): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723580. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃娽撪儗儞僘搙悢寁嶼丒惗懱寁應. 恄扟榓岶 (堛椕塹惗妛晹): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723581. [妛夛 (慡崙)] (堦斒島墘) 慜娽晹OCT傪梡偄偨怴偟偄娽撪儗儞僘搙悢寁嶼幃偺慜岦偒専徹. 嵅摗丂巌1,2, 惔悈岞栫1,2,3, 忢淎弐懢榊1,2,3, 屲廫棐復巎1,2,3, 壛摗幯栴崄2, 塱悾弜婯2, 梎悈丂妛1,2,3, 怴堜揷岶桾1,3 (1崙嵺堛椕暉巸戝妛, 2嶳墹昦堾, 3娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723582. [妛夛 (慡崙)] (堦斒島墘) 僸僩敀撪忈悈徎懱偺愒摴晹傪専弌偡傞怴偟偄夋憸夝愅朄. 攏搱惔擛1, 巗愳丂宑2, 庰堜岾峅2, 曅壀悡攷3, 堥扟彯庽3, 拞懞桭徍3, 嬍抲柧栰4, 巗愳堦晇2,5 (1娽壢柧娽堾, 2拞嫗娽壢, 3柤屆壆傾僀僋儕僯僢僋, 4JCHO拞嫗昦堾, 5娽壢) 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723583. [妛夛 (慡崙)] (堦斒島墘) 敀撪忈庤弍偵偍偗傞妏枌撪旂嵶朎枾搙尭彮偵塭嬁偡傞場巕偺専摙. 郪栘埢巕1, 彫搰棽巌2, 撪摗垽棟3, 摯堜棦奊4, 杮嫶岶旻5, 巗愳堦晇4,6 (1JCHO拞嫗昦堾娽壢, 2宑滀戝, 3拞嫗儊僨傿僇儖, 4拞嫗娽壢, 5杮嫶娽壢僋儕僯僢僋, 6娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723584. [妛夛 (慡崙)] (堦斒島墘) 椢撪忈惈帇栰堎忢偑敀撪忈庤弍屻偺僐儞僩儔僗僩姶搙偵媦傏偡塭嬁場巕偺専摙. 姳愳棦奊1, 恄扟榓岶1, 斞揷壝旻2, 摗懞晣嵅巕1, 斞搰丂宧2, 妢尨惓峴2, 彲巌怣峴2 (1堛椕塹惗妛晹, 2娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723585. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃恄宱娽壢1. 愇愳丂嬒 (堛椕塹惗妛晹): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723586. [妛夛 (慡崙)] (堦斒島墘) 拞悤惈愕柧偲峫偊傜傟傞9徢椺. 壨杮傂傠旤1, 娾嵅恀媩1,2, 嶳忋柧巕1,2, 堜忋尗帯1, 庒憅夒搊1 (1堜忋娽壢昦堾, 2娽壢): 戞74夞擔杮椪彴娽壢妛夛 (2020/11/5), Web奐嵜.
723587. [妛夛 (慡崙)] (堦斒島墘) LSFG偵偰娽寣棳宱夁傪娤嶡偱偒偨帇恄宱擕摢寣娗墛偺2椺. 暁壆堦庽1, 晉揷嫥旻1, 徏杮丂捈1, 怷愳梩寧1, 壛摗宩巕1, 暯栰岾悽1, 杧桾堦1, 愇愳丂嬒2 (1搶朚戝妛堛椕僙儞僞乕戝怷昦堾, 2堛椕塹惗妛晹): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
723588. [妛夛 (慡崙)] (堦斒島墘) 彈惈偵敪徢偟偨儗乕儀儖堚揱偟帇恄宱徢27徢椺偺専摙. 惓堜抭巕1,2,3, 娾嵅恀媩1,4, 嶳忋柧巕1,4, 堜忋尗帯1, 庒憅夒搊1, 愇愳丂嬒2, 埨杮棿攏3, 烴堜宑憿3 (1堜忋娽壢昦堾, 2堛椕塹惗妛晹, 3椪専晹, 4娽壢): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
723589. [妛夛 (慡崙)] (堦斒島墘) 旕揟宆揑側宱夁偱敪徢偟偨彫帣偺儗乕儀儖堚揱巕帇恄宱徢偺堦椺. 娾嵅恀媩1,2, 嶳忋柧巕1,2, 掃壀嶰湪巕1, 堜忋尗帯1, 庒憅夒搊1, 埨杮棿攏3, 烴堜宑憿3, 愇愳丂嬒4 (1堜忋娽壢昦堾, 2娽壢, 3椪専晹, 4堛椕塹惗妛晹): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
723590. [妛夛 (慡崙)] (堦斒島墘) 價僲儗儖價儞偵傛傞拞撆惈帇恄宱徢偑媈傢傟偨堦椺. 彫惣梪巕1, 娾嵅恀媩1,2, 嶳忋柧巕1,2, 堜忋尗帯1, 庒憅夒搊1 (1堜忋娽壢昦堾, 2娽壢): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
723591. [妛夛 (慡崙)] (堦斒島墘) 椢撪忈惛嵏偱嬼敪揑偵敪尒偝傟偨愭揤惈1/4摨柤敿栍偲峫偊傜傟偨1椺. 屻摗揷抦朚1, 彫徏揘栫1, 徏杮丂捈1, 晉揷嫥旻1, 怷愳梩寧1, 壛摗樞棦1, 杧丂桾堦1, 愇愳丂嬒2 (1搶朚戝妛堛椕僙儞僞乕戝怷昦堾, 2堛椕塹惗妛晹): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
723592. [妛夛 (慡崙)] (堦斒島墘)亂嵗挿亃彫帣恄宱娽壢. 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
723593. [妛夛 (慡崙)] (堦斒島墘) 曅娽惈偺娽媴撍弌傪宊婡偵敪尒偝傟, 恌抐偵嬯椂偟偨anterior condylar confluence偺嬤朤偺峝枌摦惷柆釕偺1椺. 崅栘寴懢榊1, 屻娭棙柧1,2, 壨栰梇椇1, 棿堜墤巕1, 愇愳丂嬒3, 彲巌怣峴1, 嶳杮戝曘4 (1娽壢, 2崙嵺堛椕暉巸戝妛擬奀昦堾, 3堛椕塹惗妛晹, 4擼奜): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
723594. [妛夛 (慡崙)] (堦斒島墘) 怓妎堎忢幰偵偍偗傞悕懱僐儞僩儔僗僩姶搙. 斞捤払栫1, 愳庣揷戱巙2, 敿揷抦栫2, 尨岥隳懢3, 彲巌怣峴4, 愇愳丂嬒2 (1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3搶杒暥壔妛墍戝妛, 4娽壢): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
723595. [妛夛 (慡崙)] (堦斒島墘) 惵怓岝傪巋寖偲偟偨懳岝斀幩偐傜傒偨曃摢捝桿敪場巕偺尋媶. 廐尦旤桪1, 尨丂捈恖2, 姍揷懽彶2, 埳摗丂桰2, 嵅乆栘堣2, 庒攡嵐怐2, 怴堜揷岶桾2,3 (1崙嵺堛椕暉巸戝妛, 2崙嵺堛椕暉巸戝妛曐寬堛椕妛晹帇婡擻椕朄妛壢, 3娽壢): 戞58夞擔杮恄宱娽壢妛夛憤夛 (2020/11/6), Web奐嵜.
731046. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 娽壢堛偐傜傒偨帇恄宱墛亅恌抐丒帯椕偺擄偟偝亅. 愇愳丂嬒 (堛椕塹惗妛晹): 帇恄宱墛僙儈僫乕in愬戜 (2020/7/29), 媨忛 (僴僀僽儕僢僪奐嵜).
731047. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 幚慔, 崅楊幰偺暋帇. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 戞211夞媨忛導娽壢廤択夛 (2020/10/10), Web奐嵜.
731048. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 椢撪忈帯椕偺摫擖偲嫮壔. 彲巌怣峴 (娽壢): 戞5夞Glaucoma Frontire Conference in Chiba (2020/10/22), Web奐嵜.
731049. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) MIGS偺岠壥偲尷奅. 彲巌怣峴 (娽壢): 戞37夞搰崻椢撪忈尋媶夛 (2020/11/1), 搰崻 (僴僀僽儕僢僪奐嵜).
731050. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 椢撪忈帯椕偺慖戰. 彲巌怣峴 (娽壢): 戞巐夞拞墇椪彴娽壢尋媶夛 (2020/11/11), Web奐嵜.
731051. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘)亂嵗挿亃摿暿島墘. 彲巌怣峴 (娽壢): 戞18夞杒棦娽壢昦恌楢実夛 (2021/1/21), Web奐嵜.
731052. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 敀撪忈帯椕愴棯傾僢僾僨乕僩. 斞揷壝旻 (娽壢): 戞18夞杒棦娽壢昦恌楢実夛 (2021/1/21), Web奐嵜.
731053. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘)亂嵗挿亃摿暿島墘I. 彲巌怣峴 (娽壢): 戞2夞SENJU Glaucoma Seminar (2021/2/16), Web奐嵜.
731054. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) MIGS偵偮偄偰巚偆偙偲. 彲巌怣峴 (娽壢): 戞27夞嶳棞椢撪忈尋媶夛 (2021/3/4), Web奐嵜.
731055. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 帇恄宱墛偲偦偺娪暿幘姵亅嶐崱偺帯椕朄偲奺壢偺栶妱亅. 愇愳丂嬒 (堛椕塹惗妛晹): 帇恄宱墛楢実僙儈僫乕 in2021 (2021/3/25), 廐揷 (僴僀僽儕僢僪奐嵜).
732031. [妛夛 (抧曽夛丒尋媶夛)] (僷僱儖僨傿僗僇僢僔儑儞)亂僐儊儞僥乕僞乕亃帇恄宱墛偺媫惈婜帯椕偵偮偄偰. 愇愳丂嬒 (堛椕塹惗妛晹): 帇恄宱墛僙儈僫乕in愬戜 (2020/7/29), 媨忛 (僴僀僽儕僢僪奐嵜).
732032. [妛夛 (抧曽夛丒尋媶夛)] (寬峃島嵗) 偊偭! 巹, 敀撪忈偱偡偐? 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 崙嵺堛椕暉巸戝妛擬奀昦堾戞69夞寬峃島嵗 (2020/8/28), 惷壀.
732033. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 椢撪忈庤弍偺徯夘僞僀儈儞僌. 妢尨惓峴 (娽壢): 椢撪忈WEB僙儈僫乕 (2020/10/13), Web奐嵜.
732034. [妛夛 (抧曽夛丒尋媶夛)] (幮撪尋廋夛) 帇恄宱墛. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 拞奜惢栻幮撪島墘夛 (2020/10/22), 惷壀 (僴僀僽儕僢僪奐嵜).
732035. [妛夛 (抧曽夛丒尋媶夛)] (幮撪島墘夛) 徤巕懱庤弍偺婎慴. 弔栘悞岹 (娽壢): 僲僶儖僥傿僗僼傽乕儅噴幮撪島墘夛 (2020/10/28), Web奐嵜.
732036. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘I. 愇愳丂嬒 (堛椕塹惗妛晹): 戞11夞徝惣娽壢傾僇僨儈乕 (2020/10/29), 恄撧愳.
732037. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘II. 彲巌怣峴 (娽壢): 戞11夞徝惣娽壢傾僇僨儈乕 (2020/10/29), 恄撧愳.
732038. [妛夛 (抧曽夛丒尋媶夛)] (幮撪尋廋夛) 敀撪忈庤弍偺擄帯徢椺偵偮偄偰. 憡郪戝曘1,2 (1奀榁柤憤崌昦堾, 2娽壢): 嫽榓幮撪尋廋夛 (2020/11/11), 恄撧愳.
732039. [妛夛 (抧曽夛丒尋媶夛)] (幮撪尋廋夛) 崅楊幰偺暋帇亅Sagging Eye Syndrome傪棟夝偡傞亅. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 傢偐傕偲惢栻幮撪島墘夛 (2020/11/12), 惷壀 (僴僀僽儕僢僪奐嵜).
732040. [妛夛 (抧曽夛丒尋媶夛)] (幮撪尋廋夛) 孅愜嫺惓庤弍偲僪儔僀傾僀偵偮偄偰. 恄扟榓岶 (堛椕塹惗妛晹): 戝捤惢栻幮撪尋廋夛 (2020/11/20), Web奐嵜.
732041. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘III. 彲巌怣峴 (娽壢): SENJU Ophthalmic Seminar 2020 in Tokyo (2020/11/21), Web奐嵜.
732042. [妛夛 (抧曽夛丒尋媶夛)] (摙榑夛) 尨敪暵嵡嬿妏徢偺媫惈敪嶌偵懳偡傞帯椕惉愌偺専摙. 斞搰丂宧 (娽壢): 戞15夞僾儘僌儗僗儗億乕僩夛媍 (杒棦戝妛堛妛晹庒庤尋媶幰敪昞丒摙榑夛) (2020/11/25), 恄撧愳.
732043. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 娽豳醶澒偵偍偗傞儃僣儕僰僗椕朄偺幚慔. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): Blepharospasm Webinar (2020/11/26), Web奐嵜.
732044. [妛夛 (抧曽夛丒尋媶夛)] (幮撪尋廋夛) 椢撪忈庤弍丒帯椕偵偮偄偰. 妢尨惓峴 (娽壢): 戝捤惢栻噴幮撪尋廋夛 (2020/11/26), Web奐嵜.
732045. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘1. 恄扟榓岶 (堛椕塹惗妛晹): 戞64夞徝惣娽壢椪彴僼僅乕儔儉 (2020/12/10), Web奐嵜.
732046. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘2. 彲巌怣峴 (娽壢): 戞64夞徝惣娽壢椪彴僼僅乕儔儉 (2020/12/10), Web奐嵜.
732047. [妛夛 (抧曽夛丒尋媶夛)] (幮撪尋廋夛) 崅楊幰偺暋帇亅Sagging Eye Syndrome傪棟夝偡傞亅. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 愮庻惢栻幮撪島墘夛 (2020/12/11), 惷壀 (僴僀僽儕僢僪奐嵜).
732048. [妛夛 (抧曽夛丒尋媶夛)] (幮撪尋廋夛) 敀撪忈庤弍, 廃弍婜偺僪儔僀傾僀偵偮偄偰. 斞揷壝旻 (娽壢): 戝捤惢栻噴幮撪尋廋夛 (2020/12/14), Web奐嵜.
732049. [妛夛 (抧曽夛丒尋媶夛)] (幮撪尋廋夛) 帇恄宱墛偺昦懺偲帯椕. 愇愳丂嬒 (堛椕塹惗妛晹): 掗恖僿儖僗働傾姅幃夛幮幮撪尋廋夛 (2021/1/26), Web奐嵜.
732050. [妛夛 (抧曽夛丒尋媶夛)] (徢椺採帵)亂夝愢亃匓嫹嬿妏娽偺敀撪忈庤弍. 彲巌怣峴 (娽壢): 椢偺鉐2021 (2021/2/2), Web奐嵜.
732051. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘2. 愇愳丂嬒 (堛椕塹惗妛晹): 戞8夞恄撧愳彫帣娽壢丒恄宱娽壢僇儞僼傽儗儞僗 (2021/2/4), Web奐嵜.
732052. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 恄宱娽壢偲尒娫堘偆懠幘姵. 巗绯媊復1,2 (1恄撧愳帟壢戝妛, 2娽壢): 戞8夞恄撧愳彫帣娽壢丒恄宱娽壢僇儞僼傽儗儞僗 (2021/2/4), Web奐嵜.
732053. [妛夛 (抧曽夛丒尋媶夛)] (僷僱儕僗僩) 帇恄宱墛恌椕偵偍偗傞娽壢偲擼恄宱撪壢偺楢実乣媫惈婜偵偍偗傞IVIG偺埵抲偯偗傪娷傔偰乣. 嶳忋柧巕1,2 (1堜忋娽壢昦堾, 2娽壢): 帇恄宱墛僙儈僫乕in搶嫗 (2021/2/17), Web奐嵜.
732054. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 嶐崱偺帇恄宱墛偺恌抐朄丒帯椕朄偲拲堄偡傋偒娪暿幘姵. 愇愳丂嬒 (堛椕塹惗妛晹): 嶳宍帇恄宱墛僙儈僫乕 (2021/2/18), Web奐嵜.
732055. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 嵗挿. 惔悈岞栫1,2 (1嶳墹昦堾傾僀僙儞僞乕, 2娽壢): 儗儞僥傿僗僐儞僼僅乕僩僩乕儕僢僋?敪攧婰擮島墘夛 (2021/2/18), Web奐嵜.
732056. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 姵幰枮懌搙岦忋傪栚巜偟偨娽撪儗儞僘慖戰. 斞揷壝旻 (娽壢): 儗儞僥傿僗僐儞僼僅乕僩僩乕儕僢僋覕瓟剫L擮島墘夛 (2021/2/18), Web奐嵜.
732057. [妛夛 (抧曽夛丒尋媶夛)] (徢椺曬崘) 旕姶愼惈妏枌慂岴偵懳偟僔傾僲傾僋儕儗乕僩偱壛椕偟偨2椺. 崅嫶惓塸 (娽壢): 戞13夞恄撧愳僋儘僗僆乕僶乕僔儞億僕僂儉 (2021/2/20), Web奐嵜.
732058. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 嵗挿. 彲巌怣峴 (娽壢): 戞6夞帇妎惗棟妛婎慴僙儈僫乕 (2021/2/21), Web奐嵜.
732059. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 崅楊幰偺暋帇乣Sagging Eye Syndrome傪棟夝偡傞乣. 屻娭棙柧1,2 (1崙嵺堛椕暉巸戝妛擬奀昦堾, 2娽壢): 僌儔僫僥僢僋Web僇儞僼傽儗儞僗 (2021/2/26), Web奐嵜.
732060. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘1. 彲巌怣峴 (娽壢): 戞65夞徝惣娽壢椪彴僼僅乕儔儉 (2021/3/11), Web奐嵜.
732061. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂嵗挿亃島墘2. 恄扟榓岶 (堛椕塹惗妛晹): 戞65夞徝惣娽壢椪彴僼僅乕儔儉 (2021/3/11), Web奐嵜.
732062. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) NMOSD偵偮偄偰丂乣娽壢堛偺棫応偐傜乣. 愇愳丂嬒 (堛椕塹惗妛晹): 娭搶NMOSD僗僾儕儞僌僙儈僫乕 (2021/3/13), 搶嫗 (僴僀僽儕僢僪奐嵜).
733112. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘)亂嵗挿亃堦斒墘戣. 愇愳丂嬒 (堛椕塹惗妛晹): 戞18夞杒棦娽壢昦恌楢実夛 (2021/1/21), Web奐嵜.
733113. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 楢実昦堾丒娭楢昦堾偺徯夘. 憡郪戝曘1,2 (1奀榁柤憤崌昦堾, 2娽壢): 戞18夞杒棦娽壢昦恌楢実夛 (2021/1/21), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-110020. [尨挊] Investigation of Stress and Distress Experienced by Guardians of Children with Strabismus and/or Amblyopia. Kitasato M, Iwamitsu Y1, Iwata Y2, Ueta T, Fukaya E, Ishikawa H2: J Binocul Vis Ocul Motil 2020/1-3; 70 (1): 21-8. (娾枮桪旤1, 娾揷丂梱2, 愇愳丂嬒2: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹)
帹旲堲岮壢丒摢栩晹奜壢妛
[妛弍榑暥]
110364. [尨挊] Effects of the Conductive Component of Hearing Loss on Speech Discrimination Ability. Kurioka T1, Sano H2, Furuki S1, Yamashita T1: J Int Adv Otol 2020/4; 16 (1): 93-7. (孖壀棽恇1, 嵅栰丂敚2, 屆栘徣屷1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹)
110365. [尨挊] Transient Conductive Hearing Loss Regulates Cross-Modal VGLUT Expression in the Cochlear Nucleus of C57BL/6 Mice. Kurioka T1, Mogi S2, Yamashita T1: Brain Sci 2020/4; 10 (5): 260. (孖壀棽恇1, 栁栘嵐抦戙2, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜, 2惗暔暔棟宯)
110366. [尨挊] Resection of Parapharyngeal Space Tumors Located in the Prestyloid Compartment: Efficacy of the Cervical Approach. Matsuki T1, Okamoto I, Tada Y, Masubuchi T, Fushimi C, Kamata S, Miyamoto S1, Yamashita T1, Miura K: Ann Surg Oncol 2021/6; 28 (6): 3066-72. (徏栘丂悞1, 媨杮弐曘1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
110367. [尨挊] Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients. Matsuki T1, Okamoto I, Fushimi C, Sawabe M, Kawakita D, Sato H, Tsukahara K, Kondo T, Okada T, Tada Y, Miura K, Omura G, Yamashita T1: Cancer Med 2020/7; 9 (14): 5015-24. (徏栘丂悞1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
110368. [尨挊] Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan. Saito Y, Hayashi R, Iida Y, Mizumachi T, Fujii T, Matsumoto F, Beppu T, Yoshida M, Shinomiya H, Kamiyama R, Kitano M, Yokoshima K, Fujimoto Y, Hama T, Yamashita T1, Okami K, Miura K, Fujisawa T, Sano D, Kato H, Minami S, Sugasawa M, Masuda M, Ota I, Iwae S, Kawata R, Monden N, Imai T, Asakage T, Okada M, Yoshikawa T, Tanioka K, Kitayama M, Doi M, Fujii S, Fujii M, Oridate N, Nakamizo M, Yoshimoto S, Homma A, Nibu K, Yane K: Cancer 2020/9; 126 (18): 4177-87. (嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
110369. [尨挊] Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma. Fushimi C, Okamoto I, Matsuki T1, Masubuchi T, Okada T, Sato H, Tsukahara K, Kondo T, Yamashita T1, Hanyu K, Omura G, Takahashi H, Tada Y, Miura K: Anticancer Res 2020/9; 40 (9): 5277-83. (徏栘丂悞1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
110370. [尨挊] Investigation of varicella-zoster virus immunoglobulin G levels in general health checkup subjects and patients with the Ramsay Hunt syndrome for a diagnosis of zoster sine herpete. Yamaguchi T1, Sano H2, Shibaki S, Yamashita S, Kobayashi S, Okamoto M1: Kitasato Med J 2020/9; 50 (2): 138-45. (嶳岥抦巕1, 嵅栰丂敚2, 壀杮杚恖1: 1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹)
110371. [尨挊] Cerebellopontine angle tumor patients with and without sudden hearing loss. Ochiai A1: Kitasato Med J 2020/9; 50 (2): 145-51. (棊崌丂撝1: 1帹旲堲岮丒摢栩奜)
110372. [尨挊] Investigation of the Efficacy and Safety of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma. Sato H, Fushimi C, Okada T, Matsuki T1, Kondo T, Omura G, Miura K, Yamashita T1, Okamoto I, Tsukahara K: In Vivo 2020/9-10; 34 (5): 2967-72. (徏栘丂悞1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
110373. [尨挊] Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma. Niwa K, Kawakita D, Nagao T, Takahashi H, Saotome T, Okazaki M, Yamazaki K, Okamoto I, Hirai H, Saigusa N, Fushimi C, Masubuchi T, Miura K, Okazaki S, Matsui H, Okada T, Iwaki S, Matsuki T1, Hanyu K, Tsukahara K, Oridate N, Tada Y: Sci Rep 2020/10; 10 (1): 16988. (徏栘丂悞1: 1帹旲堲岮丒摢栩奜)
110374. [尨挊] Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 Patients. Matsuki T1, Okamoto I, Fushimi C, Takahashi H, Okada T, Kondo T, Sato H, Ito T, Tokashiki K, Tsukahara K, Hanyu K, Masubuchi T, Tada Y, Miura K, Omura G, Sawabe M, Kawakita D, Yamashita T1: Cancers (Basel) 2020/11; 12 (11): 3427. (徏栘丂悞1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
110375. [尨挊] Age-based efficacy and safety of nivolumab for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter retrospective study. Kondo T, Okamoto I, Sato H, Koyama N, Fushimi C, Okada T, Masubuchi T, Miura K, Matsuki T1, Yamashita T1, Omura G, Takahashi H, Tsukahara K: Asia Pac J Clin Oncol 2020/12; 16 (6): 340-7. (徏栘丂悞1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
110376. [尨挊] Long-term administration of vitamin B12 and adenosine triphosphate for idiopathic sudden sensorineural hearing loss: a retrospective study. Kurioka T1, Sano H2, Furuki S1, Yamashita T1: PeerJ 2020/12; 8: e10406. (孖壀棽恇1, 嵅栰丂敚2, 屆栘徣屷1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹)
110377. [尨挊] A kinematic analysis of swallow gestures and timing using video fluoroscopic study after supracricoid laryngectomy. Seino Y1, Miayamoto S1, Nakayama M, Yamashita T1: Radiol Diagn Imaging 2020; 4: 1-7. (惔栰桼攜1, 媨杮弐曘1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
110378. [尨挊] A Study of Factors that Contribute to the Severe Progression of Peritonsillar Abscess. Fujikawa N1, Yamashita T1: Int J Pract Otolaryngol 2020; 03 (01): e1-5. (摗愳捈栫1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
110379. [尨挊] Speech discrimination impairment of the worse-hearing ear in asymmetric hearing loss. Kurioka T1, Sano H2, Furuki S1, Yamashita T1: Int J Audiol 2021/1; 60 (1): 54-9. (孖壀棽恇1, 嵅栰丂敚2, 屆栘徣屷1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹)
110380. [尨挊] Comparison of real-ear insertion gains in Japanese-speaking individuals wearing hearing aids with DSLv5 and NAL-NL2. Furuki S1, Sano H2, Kurioka T1, Ogiwara A, Nakagawa T1, Inoue R3, Umehara S3, Hara Y2, Suzuki K, Yamashita T1: Auris Nasus Larynx 2021/2; 48 (1): 75-81. (屆栘徣屷1, 嵅栰丂敚2, 孖壀棽恇1, 拞愳婱恗1, 堜忋棟奊3, 攡尨岾宐3, 尨丂桼婭2, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹, 3儕僴價儕晹)
120034. [尨挊] 曗挳婍僼傿僢僥傿儞僌僜僼僩偱偺NAL-NL, DSL朄偺弶婜愝掕抣偺懨摉惈. 屆栘徣屷1, 嵅栰丂敚2, 孖壀棽恇1, 堜忋棟奊3, 攡尨岾宐3, 尨丂桼婭2, 楅栘宐巕2, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹, 3儕僴價儕晹): Audiology Japan 2020/7; 63 (4): 256-62.
120035. [尨挊] 抧堟僌儖乕僾妶摦嶲壛崅楊幰偺挳妎昡壙偲曗挳婍帋挳. 楅栘宐巕1, 堜忋棟奊2, 攡尨岾宐2, 恅丂庒嵷1, 惔悈廆暯, 嵅栰丂敚1, 拞愳婱恗3, 壀杮杚恖3, 嶳壓丂戱3 (1堛椕塹惗妛晹, 2儕僴價儕晹, 3帹旲堲岮丒摢栩奜): Audiology Japan 2020/7; 63 (4): 263-71.
120036. [尨挊] 滸搷廃埻擽釃偺廳徢壔偵娭梌偡傞場巕偺専摙. 摗愳捈栫1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 帹旲椪彴 2020/7; 113 (7): 461-5.
310043. [徢椺曬崘] Cryptococcal osteomyelitis of the Zygomatic bone: a case report. Matsuki T1, Miyamoto S1, Yamashita T1: BMC Infect Dis 2020/6; 20 (1): 399. (徏栘丂悞1, 媨杮弐曘1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
310044. [徢椺曬崘] Transoral endoscopic surgical approach to venous malformation of the parapharyngeal space. Kimura A1, Seino Y1, Yamashita T1: SAGE Open Med Case Rep 2020/7; 8: 2050313X20938248. (栘懞庨棦1, 惔栰桼攜1, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜)
320036. [徢椺曬崘] 奜栩摦柆偺憱峴堎忢傪敽偭偨帹壓態懡宍態庮偺1庤弍徢椺. 媨搰楁巕, 徏栘丂悞1, 惔栰桼攜1, 愇堜朙懢1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 摢栩晹奜壢 2020/5; 30 (2): 223-7.
320037. [徢椺曬崘] Sistrunk朄偱愗彍偟偨峛忬愩娗娻偺1椺. 栢嶳崄曐1, 徏栘丂悞1, 媨杮弐曘1, 壛擺岶堦1, 掔丂隳暯, 屆栘埢巕1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 摢栩晹奜壢 2020/9; 30 (3): 427-31.
320038. [徢椺曬崘] 婥娗忋岮摢垷慡揈弌弍傪巤峴偟偨惡栧壓恑揥嵞敪岮摢娻偺2椺. 媨杮弐曘1, 惔栰桼攜1, 徏栘丂悞1, 壛擺岶堦1, 掔丂隳暯, 楅栘埢巕, 栢嶳崄曐1, 尨揷梇婎1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 摢栩晹娻 2020/11; 46 (3): 302-10.
320039. [徢椺曬崘] 媬嵪宱岥揑庤弍屻偵廳撃側抶敪惈弌寣傪惗偠偨嵞敪拞堲摢娻偺1椺. 尨揷梇婎1, 媨杮弐曘1, 惔栰桼攜1, 徏栘丂悞1, 壛擺岶堦1, 掔丂隳暯, 屆栘埢巕1, 栢嶳崄曐1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 摢栩晹娻 2020/12; 46 (4): 401-5.
521015. [夝愢]亂摿廤: 戞7夞妛夛僄傾儘僝儖僔儞億僕僂儉乽帹旲堲岮壢椞堟偵偍偗傞傾儗儖僊乕幘姵傊偺嬊強丒媧擖椕朄乿亃傾儗儖僊乕惈旲墛偵偍偗傞僱僽儔僀僓乕椕朄. 戝栘姴暥 (杒棦戝妛儊僨傿僇儖僙儞僞乕): 擔杮帹旲堲岮壢姶愼徢丒僄傾儘僝儖妛夛夛帍 2020/11; 8 (3): 176-9.
522104. [島嵗]亂Clinical Academic Topics亃僗僊壴暡徢姵幰偵偍偗傞愩壓柶塽椕朄偲宱旂峈僸僗僞儈儞栻暪梡偺岠壥. 戝栘姴暥1, 戝嫶寬懢榊1,2, 撨恵栰抭岝1,2, 攇懡栰塴懢2, 楅栘棫弐2, 拞懞媑惉2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2帹旲堲岮丒摢栩奜): 傾儗儖僊乕偺椪彴 2020/4; 40 (4): 290-3.
522105. [島嵗]亂摿廤: 崅楊幰偺傔傑偄傪帯偡亃崅楊傔傑偄姵幰傊偺儕僴價儕僥乕僔儑儞. 挿徖塸柧1,2 (1怴悽婭堛椕丒愭抂堛椕, 2帹旲堲岮丒摢栩晹奜): 帹旲堲岮壢丒摢栩晹奜壢 2020/5; 92 (6): 427-36.
522106. [島嵗]亂摿廤: 旲偲偺偳偺嬊強帯椕亃僱僽儔僀僓乕偵偮偄偰. 戝栘姴暥 (杒棦戝妛儊僨傿僇儖僙儞僞乕): JOHNS 2020/6; 36 (6): 677-80.
522107. [島嵗]亂Clinical Academic Topics亃旲幘姵帯椕偵偍偗傞帺摦旲峯愻忩婍巊梡偺揔惓偵偮偄偰. 戝栘姴暥1, 攇懡栰塴懢2, 戝嫶寬懢榊1,2, 媨壓孿堦2, 撨恵栰抭岝1,2, 嶳杮尗屷1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2帹旲堲岮丒摢栩奜): 傾儗儖僊乕偺椪彴 2020/7; 40 (7); 556-9.
522108. [島嵗]亂摿廤: 娍曽堛妛擖栧丂帹旲堲岮壢偱娍曽栻傪巊偄偙側偡亃巹偺悇彠亅戙昞揑側娍曽栻偺巊偄曽丂曗嵻傪偑傫巟帩椕朄偵梡偄傞. 栢嶳崄曐1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 帹旲堲岮壢丒摢栩晹奜壢 2020/11; 92 (12): 1010-3.
522109. [島嵗]亂摿廤: 僇儔乕弍拞幨恀偱傛偔傢偐傞丂払恖偵傛傞摢栩晹偑傫奼戝愗彍亃岮摢丒堲摢庤弍丂岮摢垷慡揈弍亅婎杮揑側庤媄偲棷堄偡傋偒揰偲偼? 媨杮弐曘 (帹旲堲岮丒摢栩奜): 帹旲堲岮壢丒摢栩晹奜壢 2020/12; 92 (13): 1094-9.
522110. [島嵗]亂摿廤: 挳妎専嵏偺億僀儞僩亅憗婜敪尒偲揔愗側巜摫亅亃崪摫抣偺尒曽, 偙偺崪摫抣偼惓偟偄偐. 嵅栰 丂敚 (堛椕塹惗妛晹): ENTONI 2021/1; 253: 5-10.
522111. [島嵗]亂尋廋僲乕僩亃帹旲堲岮壢堛偵昁梫側曗挳婍偺抦幆. 嵅栰 丂敚 (堛椕塹惗妛晹): 帹旲椪彴 2021/2; 114 (2): 168-9.
530019. [偦偺懠 (ASO Author Reflections)] ASO Author Reflections: What is the Best Surgical Approach for Benign Tumors Arising from the Prestyloid Compartment in the Parapharyngeal Space? Matsuki T1: Ann Surg Oncol 2021/6; 28 (6): 3073-4. (徏栘丂悞1: 1帹旲堲岮丒摢栩奜)
[挊丂彂]
620096. [妛弍彂 (暘扴幏昅)]亂帹旲堲岮壢恌椕Q&A (JOHNS 9寧憹戝崋)亃[旲壢椞堟] 3. nasal cycle偺奣擮偼崱偳偆側偭偰偄傑偡偐? 椪彴偲偺娭楢偼偳偆偱偟傚偆偐?, p.1148-50. 戝栘姴暥 (杒棦戝妛儊僨傿僇儖僙儞僞乕), 搶嫗堛妛幮, 搶嫗, 2020/9敪峴.
62097. [妛弍彂 (暘扴幏昅)]亂帹旲堲岮壢恌椕Q&A (JOHNS 9寧憹戝崋)亃[栩晹椞堟, 摢栩晹庮釃] 7. 嵞敪惈偺惡懷敀斅徢偵偳偺傛偆偵懳墳偟傑偡偐?, p.1288-90. 嶳壓丂戱 (帹旲堲岮丒摢栩奜), 搶嫗堛妛幮, 搶嫗, 2020/9敪峴.
[妛夛丒尋媶夛摍]
722191. [妛夛 (慡崙)] (嫵堢島墘)亂僱僽儔僀僓乕椕朄偺埨慡惈偲姶愼懳嶔亅怴宆僐儘僫僂僀儖僗傊偺懳墳偵妛傇亅亃僱僽儔僀僓乕椕朄偺埨慡惈偲姶愼懳嶔亅揔墳偲埨慡惈. 戝栘姴暥1 (1杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞8夞擔杮帹旲堲岮壢姶愼徢丒僄傾儘僝儖妛夛憤夛丒妛弍島墘夛 (2020/9/25-26, 10/3-16), 搶嫗 (僴僀僽儕僢僪奐嵜).
722192. [妛夛 (慡崙)] (庡戣)亂1-1: 挳妎偺壜慪惈亅婎慴尋媶偐傜椪彴強尒傑偱亃1. 揱壒擄挳偑鍡媿恄宱偵媦傏偡塭嬁偲恄宱壜慪惈偵偮偄偰. 孖壀棽恇1, 嵅栰丂敚2, 屆栘徣屷1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹): 戞65夞擔杮挳妎堛妛夛憤夛丒妛弍島墘夛 (2020/10/7-9), 柤屆壆 (僴僀僽儕僢僪奐嵜), Audiology Japan 2020/9; 63 (5): 300.
722193. [妛夛 (慡崙)] (僔儞億僕僂儉) 壒嬁惈挳妎忈奞偵偍偗傞鍡媿恄宱偲奀攏偺忈奞儊僇僯僘儉偵偮偄偰. 孖壀棽恇 (帹旲堲岮丒摢栩晹奜): 戞30夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2020/11/12), 暉壀.
723596. [妛夛 (慡崙)] (堦斒島墘) 栩捙慜廲枵懷崪壔徢偵傛傞殝壓忈奞偵懳偟崪壔憙愗彍傪峴偄堎側傞宱堒傪偨偳偭偨2徢椺. 惔栰桼攜1, 摗愳捈栫1, 拞懞媑惉1, 楅栘棫弐1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 戞43夞擔杮殝壓堛妛夛妛弍島墘夛 (2020/7/12), Web奐嵜.
723597. [妛夛 (慡崙)] (堦斒島墘) 堲摢怘摴昞嵼娻偵懳偡傞宱岥揑庤弍屻偵敪惗偟偨堎帪惈懠憻婍娻偺専摙. 壛擺岶堦1, 寴揷恊棙2, 堦屗徆柧3, 愇屗尓師2, 媨杮弐曘1, 徏栘丂悞1, 掔丂隳暯4, 屆栘埢巕1, 栢嶳崄曐1, 尨揷梇婎1, 揷绯丂憦2,5, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2徚壔婍撪, 3昦棟, 4戝妛堾堛椕宯尋媶壢, 5怴悽婭堛椕丒愭抂堛椕): 戞44夞擔杮摢栩晹娻妛夛 (2020/7/17-27), Web奐嵜.
723598. [妛夛 (慡崙)] (堦斒島墘) 僯儃儖儅僽傪搳梌偟偨嵞敪丒揮堏摢栩晹滸暯忋旂娻徢椺偺擭楊暿偺桳岠惈偲埨慡惈偺専摙亅懡巤愝嫟摨尋媶亅. 嬤摗婱恗, 壀杮埳嶌, 嵅摗岹庽, 壀揷戱楴, 暁尒愮拡, 憹暎払晇, 嶰塝峅婯, 徏栘丂悞1, 嶳壓丂戱1, 彫懞丂崑, 崅嫶廏憦, 捤尨惔彶 (1帹旲堲岮丒摢栩奜): 戞44夞擔杮摢栩晹娻妛夛 (2020/7/17-27), Web奐嵜.
723599. [妛夛 (慡崙)] (堦斒島墘) 曻幩慄帯椕屻偺媬嵪岮摢慡揈弍 堲摢旂晢釕梊杊偵偍偗傞PIG偺桳岠惈偺専摙亅懡巤愝嫟摨尋媶亅. 壀杮埳嶌, 嵅摗岹庽, 壀揷戱楴, 捤尨惔彶, 嬤摗婱恗, 暁尒愮拡, 嶰塝峅婯, 徏栘丂悞1, 嶳壓丂戱1, 彫懞丂崑 (1帹旲堲岮丒摢栩奜): 戞44夞擔杮摢栩晹娻妛夛 (2020/7/17-27), Web奐嵜.
723600. [妛夛 (慡崙)] (堦斒島墘) 嵞敪揮堏懥塼態娻偵懳偡傞僇儖儃僾儔僠儞, 僪僙僞僉僙儖暪梡椕朄偺桳岠惈偲埨慡惈偺専摙. 壀揷戱楴, 屲寧彈棽, 挿旜弐岶, 憹暎払晇, 暁尒愮拡, 徏栘丂悞1, 崅嫶廏憦, 嶰塝峅婯, 捤尨惔彶, 懡揷梇堦榊 (1帹旲堲岮丒摢栩奜): 戞44夞擔杮摢栩晹娻妛夛 (2020/7/17-27), Web奐嵜.
723601. [妛夛 (慡崙)] (堦斒島墘) 摉壢偵偍偄偰摢栩晹奜壢堛偑巤峴偟偨梀棧旂曎丒嬻挵偵傛傞摢栩晹嵞寶庤弍40椺偺専摙. 徏栘丂悞1, 媨杮弐曘1, 壛擺岶堦1, 掔丂隳暯2, 屆栘埢巕1, 栢嶳崄曐1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): 戞44夞擔杮摢栩晹娻妛夛 (2020/7/17-27), Web奐嵜.
723602. [妛夛 (慡崙)] (堦斒島墘) 岮摢垷慡揈弌弍偵偍偗傞帯椕婜娫抁弅偺帋傒. 媨杮弐曘1, 徏栘丂悞1, 壛擺岶堦1, 掔丂隳暯2, 屆栘埢巕1, 栢嶳崄曐1, 尨揷梇婎1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): 戞44夞擔杮摢栩晹娻妛夛 (2020/7/17-27), Web奐嵜.
723603. [妛夛 (慡崙)] (堦斒島墘) (Under 40 session桪廏墘戣徿庴徿) 摢栩晹昞嵼娻慡崙搊榐挷嵏丂撪帇嬀恌抐偺専摙. 壛擺岶堦1, 旲壀丂徃, 寴揷恊棙2, 摗堜惤巙, 嫿揷寷堦, 愇尨丂棫, 栧攏媣旤巕, 戝怷丂懽, 晲摗丂妛, 椦丂棽堦 (1帹旲堲岮丒摢栩奜, 2徚壔婍撪): 戞44夞擔杮摢栩晹娻妛夛 (2020/7/17-27), Web奐嵜.
723604. [妛夛 (慡崙)] (堦斒島墘) 愩壓柶塽椕朄巤峴拞偺僗僊壴暡徢姵幰偵偍偗傞宱旂峈僸僗僞儈儞栻暪梡偺桳塿惈. 戝栘姴暥1, 楅栘棫弐2, 拞懞媑惉2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2帹旲堲岮丒摢栩奜): 戞38夞擔杮帹旲堲岮壢柶塽傾儗儖僊乕妛夛 (2020/9/15-16, 10/1-7), 墶昹 (僴僀僽儕僢僪奐嵜).
723605. [妛夛 (慡崙)] (堦斒島墘) 崄椏擖傝忲婥儅僗僋憰拝偺旲峯惗棟妛揑堄媊偺専摙. 戝栘姴暥1, 嶳杮尗屷1,2, 楅栘棫弐2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2帹旲堲岮丒摢栩奜): 戞8夞擔杮帹旲堲岮壢姶愼徢丒僄傾儘僝儖妛夛憤夛丒妛弍島墘夛 (2020/9/25-26, 10/3-16), 搶嫗 (僴僀僽儕僢僪奐嵜).
723606. [妛夛 (慡崙)] (堦斒島墘) 堲摢捝傪敽偄廳撃側慡恎徢忬傪棃偟偨Pasteurella 姶愼徢偺堦椺. 嶳杮尗屷1,2, 嵶栰峗巎2, 戝栘姴暥1, 嶳壓丂戱2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2帹旲堲岮丒摢栩奜): 戞8夞擔杮帹旲堲岮壢姶愼徢丒僄傾儘僝儖妛夛憤夛丒妛弍島墘夛 (2020/9/25-26, 10/3-16), 搶嫗 (僴僀僽儕僢僪奐嵜).
723607. [妛夛 (慡崙)] (堦斒島墘) 嵼戭娚榓働傾偵梡偄傞惛桘偵偍偗傞h-CLAT 傪梡偄偨旂晢姶嶌惈偺専摙. 媑嶳桭擇, 戝栘姴暥1 (1杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞8夞擔杮帹旲堲岮壢姶愼徢丒僄傾儘僝儖妛夛憤夛丒妛弍島墘夛 (2020/9/25-26, 10/3-16), 搶嫗 (僴僀僽儕僢僪奐嵜).
723608. [妛夛 (慡崙)] (堦斒島墘) 寣塼摟愅姵幰偵崌暪偟偨媫惈姶壒擄挳偺専摙. 嶳杮尗屷1, 孖壀棽恇1, 屆栘徣屷1, 嵅栰丂敚2, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹): 戞121夞擔杮帹旲堲岮壢妛夛妛弍島墘夛 (2020/10/6), 壀嶳 (僴僀僽儕僢僪奐嵜).
723609. [妛夛 (慡崙)] (堦斒島墘) Extracellular signal-regulated kinase宱楬慾奞偵傛傞婥娗嫹嶓儅僂僗儌僨儖偺嫹嶓梊杊岠壥. 栘懞庨棦1, 峳栘岾恗, 嵅摗懽巌, 栁栘嵐愮戙2, 孖壀棽恇1, 塅栰岝桽, 峚忋戝曘, 墫扟彶峗, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2惗暔暔棟宯): 戞121夞擔杮帹旲堲岮壢妛夛妛弍島墘夛 (2020/10/6), 壀嶳 (僴僀僽儕僢僪奐嵜).
723610. [妛夛 (慡崙)] (堦斒島墘) 擄挳偑奀攏偺恄宱怴惗偵媦傏偡塭嬁偵偮偄偰. 孖壀棽恇1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 戞121夞擔杮帹旲堲岮壢妛夛妛弍島墘夛 (2020/10/6), 壀嶳 (僴僀僽儕僢僪奐嵜).
723611. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞惡栧壓堎暔12徢椺偺専摙. 摗愳捈栫1, 戝尨戩嵠1, 惔栰桼攜1, 栢嶳崄曐1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 戞121夞擔杮帹旲堲岮壢妛夛妛弍島墘夛 (2020/10/7), 壀嶳 (僴僀僽儕僢僪奐嵜).
723612. [妛夛 (慡崙)] (堦斒島墘) 崄椏擖傝忲婥儅僗僋偵傛傞旲徢忬夵慞岠壥偺専摙. 戝栘姴暥1, 戝嫶寬懢榊1,2, 撨恵栰抭岝1,2, 攇懡栰塴懢2, 楅栘夒柧 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2帹旲堲岮丒摢栩奜): 戞121夞擔杮帹旲堲岮壢妛夛妛弍島墘夛 (2020/10/6-26), 壀嶳 (僴僀僽儕僢僪奐嵜).
723613. [妛夛 (慡崙)] (堦斒島墘) 揱壒擄挳偑鍡媿恄宱偵媦傏偡塭嬁偲恄宱壜慪惈偵偮偄偰. 孖壀棽恇1, 嵅栰丂敚2, 屆栘徣屷1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹): 戞65夞擔杮挳妎堛妛夛憤夛丒妛弍島墘夛 (2020/10/7), 垽抦 (僴僀僽儕僢僪奐嵜).
723614. [妛夛 (慡崙)] (堦斒島墘) NAL-NL朄丒DSL朄偵偍偗傞僼傽儞僋僔儑僫儖僎僀儞偺専摙. 屆栘徣屷1, 嵅栰丂敚2, 孖壀棽恇1, 攡尨岾宐, 尨丂桼婭2, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹): 戞65夞擔杮挳妎堛妛夛憤夛丒妛弍島墘夛 (2020/10/8), 垽抦 (僴僀僽儕僢僪奐嵜).
723615. [妛夛 (慡崙)] (堦斒島墘) 榁恖惈擄挳僞僀僾暘椶偺帋傒. 徏嶈憦旤1, 嵅栰丂敚2 (1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹): 戞65夞擔杮挳妎堛妛夛憤夛丒妛弍島墘夛 (2020/10/9), 垽抦 (僴僀僽儕僢僪奐嵜).
723616. [妛夛 (慡崙)] (堦斒島墘) 堛尨惈悜塼旲楻傪媈偭偨抶敪惈敪徢嵶嬠惈悜枌墛偺2椺. 愺屆桳婭巕1, 楅栘棫弐1, 攇懡栰塴懢1,2, 戝栘姴暥2, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2杒棦戝妛儊僨傿僇儖僙儞僞乕): 戞59夞擔杮旲壢妛夛憤夛丒妛弍島墘夛 (2020/10/10), 搶嫗 (僴僀僽儕僢僪奐嵜).
723617. [妛夛 (慡崙)] (堦斒島墘) Retrofacial approach傪梡偄偨恖岺撪帹杽傔崬傒弍偺堦椺. 屆栘徣屷1, 孖壀棽恇1, 嵅栰丂敚2, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹): 戞30夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2020/11/12), 暉壀 (僴僀僽儕僢僪奐嵜).
723618. [妛夛 (慡崙)] (堦斒島墘) 嵍塃旕懳徧惈擄挳偵偍偗傞埆挳帹偺岅壒挳庢擻掅壓偵偮偄偰. 孖壀棽恇1, 嵅栰丂敚2, 屆栘徣屷1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2堛椕塹惗妛晹): 戞30夞擔杮帹壢妛夛憤夛丒妛弍島墘夛 (2020/11/12), 暉壀 (僴僀僽儕僢僪奐嵜).
723619. [妛夛 (慡崙)] (堦斒島墘) GJB 2堚揱巕c.235delC曄堎傪homo偱桳偡傞婬側寉搙擄挳偺1椺. 峳栘彯旤1, 朷寧弮巕2, 愇愳垷婓巕, 愳岥浠壚1, 媑懞壝峀2, 屆栘徣屷3, 嵅栰丂敚4, 崅揷巎抝1,5 (1堚揱恌椕晹, 2嶻壢, 3帹旲堲岮丒摢栩奜, 4堛椕塹惗妛晹, 5戝妛堾堛椕宯尋媶壢), 擔杮恖椶堚揱妛夛戞65夞戝夛 (2020/11/20), Web奐嵜.
723620. [妛夛 (慡崙)] (堦斒島墘) 壛楊惈暯峵忈奞偵懳偡傞暯峵嬝椡僩儗乕僯儞僌. 棊崌丂撝 (帹旲堲岮丒摢栩奜): 戞79夞擔杮傔傑偄暯峵堛妛夛憤夛丒妛弍島墘夛 (2020/11/25), 墶昹.
723621. [妛夛 (慡崙)] (堦斒島墘) 挿婜堸庰偵傛傞傾儖僐乕儖惈彫擼曄惈徢偺1椺. 拞愳婱擵1, 棊崌丂撝1, 挿徖塸柧1,2 (1帹旲堲岮丒摢栩奜, 2怴悽婭堛椕丒愭抂堛椕): 戞79夞擔杮傔傑偄暯峵堛妛夛憤夛丒妛弍島墘夛 (2020/11/27), 墶昹.
723622. [妛夛 (慡崙)] (堦斒島墘) 摉堾夁嫀30擭娫偵偍偗傞彫帣婥娗愗奐徢椺偺専摙. 戝尨戩嵠1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 戞15夞擔杮彫帣帹旲堲岮壢妛夛憤夛丒妛弍島墘夛 (2020/12/1), 崅抦 (僴僀僽儕僢僪奐嵜).
723623. [妛夛 (慡崙)] (堦斒島墘) 儚儗儞儀儖僌徢岓孮偵傛傞旲堲峯暵嵔晄慡偵懳偟堲摢曎庤弍傪巤峴偟偨堦椺. 惔栰桼攜 (帹旲堲岮丒摢栩奜): 戞44夞擔杮殝壓堛妛夛憤夛側傜傃偵妛弍島墘夛 (2021/3/6), Web奐嵜.
723624. [妛夛 (慡崙)] (堦斒島墘) 摉壢偱巤峴偟偨崅楊幰偵懳偡傞幁栰幃惡栧暵嵔弍偺宱尡. 惔栰桼攜1, 栢嶳崄曐1, 掔丂隳暯2, 媨杮弐曘1, 楅栘棫弐1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): 戞33夞擔杮岮摢壢妛夛憤夛側傜傃偵妛弍島墘夛 (2021/3/6), Web奐嵜.
731056. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 堲岮摢偑傫偵懳偡傞宱岥揑庤弍. 嶳壓丂戱 (帹旲堲岮丒摢栩晹奜): 嬨廈戝妛 Head and Neck Cancer Expert Web Meeting (2020/9/17), Web奐嵜.
731057. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 摢栩晹偑傫偺掅怤廝帯椕偲娍曽栻偺栶妱. 嶳壓丂戱 (帹旲堲岮丒摢栩晹奜): 廐揷導帹旲堲岮壢妛弍島墘夛 (2021/3/28), Web奐嵜.
732063. [妛夛 (抧曽夛丒尋媶夛)] (儚乕僋僔儑僢僾)傃傑傫惈怘摴醶澒傪掓偟偨僷乕僉儞僜儞昦徢椺丒戞擇曬乣庤弍夘擖偵傛傞曄壔乣. 抮嶳弴巕, 揷懞徆栫1, 摽揷丂隳, 岞暥丂嵤, 抮拞払墰, 憹揷岞抝, 挿扟愳堦巕 (1帹旲堲岮丒摢栩晹奜): 戞19夞孃楬僯儏乕儘僒僀僄儞僗儚乕僋僔儑僢僾 (2020/8/21-22), 孃楬.
732064. [妛夛 (抧曽夛丒尋媶夛)] (婎挷島墘) 嵞敪摢栩晹娻偵偍偗傞IO忋巗屻偺帯椕曽恓偵偮偄偰. 媨杮弐曘 (帹旲堲岮丒摢栩晹奜): Head & Neck Expert Meeting (2020/11/19), Web奐嵜.
732065. [妛夛 (抧曽夛丒尋媶夛)] (僙儈僫乕) 廳徢怱恎忈奞帣丒幰偺堛椕 (婥娗愗奐偵偮偄偰). 戝尨戩嵠 (帹旲堲岮丒摢栩晹奜): 椷榓2擭搙憡柾巗廳徢怱恎忈奞帣 (幰) 娕岇尋廋帠嬈 (2020/12/12), Web奐嵜.
733114. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 帹旲堲岮壢偺帇揰偐傜峫偊傞儅僗僋憰梡偺岟嵾. 嶳杮尗屷1,2, 戝栘姴暥1, 戝嫶寬懢榊1,2, 撨恵栰抭岝1,2 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2帹旲堲岮丒摢栩奜): 戞135夞擔帹旲嶉嬍導抧曽晹夛妛弍島墘夛 (2020/10/4), 塝榓.
733115. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 嵞敪丒揮堏摢栩晹娻偵懳偡傞 僯儃儖儅僽偺埵抲晅偗 僾儔僠僫姶庴惈徢椺偵偍偗傞専摙. 媨杮弐曘1, 徏栘丂悞1, 壛擺岶堦1, 掔丂隳暯2, 栢嶳崄曐1, 尨揷梇婎1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): Head and Neck Immuno-Oncology web Live Seminar in Kanagawa (2020/10/15), 墶昹.
733116. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) NCCN僈僀僪儔僀儞偐傜傒偨嵞敪摢栩晹娻偵偍偗傞IO忋巗屻偺帯椕曽恓偵偮偄偰. 媨杮弐曘 (帹旲堲岮丒摢栩晹奜): Head & Neck Expert Meeting (2020/11/20), Web奐嵜.
733117. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 忋堲摢懡宍態庮偺1椺. 拞懞媑惉1, 媨杮弐曘1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 擔杮帹旲堲岮壢妛夛恄撧愳導抧曽晹夛戞193夞帹旲堲岮壢丒摢栩晹奜壢妛弍島墘夛 (2020/11/28), Web奐嵜.
733118. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 擃岥奧丒忋堲摢偺崌暪愗彍傪峴偭偨壓堲摢娻嵞敪偺1椺. 崢捤廩宐1, 媨杮弐曘1, 徏栘丂悞1, 尨揷梇婎1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 擔杮帹旲堲岮壢妛夛恄撧愳導抧曽晹夛戞194夞帹旲堲岮壢丒摢栩晹奜壢妛弍島墘夛 (2021/3/27), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-110021. [尨挊] Activity-Dependent Neurodegeneration and Neuroplasticity of Auditory Neurons Following Conductive Hearing Loss in Adult Mice. Kurioka T1, Mogi S2, Tanaka M3, Yamashita T1: Cell Mol Neurobiol 2021/1; 41 (1): 31-42. (孖壀棽恇1, 栁栘嵐愮戙2, 揷拞丂妛3, 嶳壓丂戱1: 1帹旲堲岮丒摢栩奜, 2惗暔暔棟宯, 3僶僀僆僀儊乕僕尋媶僙)
'19-120004. [尨挊] 岮摢垷慡揈弌弍 (supracricoid laryngectomy) 偺揔墳偲尷奅亅愗彍慄偺娤揰偐傜傒偨専摙亅. 媨杮弐曘1, 惔栰桼攜1, 徏栘丂悞1, 壛擺岶堦1, 掔丂隳暯, 楅栘埢巕, 栢嶳崄曐1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 岮摢 2019/12; 31 (2): 84-91.
'19-320004. [徢椺曬崘] 挿婜宱夁偟偨堚巆僈乕僛傪妀偲偟偨旲愇徢偺1椺. 嶳杮尗屷1, 徏栘丂悞1, 愇堜朙懢1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜): 帹旲偲椪彴 2020/3; 66 (2): 47-51.
'19-522006. [島嵗]亂摿廤: 儊僯僄乕儖昦乗墴偝偊偰偍偒偨偄恌抐丒帯椕偺僐僣乗亃悈戙幱偲悈暘愛庢椕朄 (hydration thrapy). 挿徖塸柧1,2 (1怴悽婭堛椕丒愭抂堛椕, 2帹旲堲岮丒摢栩晹奜): ENTONI 2019/7; 234: 89-9.
'19-540005. [偦偺懠 (島廗夛彺榐)] 傔傑偄偺儕僴價儕僥乕僔儑儞. 挿徖塸柧1,2 (1怴悽婭堛椕丒愭抂堛椕, 2帹旲堲岮丒摢栩晹奜): 戞36夞擔杮傔傑偄暯峵堛妛夛堛巘島廗夛彺榐廤 2019-7.
[挊丂彂]
'19-620012. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓2020擭斉丂巹偼偙偆帯椕偟偰偄傞亃戞25復帹旲堲岮壢幘姵丂堲岮摢堎忢姶徢, p.1606-7. 嶳壓丂戱 (帹旲堲岮丒摢栩晹奜), 憤曇廤: 暉堜師栴, 崅栘丂惤, 彫幒堦惉, 堛妛彂堾, 搶嫗, 2020/1敪峴.
[妛夛丒尋媶夛摍]
'19-722005. [妛夛 (慡崙)] (彽懸島墘摍) 埨慡偵攝椂偟偨娻栻暔椕朄丂娍曽椕朄. 嶳壓丂戱 (帹旲堲岮丒摢栩奜): 戞30夞擔杮婥娗怘摴壢妛夛擣掕婥娗怘摴壢愱栧堛戝夛 (2020/2/16), 墶昹.
'19-723029. [妛夛 (慡崙)] (堦斒島墘) 摉壢偵偍偗傞婄柺恄宱杻醿徢椺偺擭楊暿帯椕梊屻偺専摙. 孖壀棽恇 (帹旲堲岮丒摢栩奜): 戞29夞擔杮帹壢妛夛 憤夛丒妛弍島墘夛 (2019/10/10), 嶳宍.
'19-723030. [妛夛 (慡崙)] (堦斒島墘) 僆僩僈僀壓旂曎偵傛傝奼戝岮摢慡揈弌屻偺堲摢嵞寶傪峴偭偨崅楊惡栧忋娻偺2椺. 媨杮弐曘1, 惔栰桼攜1, 徏栘丂悞1, 壛擺岶堦1, 掔丂隳暯2, 楅栘埢巕1, 栢嶳崄曐1, 嶳壓丂戱1 (1帹旲堲岮丒摢栩奜, 2戝妛堾堛椕宯尋媶壢): 戞30夞擔杮摢栩晹奜壢妛夛憤夛側傜傃偵妛弍島墘夛 (2020/1/30), 壂撽.
惛恄壢妛
[妛弍榑暥]
110381. [尨挊] Stroking a Real Horse Versus Stroking a Toy Horse: Effects on the Frontopolar Area of the Human Brain. Matsuura A, Aiba N, Yamamoto H1,2, Takahashi M2,3, Kido H, Suzuki T, Bando Y1,4: Anthrozo歴 2020/7; 33 (5): 673-83. (嶳杮岹柧1,2, 崅嫶丂宐2,3, 嶁搶桼婭1,4 (1杒棦戝妛儊僨傿僇儖僙儞僞乕, 2惛恄, 3杒棦戝妛杒棦尋媶強昦堾, 4彫帣)
110382. [尨挊] A reliable method to reduce electrode impedances during electroconvulsive therapy. Shimano T1, Sawayama E1, Oishi S1, Natsuyama T1, Takizawa T1, Saito M1, Tanaka K2, Miyaoka H1: Kitasato Med J 2021/3; 51 (1): 19-23. (搰栰朁栫1, 郪嶳宐攇1, 戝愇丂抭1, 壞嶳丂戩1, 戧郪婤栴1, 釼摗惓斖1, 揷拞崕弐2, 媨壀丂摍1: 1惛恄, 2戝妛堾堛椕宯尋媶壢)
220002. [弨尨挊] 擣抦徢偺偁傞恖偺壠懓夘岇幰偵懳偡傞怱棟嫵堢僾儘僌儔儉偺桳岠惈偺専摙. 汭丂慞婱1, 戝愇丂抭1, 戧郪婤栴1, 媨壀丂摍1 (1惛恄): 惛恄壢帯椕妛 2021/3; 36 (3): 357-62.
320040. [徢椺曬崘] 帯椕堟偲偝傟傞寣拞擹搙偱偁傞偵傕偐偐傢傜偢儕僠僂儉拞撆徢忬傪掓偟偨堦椺. 楅栘棿懢榊1, 汭丂慞婱1, 戝愇丂抭1, 戧郪婤栴1, 嶳妏丂孿1, 烴堜廏庽1, 挬憅悞暥1, 搰栰朁栫1, 堜忋朁巕1, 崱愥岹悞1, 釼摗惓斖1, 媨壀丂摍1 (1惛恄): 惛恄壢帯椕妛 2020/7; 35 (7): 771-6.
320041. [徢椺曬崘] 帺傜乽巹偺僩儕僙僣乿傪嶌惉偟偨帺暵僗儁僋僩儔儉徢崅峑惗徢椺偐傜偺椪彴揑嫵孭. 堜忋彑晇1, 媨壀丂摍1 (1惛恄): 帣摱惵擭惛恄堛妛偲偦偺嬤愙椞堟 2020/8; 61 (4): 453-66.
522112. [島嵗] 摿廤: 側偤惛恄壢堛偼儊僨傿傾偵忣曬傪敪怣偟, 昞尰偡傞偺偐?亃側偤儅僗儊僨傿傾傪捠偟偰敪尵偡傞偐. 媨壀丂摍 (惛恄): 惛恄壢帯椕妛 2020/7; 35 (7): 723-5.
522113. [島嵗]亂摿廤:乽戝恖偺敪払忈奞乿傪傔偖傞嵟嬤偺摦岦亃惉恖屻偵敪払忈奞偑媈傢傟偨帠椺傊偺懳墳. 媨壀丂摍 (惛恄): 惛恄堛妛 2020/7; 62 (7): 1011-7.
522114. [島嵗] 堦斒惛恄壢奜棃偵偍偗傞帺暵僗儁僋僩儔儉徢偺怱棟嵏掕. 堜忋彑晇1, 捗嶈怱栫2 (1惛恄, 2椪彴怱棟幒): 憤崌昦堾惛恄堛妛 2020/7; 32 (3): 309-16.
522115. [島嵗]亂摿廤: 敪払忈奞偲怑堟偵偍偗傞僒億乕僩傪峫偊傞亃1. 敪払忈奞傪抦傞. 媨壀丂摍 (惛恄): 嶻嬈堛妛僕儍乕僫儖 2020/9; 43 (5): 4-8.
522116. [島嵗] 岦惛恄栻偺暃嶌梡懳嶔: 傆傜偮偒丒傔傑偄丒柊婥. 彫愳梲巕1, 媨抧塸梇1, 媨壀丂摍1 (1惛恄): 儁僀儞僋儕僯僢僋 2020/12; 41 (12): 1665-70.
522117. [島嵗]亂僔儕乕僘21悽婭偺寬峃偲偼? 9亃擔杮偺埶懚徢懳嶔. 姉惗桾巌1, 媨壀丂摍1 (1惛恄): 偁偄傒偭偔 2020/12; 41 (4): 94-8.
522118. [島嵗]亂摿暿婇夋: 怱恎堛妛傪愱栧偲偡傞堛巘偵抦偭偰傕傜偄偨偄偙偲亃惛恄壢堛偺棫応偐傜. 媨壀丂摍 (惛恄): 怱恎堛妛 2020/12; 60 (8): 703-6.
522119. [島嵗]亂摿廤: 楩曈娬榖亃偆偮昦偼僗僩儗僗側偟偵婲偙偭偰帺慠偵帯傞. 媨壀丂摍 (惛恄): 擔杮堛帠怴曬 2021/1; 5045: 28-9.
522120. [島嵗]亂摿廤: 乽昗弨揑惛恄壢堛乿傊偺偡偡傔亅僾儘偲屇偽傟傞偨傔偵巹偨偪偼壗傪廗摼偡傟偽傛偄偐亅I亃惉恖偺敪払忈奞傪傒傞偨傔偺昗弨揑抦幆偲媄擻亅帺暵僗儁僋僩儔儉徢傪拞怱偵亅. 媨壀丂摍1, 戝愇丂抭1, 媨抧塸梇1 (1惛恄): 惛恄壢帯椕妛 2021/2; 36 (2): 189-93.
540044. [偦偺懠 (僐儊儞僩)] 尨挊榑暥乽惛恄暘愅揑傾僙僗儊儞僩偲惛恄堛妛揑傾僙僗儊儞僩乿(敿揷憦) 傊偺僐儊儞僩. 堜忋彑晇 (惛恄): 惵擭婜惛恄椕朄 2020/12; 16 (1): 118-9.
[挊丂彂]
620098. [妛弍彂 (暘扴幏昅)]亂怱恎堛妛梡岅帠揟丂戞3斉 (e-Book)亃揤曐塸柧1, 埦惗廋巌, 惵栘埡巕, 惵栰揘旻, 懠 (1惛恄), 曇: 擔杮怱恎堛妛夛梡岅埾堳夛, 擔杮怱椕撪壢妛夛妛弍婇夋埾堳夛, 嶰椫彂揦, 搶嫗, 2020/11敪峴.
[妛夛丒尋媶夛摍]
722194. [妛夛 (慡崙)] (夛挿婇夋僔儞億僕僂儉) 崱擔偺惛恄堛妛偺専徹亅僶僀僆儅乕僇乕傪帩偨側偄惛恄堛妛偺朷傑偟偄峲楬偲偼亅PS1-4乽惛恄堛椕偺庣旛斖埻乿. 媨壀丂摍 (惛恄): 戞116夞擔杮惛恄恄宱妛夛妛弍憤夛 (2020/9/28), Web奐嵜.
722195. [妛夛 (慡崙)] (埾堳夛僔儞億僕僂儉) 堛椕柺愙偐傜惛恄椕朄傊: 惛恄椕朄埾堳夛. 崅嫶丂宐 (惛恄): 戞116夞擔杮惛恄恄宱妛夛妛弍憤夛 (2020/9/29), Web奐嵜.
722196. [妛夛 (慡崙)] (嫵堢島墘) 惉恖屻偵帺暵僗儁僋僩儔儉徢傪媈傢傟偨帠椺傊偺懳墳. 媨壀丂摍 (惛恄): 戞36夞擔杮僗僩儗僗妛夛妛弍憤夛 (2020/10/25), Web奐嵜.
722197. [妛夛 (慡崙)] (嫵堢島墘) 惛恄椕朄偺暃嶌梡偲僀儞僼僅乕儉僪丒僐儞僙儞僩. 媨壀丂摍 (惛恄): 擔杮惛恄暘愅妛夛戞18夞丒戞19夞崌摨戝夛 (2021/3/20), Web奐嵜.
722198. [妛夛 (慡崙)] (儔儞僠儑儞僙儈僫乕)亂嵗挿亃戝妛昦堾惛恄壢偵偍偗傞惉恖婜ADHD恌椕亅捠忢奜棃乽懳墳堛乿偵傛傞恌椕偺幚嵺亅. 堜忋彑晇1, 徏壀岶桾 (1惛恄): 戞33夞擔杮憤崌昦堾惛恄堛妛夛憤夛 (2020/12/13), Web奐嵜.
731058. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 巕偳傕偺僎乕儉徢偺棟夝偲懳墳. 堜忋彑晇 (惛恄): 嫗搒嫵堢戝妛摿暿巟墖嫵堢僙儈僫乕 (2020/12/12), Web奐嵜.
曻幩慄壢妛 (夋憸恌抐妛)
[妛弍榑暥]
110383. [尨挊] Suboptimal modulation of radiation dose in the computed tomography component of whole-body positron emission tomography/computed tomography. Inoue Y1, Adachi M1, Shimizu H1, Nagahara K2, Itoh H2, Takano M2, Jinguji K2: Radiat Prot Dosimetry 2020/12; 192 (1): 69-74. (堜忋桪夘1, 埨払傒偢傎1, 惔悈岹堦1, 塱尨榓寷2, 埳摗姲懽2, 崅栰惤恖2, 恄媨帥岞擇2: 1曻幩慄 (夋憸), 2曻幩慄晹)
110384. [尨挊] Predictive factors of truncation artifacts in the arterial phase of Gd-EOB-DTPA-enhanced MRI: a nationwide multicenter study. Tsurusaki M, Sofue K, Onishi H, Goshima S, Higaki A, Isoda H, Haradome H1,2, Ishii K, Murakami T: Jpn J Radiol 2021/2; 39 (2): 165-77. (尨棷峅庽1,2: 1怴悽婭堛椕丒愭抂堛椕, 2曻幩慄 (夋憸))
110385. [尨挊] Estimation of radiation dose in CT venography of the lower extremities: phantom experiments using different automatic exposure control settings and scan ranges. Inoue Y1, Itoh H2, Nagahara K2, Takahashi Y2: Radiat Prot Dosimetry. 2020/6; 188 (1): 109-16. (堜忋桪夘1, 埳摗姲懽2, 塱尨榓寷2, 崅嫶桼壚2: 1曻幩慄 (夋憸), 2曻幩慄晹)
110386. [尨挊] Pulmonary Artery-Bronchus Fistula Treated with a Combination of Bare Metal Stent, Metallic Coil, and N-Butyl Cyanoacrylate. Woodhams R1, Fujii K1, Takigawa M, Inoue Y1: J Vasc Interv Radiol 2021/1; 32 (1): 152-5. (僂僢僪僴儉僗楁巕1, 摗堜丂奭1, 堜忋桪夘1: 1曻幩慄 (夋憸))
110387. [尨挊] Voice, rhythm, and beep stimuli differently affect the right hemisphere preponderance and components of stimulus-preceding negativity. Ohgami Y, Kotani Y, Yoshida N, Kunimatsu A, Kiryu S, Inoue Y1: Biol Psychol 2021/3; 160: 108048. (堜忋桪夘1: 1曻幩慄 (夋憸))
520015. [憤愢] 堛椕尰応偵偍偗傞朄椷夵惓偵敽偆嬶懱揑側堛椕曻幩慄埨慡娗棟懱惂偺懳墳偲堛椕曻幩慄埨慡娗棟幰偺栶妱亅杒棦戝妛偺応崌亅. 堜忋桪夘 (曻幩慄 (夋憸)): 堛椕曻幩慄杊岇 2020/9; 83: 31-2.
522121. [島嵗]亂摿廤1: 堦嫇徯夘! IVR僈僀僪儔僀儞亃嶻壢婋婡揑弌寣偵懳偡傞IVR巤峴堛僈僀僪儔僀儞偺梫揰. 僂僢僪僴儉僗楁巕 (曻幩慄 (夋憸)): Rad Fan 2020/4; 18 (5): 35-9.
522122. [島嵗]亂摿廤: 扤偵傕暦偗側偄IVR偺婎杮丗婎杮庤媄亅晹埵暿寣娗僇僥乕僥儖偺慖戰偲憓擖朄亅亃晹埵暿寣娗僇僥乕僥儖偺慖戰, 憓擖偺僐僣偲憿塭朄丂嫻晹摦柆憿塭偲嵡愷弍丂婥娗巟丒榏娫摦柆憿塭偲嵡愷弍. 僂僢僪僴儉僗楁巕 (曻幩慄 (夋憸)): 椪彴夋憸 2020/7; 36 (7): 737-47.
522123. [島嵗]亂摿廤: 價僊僫乕偺偨傔偺摢寊晹夋憸恌抐亅Q&A傾僾儘乕僠亅亃5. 徢忬偐傜偺傾僾儘乕僠丂Q3娽鈢晹偺崪愜偱尒摝偟偰偼偄偗側偄崌暪徢傪嫵偊偰偔偩偝偄. 晜廎棿懢榊 (曻幩慄 (夋憸): 夋憸恌抐 2020/7; 40 (9): 986-7.
522124. [島嵗]亂摿廤: 價僊僫乕偺偨傔偺摢寊晹夋憸恌抐亅Q&A傾僾儘乕僠亅亃5. 徢忬偐傜偺傾僾儘乕僠丂Q4 Le Fort崪愜偺僞僀僾偲撉塭偺億僀儞僩傪嫵偊偰偔偩偝偄. 晜廎棿懢榊 (曻幩慄 (夋憸): 夋憸恌抐 2020/7; 40 (9): 988-9.
522125. [島嵗]亂摿廤: 僯儏乕僲乕儅儖帪戙偺恌椕曻幩慄媄巘傪傔偞偟偰亅愱栧媄巘擣掕惂搙丒嬈柋奼戝丒撉塭偺曗彆偵偍偗傞婜懸偝傟傞栶妱偲扴偆傋偒巊柦亅亃IV. 幙偺崅偄僠乕儉堛椕偺幚尰偵岦偗偨撉塭偺曗彆傊偺婜懸丂1.曻幩慄壢堛偑媮傔傞撉塭偺曗彆嬈柋. 堜忋桪夘 (曻幩慄 (夋憸)): INNERVISION 2020/12; 35 (12): 54-5.
522126. [島嵗]亂摿廤: 娞抇鋁偺怴WHO暘椶姰慡夝愢亃椙惈娞庮釃亅尷嬊惈寢愡惈夁宍惉 (FNH), 娞嵶朎態庮 (HCA)亅. 尨棷峅庽1,2 (1怴悽婭堛椕丒愭抂堛椕, 2曻幩慄 (夋憸)): 夋憸恌抐 2021/2; 41 (3): 268-84.
[挊丂彂]
620099. [妛弍彂 (暘扴幏昅)]亂摢栩晹夋憸恌抐偺姩僪僐儘NEO亃仭幘姵曇丂08 旲暃旲峯丂惓忢夝朥偲夋憸夝朥, p.116-55. 晜廎棿懢榊1 (1曻幩慄 (夋憸), 曇: 晜廎棿懢榊1, 儊僕僇儖價儏乕幮, 搶嫗, 2020/12敪峴.
621004. [妛弍彂 (曇廤)]亂摢栩晹夋憸恌抐偺姩僪僐儘NEO亃曇: 晜廎棿懢榊1 (1曻幩慄 (夋憸), 儊僕僇儖價儏乕幮, 搶嫗, 2020/12敪峴.
[妛夛丒尋媶夛摍]
713047. [妛夛 (崙嵺)] (堦斒島墘) Functional Connectivity of Amygdala in a Simple and Short Picture Viewing Task. Kotani Y, Yoshida N, Ohgami Y, Kunimatsu A, Kiryu S, Inoue Y1: Annual Meeting of the Organization of Human Brain Mapping (2020/6/23-7/3), Web奐嵜, Abstract Listings 2020/6; p.144. (堜忋桪夘1: 1曻幩慄 (夋憸))
713048. [妛夛 (崙嵺)] (堦斒島墘) Connectivity Dynamics of the Right Anterior Insula Revealed by EEG Source Analysis. Ohgami Y, Kotani Y, Yoshida N, Kunimatsu A, Kiryu S, Inoue Y1: Annual Meeting of the Organization of Human Brain Mapping (2020/6/23-7/3), Web奐嵜, Abstract Listings 2020/6; p.144. (堜忋桪夘1: 1曻幩慄 (夋憸))
713049. [妛夛 (崙嵺)] (堦斒島墘) The Effect of Task Length on Functional Connectivity of the Amygdala in a Picture Viewing Task. Kotani Y, Ohgami Y, Yoshida N, Kunimatsu A, SKiryu S, Inoue Y1: 2020 Virtual Annual Meeting of Society for Psychophysiological Research (2020/10/4-11), Web奐嵜, Psychophysiology 2020/10; 57 (Supplement1): S20. (堜忋桪夘1: 1曻幩慄 (夋憸))
713050. [妛夛 (崙嵺)] (堦斒島墘) Information Flow of the Right Anterior Insula Revealed by fMRI-Constrained EEG Source Analysis. Ohgami Y, Kotani Y, Yoshida N, Kunimatsu A, Kiryu S, Inoue Y1: 2020 Virtual Annual Meeting of Society for Psychophysiological Research (2020/10/4-11), Web奐嵜, Psychophysiology 2020/10; 57 (Supplement1): S35. (堜忋桪夘1: 1曻幩慄 (夋憸))
721023. [妛夛 (慡崙)] (摿暿島墘) 堛椕曻幩慄旐偽偔偲偦偺杊岇. 堜忋桪夘 (曻幩慄 (夋憸)): 戞20夞擔杮妀堛妛夛弔婫戝夛 (2020/5/14), Web奐嵜.
721024. [妛夛 (慡崙)] (摿暿島墘) 妀堛妛偵偍偗傞堛椕埨慡丒娭楢朄婯丒椣棟 堜忋桪夘 (曻幩慄 (夋憸)): 戞20夞擔杮妀堛妛夛弔婫戝夛 (2020/5/14), Web奐嵜.
721025. [妛夛 (慡崙)] (摿暿島墘) 堛椕埨慡丒曻幩慄杊岇2乽夵惓堛椕朄偺弲庣 (帺巤愝偱偺帠椺徯夘)乿. 堜忋桪夘 (曻幩慄 (夋憸)): 戞79夞擔杮堛妛曻幩慄妛夛憤夛 (2020/5/15), Web奐嵜.
721026. [妛夛 (慡崙)] (摿暿島墘) 慄検娗棟偺幚慔: 堛椕曻幩慄偺埨慡棙梡偵岦偗偰. 堜忋桪夘 (曻幩慄 (夋憸)): 戞79夞擔杮堛妛曻幩慄妛夛憤夛 (2020/5/15), Web奐嵜.
722199. [妛夛 (慡崙)] (彽懸島墘摍) 尰応偵偍偗傞恌椕梡曻幩慄偺埨慡娗棟懱惂偺峔抸乽堛椕曻幩慄埨慡娗棟愑擟幰偑峴偆傋偒嬈柋乿. 堜忋桪夘 (曻幩慄 (夋憸)): 戞79夞擔杮堛妛曻幩慄妛夛憤夛 (2020/5/15), Web奐嵜.
722200. [妛夛 (慡崙)] (僔儞億僕僂儉)亂塼懱嵡愷暔幙 (NBCA) 傪嬌傔傞!丂僄僉僗僷乕僩傊偺摴亃嶻壢弌寣偵偍偗傞NBCA傪梡偄偨摦柆嵡愷弍偺昁梫惈. 僂僢僪僴儉僗楁巕1, 摗堜丂奭1, 徏塱宧擇1, 孖尨桽懢楴2 (1曻幩慄 (夋憸), 2媬柦): 戞49夞擔杮IVR妛夛憤夛 (2020/8/25), 恄屗, 擔杮僀儞僞乕儀儞僔儑僫儖儔僕僆儘僕乕妛夛嶨帍 2020/8; 35 (Suppl): p.123.
723625. [妛夛 (慡崙)] (堦斒島墘) 壒惡巋寖偺梊婜偼巋寖愭峴堿惈揹埵乮SPN乯偺慜婜惉暘傪晩妶偝偣傞. 戝忋廼旤, 彫扟懽懃, 媑揷媂惔, 殸徏丂憦, 嬎惗丂栁, 堜忋桪夘1 (1曻幩慄 (夋憸)): 戞38夞擔杮惗棟怱棟妛夛戝夛 (2020/5/23乣24), Web奐嵜丒峀搰, 戞38夞擔杮惗棟怱棟妛夛戝夛僾儘僌儔儉 2020; p.7.
723626. [妛夛 (慡崙)] (揹巕億僗僞乕) 怱憻MRI偱恡嵶朎娻傪敪尒偝傟偨1椺. 埨払傒偢傎1, 抮揷弐徍2, 嶰堜峃暯1, 徏塱宧擇1, 晜廎棿懢榊1, 堜忋桪夘1 (1曻幩慄 (夋憸), 2堫忛巗棫昦堾曻幩慄壢): 戞40夞擔杮夋憸堛妛夛妛弍廤夛 (2021/2/25-5/25), Web奐嵜 (2021/2/20慡崙妛夛揹巕億僗僞乕), JJDI 2021/2/20; 39: p.91.
731059. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 堛椕朄巤峴婯懃夵惓屻偺堛椕尰応偵偍偗傞懳墳偺幚嵺. 堜忋桪夘 (曻幩慄 (夋憸)): 戞69夞堛椕曻幩慄埨慡娗棟島廗夛 (2020/10/25), Web奐嵜.
731060. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 堛椕朄巤峴婯懃夵惓屻偺堛椕尰応偵偍偗傞懳墳偺幚嵺. 堜忋桪夘 (曻幩慄 (夋憸)): 戞70夞堛椕曻幩慄埨慡娗棟島廗夛 (2020/11/15), Web奐嵜.
731061. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 恌椕梡曻幩慄偺埨慡娗棟偺朄惂壔: 堛椕旐偽偔偺揔惓壔偵岦偗偰. 堜忋桪夘 (曻幩慄 (夋憸)): 曻幩慄忈奞杊巭拞墰嫤媍夛椷榓2擭搙 (弔婜) 曻幩慄埨慡娗棟尋廋夛 (2021/2/22), 搶嫗 (僴僀僽儕僢僪奐嵜).
732066. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 恌椕曻幩慄偺埨慡棙梡偺偨傔偺昁恵帠崁丗堛椕朄巤峴婯懃夵惓傪庴偗偰. 堜忋桪夘 (曻幩慄 (夋憸): 撈棫峴惌朄恖 崙棫昦堾婡峔 墶昹堛椕僙儞僞乕丂堾撪尋廋 (2020/10/5), 墶昹.
732067. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 2020擭恌椕梡曻幩慄偺埨慡棙梡偺偨傔偺尋廋夛亅堛椕朄巤峴婯懃夵惓傪偆偗偰亅. 堜忋桪夘 (曻幩慄 (夋憸): 憡柾尨巗堛巘夛丂堛椕埨慡島廗夛 (2020/10/20), 憡柾尨.
732068. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 旲暃旲峯偺CT丒MRI亅埶棅堛偼偙偙偑抦傝偨偄亅. 晜廎棿懢榊 (曻幩慄 (夋憸): 戞61夞Radiology Update妛弍島墘夛 (2020/11/7), Web奐嵜.
732069. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 恌椕梡曻幩慄偺埨慡棙梡偺偨傔偺尋廋偲堛椕婡娭偱偺COVID-19懳墳. 堜忋桪夘 (曻幩慄 (夋憸): 椷榓2擭搙抁婜尋廋丂堛椕曻幩慄偺揔惓娗棟偵娭偡傞尋廋 (2020/11/27), 榓岝.
732070. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 偨偐偑? 偝傟偳?亅暃旲峯墛偺CT丒MRI亅. 晜廎棿懢榊 (曻幩慄 (夋憸): 戞566夞NR崸榖夛 (2021/1/9), Web奐嵜.
732071. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘) 恌椕梡曻幩慄偺埨慡娗棟偺朄惂壔: 堛椕旐偽偔偺揔惓壔偵岦偗偰. 堜忋桪夘 (曻幩慄 (夋憸): 曻幩慄忈奞杊巭拞墰嫤媍夛丂椷榓2擭搙 (弔婜)乽曻幩慄埨慡娗棟尋廋夛乿(2021/2/22), 搶嫗.
733119. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 懁栩晹偺懡宍宆帀朾擏庮. 娾鴵浠塴1, 晜廎棿懢榊1, 徏塱抦旤1, 嶰堜峃暯1, 堜忋桪夘1, 媨杮弐曘2, 嶳壓丂戱2, 撊杮徆岶3 (1曻幩慄 (夋憸), 2帹旲堲岮丒摢栩奜, 3昦棟): 戞49夞摢栩晹丒嫻晹夋憸尋媶夛 (2020/12/12), Web奐嵜.
733120. [妛夛 (抧曽夛丒尋媶夛)] (揹巕億僗僞乕) 栩晹偺嫄戝側spindle cell lipoma. 埨払傒偢傎1, 晜廎棿懢榊1, 娾鴵浠塴1, 嶰堜峃暯1, 堜忋桪夘1, 徏栘丂悞2, 嶳壓丂戱2, 廐扟徆巎3 (1曻幩慄 (夋憸), 2帹旲堲岮丒摢栩奜, 3昦棟): 戞457夞擔杮堛妛曻幩慄妛夛娭搶抧曽夛 (2021/3/22-31), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'18-522001. [島嵗]亂摿廤: 戝宆丒拞宆寣娗墛偺夋憸恌抐亃偙偙偑偟傝偨偄!亅娞偺夋憸恌抐 update亅. 尨棷峅庽1,2 (1怴悽婭堛椕丒愭抂堛椕, 2曻幩慄 (夋憸)): 夋憸恌抐 2019/2; 39 (2): 217-8.
[妛夛丒尋媶夛摍]
'19-731001. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) Next 10 years亅揥朷偲壽戣亅妀堛妛. 堜忋桪夘 (曻幩慄 (夋憸)): 戞60夞Radiology Update妛弍島墘夛 (2019/11/16), 搶嫗.
曻幩慄壢妛 (曻幩慄庮釃妛)
[妛弍榑暥]
110388. [尨挊] Clinical outcomes and prognostic factors of limited-stage small cell lung cancer patients treated with chemoradiotherapy: a single-institutional study. Hayakawa T1, Hayakawa K, Soda I1, Sekiguchi A1, Kawakami S1, Sasaki J2,3, Naoki K3, Ishiyama H1: Kitasato Med J 2020/9; 50 (2): 130-7. (憗愳朙榓1, 憗揷丂奿1, 娭岥埄堖1, 愳忋惓屽1, 嵅乆栘帯堦榊2,3, 桺栘崕旻3, 愇嶳攷瀶1: 1曻幩慄 (庮釃), 2怴悽婭堛椕丒墶抐揑堛椕, 3屇媧婍撪)
110389. [尨挊] Size of pelvic bone metastasis as a significant prognostic factor for metastatic prostate cancer patients. Hayakawa T1, Tabata K2, Tsumura H2, Kawakami S3, Katakura T, Hashimoto M4, Watanabe Y3, Iwamura M2, Hasegawa T4, Ishiyama H3: Jpn J Radiol 2020/10; 38 (10): 993-6. (憗愳朙榓1, 揷敤寬堦2, 捗懞廏峃2, 愳忋惓屽3, 嫶杮惉悽4, 搉绯桽夘4, 娾懞惓巏2, 挿扟愳抭擵4, 愇嶳攷瀶3: 1戝妛堾堛椕宯尋媶壢, 2斿擜婍, 3曻幩慄 (庮釃), 4堛椕塹惗妛晹)
520016. [憤愢] 娻帯椕偵偍偗傞僷儔僟僀儉偺曄慗亅擕娻傪拞怱偲偟偨堛妛巎揑峫嶡亅. 愇嶳攷瀶 (曻幩慄 (庮釃)): 杒棦堛妛 2020/6; 50 (1): 9-18.
530020. [偦偺懠 (Erratum)] Corrigendum to: Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease. Hagiwara Y1, Nakayama Y1, Kudo S1, Hayakawa T1,2, Nakamura N1, Kitamoto Y1, Takahashi S1, Tsujino K1, Kubo N1, Tamaki Y1, Nagata Y1 (1Japan Radiation Oncology Study Group (JROSG) Working Subgroup for Lung and Mediastinal Tumors): J Radiat Res 2020/9; 61 (5): 817. (憗愳朙榓1,2: 2曻幩慄 (庮釃))
[妛夛丒尋媶夛摍]
713051. [妛夛 (崙嵺)] (堦斒岥墘) A Phase II Trial of Stereotactic Body Radiotherapy Using 4 Fractions for Patiants with Localized Prostate Cancer. Kawakami S1, Hayakawa T1, Kainuma T1, Tsumura H2, Satoh T2, Tabata K2, Iwamura M2, Ishiyama H1: 2020 Astro Annual Meeting (2020/10/25-28), Web奐嵜. (愳忋惓屽1, 憗愳朙榓1, 帞徖戩楴1, 捗懞廏峃2, 嵅摗埿暥2, 揷敤寬堦2, 娾懞惓巏2, 愇嶳攷瀶1: 1曻幩慄 (庮釃), 2斿擜婍)
723627. [妛夛 (慡崙)] (堦斒岥墘) 慜棫態娻塱媣憓擖枾晻彫慄尮帯椕偵偍偗傞弍拞CT壓cold spot曗惓朄偺慄尮捛壛晹埵偵娭偡傞専摙. 愳忋惓屽1, 帞徖戩楴1, 憗愳朙榓1, 捗懞廏峃2, 娾懞惓巏2, 愇嶳攷瀶1 (1曻幩慄 (庮釃), 2斿擜婍): 彫慄尮帯椕晹夛戞22夞妛弍戝夛 (2020/5/29), 帍忋奐嵜, 彫慄尮帯椕晹夛戞22夞妛弍戝夛 僾儘僌儔儉丒彺榐廤 2020; p.36.
723628. [妛夛 (慡崙)] (堦斒岥墘) 摢栩晹娻曻幩慄帯椕偺梊屻梊應場巕偲偟偰偺帯椕慜QOL僗僐傾. 憗愳朙榓1, 愳忋惓屽1, 憗揷丂奿2, 娭岥埄堖1, 栰郪錆浠壴1, 帞徖戩楴1, 媨杮弐曘3, 壛擺岶堦3, 栢嶳崄曐3, 屆栘埢巕3, 嶳壓丂戱3, 愇嶳攷瀶1 (1曻幩慄 (庮釃), 2暯捤巗柉昦堾曻幩慄帯椕壢, 3帹旲堲岮丒摢栩奜): 戞44夞擔杮摢栩晹娻妛夛 (2020/7/17-27), Web奐嵜, 摢栩晹娻 2020; 46 (2): 161.
723629. [妛夛 (慡崙)] (堦斒岥墘) 摢栩晹娻曻幩慄帯椕偺梊屻梊應場巕偲偟偰偺帯椕慜QOL僗僐傾. 憗愳朙榓1, 愳忋惓屽1, 憗揷丂奿2, 娭岥埄堖1, 栰郪錆浠壴1, 帞徖戩楴1, 媨杮弐曘3, 壛擺岶堦3, 栢嶳崄曐3, 屆栘埢巕3, 嶳壓丂戱3, 愇嶳攷瀶1 (1曻幩慄 (庮釃), 2暯捤巗柉昦堾曻幩慄帯椕壢, 3帹旲堲岮丒摢栩奜): 擔杮曻幩慄庮釃妛夛戞33夞妛弍戝夛 (2020/10/1-3), Web奐嵜, 擔杮曻幩慄庮釃妛夛戞33夞妛弍戝夛曬暥廤 2020; p.216.
723630. [妛夛 (慡崙)] (堦斒岥墘) 慜棫態娻Seed帯椕偱偺弍拞CT壓cold spot曗惓朄偺慄尮捛壛晹埵偵娭偡傞専摙. 愳忋惓屽1, 憗愳朙榓1, 捗懞廏峃2, 娾懞惓巏2, 愇嶳攷瀶1 (1曻幩慄 (庮釃), 2斿擜婍): 擔杮曻幩慄庮釃妛夛戞33夞妛弍戝夛 (2020/10/1-3), Web奐嵜, 擔杮曻幩慄庮釃妛夛戞33夞妛弍戝夛曬暥廤 2020; p.248.
杻悓壢妛
[妛弍榑暥]
110390. [尨挊] Preoperative sepsis is a predictive factor for 30-day mortality after major lower limb amputation among patients with arteriosclerosis obliterans and diabetes. Otsuka T1, Arai M2, Sugimura K1, Sakai M1, Nishizawa Y1, Suzuki Y1, Okamoto H1, Kuroiwa M1: J Orthop Sci 2020/5; 25 (3): 441-5. (戝捤抭媣1, 怴堜惓峃2, 悪懞寷椇1, 嶃堜錆桳巕1, 惣郪媊擵1, 楅栘桪懢榊1, 壀杮峗巏1, 崟娾惌擵1: 1杻悓, 2怴悽婭堛椕丒墶抐揑堛椕)
110028. [尨挊] RAMP1 signaling in immune cells regulates inflammation-associated lymphangiogenesis. Tsuru S1, Ito Y2, Matsuda H3, Hosono K2, Inoue T4, Nakamoto S1, Kurashige C3, Mishima T5, Tsujikawa K, Okamoto H3, Majima M2: Lab Invest 2020/5; 100 (5): 738-50. (捗棷悽棦1, 埳摗媊栫2, 徏揷峅旤3, 嵶栰壛撧巕2, 堜忋抭恗4, 拞杮廋巌1, 錟廳愮奊3, 旤搰棙徍5, 壀杮峗巏3, 攏搱惓棽2: 1戝妛堾堛椕宯尋媶壢, 2栻棟, 3杻悓, 4徚壔婍撪, 5怱憻寣娗奜)
110391. [尨挊] The concordance rate of L3/4 intervertebral lumbar level estimated by palpation and ultrasonography in Japanese parturients. Hosokawa Y1, Okutomi T1, Hyuga S1, Kato R2, Kuczkowski KM: J Matern Fetal Neonatal Med 2020/7; 33 (14): 2354-8. (嵶愳岾婓1, 墱晉弐擵1, 擔岦弐曘1, 壛摗棦奊2: 1杻悓, 2怴悽婭堛椕丒愭抂揑堛椕)
120037. [尨挊] 宱僇僥乕僥儖揑戝摦柆曎抲姺弍 (TEVA) 弍屻偵旕怱憻庤弍傪巤峴偝傟偨5椺偺専摙. 嶳壓丂撝1, 楅栘洅巏1, 埨摗庻宐1, 徏揷峅旤1, 悪懞寷椇1, 屗揷夒栫1, 壀杮峗巏1 (1杻悓): Cardiovascular Anesthesia 2020/8; 24 (1): 55-60.
310045. [徢椺曬崘] Venoarterial extracorporeal membrane oxygenation as an early treatment for amniotic fluid embolism with cardiac arrest: A case report. Adachi M1, Adachi T1, Fujita T1, Hyuga S1, Onishi Y2, Okutomi T1: J Obstet Gynaecol Res 2021/9; 47 (9): 3374-8. (埨払恀棞巕1, 埨払丂寬1, 摗揷撨宐1, 擔岦弐曘1, 戝惣梖巕2, 墱晉弐擵1: 1杻悓, 2嶻壢)
310046. [徢椺曬崘] First Report of Spinal Anesthesia for Cesarean Delivery in a Parturient With Jeune Syndrome: A Case Report. Kondo H1, Hyuga S1, Fujita T1, Adachi M1, Mochizuki J2, Okutomi T1: A A Pract 2021/2; 15 (2): e01400. (嬤摗峅峎1, 擔岦弐曘1, 摗揷撨宐1, 埨払恀棞巕1, 朷寧弮巕2, 墱晉弐擵1: 1杻悓, 2嶻壢)
320042. [徢椺曬崘] 堲摢偑傫偵懳偡傞宱岥揑撪帇嬀庤弍巤峴屻偵梊婜偣偢婥娗愗奐傪巤峴偟偨2徢椺. 嶃堜錆桳巕1, 抾楺柉峕1, 埨摗庻宐1, 壛擺岶堦2, 寴揷恊棙3, 惔栰桼攜2, 嶳壓丂撝1, 壀杮峗巏1 (1杻悓, 2帹旲堲岮丒摢栩奜, 3徚壔婍撪): 杻悓 2021/1; 70 (1): 81-3.
320043. [徢椺曬崘] 帩懕崢晹峝枌奜僽儘僢僋偵傛傝崢壓巿捝偑夵慞偟偨stiff-person徢岓孮偺1椺. 壨懞捈庽1, 嬥堜徍暥2, 椦丂宱恖1, 峳丂彨抭1, 崅嫶桟堦楴1, 壀杮峗巏1 (1杻悓, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮儁僀儞僋儕僯僢僋妛夛帍 2021/3; 28 (3): 39-42.
530021. [偦偺懠 (Comment)] Author's response to the comments on ""Preoperative sepsis is a predictive factor for 30-day mortality after major lower limb amputation among patients with arteriosclerosis obliterans and diabetes"". Otsuka T1, Ushiwata A, Okamoto H1, Arai M2, Kuroiwa M1: J Orthop Sci 2020/11; 25 (6): 1133-4. (戝捤抭媣1, 壀杮峗巏1, 怴堜惓峃2, 崟娾惌擵1: 1杻悓, 2怴悽婭堛椕丒墶抐揑堛椕)
540045. [偦偺懠 (姫摢尵)]亂擔杮椪彴杻悓妛夛戞39夞戝夛僔儞億僕僂儉亃乽僇僥僑儕乕1 嬞媫掗墹愗奐弍乿偵傛偣偰. 墱晉弐擵1, 揷拞丂婎 (1杻悓): 擔杮椪彴杻悓妛夛帍 2021/1; 41 (1): 65.
[挊丂彂]
620100. [妛弍彂 (暘扴幏昅)]亂擔杮偺擠嶻晈傪媬偆偨傔偵2020亃僔僗僥儉曇丂廃嶻婜堛椕偵杻悓壢堛偑愊嬌揑偵偐偐傢傟傞傛偆側娐嫬惍旛, p.169-74. 墱晉弐擵 (杻悓), 娔廋: 擔杮嶻晈恖壢堛夛堛椕埨慡晹夛, 擠嶻晈巰朣徢椺専摙昡壙埾堳夛, 曇: 娭戲柧旻, 挿扟愳弫堦, 搶嫗堛妛幮, 搶嫗, 2020/4敪峴.
620101. [妛弍彂 (暘扴幏昅)]亂杻悓壢堛偺偨傔偺廃弍婜偺恌椕僈僀僪儔僀儞妶梡弍亃3復丂徢椺偱妛傇恌椕僈僀僪儔僀儞偺幚慔乛弍拞娗棟丂3-6. 弞娐嶌摦栻, p.146-56. 惣郪媊擵1, 壀杮峗巏1 (1杻悓), 曇: 墶嶳惓彯, 娔廋: 怷揷丂寜, 拞嶳彂揦, 搶嫗, 2020/6敪峴.
620102. [妛弍彂 (暘扴幏昅)]亂嶻壢杻悓丂All in One亃V. 宱銽暘曍偺杻悓丂3. 峝枌奜杻悓, 愐悜偔傕枌壓杻悓丂1) 曽朄, p.122-7. 墱晉弐擵 (杻悓), 曇: 壛摗棦奊, 愑擟曇: 嶳杮払榊, 悈杮堦峅, 奯壴丂妛, 壛摗棦奊, 嵅摗挩堦, 暥岝摪, 搶嫗, 2020/7敪峴.
620103. [妛弍彂 (暘扴幏昅)]亂嶻壢杻悓丂All in One亃V. 宱銽暘曍偺杻悓丂3. 峝枌奜杻悓, 愐悜偔傕枌壓杻悓丂乵OPA乶恖岺擠怭拞愨偲巕媨撪戀帣巰朣偺暘曍, p.140. 墱晉弐擵 (杻悓), 曇: 壛摗棦奊, 愑擟曇: 嶳杮払榊, 悈杮堦峅, 奯壴丂妛, 壛摗棦奊, 嵅摗挩堦, 暥岝摪, 搶嫗, 2020/7敪峴.
620104. [妛弍彂 (暘扴幏昅)]亂嶻壢杻悓丂All in One亃V. 宱銽暘曍偺杻悓丂3. 峝枌奜杻悓, 愐悜偔傕枌壓杻悓丂乵OPA乶TOLAC偺柍捝暘曍, p.141. 墱晉弐擵 (杻悓), 曇: 壛摗棦奊, 愑擟曇: 嶳杮払榊, 悈杮堦峅, 奯壴丂妛, 壛摗棦奊, 嵅摗挩堦, 暥岝摪, 搶嫗, 2020/7敪峴.
620105. [妛弍彂 (暘扴幏昅)]亂嶻壢杻悓丂All in One亃V. 宱銽暘曍偺杻悓丂3. 峝枌奜杻悓, 愐悜偔傕枌壓杻悓丂乵OPA乶憃戀偺柍捝暘曍, p.142. 墱晉弐擵 (杻悓), 曇: 壛摗棦奊, 愑擟曇: 嶳杮払榊, 悈杮堦峅, 奯壴丂妛, 壛摗棦奊, 嵅摗挩堦, 暥岝摪, 搶嫗, 2020/7敪峴.
620106. [妛弍彂 (暘扴幏昅)]亂嶻壢杻悓丂All in One亃VI.掗墹愗奐弍偺杻悓丂1. 掗墹愗奐弍偺杻悓丂2) 弍慜昡壙, p.154-8. 埨払恀棞巕, 墱晉弐擵1 (1杻悓), 曇: 壛摗棦奊, 愑擟曇: 嶳杮払榊, 悈杮堦峅, 奯壴丂妛, 壛摗棦奊, 嵅摗挩堦, 暥岝摪, 搶嫗, 2020/7敪峴.
[妛夛丒尋媶夛摍]
721027. [妛夛 (慡崙)] (摿暿島墘) 捝傒偺峔憿偱峫偊傞惍宍奜壢姵幰偺醬捝娗棟. 嬥堜徍暥1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2杻悓): 戞53夞擔杮惍宍奜壢妛夛崪丒擃晹庮釃妛弍廤夛 (2020/9/17), Web奐嵜.
721028. [妛夛 (慡崙)] (摿暿島墘) 醬捝娚榓帯椕栻偵娭偡傞抦幆偺惍棟亅枬惈醬捝偵懳偡傞僆僺僆僀僪捔捝栻偺揔惓巊梡嫵堢亅杮朚偱巊梡壜擻側奺庬栻嵻偲栻棟妛揑嶌梡. 嬥堜徍暥1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2杻悓): 擔杮儁僀儞僋儕僯僢僋妛夛戞54夞妛弍廤夛 (2020/11/14-15), Web奐嵜.
721029. [妛夛 (慡崙)] (摿暿島墘) 杮朚偵偍偗傞枬惈醬捝嫵堢劅僆僺僆僀僪捔捝栻偺揔惓巊梡偵偮偄偰妛傏偆!! 杮朚偱巊梡壜擻側奺庬栻嵻偲栻棟妛揑嶌梡. 嬥堜徍暥1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2杻悓): 戞42夞擔杮醬捝妛夛 (2020/12/5), Web奐嵜.
722201. [妛夛 (慡崙)] (彽懸島墘摍) 嬫堟杻悓偑側偤枬惈醬捝偵岠偔偺偐? 嬥堜徍暥1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2杻悓): 擔杮嬫堟杻悓妛夛戞7夞妛弍廤夛 (2020/8/9), Web奐嵜.
722202. [妛夛 (慡崙)] (彽懸島墘摍) 媫惈弍屻捝偐傜枬惈弍屻捝偺梊杊: 崱壗偑, 杻悓壢堛偵媮傔傜傟偰偄傞偺偐? Neuropathic pain偐傜弍屻枬惈捝傪峫偊傞. 嬥堜徍暥1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2杻悓): 擔杮儁僀儞僋儕僯僢僋妛夛戞54夞妛弍廤夛 (2020/11/14-15), Web奐嵜.
723631. [妛夛 (慡崙)] (堦斒島墘) 偑傫醬捝姵幰偵偍偗傞揹棳抦妎鑷抣偺挷嵏. 嬥堜徍暥1,2, 杧峕嵤怐2, 峳丂彨抭2, 壨懞捈庽2, 椦丂宱恖2, 壀杮峗巏2 (1怴悽婭堛椕丒墶抐揑堛椕, 2杻悓): 擔杮杻悓壢妛夛戞67夞妛弍廤夛 (2020/7/1-8/31), Web奐嵜.
723632. [妛夛 (慡崙)] (堦斒島墘) 僷乕僉儞僜儞昦崌暪懁淾徢庤弍偺廡弍婜娗棟偺専摙. 埨晹桪棦1, 惣郪媊擵1, 嶳楬桾峅1, 挿揷愰巕1, 屗揷夒栫1, 壀杮峗巏1 (1杻悓): 擔杮杻悓壢妛夛戞67夞妛弍廤夛 (2020/7/1-8/31), Web奐嵜.
723633. [妛夛 (慡崙)] (堦斒島墘) 掗墹愗奐弍偵偍偗傞愐悜偔傕枌壓杻悓屻掅寣埑偵懳偡僼僃僯儗僼儕儞梊杊揑帩懕搳梌偺岠壥. 埨払恀棞巕1, 摗揷撨宐1, 擔岦弐曘1, 墱晉弐擵1, 壀杮峗巏1 (1杻悓): 擔杮嬫堟杻悓妛夛戞7夞妛弍廤夛 (2020/8/9), Web奐嵜.
723634. [妛夛 (慡崙)] (堦斒島墘) Zoom cloud meetings傪梡偄偨COVID-19滊姵擠晈偺廃弍婜娗棟偵娭偡傞擔暷娫webinar偺奐嵜. 杮揷悞峢1, 擔岦弐曘1, 埨払恀棞巕1, 墱晉弐擵1, 壀杮峗巏1 (1杻悓): 擔杮椪彴杻悓妛夛戞40夞戝夛 (2020/11/14), Web奐嵜.
723635. [妛夛 (慡崙)] (堦斒島墘) 桳捝惈嬝醶澒傪崌暪偟偨奐嫻弍屻醬捝徢岓孮偵懳偟愐悜巋寖椕朄偑桳梡偱偁偭偨1徢椺. 壨懞捈庽1, 椦丂宱恖1, 嬥堜徍暥1,2, 峳丂彨抭1, 杧峕嵤怐1, 壀杮峗巏1 (1杻悓, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮儁僀儞僋儕僯僢僋妛夛戞54夞妛弍廤夛 (2020/11/14-15), Web奐嵜.
723636. [妛夛 (慡崙)] (堦斒島墘) 悜偔傕枌壓捔捝偵傛傝曻幩慄帯椕傪峴偊偨埆惈挵崢嬝徢岓孮偱崅搙旍枮偺1徢椺. 椦丂宱恖1, 嬥堜徍暥1,2, 壨懞捈庽1, 峳丂彨抭1, 杧峕嵤怐1, 壀杮峗巏1 (1杻悓, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮儁僀儞僋儕僯僢僋妛夛戞54夞妛弍廤夛 (2020/11/14-15), Web奐嵜.
723637. [妛夛 (慡崙)] (堦斒島墘) 愐悜巋寖揹嬌偺棷抲晹埵偵擄廰偟偨, 廳搙懁淾徢偺1徢椺. 椦丂宱恖1, 嬥堜徍暥1,2, 壨懞捈庽1, 峳丂彨抭1, 杧峕嵤怐1, 壀杮峗巏1 (1杻悓, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮儁僀儞僋儕僯僢僋妛夛戞54夞妛弍廤夛 (2020/11/14-15), Web奐嵜.
731062. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 奜彎惈恄宱忈奞惈醬捝偺帯椕 亅醬捝妛EBM偱桳梡帯椕傪専徹亅. 嬥堜徍暥1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2杻悓): 擔杮儁僀儞僋儕僯僢僋妛夛戞1夞搶嫗丒撿娭搶巟晹妛弍廤夛 (2021/1/30), Web奐嵜.
731063. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 僆僺僆僀僪捔捝栻偺揔梡亅僐僣偲棊偲偟寠亅. 嬥堜徍暥1,2 (1怴悽婭堛椕丒墶抐揑堛椕, 2杻悓): 戞61夞娭搶惍宍嵭奞奜壢妛夛 (2021/3/27), Web奐嵜.
732072. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) ICU偵偍偗傞弞娐晄慡偺昡壙偲廤拞帯椕堛偺栶妱. 惣郪媊擵1, 嶃堜錆桳巕1, 埨払丂寬1, 戝捤抭媣1, 塱堜垷埶1, 悪懞寷椇1, 崟娾惌擵1, 怴堜惓峃1,2, 壀杮峗巏1 (1杻悓, 2怴悽婭堛椕丒墶抐揑堛椕): 擔杮廤拞帯椕堛妛夛戞4夞娭搶峛怣墇巟晹妛弍廤夛 (2020/9/6), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
H29-510001. [憤愢] A systematic review of massive transfusion protocol in obstetrics. Tanaka H, Matsunaga S, Yamashita T, Okutomi T1, Sakurai A, Sekizawa A, Hasegawa J, Terui K, Miyake Y, Murotsuki J, Ikeda T: Taiwan J Obstet Gynecol 2017/12; 56 (6): 715-8. (墱晉弐擵1: 1杻悓)
H29-522002. [島嵗]亂島嵗亃弞娐婍宯崌暪徢擠晈偺峝枌奜柍捝暘曍傪弰偭偰. 壛摗棦奊1, 墱晉弐擵2 (1怴悽婭堛椕丒愭抂堛椕, 2杻悓: 椪彴杻悓 2017/11; 41 (11): 1511-7.
'18-120001. [尨挊] 挻嬞媫掗墹愗奐弍僔儈儏儗乕僔儑儞偺怳傝曉傝偵偍偗傞4夋柺摦夋嵞惗偺桳梡惈偺専摙. 楅栘洅巏1, 嵶愳岾婓1, 摗揷撨宐1, 壛摗棦奊2, 墱晉弐擵1 (1杻悓, 2怴悽婭堛椕丒愭抂堛椕): 暘曍偲杻悓 2018; 100: 8-14.
'18-120002. [尨挊] 暘曍幒偵偍偗傞PPH僇乕僩摫擖岠壥偺専摙亅堛椕幰偺傾儞働乕僩挷嵏傛傝亅. 彫嶳垽旤, 嵶愳岾婓1, 壛摗棦奊2, 墱晉弐擵1 (1杻悓, 2怴悽婭堛椕丒愭抂堛椕): 暘曍偲杻悓 2018; 100: 15-21.
'18-522002. [島嵗]亂擔杮偺柍捝暘曍偺彨棃偼? Dr. William Camann偵暦偔匑亃姵幰偵儕僗僋傪擣幆偟偰傕傜偄廤栺壔傪. 挿嶁埨巕, 墱晉弐擵1, 徠堜崕惗, 屻摗棽媣, 妏憅峅峴 (1杻悓): LiSA 2018/4; 25 (4): 361-70.
'18-522003. [島嵗]亂擔杮偺柍捝暘曍偺彨棃偼? Dr. William Camann偵暦偔匒亃壗傪嫵偊, 扤偑偦偺帒奿傪梌偊傞偺偐. 挿嶁埨巕, 墱晉弐擵1, 徠堜崕惗, 屻摗棽媣, 妏憅峅峴 (1杻悓): LiSA 2018/5; 25 (5): 483-9.
'18-522004. [島嵗]亂摿廤: 柍捝暘曍偲僩儔僽儖僔儏乕僥傿儞僌丂彆嶻巘丒嶻壢堛偑墴偝偊偰偍偒偨偄懳墳偲傾僙僗儊儞僩亃01 柍捝暘曍偺偄傑: 崙撪丒奀奜偺尰忬. 墱晉弐擵 (杻悓): 儁儕僱僀僞儖働傾 2018/5; 37 (6): 516-21.
'18-522005. [島嵗]亂擔杮偺柍捝暘曍偺彨棃偼? Dr. William Camann偵暦偔匒亃楌巎傪妛傃, 枹棃偵岦偐偍偆. 挿嶁埨巕, 墱晉弐擵1, 徠堜崕惗, 屻摗棽媣, 妏憅峅峴 (1杻悓): LiSA 2018/6; 25 (6): 593-602.
'18-522006. [島嵗]亂摿廤: 嶻壢杻悓 (戞2夞)亃崌暪徢傪桳偡傞擠晈偺嶻壢揑, 旕嶻壢揑庤弍偺杻悓娗棟亅擠怭崅寣埑徢岓孮, HELLP徢岓孮, 巕釖亅. 摗揷撨宐1, 墱晉弐擵1 (1杻悓): 擔杮椪彴杻悓妛夛帍 2018/9; 38 (5): 678-81.
'18-522007. [島嵗]亂摿廤: 嶻壢杻悓 (戞2夞)亃崌暪徢傪桳偡傞擠晈偺嶻壢揑, 旕嶻壢揑庤弍偺杻悓娗棟亅怱幘姵丒屇媧婍幘姵亅. 摗揷撨宐1, 墱晉弐擵1 (1杻悓): 擔杮椪彴杻悓妛夛帍 2018/9; 38 (5): 682-4.
'18-522008. [島嵗]亂摿廤: 嶻壢杻悓 (戞2夞)亃崌暪徢傪桳偡傞擠晈偺嶻壢揑, 旕嶻壢揑庤弍偺杻悓娗棟亅恄宱嬝幘姵, 儕僂儅僠, 崪幘姵亅. 摗揷撨宐1, 墱晉弐擵1 (1杻悓): 擔杮椪彴杻悓妛夛帍 2018/9; 38 (5): 685-7.
'18-522009. [島嵗]亂摿廤: 嶻壢杻悓 (戞2夞)亃怴惗帣偺働傾偲慼惗朄. 嵶愳岾婓1, 墱晉弐擵1 (1杻悓): 擔杮椪彴杻悓妛夛帍 2018/9; 38 (5): 726-31.
'18-522010. [島嵗]亂摿廤: 庤弍幒婋婡娗棟亃3. 嶻壢婋婡揑弌寣偲懳墳僈僀僪儔僀儞2017. 拞懞奊旤, 墱晉弐擵1 (1杻悓): 椪彴杻悓 2019/3; 43 (3): 421-8.
'19-522011. [島嵗]亂摿廤: 柍捝暘曍丒嶻壢杻悓Update亃3. 柍捝暘曍. 墱晉弐擵 (杻悓): 嶻壢偲晈恖壢 2019/5; 86 (5): 545-9.
'19-522012. [島嵗]亂摿廤: 嵞峫! 彫帣娕岇愱栧娕岇巘偺幚慔偲栶妱亃[乽娕岇奜棃乿傗乽愱栧晹栧乿偱妶桇偡傞彫帣娕岇愱栧娕岇巘]丂匘彫帣娭楢昦搹偵偍偗傞僾儘傾僋僥傿僽儔僂儞僪偺妶摦. 戝扟彯栫1, 彫抮朁岶2, 怷埨宐幚1, 埳摗岶巕1, 埨摗丂庻3, 崟娾惌擵4, 怴堜惓峃5 (1娕岇晹, 2廤拞帯椕僙儞僞乕, 3彫帣, 4杻悓, 5怴悽婭堛椕丒墶抐揑堛椕): 彫帣娕岇 2019/6; 42 (6): 669-73.
'19-522013. [島嵗]亂摿廤: 廃嶻婜偺捝傒偺働傾亃<奺榑丂娗棟偺幚嵺> 峝枌奜杻悓偵傛傞柍捝暘曍丂峝枌奜杻悓丒愐悜偔傕枌壓杻悓. 墱晉弐擵 (杻悓): 廃嶻婜堛妛 2019/8; 49 (8): 1051-4.
'19-522014. [島嵗]亂摿廤: 嬼敪徢: 偦偺帪, 峇偰側偄偨傔偵乧亃1. 弍拞攛寣愷嵡愷徢. 埨払丂寬1, 崟娾惌擵1 (1杻悓: 椪彴杻悓 2020/3; 44 (3): 403-10.
[挊丂彂]
H28-620001. [妛弍彂 (暘扴幏昅)]亂怴丒杻悓壢尋廋偺慺杙側媈栤偵摎偊傑偡亃III弞娐娗棟丒憻婍弞娐娗棟丂051. 擠晈掅寣埑帪偵側偤巕媨嵍曽埑攔傪峴偆偺偐丠, p.156-60. 墱晉弐擵 (杻悓), 曇: 堫揷塸堦 儊僨傿僇儖丒僒僀僄儞僗丒僀儞僞乕僫僔儑僫儖 搶嫗, 2016/9敪峴.
H29-620002. [妛弍彂 (暘扴幏昅)]亂儚儞儔儞僋忋偺嶻壢杻悓偵昁梫側僄價僨儞僗亃戞1復丂掗墹愗奐偺杻悓丂6. 峝枌慂巋屻摢捝, p.91-9. 墱晉弐擵 (杻悓), 娔廋: 徠堜崕惗, 曇: 徏揷桽揟, 揷拞丂婎, 崕惤摪弌斉, 搶嫗, 2017/6敪峴.
H29-620003. [妛弍彂 (扨挊)]亂柍捝暘曍偺嬌堄亃墱晉弐擵 (杻悓), 崕惤摪弌斉, 搶嫗, 2017/11敪峴.
'18-610001. [妛弍彂 (暘扴幏昅)]亂Obstetric Anesthesia for Co-morbid Conditions亃Chapter 6: Anesthesia for the Pregnant Patient with Autoimmune Disorders, p.87-97. Kato R, Okutomi T1, Editors: Gunaydin B, Ismail S, Springer Nature, Switzerland, 2018/10. (墱晉弐擵1: 1杻悓)
'18-620003. [妛弍彂 (暘扴幏昅)]亂嶻壢堛偺偨傔偺柍捝暘曍島嵗亃戞4復 峝枌奜捔捝朄丂亂2亃庤媄偺幚嵺, p.27-37. 墱晉弐擵 (杻悓), 曇: 揤栰丂姰, 崕惤摪弌斉, 搶嫗, 2018/5敪峴.
'18-620004. [妛弍彂 (暘扴幏昅)]亂嶻壢堛偺偨傔偺柍捝暘曍島嵗亃戞5復 愐悜偔傕枌壓峝枌奜暪梡捔捝朄 (CSEA), p.67-72. 墱晉弐擵 (杻悓), 曇: 揤栰丂姰, 崕惤摪弌斉, 搶嫗, 2018/5敪峴.
'18-620005. [妛弍彂 (暘扴幏昅)]亂椪彴杻悓幚慔僔儕乕僘10 嶻壢杻悓亃戞7復崌暪徢傪桳偡傞擠晈偺嶻壢揑, 旕嶻壢揑庤弍偺杻悓娗棟丂[1] 擠怭崅寣埑徢岓孮, HELLP徢岓孮, 巕釖, p.58-63. 摗揷撨宐1, 墱晉弐擵1 (1杻悓), 曇: 擔杮椪彴杻悓妛夛, 堫奯婌嶰, 陰摗梞巌, 儔僀僼儊僨傿僐儉, 柤屆壆, 2018敪峴.
'18-620006. [妛弍彂 (暘扴幏昅)]亂椪彴杻悓幚慔僔儕乕僘10 嶻壢杻悓亃戞7復崌暪徢傪桳偡傞擠晈偺嶻壢揑, 旕嶻壢揑庤弍偺杻悓娗棟丂[2] 怱幘姵丒屇媧婍幘姵, p.64-7. 摗揷撨宐1, 墱晉弐擵1 (1杻悓), 曇: 擔杮椪彴杻悓妛夛, 堫奯婌嶰, 陰摗梞巌, 儔僀僼儊僨傿僐儉, 柤屆壆, 2018敪峴.
'18-620007. [妛弍彂 (暘扴幏昅)]亂椪彴杻悓幚慔僔儕乕僘10 嶻壢杻悓亃戞7復崌暪徢傪桳偡傞擠晈偺嶻壢揑, 旕嶻壢揑庤弍偺杻悓娗棟丂[3] 恄宱嬝幘姵, 儕僂儅僠, 崪幘姵, p.68-70. 摗揷撨宐1, 墱晉弐擵1 (1杻悓), 曇: 擔杮椪彴杻悓妛夛, 堫奯婌嶰, 陰摗梞巌, 儔僀僼儊僨傿僐儉, 柤屆壆, 2018敪峴.
'18-620008. [妛弍彂 (暘扴幏昅)]亂椪彴杻悓幚慔僔儕乕僘10 嶻壢杻悓亃戞11復怴惗帣偺働傾偲慼惗朄, p.137-44. 嵶愳岾婓, 墱晉弐擵1 (1杻悓), 曇: 擔杮椪彴杻悓妛夛, 堫奯婌嶰, 陰摗梞巌, 儔僀僼儊僨傿僐儉, 柤屆壆, 2018敪峴.
'19-620013. [妛弍彂 (暘扴幏昅)]亂嶻壢杻悓偺媈栤Q&A 60亃In Chapter 1: 擠晈偺杻悓慜昡壙, p.1-3. 墱晉弐擵 (杻悓), 娔廋: 戝浽峗巌, 曇: 忋搱峗弴, 壛摗棦奊, 拞奜堛妛幮, 搶嫗, 2019/11敪峴.
'19-620014. [妛弍彂 (暘扴幏昅)]亂嶻壢杻悓偺媈栤Q&A 60亃In Chapter 1: 擠晈偺杻悓慜昡壙, p.27-9. 墱晉弐擵 (杻悓), 娔廋: 戝浽峗巌, 曇: 忋搱峗弴, 壛摗棦奊, 拞奜堛妛幮, 搶嫗, 2019/11敪峴.
'19-620015. [妛弍彂 (曇廤)]亂嬞媫嶻壢庤弍偺杻悓偵旛偊傞丂夵掶戞2斉亃曇: 墱晉弐擵1, 壛摗棦奊, 揤栰丂姰, (1杻悓), 崕惤摪弌斉, 搶嫗, 2019/11敪峴.
[妛夛丒尋媶夛摍]
'18-723001. [妛夛 (慡崙)] (堦斒島墘) Arf6妶惈壔惂屼場巕cytohesin 2偺嬊嵼夝愅偲醬捝惂屼婡峔偵偍偗傞栶妱. 埳摗桜巕1, 怺扟徆峅2, 壀杮峗巏1, 嶃忋梞峴2 (1杻悓, 2夝朥): 戞124夞擔杮夝朥妛夛慡崙妛弍廤夛 (2019/3/27), 怴妰.
椪彴専嵏恌抐妛
[妛弍榑暥]
110207. [尨挊] Short-term Change in Resting Energy Expenditure and Body Compositions in Therapeutic Process for Graves' Disease. Hayashi A1, Takano K1, Kawakami Y2, Hitomi M2, Ohata Y1, Suzuki A1, Kamata Y1, Shichiri M1: Intern Med 2020/8; 59 (15): 1827-33. (椦丂揘斖1, 崅栰岾楬1, 愳忋桰巕2, 恖尒杻旤巕2, 戝敥峃岹1, 楅栘峍柤1, 姍揷桾擇1, 幍棦崃媊1: 1撪暘斿戙幱撪, 2塰梴晹)
110208. [尨挊] Comparison of accuracy between flash glucose monitoring and continuous glucose monitoring in patients with type 2 diabetes mellitus undergoing hemodialysis. Matoba K1,2, Hayashi A1, Shimizu N1, Moriguchi I, Kobayashi N, Shichiri M1: J Diabetes Complications 2020/11; 34 (11): 107680. (揑応寬懢1,2, 椦丂揘斖1, 惔悈弴栫1, 幍棦崃媊1: 1撪暘斿戙幱撪, 2椪専妛)
110392. [尨挊] Use of Noncontact Infrared Skin Thermometer for Peripheral Arterial Disease Screening in Patients With and Without Diabetes. Hayashi A1, Shichiri M2: Angiology 2020/8; 71 (7): 650-7. (椦丂揘斖1, 幍棦崃媊2: 1椪専妛, 2撪暘斿戙幱撪)
110095. [尨挊] Portal hemodynamic effects of lenvatinib in patients with advanced hepatocellular carcinoma: A prospective cohort study. Hidaka H1, Uojima H1, Nakazawa T1, Shao X, Hara Y1, Iwasaki S1, Wada N1, Kubota K1, Tanaka Y1, Shibuya A1, Kanoh Y2, Kokubu S1, Koizumi W1: Hepatol Res 2020/9; 50 (9): 1083-90. (擔崅丂墰1, 嫑搱惏婭1, 拞郪婱廏1, 尨丂桬曘1, 娾嶈廏堦榊1, 榓揷彯媣1, 孍揷岾夘1, 揷拞尗柧1, 廰扟柧棽1, 庪栰桳嶌2, 殸暘栁攷1, 彫愹榓嶰榊1: 1徚壔婍撪, 2椪専妛)
110209. [尨挊] The effectiveness of growth hormone replacement on energy expenditure and body composition in patients with adult growth hormone deficiency. Momozono A1, Hayashi A2, Takano K1, Shichiri M1: Endocr J 2021/4; 68 (4): 469-75. doi: 10.1507/endocrj.EJ20-0644. Epub 2020 Dec 22. (搷墍丂柧1, 椦丂揘斖2, 崅栰岾楬1, 幍棦崃媊1: 1撪暘斿戙幱撪壢妛, 2椪専妛)
110393. [尨挊] Assessment of the accuracy of an intermittent-scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study. Toyoda M, Murata T, Saito N, Kimura M, Takahashi H, Ishida N, Kitamura M, Hida M, Hayashi A1, Moriguchi I, Kobayashi N, Tsuriya D, Sakao Y, Matsushita T, Ito Y, Suzuki S, Kasama S, Kasahara M, Yamakawa T, Mori K, Kuroda A, Miura J, Hirota Y, Abe M, Fukagawa M, Sakane N, Hosoda K: Ther Apher Dial 2021/10; 25 (5): 586-94. doi: 10.1111/1744-9987.13618. Epub 2021 Feb 2. (椦丂揘斖1: 1椪専妛)
120049. [尨挊] 摐擜昦僇儞僶僙乕僔儑儞丒儅僢僾TM偵傛傞姶忣晧扴媦傃寣摐娗棟傊偺岠壥偺専摙. 愳忋桰巕1, 椦丂揘斖2, 恖尒杻旤巕1, 愇杮朷旤3, 戝娧宐巕3, 庣壆払旤4, 幍棦崃媊5, 嵅摗徠巕1 (1塰梴晹, 2椪専妛, 3娕岇晹, 4寬峃娗棟僙, 5撪暘斿戙幱撪): 擔杮昦懺塰梴妛夛帍 2020; 23 (2): 159-65.
120043. [尨挊] 僪儔僢僌僫僀乕僽2宆摐擜昦姵幰偵懳偡傞抁婜揑栻嵻旓寉尭傪娪傒偨戞堦慖戰栻僼儘乕僠儍乕僩偺岠壥. 娾郪恀婭巕1, 杧堜崉巎2, 攼栘嵤壺1, 楅栘埡奊, 彫愳尠巎3, 椦丂揘斖4, 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹, 3撪暘斿戙幱撪, 4椪専妛): 摐擜昦 2020/10; 63 (10): 701-10.
[挊丂彂]
620107. [妛弍彂 (暘扴幏昅)]亂専嵏抣傪撉傓2020 (撪壢 Vol.125 No.4 2020擭4寧憹戝崋)亃19復帺屓柶塽専嵏丂峈儗僠僋儕儞峈懱, p.872. 庪栰桳嶌 (椪専妛), 撿峕摪, 搶嫗, 2020/4敪峴.
620108. [妛弍彂 (暘扴幏昅)]亂専嵏抣傪撉傓2020 (撪壢 Vol.125 No.4 2020擭4寧憹戝崋)亃20復嵶朎惈柶塽専嵏丂儕儞僷媴梒庒壔専嵏, p.886. 庪栰桳嶌 (椪専妛), 撿峕摪, 搶嫗, 2020/4敪峴.
620109. [妛弍彂 (暘扴幏昅)]亂専嵏抣傪撉傓2020 (撪壢 Vol.125 No.4 2020擭4寧憹戝崋)亃20復嵶朎惈柶塽専嵏丂峈尨摿堎揑嵶朎彎奞惈T嵶朎夝愅 (MHC (HLA) 僥僩儔儅乕), p.889. 庪栰桳嶌 (椪専妛), 撿峕摪, 搶嫗, 2020/4敪峴.
620110. [妛弍彂 (暘扴幏昅)]亂専嵏抣傪撉傓2020 (撪壢 Vol.125 No.4 2020擭4寧憹戝崋)亃32復慂巋塼専嵏丂娭愡塼専嵏 (II宆僐儔乕僎儞乕C亅儁僾僠僪), p.1117. 庪栰桳嶌 (椪専妛), 撿峕摪, 搶嫗, 2020/4敪峴.
[妛夛丒尋媶夛摍]
723638. [妛夛 (慡崙)] (堦斒島墘) 2宆摐擜昦寣塼摟愅 (DMHD) 姵幰2椺偵偍偗傞僨僌儖僨僋 (D) /儕儔僌儖僠僪 (L) 攝崌拲 (D/L) 偺巊梡宱尡. 怷岥偄傇偒, 彫椦捈擵, 抾拞丂惤, 戝媣曐廩恖, 椦丂揘斖1, 庣壆棙壚2, 庣壆払旤3, 抾撪峃梇4 (1椪専妛, 2堛妛嫵堢, 3寬峃娗棟僙, 4恡憻撪): 戞65夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛 (2020/11/2-24), Web奐嵜.
731064. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 庮釃儅乕僇乕. 庪栰桳嶌 (椪専妛): 擔杮椪彴専嵏愱栧妛堾 (戞45婜柶塽寣惔僐乕僗) (2020/10/18), 搶嫗.
桝寣丒嵶朎堏怉妛
[妛弍榑暥]
110394. [尨挊] Functional Analysis of PTH1R Variants Found in Primary Failure of Eruption. Izumida E, Suzawa T, Miyamoto Y, Yamada A, Otsu M1, Saito T, Yamaguchi T, Nishimura K, Ohtaka M,. Nakanishi M, Yoshimura K, Sasa K, Takimoto R, Uyama R, Shirota T, Maki K,. Kamijo R: J Dent Res 2020/4; 99 (4): 429-36. (戝捗丂恀1: 1桝寣丒嵶朎堏怉)
110395. [尨挊] Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. Paciullo F, Bury L, Noris P, Falcinelli E, Melazzini F, Orsini S, Zaninetti C, Abdul-Kadir R, Obeng-Tuudah D, Heller PG, Glembotsky AC, Fabris F, Rivera J, Lozano ML, Butta N, Favier R, Cid AR, Fouassier M, Podda GM, Santoro C, Grandone E, Henskens Y, Nurden P, Zieger B, Cuker A, Devreese K, Tosetto A, De Candia E, Dupuis A, Miyazaki K1, Othman M, Gresele P: Haematologica 2020/7; 105 (7): 1948-56. (媨鴵峗擇1: 1桝寣丒嵶朎堏怉)
110396. [尨挊] Differences among hemoglobin thresholds for red blood cell transfusions in patients with hematological diseases in teaching hospitals: a real world data in Japan. Yokohama A, Okuyama Y, Ueda Y, Itoh M, Fujiwara S, Hasegawa Y, Nagai K, Arakawa K, Miyazaki K1, Makita M, Watanabe M, Ikeda K, Tanaka A, Fujino K, Matsumoto M, Makino S, Kino S, Takeshita A, Muroi K: Int J Hematol 2020/10t ;112 (4): 535-43. (媨鴵峗擇1: 1桝寣丒嵶朎堏怉)
522127. [島嵗]亂摿廤: 敀寣昦丒儕儞僷庮亃<帯椕乛幚抧堛壠偵昁梫側抦幆> 桝寣椕朄偺拲堄揰. 媨鴵峗擇 (桝寣丒嵶朎堏怉): Medical Practice 2020/9; 37 (9): 1437-42.
522128. [島嵗]亂摿廤: 寣嶼傪嬌傔傞亃 寣彫斅娭楢専嵏抣偺堄媊. 媨鴵峗擇 (桝寣丒嵶朎堏怉): 撪壢 2020/10; 126 (4): 689-92.
[妛夛丒尋媶夛摍]
713052. [妛夛 (崙嵺)] (堦斒島墘) A five-year review of the revised institutional workflow of massive transfusion protocol in our institute. Miyazaki K1, Tanabe Y, Komoto M, Arima K, Iwakiri F, Yamabe H, Ohtani S1: The 36th International ISBT Congress (2020/12/12), Web奐嵜. (媨鴵峗擇1, 戝扟怲堦1: 1桝寣丒嵶朎堏怉)
722203. [妛夛 (慡崙)] (彽懸島墘摍) 昦堾忣曬僔僗僥儉7擭娫偺曕傒. 戝扟怲堦 (桝寣丒嵶朎堏怉): 戞68夞擔杮桝寣丒嵶朎帯椕妛夛妛弍憤夛 (2020/5/29), 帍忋奐嵜.
722204. [妛夛 (慡崙)] (彽懸島墘摍) 寣塼惢嵻敪拲僔僗僥儉偺嵞峔抸. 堜忋惓峅, 戝扟怲堦1, 郷揷夒弐, 戨愳惓峅, 崅嫶峫婌 (1桝寣丒嵶朎堏怉): 戞68夞擔杮桝寣丒嵶朎帯椕妛夛妛弍憤夛 (2020/5/29), 帍忋奐嵜.
723639. [妛夛 (慡崙)] (堦斒島墘) 憿寣婍幘姵傪傕偮戝検愒寣媴桝寣姵幰偵懳偡傞揝僉儗乕僩椕朄偺尰忬. 墶郷復旻, 墱嶳旤庽, 忋揷嫳揟, 埳摗恀悷, 摗尨怲堦榊, 挿堜堦峗, 峳愳恗崄, 杚揷夒揟, 媨鴵峗擇1, 抮揷榓旻, 婭栰廋堦, 揷拞挬巙, 挿扟愳梇堦, 摗栰湪嶰, 杚栰栁媊, 徏杮恀媩, 抾壓柧桾, 幒堜堦抝 (1桝寣丒嵶朎堏怉): 戞68夞擔杮桝寣丒嵶朎帯椕妛夛妛弍憤夛 (2020/5/30), 帍忋奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-110022. [尨挊] Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC. Gresele P, Orsini S, Noris P, Falcinelli E, Alessi MC, Bury L, Borhany M, Santoro C, Glembotsky AC, Cid AR, Tosetto A, De Candia E, Fontana P, Guglielmini G, Pecci A; BAT-VAL study investigators (Miyazaki K1, et al): J Thromb Haemost 2020/3; 18 (3): 732-9. (媨鴵峗擇1: 1桝寣丒嵶朎堏怉)
[挊丂彂]
'19-620016. [妛弍彂 (暘扴幏昅)]亂怴椪彴撪壢妛丂戞10斉亃戞8復 寣塼丒憿寣婍幘姵丂寣彫斅悢偺堎忢傪惗偠傞幘姵 (憿寣婍庮釃傪彍偔)丂[4] 寣愷惈寣彫斅尭彮惈巼斄昦, 梟寣惈擜撆徢徢岓孮, p.1016-8. 媨鴵峗擇 (桝寣丒嵶朎堏怉), 娔廋: 栴嶈媊梇, 堛妛彂堾, 搶嫗, 2020/3敪峴.
'19-620017. [妛弍彂 (暘扴幏昅)]亂怴椪彴撪壢妛丂戞10斉亃戞8復 寣塼丒憿寣婍幘姵丂寣彫斅悢偺堎忢傪惗偠傞幘姵 (憿寣婍庮釃傪彍偔)丂[6] 寣彫斅偺暘晍丒挋棷偺堎忢, p.1021-2. 媨鴵峗擇 (桝寣丒嵶朎堏怉), 娔廋: 栴嶈媊梇, 堛妛彂堾, 搶嫗, 2020/3敪峴.
'19-620018. [妛弍彂 (暘扴幏昅)]亂怴椪彴撪壢妛丂戞10斉亃戞8復 寣塼丒憿寣婍幘姵丂寣彫斅悢偺堎忢傪惗偠傞幘姵 (憿寣婍庮釃傪彍偔)丂[7] 婾惈寣彫斅尭彮, p.1022-3. 媨鴵峗擇 (桝寣丒嵶朎堏怉), 娔廋: 栴嶈媊梇, 堛妛彂堾, 搶嫗, 2020/3敪峴.
'19-620019. [妛弍彂 (暘扴幏昅)]亂椪彴岺妛島嵗 椪彴堛妛憤榑 戞2斉亃戞10復 寣塼昦妛丂2. 愒寣媴偺幘姵, p.245-50. 媨鴵峗擇 (桝寣丒嵶朎堏怉), 娔廋: 擔杮椪彴岺妛媄巑嫵堢巤愝嫤媍夛, 曇: 幝尨堦旻, 彫扟丂摟, 堛帟栻弌斉, 搶嫗, 2020/3敪峴.
媬柦媬媫堛妛
[妛弍榑暥]
110397. [尨挊] Clinical Utility of Coil in Plug Method (CIP) for Internal Iliac Artery Embolization during Endovascular Aortic Aneurysm Repair. Kotoku A, Ogawa Y, Chiba K, Maruhashi T1, Mimura H, Miyairi T, Nishimaki H: Ann Vasc Dis 2020/9; 13 (3): 269-72. (娵嫶岶徍1: 1媬柦)
110398. [尨挊] Novel transcatheter arterial embolization method for hemodynamically unstable pelvic fractures to prevent complications of gluteal necrosis. Maruhashi T1, Kashimi F1, Kotoh R1, Kasahara S1, Minehara H, Kataoka Y1, Nishimaki H, Asari Y1: Eur J Trauma Emerg Surg 2020/10; 46 (5): 1129-36. (娵嫶岶徍1, 妦尒暥巬1, 屆摗棦壚1, 妢尨丂弒1, 曅壀桽堦1, 愺棙丂桋1: 1媬柦)
110399. [尨挊] Safety of arterial catheterization using the distal radial approach in intensive care unit management: A pilot study. Oi M1, Maruhashi T1, Ishikura A2, Kurihara Y1, Yaguchi Y2, Masuda K, Asari Y1: J Vasc Access 2021/3; 11297298211003374. (戝堜恀棦撧1, 娵嫶岶徍1, 愇憅丂垽2, 孖尨桽懢楴1, 栴岥岾巕2, 愺棙丂桋1: 1媬柦, 2娕岇晹)
310047. [徢椺曬崘] Intravascular treatment for ruptured facial artery aneurysm via percutaneous cardiopulmonary support device: A case report. Oi M1, Maruhashi T1, Yamamoto D2, Kurihara Y1, Koizumi H1,2, Asari Y1: Clin Case Rep 2020/4; 8 (7): 1202-5. (戝堜恀棟撧1, 娵嫶岶徍1, 嶳杮戝曘2, 孖尨桽懢楴1, 彫愹姲擵1,2, 愺棙丂桋1: 1媬柦, 2擼奜)
310048. [徢椺曬崘] Pancreatitis in a Patient with Severe Coronavirus Disease Pneumonia Treated with Veno-venous Extracorporeal Membrane Oxygenation. Kurihara Y1, Maruhashi T1, Wada T2, Osada M1, Oi M1, Yamaoka K2, Asari Y1: Intern Med 2020/11; 59 (22): 2903-6. (孖尨桽懢楴1, 娵嫶岶徍1, 榓揷払旻2, 挿揷恀桼巕1, 戝堜恀棟撧1, 嶳壀朚岹2, 愺棙丂桋1: 1媬柦, 2銹尨昦丒姶愼撪)
310049. [徢椺曬崘] Life-threatening traumatic epistaxis due to massive bleeding into the maxillary sinus. Kotoh R1, Maruhashi T1, Tamura S1, Yamamoto D2, Koizumi H2, Kurihara Y1, Osada M1, Oi M1, Asari Y1: Trauma Case Rep 2021/2; 32: 100434. (屆摗棦壚1, 娵嫶岶徍1, 揷懞丂抭1, 嶳杮戝曘2, 彫愹姲擵2, 孖尨桽懢楴1, 挿揷恀桼巕1, 戝堜恀棦撧1, 愺棙丂桋1: 1媬柦, 2擼奜)
320044. [徢椺曬崘] 捗媣堜傗傑備傝墍懡悢彎昦幰帠埬偐傜僥儘儕僘儉偺懳墳傪峫偊傞亅僪僋僞乕僇乕偵傛傞尰応妶摦傪捠偠偰亅. 暈晹丂弫1, 娵嫶岶徍1, 曅壀桽堦1, 愺棙丂桋1: 1媬柦): 擔杮椪彴媬媫堛妛夛嶨帍 2020/6; 23 (2): 179-85.
320045. [徢椺曬崘] 岆堸偟偨媊帟偵傛傝媫惈堓朓鈢怐墛傪敪徢偟偨1椺. 壛摗抭擵1, 戝堜恀棦撧1, 娵嫶岶徍1, 拞扟尋搇1, 孖尨桽懢楴1, 曅壀桽堦1, 愺棙丂桋1 (1媬柦): 擔杮媬媫堛妛夛娭搶抧曽夛嶨帍 2020/12; 41 (4): 496-9.
522129. [島嵗]亂摿廤: 徢椺偐傜峫偊傞廳徢奜彎恌椕丂偁側偨側傜偳偆偡傞!?亃III. 奐暊帪偺弌寣僐儞僩儘乕儖丂REBOA. 孖尨桽懢楴1, 娵嫶岶徍1 (1媬柦): 媬媫堛妛 2020/9; 44 (10): 1282-90.
522130. [島嵗]亂摿廤: 寣娗撪帯椕偵偍偗傞尰忬丒栤戣揰丒彨棃揥朷亃7. 暊晹僗僥儞僩僌儔僼僩撪憓弍 (EVAR) 偺尰忬偲彨棃揥朷. 彫愳晛媣, 惣姫丂攷, 愮梩丂惔, 彫摽嬇惗, 敧栘嫶崙攷, 娵嫶岶徍1, 嶰懞廏暥, 媨擖丂崉 (1媬柦): 擔杮寣娗撪帯椕妛夛帍 2020/11; 21: 44-52.
530022. [偦偺懠 (Letter to the Editor)] Preloading Coil in Plug Technique for Internal Iliac Artery Embolization During Endovascular Abdominal Aortic Aneurysm Repair. Maruhashi T1, Nishimaki H, Ogawa Y4, Chiba K, Kotoku A, Miyairi T: Cardiovasc Intervent Radiol 2021/1; 44 (1): 179-81. (娵嫶岶徍1: 1媬柦)
540046. [偦偺懠 (尋媶曬崘彂)]亂岤惗楯摥峴惌悇恑挷嵏帠嬈旓曗彆嬥 (抧堟堛椕婎斦奐敪悇恑尋媶帠嬈) 媬媫堛椕懱惂偺悇恑偵娭偡傞尋媶亃擇師媬媫堛椕婡娭偺尰忬偲昡壙偵偮偄偰. 愺棙丂桋1, 娵嫶岶徍1, 屆摗棦壚1, 峳堜峃晇2, 峳堜桳旤3, 暈晹丂弫1 (1媬柦, 2恌椕忣曬娗棟幒, 3堛椕偺幙丒埨慡悇恑幒): 媬媫堛椕懱惂偺悇恑偵娭偡傞尋媶丂椷榓2擭搙暘扴尋媶曬崘彂 2020.
[挊丂彂]
620111. [妛弍彂 (暘扴幏昅)]亂嵭奞堛椕2020亅戝婯柾僀儀儞僩, 僥儘懳墳傪娷傔偰 (擔杮堛巘夛嶨帍戞149姫摿暿崋 (1))亃VIII復. 摿庩嵭奞丒CBRNE懳墳丂弶婜懳墳, p. 294-8. 娵嫶岶徍1, 愺棙丂桋1 (1媬柦), 娔廋丒曇: 墶揷桾峴, 擔杮堛巘夛, 搶嫗, 2020/6敪峴.
620112. [妛弍彂 (暘扴幏昅)]亂DIRECT REBOA僙儈僫乕岞幃僥僉僗僩 REBOA僴儞僪僽僢僋亃III復 娗棟, p.55-74. 惵栘丂惤, 愇揷寬堦榊, 壵尨棽擵, 孖尨桽懢楴1, 崺丂桽棟, 嬤摗峗巎, 幝捤丂寬, 悪嶳戱栫, 枀旜憦旤, 晉揷孾夘, 塱搱丂懢, 恖尒丂廏, 慏塯抦峅, 徏懞梞曘, 徏杮弮堦, 娵嫶岶徍1 (媬柦1), 娔廋: DIRECT尋媶夛, 曇: DIRECT尋媶夛REBOA儚乕僉儞僌僌儖乕僾 傊傞偡弌斉, 搶嫗, 2021/3敪峴.
[妛夛丒尋媶夛摍]
722205. [妛夛 (慡崙)] (僔儞億僕僂儉) 彫宆幉棳幃曗彆弞娐億儞僾偵傛傞怴偨側怱攛慼惗朄偺壜擻惈. 娵嫶岶徍1, 嶑丂孾懢, 惣愳戱栫, 屆摗棦壚1, 孖尨桽懢楴1, 戝堜恀棦撧1, 愺棙丂桋1 (1媬柦): 戞48夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2020/11/18-20), 婒晫.
722206. [妛夛 (慡崙)] (僔儞億僕僂儉)亂懡敪奜彎偵偍偗傞巭寣愴棯偲巭寣愴弍亃偳偙偐傜媗傔傞偐? 偳偙傑偱媗傔傞偐? 僶儖乕儞僾儘僥僋僔儑儞偵傛傞慖戰揑嵡愷. 揷懞丂抭1, 娵嫶岶徍1, 孖尨桽懢楴1, 妦尒暥巬1, 愺棙丂桋1 (1媬柦): 戞48夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2020/11/18-20), 婒晫.
722207. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 崪斦奜彎偵偍偗傞REBOA偺桳岠惈傪懡柺揑偵昡壙偡傞. 娵嫶岶徍1, 妦尒暥巬1, 嶑丂孾懢, 惣愳戱栫, 孖尨桽懢楴1, 戝堜恀棦撧1, 屆摗棦壚1, 揷懞丂抭1, 惣姫丂攷, 愺棙丂桋1 (1媬柦): 戞34夞擔杮奜彎妛夛憤夛丒妛弍廤夛 (2020/12/7-8), 愬戜(web奐嵜).
723640. [妛夛 (慡崙)] (堦斒島墘) 媫惈忋挵娫枌摦柆暵嵡徢偵懳偟偰擼摦柆僗僥儞僩儕僩儕乕僶乕偵傛傞帯椕偵惉岟偟偨2椺. 揷懞丂抭1, 妦尒暥巬1, 娵嫶岶徍1, 孖尨桽懢楴1, 愺棙丂桋1 (1媬柦): 戞49夞擔杮IVR妛夛憤夛 (2020/8/25-27), 恄屗.
723641. [妛夛 (慡崙)] (堦斒島墘) Using intracerebral Stent retriever for acute superior mesenteric artery occlusion: three case reports. 揷懞丂抭1, 娵嫶岶徍1, 孖尨桽懢楴1, 妦尒暥巬1, 愺棙丂桋1 (1媬柦): 戞49夞擔杮IVR妛夛憤夛 (2020/8/25-27), 恄屗.
723642. [妛夛 (慡崙)] (堦斒島墘) The Utility of carbon dioxide angiography for detecting bleeding from the IMA at vaginal hematoma. 孖尨桽懢楴1, 僂僢僪僴儉僗楁巕2, 嶰堜峃暯2, 摗堜丂奭2, 徏塱宧擇2, 堜忋桪夘2 (1媬柦, 2曻幩慄 (夋憸)): 戞49夞擔杮IVR妛夛憤夛 (2020/8/25-27), 恄屗.
723643. [妛夛 (慡崙)] (堦斒島墘) 抇擷揈弌弍屻偵惗偠偨抇鵑壖惈摦柆釒偵懳偟TAE傪巤峴偟偨1椺. 挿揷恀桼巕1, 妦尒暥巬1, 孖尨桽懢楴1, 娵嫶岶徍1, 揷懞丂抭1, 暈晹丂弫1, 愺棙丂桋1 (1媬柦): 戞56夞擔杮暊晹媬媫堛妛夛憤夛 (2020/10/8), 柤屆壆 (web奐嵜), 擔杮暊晹媬媫堛妛夛嶨帍 2020; 40: 321.
723644. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞怴宆僐儘僫僂僀儖僗帯椕宱尡亅僀儀儖儊僋僠儞偐傜VV-ECMO傑偱亅. 孖尨桽懢楴1, 娵嫶岶徍1, 榓揷払旻2, 戝堜恀棦撧1, 嬥丂廆岻1, 嶳壀朚岹2, 愺棙丂桋1 (1媬柦, 2銹尨昦丒姶愼撪): 戞48夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2020/11/18-20), 婒晫.
723645. [妛夛 (慡崙)] (堦斒島墘) 嬤愒奜慄暘岝傪梡偄偰娪暿偟偨擃晹慻怐姶愼徢偺2椺. 戝堜恀棦撧1, 娵嫶岶徍1, 孎郪寷堦2, 孖尨桽懢楴1, 娾愳偝偍傝1, 愺棙丂桋1 (1媬柦, 2宍惉丒旤奜): 戞48夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2020/11/18-20), 婒晫.
723646. [妛夛 (慡崙)] (堦斒島墘) 媫惈忋挵娫枌摦柆暵嵡徢偵懳偟偰擼摦柆僗僥儞僩儕僩儕乕僶乕偵傛傞帯椕偵惉岟偟偨3椺. 屆摗棦壚1, 揷懞丂抭1, 娵嫶岶徍1, 孖尨桽懢楴1, 妦尒暥巬1, 愺棙丂桋1 (1媬柦): 戞48夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2020/11/18-20), 婒晫.
723647. [妛夛 (慡崙)] (堦斒島墘) 寣桭昦A姵幰偺弌寣惈僔儑僢僋傪敽偆銪懝彎偵懳偡傞寣娗撪帯椕. 挿揷恀桼巕1, 娵嫶岶徍1, 孖尨桽懢楴1, 揷懞丂抭1, 妦尒暥巬1, 愺棙丂桋1 (1媬柦): 戞48夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2020/11/18-20), 婒晫.
723648. [妛夛 (慡崙)] (堦斒島墘) 崪斦崪愜偵懳偡傞寣娗撪帯椕偵偍偗傞扽巁僈僗偺桳梡惈. 嬥丂廆岻1, 娵嫶岶徍1, 孖尨桽懢楴1, 揷懞丂抭1, 妦尒暥巬1, 戝堜恀棦撧1, 愺棙丂桋1 (1媬柦): 戞48夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2020/11/18-20), 婒晫.
723649. [妛夛 (慡崙)] (堦斒島墘) 媬柦偟偊偨栘惢敘偵傛傞塻揑IIIa怱懝彎偺1椺. 巗绯壴撧, 屆摗棦壚1, 揷懞丂抭1, 揷懞壚旤2, 娵嫶岶徍1, 杒懞丂棩2, 愺棙丂桋1 (1媬柦, 2怱憻寣娗奜): 戞48夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2020/11/18-20), 婒晫.
723650. [妛夛 (慡崙)] (堦斒島墘) 忋妠摯撪傊偺弌寣偺抳巰揑偲側偭偨奜彎惈旲弌寣偺堦椺. 嬥揷幍廳, 屆摗棦壚1, 娵嫶岶徍1, 揷懞丂抭1, 嶳杮戝曘2, 彫愹姲擵1,2, 孖尨桽懢榊1, 挿揷恀桼巕1, 愺棙丂桋1 (1媬柦, 2擼奜): 戞48夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2020/11/18-20), 婒晫.
723651. [妛夛 (慡崙)] (堦斒島墘) 慼惗揑奐嫻弍偵偰媬柦偟TEVAR傪巤峴偟偨嫻晹懡敪巋憂偺堦椺. 憹揷抭惉 (媬柦): 戞34夞擔杮奜彎妛夛憤夛丒妛弍廤夛 (2020/12/7-8), web奐嵜, 擔杮奜彎妛夛嶨帍 2020; 34 (5): 188.
732073. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉摍) 憡柾尨巗偺媬媫堛椕懱惂偲巤愝媬媫. 挬孏掯棽 (媬柦): 椷榓2擭搙丂憡柾尨巗抧堟堛椕楢実嬈柋娭學怑堳崌摨夛媍丂島墘 (2020/10/30), 憡柾尨.
'19擭搙埲慜暘
[妛弍榑暥]
'19-310004. [徢椺曬崘] Use of Multimodal Interventional Radiology with an Intracerebral Artery Stent Retriever for Acute Superior Mesenteric Artery Thrombosis: A Case Report. Tamura S1, Maruhashi T1, Kashimi F1, Kurihara Y1, Oi M1, Hanajima T1, Kataoka Y1, Asari Y1: Ann Vasc Surg 2020/2; 63: 457.e13-457.e18. (揷懞丂抭1, 娵嫶岶徍1, 妦尒暥巬1, 孖尨桽懢楴1, 戝堜恀棟撧1, 壴搰丂帒1, 曅壀桽堦1, 愺棙丂桋1: 1媬柦)
[挊丂彂]
'19-620020. [妛弍彂 (暘扴幏昅)]亂彫帣偺恌椕庤媄 (彫帣壢恌椕82姫憹姧崋)亃III. 媬媫丂媫惈拞撆偵懳偡傞徚壔娗彍愼, p. 110-5. 崺丂怢栫 (媬柦), 曇: 惎栰丂捈, 恌抐偲帯椕幮, 搶嫗, 2019/4敪峴.
'19-620021. [妛弍彂 (暘扴幏昅)]亂崱擔偺恌抐巜恓 戞8斉亃II 幘姵曇丂14. 拞撆惈幘姵丂桳婡儕儞丒僒儕儞拞撆, p. 1431-3. 娵嫶岶徍 (媬柦), 憤曇廤: 塱堜椙嶰, 堛妛彂堾, 搶嫗, 2020/3敪峴.
[妛夛丒尋媶夛摍]
H29-723002. [妛夛 (慡崙)] (堦斒島墘) 攏悓栘拞撆偺堦椺. 挿揷恀桼巕1, 娵嫶岶徍1, 妢尨丂弒1, 暈晹丂弫1, 曅壀桽堦1, 愺棙丂桋1 (1媬柦): 戞45夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2017/10/24-26), 戝嶃, 擔杮媬媫堛妛夛嶨帍 2017; 28: 573.
'18-723003. [妛夛 (慡崙)] (堦斒島墘) 崅Na寣徢偵傛傝怹摟埑惈扙悜徢岓孮傪偒偨偟偨1椺. 挿揷恀桼巕1, 娵嫶岶徍1, 戝堜恀棦撧1, 娵栘塸梇1, 孖尨桽懢楴1, 曅壀桽堦1, 愺棙丂桋1 (1媬柦): 戞46夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2018/11/19-21), 墶昹, 擔杮媬媫堛妛夛嶨帍 2018; 29: 631.
'19-723031. [妛夛 (慡崙)] (堦斒島墘) 彫帣奜彎偵懳偡傞夋憸壓帯椕偵偍偗傞弍拞娗棟朄偑庤媄偵媦傏偡塭嬁. 戝堜恀棦撧1, 娵嫶岶徍1, 妦尒暥巬1, 孖尨桽懢楴1, 揷懞丂抭1, 崺丂怢栫1, 愺棙丂桋1 (1媬柦): 戞47夞擔杮媬媫堛妛夛憤夛丒妛弍廤夛 (2019/10/2-4), 搶嫗, 擔杮媬媫堛妛夛嶨帍 2019; 30 (9): 688.
'19-732002. [妛夛 (抧曽夛丒尋媶夛)] (僷僱儖僨傿僗僇僢僔儑儞) 寣娗撪帯椕傪庡幉偲偟偨堾奜偐傜巒傑傞奜彎弶婜恌椕乣Comprehensive IR strategy in Trauma (CIST)乣. 揷懞丂抭1, 娵嫶岶徍1, 孖尨桽懢楴1, 妦尒暥巬1, 戝堜恀棦撧1, 曅壀桽堦1, 愺棙丂桋1 (1媬柦): 戞70夞擔杮媬媫堛妛夛娭搶抧曽夛妛弍廤夛 (2020/1/18), 慜嫶.
'19-732003. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 嵼戭媬媫偲媬媫堛椕偺楢実丂MC 偵偍偗傞堾奜怱掆巭姵幰偺慼惗偵懳偡傞帠慜堄巚昞帵傗朘栤丒嵼戭堛椕偲偺楢実偵娭偡傞幚懺挷嵏丒僔儞億僕僂儉偐傜尒偊偨傕偺. 挬孏掯棽 (媬柦): 戞70夞擔杮媬媫堛妛夛娭搶抧曽夛妛弍廤夛 (2020/1/18), 慜嫶.
憤崌恌椕堛妛
[妛弍榑暥]
320046. [徢椺曬崘]亂杒棦搶堛尋恌椕榐偐傜 (193)亃婫愡惈偺奝歶偵帬堿帄曮搾偑桳岠偱偁偭偨1徢椺. 屲栰桼壚棟1, 彫揷岥峗2,3, 壴椫氭旻3 (1憤崌恌椕, 2搶梞堛妛嫵堢, 3搶梞堛妛憤崌尋媶強): 娍曽偺椪彴 2020/6; 67 (6): 597-601.
320047. [徢椺曬崘]亂杒棦搶堛尋恌椕榐偐傜 (200)亃旕掕宆帟捝偵棫岠嶶椏偑桳岠偱偁偭偨1椺. 媦愳揘榊, 栴悢朏塸, 搉绯廏桾, 埳摗惓桾, 暯嶳梲帵, 埨揷戩巎, 屲栰桼壚棟1, 怷桾婭巕2, 壴椫氭旻2, 彫揷岥峗2,3 (1憤崌恌椕, 2搶梞堛妛憤崌尋媶強, 3搶梞堛妛嫵堢): 娍曽偺椪彴 2021/1; 68 (1): 95-99.
521016. [夝愢] 姵幰偵媫惈姤徢岓孮傪媈傢偣傞徢忬偑偁偭偨偺偵, 12桿摫怱揹恾傪幚巤偟側偐偭偨偙偲偐傜巰朣偵帄偭偨偲偟偰懝奞攨彏傪媮傔偨帠椺. 惵嶳捈慞 (憤崌恌椕): 堛椕敾椺夝愢 2020/4; 85: 67-86.
堛妛晹晬懏堛妛嫵堢尋媶奐敪僙儞僞乕
堛妛嫵堢尋媶晹栧
堛妛尨榑尋媶晹栧
[妛弍榑暥]
540047. [偦偺懠 (僯儏乕僗儗僞乕)] 擠晈寣塼偵傛傞弌惗慜専嵏偺20擭偲偙傟偐傜: 僈僀僪儔僀儞偑庣偭偨偙偲, 惂尷偟偨偙偲. 釼摗桳婭巕 (堛妛尨榑): 堦斒幮抍朄恖 惈偲寬峃傪峫偊傞彈惈愱栧壠偺夛僯儏乕僘儗僞乕 2020/11; 79: 1.
540048. [偦偺懠 (怴暦婰帠)] PGT-A尋媶偵娭偡傞僐儊儞僩. 釼摗桳婭巕 (堛妛尨榑): 撉攧怴暦 2020/12/12.
540049. [偦偺懠 (尋媶曬崘彂)]亂岤惗楯摥壢妛尋媶旓曗彆嬥擄帯惈幘姵惌嶔尋媶帠嬈乽恄宱曄惈幘姵椞堟偺婎斦揑挷嵏尋媶乿亃堏峴: Transition堛椕乣尰応偐傜乣. 挿扟愳堦巕, 釼摗桳婭巕1 (1堛妛尨榑): 恄宱曄惈幘姵椞堟偺婎斦揑挷嵏尋媶斍尋媶曬崘彂 2021/3; p.42-4.
540050. [偦偺懠 (尋媶曬崘彂)]亂岤惗楯摥壢妛尋媶旓曗彆嬥擄帯惈幘姵惌嶔尋媶帠嬈乽恄宱曄惈幘姵椞堟偺婎斦揑挷嵏尋媶乿亃堚揱巕偵娭偡傞栤戣傪峫偊傞. 挿扟愳堦巕, 彑栰夒墰, 娭搰椙庽, 揤栰捈擇, 釼摗桳婭巕1, 拞搰寬擇 (1堛妛尨榑): 恄宱曄惈幘姵椞堟偺婎斦揑挷嵏尋媶斍尋媶曬崘彂 2021/3; p.45-8.
[妛夛丒尋媶夛摍]
731065. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 桪惗曐岇朄偐傜曣懱曐岇朄傊 儕僾儘僟僋僔儑儞偲惗柦椣棟. 釼摗桳婭巕 (堛妛尨榑): 惷壀導曣懱曐岇朄巜掕堛巘尋廋夛 (2020/9/27), 惷壀.
732074. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍) 擠晈寣塼偵傛傞弌惗慜専嵏偺20擭偲偙傟偐傜: 僈僀僪儔僀儞偑庣偭偨偙偲丆惂尷偟偨偙偲. 釼摗桳婭巕 (堛妛尨榑): 2020擭搙堦斒幮抍朄恖惈偲寬峃傪峫偊傞彈惈愱栧壠偺夛憤夛僔儞億僕僂儉 (2020/10/10), Web奐嵜.
733121. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 拞愨傪傔偖傞彈惈傊偺傑側偞偟. 釼摗桳婭巕 (堛妛尨榑): 椷榓2擭搙慡崙彆嶻巘嫵堢嫤媍夛娭搶峛怣墇抧嬫尋廋夛 (2020/11/28), Web奐嵜.
733122. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) transition堛椕: 尰応偐傜. 挿扟愳堦巕, 釼摗桳婭巕1 (1堛妛尨榑): 椷榓2擭搙岤楯壢尋惌嶔尋媶斍恄宱曄惈幘姵椞堟偵偍偗傞婎斦揑挷嵏尋媶斍 (2020/12/11), Web奐嵜.
733123. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 拝彴慜恌抐 (PGT-M) 揔墳奼戝傪傔偖傞嵟嬤偺栤戣. 釼摗桳婭巕 (堛妛尨榑): 恄宱曄惈幘姵椞堟偵偍偗傞婎斦揑挷嵏尋媶斍堚揱巕専嵏偵娭傢傞彅栤戣傪峫偊傞夛 (2020/12/21), Web奐嵜.
733124. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 梤悈専嵏偺晛媦偐傜50擭擔杮偵偍偗傞弌惗慜専嵏偺媍榑偲崱屻偺壽戣. 釼摗桳婭巕 (堛妛尨榑): 恊巕偺枹棃傪巟偊傞夛戀帣儂僢僩儔僀儞憡択堳曞廤堢惉帠嬈擠怭妺摗憡択僂僃價僫乕 (2021/1/16), Web奐嵜.
'19擭搙埲慜暘
[妛夛丒尋媶夛摍]
'19-733019. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 僌儘乕僶儖恖尃偱側偄擔杮偺儕僾儘僟僋僔儑儞偵娭偡傞朄惂搙. 釼摗桳婭巕 (堛妛尨榑): 柧帯戝妛僌儘乕僶儖恖尃尋媶夛 (2020/3/18), Web奐嵜.
堛椕埨慡丒娗棟妛尋媶晹栧
仸乽惍宍奜壢妛乿傪嶲徠
堛椕媄弍嫵堢尋媶晹栧
仸乽恡憻撪壢妛乿傪嶲徠
妛廗巟墖尋媶晹栧
堛椕忣曬嫵堢尋媶晹栧
[妛夛丒尋媶夛摍]
723652. [妛夛 (慡崙)] (堦斒島墘) 傾儈儘僀僪壔孹岦傪桳偡傞僞儞僷僋幙丒儁僾僠僪偺嬅廤杊巭. 崟愳桪崄, 妺娧奊棞撧, 擔斾寬恖, 壨栰弐擵1, 帥榚怲堦, 庒徏丂奭 (1堛椕忣曬嫵堢): 戞59夞NMR摙榑夛 (2020/11/17), 崅嶈.
723653. [妛夛 (慡崙)] (堦斒島墘) 傾僪儗僫儕儞庴梕懱嵶朎撪戞嶰儖乕僾偲GPCR 儌僕儏儗乕僞乕Spinophilin偲偺怴偟偄梈崌僞儞僷僋幙傪梡偄偨憡屳嶌梡夝愅. 妺娧奊棞撧, 撆搰偄傇偒, 崟愳桪崄, 塝栰抭巕, 搰嶈埨婓巕, 壨栰弐擵1, 嵶揷榓抝, 帥榚怲堦, 庒徏丂奭 (1堛椕忣曬嫵堢): 戞59夞NMR摙榑夛 (2020/11/17), 崅嶈.
搶梞堛妛嫵堢尋媶晹栧
[妛弍榑暥]
110400. [尨挊] Effect of Ephedra Herb on Erlotinib Resistance in c-Met-Overexpressing Non-Small-Cell Lung Cancer Cell Line, H1993, through Promotion of Endocytosis and Degradation of c-Met. Hyuga S1, Hyuga M, Amakura Y, Yang J, Mori E1, Hakamatsuka T, Goda Y, Odaguchi H1,2, Hanawa T1: Evidence-Based Complementary and Alternative Medicine 2020/5; 2020: 1-14. Article ID 7184129. (擔岦恵旤巕1, 怷丂塴巕1, 彫揷岥峗1,2, 壴椫氭旻1: 1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢)
110401. [尨挊] Emotional Impairments and Neuroinflammation are Induced in Male Mice Invulnerable to Repeated Social Defeat Stress. Ito N1, Sasaki K, Takemoto H2, Kobayashi Y1, Isoda H, Odaguchi H1,3: Neuroscience 2020/9; 443: 148-63. (埳摗捈庽1, 抾尦桾柧2, 彫椦媊揟1, 彫揷岥峗1,3: 1搶梞堛妛憤崌尋媶強, 2栻妛晹, 3搶梞堛妛嫵堢)
110402. [尨挊] Hochuekkito comprising Atractylodis lanceae rhizoma prevents pulmonary infection of Streptococcus pneumoniae in cyclophosphamide-treated mice through acceleration of anti-bacterial protein production. Ideno S, Tanaka Y, Sasou K, Hosaka H, Matsui H1, Maruyama H, Tonooka M, Endo M2, Nagai T2, Seki H, Hanawa T2, Ito G, Odaguchi H2,3, Morisaki H, Hiroaki Kiyohara H2: TRADITIONAL & KAMPO MEDICINE 2020/12; 7 (3): 166-79. (徏堜塸懃1, 墦摗恀棟2, 塱堜棽擵2, 壴椫氭旻2, 彫揷岥峗2,3, 惔尨姲復2: 1戝懞抭婰擮尋媶強, 2搶梞堛妛憤崌尋媶強, 3搶梞堛妛嫵堢)
320048. [徢椺曬崘] 寣偺摴徢偵懳偟, 彈恄嶶偑桳岠偲峫偊傜傟偨10徢椺偺椪彴揑専摙. 怷丂塴巕1, 媦愳揘榊1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 擔杮搶梞堛妛夛嶨帍 2020/4; 71 (2): 121-6.
320049. [徢椺曬崘]亂杒棦搶堛尋恌椕榐偐傜 (195)亃恄岠搾偑桳岠偩偭偨巕媨撪枌徢偵傛傞擄帯惈枬惈壓暊晹捝. 怷桾婭巕1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 娍曽偺椪彴 2020/8; 67 (8): 805-10.
320050. [徢椺曬崘]亂杒棦搶堛尋恌椕榐偐傜 (196)亃晄柊偵敀屨壛墿楢搾偑桳梡偱偁偭偨1椺. 愇栄払栫1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 娍曽偺椪彴 2020/9; 67 (9): 919-22.
320051. [徢椺曬崘]亂杒棦搶堛尋恌椕榐偐傜 (197)亃婡擻惈堓挵忈奞偵孾銪搾, 婣闼寶拞搾偑憈岠偟偨侾椺. 惎栰戩擵1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 娍曽偺椪彴 2020/10; 67 (10): 1005-8.
320052. [徢椺曬崘]亂杒棦搶堛尋恌椕榐偐傜 (198)亃孾銪搾偲嶲楄敀濹嶶偺娪暿偑栤戣偲側偭偨1椺. 彫揷岥峗1,2, 壴椫氭旻2 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強): 娍曽偺椪彴 2020/11; 67 (11): 1095-9.
[妛夛丒尋媶夛摍]
713053. [妛夛 (崙嵺)] (堦斒島墘) Proposalon Kampo (Traditional Japanese Medicine) treatment for COVID-19. Odaguchi H1,2: 5th Conference for Trilateral Communication between East Asian Pharmacopoeia Committees on Natural Medicines (TEAPN) (2020/12/18), WEB奐嵜. (彫揷岥峗1,2: 1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強)
722208. [妛夛 (慡崙)] (彽懸島墘摍) 彈惈偺寬峃巟墖偵娍曽堛妛偺椡傪妶梡偡傞. 彫揷岥峗1,2 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強): 戞22夞擔杮曣惈娕岇妛夛妛弍廤夛 (2020/7/3-16), web奐嵜.
722209. [妛夛 (慡崙)] (彽懸島墘摍) 崅楊幰偵懳偡傞娍曽帯椕乣峫偊曽偲幚慔乣. 彫揷岥峗1,2 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強): 戞37夞榓娍堛栻妛夛妛弍戝夛 (2020/8/30), web奐嵜.
723654. [妛夛 (慡崙)] (堦斒島墘) Relevance between age-related psychological symptoms and neuroinflammaging in SAMP8 mice - a validation of presymptomatic or pre-frailty animal model for pathological senescence. 埳摗捈庽1, 抾尦桾柧2, 挿扟愳埢撨1, 悪嶳愮壚1, 杮娫寬屽1, 塱堜棽擵, 彫椦媊揟2, 彫揷岥峗1,3 (1搶梞堛妛憤崌尋媶強, 2栻妛晹, 3搶梞堛妛嫵堢): 戞43夞擔杮恄宱壢妛戝夛 (2020/7/29), web奐嵜.
723655. [妛夛 (慡崙)] (堦斒島墘) 弍屻挵娗杻醿儌僨儖儅僂僗偱偺嬝憌晹墛徢偵懳偡傞敿壞岤杙搾愾嵻偺嶌梡偺夝愅. 揳壀幚庽1, 嶳岥榓婸1, 墦摗恀棟1, 彫揷岥峗1,2, 壴椫氭旻1, 惔尨姲復1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞37夞榓娍堛栻妛夛妛弍戝夛 (2020/8/29), web奐嵜.
723656. [妛夛 (慡崙)] (堦斒島墘) 弍屻挵娗杻醿儌僨儖儅僂僗偵懳偡傞敿壞岤杙搾愾嵻偺岲拞媴怹弫梷惂嶌梡偺婡彉偺夝愅. 嶳岥榓婸1, 揳壀幚庽1, 墦摗恀棟1, 彫揷岥峗1,2, 壴椫氭旻1, 惔尨姲復1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞37夞榓娍堛栻妛夛妛弍戝夛 (2020/8/29), web奐嵜.
723657. [妛夛 (慡崙)] (堦斒島墘) 曗拞塿婥搾怶闼-敀濹攝崌嵻偺彫挵擲枌墛徢偵懳偡傞夵慞嶌梡偺婡彉偺夝柧. 壧愳帊怐1, 墦摗恀棟1, 彫揷岥峗1,2, 壴椫氭旻1, 惔尨姲復1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞37夞榓娍堛栻妛夛妛弍戝夛 (2020/8/29), web奐嵜.
723658. [妛夛 (慡崙)] (堦斒島墘) 峈CD3峈懱搳梌儌僨儖儅僂僗偺柶塽墳摎偵懳偡傞敀濹攝崌曗拞塿婥搾偺怶闼丒墿闼攝崌嵻偺嶌梡偺斾妑専摙. 墦摗恀棟1, 壧愳帊怐1, 惔尨姲復1, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞37夞榓娍堛栻妛夛妛弍戝夛 (2020/8/29), web奐嵜.
723659. [妛夛 (慡崙)] (堦斒島墘) COX-2峺慺妶惈偵懳偡傞杻墿僄僉僗, EFE, 僄僼僃僪儕儞傾儖僇儘僀僪偺慾奞嶌梡. 撿丂壜宐1, 擔岦恵旤巕2, 抾撪丂弮1, 拞怷弐曘1, 媨搱捈婭1, 梜丂嬥堒, 撪嶳撧曚巕, 擔岦徆巌, 戝搱捈峗, 揤憅媑復, 屟捤崅巙, 崌揷岾峀, 彫揷岥峗2,3, 壴椫氭旻3, 彫椦媊揟1 (1栻妛晹, 2搶梞堛妛嫵堢, 3搶梞堛妛憤崌尋媶強): 戞37夞榓娍堛栻妛夛妛弍戝夛 (2020/8/29), web奐嵜.
723660. [妛夛 (慡崙)] (堦斒島墘) 杻墿偵娷傑傟傞僄僼僃僪儕儞傾儖僇儘僀僪偺悋柊媦傃塣摦婡擻偵懳偡傞嶌梡偺夝愅. 扟奯旳擳夘1, 墿丂愥扥1, 旜栰镈嵠1, 搉晹峗暯1, 擔岦恵旤巕2, 抾尦桾柧2, 嶳壓拤弐, 梜丂嬥堒, 撪嶳撧曚巕, 擔岦徆巌, 戝搱捈峗, 揤憅媑復, 屟捤崅巙, 崌揷岾峀, 彫揷岥峗2,3, 壴椫氭旻2, 彫椦媊揟1 (1栻妛晹, 2搶梞堛妛憤崌尋媶強, 3搶梞堛妛嫵堢): 戞37夞榓娍堛栻妛夛妛弍戝夛 (2020/8/29), web奐嵜.
723661. [妛夛 (慡崙)] (堦斒島墘) EFE偺扨夞媦傃2夞搳梌偵傛傞捔捝嶌梡偺斾妑偲EFE偺妶惈惉暘偺扵嶕. 拞怷弐曘1, 媨搱捈婭1, 擔岦恵旤巕2, 岲懞庣惗, 揤憅媑復, 梜丂嬥堒, 撪嶳撧曚巕, 擔岦徆巌, 戝搱捈峗, 屟捤崅巙, 崌揷岾峀, 彫揷岥峗2,3, 壴椫氭旻3, 彫椦媊揟1 (1栻妛晹, 2搶梞堛妛嫵堢, 3搶梞堛妛憤崌尋媶強): 戞37夞榓娍堛栻妛夛妛弍戝夛 (2020/8/29), web奐嵜.
723662. [妛夛 (慡崙)] (堦斒島墘) 傾僋僠價儞E僾儘儌乕僞乕妶惈傪忋徃偝偣傞惗栻偺扵嶕. 嫶杮丂摑, 擔岦恵旤巕1, 惔悈峃惏, 杧丂憦巕, 杧丂丂岤, 壴椫氭旻1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞37夞榓娍堛栻妛夛妛弍戝夛 (2020/8/29), web奐嵜.
723663. [妛夛 (慡崙)] (堦斒島墘) EGFR妶惈宆曄堎傪桳偡傞暘巕昗揑帯椕栻懴惈旕彫嵶朎攛偑傫桼棃H1975嵶朎偵懳偡傞杻墿偺岠壥. 怷丂塴巕1, 擔岦恵旤巕1, 壴椫氭旻1, 彫揷岥峗1,2 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞37夞榓娍堛栻妛夛妛弍戝夛 (2020/8/29), web奐嵜.
723664. [妛夛 (慡崙)] (堦斒島墘) 懞堜嬚嶳亀曽嬌檲掕亁偵懳偡傞斸敾偲偦偺尰戙揑堄媊乗ICD-11乽栻曽偺徹乿婰弎偵岦偗偰. 惎栰戩擵1,2, 彫揷岥峗1,2, 壴椫氭旻2 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強): 戞121夞擔杮堛巎妛夛憤夛丒妛弍戝夛 (2020/12/19), web奐嵜.
723665. [妛夛 (慡崙)] (堦斒島墘) 愇愳尦崿愶亀媱寠恾夝亁偵尒傞娍棖愜拸. 壛敤憦巕1, 惎栰戩擵1,2, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞121夞擔杮堛巎妛夛憤夛丒妛弍戝夛 (2020/12/19-28), web奐嵜, 擔杮堛巎妛嶨帍 2020/6; 66 (2): 232.
723666. [妛夛 (慡崙)] (堦斒島墘) 杻墿僄僉僗媦傃僄僼僃僪儕儞傾儖僇儘僀僪偵傛傝桿摫偝傟傞帺敪塣摦検掅壓偺嶌梡婡彉偺夝柧. 埳摗帊擳1, 扟奯旳擵夘1, 墿丂愥扥1, 擔岦恵旤巕2, 撪嶳撧曚巕, 擔岦徆巌, 戝搱捈峗, 揤憅媑復, 屟捤崅巙, 崌揷岾峀, 彫揷岥峗2,3, 壴椫氭旻2, 彫椦媊揟1 (1栻妛晹, 2搶梞堛妛憤崌尋媶強, 3搶梞堛妛嫵堢): 擔杮栻妛夛戞141擭夛 (2021/3/27), web奐嵜.
723667. [妛夛 (慡崙)] (堦斒島墘) 僄僼僃僪儕儞傾儖僇儘僀僪彍嫀杻墿僄僉僗攝崌娍曽栻偺昳幙娗棟偵偍偗傞巜昗惉暘偺専摙. 拞怷弐曘1, 抾撪丂弮1, 擔岦恵旤巕2, 撪嶳撧曚巕, 捯杮丂嫳, 媨搱捈婭, 梜丂嬥堒, 戝搱捈峗, 揤憅媑復, 擔岦徆巌, 屟捤崅巙, 崌揷岾峀, 彫揷岥峗2,3, 壴椫氭旻2, 彫椦媊揟1 (1栻妛晹, 2搶梞堛妛憤崌尋媶強, 3搶梞堛妛嫵堢): 擔杮栻妛夛戞141擭夛 (2021/3/28), web奐嵜.
723668. [妛夛 (慡崙)] (堦斒島墘) EFE攝崌杻埱娒愇搾嫀杻墿僄僉僗偺捔捝嶌梡偺夝愅. 抾撪丂弮1, 拞怷弐曘1, 擔岦恵旤巕2, 媨搱捈婭, 梜丂嬥堒, 撪嶳撧曚巕, 擔岦徆巌, 戝搱捈峗, 揤憅媑復, 屟捤崅巙, 崌揷岾峀, 彫揷岥峗2,3, 壴椫氭旻2, 彫椦媊揟1 (1栻妛晹, 2搶梞堛妛憤崌尋媶強, 3搶梞堛妛嫵堢): 擔杮栻妛夛戞141擭夛 (2021/3/28), web奐嵜.
732075. [妛夛 (抧曽夛丒尋媶夛)] (彽懸島墘摍)亂娍曽堛妛偺懡條惈亅拞堛妛偲偺堘偄傪抦傞亅亃II 昞擬丒昞姦偺掕媊. 惎栰戩擵1,2 (1搶梞堛妛嫵堢, 2搶梞堛妛憤崌尋媶強): 戞30夞娍曽帯椕尋媶夛 (2020/9/27), 愮梩.
733125. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 晄埨恄宱徢偺彅徢忬偵楄宩娒灔搾壛峠壴偑桳岠偱偁偭偨堦徢椺. 拞旜宩巕1, 惎栰戩擵1,2, 彫揷岥峗1,2, 壴椫氭旻1 (1搶梞堛妛憤崌尋媶強, 2搶梞堛妛嫵堢): 戞30夞娍曽帯椕尋媶夛 (2020/9/27), 愮梩.
昦堾楢実嫵堢尋媶晹栧
仸乽壓晹徚壔娗奜壢妛乿傪嶲徠
椪彴夝朥嫵堢媶晹栧
仸乽夝朥妛乮彫愳扨埵乯乿傪嶲徠
抧堟堛椕妛嫵堢尋媶晹栧
仸乽怱憻寣娗奜壢妛乿傪嶲徠
堛妛晹晬懏椪彴尋媶僙儞僞乕
婇夋奐敪晹栧
[挊丂彂]
620113. [妛弍彂 (暘扴幏昅)]亂栻妛恖偺偨傔偺帠椺偱妛傇椣棟妛亃戞IV晹丂椪彴尰応偱捈柺偡傞椣棟揑栤戣, p.228-30. 搉绯払栫 (椪彴尋媶丒婇夋), 曇: 桳揷墄巕, 懌棫抭峫, 撿峕摪, 搶嫗, 2020/4敪峴.
[妛夛丒尋媶夛摍]
722210. [妛夛 (慡崙)] (彽懸島墘摍) 擔杮昦堾栻嵻巘夛偵傛傞CRC丒帠柋嬊僗僞僢僼嫵堢尋廋偵偮偄偰. 庰堜峗, 嬤摗捈庽, 栘枔旤捗晇, 帥尦丂崉, 榁杮柤捗巕, 崟揷丂抭, 搉绯払栫1, 悈堜婱帉, 掃娵夒巕, 揷嶈壝堦 (1椪彴尋媶丒婇夋): 戞20夞CRC偲椪彴帋尡偺偁傝曽傪峫偊傞夛媍 2020 in 挿嶈 (2020/11/3), Web奐嵜.
722211. [妛夛 (慡崙)] (彽懸島墘摍) 椪彴尋媶僐乕僨傿僱乕僞乕偐傜尋媶椣棟僐儞僒儖僞儞僩 (憡択堳) 傪栚巜偟偰. 搉绯払栫 (椪彴尋媶丒婇夋): 戞41夞擔杮椪彴栻棟妛夛妛弍憤夛 (2020/12/3), 暉壀 (僴僀僽儕僢僪奐嵜).
723669. [妛夛 (慡崙)] (堦斒島墘) 堛巘偺尋媶椣棟偺懆偊曽偵娭偡傞幙揑尋媶乣傛傝揔愗側尋媶椣棟嫵堢偺偨傔偵乣. 搉绯払栫1, 彫憅枹棃, 抾暯棟宐巕, 桳揷墄巕 (1椪彴尋媶丒婇夋): 戞14夞擔杮僼傽乕儅僔儏乕僥傿僇儖僐儈儏僯働乕僔儑儞妛夛戝夛 (2020/6/28), Web奐嵜.
723670. [妛夛 (慡崙)] (堦斒島墘) 帯尡摨堄儘乕儖僾儗僀幚廗偵偍偗傞妛惗偺堄幆曄壔偺幙揑尋媶. 壀揷埢壚, 桳揷墄巕, 杮嫶棟嵐, 忋擵尨桼壚, 悪塝杻堖, 惣懞婱巕, 嶳懞惤巕, 惣榚恀幚巕, 搉绯払栫1, 巵尨丂弤 (1椪彴尋媶丒婇夋): 戞14夞擔杮僼傽乕儅僔儏乕僥傿僇儖僐儈儏僯働乕僔儑儞妛夛戝夛 (2020/6/28), Web奐嵜.
'19擭搙埲慜暘
[妛夛丒尋媶夛摍]
'19-723032. [妛夛 (慡崙)] (堦斒島墘) 栻嬊栻嵻巘偺尋媶椣棟偺懆偊曽偵娭偡傞幙揑尋媶乣傛傝揔愗側尋媶椣棟嫵堢偺偨傔偵乣. 彫憅枹棃, 抾暯棟宐巕, 搉绯払栫1, 桳揷墄巕 (1椪彴尋媶丒婇夋): 擔杮栻妛夛戞140擭夛 (2020/3/25), 妛夛拞巭 (Web梫巪偵偰嶲壛惉棫).
僾儘僕僃僋僩幚巤晹栧
[妛弍榑暥]
110403. [尨挊] A 3-Part Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DSP-6952 in Healthy Japanese Subjects and Those With �3 Spontaneous Bowel Movements per Week. Yumizaki T, Maeda M1, Fujita T, Kakuyama H, Kumagai Y2: Clin Pharmacol Drug Dev 2020/4; 9 (3): 353-65. (慜揷幚壴1, 孎扟梇帯2: 1戝妛堾堛椕宯尋媶壢, 2椪彴尋媶 (僾儘僕僃僋僩))
110404. [尨挊] A Drug-Drug Interaction Study to Evaluate the Effect of TAS-303 on CYP3A Activity in the Small Intestine and Liver. Kumagai Y1, Fujita T, Maeda M2, Sasaki Y3, Nagaoka M, Huang J, Takenaka T, Kawai M: J Clin Pharmacol 2020/6; 60 (6): 702-10. (孎扟梇帯1, 慜揷幚壴2, 嵅乆栘慞怣3: 1椪彴尋媶 (僾儘僕僃僋僩), 2戝妛堾堛椕宯尋媶壢, 3栻嵻晹)
110405. [尨挊] Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study. Fujishima H, Hasunuma T1, Kawakita T, Sekiya T, Gomes P, Hollander DA: Ocul Immunol Inflamm 2020/6; 1-6. (楡徖抭巕1: 1椪彴尋媶 (僾儘僕僃僋僩))
110406. [尨挊] Hepatic Adaptation to Therapeutic Doses of Acetaminophen: An Exploratory Study in Healthy Individuals. Maeda M1, Tanaka R, Aso M, Sakamoto Y, Song I, Ochiai M, Saito Y, Maekawa K, Arakawa N, Ohno Y, Kumagai Y2: Clin Ther 2020/7; 42 (7): 1276-91.e1. (慜揷幚壴1, 孎扟梇帯2: 1戝妛堾堛椕宯尋媶壢, 2椪彴尋媶 (僾儘僕僃僋僩))
110407. [尨挊] Novel concentration-QTc models for early clinical studies with parallel placebo controls: A simulation study. Orihashi Y, Kumagai Y1, Shiosakai K: Pharm Stat 2021/3; 20 (2): 375-89. (孎扟梇帯1: 1椪彴尋媶 (僾儘僕僃僋僩))
530023. [偦偺懠 (妛夛彺榐)] ELOBIXIBAT, ILEAL BILE ACID TRANSPORTER INHIBITOR, INCREASES FECAL BILE ACIDS IN PATIENTS WITH CHRONIC CONSTIPATION. Nakajima A, Ishizaki S, Kurosu S, Taniguchi S, Gillberg P-G, Mattsson JP, Hasunuma T1, Camilleri M: Gastroenterology 2020/5; 158 (6, Suppl 1): S-394-5. (楡徖抭巕1: 1椪彴尋媶 (僾儘僕僃僋僩))
[挊丂彂]
620114. [妛弍彂 (娔廋)]亂夵掶 僇儖僥惛慖梡岅廤亃娔廋: 孎扟梇帯1, 曇: 嵅乆栘慞怣2, 朏揷丂峷3, 杒搰峗旤4, (1椪彴尋媶丒僾儘僕僃僋僩, 2栻嵻晹, 3椪専晹, 4娕岇晹), 僴僀僒儉媄尋, 戝嶃, 2020/8敪峴.
[妛夛丒尋媶夛摍]
712007. [妛夛 (崙嵺)] (彽懸島墘摍) Japan-Korea Clinical Pharmacology Collaborative Trials. Kumagai Y1: 2020 KoNECT-MOHW-MFDF International Conference Virtual (2020/9/11), Web奐嵜. (孎扟梇帯1: 1椪彴尋媶丒僾儘僕僃僋僩)
712008. [妛夛 (崙嵺)] (彽懸島墘摍) Sharing Experiences on FIH Clinical Trials. Kumagai Y1: PMDA-ATC Pharmaceuticals Review Webinar 2020 for NPRA, Malaysia (2020/11/6), Web奐嵜. (孎扟梇帯1: 1椪彴尋媶丒僾儘僕僃僋僩)
722212. [妛夛 (慡崙)] (彽懸島墘摍) 僩僉僔僐儘僕僗僩傪摟帇偡傞 -奜偐傜尒偨婜懸- 憗婜椪彴帋尡幚巤扴摉堛巘偐傜偺婜懸. 孎扟梇帯 (椪彴尋媶丒僾儘僕僃僋僩): 戞47夞擔杮撆惈妛夛妛弍擭夛 (2020/7/1), Web奐嵜.
722213. [妛夛 (慡崙)] (彽懸島墘摍) 尋媶幰丒妛夛棟帠偺棫応偐傜擣掕CRC偵朷傓偙偲. 孎扟梇帯 (椪彴尋媶丒僾儘僕僃僋僩): 戞41夞擔杮椪彴栻棟妛夛妛弍憤夛 (2020/12/5), 暉壀 (僴僀僽儕僢僪奐嵜).
723671. [妛夛 (慡崙)] (堦斒島墘) 娯崙偲偺崙嵺嫟摨摿掕椪彴尋媶傪宱尡偟偰. 孠枖恀桼旤, 忋擵尨桼壚, 惣懞婱巕, 惣榚恀幚巕, 悰栰斖巕, 憊丂堦戝, 彫憗愳夒抝, 孎扟梇帯1, 楡徖抭巕1 (1椪彴尋媶丒僾儘僕僃僋僩): 戞41夞擔杮椪彴栻棟妛夛妛弍憤夛 (2020/12/5), 暉壀 (僴僀僽儕僢僪奐嵜).
僶僀僆僄僔僢僋僗晹栧
憂栻僔乕僘尋媶奐敪晹栧
堛妛晹晬懏怴悽婭堛椕奐敪僙儞僞乕
愭抂堛椕椞堟奐敪晹栧
(媑揷堦惉)
仸乽斿擜婍壢妛乿傪嶲徠
(揷绯丂憦)
仸乽徚壔婍撪壢妛乿傪嶲徠
(挿徖塸柧)
仸乽帹旲堲岮壢丒摢栩晹奜壢妛乿傪嶲徠
(揷拞丂寜)
仸乽堦斒丒彫帣丒娞抇鋁奜壢妛乿傪嶲徠
(尨棷峅庽)
仸乽曻幩慄壢妛乮夋憸恌抐妛乯乿傪嶲徠
(愭嶈廏柧)
仸乽彫帣壢妛乿傪嶲徠
(拞惣廏旻)
仸乽彫帣壢妛乿傪嶲徠
墶抐揑堛椕椞堟奐敪晹栧
(嬥堜徍暥)
仸乽杻悓壢妛乿傪嶲徠
(嶳壓宲巎)
仸乽忋晹徚壔娗奜壢妛乿傪嶲徠
(怴堜惓峃)
仸乽杻悓壢妛乿傪嶲徠
(嵅乆栘帯堦榊)
仸乽屇媧婍撪壢妛乿傪嶲徠
(彫椦惔揟)
仸乽徚壔婍撪壢妛乿傪嶲徠
(崅嶳梲巕)
仸乽杒棦戝妛昦堾姶愼娗棟幒乿傕嶲徠
[妛弍榑暥]
110408. [尨挊] Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015. Eda R1, Nakamura M2, Takayama Y3, Maehana S2, Nakano R, Yano H, Kitasato H2: J Infect Chemother 2020/7; 26 (7): 667-71. (峕揷椚懢榊1, 拞懞惓庽2, 崅嶳梲巕3, 慜壴徦懢榊2, 杒棦塸榊2: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3怴悽婭堛椕丒墶抐揑堛椕)
[妛夛丒尋媶夛摍]
722214. [妛夛 (慡崙)] (彽懸島墘摍) 昦堾姶愼懳嶔偺幚嵺. 崅嶳梲巕 (怴悽婭堛椕丒墶抐揑堛椕): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20-7/19), Web奐嵜.
723672. [妛夛 (慡崙)] (堦斒島墘) 壓晹徚壔娗庤弍偵偍偗傞廃弍婜梊杊-峈嬠栻偺寣拞偍傛傃慻怐撪擹搙偺娭學惈. 崅嶳梲巕1,2, 彫徏晀彶2,3, 擇杮桍怢2, 榓揷払旻2,4, 岤揷岾堦榊3, 壴栘廏柧5 (1怴悽婭堛椕丒墶抐揑堛椕, 2姶愼娗棟幒, 3栻嵻晹, 4銹尨昦丒姶愼撪, 5杒棦惗柦尋媶強): 戞68夞擔杮壔妛椕朄妛夛憤夛 (2020/9/14), 恄屗 (僴僀僽儕僢僪奐嵜).
'19擭搙埲慜暘
[妛弍榑暥]
H14-110001. [尨挊] Apoptosis of intestinal crypt epithelium after Cryptosporidium parvum infection. Sasahara T1, Maruyama H, Aoki M, Kikuno R, Sekiguchi T, Takahashi A, Satoh Y, Kitasato H2, Takayama Y3, Inoue M: J Infect Chemother 2003/9; 9 (3): 278-81. (嶚尨晲巙1, 杒棦塸榊2, 崅嶳梲巕3: 1旝惗暔, 2堛椕塹惗妛晹, 3怴悽婭堛椕丒墶抐揑堛椕)
H14-110002. [尨挊] Pretreatment of Pseudomonas aeruginosa with a sub-MIC of imipenem enhances bactericidal activity of neutrophils. Sasahara T1, Satoh Y, Sekiguchi T, Suzuki K, Irinoda K, Takayama Y2, Sakamoto A, Kitasato H3, Okamoto R, Inoue M: J Infect Chemother 2003/12; 9 (4): 297-303. (嶚尨晲巙1, 崅嶳梲巕2, 杒棦塸榊3: 1旝惗暔, 2怴悽婭堛椕丒墶抐揑堛椕, 3堛椕塹惗妛晹)
堛妛晹嫵堢宯媄弍怑堳
宍懺宯
惗暔暔棟宯
昦懺丒恌椕宯
[妛弍榑暥]
110254. [尨挊] Method for preservation of DNA stability of liquid-based cytology specimens from a lung adenocarcinoma cell line. Matsuo Y1, Yamashita K2, Yoshida T3, Satoh Y4: Virchows Arch 2021/3; 478 (3): 507-16. (徏旜桼婭巕1, 嶳壓榓栫2, 媑揷丂岟3, 嵅摗擵弐4: 1昦懺丒恌椕宯, 2昦棟晹, 3昦棟, 4屇媧婍奜)
[妛夛丒尋媶夛摍]
723338. [妛夛 (慡崙)] (堦斒島墘) 尨敪惈旕彫嵶朎攛娻偺堚揱巕夝愅偵偍偗傞塼忬壔専懱嵶朎恌偺桳岠惈. 徏旜桼婭巕1, 嶳壓榓栫2, 媑揷丂岟3, 媣応丂庽2, 郪栰恀棟巕, 懞塤朏庽3, 嵅摗擵弐4 (1昦懺丒恌椕宯, 2昦棟晹, 3昦棟, 4屇媧婍奜): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20), Web奐嵜.
梊杊堛妛宯
暘巕堛壢妛丒惂屼宯
搶昦堾尋媶宯
慻怐攟梴僙儞僞乕
DNA幚尡僙儞僞乕
僶僀僆僀儊乕僕儞僌尋媶僙儞僞乕
堚揱巕崅師婡擻夝愅僙儞僞乕
寬峃娗棟僙儞僞乕
[妛弍榑暥]
110409. [尨挊] Association between Low Protein Intake and Mortality in Patients with Type 2 Diabetes. Yamaoka T, Araki A, Tamura Y, Tanaka S, Fujihara K, Horikawa C, Aida R, Kamada C, Yoshimura Y, Moriya T1, Ohashi Y, Akanuma Y, Ito H, Sone H: Nutrients 2020/6; 12 (6): 1629. (庣壆払旤1: 1寬峃娗棟僙)
110410. [尨挊] Vitamin B6 intake and incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: analysis of data from the Japan Diabetes Complications Study (JDCS). Horikawa C1, Aida R1, Kamada C1, Fujihara K1, Tanaka S1, Tanaka S1, Araki A1, Yoshimura Y1, Moriya T1,2, Akanuma Y1, Sone H1 (1Japan Diabetes Complications Study Group); Eur J Nutr 2020/6; 59 (4): 1585-94. (庣壆払旤1,2: 2寬峃娗棟僙)
110411. [尨挊] Development of glomerular hyperfiltration, a multiphasic phenomenon. Shimada Y, Nakasone Y, Hirabayashi K, Sakuma T, Koike H, Oguchi T, Yamashita K, Uchimido R, Moriya T1, Komatsu M, Aizawa T: Am J Physiol Renal Physiol 2020/12; 319 (6): F1037-41. (庣壆払旤1: 1寬峃娗棟僙)
520017. [憤愢]亀岥廘徢亁偺惛恄堛妛揑懁柺. 媨抧塸梇 (寬峃娗棟僙): 擔杮岥廘妛夛夛帍 2020/4; 11 (1): 5-10.
522131. [島嵗]亂摿廤: 儕僄僝儞惛恄堛妛偵偍偗傞恌棫偰偲懳墳匑亃儕僄僝儞惛恄堛妛偵偍偗傞恎懱徢忬徢. 媨抧塸梇 (寬峃娗棟僙): 椪彴惛恄堛妛 2021/2; 50 (2): 143-7.
540051. [偦偺懠 (椺夛曬崘)] 榖戣採嫙傪偝偣偰偄偨偩偄偰. 嶳揷桾巕 (寬峃娗棟僙): 戞102夞娭搶抧嬫妛惗憡択尋媶夛椺夛曬崘 2020. https://www.kantogakuso.jp/member/reikai_houkoku/102houkoku_yamada.pdf.
540052. [偦偺懠 (擭曬)] 2019擭搙傪怳傝曉偭偰. 嶳揷桾巕 (寬峃娗棟僙): 杒棦戝妛寬峃娗棟僙儞僞乕擭曬 2020; 戞4崋: 17-20.
540053. [偦偺懠 (幚巤曬崘彂)]亂壢尋旓乽傾僋僥傿僽儔乕僯儞僌偵婑梌偡傞僐儈儏僯働乕僔儑儞僗僉儖岦忋僾儘僌儔儉偺峔抸偲専徹乿亃尋媶戙昞幰: 愇捤徆曐 (寬峃娗棟僙):乽傾僋僥傿僽儔乕僯儞僌偵婑梌偡傞僐儈儏僯働乕僔儑儞僗僉儖岦忋僾儘僌儔儉偺峔抸偲専徹乿幚巤曬崘彂 2021/3. https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-20K14036/20K140362020hokoku/.
[挊丂彂]
620115. [妛弍彂 (暘扴幏昅)]亂帣摱怱棟妛偺恑曕 (2020擭斉)亃俈復 崅摍嫵堢偵偍偗傞敪払忈奞, p.151-74. 戝挰抦媣 (寬峃娗棟僙), 娔廋: 擔杮帣摱尋媶強, 嬥巕彂朳, 搶嫗, 2020/6敪峴.
620116. [妛弍彂 (暘扴幏昅)]亂壠懓怱棟妛擭曬38亃[奺榑] 嫵堢暘栰偵偍偗傞屄偲壠懓巟墖偺幚慔丂戝妛偵偍偗傞巕偳傕偲壠懓傊偺巟墖, p.44-52. 戝挰抦媣 (寬峃娗棟僙), 曇: 擔杮壠懓怱棟妛夛, 嬥巕彂朳, 搶嫗, 2020/8敪峴.
[妛夛丒尋媶夛摍]
722215. [妛夛 (慡崙)] (僔儞億僕僂儉) 擄帯惈醬捝亅恎懱晹埵暿偵尒偨懳墳偺嵎偲嫟捠揰亅乽岥峯椞堟偺醬捝乿. 媨抧塸梇 (寬峃娗棟僙): 戞116夞擔杮惛恄恄宱妛夛妛弍憤夛 (2020/9/28), Web奐嵜.
722216. [妛夛 (慡崙)] (僔儞億僕僂儉) 惛恄壢堛偐傜傒偨岥峯椞堟偺恎懱徢忬亅擄偟偔旔偗傜傟偑偪側昦懺偵棫偪岦偐偆乽帟壢堛巘偲偺楢実乿. 媨抧塸梇 (寬峃娗棟僙): 戞116夞擔杮惛恄恄宱妛夛妛弍憤夛 (2020/9/30), Web奐嵜.
722217. [妛夛 (慡崙)] (僔儞億僕僂儉) 摐擜昦惈恡徢偺恡婡擻掅壓傪梊應偡傞偺偼幚偼摐擜昦栐枌徢? 庣壆払旤 (寬峃娗棟僙): 戞35夞擔杮摐擜昦崌暪徢妛夛丒戞26夞擔杮摐擜昦娽妛夛憤夛 (2020/12/7-21), Web奐嵜.
723673. [妛夛 (慡崙)] (億僗僞乕)亂嵗挿亃抧堟堛椕丒堛椕忣曬2 億僗僞乕149. 徏尨傑偳偐 (寬峃娗棟僙): 戞63夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2020/10/5-16) Web奐嵜.
723674. [妛夛 (慡崙)] (堦斒島墘) 僐儘僫壭偱偺僆儞儔僀儞偵傛傞亀偙偙傠偺寬峃挷嵏亁偲傾僂僩儕乕僠宆巟墖偺幚慔曬崘. 嶳揷桾巕1, 愇捤徆曐1, 戝挰抦媣1, 壨尨媣旤巕, 揷拞偁備傒, 棫壴丂昘, 庣壆払旤1 (1寬峃娗棟僙): 戞58夞慡崙戝妛曐寬娗棟尋媶廤夛 (2020/11/25), Web奐嵜, Campus Health 2021; 58 (1): 309.
723675. [妛夛 (慡崙)] (堦斒島墘) COVID-19壭偵偍偗傞戝妛昦堾怑堳偺儊儞僞儖僿儖僗傊偺庢傝慻傒. 媨抧塸梇1, 嶳壓恀桼1, 愳忋旤抭戙1,2, 慜愳壚巕1,2, 憹揷愮廐1,2, 悈岥丂恊1,2, 搷墍丂擡1,2, 媑揷桭婭1, 徏尨傑偳偐1, 庣壆払旤1 (1寬峃娗棟僙, 2娕岇晹): 戞58夞慡崙戝妛曐寬娗棟尋媶廤夛 (2020/11/25-26), Web奐嵜.
723676. [妛夛 (慡崙)] (堦斒島墘) COVID-19壭偵偍偗傞寬峃娗棟僙儞僞乕偺栶妱偼懡婒偵傢偨傞. 庣壆払旤1, 愳忋旤抭戙1,2, 慜愳壚巕1,2, 憹揷愮廐1,2, 悈岥丂恊1,2, 搷墍丂擡1,2, 媑揷桭婭1, 媨抧塸梇1, 嶳壓恀桼1, 嶳揷桾巕1, 徏尨傑偳偐1 (1寬峃娗棟僙, 2娕岇晹): 戞58夞慡崙戝妛曐寬娗棟尋媶廤夛 (2020/11/25-26), Web奐嵜.
723677. [妛夛 (慡崙)] (堦斒島墘) 旕庡懱揑棃択妛惗偵懳偡傞僇僂儞僙儔乕偺棟夝偲懳墳偵娭偡傞僀儞僞價儏乕挷嵏亅旕庡懱揑側忬懺偱棃択偟偨妛惗偑庡懱揑側憡択幰偲側偭偰偄偔傑偱偺巟墖偵偮偄偰亅. 戝挰抦媣1, 嶳揷桾巕1, 庣壆払旤1 (1寬峃娗棟僙): 擔杮怱棟椪彴妛夛戞39夞戝夛 (2020/11/20-26), Web奐嵜.
723678. [妛夛 (慡崙)] (堦斒島墘) 憡択偡傞帠偵旕庡懱揑側忬懺偱棃択偡傞妛惗偵懳偡傞僇僂儞僙儔乕偺棟夝偲懳墳亅妛惗憡択婡娭偵嬑傔傞僇僂儞僙儔乕傊偺僀儞僞價儏乕挷嵏偵傛傞幙揑専摙亅. 戝挰抦媣1, 嶳揷桾巕1, 庣壆払旤1 (1寬峃娗棟僙): 擔杮怱棟椪彴妛夛戞39夞戝夛 (2020/11/20-26), Web奐嵜.
732076. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 怴宆僐儘僫僂傿儖僗塭嬁壓偱偺杒棦戝妛偺庢慻傒. 嶳揷桾巕 (寬峃娗棟僙): 擔杮妛惗憡択妛夛戞51夞妛惗憡択僙儈僫乕 (2020/8/2), Web奐嵜.
733126. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 懳柺憡択, 僆儞儔僀儞憡択, 揹榖憡択傪宱尡偟偰峫偊偨偙偲. 嶳揷桾巕 (寬峃娗棟僙): 娭搶抧嬫妛惗憡択尋媶夛戞102夞椺夛 (2020/12/6), Web奐嵜.
733127. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 挿婜宱夁偱摐擜昦枬惈崌暪徢偑弌尰偟偨偑帯椕偵傛傝姲夝/戅弅偟偨1椺. 徏尨傑偳偐 (寬峃娗棟僙): 戞58夞擔杮摐擜昦妛夛娭搶峛怣墇抧曽夛 (2021/1/30), Web奐嵜.
'19擭搙埲慜暘
[妛弍榑暥]
'19-110023. [尨挊] Serial renal biopsies in normo- and microalbuminuric patients with type 2 diabetes demonstrate that loss of renal function is associated with a reduction in glomerular filtration surface secondary to mesangial expansion. Moriya T1, Yamagishi T, Matsubara M1, Ouchi M: J Diabetes Complications 2019/5; 33 (5): 368-73. (庣壆払旤1, 徏尨傑偳偐1: 1寬峃娗棟僙)
'19-120005. [尨挊] 旍枮戝妛惗偺懱慻惉應掕偲夵慞傊偺庢傝慻傒. 徏尨傑偳偐1, 媑揷桭婭1, 媨抧塸梇1, 搷墍丂擡1,2, 愳忋旤抭戙1,2, 憹揷愮廐1,2, 悈岥丂恊1,2, 慜愳壚巕1,2, 庣壆払旤1 (1寬峃娗棟僙, 2娕岇晹): CAMPUS HEALTH 2020/3; 57 (1): 130-2.
杒棦戝妛昦堾
娕岇晹
[妛弍榑暥]
110412. [尨挊] Exploring the components of the quality of death in Japanese emergency departments: A qualitative study. Ito Y, Tsubaki M1, Fujimoto M, Sakaguchi Y: Appl Nurs Res 2020/12; 56: 151371. (捴旤抭攷1: 1娕岇晹)
120038. [尨挊] 拞寴娕岇巘偺娕岇幚慔擻椡偲儗僕儕僄儞僗偍傛傃僠乕儉傾僾儘乕僠偲偺娭楢亅娕岇幚慔擻椡岦忋偵岦偗偰偺懖屻娕岇巘嫵堢偺偁傝曽亅. 揷拞丂怢1, 壓巌塮堦1, 埨晹憦巕1, 墊揷傔偖傒1, 暉抧杮惏旤1, 捴旤抭攷2, 摗屻廏曘1, 挿搱峩暯1, 敀屗怣峴1 (1徍榓戝妛, 2娕岇晹): 徍榓妛巑夛嶨帍 2020/7; 80 (2): 131-43.
120039. [尨挊] 彫帣婜偵惗懱娞堏怉傪庴偗偨姵幰偑懆偊偰偄傞壠懓偺條憡亅椕梴惗妶偵偮偄偰偺岅傝偐傜亅. 徏撪壚巕1, 拞搰愡巕1 (1娕岇晹): 擔杮堏怉丒嵞惗堛椕娕岇妛夛帍 2020/7; 15: 1-13.
120040. [尨挊] 媬柦媬媫僙儞僞乕偵偍偗傞乬憻婍丒慻怐採嫙偺堄巚偵懳偡傞傾儞働乕僩乭傪巊梡偟偨慖戰巿採帵偑壠懓偺憻婍採嫙偵娭楢偡傞峴摦傪懀偡岠壥. 捴旤抭攷1, 壓巌塮堦2, 摗屻廏曘2, 孎戲恀媩2, 揷拞丂怢2 (1娕岇晹, 2徍榓戝妛): 徍榓妛巑夛嶨帍 2021/3; 80 (6): 546-56.
120041. [尨挊] 恑峴鋁偑傫姵幰丒壠懓偲偑傫娕岇愱栧娕岇巘偲偺僷乕僩僫乕僔僢僾偵婎偯偔娕岇柺択偺昡壙. 愮旤搊巕1, 帣嬍旤桼婭1, 孠柤庻旤1, 彫嶳岾戙2 (1娕岇晹, 2娕岇妛晹): 栘懞娕岇嫵堢怳嫽嵿抍娕岇尋媶廤榐 2020/9; 27: 61-99.
220003. [弨尨挊] 働傾採嫙幰傪懳徾偲偟偨乽擣抦徢偺恖偲偺僐儈儏僯働乕僔儑儞僗僉儖傾僢僾僙儈僫乕乿偺幚巤偲偦偺昡壙. 彫嶳岾戙1, 曅堜旤嵷巕2, 鍌柤桼壛棦3, 峴弐壜垽3, 榓揷撧旤巕4 (1娕岇妛晹, 2挰揷巗崅楊幰暉巸僙儞僞乕, 3娕岇晹, 4杒棦戝妛杒棦尋媶強昦堾): 擔杮憗婜擣抦徢妛夛帍 2020/6; 13 (1): 75-80.
520018. [憤愢] (Secondary Publication) 娕岇妛惗偺憻婍採嫙傊偺懺搙偵娭偡傞僫儔僥傿僽儗價儏乕. 捴旤抭攷1, 摗屻廏曘2, 彫椦姴峢3, 峳愳丂憦1, 媑揷堦惉4 (1娕岇晹, 2徍榓戝妛摗偑媢昦堾, 3戝妛堾娕岇妛尋媶壢, 4怴悽婭堛椕丒愭抂堛椕) 堏怉 2020/7; 55 (2): 109-18.
522132. [島嵗]亂彫帣娕岇偵偍偗傞宲懕嫵堢亅2擭栚埲崀偺娕岇巘傪懳徾偵亅亃[憤榑] 匑2擭栚埲崀偺宲懕嫵堢偺堄媊丒壽戣; 戝妛昦堾偺棫応偐傜. 栘懞備傒巕 (娕岇晹): 彫帣娕岇 2020/7; 43 (7): 778-83.
522133. [島嵗]亂僨乕僞傪梡偄偨尰応偺壜帇壔偱, 慻怐偺幙傪崅傔傞! 杒棦戝妛昦堾偺忣曬儅僱僕儊儞僩亃忣曬扴摉娕岇巘偺栶妱偲幚慔. 惔悈洅摑 (娕岇晹): 娕岇娗棟 2020/8; 30 (8): 708-16.
522134. [島嵗]亂僨乕僞傪梡偄偨尰応偺壜帇壔偱, 慻怐偺幙傪崅傔傞! 杒棦戝妛昦堾偺忣曬儅僱僕儊儞僩亃栚昗娗棟偵偍偗傞僀儞僨傿働乕僞偺妶梡丂忣曬扴摉娕岇巘偵傛傞娕岇娗棟幰偺巟墖. 惔悈洅摑 (娕岇晹): 娕岇娗棟 2020/8; 30 (8): 717-25.
522135. [島嵗]亂僨乕僞傪梡偄偨尰応偺壜帇壔偱, 慻怐偺幙傪崅傔傞! 杒棦戝妛昦堾偺忣曬儅僱僕儊儞僩亃幚慔曬崘 [晹彁偺僨乕僞妶梡2] 廳徢搙, 堛椕丒娕岇昁梫搙僨乕僞偺妶梡. 岺摗媣旤巕 (娕岇晹): 娕岇娗棟 2020/8; 30 (8): 732-5.
522136. [島嵗]亂僨乕僞傪梡偄偨尰応偺壜帇壔偱, 慻怐偺幙傪崅傔傞! 杒棦戝妛昦堾偺忣曬儅僱僕儊儞僩亃幚慔曬崘 [晹彁偺僨乕僞妶梡3] 娕岇曗彆幰偺擭師桳媼媥壣庢摼丂乽嬑柋帪娫娙堈寁嶼昞乿傪梡偄偨, 昦搹傪墇偊偨嬑柋昞嶌惉. 壨揷懡壛 (娕岇晹): 娕岇娗棟 2020/8; 30 (8): 736-40.
522137. [島嵗]亂僨乕僞傪梡偄偨尰応偺壜帇壔偱, 慻怐偺幙傪崅傔傞! 杒棦戝妛昦堾偺忣曬儅僱僕儊儞僩亃幚慔曬崘 [晹彁偺僨乕僞妶梡5] 楯柋娗棟: 帪娫奜嬑柋偺嶍尭.丂 搷墍丂擡 (娕岇晹): 娕岇娗棟 2020/8; 30 (8): 747-53.
522138. [島嵗]亂摿廤: 怱憻寣娗奜壢偺僴乕僩僠乕儉偵偍偗傞娕岇巘偺栶妱亃懠怑庬偲嫤摥偟偰幚慔偡傞怱憻寣娗奜壢廃弍婜偺働傾. 撪摗垷庽 (娕岇晹): 擔杮弞娐婍娕岇妛夛帍 2020/8; 16 (1): 29-30.
522139. [島嵗]亂摿暿婇夋: 僐儘僫偑曄偊傞幮夛偲偙偙傠亃杒棦戝妛昦堾偵偍偗傞怴宆僐儘僫僂傿儖僗懳墳亅娕岇偲儊儞僞儖僿儖僗巟墖傪拞怱偵亅. 敀堜嫵巕 (娕岇晹): 偙偙傠偺壢妛 2020/12; 215: 70-4.
522140. [島嵗]亂娚榓働傾娕岇媄弍11亃娚榓働傾偵偍偗傞徢忬儅僱僕儊儞僩: 醬捝. 孠柤庻旤 (娕岇晹): 擔杮斉Nursing Skill倱 (僆儞儔僀儞嫵堢僣乕儖) 2020/12.
522141. [島嵗]亂楢嵹: 僆僺僆僀僪桿敪惈曋旈徢 (OIC) 偺傾僙僗儊儞僩偲帯椕栻偺巊偄曽亃戞4夞 [帠椺徯夘] 僆僺僆僀僪桿敪惈曋旈徢 (OIC) 傊偺働傾偺幚嵺. 徏尨峃旤1, 惣尨抦巬2, 壀揷悙宐2 (1娕岇妛晹, 2娕岇晹): 僫乕僗愱壢 2021/1; https://knowledge.nurse-senka.jp/500003.
522142. [島嵗]亂楢嵹: 僯儏乕儅儞棟榑丒尋媶丒幚慔尋媶夛偺峀応亃COVID�19僷儞僨儈僢僋偐傜偺妛傃: 儅乕僈儗僢僩丒僯儏乕儅儞棟榑偵婎偯偄偨帺屓偺懱尡偺堄枴偺曄壔丂COVID�19枲墑偺拞偱丄帺屓偺僷僞乕儞傊偺婥偯偒. 恄扟朏奊 (娕岇晹): 娕岇幚慔偺壢妛 2021/2; 46 (3): 73�5.
540054. [偦偺懠 (峀曬帍)] 抝惈娕岇巘偺堢帣媥嬈庢摼傊偺庢傝慻傒. 捴旤抭攷 (娕岇晹): 偐側偑傢娕岇楢柨捠怣 2020/8; No.73: 7.
[挊丂彂]
620117. [妛弍彂 (暘扴幏昅)]亂娚榓働傾偵偍偗傞壠懓働傾儀僗僩僾儔僋僥傿僗 (娚榓働傾30姫憹姧崋)亃戞II晹 僔僠儏僄乕僔儑儞偵増偭偨奺愱栧壠偺壠懓働傾儀僗僩僾儔僋僥傿僗丂II-26. 柺夛偵棃側偔側偭偨巚弔婜偺巕偳傕偑偄傞偲偒亅彫帣娕岇偺棫応偐傜亅, p.161-5. 戝捤丂崄 (娕岇晹), 惵奀幮, 搶嫗, 2020/6敪峴.
620118. [妛弍彂 (暘扴幏昅)]亂尒偰偱偒傞椪彴働傾恾娪丂彫帣娕岇價僕儏傾儖僫乕僔儞僌亃戞2復 彫帣偺摿挜丂尒偰弌棃傞椪彴働傾, 倫.14-34. 戝捤丂崄1 (1娕岇晹), 曇: 戝捤丂崄1, 敿揷峗旤2 (2恄屗巗娕岇戝妛), 妛尋儊僨傿僇儖廏弫幮, 搶嫗, 2020/6敪峴.
620119. [妛弍彂 (暘扴幏昅)]亂尒偰偱偒傞椪彴働傾恾娪丂彫帣娕岇價僕儏傾儖僫乕僔儞僌亃戞7復 彫帣壢偺専嵏偲働傾丂1. 専懱嵦庢, p.157-60. 栘懞備傒巕1 (1娕岇晹), 曇: 戝捤丂崄1, 敿揷峗旤2 (2恄屗巗娕岇戝妛), 妛尋儊僨傿僇儖廏弫幮, 搶嫗, 2020/6敪峴.
620120. [妛弍彂 (暘扴幏昅)]亂尒偰偱偒傞椪彴働傾恾娪丂彫帣娕岇價僕儏傾儖僫乕僔儞僌亃戞7復 彫帣壢偺専嵏偲働傾丂2. 彫帣偺娤嶡丂匑恎懱偺寁應, 匒僶僀僞儖僒僀儞應掕, 匓儌僯僞乕偺寁應, p.161-87. 徏撪壚巕1 (1娕岇晹), 曇: 戝捤丂崄1, 敿揷峗旤2 (2恄屗巗娕岇戝妛), 妛尋儊僨傿僇儖廏弫幮, 搶嫗, 2020/6敪峴.
620121. [妛弍彂 (暘扴幏昅)]亂尒偰偱偒傞椪彴働傾恾娪丂彫帣娕岇價僕儏傾儖僫乕僔儞僌亃戞8復 彫帣壢偺帯椕丒張抲偲働傾丂4. 張抲, p.276-9. 栘懞備傒巕1 (1娕岇晹), 曇: 戝捤丂崄1, 敿揷峗旤2 (2恄屗巗娕岇戝妛), 妛尋儊僨傿僇儖廏弫幮, 搶嫗, 2020/6敪峴.
620122. [妛弍彂 (暘扴幏昅)]亂恡堏怉偲偔偡傝亃戞2復 栻傪惓偟偔堸傒懕偗傞偨傔偵丂栻偺娗棟偲堸傒朰傟側偄岺晇, 嵭奞偵旛偊偰, p.119. 栰岥暥擳1, 媑揷堦惉2, 彫椦徆岹3 (1娕岇晹, 2怴悽婭堛椕丒愭抂堛椕, 3栻妛晹), 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
620123. [妛弍彂 (暘扴幏昅)]亂娕岇妛僥僉僗僩NiCE丂偑傫娕岇丂條乆側敪払抜奒丒帯椕宱夁偵偁傞偑傫姵幰傪巟偊傞亃戞VI復 娚榓働傾丂3.奺徢忬偺儅僱僕儊儞僩丂C. 埆塼幙, p.214-7. 愮旤搊巕 (娕岇晹), 曇: 楅栘媣旤, 椦丂捈巕, 嵅摗傑備傒, 撿峕摪, 搶嫗, 2021/1敪峴.
620124. [妛弍彂 (暘扴幏昅)]亂怴宆僐儘僫僂傿儖僗 僫乕僗偨偪偺尰応儗億乕僩亃暘曍庢傝埖偄堛椕婡娭丂file #026 COVID-19擠晈偺掗墹愗奐傪宱尡偟偰, p.229-37. 彫愳婌旤巕 (娕岇晹), 曇: 擔杮娕岇嫤夛弌斉夛曇廤晹, 搶嫗, 2021/2敪峴.
620125. [妛弍彂 (暘扴幏昅)]亂椕梴夁掱傪巟偊傞偑傫丒旕偑傫姵幰偺娚榓働傾亃CHAPTER 1 娚榓働傾偲娕岇巘偺栶妱丂係 娚榓働傾偵偍偗傞僠乕儉堛椕偺晛媦偲娕岇巘偺栶妱, p.26-34. 嵅摗旤婭1, 愮旤搊巕1 (1娕岇晹), 曇: 愮旤搊巕1, 彫嶳岾戙2 (2娕岇妛晹), 堛帟栻弌斉, 搶嫗, 2021/3敪峴.
620126. [妛弍彂 (暘扴幏昅)]亂椕梴夁掱傪巟偊傞偑傫丒旕偑傫姵幰偺娚榓働傾亃CHAPTER 2 徢忬傾僙僗儊儞僩偲昗弨揑働傾丂1 醬捝, p.36-45 彫嶳桭棦峕1, 愮旤搊巕2 (1娕岇妛晹, 2娕岇晹), 曇: 愮旤搊巕2, 彫嶳岾戙1, 堛帟栻弌斉, 搶嫗, 2021/3敪峴.
620127. [妛弍彂 (暘扴幏昅)]亂椕梴夁掱傪巟偊傞偑傫丒旕偑傫姵幰偺娚榓働傾亃CHAPTER 2 徢忬傾僙僗儊儞僩偲昗弨揑働傾丂5 埆塼幙, p.62-8. 愮旤搊巕1 (1娕岇晹), 曇: 愮旤搊巕1, 彫嶳岾戙2 (2娕岇妛晹), 堛帟栻弌斉, 搶嫗, 2021/3敪峴.
620128. [妛弍彂 (暘扴幏昅)]亂椕梴夁掱傪巟偊傞偑傫丒旕偑傫姵幰偺娚榓働傾亃CHAPTER 俁 椕梴夁掱偲帠椺偐傜妛傇娚榓働傾偺幚嵺丂1 恑峴偑傫丂(1) 椕梴夁掱偲娚榓働傾偺摿挜, p.82-4. 愮旤搊巕1 (1娕岇晹), 曇: 愮旤搊巕1, 彫嶳岾戙2 (2娕岇妛晹), 堛帟栻弌斉, 搶嫗, 2021/3敪峴.
620129. [妛弍彂 (暘扴幏昅)]亂椕梴夁掱傪巟偊傞偑傫丒旕偑傫姵幰偺娚榓働傾亃CHAPTER 俁 椕梴夁掱偲帠椺偐傜妛傇娚榓働傾偺幚嵺丂1 恑峴偑傫丂(2) 帠椺亅恌抐弶婜偐傜娚榓働傾傪婓朷偝傟偨A偝傫, p.85-9. 悈栰壚搒旤1, 愮旤搊巕1 (1娕岇晹), 曇: 愮旤搊巕1, 彫嶳岾戙2 (2娕岇妛晹), 堛帟栻弌斉, 搶嫗, 2021/3敪峴.
620130. [妛弍彂 (暘扴幏昅)]亂椕梴夁掱傪巟偊傞偑傫丒旕偑傫姵幰偺娚榓働傾亃CHAPTER 俁 椕梴夁掱偲帠椺偐傜妛傇娚榓働傾偺幚嵺丂2 怱晄慡, p.98-112. 鍌柤桼壛棦1 (1娕岇晹), 曇: 愮旤搊巕1, 彫嶳岾戙2 (2娕岇妛晹), 堛帟栻弌斉, 搶嫗, 2021/3敪峴.
620131. [妛弍彂 (暘扴幏昅)]亂椕梴夁掱傪巟偊傞偑傫丒旕偑傫姵幰偺娚榓働傾亃CHAPTER 俁 椕梴夁掱偲帠椺偐傜妛傇娚榓働傾偺幚嵺丂3 枬惈暵嵡惈攛幘姵 (COPD)丂(1) 椕梴夁掱偲娚榓働傾偺摿挜, p.113-6. 悈栰壚搒旤1 (1娕岇晹), 曇: 愮旤搊巕1, 彫嶳岾戙2 (2娕岇妛晹), 堛帟栻弌斉, 搶嫗, 2021/3敪峴.
620132. [妛弍彂 (暘扴幏昅)]亂椕梴夁掱傪巟偊傞偑傫丒旕偑傫姵幰偺娚榓働傾亃CHAPTER 俁 椕梴夁掱偲帠椺偐傜妛傇娚榓働傾偺幚嵺丂3 枬惈暵嵡惈攛幘姵 (COPD)丂(2) 帠椺亅屇媧曗彆椕朄偵傛傞嬯捝傪書偊傞E偝傫, p.117-21. 嶳杮枹嵷1 (1娕岇晹), 曇: 愮旤搊巕1, 彫嶳岾戙2 (2娕岇妛晹), 堛帟栻弌斉, 搶嫗, 2021/3敪峴.
620133. [妛弍彂 (暘扴幏昅)]亂椕梴夁掱傪巟偊傞偑傫丒旕偑傫姵幰偺娚榓働傾亃CHAPTER 俁 椕梴夁掱偲帠椺偐傜妛傇娚榓働傾偺幚嵺丂3 枬惈暵嵡惈攛幘姵 (COPD)丂(3) 帠椺亅徢忬偺恑峴偵敽偄晄埨偑憹嫮偟偨F偝傫, p.122-7. 尯奀懽巕1 (1娕岇晹), 曇: 愮旤搊巕1, 彫嶳岾戙2 (2娕岇妛晹), 堛帟栻弌斉, 搶嫗, 2021/3敪峴.
620134. [妛弍彂 (暘扴幏昅)]亂椕梴夁掱傪巟偊傞偑傫丒旕偑傫姵幰偺娚榓働傾亃CHAPTER 俁 椕梴夁掱偲帠椺偐傜妛傇娚榓働傾偺幚嵺丂4 嬝堔弅惈懁嶕峝壔徢 (ALS), p.128-42. 戝塱棦旤1 (1娕岇晹), 曇: 愮旤搊巕1, 彫嶳岾戙2 (2娕岇妛晹), 堛帟栻弌斉, 搶嫗, 2021/3敪峴.
620135. [妛弍彂 (暘扴幏昅)]亂働傾傪壜帇壔! 拞斖埻棟榑丒娕岇儌僨儖丂帠椺傪撉傒夝偔宆巻亃崲擄帠椺傪棟榑偱撉傒夝偄偰傒傛偆丂1. 僯儏乕儅儞棟榑: 枛婜偡偄憻偑傫偺崘抦傪庴偗偰僗僺儕僠儏傾儖儁僀儞傪懱尡偟偰偄傞憇擭婜偺A偝傫, p.2-15. 愮旤搊巕1, 嶰師恀棟2 (1娕岇晹, 2晲憼栰戝妛娕岇妛晹), 曇: 峳旜惏宐, 撿峕摪, 搶嫗, 2021/3敪峴.
621005. [妛弍彂 (曇廤)]亂尒偰偱偒傞椪彴働傾恾娪丂彫帣娕岇價僕儏傾儖僫乕僔儞僌亃曇: 戝捤丂崄1 (1娕岇晹), 敿揷峗旤2 (2恄屗巗娕岇戝妛), 妛尋儊僨傿僇儖廏弫幮, 搶嫗, 2020/6敪峴.
621006. [妛弍彂 (曇廤)]亂椕梴夁掱傪巟偊傞偑傫丒旕偑傫姵幰偺娚榓働傾亃曇: 愮旤搊巕1, 彫嶳岾戙2 (1娕岇晹, 2娕岇妛晹), 堛帟栻弌斉, 搶嫗, 2021/3敪峴.
[妛夛丒尋媶夛摍]
721030. [妛夛 (慡崙)] (摿暿島墘) 堏怉堛偲RTC偑庢傝慻傫偩怴宆僐儘僫僂僀儖僗姶愼徢懳嶔. 堜懞梉昉1, 惵垷旤1, 怷壀桪巕2, 嶳杮桰庽3, 媑揷朁巕2, 栰岥暥擳1, 杒搰榓庽4, 愇堜戝曘4, 媑揷堦惉4,5 (1娕岇晹, 2塰梴晹, 3栻嵻晹, 4斿擜婍, 5怴悽婭堛椕丒愭抂堛椕): 戞54夞擔杮椪彴恡堏怉妛夛 (2021/2/17), web奐嵜, 戞54夞擔杮椪彴恡堏怉妛夛僾儘僌儔儉彺榐廤 2021/1; p.63.
722218. [妛夛 (慡崙)] (僔儞億僕僂儉) 娕岇偺昡壙偺偨傔偺僨乕僞妶梡丂娕岇娗棟幰偑乽庤抜乿偲偟偰僨乕僞傪妶梡偱偒傞傛偆偵偡傞偨傔偺忣曬扴摉娕岇巘偵傛傞巟墖偺幚嵺. 惔悈洅摑 (娕岇晹): 戞24夞擔杮娕岇娗棟妛夛妛弍廤夛 (2020/8/28), web奐嵜, 戞24夞擔杮娕岇娗棟妛夛妛弍廤夛彺榐廤 2020/7; p.117.
722219. [妛夛 (慡崙)] (僔儞億僕僂儉) 怴恖娕岇巘偺帪婜傪怳傝曉偭偰. 晉揷崄撧 (娕岇晹): 戞36夞擔杮僗僩儗僗妛夛妛弍憤夛 (2020/10/24), web奐嵜, 僗僩儗僗壢妛 2020/10; 35 (2): 124.
722220. [妛夛 (慡崙)] (僔儞億僕僂儉) 巕堢偰悽戙偺棫応偐傜. 屲廫棐垷婓巕 (娕岇晹): 戞36夞擔杮僗僩儗僗妛夛妛弍憤夛 (2020/10/24), web奐嵜, 僗僩儗僗壢妛 2020/10; 35 (2): 125.
722221. [妛夛 (慡崙)] (僔儞億僕僂儉) 抝惈娕岇巘偲偟偰偺僉儍儕傾奐敪. 塱壀丂桋 (娕岇晹): 戞36夞擔杮僗僩儗僗妛夛妛弍憤夛 (2020/10/24), web奐嵜, 僗僩儗僗壢妛 2020/10; 35 (2): 126.
722222. [妛夛 (慡崙)] (僔儞億僕僂儉) 娕岇巘挿偺僗僩儗僗儅僱僕儊儞僩乣娕岇娗棟傪妝偟傒惗偒惗偒偲摥偔偨傔偵乣. 挅堜復巕 (娕岇晹): 戞36夞擔杮僗僩儗僗妛夛妛弍憤夛 (2020/10/24), web奐嵜, 僗僩儗僗壢妛 2020/10; 35 (2): 127.
722223. [妛夛 (慡崙)] (僔儞億僕僂儉) 娕岇晹偵偍偗傞僗僩儗僗懳嶔. 扟岥梲巕 (娕岇晹): 戞36夞擔杮僗僩儗僗妛夛妛弍憤夛 (2020/10/24), web奐嵜, 僗僩儗僗壢妛 2020/10; 35 (2): 128.
722224. [妛夛 (慡崙)] (僔儞億僕僂儉) 廔枛婜堛椕偺壠懓働傾丂媬媫丒廤拞帯椕椞堟偵偍偗傞廔枛婜姵幰壠懓働傾傪峫偊傞. 崅嫶丂宐1,2 (1娕岇晹, 2堏怉堛椕巟墖幒): 戞56夞擔杮堏怉妛夛憤夛 (2020/11/1-30), web奐嵜, 堏怉 2020/10; 55 (憤夛椪帪): 325.
722225. [妛夛 (慡崙)] (儚乕僋僔儑僢僾)亂憻婍採嫙偲堏怉堛椕丒娕岇偺崱乣COVID-19帪戙偺專恡堏怉乣亃揹榖偑棃傞偺偼柧擔偐傕抦傟側偄. 栰岥暥擳 (娕岇晹): 戞23夞擔杮恡晄慡娕岇妛夛妛弍廤夛丒憤夛 (2020/11/22), web奐嵜, 戞23夞擔杮恡晄慡娕岇妛夛妛弍廤夛丒憤夛彺榐廤 2020/10; p.126.
722226. [妛夛 (慡崙)] (僔儞億僕僂儉)亂SSI偩偗偠傖側偄!廃弍婜偵偍偗傞僨僶僀僗僒乕儀僀儔儞僗偺妶梡亃廃弍婜丒ICU偵偍偗傞VAE僒乕儀僀儔儞僗偺妶梡乣VAE僒乕儀僀儔儞僗偺婎杮乣. 嵅乆栘尠巕 (娕岇晹): 戞33夞擔杮奜壢姶愼徢妛夛憤夛妛弍廤夛 (2020/11/27), web奐嵜, 擔杮奜壢姶愼徢妛夛嶨帍 2020/10; 17 (5): 333.
722227. [妛夛 (慡崙)] (僷僱儖僨傿僗僇僢僔儑儞) COVID-19偲嵭奞丒寬峃婋婡娗棟. 妬嶳榓旤 (娕岇晹): 戞40夞擔杮娕岇壢妛妛夛妛弍廤夛 (2020/12/13), web奐嵜.
722228. [妛夛 (慡崙)] (僔儞億僕僂儉)亂懱奜弞娐僔僗僥儉偺枹棃梊憐恾亅30擭屻偼偙偆側偭偰偄傞!亃娕岇偺帇揰偐傜峫偊傞曗彆弞娐帯椕偺枹棃. 撪摗垷庽 (娕岇晹): 戞49夞恖岺怱憻偲曗彆弞娐崸榖夛妛弍廤夛 (2021/2/7), web奐嵜.
722229. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 專恡堏怉偺挿婜懸婡傪巟偊傞怱偺働傾. 栰岥暥擳1, 堜懞梉昉1, 杒搰榓庽2, 愇堜戝曘2, 媑揷堦惉2,3 (1娕岇晹, 2斿擜婍, 3怴悽婭堛椕丒愭抂堛椕): 戞31夞擔杮僒僀僐僱僼儘儘僕乕妛夛妛弍廤夛丒憤夛 (2021/2/13), web奐嵜, 戞31夞擔杮僒僀僐僱僼儘儘僕乕妛夛妛弍廤夛丒憤夛丂僾儘僌儔儉丒彺榐廤 2021/1; p.49.
722230. [妛夛 (慡崙)] (彽懸島墘摍) 堏怉堛偲RTC偑庢傝慻傫偩怴宆僐儘僫僂僀儖僗姶愼徢懳嶔. 堜懞梉昉2, 惵桍垷旤2, 怷壀桪巕2, 嶳杮桰庽3, 媑揷朁巕2, 栰岥暥擳2, 杒搰榓庽4, 愇堜戝曘4, 媑揷堦惉4,5 (2娕岇晹, 2塰梴晹, 3栻嵻晹, 4斿擜婍, 5怴悽婭堛椕丒愭抂堛椕): 戞54夞擔杮椪彴恡堏怉妛夛 (2021/2/17), Web奐嵜.
722231. [妛夛 (慡崙)] (儚乕僋僔儑僢僾) 憻婍採嫙偵娭偡傞堄巚寛掕巟墖偺尰忬偲僐儘僫壭偱偺壽戣傪峫偊傞. 崅嫶丂宐1,2 (1娕岇晹, 2堏怉堛椕巟墖幒): 戞54夞擔杮椪彴恡堏怉妛夛 (2021/2/18), web奐嵜, 擔杮椪彴恡堏怉妛夛僾儘僌儔儉丒彺榐廤 2021/2; 54: 97.
723679. [妛夛 (慡崙)] (億僗僞乕) 僗僉儞働傾奜棃偱働傾傪庴偗偨攔擜忈奞傪桳偡傞姵幰偺働傾夘擖慜屻偱偺QOL昡壙. 屟揷彨巏1, 惔媨旤塺1, 徏尨峃旤2, 暯嶳婱攷3 (1娕岇晹, 2娕岇妛晹, 3斿擜婍): 戞29夞擔杮憂彎丒僆僗僩儈乕丒幐嬛娗棟妛夛妛弍廤夛 (2020/7/23), web奐嵜, 擔杮憂彎丒僆僗僩儈乕丒幐嬛娗棟妛夛帍 2020/7; 24 (2): 184.
723680. [妛夛 (慡崙)] (億僗僞乕) 擼懖拞媫惈婜偺僀儗僂僗梊杊偲偟偰偺攔曋僾儘僩僐儖偺桳梡惈. 楅栘払栫1, 婽愇楃巕1, 崅嫶偐偍傝1, 惣揷宐旤1, 惣嶳榓棙2, 杒懞塸擇2, 垻媣捗擇晇2 (1娕岇晹, 2擼恄宱撪): 戞45夞擔杮擼懖拞妛夛憤夛 (2020/8/23-25), web奐嵜.
723681. [妛夛 (慡崙)] (堦斒岥墘) 妛惗巜摫偵傛傞庒庤娕岇巘偺惉挿. 棊崌杻婱1, 媑晹宐棟巕1, 墶揷愮宐1, 屲摗梲巕1 (1娕岇晹): 戞24夞擔杮娕岇娗棟妛夛妛弍廤夛 (2020/8/28), web奐嵜, 戞24夞擔杮娕岇娗棟妛夛妛弍廤夛彺榐廤 2020/7; p.268.
723682. [妛夛 (慡崙)] (億僗僞乕) 昦搹娕岇巘偺嬑柋懷儕乕僟乕栶妱帺屓昡壙偲怑柋僄儞僷儚儊儞僩偺娭楢. 墶嶳棙崄1, 揷拞岾巕2 (1娕岇晹, 2搶嫗帨宐夛堛壢戝妛堛妛晹娕岇妛壢): 戞24夞擔杮娕岇娗棟妛夛妛弍廤夛 (2020/8/28), web奐嵜, 戞24夞擔杮娕岇娗棟妛夛妛弍廤夛彺榐廤 2020/7; p.280.
723683. [妛夛 (慡崙)] (億僗僞乕) 婋婡娗棟偺儕乕僟乕僔僢僾帺屓岠椡姶偺娭楢梫場亅娕岇巘挿偵徟揰傪摉偰偰亅. 挅庪椛巕 (娕岇晹): 戞24夞擔杮娕岇娗棟妛夛妛弍廤夛 (2020/8/28), web奐嵜, 戞24夞擔杮娕岇娗棟妛夛妛弍廤夛彺榐廤 2020/7; p.342.
723684. [妛夛 (慡崙)] (堦斒岥墘) 拞寴娕岇巘傊偺彫帣娕岇宲懕嫵堢偵偮偄偰峫偊傛偆. 栘懞備傒巕 (娕岇晹): 擔杮彫帣娕岇妛夛戞30夞妛弍廤夛 (2020/9/19-30), web奐嵜, 擔杮彫帣娕岇妛夛妛弍廤夛島墘廤 2020/8; 30th: 55.
723685. [妛夛 (慡崙)] (堦斒島墘) 惍宍奜壢庁梡婡婍儊僯儏乕昞丂姡憞晄椙偵學傞専徹. 嬥尨弮巌1, 揷拞丂寜2,3, 搉绯丂揙 (1娕岇晹, 2怴悽婭堛椕丒愭抂堛椕, 3堦斒丒彫帣丒娞抇鋁奜): 戞95夞擔杮堛椕婡婍妛夛戝夛 (2020/9/20-10/19), Web奐嵜.
723686. [妛夛 (慡崙)] (堦斒岥墘) 恖堳妋曐偵偍偗傞嵭奞帪帠嬈宲懕寁夋 (BCP) 偵偮偄偰偺専摙. 愳忋戝曘1, 妬嶳榓旤1, 忋懞桼帡1 (1娕岇晹): 擔杮嵭奞娕岇妛夛戞22夞擭師戝夛 (2020/9/28-10/11), web奐嵜, 擔杮嵭奞娕岇妛夛帍 2020/9; 22 (1): 118.
723687. [妛夛 (慡崙)] (堦斒岥墘) 嵭奞懳嶔儕儞僋僫乕僗夛偵偍偗傞3擭娫偺妶摦曬崘. 忋懞桼帡1, 扟丂岾堦1, 妬嶳榓旤1 (1娕岇晹): 擔杮嵭奞娕岇妛夛戞22夞擭師戝夛 (2020/9/28-10/11), web奐嵜, 擔杮嵭奞娕岇妛夛帍 2020/9; 22 (1): 119.
723688. [妛夛 (慡崙)] (堦斒岥墘) 娕岇働傾偵偍偗傞嵭奞帪帠嬈宲懕寁夋偺庢傝慻傒: 嵭奞儌乕僪娕岇働傾梊掕昞偺嶌惉. 惎栰惓桾1, 屆巗懃岝1, 忋懞桼帡1 (1娕岇晹): 擔杮嵭奞娕岇妛夛戞22夞擭師戝夛 (2020/9/28-10/11), web奐嵜, 擔杮嵭奞娕岇妛夛帍 2020/9; 22 (1): 119.
723689. [妛夛 (慡崙)] (億僗僞乕) 惗柦偺婋婡揑忬嫷偵偍偄偰廤拞娗棟壓偵偁傞曣懱偺壠懓傊偺夘擖帠椺偺専摙. 旜娭媣巕1, 怴堜梲巕2 (1娕岇晹, 2娕岇妛晹): 戞61夞擔杮曣惈塹惗妛夛憤夛丒妛弍廤夛 (2020/10/9-10), web奐嵜, 曣惈塹惗妛弍廤夛彺榐廤 2020/9; 61 (3): 206.
723690. [妛夛 (慡崙)] (億僗僞乕) 戝摦柆曎嫹嶓徢偺崅楊擣抦徢姵幰偵懳偡傞QOL傪懜廳偟偨堄巚寛掕巟墖. 鍌柤桼壛棦 (娕岇晹): 戞17夞擔杮弞娐婍娕岇妛夛妛弍廤夛 (2020/10/10), web奐嵜, 戞17夞擔杮弞娐婍娕岇妛夛妛弍廤夛彺榐 (僆儞僨儅儞僪攝怣) WEB p.41.
723691. [妛夛 (慡崙)] (億僗僞乕) A昦堾偵偍偗傞儕儞僷晜庮暋崌揑帯椕壢偺恌椕摫擖偺幚嵺偲崱屻偺揥朷. 悾屗杚巕1, 惸摗憦巕1, 搚昅桼旤1, 搶奀椦偪偊傒1, 愬愇婭旻2, 彫嶁桖尗2, 惣媨梞巎2, 媏抮恀棟巕2 (1娕岇晹, 2擕態丒峛忬態奜): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/12), web奐嵜, 擔杮擕娻妛夛憤夛僾儘僌儔儉彺榐廤 2020/10; 28: 115.
723692. [妛夛 (慡崙)] (億僗僞乕) PST奐巒屻, 憗婜偵帯椕偑憈岠偟QOL偑夵慞偝傟偨1椺. 埳摗惏崄1, 崅旜恀婭1, 廐嶳抭巙1, 惸摗憦巕1, 悾屗杚巕1, 搚昅桼旤1, 愬愇婭旻2, 彫嶁桖尗2, 惣媨梞巎2, 媏抮恀棟巕2 (1娕岇晹, 2擕態丒峛忬態奜): 戞28夞擔杮擕娻妛夛妛弍憤夛 (2020/10/12), web奐嵜, 擔杮擕娻妛夛憤夛僾儘僌儔儉彺榐廤 2020/10; 28: 349.
723693. [妛夛 (慡崙)] (堦斒岥墘) 姵幰壠懓巟墖傪栚揑偲偟偨僇儞僼傽儗儞僗偐傜尒偊偨, 媬媫奜棃娕岇巘偲昦搹娕岇巘偺帇揰偺憡堘. 惎栰惓桾1, 峕忋愮徎1 (1娕岇晹): 戞22夞擔杮媬媫娕岇妛夛妛弍廤夛 (2020/12/1-31), web奐嵜, 擔杮媬媫娕岇妛夛嶨帍 2020/12; 22 (supple): 121.
723694. [妛夛 (慡崙)] (堦斒岥墘) 嵼戭巟墖僙儞僞乕偵偍偗傞恎懱峉懇夝彍偺幚懺挷嵏. 暉杮撧墰1, 戝塱棦旤2, 撧椙捈旤2, 摗巬丂岾2, 釼摗榓旤2, 栄捤桼旤巕2 (1撿挰揷朘栤娕岇僗僥乕僔儑儞 儁儞僊儞, 2娕岇晹): 戞51夞2020擭搙擔杮娕岇妛夛妛弍廤夛 (2020/11/1-30), web奐嵜, 戞51夞擔杮娕岇妛夛妛弍廤夛彺榐廤 2020/10; p.175.
723695. [妛夛 (慡崙)] (堦斒岥墘) COVID亅19昦搹偱偺媫曄懳墳僔儈儏儗乕僔儑儞偺桳梡惈. 媨杮婱擵1, 戝扟彯栫1, 懢揷嵅抦巕1, 嵅摗嵅搒旤1 (1娕岇晹): 戞48夞擔杮廤拞帯椕堛妛夛妛弍廤夛 (2021/2/12), web奐嵜, 僂僃僽彺榐 2021/2; p.GP-NE1-3.
723696. [妛夛 (慡崙)] (堦斒岥墘) 僗僩乕儅偵嬤愙偟偨憂彎娗棟偵摿掕峴堊尋廋傪廋椆偟偨旂晢丒攔煏働傾擣掕娕岇巘偑夘擖偟偨1帠椺. 搉曈嵐怐 (娕岇晹): 戞38夞擔杮僗僩乕儅丒攔煏儕僴價儕僥乕僔儑儞妛夛憤夛 (JSSCR) (2021/2/27), 暉壀 (web奐嵜), 擔杮僗僩乕儅丒攔煏儕僴價儕僥乕僔儑儞妛夛帍 2021/1; 37 (1): 141.
723697. [妛夛 (慡崙)] (億僗僞乕) 恑峴鋁偑傫姵幰丒壠懓偲偑傫娕岇愱栧娕岇巘偲偺僷乕僩僫乕僔僢僾偵婎偯偔娕岇柺択偺昡壙. 愮旤搊巕1, 帣嬍旤桼婭1, 孠柤庻旤1, 彫嶳岾戙2 (1娕岇晹, 2娕岇妛晹): 戞35夞擔杮偑傫娕岇妛夛妛弍廤夛 (2021/2/27-4/30), web奐嵜, 戞35夞擔杮偑傫娕岇妛夛妛弍廤夛島墘廤 WEB; p.P9-139.
723698. [妛夛 (慡崙)] (億僗僞乕) 怘梸晄怳傪桳偡傞奜棃壔妛椕朄姵幰偺媮傔傞娕岇巟墖偵娭偡傞幙揑尋媶. 嫜揷棦撧1, 敧桍愮弔1, 挿揷恀桼旤1, 怺戲嵅宐巕2, 嵅乆栘帯堦榊3 (1娕岇晹, 2塰梴晹, 3怴悽婭堛椕丒墶抐揑堛椕): 戞18夞擔杮椪彴庮釃妛夛妛弍廤夛 (2021/3/1-31), web奐嵜, 戞18夞椪彴庮釃妛夛妛弍廤夛僾儘僌儔儉彺榐 Web; p.P35-5.
731066. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 暊枌摟愅偺僶僢僌岎姺. 彫憅棷旤1, 搷墍丂擡1 (1娕岇晹): 朘栤娕岇Web僙儈僫乕 (2021/2/6, 2/20), 恄撧愳.
732077. [妛夛 (抧曽夛丒尋媶夛)] (僔儞億僕僂儉) 僀儞僔僨儞僩曬崘偐傜峫偊傞桝寣椕朄偺埨慡妋曐: 庤弍幒偺棫応偐傜. 崅栰丂憦 (娕岇晹): 戞151夞擔杮桝寣丒嵶朎帯椕妛夛娭搶峛怣墇巟晹椺夛 (2021/2/20), web奐嵜, 戞151夞擔杮桝寣丒嵶朎帯椕妛夛娭搶峛怣墇巟晹椺夛僾儘僌儔儉廤 2021/2; p.8-9.
733128. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 戀帣幘姵傪桳偡傞擠晈傊偺廃嶻婜僠乕儉偲偟偰偺娭傢傝. 奀榁郪塴巕1, 拞撪嵐抦1, 愇尨嵐怐1, 攱桭崄巕1, 彫愳婌旤巕1, 暯椦撧昪1 (1娕岇晹): 戞34夞恄撧愳曣惈塹惗妛夛 (2021/2/6), 恄撧愳 (web奐嵜), 恄撧愳曣惈塹惗妛夛帍 2021/3; 24 (1): 65.
733129. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 愐悜懝彎擠晈偺弌嶻傑偱偺娗棟乣偦偺恖傜偟偝傪妶偐偟偨働傾乣. 嶰塝恀婭1, 愳抂朳奊1 (1娕岇晹): 戞34夞恄撧愳曣惈塹惗妛夛 (2021/2/6), 恄撧愳 (web奐嵜), 恄撧愳曣惈塹惗妛夛帍 2021/3; 24 (1): 70.
733130. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) 怴惗帣慼惗朄偺嫵堢丒巟墖僔僗僥儉偵岦偗偨庢傝慻傒. 彫扟栰傒偳傝1, 愳壓夎惗1, 悰尨丂嬚1, 彫愳婌旤巕1, 拞惣廏旻2,3, 悈忋偄偯傒1 (1娕岇晹, 2怴悽婭堛椕丒愭抂堛椕, 3彫帣): 戞34夞恄撧愳曣惈塹惗妛夛 (2021/2/6), 恄撧愳 (web奐嵜), 恄撧愳曣惈塹惗妛夛帍 2021/3; 24 (1): 76.
733131. [妛夛 (抧曽夛丒尋媶夛)] (堦斒岥墘) COVID-19寉徢乣拞摍徢偺娕岇幚慔偱娕岇巘偑姶偠偨崲擄傗妺摗偲晄埨乣. 懢搧愳垷婭1, 愇愳旤愥1, 嵅摗嵅搒旤1 (1娕岇晹): 擔杮堛椕儅僱僕儊儞僩妛夛戞20夞恄撧愳巟晹妛弍廤夛 (2021/3/13), web奐嵜.
'18擭搙埲慜暘
[妛弍榑暥]
'19-320005. [徢椺曬崘] 懱奜幃枌宆恖岺攛傪憰拝偟偨恄宱惈傗偣徢姵幰偺惗棟揑梸媮偺廩懌偵岦偗偨傾僾儘乕僠偺1椺. 暉搱嵐怐1, 徏揷廏堦1, 愇憅丂垽1, 憹揷惓榓1, 娵嫶岶徍2, 戝堜恀棦撧2, 愺棙丂桋2 (1娕岇晹, 2媬柦): 擔杮媬媫堛妛夛娭搶抧曽夛嶨帍 2020/3; 41 (2): 352-5.
[挊丂彂]
'19-620022. [妛弍彂 (暘扴幏昅)]亂怴懱宯娕岇妛慡彂丂娕岇偺摑崌偲幚慔匒丂嵭奞娕岇妛丂戞3斉亃戞2復 挻媫惈婜丒媫惈婜偺嵭奞曐寬堛椕偲娕岇幚慔, p.38-73. 妬嶳榓旤 (娕岇晹), 曇: 彫堜搚梇堦, 愇堜旤宐巕, 儊僡僇儖僼儗儞僪幮, 搶嫗, 2020/2敪峴.
椪彴専嵏晹
[妛弍榑暥]
320053. [徢椺曬崘] AIDS偵崌暪偟偨攄庬惈僸僗僩僾儔僗儅徢偺堦椺. 埨払丂忳1, 擇杮桍怢1,2, 榓揷払旻2,3, 嬥栘丂梱1, 妢堜埱巕1, 彫娧抭悽1, 拞嶈怣旻1, 烴堜宑憿1, 搹曽怢堦1, 崅嶳梲巕2,4, 媣暷丂岝, 婽堜崕旻, 庪栰桳嶌5 (1椪専晹, 2姶愼娗棟幒, 3銹尨昦丒姶愼撪, 4怴悽婭堛椕丒墶抐揑堛椕, 5椪専妛): 擔杮椪彴旝惗暔妛夛嶨帍 2021/3; 31 (2): 87-91.
522143. [島嵗]亂挳妎専嵏僴儞僘僆儞僙儈僫乕 亃帺怣傪傕偭偰専嵏傪偟偰偄傑偡偐? 彫敠丂恑 (椪専晹): 搶嫗搒堛妛専嵏 2020/6; 48 (2): 121-3.
522144. [島嵗]亂摿廤: 椪彴壔妛専嵏偱僺僢僩僼僅乕儖偵棊偪側偄偨傔偵亃3. 専嵏屻丂2) 捛壛應掕埶棅帪 (庢傝堘偄, 曐懚埨掕惈偺掅偄崁栚側偳). 摗懞慞峴 (椪専晹): Medical Technology 2020/6; 48 (6): 619-21.
522145. [島嵗]亂媄弍島嵗亃傛偔傢偐傞! 晈恖壢僄僐乕偺婎杮偲媄弍. 塅帯嫶慞彑 (椪専晹): Medical Technology 2020/7; 48 (7): 798-804.
[挊丂彂]
620136. [妛弍彂 (暘扴幏昅)]亂偙傟偱枩慡! 嬞媫傪梫偡傞僄僐乕強尒 (椪彴専嵏2020擭 4寧憹姧崋)亃仭4復 晈恖壢僄僐乕丂堎強惈擠怭 (擠怭), p.470-3. 塅帯嫶慞彑1, 搹曽怢堦1, 庪栰桳嶌2 (1椪専晹, 2椪専妛), 曇: 嬥尨丂弐, 堛妛彂堾, 搶嫗, 2020/4敪峴.
620137. [妛弍彂 (暘扴幏昅)]亂昳幙曐徹丒惛搙娗棟嫵杮亃3復 椪彴壔妛丒柶塽壔妛専嵏丂3.6 帋栻娗棟戜挔, p.66-72. 搚昅抭徎 (椪専晹), 娔廋: 擔杮椪彴塹惗専嵏媄巘夛, 偠傎偆, 搶嫗, 2020/11敪峴.
[妛夛丒尋媶夛摍]
723699. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞嬞媫桝寣偺尰忬偵偮偄偰. 揷晹桾擇1,2, 彫杮旤撧1,2, 桳攏榓撧1,2, 娾愗暥巕1,2, 嶳曈惏旤1,2, 嶳杮枮棦撧1,2, 媨峗擇3, 戝扟怲堦3 (1椪専晹, 2桝寣晹, 3桝寣丒嵶朎堏怉): 戞68夞擔杮桝寣丒嵶朎帯椕妛夛妛弍憤夛 (2020/5/28), 帍忋奐嵜, 擔杮桝寣嵶朎帯椕妛夛帍 2020/5; 66 (2): 311.
723700. [妛夛 (慡崙)] (堦斒島墘) CP3000偵偍偗傞僼傽僋僞乕僆乕僩: P-FDP丒D僟僀儅乕帋栻偺惈擻昡壙. 垻晹桳崄1, 堜忋鉟嵷1, 楅栘憗婭1, 彫栰椙懢1, 嵅媣娫撝巕1, 忋尨桼壚棟1, 拞惣丂孫1, 撪揷堦峅1, 搹曽怢堦1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 戞21夞擔杮専嵏寣塼妛夛妛弍廤夛 (2020/7/11-12, 7/23-9/30), Web奐嵜, 擔杮専嵏寣塼妛夛嶨帍 専嵏偲寣塼 2020/6; 21: 155.
723701. [妛夛 (慡崙)] (堦斒島墘) 儂儖僞乕怱揹恾偺僷僯僢僋抣曬崘偺桳梡惈偵偮偄偰. 奆愳丂曕1, 彫栰嶳巙怐1, 嵅嫶媣旤巕1, 媨撪榓旤1, 塅帯嫶慞彑1, 搹曽怢堦1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 戞69夞擔杮堛妛専嵏妛夛 (2020/9/5-6, 10/1-31), 愮梩/Web奐嵜, 戞69夞擔杮堛妛専嵏妛夛丂僾儘僌儔儉廤 2020/4; 69: 78.
723702. [妛夛 (慡崙)] (堦斒島墘) 僗僥儘僀僪嵻巊梡姵幰偵尒傜傟偨暢慄拵徢偺1徢椺. 埳摗垷栱崄1, 搚昅抭徎1, 斞捤崅惗1, 隊揷榓曚1, 嶰塝朏揟1, 撪揷堦峅1, 搹曽怢堦1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 戞69夞擔杮堛妛専嵏妛夛 (2020/9/5-6, 10/1-31), 愮梩/Web奐嵜, 戞69夞擔杮堛妛専嵏妛夛彺榐廤 2020/9; 69: 359.
723703. [妛夛 (慡崙)] (堦斒島墘) 庒擭彈惈偵偍偗傞寣惔垷墧擹搙偍傛傃怘廗姷偲偺娭楢惈偵偮偄偰. 搚昅抭徎1, 嬤摗棷旤巕2, 庣壆払旤3, 搹曽怢堦1, 庪栰桳嶌1,4 (1椪専晹, 2栻嵻晹, 3寬峃娗棟僙, 4椪専妛): 戞42夞擔杮椪彴塰梴妛夛憤夛丒戞41夞擔杮椪彴塰梴嫤夛憤夛丒戞18夞戝楢崌戝夛 (2020/10/19-11/2), Web奐嵜, New Diet Therapy 2020/9; 36 (2): 131.
723704. [妛夛 (慡崙)] (堦斒島墘) 杒棦戝妛昦堾偵偍偗傞堚揱巕専嵏懱惂偺峔抸. 妢堜埱巕1, 埨杮棿攏1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 戞67夞擔杮椪彴専嵏堛妛夛妛弍廤夛 (2020/11/19-22), 娾庤 (僴僀僽儕僢僪奐嵜).
723705. [妛夛 (慡崙)] (堦斒島墘) 戝摦柆曎抲姺弍屻偵銯嶕抐楐傪惗偠偨姶愼惈怱撪枌墛偺1椺. 隊揷婌擵1, 慜愳宐旤2, 墦摗棷旤巕1, 愇揷桾旤1, 桍尨旤抭巕1, 攼扟撨寧1, 塅帯嫶慞彑1, 彫斅嫶弐旤2, 垻屆弫栫2, 庪栰桳嶌1,3 (1椪専晹, 2弞娐婍撪, 3椪専妛): 擔杮挻壒攇堛妛夛戞93夞妛弍廤夛 (2020/12/1-2021/1/14), Web奐嵜, 挻壒攇堛妛 2020/11; 47 (Suppl): S247.
723706. [妛夛 (慡崙)] (堦斒島墘) Cartinoma with neuroendocrine features偺1椺. 搉曈偁偡偼1, 楅栘惌巕1, 拞惣媣岾1, 塅帯嫶慞彑1, 隊揷婌擵1, 搹曽怢堦1, 愬愇婭旻2, 妬揷嶇旤擳3, 庪栰桳嶌1,4 (1椪専晹, 2擕態丒峛忬態奜, 3昦棟, 4椪専妛): 戞45夞擔杮挻壒攇専嵏妛夛妛弍廤夛 (2020/12/19-2021/1/31), Web奐嵜, 挻壒攇専嵏媄弍 2020; 45 (Suppl): S202.
723707. [妛夛 (慡崙)] (堦斒島墘) 恡徢敪徢慜摐擜昦儔僢僩偺恡旂幙偵偍偗傞儈僩僐儞僪儕傾偺昳幙娗棟婡峔偵偮偄偰. 愇堜捈恗1, 崟嶈徦巎1, 堜杮柧旤1, 抮塱廏庽2, 搚昅抭徎3, 彫敠丂恑3, 楅栘塸柧4, 墶応惓揟1, 抾拞峆晇5 (1堛椕塹惗妛晹, 2堛椕朄恖惞堛夛, 3椪専晹, 4暉搰導棫堛壢戝妛曐寬壢妛晹, 5崙嵺堛椕暉巸戝妛堛妛晹恡憻撪壢妛): 戞60夞擔杮椪彴壔妛夛擭師妛弍廤夛 (2020/10/30-11/1), Web奐嵜, 椪彴壔妛 2020/10; 49 (suppl 1): 180.
731067. [妛夛 (抧曽夛丒尋媶夛)] (摿暿島墘) 専嵏僨乕僞傪撉傒夝偔. 搚昅抭徎 (椪専晹): 戞69夞恄撧愳導堛妛専嵏妛夛 (2021/1/1-11), Web奐嵜, 戞69夞恄撧愳導堛妛専嵏妛夛僾儘僌儔儉廤 2020/12; p.10.
733132. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 婎慴抦幆偲戙昞揑側幘姵偺恌抐曽朄丂戞3晹乽峛忬態乿丂戞4晹乽寊摦柆乿. 拞惣媣岾 (椪専晹): 戞137夞堛梡挻壒攇島媊島廗夛 (2020/12/25-2021/3/24), Web奐嵜.
733133. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 彔偺偙偩傢傝丂峛忬態椞堟. 拞惣媣岾 (椪専晹): JSS巐崙戞39夞抧曽夛尋廋夛 (2021/2/21), Web奐嵜.
733134. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 傔傑偄奜棃傛傝埶棅偝傟偨揹婥娽怳恾専嵏偵偍偗傞拲帇娽怳偺専弌忬嫷. 彫敠丂恑1, 娾弢嬙墰1, 栴搱惓懢榊1, 懞嶳恀媩1, 憗愳桼棙1, 彫椦恀旤1, 壨搰峕旤1, 楅栘弤巕1, 塅帯嫶慞彑1, 搹曽怢堦1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 戞69夞恄撧愳導堛妛専嵏妛夛 (2021/1/1-11), Web奐嵜, 戞69夞恄撧愳導堛妛専嵏妛夛僾儘僌儔儉廤 2020/12; p.15.
733135. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 杒棦戝妛昦堾偵偍偗傞ALP偍傛傃LD専嵏偺IFCC朄摫擖偵娭偡傞庢傝慻傒. 摗懞慞峴1, 怴忛峢巕1, 壀揷桼婭1, 拞嶈峀巕1, 烴堜宑憿1, 撪揷堦峅1, 搹曽怢堦1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 戞69夞恄撧愳導堛妛専嵏妛夛 (2021/1/1-11), Web奐嵜, 戞69夞恄撧愳導堛妛専嵏妛夛僾儘僌儔儉廤 2020/12; p.15.
733136. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 戝摦柆曎抲姺弍屻偵銯嶕抐楐傪惗偠偨姶愼惈怱撪枌墛偺1椺. 隊揷婌擵1, 墦摗棷旤巕1, 愇揷桾旤1, 愇嫿壀旤壛巕1, 栘尨弮巕1, 攼扟撨寧1, 憪撱愮徎1, 塅帯嫶慞彑1, 搹曽怢堦1, 慜愳宐旤2, 彫斅嫶弐旤2, 庪栰桳嶌1,3 (1椪専晹, 2弞娐婍撪, 3椪専妛): 戞69夞恄撧愳導堛妛専嵏妛夛 (2021/1/1-11), Web奐嵜, 戞69夞恄撧愳導堛妛専嵏妛夛僾儘僌儔儉廤 2020/12; p.15.
733137. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 摉堾偵偍偗傞儂儖僞乕怱揹恾偺僷僯僢僋抣曬崘偺奣梫偍傛傃憗婜帯椕傊偲宷偑偭偨1椺. 奆愳丂曕1, 彫栰嶳巙怐1, 嵅嫶媣旤巕1, 媨撪榓旤1, 塅帯嫶慞彑1, 搹曽怢堦1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 戞69夞恄撧愳導堛妛専嵏妛夛 (2021/1/1-11), Web奐嵜, 戞69夞恄撧愳導堛妛専嵏妛夛丂僾儘僌儔儉廤 2020/12; p.15.
733138. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 杒棦戝妛昦堾偵偍偗傞HCV峈懱専嵏偺梲惈懍曬偺庢傝慻傒偲岠壥偵偮偄偰. 幝尨椇懢1, 摗懞慞峴1, 搚昅抭徎1, 拞嶈峀巕1, 撪揷堦峅1, 搹曽怢堦1, 庪栰桳嶌1,2 (1椪専晹, 2椪専妛): 戞69夞恄撧愳導堛妛専嵏妛夛 (2021/1/1-11), Web奐嵜, 戞69夞恄撧愳導堛妛専嵏妛夛丂僾儘僌儔儉廤 2020/12; p.15.
733139. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 杒棦戝妛昦堾偵偍偗傞堚揱巕専嵏懱惂偺峔抸. 妢堜埱巕 (椪専晹): 戞69夞恄撧愳導堛妛専嵏妛夛 (2021/1/1-11), Web奐嵜, 戞69夞恄撧愳導堛妛専嵏妛夛丂僾儘僌儔儉廤 2020/12; p.16.
733140. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恖岺娭愡姶愼徢偵偍偗傞嵶嬠堚揱巕専嵏Tm丂mapping掕検應掕傪梡偄偨婲墛嬠敾掕偺帋傒. 烴堜宑憿 (椪専晹): 戞69夞恄撧愳導堛妛専嵏妛夛 (2021/1/1-11), Web奐嵜, 戞69夞恄撧愳導堛妛専嵏妛夛丂僾儘僌儔儉廤 2020/12; p.16.
733141. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 杒棦戝妛昦堾偵偍偗傞寣塼攟梴専嵏偐傜暘棧偟偨峺曣條恀嬠偺専弌忬嫷. 嬥栘丂梱1, 擇杮桍怢1,2, 埨払丂忳1, 拞嶈怣旻1, 撪揷堦峅1, 搹曽怢堦1, 庪栰桳嶌1,3 (1椪専晹, 2姶愼娗棟幒, 3椪専妛): 戞69夞恄撧愳導堛妛専嵏妛夛 (2021/1/1-11), Web奐嵜, 戞69夞恄撧愳導堛妛専嵏妛夛丂僾儘僌儔儉廤 2020/12; p.16.
733142. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 寣塼攟梴偐傜専弌偝傟偨Prototheca wickerhamii偺堦椺. 埳郪峢婸1, 埨払丂忳1, 拞嶈怣旻1, 撪揷堦峅1, 搹曽怢堦1, 壓庤岞夘2, 榓揷払旻2, 庪栰桳嶌1,3 (1椪専晹, 2銹尨昦丒姶愼撪, 3椪専妛): 戞69夞恄撧愳導椪彴専嵏媄巘夛 (2021/1/1-11), Web奐嵜, 戞69夞恄撧愳導堛妛専嵏妛夛丂僾儘僌儔儉廤 2020/12; p.16.
'19擭搙埲慜暘
[妛夛丒尋媶夛摍]
'19-723033. [妛夛 (慡崙)] (堦斒島墘) 挿婜揑偵宱夁傪娤嶡偟摼偨僋儘僀僣僼僃儖僩丒儎僐僽昦偺1徢椺. 壛摗岾巕1, 彫栰郪桾栫1, 墴揷岲旤1, 昉揷媣旤1, 憗愳桼棙1, 壨搰峕旤1, 楅栘弤巕1, 搹曽怢堦1 (1椪専晹): 戞68夞擔杮堛妛専嵏妛夛 (2019/5/18-19), 嶳岥, 擔杮堛妛専嵏妛夛彺榐廤 2019/5; 68: 75.
曻幩慄晹
[妛弍榑暥]
110413. [尨挊] Traceable point-like 68Ge/68Ga source with a spherically symmetric positron absorber for PET scanners. Hasegawa T1, Okamoto M, Yamada T, Ishizu H, Mikamoto T, Sato Y, Miyatake H2, Kikuchi K2, Inoue Y3: Radiol Phys Technol 2020/6; 13 (2): 170-6. (挿扟愳抭擵1, 媨晲斾楥庽2, 媏抮丂宧2, 堜忋桪夘3: 1堛椕塹惗妛晹, 2曻幩慄晹, 3曻幩慄 (夋憸))
[妛夛丒尋媶夛摍]
723708. [妛夛 (慡崙)] (堦斒島墘) X慄CT偵偍偗傞2庬椶偺Organ Dose Modulation僜僼僩僂僄傾偺斾妑. 埳摗姲懽1, 堜忋桪夘2, 恅丂攷暥1 (1曻幩慄晹, 2曻幩慄 (夋憸)): 戞76夞擔杮曻幩慄媄弍妛夛憤夛妛弍戝夛 (2020/5/15-6/14), web奐嵜, 擔杮曻幩慄媄弍妛夛戞75夞憤崌妛弍戝夛梊峞廤 2020; p.155.
723709. [妛夛 (慡崙)] (堦斒島墘) 嫻晹CT偵偍偗傞僗僇僂僩夋憸偺嶣塭忦審偑娗揹棳曄挷偵梌偊傞塭嬁. 埳摗姲懽1, 堜忋桪夘2, 枛淎捈庽1 (1曻幩慄晹, 2曻幩慄 (夋憸)): 戞76夞擔杮曻幩慄媄弍妛夛憤夛妛弍戝夛 (2020/5/15-6/14), web奐嵜, 擔杮曻幩慄媄弍妛夛戞75夞憤崌妛弍戝夛梊峞廤 2020; p.156.
栻嵻晹
[妛弍榑暥]
110414. [尨挊] The Population Pharmacokinetics of Rifampicin in Japanese Pulmonary Tuberculosis Patients. Nishimura T, Kohno H, Nagai H, Maruoka D, Koike Y, Kobayashi M1,2, Atsuda K1,2: Drug Res (Stuttg) 2020/5; 70 (5): 199-205. (彫椦徆岹1,2, 岤揷岾堦榊1,2: 1栻妛晹, 2栻嵻晹)
110415. [尨挊] Pharmacokinetic Analysis, Analgesic Effects, and Adverse Effects of Tapentadol in Cancer Patients with Pain. Homma M1, Kokubun H2, Okuwaki K3, Katada C3, Hayashi N4, Kanai A5, Koizumi W3, Atsuda K1,6: Biol Pharm Bull 2020/6; 43 (6): 1000-6. (杮娫夒巑1, 崙暘廏栫2, 墱榚嫽夘3, 寴揷恊棙3, 椦丂宱恖4, 嬥堜徍暥5, 彫愹榓嶰榊3, 岤揷岾堦榊1,6: 1栻嵻晹, 2搶嫗栻壢戝妛栻妛晹幚柋幚廗嫵堢僙儞僞乕, 3徚壔婍撪, 4杻悓, 5怴悽婭堛椕丒墶抐揑堛椕, 6栻妛晹)
110416. [尨挊] Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib. Azuma S1, Uojima H2, Chuma M, Shao X2, Hidaka H2, Nakazawa T2, Kondo M, Numata K, Iwabuchi S, Kako M, Maeda S, Koizumi W2, Atsuda K1,3: Sci Rep 2020/10; 10 (1): 17054. (搶怣懢楴1, 嫑搱惏婭2, Xue Shao2, 擔崅丂墰2, 拞郪婱廏2, 彫愹榓嶰榊2, 岤揷岾堦榊1,3: 1栻嵻晹, 2徚壔婍撪, 3栻妛晹)
110417. [尨挊] Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib. Azuma S1, Uojima H2, Chuma M, Shao X, Hidaka H2, Nakazawa T2, Kondo M, Numata K, Iwabuchi S, Kako M, Maeda S, Koizumi W2, Atsuda K1: Sci Rep 2020; 10 (1): 17054. (搶怣懢楴1, 嫑搱惏婭2, 擔崅丂墰2, 拞郪婱廏2, 彫愹榓嶰榊2, 岤揷岾堦榊1: 1栻嵻晹, 2徚壔婍撪)
110418. [尨挊] Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1-4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Minatogawa H, Izawa N, Kawaguchi T, Miyaji T, Shimomura K, Honda K, Iihara H, Ohno Y, Inada Y, Arioka H, Morita H, Hida N, Sugawara M1, Katada C2, Nawata S, Ishida H, Tsuboya A, Tsuda T, Yamaguchi T, Eguchi-Nakajima T: BMJ Open 2020/12; 10 (12): e041737. (悰尨廩峀1, 寴揷恊棙2: 1栻嵻晹, 2徚壔婍撪)
110419. [尨挊] The Japan Society for Surgical Infection: guidelines for the prevention, detection, and management of gastroenterological surgical site infection, 2018. Ohge H1, Mayumi T1, Haji S1, Kitagawa Y1, Kobayashi M1,2,3, Kobayashi M1, Mizuguchi T1, Mohri Y1, Sakamoto F1, Shimizu J1, Suzuki K1, Uchino M1, Yamashita C1, Yoshida M1, Hirata K1, Sumiyama Y1, Kusachi S1 (1Committee for Gastroenterological Surgical Site Infection Guidelines, the Japan Society for Surgical Infection): Surg Today 2021/1; 51 (1): 1-31. (彫椦徆岹1,2,3: 2栻妛晹, 3栻嵻晹)
110420. [尨挊] Association between preoperative tumor necrosis factor alpha inhibitor and surgical site infection after surgery for inflammatory bowel disease: a systematic review and meta-analysis. Uchino M, Ikeuchi H, Shimizu J, Ohge H, Haji S, Mizuguchi T, Mohri Y, Yamashita C, Kitagawa Y, Suzuki K, Kobayashi M, Kobayashi M1,2, Sakamoto F, Yoshida M, Mayumi T, Hirata K, Takesue Y: Surg Today 2021/1; 51 (1): 32-43. (彫椦徆岹1,2: 1栻妛晹, 2栻嵻晹)
110421. [尨挊] On-label use of sodium-glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes. Horii T1, Oikawa Y, Atsuda K1,2, Shimada A: J Diabetes Investig 2021/1. doi: 10.1111/jdi.13506. Online ahead of print. (杧堜崉巎1, 岤揷岾堦榊1,2: 1栻妛晹, 2栻嵻晹)
110422. [尨挊] Effects of intermittent pneumatic compression on femoral vein peak venous velocity during active ankle exercise. Sakai K, Takahira N1, Tsuda K, Akamine A2,3: J Orthop Surg (Hong Kong) 2021/1-4; 29 (1): 2309499021998105. (崅暯彯怢1, 愒椾憦旻2,3: 1堛椕塹惗妛晹, 2戝妛堾堛椕宯尋媶壢, 3栻嵻晹)
110423. [尨挊] Population Pharmacokinetic and Pharmacodynamic Target Attainment Analysis of Cefazolin in the Serum and Hip Joint Capsule of Patients Undergoing Total Hip Arthroplasty. Komatsu T1, Natsume Y, Uchiyama K2,3, Ikeda S3, Tomoda Y4, Takayama Y5, Takaso M3, Hanaki H6, Atsuda K1,4: Antimicrob Agents Chemother 2021/3; 65 (4): e02114-20. (彫徏晀彶1, 撪嶳彑暥2,3, 抮揷怣夘3, 桭揷媑懃4, 崅嶳梲巕5, 崅憡徎巑3, 壴栘廏柧6, 岤揷岾堦榊1,4: 1栻嵻晹, 2堛椕埨慡丒娗棟, 3惍奜, 4栻妛晹, 5怴悽婭堛椕丒墶抐揑堛椕, 6戝懞尋)
120042. [尨挊] 偑傫壔妛椕朄姵幰偺惂揻帯椕偵偍偗傞僆儔儞僓僺儞偺巊梡幚懺偵娭偡傞挷嵏. 嶁憅抭巕1, 娾郪恀婭巕2, 桍郪桪棦2, 悾屗椙嫵1, 捙丂丂悞1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 擔杮昦堾栻嵻巘夛嶨帍 2020/10; 56 (10): 1137-42.
120043. [尨挊] 僪儔僢僌僫僀乕僽2宆摐擜昦姵幰偵懳偡傞抁婜揑栻嵻旓寉尭傪娪傒偨戞堦慖戰栻僼儘乕僠儍乕僩偺岠壥. 娾郪恀婭巕1, 杧堜崉巎2, 攼栘嵤壺, 楅栘埡奊, 彫愳尠巎3, 椦丂揘斖3, 岤揷 岾堦榊1,2 (1栻妛晹, 2栻嵻晹, 3撪暘斿戙幱撪): 摐擜昦 2020/10; 63 (10): 701-10.
120044. [尨挊] 娍曽惢嵻偺惉暘暘愅亅銹埞偍傛傃戝寶拞搾偺摐椶暘愅偲偦傟傜偺寣摐抣傊偺塭嬁亅. 捙丂丂悞1,2, 崟揷柧暯1, 暷憅朑徫1, 徏旜樞婓巕1, 堫梩擇楴1, 嶰姫徦峗1 (1搶嫗栻壢戝妛栻妛晹, 2栻嵻晹): 墳梡栻棟 2020/11; 99 (3/4): 79-84.
120045. [尨挊] 庤弍慜偺峈寣愷栻暈梡姵幰偵偍偗傞擖堾慜栻嵻巘柺択偺幚懺挷嵏. 晊郪丂弤1, 愒椾憦旻1, 怷垷嵐旤1, 捙丂丂悞1, 嬤摗棷旤巕1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 擔杮昦堾栻嵻巘夛嶨帍 2021/1; 57 (1): 86-92.
521017. [夝愢]亂幙媈墳摎: 栻昳亃揬晅晹埵偵傛傞揬晅栻偺岠壥偺堘偄. 愳栰愮恞1, 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹): 擔杮堛帠怴曬 2020/4; 5007: 52-3.
522146. [島嵗]亂僔儕乕僘乽偁偺傂偲偺攚拞乿亃堛巘亊栻嵻巘僋儘僗僩乕僋 抧堟偵揱偊偨偄偙傟偐傜偺摐擜昦帯椕亅昦堾栻嵻巘曇亅. 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): THINK CUBE 2020/8; 15: 12-5.
522147. [島嵗]亂楢嵹: 尰応偺崲偭偨!丂偵僄僉僗僷乕僩偑摎偊傞 Q&A娙堈寽戺朄亃宱岥僇儕僂儉惢嵻偺L-傾僗僷儔僊儞巁僇儕僂儉嶶丒忶偺宱娗搳梌偵崲偭偰偄傑偡. 椙偄曽朄偼偁傝傑偡偐. 憅揷側偍傒, 媨嶁桪恖1, 惵栘妛堦, 廐嶳帬抝 (1栻嵻晹): 挷嵻偲忣曬 2021/1; 27 (1): 103-6.
522148. [島嵗]亂摿廤: 僠乕儉堛椕偵傛傞摐擜昦姵幰偺巟墖乣偙傟傑偱偲偙傟偐傜乣亃II. 愱栧怑偺棫応偐傜丂4. 栻嵻巘. 堫栰丂姲1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 寧姧摐擜昦 2021/3; 13 (4): 33-9.
[挊丂彂]
620138. [妛弍彂 (暘扴幏昅)]亂僗儁僔儍儖丒億僺儏儗乕僔儑儞偺峈嬠栻搳梌愝寁丂栻暔摦懺丒栻暔憡屳嶌梡丒栻暔傾儗儖僊乕偐傜嵟揔壔 (寧姧栻帠2020擭7寧憹姧崋)亃III. 摿庩昦懺偺姵幰丂2. 擬彎姵幰, p.2028-36. 彫椦徆岹 (栻妛晹), 曇: 懞栘桪堦, 崅嫶壚巕, 偠傎偆, 搶嫗, 2020/7敪峴.
620139. [妛弍彂 (暘扴幏昅)]亂昦婥偲偔偡傝2021丂婎慴偲幚慔 Expert's Guide (栻嬊2021擭憹姧Vol.72 No.4)亃10. 栻妛揑娗棟丂帯椕栻偺栻棟偲栻妛娗棟忋偺拲堄揰, p.918-33. 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹), 撿嶳摪, 搶嫗, 2020/4敪峴.
620140. [妛弍彂 (暘扴幏昅)]亂恡堏怉偲偔偡傝亃戞2復 栻傪惓偟偔堸傒懕偗傞偨傔偵丂3. 柶塽梷惂栻丂堸傒崌傢偣偺拲堄揰 [栻嵻]丂旂晢壢, p.111-2. 4. 壠懓偱庢傝慻傓暈栻娗棟丂崅楊幰偺暈栻娗棟, p.123-4. 堫栰丂姲1 (1栻嵻晹), 曇: 媑揷堦惉2,3, 彫椦徆岹4 (2怴悽婭堛椕丒愭抂堛椕, 3斿擜婍, 4栻妛晹), 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
620141. [妛弍彂 (暘扴幏昅)]亂恡堏怉偲偔偡傝亃戞2復 栻傪惓偟偔堸傒懕偗傞偨傔偵丂3. 柶塽梷惂栻丂堸傒崌傢偣偺拲堄揰 [栻嵻]丂帹旲堲岮壢, p.113-4. 戞3復 偔偡傝偵娭偡傞Q&A丂柶塽梷惂栻, 偔偡傝慡斒丂堦晹, p.131, p.137. 媨嶁桪恖1 (1栻嵻晹), 曇: 媑揷堦惉2,3, 彫椦徆岹4 (2怴悽婭堛椕丒愭抂堛椕, 3斿擜婍, 4栻妛晹), 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
620142. [妛弍彂 (暘扴幏昅)]亂恡堏怉偲偔偡傝亃戞2復 栻傪惓偟偔堸傒懕偗傞偨傔偵丂4. 壠懓偱庢傝慻傓暈栻娗棟丂彫帣偺暈栻娗棟, p.125-7. 戞3復 偔偡傝偵娭偡傞Q&A丂柶塽梷惂栻, 偔偡傝慡斒丂堦晹 p.138. 彫栰帥傒偝偒1 (1栻嵻晹), 曇: 媑揷堦惉2,3, 彫椦徆岹4 (2怴悽婭堛椕丒愭抂堛椕, 3斿擜婍, 4栻妛晹), 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
620143. [妛弍彂 (嫟挊)]亂夵掶 僇儖僥惛慖梡岅廤亃嵅乆栘慞怣1, 朏揷丂峷2, 杒搰峗旤3, 孎扟梇帯4 (1栻嵻晹, 2椪専晹, 3娕岇晹, 4椪彴尋媶丒僾儘僕僃僋僩), 僴僀僒儉媄尋, 搶嫗, 2020/8敪峴.
620144. [妛弍彂 (暘扴幏昅)]亂栻嵻巘偺椪彴僙儞僗傪杹偔僩儗乕僯儞僌僽僢僋丂栻僩儗 娞丒恡亃B宆娞墛, p.13-4, p.21-4. C宆娞墛, p.35-6, p.47-50. 帺屓柶塽惈娞墛, p.79-82. 娞峝曄: 栧柆埑槾恑徢, p.159-60. 旕戙彏惈娞峝曄: 栧柆埑槾恑徢, p.161-2. 娞峝曄偵偍偗傞塰梴娗棟, p.173-4. 懢揷抭攷1 (1栻嵻晹), 曇: 戝栰擻擵2, 嵅懞丂桪3, 嶰惎丂抦4, 塝揷尦庽5 (2搶嫗戝妛堛妛晹晅懏昦堾栻嵻晹, 3墶昹憤崌昦堾栻嵻晹, 4壓墇昦堾栻嵻壽, 5戝栰婰擮昦堾栻嵻晹), 撿嶳摪, 搶嫗, 2020/12敪峴.
620145. [妛弍彂 (暘扴幏昅)]亂帯椕錤僴儞僪僽僢僋2021亃摐擜昦帯椕栻丒帀幙堎忢徢帯椕栻丒崅擜巁寣徢, 捝晽帯椕栻, p.633-721. 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹), 娔廋: 崅媣巎枦, 曇: 杧丂惓擇, 悰栰寬懢榊, 栧榚岶, 姡丂尗堦, 椦丂徆梞, 偠傎偆, 搶嫗, 2021/1敪峴.
620146. [妛弍彂 (暘扴幏昅)]亂崱擔偺帯椕巜恓2021丂巹偼偙偆帯椕偟偰偄傞亃憤榑丂11. 戙幱幘姵丂2宆摐擜昦 (暈栻巜摫丒栻嵻忣曬), p.754, p.758. 彫帣偺摐擜昦 (暈栻巜摫丒栻嵻忣曬), p.771. 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹), 憤曇廤: 暉堜師栴, 堛妛彂堾, 搶嫗, 2021/1敪峴.
620147. [妛弍彂 (暘扴幏昅)]亂僫乕僔儞僌僌儔僼傿僇丂幘昦偺惉傝棫偪 (2): 椪彴栻棟妛 戞5斉亃戞2復, p.65-70. 戞4復, p.93-128. 姫枛帒椏, p.264-5. 恄丂堦柌1 (1栻嵻晹), 曇: 屆愳桾擵, 愒悾抭巕, 椦惓寬擇, 戝惣峅崅, 儊僨傿僇弌斉, 戝嶃, 2021/1敪峴.
620148. [妛弍彂 (暘扴幏昅)]亂惛恄壢栻暔椕朄僈僀僪 夵掶斉 (挷嵻偲忣曬2021擭1寧椪帪憹姧崋)亃IV 惛恄壢偺栻妛揑娗棟丂僋儕僯僇儖僋僄僗僠儑儞, p.210-2. 捙丂丂悞1 (1栻嵻晹), 娔廋: 媑旜丂棽2 (2搶朚戝妛), 曇廤戙昞: 嶰椫崅巗3 (3楅幁堛椕壢妛戝妛), 曇: 擔杮惛恄栻妛夛, 偠傎偆, 搶嫗, 2021/1敪峴.
620149. [妛弍彂 (暘扴幏昅)]亂Pocket Drugs 2021亃娻帯椕娭楢栻丂64. 戙幱漢峈栻, p.483-97. 壀杮宐旤巕1, 彫愹榓嶰榊2 (1栻嵻晹, 2徚壔婍撪), 娔廋: 暉堜師栴3 (3惞楬壛崙嵺昦堾), 曇: 彫徏峃岹3, 搉绯桾巌4 (4昹徏堛壢戝妛), 堛妛彂堾, 搶嫗, 2021/1敪峴.
621007. [妛弍彂 (曇廤)]亂恡堏怉偲偔偡傝亃曇: 媑揷堦惉1,2, 彫椦徆岹3 (1怴悽婭堛椕丒愭抂堛椕, 2斿擜婍, 3栻妛晹), 僶儕儏乕僾儘儌乕僔儑儞, 搶嫗, 2020/7敪峴.
[妛夛丒尋媶夛摍]
713054. [妛夛 (崙嵺)] (億僗僞乕) The Reality of Diabetic Ketoacidosis in Patients with Type 2 Diabetes Using SGLT2 Inhibitors Revealed by a Nationwide Claim-Based Database in Japan. Horii T1, Oikawa Y2, Higashiyama T1, Atsuda K1,3, Shimada A2: ADA 80th Scientific Session 2020 (戞80夞暷崙摐擜昦妛夛媍) (2020/6/12-16), Web奐嵜. (杧堜崉巎1, 搶嶳椣巕1, 岤揷岾堦榊1,3: 1栻妛晹, 2嶉嬍堛壢戝妛摐擜昦丒撪暘斿撪壢, 3栻嵻晹)
713055. [妛夛 (崙嵺)] (億僗僞乕) Investigating the Risk of Severe Hypoglycemia in Elderly Patients with Type 2 Diabetes Mellitus. Horii T1, Atsuda K1,2: ADA 80th Scientific Session 2020 (戞80夞暷崙摐擜昦妛夛媍) (2020/6/12-16), Web奐嵜. (杧堜崉巎1, 岤揷岾堦榊1,2: 1栻妛晹, 2栻嵻晹)
722232. [妛夛 (慡崙)] (僔儞億僕僂儉) 杮妛夛僈僀僪儔僀儞嶌惉傑偱偺曕傒. 戝栄岹婌1, 恀媩弐旻1, 撪栰丂婎1, 杒愳梇堦1, 彫椦徆岹1,2,3, 彫椦丂媮1, 嶁杮巎堖1, 惔悈弫嶰1, 楅栘崕揟1, 搚巘惤擇1, 悈岥丂揙1, 栄棙桋旻1, 嶳壓愮掃1, 媑揷夒攷1, 嶳岥捈斾屆1, 暯揷岞堦1 (1徚壔婍奜壢SSI梊杊偺偨傔偺廃弍婜娗棟僈僀僪儔僀儞嶌惉埾堳夛, 2栻嵻晹, 3栻妛晹): 戞33夞擔杮奜壢姶愼徢妛夛憤夛妛弍廤夛 (2020/11/27), Web奐嵜, 擔杮奜壢姶愼徢妛夛嶨帍 2020/10; 17 (5): 317.
723710. [妛夛 (慡崙)] (堦斒岥墘) 儗儞僶僠僯僽椕朄偵偍偗傞岠壥梊應場巕偍傛傃梊屻場巕偵娭偡傞尋媶. 搶怣懢楴1, 嫑搱惏婭2, 拞攏丂惤3 (1栻嵻晹, 2徚壔婍撪, 3墶昹巗棫戝妛晬懏巗柉憤崌堛椕僙儞僞乕徚壔婍昦僙儞僞乕): 戞56夞擔杮娞憻妛夛憤夛 (2020/8/28-29), 戝嶃 (僴僀僽儕僢僪奐嵜), 娞憻 2020; 61 (suppl 1): A336.
723711. [妛夛 (慡崙)] (億僗僞乕) 僇儖僶儁僱儉宯峈嬠栻偺揔惓巊梡偵岦偗偨庢傝慻傒. 彫徏晀彶1,2, 擇杮桍怢1, 榓揷払旻3, 崅嶳梲巕1,4, 岤揷岾堦榊2,5 (1姶愼娗棟幒, 2栻嵻晹, 3銹尨昦丒姶愼撪, 4怴悽婭堛椕丒墶抐揑堛椕, 5栻妛晹): 戞68夞擔杮壔妛椕朄妛夛憤夛 (2020/9/12-14), 恄屗 (僴僀僽儕僢僪奐嵜).
723712. [妛夛 (慡崙)] (堦斒岥墘) Thrombocytopenia associated with obinutuzumab in patients with CD20-positive follicular lymphoma. 媨搰棩巕1, 姍揷峗柅2, 楅栘棽峗2, 岤揷岾堦榊1,3 (1栻嵻晹, 2寣塼撪, 3栻妛晹): 戞82夞擔杮寣塼妛夛妛弍廤夛 (2020/10/10-11/8), Web奐嵜.
723713. [妛夛 (慡崙)] (億僗僞乕) 2宆摐擜昦偵偍偗傞億儕僼傽乕儅僔乕偲廳徢掅寣摐敪徢儕僗僋偺娭楢. 杧堜崉巎1, 岤揷岾堦榊1,2 (1栻妛晹, 2栻嵻晹): 戞63夞擔杮摐擜昦妛夛擭師妛弍廤夛 (2020/10/16), Web奐嵜.
723714. [妛夛 (慡崙)] (億僗僞乕) 宱嵪惈傪峫椂偟偨峈偑傫嵻搳梌検愝掕偺幚懺挷嵏. 堫栰丂姲1, 怉揷錆棞奊1, 悰尨廩峀1, 嵅乆栘帯堦榊2, 岤揷岾堦榊1,3 (1栻嵻晹, 2怴悽婭堛椕丒墶抐揑堛椕, 3栻妛晹): 戞30夞擔杮堛椕栻妛夛擭夛 (2020/10/24-11/1), Web奐嵜.
723715. [妛夛 (慡崙)] (億僗僞乕) 柶塽僠僃僢僋億僀儞僩慾奞栻偺旕彫嵶朎攛娻傊偺揔墳捛壛偑奜棃偑傫壔妛椕朄挷惢嬈柋偵梌偊傞塭嬁: 杮朚4巤愝偵傛傞嫟摨挷嵏. 怷尦擻恗1, 堫栰丂姲2, 愇娵攷夒3, 壨崌桽曘4, 挿郪抦摽5, 旜嶈惓棽5, 塒堜峗柧5, 揷懞彑旻5, 媑揷丂惓5, 媑惉惔巙5, 幝尨崅梇5, 搉晹堦岹5, 淎尨惓媂5 (1徍榓栻壢戝妛椪彴栻妛嫵堢尋媶僙儞僞乕, 2栻嵻晹, 3惞楬壛崙嵺昦堾栻嵻晹, 4嵒愳巗棫昦堾栻嵻晹, 5埱椦戝妛堛妛晹晅懏昦堾栻嵻晹): 戞30夞擔杮堛椕栻妛夛擭夛 (2020/10/24-11/1), Web奐嵜.
723716. [妛夛 (慡崙)] (堦斒岥墘) 掅傾儖僽儈儞寣徢姵幰偵偍偗傞僥僀僐僾儔僯儞偺帄揔晧壸搳梌検偺扵嶕. 媑悾奊棟1, 彫徏晀彶1, 媨嶁桪恖1, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 戞30夞擔杮堛椕栻妛夛擭夛 (2020/10/24-11/1), Web奐嵜.
723717. [妛夛 (慡崙)] (億僗僞乕) 堾撪惢嵻0.5%僨僲僔儞揰娽塼偺6偐寧娫埨掕惈帋尡. 楅栘杻暥1, 堷抧丂暥1, 桭揷媑懃2, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 戞30夞擔杮堛椕栻妛夛擭夛 (2020/10/24-11/1), Web奐嵜.
723718. [妛夛 (慡崙)] (億僗僞乕) 僶儞僐儅僀僔儞偺TDM偵偍偗傞堾撪傾儖僑儕僘儉偺弲庣忬嫷偲昡壙. 悾屗椙嫵1, 墱榚払栫2, 彫徏晀彶2, 崅嶳梲巕1,3, 岤揷岾堦榊2,4 (1姶愼娗棟幒, 2栻嵻晹, 3怴悽婭堛椕丒墶抐揑堛椕, 4栻妛晹): 戞30夞擔杮堛椕栻妛夛擭夛 (2020/10/24-11/1), Web奐嵜.
723719. [妛夛 (慡崙)] (億僗僞乕) 栻妛晹偲偺嫤摥偵傛傞昦堾栻嵻巘偺懖屻嫵堢尋廋偺帋傒. 嶁憅抭巕1, 堫栰丂姲1, 彫嶳堣旤1, 晈愳婱攷2, 栄棙弴堦2, 娾郪恀婭巕2, 杧堜崉巎2, 搶嶳椣巕2, 悾屗椙嫵1, 帥徏梞旤1, 嶳杮桰庽1, 嬤摗棷旤巕1, 暯嶳晲巌1,2, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 戞30夞擔杮堛椕栻妛夛擭夛 (2020/10/24-11/1), Web奐嵜.
723720. [妛夛 (慡崙)] (億僗僞乕) 昦堾栻嵻巘怑堳嫵堢僔僗僥儉偺峔抸 (戞堦曬)亅僐儞僺僥儞僔乕棟榑傪梈崌偟偨僋儕僯僇儖儔僟乕嶌惉偺庢慻傒亅. 彫嶳堣旤1, 堫栰丂姲1, 嶁憅抭巕1, 嬤摗棷旤巕1, 晈愳婱攷1,2, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹): 戞30夞擔杮堛椕栻妛夛擭夛 (2020/10/24-11/1), Web奐嵜.
723721. [妛夛 (慡崙)] (億僗僞乕) 峈惛恄昦栻扨嵻巊梡姵幰偵偍偗傞岆殝惈攛墛敪徢偺婋尟場巕偵娭偡傞尋媶. 愳栰愮恞1,2, 懞揷丂壺2, 彫尨旤峕1, 暯嶳晲巌1,2, 戧郪婤栴3, 戝愇丂抭3, 媨壀丂摍3, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹, 3惛恄): 戞30夞擔杮堛椕栻妛夛擭夛 (2020/10/24-11/1), Web奐嵜.
723722. [妛夛 (慡崙)] (堦斒岥墘) 娞嵶朎娻徢椺偵偍偗傞儗儞僶僠僯僽椕朄偵懳偡傞庮釃寣娗怴惗娭楢堚揱巕偺塭嬁. 搶怣懢楴1, 嫑搱惏婭2, 拞攏丂惤3 (1栻嵻晹, 2徚壔婍撪, 3墶昹巗棫戝妛晬懏巗柉憤崌堛椕僙儞僞乕 徚壔婍昦僙儞僞乕): 戞28夞擔杮徚壔婍娭楢妛夛廡娫 (JDDW 2020 KOBE) (2020/11/5), 恄屗, 娞憻 2020; 61 (suppl 2): 65.
723723. [妛夛 (慡崙)] (堦斒岥墘) 栻嵻巘丒堛椕忣曬媄巘 (HIT-Pharmacist) 偵懳偡傞尰忬挷嵏 2020亅戞1復 栻嵻巘丒堛椕忣曬媄巘偺攚宨, 嬈柋偍傛傃妶摦偵偮偄偰亅. 彫抮寬懢1, 戝掚棟姲2, 扟岥旤桰3, 峳丂媊徍4, 崅嫶惓柧5, 忋懞拤惞6, 恵摗抭媣7, 悾屗椙嫵8, 嵅摗峅峃9 (1堛椕朄恖幮抍惤奭夛憤愹昦堾栻嵻晹, 2JA恄撧愳導岤惗楢埳惃尨嫤摨昦堾栻嬊, 3栻嵻巘丒堛椕忣曬媄巘夛, 4崙棫昦堾婡峔怣廈忋揷堛椕僙儞僞乕栻嵻晹, 5幮夛堛椕朄恖庒抾夛偮偔偽僙儞僩儔儖昦堾栻嵻晹, 6堦斒嵿抍朄恖恄撧愳導寈桭夛偗偄備偆昦堾栻嵻晹, 7崙棫偑傫尋媶僙儞僞乕 偑傫僎僲儉忣曬娗棟僙儞僞乕, 8栻嵻晹, 9JA杒奀摴岤惗楢懷峀岤惗昦堾栻嵻晹): 戞40夞堛椕忣曬妛楢崌戝夛丒戞21夞擔杮堛椕忣曬妛夛妛弍戝夛 (2020/11/18-22), 昹徏, 戞40夞堛椕忣曬妛夛楢崌戝夛丂彺榐廤 2020; p.324.
723724. [妛夛 (慡崙)] (堦斒岥墘) 栻嵻巘丒堛椕忣曬媄巘 (HIT-Pharmacist) 偵懳偡傞尰忬挷嵏 2020亅戞2復 強懏堛椕婡娭偺栻嵻晹栧僔僗僥儉偵偮偄偰亅. 扟岥旤桰1, 戝掚棟姲2, 彫抮寬懢3, 扟岥旤桰3, 峳丂媊徍4, 崅嫶惓柧5, 忋懞拤惞6, 恵摗抭媣7, 悾屗椙嫵8, 嵅摗峅峃9 (1栻嵻巘丒堛椕忣曬媄巘夛, 2JA恄撧愳導岤惗楢埳惃尨嫤摨昦堾栻嬊, 3堛椕朄恖幮抍惤奭夛憤愹昦堾栻嵻晹, 4崙棫昦堾婡峔怣廈忋揷堛椕僙儞僞乕栻嵻晹, 5幮夛堛椕朄恖庒抾夛偮偔偽僙儞僩儔儖昦堾栻嵻晹, 6堦斒嵿抍朄恖恄撧愳導寈桭夛偗偄備偆昦堾栻嵻晹, 7崙棫偑傫尋媶僙儞僞乕偑傫僎僲儉忣曬娗棟僙儞僞乕, 8栻嵻晹, 9JA杒奀摴岤惗楢懷峀岤惗昦堾栻嵻晹): 戞40夞堛椕忣曬妛楢崌戝夛丒戞21夞擔杮堛椕忣曬妛夛妛弍戝夛 (2020/11/18-22), 昹徏, 戞40夞堛椕忣曬妛夛楢崌戝夛丂彺榐廤 2020; p.325.
723725. [妛夛 (慡崙)] (堦斒岥墘) 栻嵻巘丒堛椕忣曬媄巘 (HIT-Pharmacist) 偵懳偡傞尰忬挷嵏 2020亅戞3復 昦堾忣曬僔僗僥儉偵偮偄偰亅. 戝掚棟姲1, 扟岥旤桰2, 彫抮寬懢3, 扟岥旤桰3, 峳丂媊徍4, 崅嫶惓柧5, 忋懞拤惞6, 恵摗抭媣7, 悾屗椙嫵8, 嵅摗峅峃9 (1JA恄撧愳導岤惗楢埳惃尨嫤摨昦堾栻嬊, 2栻嵻巘丒堛椕忣曬媄巘夛, 3堛椕朄恖幮抍惤奭夛憤愹昦堾栻嵻晹, 4崙棫昦堾婡峔怣廈忋揷堛椕僙儞僞乕 栻嵻晹, 5幮夛堛椕朄恖庒抾夛偮偔偽僙儞僩儔儖昦堾栻嵻晹, 6堦斒嵿抍朄恖恄撧愳導寈桭夛偗偄備偆昦堾栻嵻晹, 7崙棫偑傫尋媶僙儞僞乕偑傫僎僲儉忣曬娗棟僙儞僞乕, 8栻嵻晹, 9JA杒奀摴岤惗楢懷峀岤惗昦堾栻嵻晹): 戞40夞堛椕忣曬妛楢崌戝夛丒戞21夞擔杮堛椕忣曬妛夛妛弍戝夛 (2020/11/18-22), 昹徏, 戞40夞堛椕忣曬妛夛楢崌戝夛丂彺榐廤 2020; p.325.
723726. [妛夛 (慡崙)] (億僗僞乕) 弍慜媥栻偺埨慡側塣梡偵岦偗偨庢傝慻傒 (戞1曬)亅傾僗僺儕儞僗僀僢僠傪庢傝擖傟偨怴偨側弍慜媥栻塣梡僼儘乕偺峔抸亅. 恄丂堦柌1,2, 捗懞廏峃3, 壓昹岶榊4, 彫愹杻旤5, 晊郪丂弤2, 峳堜桳旤1, 撪嶳彑暥1,6, 垻屆弫嵠4 (1堛椕偺幙丒埨慡悇恑幒, 2栻嵻晹, 3斿擜婍, 4弞娐婍撪, 5恌椕忣曬娗棟幒, 6堛椕埨慡丒娗棟): 戞15夞堛椕偺幙丒埨慡妛夛妛弍廤夛 (2020/11/22), Web奐嵜, 堛椕偺幙丒埨慡妛夛帍 2020/11; 15 (1): 234.
723727. [妛夛 (慡崙)] (堦斒岥墘) 僪儖僥僌儔價儖/儕儖僺價儕儞偵偰娗棟偟摼偨HIV梲惈恡堏怉儗僔僺僄儞僩偺1椺. 帩揷弐栫1, 桭揷媑懃2, 晲摴椓暯1, 榓揷払旻3, 愇堜戝曘4, 怴堜枩棟巕1, 徠壆彑帯5, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹, 3銹尨昦丒姶愼撪, 4斿擜婍, 5崙棫崙嵺堛椕尋媶僙儞僞乕丒僄僀僘帯椕丒尋媶奐敪僙儞僞乕): 戞34夞擔杮僄僀僘妛夛妛弍廤夛丒憤夛 (2020/11/27-12/25), Web奐嵜, 擔杮僄僀僘妛夛帍 2020/11; 22 (4): 451.
723728. [妛夛 (慡崙)] (堦斒岥墘) 弍幃暿廃弍婜姶愼懳嶔偺尰忬偲栤戣揰亅SSI梊杊偺廃弍婜娗棟僈僀僪儔僀儞偺敪姧慜挷嵏: 尰忬偺栤戣揰亅. 悈岥丂揙1, 愇娧抭桾1, 媣栰朏壚1, 戝栄岹婌1, 撪栰丂婎1, 杒愳梇堦1, 彫椦徆岹1,2,3, 彫椦丂媮1, 惔悈弫嶰1, 楅栘崕揟1, 搚巘惤擇1, 栄棙桋旻1, 嶳壓愮掃1, 媑揷夒攷1, 恀媩弐旻1 (1徚壔婍奜壢SSI梊杊偺偨傔偺廃弍婜娗棟僈僀僪儔僀儞嶌惉埾堳夛, 2栻嵻晹, 3栻妛晹): 戞45夞擔杮奜壢宯楢崌妛夛妛弍廤夛 (2020/12/22), Web奐嵜, 擔杮奜壢宯楢崌妛夛帍 2020/12; 45 (5): 514.
723729. [妛夛 (慡崙)] (億僗僞乕) 惷柆寣愷嵡愷徢偵懳偡傞梊杊揑峈嬅屌栻偺怴Bleeding Risk Score昞偺峔抸. 廰扟塮恖1, 晊郪丂弤1, 愒椾憦旻1, 娵嫶岶徍2, 崟娾惌擵3, 岤揷岾堦榊1,4 (1栻嵻晹, 2媬柦, 3杻悓, 4栻妛晹): 戞10夞擔杮栻嵻巘儗僕僨儞僩僼僅乕儔儉 (2021/3/14), Web奐嵜.
723730. [妛夛 (慡崙)] (億僗僞乕) Mueller Hinton攟抧偵偍偗傞儕僼傽儞僺僔儞偺暘夝斀墳偲偦偺梷惂偵娭偡傞専摙. 桍郪桪棦1, 桭揷媑懃2, 彫椦徆岹2, 拞懞惓庽3, 岤揷岾堦榊1,2 (1栻嵻晹, 2栻妛晹, 3堛椕塹惗妛晹): 擔杮栻妛夛戞141擭夛 (峀搰) (2021/3/28), Web奐嵜. 擔杮栻妛夛擭夛梫巪廤 (揹巕梫巪廤) 2021/3.
'19擭搙埲慜暘
[挊丂彂]
'19-620023. [妛弍彂 (暘扴幏昅)]亂昦婥偲栻暔椕朄 惛恄幘姵丂恄宱丒嬝幘姵曇丂夵掶戞2斉亃恄宱丒嬝幘姵 曇丂Charpter3 擣抦徢, p.147-61. Chapter5 偰傫偐傫, p.175-88. Chapter6 偦偺懠偺恄宱丒嬝幘姵丂2. 僊儔儞丒僶儗乕徢岓孮, p.192-3. 愳栰愮恞1 (1栻妛晹), 娔廋: 岤揷岾堦榊1,2 (2栻嵻晹), 曇: 悿丂災3, 崟嶳惌堦1, 抾撪桾婭3, 暯嶳晲巌1 (3搶嫗栻壢戝妛), 僆乕儉幮, 搶嫗, 2019/4敪峴.
儕僴價儕僥乕僔儑儞晹
[妛弍榑暥]
110424. [尨挊] Preoperative skeletal muscle density is associated with postoperative mortality in patients with cardiovascular disease. Yamashita M1, Kamiya K2, Matsunaga A2, Kitamura T3, Hamazaki N4, Matsuzawa R, Nozaki K4, Ichikawa T4, Nakamura T1, Yamamoto S1, Kariya H4, Maekawa E5, Meguro K5, Ogura M2, Yamaoka-Tojo M2, Ako J5, Miyaji K3: Interact Cardiovasc Thorac Surg 2020/4; 30 (4): 515-22. (嶳壓恀巌1, 恄扟寬懢榊2, 徏塱撃旻2, 杒懞丂棩3, 郷嶈怢柧4, 栰嶈峃暯4, 巗愳婱暥4, 拞懞妜巎1, 嶳杮彯暯1, 姟扟塸婭4, 慜愳宐旤5, 栚崟寬懢榊5, 彫憅丂嵤2, 搶瀶旤撧巕2, 垻屆弫嵠5, 媨抧丂娪3: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3怱憻寣娗奜, 4儕僴價儕晹, 5弞娐婍撪)
110425. [尨挊] Usefulness of the Simplified Frailty Scale in Predicting Risk of Readmission or Mortality in Elderly Patients Hospitalized with Cardiovascular Disease. Aida K, Kamiya K1, Hamazaki N2, Matsuzawa R, Nozaki K2, Ichikawa T2, Nakamura T3, Yamashita M3, Maekawa E4, Yamaoka-Tojo M1, Matsunaga A1, Ako J4: Int Heart J 2020/5; 61 (3): 571-8. (恄扟寬懢榊1, 郷嶈怢柧2, 栰嶈峃暯2, 巗愳婱暥2, 拞懞妜巎3, 嶳壓恀巌3, 慜愳宐旤4, 搶瀶旤撧巕1, 徏塱撃旻1, 垻屆弫嵠4: 1堛椕塹惗妛晹, 2儕僴價儕晹, 3戝妛堾堛椕宯尋媶壢, 4弞娐婍撪)
110426. [尨挊] Rising time from bed in acute phase after hospitalization predicts frailty at hospital discharge in patients with acute heart failure. Nozaki K1, Hamazaki N1, Kamiya K2, Ichikawa T1, Nakamura T3, Yamashita M3, Maekawa E4, Matsunaga A2, Yamaoka-Tojo M2, Ako J4: J Cardiol 2020/6; 75 (6): 587-93. (栰嶈峃暯1, 郷嶈怢柧1, 恄扟寬懢榊2, 巗愳婱暥1, 拞懞妜巎3, 嶳壓恀巌3, 慜愳宐旤4, 徏塱撃旻2, 搶瀶旤撧巕2, 垻屆弫嵠4: 1儕僴價儕晹, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢, 4弞娐婍撪)
110427. [尨挊] Association between sarcopenia and atherosclerosis in elderly patients with ischemic heart disease. Uchida S1, Kamiya K2, Hamazaki N3, Matsuzawa R, Nozaki K3, Ichikawa T3, Suzuki Y1, Nakamura T1, Yamashita M1, Kariya H3, Maekawa E4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: Heart Vessels 2020/6; 35 (6): 769-75. (撪揷隳懢1, 恄扟寬懢榊2, 郷嶈怢柧3, 栰嶈峃暯3, 巗愳婱暥3, 楅栘桾懢1, 拞懞妜巎1, 嶳壓恀巌1, 姟扟塸婭3, 慜愳宐旤4, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠4: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3儕僴價儕晹, 4弞娐婍撪)
110428. [尨挊] The Effects of tissue flossing and static stretching on gastrocnemius exertion and flexibity. Kaneda H, Takahira N1,Tsuda K, Tozaki K, Kudo S, Takahashi Y, Sasaki S2, Kensuke Fukushima K3, Kenmoku T3: Isokinetics and exercise science 2020/7; 28 (2): 205-13. (崅暯彯怢1, 嵅乆栘廏堦2, 暉搰寬夘3, 尒栚抭婭3: 1堛椕塹惗妛晹, 2儕僴價儕晹, 3惍奜)
110429. [尨挊] Cognitive impairment measured by Mini-Cog provides additive prognostic information in elderly patients with heart failure. Saito H, Yamashita M, Endo Y, Mizukami A, Yoshioka K, Hashimoto T, Koseki S1, Shimode Y, Kitai T, Maekawa E2, Kasai T, Kamiya K3, Matsue Y: J Cardiol 2020/10; 76 (4): 350-6. (彫娭徦巕1, 慜愳宐旤2, 恄扟寬懢榊3: 1儕僴價儕晹, 2弞娐婍撪, 3堛椕塹惗妛晹)
110430. [尨挊] Prognostic value of pupil area for all-cause mortality in patients with heart failure. Nozaki K1, Hamazaki N1, Yamamoto S2, Kamiya K3, Tanaka S, Ichikawa T1, Nakamura T2, Yamashita M2, Maekawa E4, Matsunaga A3, Yamaoka-Tojo M3, Ako J4: ESC Heart Fail 2020/10; 7 (5): 3067-74. (栰嶈峃暯1, 郷嶈怢柧1, 嶳杮彯暯2, 恄扟寬懢榊3, 巗愳婱暥1, 拞懞妜巎2, 嶳壓恀巌2, 慜愳宐旤4, 徏塱撃旻3, 搶瀶旤撧巕3, 垻屆弫嵠4: 1儕僴價儕晹, 2戝妛堾堛椕宯尋媶壢, 3堛椕塹惗妛晹, 4弞娐婍撪)
110431. [尨挊] Efficacy of Exercise Therapy Initiated in the Early Phase After Kidney Transplantation: A Pilot Study. Yamamoto S1, Matsuzawa R, Kamitani T, Hoshi K, Ishii D2, Noguchi F3, Hamazaki N4, Nozaki K4, Ichikawa T4, Maekawa E5, Matsunaga A6, Yoshida K2,7: J Ren Nutr 2020/11; 30 (6): 518-25. (嶳杮彯暯1, 愇堜戝曘2, 栰岥暥擳3, 郷嶈怢柧4, 栰嶈峃暯4, 巗愳婱暥4, 慜愳宐旤5, 徏塱撃旻6, 媑揷堦惉2,7: 1戝妛堾堛椕宯尋媶壢, 2斿擜婍, 3娕岇晹, 4儕僴價儕晹, 5弞娐婍撪, 6堛椕塹惗妛晹, 7怴悽婭堛椕丒愭抂堛椕)
110432. [尨挊] Effects of Tissue Flossing and Dynamic Stretching on Hamstring Muscles Function. Kaneda H, Takahira N1, Tsuda K, Tozaki K, Kudo S, Takahashi Y, Sasaki S2, Kenmoku T3: J Sports Sci Med 2020/11; 19 (4): 681-9. (崅暯彯怢1, 嵅乆栘廏堦2, 尒栚抭婭3: 1堛椕塹惗妛晹, 2儕僴價儕晹, 3惍奜)
110433. [尨挊] Effect of atrial fibrillation on response to exercise-based cardiac rehabilitation in older individuals with heart failure. Hamazaki N1, Kamiya K2, Fukaya H3, Nozaki K1, Ichikawa T1, Matsuzawa R, Yamashita M4, Uchida S4, Maekawa E3, Meguro K3, Yamaoka-Tojo M2, Matsunaga A2, Ako J3: Ann Phys Rehabil Med 2020/12; 101466. doi: 10.1016/j.rehab.2020.101466. Online ahead of print. (郷嶈怢柧1, 恄扟寬懢榊2, 怺扟塸暯3, 栰嶈峃暯1, 巗愳婱暥1, 嶳壓恀巌4, 撪揷隳懢4, 慜愳宐旤3, 栚崟寬懢榊3, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠3: 1儕僴價儕晹, 2堛椕塹惗妛晹, 3弞娐婍撪, 4戝妛堾堛椕宯尋媶壢)
110434. [尨挊] Preoperative malnutrition is a risk factor for delayed recovery of mobilization after total hip arthroplasty. Nanri Y1, Shibuya M1, Fukushima K2, Uchiyama K3, Takahira N4, Takaso M2: PM R 2021/2. doi: 10.1002/pmrj.12570. Online ahead of print. (撿棦桟懢1, 郌扟恀崄1, 暉搰寬夘2, 撪嶳彑暥3, 崅暯彯怢4, 崅憡徎巑2: 1儕僴價儕晹, 2惍奜, 3堛椕埨慡丒娗棟, 4堛椕塹惗妛晹)
110435. [尨挊] Reliability and validity of Japanese version of Fugl-Meyer assessment for the lower extremities. Nakazono T1, Takahashi K2, Suzuki Y1, Mizuno K1, Nomura Y1, Hiraga Y1, Matsumoto S, Nishiyama K3, Fukuda M2: Top Stroke Rehabil 2021/3; p.1-8. (拞墍揘帯1, 崅嫶崄戙巕2, 楅栘椙榓1, 悈栰岞曘1, 栰懞桪巕1, 暯夑傛偟傒1, 惣嶳榓棙3, 暉揷椣栫2: 1儕僴價儕晹, 2堛椕塹惗妛晹, 3擼恄宱撪)
110436. [尨挊] Quadriceps Strength and Mortality in Older Patients With Heart Failure. Nakamura T1, Kamiya K2, Hamazaki N3, Matsuzawa R, Nozaki K3, Ichikawa T3, Yamashita M1, Maekawa E4, Reed Rkin JL, Noda C4, Meguro K4, Yamaoka-Tojo M2, Matsuzawa A2, Ako J4: Can J Cardiol 2021/3; 37 (3): 476-83. (拞懞妜巎1, 恄扟寬懢榊2, 郷嶈怢柧3, 栰嶈峃暯3, 巗愳婱暥3, 嶳壓恀巌1, 慜愳宐旤4, 栰揷愮弔4, 栚崟寬懢榊4, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠4: 1戝妛堾堛椕宯尋媶壢, 2堛椕塹惗妛晹, 3儕僴價儕晹, 4弞娐婍撪)
110437. [尨挊] The impact of social anxiety disorder on the duration of speech and language therapy at a medical institution for Japanese individuals who stutter. Yoshizawa K1, Ishizaka I2, Yasuda N1, Yukimoto Y1, Higashikawa M2, Hara Y2, Hata W2, Fukuda M2: Kitasato Med J 2021/3; 51 (1): 10-8. (媑郪寬懢榊1, 愇嶁堣戙2, 埨揷嵷曚1, 愥杮桼旤1, 搶愳杻棦2, 尨丂桼婭2, 恅丂庒嵷2, 暉揷椣栫2: 1儕僴價儕晹, 2堛椕塹惗妛晹)
120046. [尨挊] 擔杮恖抧堟嵼廧崅楊幰偺屇媧婡擻偼嬝椡, 堏摦擻椡, 擣抦婡擻偲娭楢偡傞. 慜揷戱栫1, 忋弌捈恖2, 屗嶈丂惛, 幠丂婌悞2, 嶁杮旤婌2 (1儕僴價儕晹, 2堛椕塹惗妛晹): 棟妛椕朄妛 2020/10; 48 (1): 29-36.
120047. [尨挊] 惉恖媓壒姵幰偺帺暵僗儁僋僩儔儉徢孹岦偍傛傃拲堄寚擛丒懡摦徢孹岦偲幮岎晄埨偲偺娭楢. 媑郪寬懢榊1, 愇嶁堣戙2, 埨揷嵷曚1, 暉揷椣栫2, 愥杮桼旤1, 恅丂庒嵷2, 搶愳杻棦2, 尨丂桼婭2 (1儕僴價儕晹, 2堛椕塹惗妛晹): 壒惡尵岅堛妛 2021/1; 62 (1): 24-32.
120048. [尨挊] 曻幩慄帯椕傪庴偗偨殝壓忈奞傪桳偡傞摢栩晹娻姵幰偺怘帠崲擄姶亅幙揑尋媶偵傛傞帯椕宱夁偱偺曄梕僾儘僙僗亅. 搾杮丂摰1, 惔栰桼攜2, 嶳壓丂戱2, 怷堜揥巕, 愳娫寬擵彆, 媑栰崃棟巕 (1儕僴價儕晹, 2帹旲堲岮丒摢栩奜): 殝壓堛妛 2021/2; 10 (1): 80-91.
522149. [島嵗]亂摿廤: 怱晄慡僷儞僨儈僢僋傊偺挧愴亃怱晄慡偵懳偡傞儕僴價儕僥乕僔儑儞帯椕update. 郷嶈怢柧1, 垻屆弫嵠2 (1儕僴價儕晹, 2弞娐婍撪): 弞娐婍撪壢 2020/4; 87 (4): 476-81.
522150. [島嵗]亂摿廤: 僄僉僗僷乕僩偑僘僶儕夝愢!丂 屇媧娗棟偵娭楢偡傞僈僀僪儔僀儞偺尒曽丒撉傒曽丒巊偄曽亃丂(1) 偙傫側偲偒, 巹偼偙偆巊偆! 棧彴偲屇媧儕僴偺僈僀僪儔僀儞. 郷嶈怢柧 (儕僴價儕晹): 傒傫側偺屇媧婍Respica 2020/7; 18 (4): 521-31.
[挊丂彂]
620150. [妛弍彂 (暘扴幏昅)]亂嬌傔傞弞娐婍棟妛椕朄丂弞娐婍昦傪桳偡傞姵幰偺忈奞憸偵挧傓亃Part II 弞娐婍棟妛椕朄偵昁梫側抦幆丒忣曬廂廤丒應掕丒昡壙丂7. 怱婡擻偲屇媧婡擻偲偺娭楢丂1) 怱攛楢娭, p.116-21. 郷嶈怢柧 (儕僴價儕晹), 曇: 惸摗廏擵, 壛摗丂峗, 栘懞夒旻, 暥岝摪, 搶嫗, 2020/7敪峴.
620151. [妛弍彂 (暘扴幏昅)]亂嬌傔傞弞娐婍棟妛椕朄丂弞娐婍昦傪桳偡傞姵幰偺忈奞憸偵挧傓亃Part III 幘姵偍傛傃昦婜暿偺棟妛椕朄偲拲堄揰丂1. 曐懚婜偺枬惈怱晄慡姵幰偵懳偡傞棟妛椕朄, p.166-75. 墦尨恀堦 (儕僴價儕晹), 曇: 惸摗廏擵, 壛摗丂峗, 栘懞夒旻, 暥岝摪, 搶嫗, 2020/7敪峴.
[妛夛丒尋媶夛摍]
713056. [妛夛 (崙嵺)] (堦斒島墘) Correlation between respiratory muscle weakness and frailty status as risk markers for prognosis in patients with cardiovascular disease (Nursing and Allied Proffesions Investigator Award Runners-Up Prize 庴徿墘戣). Hamazaki N1, Kamiya K2, Nozaki K1, Ichikawa T1, Yamashita M3, Uchida S3, Tabata M, Maekawa E4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: ESC Congress 2020 The Digital Experience (2020/8/29-9/1), Web奐嵜. (郷嶈怢柧1, 恄扟寬懢榊2, 栰嶈峃暯1, 巗愳婱暥1, 嶳壓恀巌3, 撪揷隳懢3, 慜愳宐旤4, 搶瀶旤撧巕2, 徏塱撃旻2, 垻屆弫嵠4: 1儕僴價儕晹, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢, 4弞娐婍撪)
713057. [妛夛 (崙嵺)] (堦斒島墘) Kinematic analysis of satic balance and temporal and spatial characteristics of gait in 2- to 3- year-old preterm and full-term infants. Nomura Y1, Sato H2, Kamide K3, Ooka M4, Kemmochi M4: The American Academy for Cerebral Palsy and Developmental Medicine 2020 (2020/9/23-26), Web奐嵜. (栰懞桪巕1, 嵅摗弔旻2, 忋弌崄攇3, 戝壀杻棟4, 巛帩丂妛4: 1儕僴價儕晹, 2堛椕塹惗妛晹, 3柧惎戝妛, 4彫帣)
722233. [妛夛 (慡崙)] (彽懸島墘摍) U-40摿暿婇夋 Pros-Cons 崅楊怱晄慡偵棫偪岦偐偆: 桳巁慺塣摦偺桳梡惈. 栰嶈峃暯 (儕僴價儕晹): 戞26夞擔杮怱憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛 (2020/7/18-19), Web奐嵜.
722234. [妛夛 (慡崙)] (僠乕儉堛椕悇恑埾堳夛僙僢僔儑儞) COVID帪戙 (post COVID偺怴偟偄惗妶條幃帪戙偺) 偵偍偗傞怱晄慡懡怑庬夘擖. 郷嶈怢柧 (儕僴價儕晹): 戞24夞擔杮怱晄慡妛夛妛弍廤夛 (2020/10/15-17), Web奐嵜.
723731. [妛夛 (慡崙)] (堦斒島墘) 敪徢5擔埲撪偺壓巿Fugl-Meyer Assessment偼2廡娫埲撪偺曕峴帺棫偺梊應偵桳梡偱偁傞. 拞墍揘帯1, 悈栰岞曘1, 栰懞桪巕1, 嫽捗棦曕1, 暯夑傛偟傒1, 崅嫶崄戙巕2, 惣嶳榓棙3, 暉揷椣栫2 (1儕僴價儕晹, 2堛椕塹惗妛晹, 3擼恄宱撪): 戞45夞擔杮擼懖拞妛夛憤夛 (2020/8/23-25), Web奐嵜.
723732. [妛夛 (慡崙)] (堦斒島墘) 媫惈婜擼懖拞幰偵懳偡傞ADOC傪梡偄偨OBP偺幚慔偵傛傝昦慜偺栶妱傪嵞妉摼偟偨1椺. 崟嶈丂嬻1, 嵅乆栘廏堦1, 揷岥惏婱1, 嶳杮宐棦崄1, 暉揷椣栫2 (1儕僴價儕晹, 2堛椕塹惗妛晹): 戞54夞擔杮嶌嬈椕朄妛夛 (2020/9/25-10/25), Web奐嵜.
723733. [妛夛 (慡崙)] (堦斒島墘) Eaton暘椶Stage3偺曣巜CM娭愡徢偵懳偡傞杒棦幃曣巜CM娭愡憰嬶偺桳梡惈. 嵅乆栘廏堦1, 彫徖尗帯2, 彆愳峗巑2, 崅暯彯怢3, 崅憡徎巑2 (1儕僴價儕晹, 2惍奜, 3堛椕塹惗妛晹): 戞54夞擔杮嶌嬈椕朄妛夛 (2020/9/25-10/25), Web奐嵜.
723734. [妛夛 (慡崙)] (堦斒島墘) 抧堟嵼廧崅楊彈惈偵偍偗傞屇媧婡擻偺僼儗僀儖傊偺塭嬁: 廲抐揑娤嶡尋媶. 慜揷戱栫1, 忋弌捈恖2,3, 嵅摗弔旻2,3, 幠丂婌悞2, 嶁杮旤婌2 (1儕僴價儕晹, 2堛椕塹惗妛晹, 3戝妛堾堛椕宯尋媶壢): 戞7夞擔杮梊杊棟妛椕朄妛夛妛弍戝夛 (2020/9/27), Web奐嵜.
723735. [妛夛 (慡崙)] (堦斒島墘) 堛椕婡娭傪庴恌偡傞惉恖媓壒幰偺儗僕儕僄儞僗偵娭偡傞専摙. 媑郪寬懢榊1, 愇嶁堣戙2, 埨揷嵷曚1, 挿扟夒峃1, 暉揷椣栫2 (1儕僴價儕晹, 2堛椕塹惗妛晹): 擔杮媓壒丒棳挩惈忈奞妛夛戞8夞戝夛 (2020/10), WEB奐嵜.
723736. [妛夛 (慡崙)] (堦斒島墘) 恖岺旼娭愡慡抲姺弍姵幰偵偍偗傞弍慜恎懱婡擻偲弍屻14擔埲撪偺帺戭戅堾壜斲偲偺娭楢. 憹娫峅徦1, 撿棦桟懢1, 憡愳丂弤2, 娾悾丂戝2, 崅憡徎巑2 (1儕僴價儕晹, 2惍奜): JOSKAS-JOSSM 2020 (戞12夞擔杮娭愡嬀丒旼丒僗億乕僣惍宍奜壢妛夛丒戞46夞擔杮惍宍奜壢僗億乕僣堛妛夛) (2020/12/17-19), Web奐嵜.
733143. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 昞柺嬝揹恾偵傛傞ARCR屻偵忋巿帺廳柶壸偱峴偆孭楙偺桳梡惈. 嵅乆栘廏堦1, 尒栚抭婭2, 抾撪姲恖1, 恄曐晲懃1, 崅憡徎巑2 (1儕僴價儕晹, 2惍奜): 戞17夞擔杮尐偺塣摦婡擻尋媶夛 (2020/10/9-10), 嶥杫 (僴僀僽儕僢僪奐嵜).
733144. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 恖岺屢娭愡慡抲姺弍偵偍偗傞弍屻憗婜偺曕峴懍搙夵慞偵偼醬捝偺夵慞偑娭梌偡傞. 撿棦桟懢1, 暯夑傛偟傒1, 尒堜揷榓惓1, 徏娵弮壚1, 郌扟恀崄1, 嶰暯椇懢1, 撪嶳彑暥2,3, 暉搰寬夘3, 崅暯彯怢4, 暉揷椣栫4 (1儕僴價儕晹, 2堛椕埨慡丒娗棟, 3惍奜, 4堛椕塹惗妛晹): 戞37夞恄撧愳導棟妛椕朄巑妛夛 (2020/11/22-29), Web奐嵜.
733145. [妛夛 (抧曽夛丒尋媶夛)] (堦斒島墘) 婥娗愗奐傪巤峴偟偨ALS姵幰偵懳偟, 怴偨側僐儈儏僯働乕僔儑儞庤抜偺妉摼偵岦偗, 抁偄擖堾婜娫偱堄巚揱払憰抲傪摫擖偟偨徢椺. 暉揷丂朑1, 嵅乆栘廏堦1 (1儕僴價儕晹): 戞21夞杒棦嶌嬈椕朄妛夛妛弍廤夛 (2020/12/12), Web奐嵜.
塰梴晹
[妛弍榑暥]
120049. [尨挊] 摐擜昦僇儞僶僙乕僔儑儞丒儅僢僾TM偵傛傞姶忣晧扴媦傃寣摐娗棟傊偺岠壥偺専摙. 愳忋桰巕1, 椦丂揘斖2, 恖尒杻旤巕1, 愇杮朷旤3, 戝娧宐巕3, 庣壆払旤4, 幍棦崃媊5, 嵅摗徠巕1 (1塰梴晹, 2椪専妛, 3娕岇晹, 4寬峃娗棟僙, 5撪暘斿戙幱撪): 擔杮昦懺塰梴妛夛帍 2020; 23 (2): 159-65.
120050. [尨挊] 怴婯堐帩寣塼摟愅姵幰偺旕寁夋摫擖偑擖堾帪偺塰梴忬懺偍傛傃擔忢惗妶摦嶌偵梌偊傞塭嬁. 媑揷朁巕1, 惵嶳搶屲2, 摗堜錆幚1, 怷壀桪巕1, 撪摗惓媑2, 嵅栰丂棽2, 抾撪峃梇2 (1塰梴晹, 2恡憻撪): 擔杮摟愅堛妛夛嶨帍 2021/2; 54 (2): 69-76.
120051. [尨挊] 枬惈娞幘姵偵偍偗傞僒儖僐儁僯傾偲偨傫傁偔幙愛庢検偵娭偡傞専摙. 媏抮撧曚巕1, 嫑搱惏婭2, 擔崅丂墰2 (1塰梴晹, 2徚壔婍撪): 擔杮栧柆埑槾恑徢妛夛嶨帍 2021/3; 27 (1): 34-40.
[妛夛丒尋媶夛摍]
713058. [妛夛 (崙嵺)] (堦斒島墘) Multidisciplinary Predialyis Team Education for patients with Diabetic Nephropathy, Postponed Hemodialysis Induction, and Prolonged Survival After Hemodialysis Induction. Hitomi M1, Sato T1, Moriya T2: 戞80夞暷崙摐擜昦妛夛 (ADA2020) (2020/6/12-16), web奐嵜, Diabetes 2020/6; 69 (Suppl 1): 656-P. (恖尒杻旤巕1, 嵅摗徠巕1, 庣壆払旤2: 1塰梴晹, 2寬峃娗棟僙)
722235. [妛夛 (慡崙)] (嫵堢島墘) 摐戙幱堎忢崌暪擠怭偲塰梴. 恖尒杻旤巕 (塰梴晹): 戞36夞擔杮摐擜昦丒擠怭妛夛擭師妛弍廤夛 (2020/11/14), 搶嫗.
722236. [妛夛 (慡崙)] (儚乕僋僔儑僾) 栧柆埑槾恑徢偵偍偗傞僒儖僐儁僯傾偺幚嵺偲懳嶔: 枬惈娞幘姵偵偍偗傞僒儖僐儁僯傾偲偨傫傁偔幙愛庢検偵娭偡傞専摙. 媏抮撧曚巕1, 嫑搱惏婭2, 擔崅丂墰2 (1塰梴晹, 2徚壔婍撪): 戞27夞擔杮栧柆埑槾恑徢妛夛憤夛 (2020/10/28-11/18), web奐嵜, 擔杮栧柆埑槾恑徢妛夛嶨帍 2020/10; 26 (3): 122.
722237. [妛夛 (慡崙)] (僔儞億僕僂儉) 僠乕儉偱峔抸偟偨恡堏怉儗僔僺僄儞僩偺塰梴娗棟. 媑揷朁巕1, 愇堜戝曘2, 栰岥暥擳3, 堜懞梉昉3, 怷壀桪巕1, 杒搰榓庽2, 抾撪峃梇4, 媑揷堦惉2,5 (1塰梴晹, 2斿擜婍, 3娕岇晹, 4恡憻撪, 5怴悽婭堛椕丒愭抂堛椕): 戞54夞擔杮椪彴恡堏怉妛夛 (2021/2/19), web奐嵜, 戞54夞擔杮椪彴恡堏怉妛夛僾儘僌儔儉丒彺榐廤 2020/12; p.82.
722238. [妛夛 (慡崙)] (僔儞億僕僂儉摍)亂傛偔傢偐傞僔儕乕僘: 摟愅姵幰偺塰梴娗棟亃僥乕儔乕儊僀僪側塰梴娗棟偲懡怑庬偱恡憻儕僴價儕僥乕僔儑儞傪幚慔偟傛偆. 媑揷朁巕1, 惵嶳搶屲2 (1塰梴晹, 2恡憻撪): 戞11夞擔杮恡憻儕僴價儕僥乕僔儑儞妛夛妛弍廤夛 (2021/3/20-4/30), web奐嵜, 戞11夞擔杮恡憻儕僴價儕僥乕僔儑儞妛夛僾儘僌儔儉丒彺榐廤 2021/3; p.156.
723737. [妛夛 (慡崙)] (億僗僞乕) 怘摴娻廃弍婜僒億乕僩僠乕儉偱庢傝慻傓塰梴娗棟: e癝heet摫擖偺岠壥. 媏抮撧曚巕1, 媿媣廏庽2, 嵶揷丂宩2, 榟旜恀棟垽2, 怷扟岹岝2,3, 怴尨惓戝2, 烴扟旤婱巕2, 尨揷岹婸2, 嶳壓宲巎2,4, 斾婇捈庽2 (1塰梴晹, 2忋晹徚壔娗奜, 3崙棫憡柾尨昦堾, 4怴悽婭堛椕丒墶抐揑堛椕): 戞74夞擔杮怘摴妛夛妛弍廤夛 (2020/12/10-11), 摽搰 (僴僀僽儕僢僪奐嵜), 戞74夞擔杮怘摴妛夛僾儘僌儔儉丒彺榐廤 2020/12; p.213.
723738. [妛夛 (慡崙)] (堦斒島墘) 廳徢姵幰偵偍偗傞僞儞僷僋幙搳梌検偲 儕儞僷媴尭彮徢偵偮偄偰. 怺戲嵅宐巕1,2, 曅壀桽堦3, 揷懞丂抭3, 庣壆棦嵐1, 墦摗惉巕1, 揷懞抭巕4, 嵅摗徠巕1, 榟郪彯岹2, 彫惣晀榊2 (1塰梴晹, 2搶嫗堛椕曐寬戝妛戝妛堾, 3媬柦, 4堛椕塹惗妛晹): 擔杮奜壢戙幱塰梴妛夛戞57夞妛弍廤夛 (2020/12/24), web奐嵜, 擔杮奜壢戙幱塰梴妛夛戞57夞妛弍廤夛僾儘僌儔儉丒彺榐廤 2020/12; 54 (5): 25.
昦堾昦棟晹
[妛弍榑暥]
110438. [尨挊] Cytology Reporting System for Lung Cancer from the Japan Lung Cancer Society and Japanese Society of Clinical Cytology: An Interobserver Reproducibility Study and Risk of Malignancy Evaluation on Cytology Specimens.ens. Hiroshima K, Akihiko Yoshizawa A, Takenaka A, Haba R, Kawahara K, Minami Y, Kakinuma H1, Shibuki Y, Miyake S, Kajio K, Miyamoto K, Nagatomo M, Nishimura S, Mano M, Matsubayashi J, Motoi N, Nagao T, Nakatsuka S, Yoshida T2, Satoh Y3: Acta Cytol 2020/9-10; 64 (5): 452-62. (奰徖淎朚1, 媑揷丂岟2, 嵅摗擵弐3: 1昦棟晹, 2昦棟, 3屇媧婍奜)
120052. [尨挊] 杮朚偵偍偗傞昦棟慻怐専懱屌掕庤媄偺幚懺挷嵏亅擔椪媄惛搙娗棟挷嵏傾儞働乕僩偵傛傞曬崘亅. 搶丂丂妛, 嶳壓榓栫1, 愇揷崕惉, 徏尨恀撧旤, 椦丂桾巌, 嶁崻弫堦, 楅栘弐婭, 屆壆廃堦榊 (1昦棟晹): 堛妛専嵏 2020/10; 69 (4): 660-70.
320054. [徢椺曬崘] 揮堏惈攛庮釃偑媈傢傟偨墛徢惈嬝慄堐夎嵶朎庮釃偺1椺. 楅栘榓壚撧1, 奰徖淎朚1, 嶳壓榓栫1, 嵅摗擵弐2, 堦屗徆柧3, 媑揷丂岟3, 嶰巬 怣3 (1昦棟晹, 2屇媧婍奜, 3昦棟): 恄撧愳導椪彴嵶朎妛夛帍 2020/9; 25 (1): 44-9.
[挊丂彂]
620152. [妛弍彂 (暘扴幏昅)]亂JAMT嫵杮僔儕乕僘丂昳幙曐徹丒惛搙娗棟嫵杮亃9復 昦棟慻怐専嵏, p.215-9. 嶳壓榓栫 (昦棟晹), 娔廋: 堦斒幮抍朄恖 擔杮椪彴塹惗専嵏媄巘夛, 偠傎偆, 搶嫗, 2020/11敪峴.
620153. [妛弍彂 (暘扴幏昅)]亂JAMT嫵杮僔儕乕僘丂昳幙曐徹丒惛搙娗棟嫵杮亃13復 堚揱巕専嵏丂2. 懱嵶朎堚揱巕専嵏, p.363-70. 嶳壓榓栫 (昦棟晹), 娔廋: 堦斒幮抍朄恖 擔杮椪彴塹惗専嵏媄巘夛, 偠傎偆, 搶嫗, 2020/11敪峴.
[妛夛丒尋媶夛摍]
721031. [妛夛 (慡崙)] (摿暿島墘) 僎僲儉堛椕偵岦偗偨嵶朎恌嵽椏偺桳梡惈偵偮偄偰. 嶳壓榓栫1, 媑揷丂岟2, 媣応丂庽1, 徏旜桼婭巕3, 嵅摗擵弐4, 嶰巬丂怣2 (1昦棟晹, 2昦棟, 3昦懺丒恌椕宯, 4屇媧婍奜): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20-俈/19), web奐嵜, 擔杮椪彴嵶朎妛夛嶨帍 2020/5; 59 (曗嶜1崋): 177.
723739. [妛夛 (慡崙)] (堦斒岥墘) 棏憙儔僀僨傿僢僸嵶朎庮Leydig cell tumor偺1椺. 懞揷浠幯1, 奰徖淎朚1, 嶁岥丂擡1, 嶳壓榓栫1, 崅嫶攷擵2, 妬揷嶇旤擳3, 媑揷丂岟3, 嶰巬丂怣3 (1昦棟晹, 2堛椕塹惗妛晹, 3昦棟): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20-俈/19), web奐嵜, 擔杮椪彴嵶朎妛夛嶨帍 2020/5; 59 (曗嶜1崋): 213.
723740. [妛夛 (慡崙)] (堦斒岥墘) 拞廲妘偵敪惗偟偨扙暘壔宆帀朾擏庮偺堦椺. 拞愳恗旤1, 奰徖淎朚1, 娳椦柇巕1, 嶳壓榓栫1, 嵅摗擵弐2, 堦屗徆柧3, 崅嫶攷擵4, 妬揷嶇旤擳3, 媑揷丂岟3, 嶰巬丂怣3 (1昦棟晹, 2屇媧婍奜, 3昦棟, 4堛椕塹惗妛晹): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20-俈/19), web奐嵜, 擔杮椪彴嵶朎妛夛嶨帍 2020/5; 59 (曗嶜1崋): 219.
723741. [妛夛 (慡崙)] (堦斒岥墘) 墶栦嬝擏庮偲偺娪暿偑崲擄偱偁偭偨巕媨娻擏庮偺堦椺. 奰徖桪旤巕1, 奰徖淎朚1, 拞愳恗旤1, 嶳壓榓栫1, 妬揷嶇旤擳2, 崅嫶攷擵3, 媑揷丂岟2, 嶰巬丂怣2 (1昦棟晹, 2昦棟, 3堛椕塹惗妛晹): 戞61夞擔杮椪彴嵶朎妛夛憤夛 (弔婜戝夛) (2020/6/20-俈/19), web奐嵜, 擔杮椪彴嵶朎妛夛嶨帍 2020/5; 59 (曗嶜1崋): 228.
723742. [妛夛 (慡崙)] (堦斒岥墘) 2019擭搙擔椪媄昦棟専嵏昗弨壔丒惛搙娗棟崌摨傾儞働乕僩挷嵏偺曬崘. 嶳壓榓栫1, 屆壆廃堦榊2, 愇揷崕惉3, 搶丂丂妛4, 嶁崻弫堦5, 徏尨恀撧旤6, 椦丂桾巌7, 楅栘弐婭8 (1昦棟晹, 2拀攇戝妛晅懏昦堾昦棟恌抐壢, 3峀搰戝妛堛妛晹晅懏昦堾昦棟恌抐壢, 4撈棫峴惌朄恖崙棫昦堾婡峔敓娰昦堾椪彴専嵏壢, 5惷壀導棫偙偳傕昦堾, 6帬夑堛壢戝妛堛妛晹晅懏昦堾, 7搰崻導棫拞墰昦堾 専嵏媄弍壢, 8嶳宍戝妛晬懏昦堾昦棟恌抐壢): 戞69夞擔杮堛妛専嵏妛夛 (2020/9/5-6, 10/1-31), 暉搰/web奐嵜, 堛妛専嵏 2020/9; 69 (暿嶜): 199.
723743. [妛夛 (慡崙)] (堦斒岥墘) 傾儖僊儞巁僫僩儕僂儉朄僙儖僽儘僢僋嶌惢偵偍偗傞揔惓側屌掕丒扙奃朄偺専摙. 墶嶳偄偝傒1, 娳椦柇巕1, 嶁岥丂擡1, 媣応丂庽1, 嶳壓榓栫1, 媑揷丂岟2, 嶰巬丂怣2 (1昦棟晹, 2昦棟): 戞69夞擔杮堛妛専嵏妛夛 (2020/9/5-6, 10/1-31), 暉搰/web奐嵜, 堛妛専嵏 2020/9; 69 (暿嶜): 219.
723744. [妛夛 (慡崙)] (堦斒岥墘) 婬側攛庮釃丂摉堾偱宱尡偟偨Ciliated muconodular papillary tumors偺嵶朎憸偲慻怐憸. 嶁岥丂擡1, 嶰孍彨巎2, 奰徖淎朚1, 嶳壓榓栫1, 堦屗徆柧3, 媑揷丂岟3, 嵅摗擵弐2, 嶰巬丂怣3 (1昦棟晹, 2屇媧婍奜, 3昦棟): 戞59夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2020/11/21-22, 12/11-27), 恄撧愳/web奐嵜, 擔杮椪彴嵶朎妛夛嶨帍 2020/11; 59 (曗嶜2崋): 464.
723745. [妛夛 (慡崙)] (堦斒岥墘) 憻婍墶抐揑恄宱撪暘斿庮釃偺嵶朎恌: 屇媧婍恄宱撪暘斿庮釃偺嵶朎恌. 奰徖淎朚1, 嶳壓榓栫1, 嵅摗擵弐2, 妬揷嶇旤擳3, 媑揷丂岟3, 懞塤朏庽3, 嶰巬丂怣3 (1昦棟晹, 2屇媧婍奜, 3昦棟): 戞59夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2020/11/21-22, 12/11-27), 恄撧愳/web奐嵜, 擔杮椪彴嵶朎妛夛嶨帍 2020/11; 59 (曗嶜2崋): 477.
723746. [妛夛 (慡崙)] (堦斒岥墘) 弍慜慂巋媧堷嵶朎恌偵偰悇掕偟摼偨峛忬態徤巕壔嶕忬庮釃偺1椺. 懞揷浠幯1, 奰徖淎朚1, 拞愳恗旤1, 楅栘榓壚撧1, 嶳壓榓栫1, 將帞丂墌2, 妬揷嶇旤擳3, 媑揷丂岟3, 懞塤朏庽3, 嶰巬丂怣3 (1昦棟晹, 2擼奜, 3昦棟): 戞59夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2020/11/21-22, 12/11-27), 恄撧愳/web奐嵜, 擔杮椪彴嵶朎妛夛嶨帍 2020/11; 59 (曗嶜2崋): 625.
723747. [妛夛 (慡崙)] (堦斒島墘) 攛娻嵶朎恌敾掕婎弨偺崙嵺壔傪栚巜偟偰. 撿丂桪巕, 奰徖淎朚1, 壨尨朚岝, 郌栘峃梇, 抾拞柧旤, 塇応楃師, 淎搰寶嶰, 嶰戭恀巌, 媑郪柧旻, 嵅摗擵弐2 (1昦棟晹, 2屇媧婍奜): 戞59夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2020/11/21-22, 12/11-27), 恄撧愳/Web奐嵜.
723748. [妛夛 (慡崙)] (堦斒島墘) COVID-19懳嶔偲嵶朎専嵏巑梴惉嫵堢: 尰忬偲壽戣. 惣懞桼崄棦1, 垻晹捈栫1, 嶳壓榓栫2, 崅嫶攷擵1, 嶰巬丂怣3, 嵅摗擵弐4, 屆揷楁巕1 (1堛椕塹惗妛晹, 2昦棟晹, 3昦棟, 4屇媧婍奜): 戞59夞擔杮椪彴嵶朎妛夛廐婜戝夛 (2020/11/22), 墶昹.
ME晹
[妛弍榑暥]
120053. [尨挊] 堿埑媧堷曗彆扙寣巊梡帪偺僩儔僽儖懳墳偵懳偡傞媧堷傾僂僩儗僢僩晅偒億乕僞僽儖媧堷尮傪巊梡偟偨嬞媫懳墳偵娭偡傞幚尡揑専摙. 戝搰峅擵1, 搶瀶孿堦1, 孠尨幯堖1, 揷拞桪旤1, 埳搶徦懢1, 媨抧丂娪2 (1ME晹, 2怱憻寣娗奜): 懱奜弞娐媄弍 2021/3; 48 (1): 1-11.
220004. [弨尨挊] 媧堷偍傛傃儀儞僩億儞僾偵偍偗傞埑暵搙挷惍曽朄偺峫埬. 戝搰峅擵1, 搶瀶孿堦1, 屆暯丂憦1, 晲揷復悢1, 桳攏丂巌1, 孠尨幯堖1 (1ME晹): 擔杮椪彴岺妛媄巑夛夛帍 2020/9; No.70: 76-8.
520019. [憤愢] 怴宆僐儘僫僂僀儖僗姶愼徢 (COVID-19) 偵懳偡傞ECMO娗棟. 搶瀶孿堦1,2, 埨栰丂惤1, 楅栘寬堦1, 屻摗丂晲1, 慜拞懃晲1, 栰揷惌岹1, 媨杮憦巎1, 峳栘峃岾1, 昐悾捈庽1 (1擔杮懱奜弞娐媄弍堛妛夛妛弍埾堳夛妛弍埾堳夛, 2ME晹): 懱奜弞娐媄弍 2020/10; 47 (3): 230-8.
522151. [島嵗]亂摿廤: 偳偆杊偖? 柦偺婋婡偵捈寢偡傞懱奜弞娐僩儔僽儖亃揹婥宯摑偵娭偡傞僩儔僽儖偺懳張偲埨慡懳嶔. 搶瀶孿堦1, 戝搰峅擵1 (1ME晹): Clinical Engineering 2020/11; 31 (12): 1000-7.
[妛夛丒尋媶夛摍]
732078. [妛夛 (抧曽夛丒尋媶夛)] (妛弍僙儈僫乕) 傾僽儗乕僔儑儞偺嫵堢偲嬈柋岺晇. 晲揷復悢1, 搶瀶孿堦1, 奀榁崻抭戙1, 恵摗峃巕1 (1ME晹): 戞3夞恄撧愳導椪彴岺妛夛 (2020/11/22), 墶昹, 恄撧愳導椪彴岺妛媄巑夛帍 2020/11; 32: 31.
堛椕偺幙丒埨慡悇恑幒
[妛夛丒尋媶夛摍]
723749. [妛夛 (慡崙)] (堦斒島墘) 摉堾偵偍偗傞姵幰岆擣杊巭懳嶔偺岠壥偲崱屻偺壽戣 (戞堦曬)乣堾撪曻憲幚巤慜屻偵偍偗傞姵幰岆擣妱崌偺曄壔乣. 敔揷旤抦宐1, 峳堜桳旤1, 恄丂堦柌1, 惔丂崉巑2, 扟丂岾堦1, 嶳岥晳壴1, 媏抧峅旤1, 庒椦椙梇1, 撪嶳彑暥3, 垻屆弫嵠4 (1堛椕偺幙丒埨慡悇恑幒, 2娕岇晹, 3堛椕埨慡丒娗棟, 4弞娐婍撪): 戞15夞堛椕偺幙丒埨慡妛夛妛弍廤夛 (2020/11/22), Web奐嵜.
723750. [妛夛 (慡崙)] (堦斒島墘) 恦懍側嫻崪埑敆偺僗僉儖廗摼偵徟揰傪偁偰偨摉堾偺乽BLS僗僉儖傾僢僾僙儈僫乕乿偺岠壥. 扟丂岾堦1, 撪嶳彑暥2, 敔揷旤抦宐1, 搚壆巙曐4, 惔丂崉巑3, 恄丂堦柌1, 杧峕愮宐巕3, 庒椦椙梇1, 峳堜桳旤1, 扟岥梲巕3 (1堛椕偺幙丒埨慡悇恑幒, 2堛椕埨慡丒娗棟, 3娕岇晹): 戞15夞堛椕偺幙丒埨慡妛夛妛弍廤夛 (2020/11/23), Web奐嵜.
姶愼娗棟幒
[妛弍榑暥]
522152. [島嵗]亂楢嵹: 椪彴専嵏媄巘偺偮傇傗偒亃姶愼徢. 擇杮桍怢 (姶愼娗棟幒): 婫姧帍Pipette 2020/4; 27: 1.
恌椕忣曬娗棟幒
椪彴怱棟幒
[妛弍榑暥]
110439. [尨挊] Lavender Oil Reduces Depressive Mood in Healthy Individuals and Enhances the Activity of Single Oxytocin Neurons of the Hypothalamus Isolated from Mice: A Preliminary Study. Ogata K1, Ataka K, Suzuki H, Yagi T, Okawa A, Fukumoto T, Zhang B, Nakata M, Yada T, Asakawa A: Evid Based Complement Alternat Med 2020/7; 2020: 5418586. (弿曽宑嶰榊1: 1椪彴怱棟幒)
110440. [尨挊] The relationship between premorbid intelligence and symptoms of severe anorexia nervosa restricting type. Ogata K1, Koyama K, Fukumoto T, Kawazu S, Kawamoto M, Yamaguchi E, Fuku Y, Amitani M, Amitani H, Sagiyama K, Inui A, Asakawa A: Int J Med Sci 2021/2; 18 (7): 1566-9. (弿曽宑嶰榊1: 1椪彴怱棟幒)
220005. [弨尨挊] 僊儍儞僽儖忈奞偵偍偗傞怱棟専嵏傪梡偄偨擣抦婡擻摿惈偺専徹. 弿曽宑嶰榊1, 挬憅悞暥2, 戧郪婤栴2, 弌悈楁撧2, 戝愇丂抭2, 媨壀丂摍2 (1椪彴怱棟幒, 2惛恄): 岞塿嵿抍朄恖堜擵摢昦堾尋媶婭梫椷榓堦擭搙 2020/12; P.33-6.
僩乕僞儖僒億乕僩僙儞僞乕
堏怉堛椕巟墖幒
椪彴尋媶巟墖幒
僌儘乕僶儖椪彴尋媶巟墖僙儞僞乕
[妛弍榑暥]
110441. [尨挊] The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG. Kondo E, Tabata T, Suzuki N, Aoki D, Yahata H, Kotera Y1, Tokuyama O, Fujiwara K, Kimura E, Terauchi F, Sumi T, Okamoto A, Yaegashi N, Enomoto T, Sugiyama T: J Gynecol Oncol 2020/11; 31 (6): e94. (彫帥椙晇1: 1僌儘乕僶儖椪彴尋媶巟墖僙)
110442. [尨挊] Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial. Motohashi T, Yabuno A, Michimae H, Ohishi T, Nonaka M1, Takano M, Nishio S, Fujiwara H, Fujiwara K, Kondo E, Sugiyama T, Tabata T: J Gynecol Oncol 2021/1; 32 (1): e9. )栰拞旤榓1: 1僌儘乕僶儖椪彴尋媶巟墖僙)
[妛夛丒尋媶夛摍]
723751. [妛夛 (慡崙)] (億僗僞乕) ARO偵偍偗傞儊儞僞乕惂搙幚巤偺徯夘偍傛傃, 惂搙偺摫擖慜屻偵偍偗傞摥偒堈偝偺斾妑乣尦婥偵挿婜揑偵摥偗傞壓抧嶌傝乣. 嬥巕嵐奊1, 懞忋柇巕1, 庰堜埡巕1, 愇怷媣旤巕1, 堜僲岥樞婤1 (1僌儘乕僶儖椪彴尋媶巟墖僙): 戞20夞CRC偲椪彴帋尡偺偁傝曽傪峫偊傞夛媍2020 in 挿嶈 (2020/11/3-16), WEB奐嵜, 僾儘僌儔儉丒彺榐廤 2021; p.100.
723752. [妛夛 (慡崙)] (億僗僞乕) JCTN偱偺COVID-19偺椪彴帋尡僌儖乕僾偺妶摦傊偺塭嬁偺挷嵏寢壥. 嶁杮嵅撧巬, 揷绯桼旤巕, 悪旜尗擇, 彫徏壝恖, 晲揷峎巌, 嵅摗怣栫, 釼摗柧巕, 栰拞旤榓1, 拞懞寬堦, 暉揷帯旻 (1僌儘乕僶儖椪彴尋媶巟墖僙): 戞20夞CRC偲椪彴帋尡偺偁傝曽傪峫偊傞夛媍2020 in 挿嶈 (2020/11/3-16), WEB奐嵜, 僾儘僌儔儉丒彺榐廤 2021; p.131.